Psyllid ID: psy11119

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------
Protein Sequence
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAIDS
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHcccccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccHHHHHHHHHcHHHHHccccccccccccccccccccccccccccccccccEEEccccccccHHccccccccccccccccccccccccHHHHHHHcccccccccccccccccHHHHHHHcccccccEEEcccccHHHHHHHHHHHHHHcccEEEEEcccEEEEEEEcccccEEEEEEEEEEEcccEEEEEEEccccHHHHHHHHHHHHHHccccEEEccccEEEEEcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccEEcHcccccccEcccccccccccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccEEccccccHHccHHHHHHHHHHccccccccccHHHHHccHHHHHcccHHcccccccccccHHHccccHHHcHcHHEccccccccccccccccccccccccccccccccEEccccccccHHcccHHccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEEEcccccEEEEEEEEEEEcccEEEEEEccccccHHHHHHHHHHHHHHHHHHHccccEcEEEEcc
Coil and Loop (DISEMBL)
MAQWEAQKFFRQLISGVEylhskgiahrdlkpenvLLDLQDTLKISDFGLATVFRmngkerpldkkcgtlpyvapeVLVRSylaepadiwSCGIILVAMLagelpwdkptaDCIEYLewkdnrhmqrspwdrldVNCLSLIRRIlaplpstrlniekikshrwyskhmpndivdgppssdfnstAKRMRSDLEteanracptfddracvsqpepfalrgpmsvcevephlfsfsqpthlddllvSSQFvstqstqsnqhgteasqkDDQVLRKihggggcrktlyDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKlgyswrsyspaivTISTVDSRKAQLVFKASVLTldnqtlldfrlskgcgiefkTRFLCIKRALAEdiinkpiswsvaids
Flexible Loop (DISEMBL)
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNgkerpldkkcgtlpYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEwkdnrhmqrspwDRLDVNCLSLIRRilaplpstrlniEKIKSHRWYSkhmpndivdgppssdFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLVSSQFVSTQstqsnqhgteasqkddqVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASvltldnqtlLDFRLSKGCGIEFKTRFLCIKRAlaediinkpiswsvaids
Low Complexity Region (SEG)
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLvssqfvstqstqsnqHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAIDS
Disordered region (IsUnstruct)
*****AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK*****************************************C******FALRGPMSVCEVEPHLFSFSQPTHLDDLLV**************************LRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVA***
Disordered Region (DISOPRED)
*AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND**********************************************************************************************************************************IRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSV**D*
Disordered Region (DISEMBL)
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLVSSQ*******************DDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAIDS
Disordered Region (DISPRO)
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMR**LETE*NRA********************PMSVCEVEPHLFSFSQPTHLDDLLVSSQF************************************************LFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAIDS
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAIDS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	407	2.2.26 [Sep-21-2011]
O61661	512	Serine/threonine-protein	yes	N/A	0.899	0.714	0.424	5e-87
O14757	476	Serine/threonine-protein	yes	N/A	0.877	0.75	0.412	1e-78
Q6DE87	474	Serine/threonine-protein	N/A	N/A	0.835	0.717	0.404	1e-76
Q91ZN7	476	Serine/threonine-protein	yes	N/A	0.874	0.747	0.406	2e-76
Q8AYC9	476	Serine/threonine-protein	yes	N/A	0.879	0.752	0.415	6e-76
O35280	476	Serine/threonine-protein	yes	N/A	0.874	0.747	0.401	8e-76
Q61RA2	493	Serine/threonine-protein	N/A	N/A	0.835	0.689	0.330	4e-55
Q9N3Z3	503	Serine/threonine-protein	no	N/A	0.832	0.673	0.298	7e-47
P0C198	662	Serine/threonine-protein	N/A	N/A	0.407	0.250	0.452	2e-46
P34208	496	Serine/threonine-protein	yes	N/A	0.909	0.745	0.280	3e-36

>sp|O61661|CHK1_DROME Serine/threonine-protein kinase grp OS=Drosophila melanogaster GN=grp PE=1 SV=2

 Score =  321 bits (823), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 183/431 (42%), Positives = 250/431 (58%), Gaps = 65/431 (15%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M Q EAQ++F QL+SG+ YLH +GIAHRDLKPEN+LLD  D +KISDFG+AT+FR  GKE
Sbjct: 115 MPQHEAQRYFTQLLSGLNYLHQRGIAHRDLKPENLLLDEHDNVKISDFGMATMFRCKGKE 174

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R LDK+CGTLPYVAPEVL ++Y A+PAD+WSCG+ILV MLAGELPWD+P+ +C E+  W+
Sbjct: 175 RLLDKRCGTLPYVAPEVLQKAYHAQPADLWSCGVILVTMLAGELPWDQPSTNCTEFTNWR 234

Query: 121 DNRHMQ-RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN-----DIVD 174
           DN H Q ++PW +LD   +SL+R++LA  P TRL +EK   H+W +    +     D+VD
Sbjct: 235 DNDHWQLQTPWSKLDTLAISLLRKLLATSPGTRLTLEKTLDHKWCNMQFADNERSYDLVD 294

Query: 175 GPPSSDFNS-TAKRMRSDLETEANRACPTFDDRACVSQPEP-------FALR-------- 218
              + +  S  AKR R       +        R   SQP P       F +R        
Sbjct: 295 SAAALEICSPKAKRQRLQSSAHLSNGLDDSISRNYCSQPMPTMRSDDDFNVRLGSGRSKE 354

Query: 219 --GPMSVCEVEPHL-FSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIH 275
             G       E  L +SFSQP  LDDLL+++Q   TQ+   N                  
Sbjct: 355 DGGDRQTLAQEARLSYSFSQPALLDDLLLATQMNQTQNASQN------------------ 396

Query: 276 GGGGCRKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKL-GYSWRS 334
                                 F   +RRMTRFFV    ++ +++L   +++L GY+ + 
Sbjct: 397 ---------------------YFQRLVRRMTRFFVTTRWDDTIKRLVGTIERLGGYTCKF 435

Query: 335 YSPAIVTISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDI 394
               +VT+STVD  K +LVFKA ++ +D + L+D RLSKGCG+EFK RF+ IK AL + +
Sbjct: 436 GDDGVVTVSTVDRNKLRLVFKAHIIEMDGKILVDCRLSKGCGLEFKRRFIKIKNALEDIV 495

Query: 395 INKPISWSVAI 405
           +  P +W +AI
Sbjct: 496 LKGPTTWPIAI 506

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. May phosphorylate the CDC25 phosphatase stg, which promotes its degradation. This results in increased inhibitory tyrosine phosphorylation of CDC2-cyclin complexes and consequent inhibition of cell cycle progression.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O14757|CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens GN=CHEK1 PE=1 SV=2

 Score =  293 bits (751), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 171/415 (41%), Positives = 237/415 (57%), Gaps = 58/415 (13%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280

Query: 175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHL--- 230
           G  S   +  +K ++S+L+ +  N A    + +   SQPEP   R  +S+ +  P     
Sbjct: 281 GGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEP---RTGLSLWDTSPSYIDK 337

Query: 231 ----FSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYD 286
                SFSQPT  D +L++SQ + T  +  N                             
Sbjct: 338 LVQGISFSQPTCPDHMLLNSQLLGTPGSSQNP---------------------------- 369

Query: 287 VGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVD 346
                      +   ++RMTRFF K  A+++ + L    +KLGY W+      VTIST D
Sbjct: 370 -----------WQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTD 418

Query: 347 SRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISW 401
            R  +L+FK ++L +D++ L+DFRLSKG G+EFK  FL IK  L  DI++    W
Sbjct: 419 RRNNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLI-DIVSSQKIW 472

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C. Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A. Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. Also phosphorylates NEK6. Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination. Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation. Also promotes repair of DNA cross-links through phosphorylation of FANCE. Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A. This may enhance chromatin assembly both in the presence or absence of DNA damage. May also play a role in replication fork maintenance through regulation of PCNA. May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes. May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6DE87|CHK1_XENLA Serine/threonine-protein kinase Chk1 OS=Xenopus laevis GN=chek1 PE=1 SV=2

 Score =  287 bits (734), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 166/410 (40%), Positives = 236/410 (57%), Gaps = 70/410 (17%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQKFF+QLI+GVEYLHS GI HRD+KPEN+LLD +D LKISDFGLATVFR NGKE
Sbjct: 102 MPEQDAQKFFQQLIAGVEYLHSIGITHRDIKPENLLLDERDQLKISDFGLATVFRHNGKE 161

Query: 61  RPLDKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE++  R++ A+P D+WSCGI+L AMLAGELPWD+P   C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELIKSRAFHADPVDVWSCGIVLTAMLAGELPWDQPNEVCQEYCDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS----KHMPNDIVDG 175
           K+  H   +PW ++    L+L+ ++L   P +R+ I  IK  RW++    K +    V  
Sbjct: 222 KEKNHY-LTPWKKISATPLALLCKMLTENPQSRITIPDIKKDRWFTEIIKKGLKRSRVIS 280

Query: 176 PPSSDFNSTAKRMRSDLE------TEANRACPTFDDRACVSQPEPFALRGPMSVCE---- 225
             SSD +   K++RSD++      +E   A  +       +QPEP   R  ++  +    
Sbjct: 281 GGSSDSSVLCKQIRSDIDISHFSHSEEKTALSS-------TQPEP---RTALATWDSNSS 330

Query: 226 -----VEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGC 280
                V+    SFSQP   D++L++SQ + T  +  N            V +++      
Sbjct: 331 YIDNLVQGKGISFSQPACPDNMLLNSQLIGTPGSSQN------------VWQRL------ 372

Query: 281 RKTLYDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIV 340
                                ++RMTRFF K  AE +   L    +K+GY  +      V
Sbjct: 373 ---------------------VKRMTRFFTKVNAESSYSNLMDTCEKMGYVLKKSCANEV 411

Query: 341 TISTVDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRAL 390
           T+ST D R  +L+FK +++ ++++ LLDFRLSKG G+EFK  FL IK+ +
Sbjct: 412 TLSTTDRRNNKLIFKVNLVEMEDRILLDFRLSKGDGLEFKRHFLKIKKKM 461

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Phosphorylates wee1 at 'Ser-549' and cdc25c at 'Ser-287', which creates binding sites for 14-3-3 proteins which activate wee1 and inhibit cdc25c. Phosphorylates cdc25a at 'Ser-504' which prevents the interaction of cdc25a with CDK2-cyclin E1, CDC2-cyclin A1 and CDC2-cyclin B1. This inhibitory effect does not require 14-3-3 protein binding. Activation of wee1 and inhibition of CDC25 results in increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and consequent inhibition of cell cycle progression. May promote DNA repair, regulate chromatin assembly and the transcription of genes that regulate cell-cycle progression. May also play a role in replication fork maintenance.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91ZN7|CHK1_RAT Serine/threonine-protein kinase Chk1 OS=Rattus norvegicus GN=Chek1 PE=2 SV=1

 Score =  286 bits (732), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 169/416 (40%), Positives = 237/416 (56%), Gaps = 60/416 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRHNNRE 161

Query: 61  RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K + N     P ++
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL-NRGAKRPRAT 279

Query: 180 ------DFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEP---- 228
                   +  +K + S+L+ +  N      + +   SQPEP   R  +S+ +  P    
Sbjct: 280 SGGMSESSSGFSKHIHSNLDFSPINSGSSEENVKFSSSQPEP---RTGLSLWDTGPSNVD 336

Query: 229 ---HLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLY 285
                 SFSQPT  D +LV+SQ + T  +  N                            
Sbjct: 337 KLVQGISFSQPTCPDHMLVNSQLLGTPGSSQNP--------------------------- 369

Query: 286 DVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTV 345
                       +   ++RMTRFF K  A+++ + L    +KLGY W+      VT+ST+
Sbjct: 370 ------------WQRLVKRMTRFFTKLDADKSYQCLKETFEKLGYQWKKSCMNQVTVSTM 417

Query: 346 DSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISW 401
           D R  +L+FK +++ +D + L+DFRLSKG G+EFK  FL IK  L+ DI++    W
Sbjct: 418 DRRNNKLIFKINLVEMDEKILVDFRLSKGDGLEFKRHFLKIKGKLS-DIVSSQKVW 472

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. This inhibits their activity through proteasomal degradation, nucleo-cytoplasmic shuttling and inhibition by proteins of the 13-3-3 family. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. Also phosphorylates NEK6. Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination. Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation. Also promotes repair of DNA cross-links through phosphorylation of FANCE. Binds to and phosphorylates TLK1, which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A. This may enhance chromatin assembly both in the presence or absence of DNA damage. May also play a role in replication fork maintenance through regulation of PCNA. May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes. May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8AYC9|CHK1_CHICK Serine/threonine-protein kinase Chk1 OS=Gallus gallus GN=CHEK1 PE=1 SV=1

 Score =  285 bits (728), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 172/414 (41%), Positives = 239/414 (57%), Gaps = 56/414 (13%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EAQ+FF+QLI+GV YLHS GI HRDLKPEN+LLD +D LKISDFGLATVF+ NG+E
Sbjct: 102 MPEPEAQRFFQQLIAGVVYLHSMGITHRDLKPENLLLDERDNLKISDFGLATVFKHNGRE 161

Query: 61  RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L R  + AEP D+W+CG++L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLRRPEFRAEPVDVWACGVVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
           K+ R    +PW ++D   L+L+ +IL   P+ R+ I  IK  RWY + +      G  SS
Sbjct: 222 KE-RKTYLAPWRKIDSAPLALLHKILTENPTARITIPDIKKDRWYCRPLKKGTKRGRVSS 280

Query: 180 DF-----NSTAKRMRSDLETEANRACPTFDDRAC--VSQPEPFALRGPM---SVCEVEPH 229
                   +  K +RSD +    ++    +D+A    SQPEP    G +   S   ++  
Sbjct: 281 GGVTESPGALPKHIRSDTDFSPVKSA-LGEDKASYSTSQPEP-GTGGALWDSSTGSIDRL 338

Query: 230 L--FSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDV 287
           +   SFSQP   + +L++SQ + T  +         SQ   Q L                
Sbjct: 339 VQGISFSQPACPEHMLLNSQLLGTPGS---------SQSPWQRL---------------- 373

Query: 288 GQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDS 347
                         +RRMTRFF K  A+ +   L  + +K+GY W+      VTIST D 
Sbjct: 374 --------------VRRMTRFFTKLDADGSYRSLRDVCEKMGYGWKQSCTNQVTISTTDR 419

Query: 348 RKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISW 401
           R  +L+FK ++L ++++ L+DFRLSKG G+EFK  FL IK  L+ D+++    W
Sbjct: 420 RNNKLIFKVNLLEMESRILVDFRLSKGDGLEFKRHFLKIKGKLS-DVVSTQKVW 472

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. This inhibits their activity through proteasomal degradation, nucleo-cytoplasmic shuttling and inhibition by proteins of the 13-3-3 family. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May promote DNA repair, regulate chromatin assembly and the transcription of genes that regulate cell-cycle progression. May also play a role in replication fork maintenance.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O35280|CHK1_MOUSE Serine/threonine-protein kinase Chk1 OS=Mus musculus GN=Chek1 PE=1 SV=2

 Score =  284 bits (727), Expect = 8e-76,   Method: Compositional matrix adjust.
 Identities = 167/416 (40%), Positives = 235/416 (56%), Gaps = 60/416 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRHNNRE 161

Query: 61  RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K + N     P ++
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVETPSARITIPDIKKDRWYNKPL-NRGAKRPRAT 279

Query: 180 ------DFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEP---- 228
                   +  +K + S+L+ +  N        +   SQPEP   R  +S+ +  P    
Sbjct: 280 SGGMSESSSGFSKHIHSNLDFSPVNNGSSEETVKFSSSQPEP---RTGLSLWDTGPSNVD 336

Query: 229 ---HLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLY 285
                 SFSQPT  + +LV+SQ + T  +  N                            
Sbjct: 337 KLVQGISFSQPTCPEHMLVNSQLLGTPGSSQNP--------------------------- 369

Query: 286 DVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTV 345
                       +   ++RMTRFF K  A+++ + L    +KLGY W+      VT+ST 
Sbjct: 370 ------------WQRLVKRMTRFFTKLDADKSYQCLKETFEKLGYQWKKSCMNQVTVSTT 417

Query: 346 DSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISW 401
           D R  +L+FK +++ +D + L+DFRLSKG G+EFK  FL IK  L+ D+++    W
Sbjct: 418 DRRNNKLIFKINLVEMDEKILVDFRLSKGDGLEFKRHFLKIKGKLS-DVVSSQKVW 472

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. This inhibits their activity through proteasomal degradation, nucleo-cytoplasmic shuttling and inhibition by proteins of the 13-3-3 family. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. Also phosphorylates NEK6. Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination. Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation. Also promotes repair of DNA cross-links through phosphorylation of FANCE. Binds to and phosphorylates TLK1, which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A. This may enhance chromatin assembly both in the presence or absence of DNA damage. May also play a role in replication fork maintenance through regulation of PCNA (By similarity). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes. May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q61RA2|CHK1_CAEBR Serine/threonine-protein kinase chk-1 OS=Caenorhabditis briggsae GN=chk-1 PE=3 SV=1

 Score =  215 bits (548), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 129/390 (33%), Positives = 192/390 (49%), Gaps = 50/390 (12%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           AQ +FRQLI G++Y+H   I HRD+KPEN+LL     LKISDFG+AT++R  GKER LD 
Sbjct: 127 AQFYFRQLIEGLKYIHDCDIVHRDIKPENLLLTTSHVLKISDFGMATLYRNEGKERLLDL 186

Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
            CGT+PY APEV     Y   P D+WS GI+L+AML GELPWD+ +     YL+W  N +
Sbjct: 187 SCGTIPYAAPEVCAGGKYRGPPIDVWSSGIVLIAMLTGELPWDRASDSSYAYLQWLGNNN 246

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNST 184
           +  +PW ++DV  L ++RRIL      R  IE+IK+  W++ +       G     +   
Sbjct: 247 LDENPWRKMDVRALCMLRRILTDNVHRRATIEQIKTDPWFTHNY------GKLEMTYGRP 300

Query: 185 AKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLV 244
            KR R   E   +    +      VS  +   L  P  V  VE    SFSQPT  +DLL+
Sbjct: 301 LKRARYADENSPDCNISSTQQADAVSTAKRRHLETPDKVAHVERQNASFSQPTRTEDLLL 360

Query: 245 SSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIRR 304
           +                + SQ +  +L ++                           + R
Sbjct: 361 TQNI-------------DMSQNNTNLLERM---------------------------VCR 380

Query: 305 MTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLDNQ 364
           MTRF  K+    +  +L    +  GY  R  +   + ++    R+  ++     L  +++
Sbjct: 381 MTRFCTKFDVPTSYRQLIHASEHAGYEVRQTADNRLLVTF---REVSMMVTLYSLKTESR 437

Query: 365 TLLDFRLSKGCGIEFKTRFLCIKRALAEDI 394
            ++DFR S+G GI+FK  FL ++  + + I
Sbjct: 438 VMVDFRRSRGDGIQFKKMFLEVRNRMNDSI 467

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. Required for checkpoint mediated cell cycle arrest in response to DNA damage in germline cells. Essential for embryogenesis.

Caenorhabditis briggsae (taxid: 6238)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9N3Z3|CHK1_CAEEL Serine/threonine-protein kinase chk-1 OS=Caenorhabditis elegans GN=chk-1 PE=2 SV=2

 Score =  188 bits (477), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 120/402 (29%), Positives = 189/402 (47%), Gaps = 63/402 (15%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           AQ +F+QLI G++++H   + HRD+KPEN+LL     LKISDFG+AT++R  G+ER LD 
Sbjct: 127 AQFYFKQLICGLKFIHDNDVVHRDIKPENLLLTGTHVLKISDFGMATLYRNKGEERLLDL 186

Query: 66  KCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
            CGT+PY APE+   + Y   P D+WS GI+L+AML GELPWD+ +     Y+ W  N  
Sbjct: 187 SCGTIPYAAPELCAGKKYRGPPVDVWSSGIVLIAMLTGELPWDRASDASQSYMGWISNTS 246

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNST 184
           +   PW ++DV  L ++R+I+      R  IE+I++  WY  +       G   +     
Sbjct: 247 LDERPWKKIDVRALCMLRKIVTDKTDKRATIEQIQADPWYQHNF------GQVETPNGRP 300

Query: 185 AKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCE-----VEPHLFSFSQPTHL 239
            KR R++ E           +  C  Q E  A R  +          E    SFSQPT  
Sbjct: 301 LKRARNNDE-----------NITCTQQAECSAKRRHLETPNEKSTLAERQNASFSQPTKT 349

Query: 240 DDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFS 299
           +DLL++            QH  + SQ +  +L+++                         
Sbjct: 350 EDLLLT------------QH-IDMSQTNSNLLQRM------------------------- 371

Query: 300 CHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVL 359
             + RMTRF V        +K+    +  G+  R      + ++  +      ++    +
Sbjct: 372 --VCRMTRFCVVTDIRSTYQKVARASEHAGFGVRETDDYRLLVTWREVSMMVSLYTMGDI 429

Query: 360 TLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISW 401
               + ++DFR S+G GI+FK  F+ ++  + E I     +W
Sbjct: 430 PDKPRVMVDFRRSRGDGIQFKKMFMDVRNRMHEWICTDGNNW 471

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. Required for checkpoint mediated cell cycle arrest in response to DNA damage in germline cells. Essential for embryogenesis.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C198|CHK1_USTMA Serine/threonine-protein kinase CHK1 OS=Ustilago maydis (strain 521 / FGSC 9021) GN=CHK1 PE=3 SV=1

 Score =  186 bits (473), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 76/168 (45%), Positives = 117/168 (69%), Gaps = 2/168 (1%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A  +F+QL++G+EY+HS+G+ HRD+KPEN+LLD +  LKI+DFGL +V++  GKER L  
Sbjct: 170 AHFYFQQLLAGLEYIHSQGVTHRDIKPENMLLDAEGNLKIADFGLCSVYKYKGKERELTG 229

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CG+LPY+APE+  + Y  EP D+WS G++L AML G  PWD+PT+   EY  ++  +  
Sbjct: 230 ACGSLPYIAPEMNGKPYRGEPVDVWSSGVVLFAMLVGSTPWDEPTSRSPEYSAYRTGKLF 289

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           +  PW R+  + LSL+++++ P P  R+  E I+ HRW+ +   ND++
Sbjct: 290 EYDPWPRIPQDALSLLKKMMHPTPEKRITFEGIRRHRWFKR--ANDLM 335

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles.

Ustilago maydis (strain 521 / FGSC 9021) (taxid: 237631)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P34208|CHK1_SCHPO Serine/threonine-protein kinase chk1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=chk1 PE=1 SV=2

 Score =  152 bits (385), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 114/406 (28%), Positives = 181/406 (44%), Gaps = 36/406 (8%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           AQ +F QL+ G+ ++HSKG+AHRDLKPEN+LLD    LKISDFG A++F   GK R L+ 
Sbjct: 114 AQFYFAQLMEGISFMHSKGVAHRDLKPENILLDYNGNLKISDFGFASLFSYKGKSRLLNS 173

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RH 124
             G+ PY APE+  + Y     D+WSCGIIL A+L G  PWD+  ++  +YL +K     
Sbjct: 174 PVGSPPYAAPEI-TQQYDGSKVDVWSCGIILFALLLGNTPWDEAISNTGDYLLYKKQCER 232

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNST 184
               PW+ L     S+I  +L   P  R +++ +  H W +   P    +G   +D  + 
Sbjct: 233 PSYHPWNLLSPGAYSIITGMLRSDPFKRYSVKHVVQHPWLTSSTPFRTKNG-NCADPVAL 291

Query: 185 AKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQPTHLDDLLV 244
           A R+   L  + ++  P             F++  P          F  +    LD + V
Sbjct: 292 ASRLMLKLRIDLDK--PRLASSRASQNDSGFSMTQPA---------FKKNDQKELDRVEV 340

Query: 245 SSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCR------KTLYDVGQAGLLVAILF 298
                       N   TE  +KD  + +     G  +      K  Y++           
Sbjct: 341 YGALSQPVQLNKNIDVTEILEKDPSLSQFCENEGFIKRLAKKAKNFYEI----------- 389

Query: 299 SCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRS---YSPAIVTISTVDSRKAQLVFK 355
            C   R+TRF+ + + E  ++ L   L  L  S       +  I+ ++  D RK  L   
Sbjct: 390 -CPPERLTRFYSRASRETIIDHLYDSLRLLAISVTMKYVRNQTILYVNLHDKRKCLLQGV 448

Query: 356 ASVLTLD-NQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPIS 400
             +  L  N  L++F    G  +E++  F  +  ++ + I+   +S
Sbjct: 449 IELTNLGHNLELINFIKRNGDPLEWRKFFKNVVSSIGKPIVLTDVS 494

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. Binds to and phosphorylates CDC25. This leads to negative regulation of CDC25 and prevents mitotic entry.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
158297035	505	AGAP008118-PA [Anopheles gambiae str. PE	0.879	0.708	0.461	7e-99
66525079	467	PREDICTED: serine/threonine-protein kina	0.877	0.764	0.466	4e-97
346474086	499	hypothetical protein [Amblyomma maculatu	0.886	0.723	0.467	4e-96
383861035	466	PREDICTED: serine/threonine-protein kina	0.874	0.763	0.464	2e-95
350403903	470	PREDICTED: serine/threonine-protein kina	0.872	0.755	0.463	3e-95
321476736	489	hypothetical protein DAPPUDRAFT_43327 [D	0.874	0.728	0.450	3e-95
340725398	470	PREDICTED: serine/threonine-protein kina	0.882	0.763	0.458	4e-95
427796729	483	Putative checkpoint kinase 1, partial [R	0.882	0.743	0.473	4e-95
307193503	454	Serine/threonine-protein kinase grp [Har	0.842	0.755	0.470	7e-94
242014250	469	cAMP-dependent protein kinase catalytic	0.847	0.735	0.460	5e-91

>gi|158297035|ref|XP_317338.4| AGAP008118-PA [Anopheles gambiae str. PEST] gi|157015001|gb|EAA12568.4| AGAP008118-PA [Anopheles gambiae str. PEST]

 Score =  367 bits (941), Expect = 7e-99,   Method: Compositional matrix adjust.
 Identities = 194/420 (46%), Positives = 269/420 (64%), Gaps = 62/420 (14%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EAQ++F QL++GV+YLH++G+AHRDLKPEN+LLD  D +KISDFG+AT+FRM G+ER LD
Sbjct: 123 EAQRYFNQLLAGVDYLHTRGVAHRDLKPENLLLDEHDNVKISDFGMATMFRMKGRERLLD 182

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
           KKCGTLPYVAPEVLV+ Y A PAD+WSCGIILV MLAGELPWD+P++ C EYL WK+N++
Sbjct: 183 KKCGTLPYVAPEVLVKPYRATPADLWSCGIILVTMLAGELPWDQPSSGCAEYLCWKENKY 242

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK--HMPN-----------D 171
              +PW +LD   LSL+R+IL   P+ RL ++K++ H+W     H+             D
Sbjct: 243 TTSTPWCKLDTLTLSLLRKILVANPAQRLTLDKLQDHKWCQTQFHLQGGAGAGGAAGGCD 302

Query: 172 IVDGPPSSDFNSTAKRMRSDLETEANRACPTFDD---RACVSQPEPFALRGPMSVCE--V 226
           ++DG PS      AKR+ S+ +  +       DD   R C SQP P  +   M+  E  +
Sbjct: 303 VIDGRPS----PRAKRLCSNQDISS-----PLDDSISRMCHSQPVPMTVHTEMNGVEEAI 353

Query: 227 EP-HLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLY 285
           E  + F FSQPT LDDL++ +Q   TQS      GT+  Q++                  
Sbjct: 354 EARNGFCFSQPTMLDDLILCTQLNPTQSV-----GTQQQQQNP----------------- 391

Query: 286 DVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTV 345
                       F   +RRMTRFFV    +E +++L  +L+KLGY W+S    ++TIST+
Sbjct: 392 ------------FQRLVRRMTRFFVSTRCDETLKRLSAVLEKLGYGWKSNDEGVITISTI 439

Query: 346 DSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           D RK QL+FKA+++ +D + L DFRLSKGCG+EFK RF+ IK++LA+ ++  P++W +AI
Sbjct: 440 DRRKLQLIFKANIVEMDGKILCDFRLSKGCGLEFKRRFIKIKQSLADIVMKGPVTWPIAI 499

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|66525079|ref|XP_623436.1| PREDICTED: serine/threonine-protein kinase grp isoform 2 [Apis mellifera] gi|380016394|ref|XP_003692170.1| PREDICTED: serine/threonine-protein kinase grp-like [Apis florea]

 Score =  361 bits (926), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 191/409 (46%), Positives = 254/409 (62%), Gaps = 52/409 (12%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M  WEAQK+F+QLISG+EYLHSKGIAHRDLKPEN+LLD  D LK+SDFG+AT++R+ GKE
Sbjct: 101 MPIWEAQKYFKQLISGIEYLHSKGIAHRDLKPENLLLDEHDNLKVSDFGMATIYRLQGKE 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R L+K+CGTLPYVAPEVL+R Y AEPADIWSCGIILVA+L GELPWD+  A+C EY+ W+
Sbjct: 161 RCLEKRCGTLPYVAPEVLLRPYHAEPADIWSCGIILVALLTGELPWDQSLAECPEYMAWR 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
           D ++M  +PW +LD + LSLI+ IL   P +R  I+ IK HRW+ K              
Sbjct: 221 DGKYMSLTPWKKLDNSSLSLIKNILMHSPQSRFTIKNIKQHRWFIKKF----------QK 270

Query: 181 FNSTAKRMRSDLETEANRACPTFD-DRACVSQPEPFALRGPMSV---CEVEPHLFSFSQP 236
             +    +R D ET++ +     +  R C+SQPE  A+    +V    E  P  FSFSQP
Sbjct: 271 AGNIEGYIRPD-ETDSRQIIEDENLTRFCLSQPELPAIENTNTVEINLEERPG-FSFSQP 328

Query: 237 THLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAI 296
            H++DLL+ +Q  + Q TQ++Q  T                                   
Sbjct: 329 AHIEDLLLCTQVQTKQFTQTSQQNT----------------------------------- 353

Query: 297 LFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKA 356
            F   +RRMTRFFVK   E  V++L   L    Y++R  +   +TIS VD RK  LVFKA
Sbjct: 354 -FQRLVRRMTRFFVKTELETTVKRLINCLKDENYTYRISNFGTITISGVDRRKMPLVFKA 412

Query: 357 SVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           +++ +D + L+DFRLSKGCG+EFK RF+ IK  L + I+  P++W +A+
Sbjct: 413 NIVEMDGKILVDFRLSKGCGLEFKRRFVKIKSLLEDIILKGPVTWPIAV 461

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|346474086|gb|AEO36887.1| hypothetical protein [Amblyomma maculatum]

 Score =  357 bits (917), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 193/413 (46%), Positives = 261/413 (63%), Gaps = 52/413 (12%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           Q +AQ++FRQ+ISGVEYLHSKG+AHRDLKPEN+LLD  D +KISDFGLATVFR  G+ER 
Sbjct: 123 QADAQRYFRQIISGVEYLHSKGVAHRDLKPENILLDANDNVKISDFGLATVFRFRGEERL 182

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
           L K+CGTLPY+APEVLV+ Y AEPADIWSCG+ILVA+L GELPWDKP A C EY +WK+ 
Sbjct: 183 LVKRCGTLPYIAPEVLVKQYHAEPADIWSCGVILVALLGGELPWDKPAASCTEYKDWKEC 242

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM-PNDIVDGPPSSDF 181
           + +   PW +LD   LSL+R+IL P P  R  IE+IK+H+W  KH+ P +      +S  
Sbjct: 243 K-ITVPPWSKLDNAVLSLLRKILMPSPGKRYTIEQIKNHQWMKKHLKPKNTNSKWLASGA 301

Query: 182 NSTAKRMRSDLETEANRACPTFDD---RACVSQPEPF-ALRGPM-----SVCEVEPHLFS 232
           +S A R +S  +   +    T DD   R   SQP+P  +L  P      +  E+  H+ S
Sbjct: 302 DSLA-RKKSCFDI-GHSGDATRDDTITRLSSSQPDPVRSLEEPGQELAPAAKELAQHIIS 359

Query: 233 FSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGL 292
           FSQP  LDD+L+S+Q + TQ +         SQ   Q L                     
Sbjct: 360 FSQPAQLDDMLLSTQTLGTQGS---------SQTPLQKL--------------------- 389

Query: 293 LVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQL 352
                    ++RMTRFFV   A++ +E+L  + ++LGY+W++ S   +T++T D RKAQL
Sbjct: 390 ---------VKRMTRFFVTTDAQQTLEELKSLFERLGYTWKTNSFGQITVTTQDKRKAQL 440

Query: 353 VFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           VFKAS++ +  + L+DFRLS+G G+EFK  F+ I+  L+E I   P+SW +A+
Sbjct: 441 VFKASLIEMSAKILVDFRLSRGDGLEFKKHFVIIRNHLSEHIAKGPVSWPIAV 493

Source: Amblyomma maculatum

Species: Amblyomma maculatum

Genus: Amblyomma

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383861035|ref|XP_003705992.1| PREDICTED: serine/threonine-protein kinase grp-like [Megachile rotundata]

 Score =  355 bits (912), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 190/409 (46%), Positives = 252/409 (61%), Gaps = 53/409 (12%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M  WEAQK+F+QLIS VEYLHSKGIAHRDLKPEN+LLD  D LK+SDFGLAT++R+ GKE
Sbjct: 101 MPAWEAQKYFKQLISAVEYLHSKGIAHRDLKPENLLLDENDNLKVSDFGLATIYRLQGKE 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R L+K+CGTLPYVAPEVL+  Y AEPADIWSCGIILVA+LAGELPWD+  A+C EY+ W+
Sbjct: 161 RYLEKRCGTLPYVAPEVLLHPYHAEPADIWSCGIILVALLAGELPWDQSLAECPEYMAWR 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN-DIVDGPPSS 179
           D ++M  +PW +LD + LSLI+ IL   PS R  I+ IK HRW+ K       ++G    
Sbjct: 221 DGKYMSLTPWKKLDNSSLSLIKNILIHSPSARCTIKDIKKHRWFVKKFQRAGTIEGYIRP 280

Query: 180 DFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSV---CEVEPHLFSFSQP 236
           D  ++ + +  +  T           R C+SQPE        +V    E  P  FSFSQP
Sbjct: 281 DETNSRQVLEDENLT-----------RFCLSQPELPTTENANAVQINLEERPG-FSFSQP 328

Query: 237 THLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAI 296
            H++DLL+ +Q V T+ TQ++Q  T                                   
Sbjct: 329 AHIEDLLLCTQ-VQTKFTQASQQNT----------------------------------- 352

Query: 297 LFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKA 356
            F   +RRMTRFFVK   +E + +L   L    Y+ R  +   +T+ST+D RK  LVFKA
Sbjct: 353 -FQRLVRRMTRFFVKTELDETINRLVNCLKNESYNCRINNVGTITVSTMDRRKMPLVFKA 411

Query: 357 SVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           +++ +D + L+DFRLSKGCG+EFK RF+ IK  L + I+  P++W +A+
Sbjct: 412 NIVEMDGKILVDFRLSKGCGLEFKRRFVKIKSLLEDIILKGPVTWPIAV 460

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350403903|ref|XP_003486943.1| PREDICTED: serine/threonine-protein kinase grp-like [Bombus impatiens]

 Score =  355 bits (910), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 192/414 (46%), Positives = 253/414 (61%), Gaps = 59/414 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M  WEAQK+F+QLIS +EYLHSKGIAHRDLKPEN+LLD  D LK+SDFGLAT++R+ GKE
Sbjct: 101 MPIWEAQKYFKQLISAIEYLHSKGIAHRDLKPENLLLDEHDNLKVSDFGLATIYRLQGKE 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R L+K+CGTLPYVAPEVL+ +Y AEPADIWSCGIILVA+L+GELPWD+  ADC EY+ W+
Sbjct: 161 RCLEKRCGTLPYVAPEVLLCAYHAEPADIWSCGIILVALLSGELPWDQSLADCPEYMAWR 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN-DIVDG---P 176
           D ++M  +PW +LD + LSL++ +L   P TR  I+ IK HRW+ K       V+G   P
Sbjct: 221 DGKYMSLTPWKKLDNSSLSLLKNVLMHAPVTRYTIKDIKQHRWFVKKFQEAGSVEGYIRP 280

Query: 177 PSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHL-----F 231
             +DF +  + ++ +  T           R C+SQPE   L G  +   VE +L     F
Sbjct: 281 DETDFENRRQAIQDENLT-----------RFCLSQPE---LPGVENANPVEINLEERPGF 326

Query: 232 SFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAG 291
           SFSQP H++DLL+ +Q  + Q TQ++Q  T                              
Sbjct: 327 SFSQPAHIEDLLLCTQVQNKQFTQTSQQNT------------------------------ 356

Query: 292 LLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQ 351
                 F   +RRMTRFFVK   E  V++L   L    Y+ R  +   +T++  D RK  
Sbjct: 357 ------FQRLVRRMTRFFVKTDLETTVKRLLNYLKNENYTCRINNFGTITVTANDRRKMP 410

Query: 352 LVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           LVFK +V  +D + L+DFRLSKGCG+EFK  F+ IK  L E I+  PI+W VA+
Sbjct: 411 LVFKVNVFEMDGKILVDFRLSKGCGLEFKRIFVKIKSLLEEIILKGPITWPVAV 464

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321476736|gb|EFX87696.1| hypothetical protein DAPPUDRAFT_43327 [Daphnia pulex]

 Score =  355 bits (910), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 188/417 (45%), Positives = 257/417 (61%), Gaps = 61/417 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M Q EAQ++F+QLI+GV YLHS+GIAHRD+KPEN+LLD  D LKISDFG+ATVFR  G+E
Sbjct: 114 MPQVEAQRYFKQLIAGVSYLHSRGIAHRDIKPENLLLDANDNLKISDFGMATVFRFQGRE 173

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R LDK+CGTLPY+APEVL R Y AEPADIWSCG++LVAMLAGELPWD P+ DC  Y  WK
Sbjct: 174 RHLDKRCGTLPYIAPEVLCRKYAAEPADIWSCGVVLVAMLAGELPWDVPSNDCPLYTSWK 233

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
           + + + R PW ++D   LSL+R++L PLP  R  I++I +H+W+ K    ++        
Sbjct: 234 ECQ-ITRLPWTKIDTLALSLLRKVLMPLPGKRYTIQQITNHQWFQKKFKENM-------- 284

Query: 181 FNSTAKRMRSDLETEANRACPTFD-DRACVSQPEPFALRGPMSVCE------VEPH---- 229
               +KR+ SD+  +A  + P+ D      SQP      G   V +       EP+    
Sbjct: 285 --PVSKRLCSDV-VDAGLSPPSSDATHLSYSQPGLGFFSGSQPVHQNDTNDDQEPNKHLP 341

Query: 230 --LFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDV 287
             +FSFSQP H+DD+L++SQ ++TQ+                                  
Sbjct: 342 GAMFSFSQPAHIDDMLLNSQ-LNTQTA--------------------------------- 367

Query: 288 GQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDS 347
             +G  ++      ++RMTR   K + EEA++ L   L KLGY+W+ ++P +VTIST D 
Sbjct: 368 --SGSSISSPLQRLVKRMTRLVAKVSCEEAIKHLSQQLIKLGYTWKIHTPGVVTISTQDR 425

Query: 348 RKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVA 404
           RK QLVFKA+V  +    LLDFRLS+GCG++FK  FL IK  LA+ + + P++WS+A
Sbjct: 426 RKMQLVFKATVYDMQTMVLLDFRLSRGCGLDFKRHFLAIKHKLADILCSAPVTWSIA 482

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340725398|ref|XP_003401057.1| PREDICTED: serine/threonine-protein kinase grp-like [Bombus terrestris]

 Score =  354 bits (909), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 188/410 (45%), Positives = 247/410 (60%), Gaps = 51/410 (12%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M  WEAQK+F+QLIS +EYLHSKGIAHRDLKPEN+LLD  D LK+SDFGLAT++R+ GKE
Sbjct: 101 MPIWEAQKYFKQLISAIEYLHSKGIAHRDLKPENLLLDEHDNLKVSDFGLATIYRLQGKE 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R L+K+CGTLPYVAPEVL+ +Y AEPADIWSCGIILVA+L+GELPWD+  ADC EY+ W+
Sbjct: 161 RCLEKRCGTLPYVAPEVLLCAYHAEPADIWSCGIILVALLSGELPWDQSLADCPEYMAWR 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
           D ++M  +PW +LD + LSL++ +L   P TR  I+ IK HRW+ K             +
Sbjct: 221 DGKYMSLTPWKKLDNSSLSLLKNVLMHSPVTRYTIKDIKQHRWFVKKF----------QE 270

Query: 181 FNSTAKRMRSDLETEANRACPTFDD---RACVSQPEPFALR--GPMSVCEVEPHLFSFSQ 235
             S    +R D     NR   T D+   R C+SQPE   +    P+ +   E   FSFSQ
Sbjct: 271 AGSVEGYIRPDETDFENRRQATQDENITRFCLSQPELPGVENANPVEINLEERSGFSFSQ 330

Query: 236 PTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVA 295
           P H++DLL+ +Q  + Q TQ++Q  T                                  
Sbjct: 331 PAHIEDLLLCTQVQNKQFTQTSQQNT---------------------------------- 356

Query: 296 ILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFK 355
             F   +RRMTRFFVK   E  V++L        Y+ R  +   +T++  D RK  LVFK
Sbjct: 357 --FQRLVRRMTRFFVKTDLETTVKRLLNYFKNENYTCRINNFGTITVTANDRRKMPLVFK 414

Query: 356 ASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
            +V  +D + L+DFRLSKGCG+EFK  F+ IK  L E I+  PI+W +A+
Sbjct: 415 VNVFEMDGKILVDFRLSKGCGLEFKRIFVKIKSLLEEIILKGPITWPIAV 464

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|427796729|gb|JAA63816.1| Putative checkpoint kinase 1, partial [Rhipicephalus pulchellus]

 Score =  354 bits (909), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 193/408 (47%), Positives = 259/408 (63%), Gaps = 49/408 (12%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           AQK+F+Q+++GVEYLH+KG+AHRDLKPEN+LLD  DT+KISDFG+ATVFR  G+ER L K
Sbjct: 111 AQKYFKQIMAGVEYLHAKGVAHRDLKPENILLDANDTIKISDFGMATVFRFRGEERLLVK 170

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
           +CGTLPY+APEVLV+ Y AEPADIWSCG+ILVA+L GELPWDKP+A C EY +WKD + +
Sbjct: 171 RCGTLPYIAPEVLVKQYRAEPADIWSCGVILVALLGGELPWDKPSACCQEYKDWKDCK-I 229

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP--PSSDFNS 183
              PW +LD   LSL+R+IL P P+ R  IE+IK+H+W  K + +   +     SS  + 
Sbjct: 230 TVPPWSKLDNAVLSLLRKILMPNPAKRYTIEQIKNHQWMKKVLKSKNANTKWLGSSADSH 289

Query: 184 TAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGP------MSVCEVEPHLFSFSQPT 237
           T K    D+   A+ +      R   SQP+P   RG        S  +V     SFSQP 
Sbjct: 290 TRKVSCFDIGQAADASRDDTITRLSSSQPDPLR-RGVEPSLELASDADVLAQRVSFSQPA 348

Query: 238 HLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAIL 297
           HLDD+L+S+Q   TQ TQS      +SQ   Q L                          
Sbjct: 349 HLDDMLLSTQ---TQGTQS------SSQTPLQRL-------------------------- 373

Query: 298 FSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKAS 357
               ++RMTRFFV   A++ VE+L  + ++LGYSW++ SP  +T++T D RKAQLVFKAS
Sbjct: 374 ----VKRMTRFFVTTDAQQTVEELKSLFERLGYSWKTNSPGQITVTTQDKRKAQLVFKAS 429

Query: 358 VLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWSVAI 405
           ++ +  + L+DFRLS+G G+EFK  F+ I+  L+E I   P+SW +A+
Sbjct: 430 LIEMSAKILVDFRLSRGDGLEFKKHFVIIRGHLSEHIAKGPVSWPIAV 477

Source: Rhipicephalus pulchellus

Species: Rhipicephalus pulchellus

Genus: Rhipicephalus

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307193503|gb|EFN76280.1| Serine/threonine-protein kinase grp [Harpegnathos saltator]

 Score =  350 bits (898), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 193/410 (47%), Positives = 251/410 (61%), Gaps = 67/410 (16%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M +++AQK+FRQLISGVEYLH +G+AHRDLKPEN+LLD  D LKISDFGLAT++R+ GKE
Sbjct: 101 MPRYQAQKYFRQLISGVEYLHGRGVAHRDLKPENLLLDGNDNLKISDFGLATIYRLQGKE 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R L+KKCGTLPYVAPE+L R+YLAEPADIWSCGIILVA+L+GELPWDK +A+C EY+ WK
Sbjct: 161 RHLEKKCGTLPYVAPEILERTYLAEPADIWSCGIILVALLSGELPWDKASAECPEYVAWK 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
           + ++M  +PW +LD   LSLI+ ILA  PS R  I  IK HRW+              + 
Sbjct: 221 NGKYMSLTPWKKLDNTSLSLIKNILADSPSARYKIADIKQHRWF-------------VTS 267

Query: 181 FNSTAKRMRSDLETEANRACPTFDD---RACVSQPEPFALRGPMSVCEVEPHL-----FS 232
           FN      R D E +      T D+     C+SQPE   L G  S   ++ +L     FS
Sbjct: 268 FN------RGD-EPDGRNPAYTEDENLRNVCLSQPE---LPGMESNSVIQFNLNGRPAFS 317

Query: 233 FSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGL 292
           FSQP H++DLL+ +Q  + Q TQ +Q  T         L+K+                  
Sbjct: 318 FSQPAHVEDLLLCTQLQAMQQTQPSQQNT---------LQKL------------------ 350

Query: 293 LVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQL 352
                    +RRMTRFFVK    + +++L  +  K  YS R      VTIST+D RK  L
Sbjct: 351 ---------VRRMTRFFVKTECGDVIKRLMRICAKENYSCRVNECGTVTISTIDRRKMTL 401

Query: 353 VFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKPISWS 402
           VFK + + +D   L+DFRLSKGCG+EFK  F+ I+ AL + I+   I++S
Sbjct: 402 VFKVNFIDMDGNILVDFRLSKGCGLEFKKAFIKIRSALEDVILRNSIAYS 451

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242014250|ref|XP_002427804.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212512273|gb|EEB15066.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis]

 Score =  341 bits (874), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 190/413 (46%), Positives = 248/413 (60%), Gaps = 68/413 (16%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M  WEAQK+F QLISGVEYLHS+G++HRD+KPEN+LLD  D +KISDFG+AT+FR NG E
Sbjct: 102 MKLWEAQKYFVQLISGVEYLHSRGVSHRDIKPENILLDDNDNVKISDFGMATLFRKNGIE 161

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
           R LDKKCGT+PYVAPEVL+R Y A PAD+WSCGI+LVAMLAGELPWD P + C E+  WK
Sbjct: 162 RLLDKKCGTMPYVAPEVLLRPYKAAPADVWSCGIVLVAMLAGELPWDVPASTCKEFSLWK 221

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
           +N  +  SPW++L+ + L+L+++IL PLP  RL   +I  HRW SK  PN+    P   +
Sbjct: 222 NNI-ITHSPWNKLNNSVLNLLKKILIPLPDKRLTASQILKHRWCSKIYPNE----PVQVN 276

Query: 181 FNSTAKRMRSDLETEANRACPTFD-DRACVSQPEPFALRGPMSVCEVEPH---------- 229
               +KR+ S  E   + +    +  R C SQP P         C+ E +          
Sbjct: 277 ITPASKRLYSGSELAPSMSASEEEFSRYCFSQPAP-------QFCDSEGNKGKFEKDDDD 329

Query: 230 LFS-----FSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTL 284
           L+S     FSQP H+DDLL+SSQ  STQ+   +                           
Sbjct: 330 LYSNKIVCFSQPVHIDDLLLSSQLHSTQTAALD--------------------------- 362

Query: 285 YDVGQAGLLVAILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTIST 344
              G   L         IRRMTRFFV   AE A++K+  +L+    SW+   P I+T +T
Sbjct: 363 ---GYQNL---------IRRMTRFFVTVDAETAIKKVVDVLESSACSWKRGPPFILTFTT 410

Query: 345 VDSRKAQLVFKASVLTLDNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINK 397
           +D RK  L+FK SV+ ++ + LLDFRLS+GCG+EFK  FL +K  L EDI+ K
Sbjct: 411 IDRRKNNLIFKTSVVEMNGKVLLDFRLSRGCGLEFKKLFLLVKEKL-EDILLK 462

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
FB|FBgn0261278	512	grp "grapes" [Drosophila melan	0.525	0.417	0.524	1.6e-87
UNIPROTKB|E7EPP6	492	CHEK1 "Serine/threonine-protei	0.587	0.485	0.470	7.5e-76
UNIPROTKB|O14757	476	CHEK1 "Serine/threonine-protei	0.587	0.502	0.470	7.5e-76
UNIPROTKB|F1PUR2	435	CHEK1 "Uncharacterized protein	0.587	0.549	0.474	9.6e-76
RGD|620545	476	Chek1 "checkpoint kinase 1" [R	0.592	0.506	0.474	2.5e-75
MGI|MGI:1202065	476	Chek1 "checkpoint kinase 1" [M	0.592	0.506	0.470	6.7e-75
UNIPROTKB|A5D7V1	476	CHEK1 "CHEK1 protein" [Bos tau	0.584	0.5	0.476	1.4e-74
UNIPROTKB|F1S774	478	CHEK1 "Uncharacterized protein	0.587	0.5	0.467	2.3e-74
UNIPROTKB|Q8AYC9	476	CHEK1 "Serine/threonine-protei	0.520	0.445	0.509	3.7e-74
UNIPROTKB|Q6DE87	474	chek1 "Serine/threonine-protei	0.589	0.506	0.486	4.1e-73

FB|FBgn0261278 grp "grapes" [Drosophila melanogaster (taxid:7227)]

 Score = 608 (219.1 bits), Expect = 1.6e-87, Sum P(3) = 1.6e-87
 Identities = 116/221 (52%), Positives = 151/221 (68%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M Q EAQ++F QL+SG+ YLH +GIAHRDLKPEN+LLD  D +KISDFG+AT+FR  GKE
Sbjct:   115 MPQHEAQRYFTQLLSGLNYLHQRGIAHRDLKPENLLLDEHDNVKISDFGMATMFRCKGKE 174

Query:    61 RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
             R LDK+CGTLPYVAPEVL ++Y A+PAD+WSCG+ILV MLAGELPWD+P+ +C E+  W+
Sbjct:   175 RLLDKRCGTLPYVAPEVLQKAYHAQPADLWSCGVILVTMLAGELPWDQPSTNCTEFTNWR 234

Query:   121 DNRHMQ-RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN-----DIVD 174
             DN H Q ++PW +LD   +SL+R++LA  P TRL +EK   H+W +    +     D+VD
Sbjct:   235 DNDHWQLQTPWSKLDTLAISLLRKLLATSPGTRLTLEKTLDHKWCNMQFADNERSYDLVD 294

Query:   175 GPPSSDFNST-AKRMRSDLETEANRACPTFDDRACVSQPEP 214
                + +  S  AKR R       +        R   SQP P
Sbjct:   295 SAAALEICSPKAKRQRLQSSAHLSNGLDDSISRNYCSQPMP 335

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;TAS

GO:0006468 "protein phosphorylation" evidence=ISS;NAS

GO:0005634 "nucleus" evidence=IDA

GO:0000077 "DNA damage checkpoint" evidence=ISS;IMP;TAS

GO:0007348 "regulation of syncytial blastoderm mitotic cell cycle" evidence=IMP;TAS

GO:0007049 "cell cycle" evidence=IMP

GO:0004672 "protein kinase activity" evidence=ISS;NAS

GO:0000075 "cell cycle checkpoint" evidence=ISS;TAS

GO:0007349 "cellularization" evidence=TAS

GO:0007093 "mitotic cell cycle checkpoint" evidence=TAS

GO:0001700 "embryonic development via the syncytial blastoderm" evidence=TAS

GO:0007444 "imaginal disc development" evidence=TAS

GO:0009314 "response to radiation" evidence=TAS

GO:0016321 "female meiosis chromosome segregation" evidence=IMP

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0030162 "regulation of proteolysis" evidence=TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0051225 "spindle assembly" evidence=IMP

GO:0051299 "centrosome separation" evidence=IMP

GO:0042060 "wound healing" evidence=IMP

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IGI;IMP

GO:0033314 "mitotic DNA replication checkpoint" evidence=IMP

UNIPROTKB|E7EPP6 CHEK1 "Serine/threonine-protein kinase Chk1" [Homo sapiens (taxid:9606)]

 Score = 563 (203.2 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 121/257 (47%), Positives = 163/257 (63%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:   118 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 177

Query:    61 RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   178 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 237

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct:   238 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 296

Query:   175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLF-- 231
             G  S   +  +K ++S+L+ +  N A    + +   SQPEP   R  +S+ +  P     
Sbjct:   297 GGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEP---RTGLSLWDTSPSYIDK 353

Query:   232 -----SFSQPTHLDDLL 243
                  SFSQPT  D +L
Sbjct:   354 LVQGISFSQPTCPDHML 370

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|O14757 CHEK1 "Serine/threonine-protein kinase Chk1" [Homo sapiens (taxid:9606)]

 Score = 563 (203.2 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 121/257 (47%), Positives = 163/257 (63%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:   102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query:    61 RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct:   222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280

Query:   175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLF-- 231
             G  S   +  +K ++S+L+ +  N A    + +   SQPEP   R  +S+ +  P     
Sbjct:   281 GGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEP---RTGLSLWDTSPSYIDK 337

Query:   232 -----SFSQPTHLDDLL 243
                  SFSQPT  D +L
Sbjct:   338 LVQGISFSQPTCPDHML 354

GO:0005524 "ATP binding" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0005657 "replication fork" evidence=IEA

GO:0033261 "regulation of S phase" evidence=IEA

GO:0042127 "regulation of cell proliferation" evidence=IEA

GO:0071313 "cellular response to caffeine" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000077 "DNA damage checkpoint" evidence=IDA;IMP

GO:0006281 "DNA repair" evidence=IMP

GO:0071260 "cellular response to mechanical stimulus" evidence=IEP

GO:0006974 "response to DNA damage stimulus" evidence=IMP

GO:0031572 "G2 DNA damage checkpoint" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0006975 "DNA damage induced protein phosphorylation" evidence=IDA

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=IDA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0000794 "condensed nuclear chromosome" evidence=IDA

GO:0046602 "regulation of mitotic centrosome separation" evidence=IDA

GO:0045839 "negative regulation of mitosis" evidence=IDA

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=IDA

GO:0000785 "chromatin" evidence=ISS

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=ISS

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=ISS

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=ISS

GO:0000075 "cell cycle checkpoint" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0006260 "DNA replication" evidence=TAS

GO:0000781 "chromosome, telomeric region" evidence=IDA

GO:0090399 "replicative senescence" evidence=NAS

GO:0035407 "histone H3-T11 phosphorylation" evidence=IDA

UNIPROTKB|F1PUR2 CHEK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 566 (204.3 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 122/257 (47%), Positives = 163/257 (63%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:    61 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDDRDNLKISDFGLATVFRHNNRE 120

Query:    61 RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   121 RLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 180

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct:   181 KEKK-TYLNPWKKIDSAPLALLHKILVENPSVRITIPDIKKDRWYNKPLKKGAKRPRVTS 239

Query:   175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLF-- 231
             G  S   +  +K ++S+L+ +  N A    + +   SQPEP   R  +SV +  P     
Sbjct:   240 GGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEP---RTGLSVWDTSPSYIDK 296

Query:   232 -----SFSQPTHLDDLL 243
                  SFSQPT  D +L
Sbjct:   297 LVQGISFSQPTCPDHML 313

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=IEA

GO:0046602 "regulation of mitotic centrosome separation" evidence=IEA

GO:0045839 "negative regulation of mitosis" evidence=IEA

GO:0042127 "regulation of cell proliferation" evidence=IEA

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=IEA

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=IEA

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005657 "replication fork" evidence=IEA

GO:0000794 "condensed nuclear chromosome" evidence=IEA

GO:0000785 "chromatin" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

RGD|620545 Chek1 "checkpoint kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 560 (202.2 bits), Expect = 2.5e-75, Sum P(2) = 2.5e-75
 Identities = 121/255 (47%), Positives = 163/255 (63%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:   102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRHNNRE 161

Query:    61 RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI-----VD 174
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +           
Sbjct:   222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLNRGAKRPRATS 280

Query:   175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEP---FAL--RGPMSVCEVEP 228
             G  S   +  +K + S+L+ +  N      + +   SQPEP    +L   GP +V ++  
Sbjct:   281 GGMSESSSGFSKHIHSNLDFSPINSGSSEENVKFSSSQPEPRTGLSLWDTGPSNVDKLVQ 340

Query:   229 HLFSFSQPTHLDDLL 243
              + SFSQPT  D +L
Sbjct:   341 GI-SFSQPTCPDHML 354

GO:0000077 "DNA damage checkpoint" evidence=ISO;ISS

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA;ISO

GO:0000781 "chromosome, telomeric region" evidence=IEA;ISO

GO:0000785 "chromatin" evidence=ISO;ISS

GO:0000794 "condensed nuclear chromosome" evidence=ISO;ISS

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0005634 "nucleus" evidence=ISO;ISS

GO:0005657 "replication fork" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;ISS

GO:0006281 "DNA repair" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0006974 "response to DNA damage stimulus" evidence=ISO;ISS

GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISO;IMP

GO:0010468 "regulation of gene expression" evidence=ISO

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=ISO;ISS

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=ISO;ISS

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISO;ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO;IMP

GO:0033261 "regulation of S phase" evidence=IMP

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=ISO;ISS

GO:0035407 "histone H3-T11 phosphorylation" evidence=ISO;ISS

GO:0042127 "regulation of cell proliferation" evidence=IEA;ISO

GO:0045839 "negative regulation of mitosis" evidence=ISO;ISS

GO:0046602 "regulation of mitotic centrosome separation" evidence=ISO;ISS

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=ISO;ISS

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA;ISO

GO:0071310 "cellular response to organic substance" evidence=IEP

GO:0071313 "cellular response to caffeine" evidence=IEP

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=ISO;ISS

MGI|MGI:1202065 Chek1 "checkpoint kinase 1" [Mus musculus (taxid:10090)]

 Score = 558 (201.5 bits), Expect = 6.7e-75, Sum P(2) = 6.7e-75
 Identities = 120/255 (47%), Positives = 162/255 (63%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:   102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRHNNRE 161

Query:    61 RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI-----VD 174
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +           
Sbjct:   222 KEKK-TYLNPWKKIDSAPLALLHKILVETPSARITIPDIKKDRWYNKPLNRGAKRPRATS 280

Query:   175 GPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEP---FAL--RGPMSVCEVEP 228
             G  S   +  +K + S+L+ +  N        +   SQPEP    +L   GP +V ++  
Sbjct:   281 GGMSESSSGFSKHIHSNLDFSPVNNGSSEETVKFSSSQPEPRTGLSLWDTGPSNVDKLVQ 340

Query:   229 HLFSFSQPTHLDDLL 243
              + SFSQPT  + +L
Sbjct:   341 GI-SFSQPTCPEHML 354

GO:0000077 "DNA damage checkpoint" evidence=ISO;IDA;IMP

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000785 "chromatin" evidence=IDA

GO:0000794 "condensed nuclear chromosome" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005657 "replication fork" evidence=IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0006281 "DNA repair" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IMP;IDA

GO:0006974 "response to DNA damage stimulus" evidence=ISO;IDA

GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0010468 "regulation of gene expression" evidence=IGI

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=ISO

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISO

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0033261 "regulation of S phase" evidence=ISO

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=ISO;IDA

GO:0035407 "histone H3-T11 phosphorylation" evidence=ISO

GO:0042127 "regulation of cell proliferation" evidence=IMP

GO:0045839 "negative regulation of mitosis" evidence=ISO

GO:0046602 "regulation of mitotic centrosome separation" evidence=ISO

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=IMP

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=IDA

UNIPROTKB|A5D7V1 CHEK1 "CHEK1 protein" [Bos taurus (taxid:9913)]

 Score = 555 (200.4 bits), Expect = 1.4e-74, Sum P(2) = 1.4e-74
 Identities = 123/258 (47%), Positives = 160/258 (62%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct:   102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRHNNRE 161

Query:    61 RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP DIWSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELLKRKEFHAEPVDIWSCGIVLTAMLAGELPWDQPSDSCQEYCDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM------PNDIV 173
             K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K        P    
Sbjct:   222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSVRITISDIKKDRWYNKPFKKGAKRPRATS 280

Query:   174 DGPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLF- 231
              G   S     +K ++S+L+ +  N A      +   SQPEP   R  +S+ +  P    
Sbjct:   281 SGVSESP-GGFSKHIQSNLDFSPVNCASSEESVKYSSSQPEP---RTGLSLWDTSPSYID 336

Query:   232 ------SFSQPTHLDDLL 243
                   SFSQPT  D +L
Sbjct:   337 KLVQGISFSQPTCPDHML 354

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=IEA

GO:0046602 "regulation of mitotic centrosome separation" evidence=IEA

GO:0045839 "negative regulation of mitosis" evidence=IEA

GO:0042127 "regulation of cell proliferation" evidence=IEA

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=IEA

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=IEA

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005657 "replication fork" evidence=IEA

GO:0000794 "condensed nuclear chromosome" evidence=IEA

GO:0000785 "chromatin" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1S774 CHEK1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 554 (200.1 bits), Expect = 2.3e-74, Sum P(2) = 2.3e-74
 Identities = 121/259 (46%), Positives = 163/259 (62%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNG 58
             M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +  D LKISDFGLATVFR N 
Sbjct:   102 MPEQDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERGLDNLKISDFGLATVFRHNN 161

Query:    59 KERPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
             +ER L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY 
Sbjct:   162 RERLLNKMCGTLPYVAPELLKRKEFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYC 221

Query:   118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----I 172
             +WK+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +
Sbjct:   222 DWKEKK-TYLNPWKKIDSAPLALLHKILVENPSVRITIPDIKKDRWYNKPLKKGAKRPRV 280

Query:   173 VDGPPSSDFNSTAKRMRSDLE-TEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLF 231
               G  S   +  +K ++S+L+ +  N A    + +   SQPEP   R  +S+ +  P   
Sbjct:   281 TSGGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEP---RTGLSLWDTSPSYI 337

Query:   232 -------SFSQPTHLDDLL 243
                    SFSQPT  D +L
Sbjct:   338 DKLVQGISFSQPTCPDHML 356

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=IEA

GO:0046602 "regulation of mitotic centrosome separation" evidence=IEA

GO:0045839 "negative regulation of mitosis" evidence=IEA

GO:0042127 "regulation of cell proliferation" evidence=IEA

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=IEA

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=IEA

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005657 "replication fork" evidence=IEA

GO:0000794 "condensed nuclear chromosome" evidence=IEA

GO:0000785 "chromatin" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q8AYC9 CHEK1 "Serine/threonine-protein kinase Chk1" [Gallus gallus (taxid:9031)]

 Score = 550 (198.7 bits), Expect = 3.7e-74, Sum P(2) = 3.7e-74
 Identities = 113/222 (50%), Positives = 149/222 (67%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + EAQ+FF+QLI+GV YLHS GI HRDLKPEN+LLD +D LKISDFGLATVF+ NG+E
Sbjct:   102 MPEPEAQRFFQQLIAGVVYLHSMGITHRDLKPENLLLDERDNLKISDFGLATVFKHNGRE 161

Query:    61 RPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE+L R  + AEP D+W+CG++L AMLAGELPWD+P+  C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELLRRPEFRAEPVDVWACGVVLTAMLAGELPWDQPSDSCQEYSDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
             K+ R    +PW ++D   L+L+ +IL   P+ R+ I  IK  RWY + +      G  SS
Sbjct:   222 KE-RKTYLAPWRKIDSAPLALLHKILTENPTARITIPDIKKDRWYCRPLKKGTKRGRVSS 280

Query:   180 DF-----NSTAKRMRSDLETEANRACPTFDDRAC--VSQPEP 214
                     +  K +RSD +    ++    +D+A    SQPEP
Sbjct:   281 GGVTESPGALPKHIRSDTDFSPVKSA-LGEDKASYSTSQPEP 321

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000724 "double-strand break repair via homologous recombination" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006281 "DNA repair" evidence=TAS

GO:0006302 "double-strand break repair" evidence=TAS

GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISS

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=ISS

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISS

GO:0045839 "negative regulation of mitosis" evidence=ISS

GO:0046602 "regulation of mitotic centrosome separation" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0000794 "condensed nuclear chromosome" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0000077 "DNA damage checkpoint" evidence=ISS

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=ISS

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=ISS

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=ISS

GO:0000785 "chromatin" evidence=ISS

GO:0035407 "histone H3-T11 phosphorylation" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0006974 "response to DNA damage stimulus" evidence=ISS

UNIPROTKB|Q6DE87 chek1 "Serine/threonine-protein kinase Chk1" [Xenopus laevis (taxid:8355)]

 Score = 561 (202.5 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
 Identities = 124/255 (48%), Positives = 166/255 (65%)

Query:     1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             M + +AQKFF+QLI+GVEYLHS GI HRD+KPEN+LLD +D LKISDFGLATVFR NGKE
Sbjct:   102 MPEQDAQKFFQQLIAGVEYLHSIGITHRDIKPENLLLDERDQLKISDFGLATVFRHNGKE 161

Query:    61 RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             R L+K CGTLPYVAPE++  R++ A+P D+WSCGI+L AMLAGELPWD+P   C EY +W
Sbjct:   162 RLLNKMCGTLPYVAPELIKSRAFHADPVDVWSCGIVLTAMLAGELPWDQPNEVCQEYCDW 221

Query:   120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS----KHMPNDIVDG 175
             K+  H   +PW ++    L+L+ ++L   P +R+ I  IK  RW++    K +    V  
Sbjct:   222 KEKNHYL-TPWKKISATPLALLCKMLTENPQSRITIPDIKKDRWFTEIIKKGLKRSRVIS 280

Query:   176 PPSSDFNSTAKRMRSDLETEANRACPTFDDRACVS-QPEP-FALR---GPMSVCE--VEP 228
               SSD +   K++RSD++   +    + +  A  S QPEP  AL       S  +  V+ 
Sbjct:   281 GGSSDSSVLCKQIRSDIDI--SHFSHSEEKTALSSTQPEPRTALATWDSNSSYIDNLVQG 338

Query:   229 HLFSFSQPTHLDDLL 243
                SFSQP   D++L
Sbjct:   339 KGISFSQPACPDNML 353

GO:0000077 "DNA damage checkpoint" evidence=ISS

GO:0000785 "chromatin" evidence=ISS

GO:0000794 "condensed nuclear chromosome" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0006974 "response to DNA damage stimulus" evidence=ISS

GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISS

GO:0010569 "regulation of double-strand break repair via homologous recombination" evidence=ISS

GO:0010767 "regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage" evidence=ISS

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0035402 "histone kinase activity (H3-T11 specific)" evidence=ISS

GO:0035407 "histone H3-T11 phosphorylation" evidence=ISS

GO:0045839 "negative regulation of mitosis" evidence=ISS

GO:0046602 "regulation of mitotic centrosome separation" evidence=ISS

GO:0048096 "chromatin-mediated maintenance of transcription" evidence=ISS

GO:2000615 "regulation of histone H3-K9 acetylation" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q91ZN7	CHK1_RAT	2, ., 7, ., 1, 1, ., 1	0.4062	0.8746	0.7478	yes	N/A
O14757	CHK1_HUMAN	2, ., 7, ., 1, 1, ., 1	0.4120	0.8771	0.75	yes	N/A
O61661	CHK1_DROME	2, ., 7, ., 1, 1, ., 1	0.4245	0.8992	0.7148	yes	N/A
O35280	CHK1_MOUSE	2, ., 7, ., 1, 1, ., 1	0.4014	0.8746	0.7478	yes	N/A
Q8AYC9	CHK1_CHICK	2, ., 7, ., 1, 1, ., 1	0.4154	0.8796	0.7521	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	407
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-35
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-30
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-25
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-24
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-21
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-21
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-20
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-17
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-17
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.002
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.004
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (441), Expect = 1e-51
 Identities = 60/159 (37%), Positives = 84/159 (52%), Gaps = 3/159 (1%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA+ + RQ++S +EYLHSKGI HRDLKPEN+LLD    +K++DFGLA       K   L 
Sbjct: 98  EARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LT 154

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
              GT  Y+APEVL+     +  DIWS G+IL  +L G+ P+         + +    + 
Sbjct: 155 TFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP 214

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               P   +      LIR++L   P  RL  E+   H +
Sbjct: 215 PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  161 bits (410), Expect = 5e-47
 Identities = 61/165 (36%), Positives = 81/165 (49%), Gaps = 8/165 (4%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            EA+K   Q++ G+EYLHS GI HRDLKPEN+LLD    +KI+DFGLA     +     L
Sbjct: 98  DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSL 155

Query: 64  DKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIILVAMLAGELPW-DKPTAD---CIEYLE 118
               GT  Y+APEVL   +      D+WS G+IL  +L G+ P+  +   D    I  + 
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL 215

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                      W         LI++ L   PS R   E+I  H W
Sbjct: 216 GPPLEFD-EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  128 bits (323), Expect = 5e-35
 Identities = 55/160 (34%), Positives = 76/160 (47%), Gaps = 39/160 (24%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERP 62
            E  +   Q++ G+EYLHS GI HRDLKPEN+LLD     +K++DFGL+    +   +  
Sbjct: 92  DEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSL 149

Query: 63  LDKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           L    GT  Y+APEVL  + Y +E +DIWS G+IL      ELP                
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY-----ELPE--------------- 189

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                             LIR++L   P  R + ++I  H
Sbjct: 190 ---------------LKDLIRKMLQKDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 3e-31
 Identities = 54/158 (34%), Positives = 82/158 (51%), Gaps = 13/158 (8%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++  +EYLHS GI +RDLKPEN+LLD    +K++DFGLA     +   R  +  CGT  
Sbjct: 101 EIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRT-NTFCGTPE 158

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPW- 130
           Y+APEVL+     +  D WS G++L  ML G+ P+       I        + ++     
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI------YEKILKDPLRF 212

Query: 131 -DRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWY 164
            + L      LI  +L   P+ RL     E+IK+H ++
Sbjct: 213 PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (295), Expect = 2e-30
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 11/162 (6%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +K+ RQ++ G+ YLHS GI HRD+K  N+L+D    +K++DFG A               
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW---DKPTADCIEYLEWKDNR 123
            GT  ++APEV+        ADIWS G  ++ M  G+ PW     P A       +K   
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGS 218

Query: 124 HMQRSPW--DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +  P   + L       +R+ L   P  R   +++  H +
Sbjct: 219 SGE-PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  117 bits (294), Expect = 3e-30
 Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 11/164 (6%)

Query: 5   EAQKFFR-QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           E  KF+  +++  +EYLHSKGI HRD+KP+N+LLD Q  + I+DF +AT       +   
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLT 156

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
               GT  Y+APEVL R   +   D WS G+     L G+ P+   +    + +  K   
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET 216

Query: 124 HMQRSP--WDRLDVNCLSLIRRILAPLPSTRL--NIEKIKSHRW 163
                P  W       +  I ++L   P  RL  N++ +K+H +
Sbjct: 217 ADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (284), Expect = 7e-29
 Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 17/172 (9%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT---VFRMNGKERP 62
           A+ +  +++  +EYLHS GI HRDLKP+N+L+D    LK++DFGL+    V R       
Sbjct: 95  ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154

Query: 63  LDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             +     GT  Y+APEV++    ++  D WS G IL   L G  P+   T + I     
Sbjct: 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---- 210

Query: 120 KDNRHMQRSPWDRLDV---NCLSLIRRILAPLPSTRL---NIEKIKSHRWYS 165
             N    +  W          + LI ++L P P  RL   +IE+IK+H ++ 
Sbjct: 211 -QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  112 bits (282), Expect = 2e-28
 Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 26/175 (14%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +++  +EYLHSKGI HRDLKPEN+LLD    +KI+DFG A V   N              
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 67  -------------CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC 113
                         GT  YV+PE+L      + +D+W+ G I+  ML G+ P+       
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226

Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----EKIKSHRWY 164
            EYL ++    ++ S       +   LI ++L   P  RL +    +++K+H ++
Sbjct: 227 -EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (275), Expect = 6e-27
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 17/203 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERP- 62
           EA     Q++S +EYLHSKGI HRD+KPEN+LLD     +K+ DFGLA +    G     
Sbjct: 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Query: 63  ---LDKKCGTLPYVAPEVLVRSYLAEP---ADIWSCGIILVAMLAGELPWDKPTADCIEY 116
                   GT  Y+APEVL+   LA     +DIWS GI L  +L G  P++         
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221

Query: 117 LEWKDNR---------HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
              K             +  S  + +      L++++LA  P  RL+     SH   +  
Sbjct: 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281

Query: 168 MPNDIVDGPPSSDFNSTAKRMRS 190
              +          +S   R+  
Sbjct: 282 KLKESDLSDLLKPDDSAPLRLSL 304

Length = 384

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  103 bits (259), Expect = 3e-25
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 30/188 (15%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + + + R L+ GV Y+H+ GI HRDLKP N+L+     LKI+DFGLA +F    + R   
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYS 158

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE--LPWDK------------ 108
            +  T  Y APE+L   R Y     D+W+ G I   +L G    P +             
Sbjct: 159 HQVATRWYRAPELLYGARKYDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL 217

Query: 109 --PT-ADCIEYLEWKD-----NRHMQRSPWDRLDVNC----LSLIRRILAPLPSTRLNIE 156
             P            D         +  P + +  +     L L++ +L   PS RL+  
Sbjct: 218 GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277

Query: 157 KIKSHRWY 164
           +   H ++
Sbjct: 278 EALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 28/166 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----C 67
           Q++  +EYLHS  I +RDLKPEN+LLD    +KI+DFG A         + +  +    C
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA---------KRVKGRTYTLC 159

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY---LEWKDNRH 124
           GT  Y+APE+++     +  D W+ GI++  MLAG  P+       I Y   LE K    
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-YEKILEGK---- 214

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           ++   +     +   LIR +L    + RL      +  IK+H W++
Sbjct: 215 VRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 56/172 (32%), Positives = 87/172 (50%), Gaps = 10/172 (5%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             ++ A+ +   ++   EYLH++GI +RDLKPEN+LLD    +K+ DFG A   +   K 
Sbjct: 90  FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE-YLEW 119
                 CGT  YVAPE+++        D WS GI+L  +L G  P+ +   D +E Y + 
Sbjct: 150 WTF---CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
                    P + +D     LI+++L   P  RL      I+ IK H+W++ 
Sbjct: 207 LKGNGKLEFP-NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 7e-25
 Identities = 41/100 (41%), Positives = 56/100 (56%), Gaps = 3/100 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             +    QL+ G+ Y HS  I HRDLKP+N+L++    LK++DFGLA  F +    R   
Sbjct: 99  LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI--PLRTYT 156

Query: 65  KKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE 103
            +  TL Y APE+L+ S     A DIWS G I   M+ G+
Sbjct: 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 1e-24
 Identities = 42/89 (47%), Positives = 56/89 (62%), Gaps = 3/89 (3%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQL+ GV++LHS  I HRDLKP+N+L+     +KI+DFGLA ++     E  L     TL
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTL 170

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAM 99
            Y APEVL++S  A P D+WS G I   +
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 3/95 (3%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           ++L+ G+EYLHS GI HRD+K  N+LL     +K+ DFGL+   +++   +  +   GT 
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLS-DTKARNTMVGTP 161

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV+        ADIWS GI  + +  G+ P
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 22/172 (12%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
            W A+++  +++ GVE LH +GI HRD+KPEN+L+D    LK++DFGL+     N     
Sbjct: 97  DW-AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI------EY 116
             K  GT  Y+APE ++     + +D WS G ++   L G  P+   T D +        
Sbjct: 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN---IEKIKSHRWYS 165
           + W +      SP        + LI R+L   P+ RL     ++IKSH ++ 
Sbjct: 210 INWPEEVKEFCSP------EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 61/184 (33%), Positives = 92/184 (50%), Gaps = 35/184 (19%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN-------- 57
           A+ +F + +  +EYLH+ GI HRDLKP+N+L+     +K++DFGL+ +  M+        
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162

Query: 58  ----GKERPLDKK-CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPT 110
                    LDK+ CGT  Y+APEV++R    +P D W+ GIIL   L G +P+  D P 
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222

Query: 111 A-------DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI---EKIKS 160
                   D IE+ E            + L  +   LI R+L   P  RL      ++K 
Sbjct: 223 ELFGQVISDDIEWPEGD----------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272

Query: 161 HRWY 164
           HR++
Sbjct: 273 HRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.1 bits (234), Expect = 5e-22
 Identities = 42/108 (38%), Positives = 66/108 (61%), Gaps = 8/108 (7%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F RQ++ G+ YLH++GI HRD+K  N+L+D +  +KISDFG++     N         RP
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT 110
             +  G++ ++APEV+ ++     ADIWS G ++V ML G+ P+   T
Sbjct: 171 SLQ--GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 40/92 (43%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+ + HS GI HRDLKPEN+L++ +  LK++DFGLA  F      RP      T  
Sbjct: 106 QLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG--SPVRPYTHYVVTRW 163

Query: 72  YVAPEVLVRS-YLAEPADIWSCGIILVAMLAG 102
           Y APE+L+     + P DIWS G I   +L+ 
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 2/96 (2%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           + +QL+ G++YLHS GI HRD+K  N+L++    LK++DFGLA  +           +  
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVI 163

Query: 69  TLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE 103
           TL Y  PE+L+ +    P  D+WS G IL  +  G+
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 40/105 (38%), Positives = 56/105 (53%), Gaps = 5/105 (4%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLD 64
           + +  QL+ G+ YLHS GI HRD+KP N+ LD    +K+ DFG A   + N       + 
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161

Query: 65  KKCGTLPYVAPEVLVRSYLAE---PADIWSCGIILVAMLAGELPW 106
              GT  Y+APEV+           ADIWS G +++ M  G+ PW
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 33/192 (17%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT------------ 52
            A+ +  +L+  ++ +H  G  HRD+KP+N+L+D    +K++DFGL              
Sbjct: 102 TARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 53  ------VFRMNGKERPLDKKC---------GTLPYVAPEVLVRSYLAEPADIWSCGIILV 97
                 +FR N   R  D K          GT  Y+APEVL  +      D WS G+IL 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 98  AMLAGELPW--DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-N 154
            ML G  P+  D       + + WK    ++  P   +    + LI R+L   P  RL +
Sbjct: 222 EMLYGFPPFYSDTLQETYNKIINWK--ESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGS 278

Query: 155 IEKIKSHRWYSK 166
            E+IKSH ++  
Sbjct: 279 FEEIKSHPFFKG 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 91.0 bits (227), Expect = 5e-21
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK-- 65
            +F QL   ++YLHS+ I HRD+KP+N+ L     +K+ DFG++ V         +D   
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAK 161

Query: 66  -KCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK-DN 122
              GT  Y++PE+   + Y    +DIWS G +L  +   + P++    + +  L  K   
Sbjct: 162 TVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFE---GENLLELALKILK 217

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
                 P  +      +L+  +L   P  R +I +I
Sbjct: 218 GQYPPIP-SQYSSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 57/170 (33%), Positives = 84/170 (49%), Gaps = 34/170 (20%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK---CG 68
           +++  +EYLHSK I +RDLKPEN+LLD +  +K++DFG A   R        D+    CG
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--------DRTWTLCG 160

Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY-------LEWKD 121
           T  Y+APEV+      +  D W+ GI++  ML G  P+       I Y       LE+  
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-YEKILAGKLEFP- 218

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK-----IKSHRWYSK 166
            RH+     D        LI+++L    + RL   K     +K+HRW+  
Sbjct: 219 -RHLDLYAKD--------LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.0 bits (226), Expect = 8e-21
 Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 20/109 (18%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL--------ATVFRMNGKE 60
           F  Q++ G+ YLHSKGI HRDLK +N+L+D     KISDFG+             M+ + 
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ- 171

Query: 61  RPLDKKCGTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW 106
                  G++ ++APEV+    + Y A+  DIWS G +++ M AG  PW
Sbjct: 172 -------GSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPW 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 49/205 (23%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---------- 55
           A+ +  +L   +E +H  G  HRD+KP+N+L+D    +K++DFGL T FR          
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162

Query: 56  ------------------MNGKERPLDKK-------------CGTLPYVAPEVLVRSYLA 84
                                + +PL+++              GT  Y+APEVL+R+   
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222

Query: 85  EPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIR 142
           +  D WS G+IL  ML G+ P+  D P    ++ + W+   H+      +L      LI 
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI--PSQAKLSREASDLIL 280

Query: 143 RILAPLPSTRL---NIEKIKSHRWY 164
           R+       RL     ++IK+H ++
Sbjct: 281 RLCCG-AEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 59/174 (33%), Positives = 94/174 (54%), Gaps = 30/174 (17%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-- 66
           +  ++   +E+LH +GI +RDLKPEN+LLD Q  +K++DFGL        KE   +    
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC-------KESIHEGTVT 157

Query: 67  ---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEW 119
              CGT+ Y+APE+L+RS   +  D WS G ++  ML G  P+     K T D I  L+ 
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKG 215

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHM 168
           K N     +P  R       L++++L   PS+RL     +  +++SH ++ +H+
Sbjct: 216 KLNLPPYLTPEAR------DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF-RHV 262

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 62/174 (35%), Positives = 92/174 (52%), Gaps = 24/174 (13%)

Query: 5   EAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           E  KF+  +L   +++LHS GI +RDLKPEN+LLD +  +K++DFGL+       KE  +
Sbjct: 98  EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KE-SI 149

Query: 64  D--KK----CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           D  KK    CGT+ Y+APEV+ R    + AD WS G+++  ML G LP+          +
Sbjct: 150 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209

Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
             K    M +     L     SL+R +    P+ RL      +E+IK H ++S 
Sbjct: 210 ILKAKLGMPQF----LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 41/96 (42%), Positives = 58/96 (60%), Gaps = 5/96 (5%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ Y HS  + HRDLKP+N+L+D +  LK++DFGLA  F +    R    +
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV--PVRTYTHE 159

Query: 67  CGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAML 100
             TL Y APE+L+  R Y + P DIWS G I   M+
Sbjct: 160 VVTLWYRAPEILLGSRQY-STPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 19/166 (11%)

Query: 8   KFFR-QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           KF+  +L+   EYLHSK I +RDLKPEN+LLD +  +K++DFG A   ++  +   L   
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTL--- 175

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRH 124
           CGT  Y+APEV+      +  D W+ G++L   +AG  P+  D P     + L  +    
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---- 231

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           ++   W   D     L++ +L    + RL      +  +K+H ++ 
Sbjct: 232 LKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275

Length = 329

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 49/141 (34%), Positives = 67/141 (47%), Gaps = 27/141 (19%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+  + Y HS  I HRD+KPEN+L+     LK+ DFG A   R      PL     T  
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVATRW 166

Query: 72  YVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP 129
           Y APE+LV   +Y  +P D+W+ G I+  +L GE  +                      P
Sbjct: 167 YRAPELLVGDTNY-GKPVDVWAIGCIMAELLDGEPLF----------------------P 203

Query: 130 WDRLDVNCLSLIRRILAPLPS 150
            D  D++ L LI++ L PLP 
Sbjct: 204 GDS-DIDQLYLIQKCLGPLPP 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 4/106 (3%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  Q++ G+ YLH +G+ HRD+K  N+L      +K++DFG+AT  ++N   +      
Sbjct: 103 VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVV 160

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WD-KPTA 111
           GT  ++APEV+  S  +  +DIWS G  ++ +L G  P +D  P A
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 26/232 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+++LH KGI +RDLK +NVLLD    +KI+DFG+     MNG E      CGT  
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNG-EGKASTFCGTPD 161

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+APE+L      E  D WS G++L  ML G+ P+     D +      D  H  R  W 
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W- 218

Query: 132 RLDVNCLSLIRRILAPLPSTRLNIE-KIKSHRWYS----KHMPNDIVDGP--PSSDFNST 184
            +       + ++    P+ RL ++  I+ H ++     + +    +  P  P     S 
Sbjct: 219 -ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSD 277

Query: 185 AKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQP 236
           A     +   E  R  P   D+  ++  +    RG           FSF+ P
Sbjct: 278 ASNFDREFTNEKVRLSPV--DKKLLASMDQEQFRG-----------FSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 40/90 (44%), Positives = 55/90 (61%), Gaps = 3/90 (3%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ + G+++LH+  I HRDLKPEN+L+     +K++DFGLA   R+   +  L     TL
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA---RIYSCQMALTPVVVTL 171

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAML 100
            Y APEVL++S  A P D+WS G I   M 
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 39/106 (36%), Positives = 63/106 (59%), Gaps = 9/106 (8%)

Query: 8   KFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
              RQ++ G++YLH+K  I HRD+KP N+L++ +  +KI+DFG++ V      E  LD+ 
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-----ENTLDQC 157

Query: 67  ---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKP 109
               GT+ Y++PE +     +  ADIWS G+ L+    G+ P+  P
Sbjct: 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           + F QL+ G++ LH + I HRDLK  N+LL   D +KI D G++ V     K+     + 
Sbjct: 107 RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQI 162

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR 127
           GT  Y+APEV      +  +DIWS G +L  M     P++   A  ++ L +K    +QR
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYK----VQR 215

Query: 128 SPWDRL------DVNCLSLIRRILAPLPSTRLNIEKIKSH 161
             +  +      D+   + IR +L   P  R N +KI + 
Sbjct: 216 GKYPPIPPIYSQDLQ--NFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 29/164 (17%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER--PLDKK---CGTL 70
           G++YLH   I +RDLK +N+LLD +  +KI+DFGL        KE     D+    CGT 
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTP 165

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTADCIEYLEWKDNRHMQ 126
            ++APEVL  +      D W  G+++  ML GE P+    ++   D I   E +  R + 
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 225

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           R          +S++RR+L   P  RL     + E +K   ++ 
Sbjct: 226 R--------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 7/105 (6%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFG----LATVFRMNGKER 61
            +K+ RQ++ GVEYLHS  I HRD+K  N+L D    +K+ DFG    L T+       +
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            +    GT  +++PEV+        AD+WS G  +V ML  + PW
Sbjct: 166 SV---TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 3/95 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+I G+E+LH + I +RDLKPENVLLD    ++ISD GLA   +     + +  + GT  
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGRAGTPG 159

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APEVL         D ++ G  L  M+AG  P+
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 6/98 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ++ G+EYLH +   HRD+K  N+L+D    +K++DFG+A         +      G+ 
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSP 165

Query: 71  PYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ +   Y    ADIWS G  ++ M  G+ PW
Sbjct: 166 YWMAPEVIAQQGGY-GLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 40/97 (41%), Positives = 58/97 (59%), Gaps = 6/97 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-CGT 69
           R+++ G+EYLHS+ + HRD+K +N+LL    ++K++DFG A       KE+       GT
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGT 179

Query: 70  LPY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            PY +APEV+ R       DIWS GI+ + M  GE P
Sbjct: 180 -PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 41/103 (39%), Positives = 57/103 (55%), Gaps = 10/103 (9%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLD 64
            + F  QL+ GV + H  G+ HRDLKP+N+L+D Q   LKI+D GL   F +     P+ 
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-----PVK 166

Query: 65  K---KCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGE 103
               +  TL Y APEVL+  ++ + P DIWS G I   M   +
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 21/160 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +++ G+++LH +GI +RDLK +NVLLD +  +KI+DFG+        KE  L        
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTF 156

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE+L         D W+ G++L  MLAG+ P++    D +     +D     
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRLNI-----EKIKSH 161
           R     L     S+++  L   P  RL       + IK H
Sbjct: 217 RW----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 43/104 (41%), Positives = 61/104 (58%), Gaps = 7/104 (6%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + F +QL+ G+ Y H K   HRD+K  N+LL+ +  +K++DFGLA ++  + + RP   K
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRPYTNK 177

Query: 67  CGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPWDKP 109
             TL Y  PE+L+      PA D+WSCG IL     GEL   KP
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCIL-----GELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 44/202 (21%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK----- 59
           E + +  + I  ++ +H  G  HRD+KP+N+LLD +  +K+SDFGL T  + + +     
Sbjct: 102 ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161

Query: 60  --------------ERPLDKK-----------------CGTLPYVAPEVLVRSYLAEPAD 88
                          +P+  K                  GT  Y+APEV +++   +  D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221

Query: 89  IWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA 146
            WS G+I+  ML G  P+  D P     + + WK+   +Q      L      LI+R+  
Sbjct: 222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET--LQFPDEVPLSPEAKDLIKRLCC 279

Query: 147 PLPSTRL---NIEKIKSHRWYS 165
                RL    + +IKSH ++ 
Sbjct: 280 -EAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 48/170 (28%), Positives = 89/170 (52%), Gaps = 12/170 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E + +  +++  +++LH  GI +RD+K EN+LLD +  + ++DFGL+  F    +ER   
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165

Query: 65  KKCGTLPYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
             CGT+ Y+APEV+        +  D WS G++   +L G  P+   T D  +  + + +
Sbjct: 166 -FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF---TVDGEQNSQSEIS 221

Query: 123 RHMQRS--PW-DRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYSK 166
           R + +S  P+   +       I+++L   P  RL     ++IK+H ++  
Sbjct: 222 RRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 42/104 (40%), Positives = 57/104 (54%), Gaps = 5/104 (4%)

Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER 61
            Q E +    QL+SGV +LH   I HRDLK  N+LL+ +  LKI DFGLA  +    K  
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-- 161

Query: 62  PLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
           P  +   TL Y APE+L+  + Y +   D+WS G I   +L  +
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEY-STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 54/149 (36%), Positives = 77/149 (51%), Gaps = 14/149 (9%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
           +Q++ G++YLH   I HRD+K +NVL++     +KISDFG  T  R+ G     +   GT
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG--TSKRLAGINPCTETFTGT 172

Query: 70  LPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW---DKPTADCIEYLEWKDNR 123
           L Y+APEV+    R Y A PADIWS G  +V M  G+ P+    +P A   +   +K + 
Sbjct: 173 LQYMAPEVIDKGPRGYGA-PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP 231

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTR 152
            +  S    L     + I R   P P  R
Sbjct: 232 EIPES----LSAEAKNFILRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 55/183 (30%), Positives = 82/183 (44%), Gaps = 35/183 (19%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
             + G+EYLHS  I HRDLKP N+L+     LK++DFGLA  F      R +  +  T  
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRW 167

Query: 72  YVAPEVLV--RSYLAEPADIWSCGIIL------VAMLAGELPWDK----------PTADC 113
           Y APE+L   R Y     D+WS G I       V  L G+   D+          PT + 
Sbjct: 168 YRAPELLFGARHY-GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226

Query: 114 IE-------YLEWKDNRHMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIKSHR 162
                    Y+E+K       +P  ++      + L L++R+L   P+ R+   +   H 
Sbjct: 227 WPGVTSLPDYVEFK---PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 163 WYS 165
           ++S
Sbjct: 284 YFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 12/92 (13%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE----RPLDKK 66
            Q++ G+ ++H  G  HRDLKPEN+L+   + +KI+DFGLA       +E     P    
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA-------REIRSRPPYTDY 158

Query: 67  CGTLPYVAPEVLVRS-YLAEPADIWSCGIILV 97
             T  Y APE+L+RS   + P DIW+ G I+ 
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMA 190

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-P 62
            + +   +QL+  VEY+H K + HRD+K EN+ L+    + + DFG A  F    KER  
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE---KEREA 323

Query: 63  LDKK-CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGEL 104
            D    GT+   +PE+L      E  DIWSCG+IL+ ML+ + 
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 8/120 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+EYL SK   HRDL   N L+     +KISDFGL+   R    +    K+ 
Sbjct: 106 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYRKRG 162

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPWDKPTADCIEYLEWKDNR 123
           G LP   +APE L        +D+WS G++L  +  L  +        + +EYL+    R
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYR 221

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.4 bits (202), Expect = 4e-17
 Identities = 42/103 (40%), Positives = 55/103 (53%), Gaps = 12/103 (11%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F  Q++ G++YLHS  + HRDLKP N+L++    LKI DFGLA   R  G +   D+K
Sbjct: 106 QYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA---R--GVDPDEDEK 160

Query: 67  CGTLPYV------APEV-LVRSYLAEPADIWSCGIILVAMLAG 102
                YV      APE+ L  S   +  DIWS G I   +L  
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 3/95 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ +LHS  I +RD+KPENVLLD Q   ++SD GLA   + +GK   + ++ GT  
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGK--TITQRAGTNG 159

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APE+L     + P D ++ G  +  M+AG  P+
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 41/115 (35%), Positives = 56/115 (48%), Gaps = 7/115 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+EYL SK   HRDL   N L+     +KISDFGL+   R    +     K 
Sbjct: 107 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYKVKG 163

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPWDKPTADCIEYLE 118
           G LP   +APE L        +D+WS G++L  +  L  E       A+ +EYL+
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + F  QL+ G++Y+HS  + HRDLKP N+L++    L+I DFG+A     +    P + K
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS----PTEHK 165

Query: 67  ------CGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLA------GELPWDK----- 108
                   T  Y APE+L+       A D+WS G I   ML       G+    +     
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225

Query: 109 -----PTADCIE---------YLEWKDNRHMQRSPWDRL--DVNC--LSLIRRILAPLPS 150
                P+ + +          Y++  +    Q  PW ++    +   L L+ ++L   P 
Sbjct: 226 SVLGSPSEEVLNRIGSDRVRKYIQ--NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE 283

Query: 151 TRLNIEKIKSHRWYSK-HMPNDIVDGPPSSDFNSTAKRMRSDLETEA 196
            R+ +E+   H + ++ H P+D    PP  DF+  A  +  +   EA
Sbjct: 284 ERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKEA 330

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 40/201 (19%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLD 64
            Q F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA +          L 
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 65  KKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LP--------------WD 107
           +   T  Y APE+++ S     A DIWS G IL  ML+     P                
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227

Query: 108 KPTAD---CI------EY---LEWKDNRHMQRSPWDRL----DVNCLSLIRRILAPLPST 151
            P+ +   CI       Y   L +K        PW++L    D   L L+ ++L   P  
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKV-----PWNKLFPNADPKALDLLDKMLTFNPHK 282

Query: 152 RLNIEKIKSHRWYSK-HMPND 171
           R+ +E+  +H +  + H P+D
Sbjct: 283 RITVEEALAHPYLEQYHDPSD 303

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 40/97 (41%), Positives = 58/97 (59%), Gaps = 12/97 (12%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-----CGTL 70
           G+ +LHSKGI +RDLK +NV+LD +  +KI+DFG+        KE     K     CGT 
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC-------KENIFGGKTTRTFCGTP 165

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
            Y+APE++      +  D W+ G++L  MLAG+ P+D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 40/95 (42%), Positives = 59/95 (62%), Gaps = 2/95 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+++LHSKGI +RDLK +N+LLD    +KI+DFG+     M G  +     CGT  
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKT-CTFCGTPD 161

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APE+L+        D WS G++L  ML G+ P+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 4/96 (4%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+++ G+EYLH +G  HRD+K  N+LL  +  +K++DFG++        +R  +   GT 
Sbjct: 105 REVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR--NTFVGT- 161

Query: 71  PY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           P+ +APEV+ +S   E ADIWS GI  + +  GE P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 40/94 (42%), Positives = 56/94 (59%), Gaps = 3/94 (3%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            QL+ G++YLH   I HRDLK  N+LL  +  LKI+DFGLA  + +    +P+  K  TL
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL--PAKPMTPKVVTL 172

Query: 71  PYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE 103
            Y APE+L+       A D+W+ G IL  +LA +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 5/106 (4%)

Query: 8   KFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           K    ++ G+ YLH K  I HRD+KP N+L++ +  +K+ DFG++    +N         
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLA---KTF 159

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
            GT  Y+APE +  +  +  +DIWS G+ L+ +  G  P+      
Sbjct: 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--RMNGKERP 62
           E +K  + L++G+ Y+H   I HRD+K  N+L+     LK++DFGLA  F    N K   
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAM 99
              +  TL Y  PE+L+  R Y   P D+W  G I+  M
Sbjct: 180 YTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 6/148 (4%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  ++ S + +LH KGI +RDLK +NVLLD +   K++DFG+      NGK      
Sbjct: 98  ARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS--T 155

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APE+L         D W+ G++L  ML G  P++    D  +  E   N  +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILNDEV 213

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL 153
               W  L  + + +++  +   P+ RL
Sbjct: 214 VYPTW--LSQDAVDILKAFMTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 39/102 (38%), Positives = 61/102 (59%), Gaps = 11/102 (10%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            + F  QL+ G+ + H   + HRDLKP+N+L++ +  LK++DFGLA  F +     P++ 
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-----PVNT 156

Query: 66  ---KCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG 102
              +  TL Y AP+VL+  R+Y +   DIWS G I+  M+ G
Sbjct: 157 FSNEVVTLWYRAPDVLLGSRTY-STSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 38/202 (18%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F  QL+ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA     + K   + + 
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEY 168

Query: 67  CGTLPYVAPEVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCI---------- 114
             T  Y APE+L+    Y     D+WS G I   +L  +  +  P  D +          
Sbjct: 169 VVTRWYRAPELLLNCSEYTTA-IDVWSVGCIFAELLGRKPLF--PGKDYVHQLKLITELL 225

Query: 115 -----EYLEWKDN-------RHMQRSP-------WDRLDVNCLSLIRRILAPLPSTRLNI 155
                E L +  N       R +  +P       +   +   + L+ ++L   PS R+ +
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285

Query: 156 EKIKSHRWYSKHMPNDIVDGPP 177
           E+  +H + +    +D  D P 
Sbjct: 286 EEALAHPYLASL--HDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 15/180 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A+ +  ++   V+ LH  G  HRDLKPEN L+D    +K++DFGL+            +
Sbjct: 102 HARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYA-N 156

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD--CIEYLEWKDN 122
              G+  Y+APEVL         D WS G +L   L G  P+   T +        WK+ 
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216

Query: 123 RHMQRSPWDR----LDVNCLSLIRRILAPLPSTRL-NIEKIKSHRWYSKHMPNDIVDGPP 177
             +QR  +D     L      LI +++   PS R  ++E IK+H ++ +   N++ +  P
Sbjct: 217 --LQRPVYDDPRFNLSDEAWDLITKLIND-PSRRFGSLEDIKNHPFFKEVDWNELRELKP 273

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 12/180 (6%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           AQ +  +L+  +  +H  G  HRD+KPENVL+D    +K++DFG A     N        
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK-L 162

Query: 66  KCGTLPYVAPEVLVR-------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             GT  Y+APEVL         +Y  E  D WS G+I   M+ G  P+ + T+    Y  
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGTS-AKTYNN 220

Query: 119 WKDNRHMQRSPWD-RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPP 177
             + +   + P D ++  + L LI+ +L      RL  E +  H ++SK   N+I +  P
Sbjct: 221 IMNFQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERLGYEGLCCHPFFSKIDWNNIRNSLP 279

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 36/194 (18%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--RMNGKERP-LDKKCG 68
           QL+  ++Y+HS  + HRDLKP N+LL+    +K++DFGLA          E P L     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 69  TLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG-----------------ELPWDKP 109
           T  Y APE+L+    Y  +  D+WS G IL  ML G                 E+    P
Sbjct: 175 TRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG-PP 232

Query: 110 TADCIEYLE----WKDNRHMQRSPWDRLDV-------NCLSLIRRILAPLPSTRLNIEKI 158
           +A+ IE ++          +   P   LD        + L L++++L   P+ RL  E+ 
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292

Query: 159 KSHRWYSK-HMPND 171
             H + ++ H P+D
Sbjct: 293 LEHPYVAQFHNPSD 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 3/90 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +  TL 
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLW 165

Query: 72  YVAPEVLVRS-YLAEPADIWSCGIILVAML 100
           Y APE+L+   Y +   DIWS G I   M+
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 42/102 (41%), Positives = 58/102 (56%), Gaps = 12/102 (11%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV--FRMNGKERPL 63
            Q F  Q++ G++Y+HS G+ HRDLKP N+L++    LKI DFGLA +   +M G     
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG----- 164

Query: 64  DKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
                T  Y APE+++  + Y  E  DIWS G I   ML G+
Sbjct: 165 --YVSTRYYRAPEIMLTWQKYDVE-VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 9/147 (6%)

Query: 9   FFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG-KERPLDKK 66
           F+   IS G+ +LH +GI +RDLK +NV+LD +  +KI+DFG+     ++G   R     
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF--- 161

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE++      +  D W+ G++L  MLAG+ P+D    D +     + N    
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL 153
           +S    L    +S+ + ++   PS RL
Sbjct: 222 KS----LSKEAVSICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 5/104 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-- 66
             ++++ G+EYLHS G  HRD+K  N+LL    ++KI+DFG++      G      +K  
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 67  CGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
            GT  ++APEV+  V  Y    ADIWS GI  + +  G  P+ K
Sbjct: 167 VGTPCWMAPEVMEQVHGY-DFKADIWSFGITAIELATGAAPYSK 209

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 51/173 (29%), Positives = 96/173 (55%), Gaps = 16/173 (9%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E Q +  +++  +E+LH  GI +RD+K EN+LLD    + ++DFGL+  F  +  ER   
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
             CGT+ Y+AP+++        +  D WS G+++  +L G  P+   T D  +  + + +
Sbjct: 166 -FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKNSQAEIS 221

Query: 123 RHMQRS--PWDRLDVNCLS--LIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
           R + +S  P+ + +++ L+  +I+R+L   P  RL     + ++IK H ++ K
Sbjct: 222 RRILKSEPPYPQ-EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 4/100 (4%)

Query: 8   KFFRQLISGVEYLH-SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
             F Q++  + YLH  K I HRDL P N++L   D + I+DFGLA   +    E  L   
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSV 173

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            GT+ Y  PE++      E AD+W+ G IL  M   + P+
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 40/102 (39%), Positives = 59/102 (57%), Gaps = 12/102 (11%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD-----KKCGTL 70
           G+ +LHSKGI +RDLK +NV+LD +  +KI+DFG+        KE   D       CGT 
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENMWDGVTTKTFCGTP 165

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
            Y+APE++      +  D W+ G++L  MLAG+ P++    D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 11/164 (6%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--TVFRMNGKER 61
           + A  +  +++ G+++LHSKGI +RDLK +NV+LD    +KI+DFG+    VF   G  R
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNR 152

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
                CGT  Y+APE+L         D WS G++L  ML G+ P+     D +      D
Sbjct: 153 A-STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE-KIKSHRWY 164
             H  R  W   +     ++ ++    P+ RL +   I+ H ++
Sbjct: 212 TPHYPR--WITKESK--DILEKLFERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 39/94 (41%), Positives = 58/94 (61%), Gaps = 4/94 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKC 67
           +  Q++ G+ Y HS  + HRDLKP+N+L+D + + LK++DFGLA  F +    R    + 
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--PVRTFTHEV 164

Query: 68  GTLPYVAPEVLVRS-YLAEPADIWSCGIILVAML 100
            TL Y APE+L+ S + + P DIWS G I   M+
Sbjct: 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 2/95 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            Q + G+EYLHS    HRD+K  N+LL+ +   K++DFG++   ++       +   GT 
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTP 163

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV+        ADIWS GI  + M  G+ P
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 54/161 (33%), Positives = 84/161 (52%), Gaps = 18/161 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYL S  I +RDLKPEN+LLD    +K++DFG A V      +      CGT  
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+L+     + AD W+ GI +  +L G  P+  ++P     + LE      +   P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-----GIIYFP 248

Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-NIEK----IKSHRWYS 165
              LD NC  L++++L+   + R  N++K    +K H W+ 
Sbjct: 249 -KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288

Length = 340

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 8   KFFRQLISGVEYLHSKG-----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +   QL+  +   H++      + HRDLKP N+ LD  + +K+ DFGLA   ++ G +  
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA---KILGHDSS 165

Query: 63  LDKKC-GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
             K   GT  Y++PE L      E +DIWS G ++  + A   P
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 38/89 (42%), Positives = 55/89 (61%), Gaps = 3/89 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++     +  L     TL 
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEVL++S  A P D+WS G I   M 
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 2/95 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S + YLHS  + +RDLK EN++LD    +KI+DFGL      +G    +   CGT  
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPE 160

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APEVL  +      D W  G+++  M+ G LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 40/100 (40%), Positives = 58/100 (58%), Gaps = 5/100 (5%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP--LD 64
           Q F  Q++ G++Y+HS  + HRDLKP N+L++    LKI DFGLA  F  N  E    + 
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG 102
           +   T  Y APE+++  +SY  +  D+WS G IL  +L  
Sbjct: 168 EYVATRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 34/97 (35%), Positives = 58/97 (59%), Gaps = 4/97 (4%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
             ++  + +LH++G+ HRD+K +++LL     +K+SDFG  A V +   + + L    GT
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGT 178

Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
             ++APEV+ R       DIWS GI+++ M+ GE P+
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ISG+E+LH + I +RDLKPENVLLD    ++ISD GLA V   +G+ +      GT  
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT-KGYAGTPG 162

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPW- 130
           ++APE+L         D ++ G+ L  M+A   P+ +   + +E  E K  R +  S   
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELK-QRILNDSVTY 220

Query: 131 -DRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
            D+      S    +LA  P  RL     N + +++H  +       +  G     F
Sbjct: 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 17/169 (10%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +L+  +E LH   + +RDLKPEN+LLD Q  + + DFGL  +  M   ++  + 
Sbjct: 95  ARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKT-NT 152

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRH 124
            CGT  Y+APE+L+     +  D W+ G++L  ML G  P +D+   +          R 
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY--------RK 204

Query: 125 MQRSPW---DRLDVNCLSLIRRILAPLPSTRLNI---EKIKSHRWYSKH 167
           + + P    D  D +   L+  +L+  P+ RL     ++IK+H ++S+ 
Sbjct: 205 ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 16/170 (9%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A  +  ++  G+E LH + I +RDLKPEN+LLD    ++ISD GLA           +  
Sbjct: 104 AVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRG 160

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN--- 122
           + GT+ Y+APEV+         D W  G ++  M+ G+ P+ +      E ++ ++    
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVERR 216

Query: 123 -RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----EKIKSHRWYSK 166
            +  Q    ++      S+ R++L   P  RL       E++K+H ++  
Sbjct: 217 VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 36/95 (37%), Positives = 57/95 (60%), Gaps = 2/95 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +   CGT  
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 160

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APEVL  +      D W  G+++  M+ G LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 7/105 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLD-- 64
            +  QL+ G+ YLH   I HRD+K  N+L+D     L+I+DFG A   R+  K       
Sbjct: 107 NYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAA--RLAAKGTGAGEF 164

Query: 65  --KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
             +  GT+ ++APEVL         D+WS G +++ M   + PW+
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 20/174 (11%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRM--NGKE 60
           +W A+ +  +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG  T  +M  NG  
Sbjct: 142 KW-ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMV 198

Query: 61  RPLDKKCGTLPYVAPEVL----VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI-- 114
           R  D   GT  Y++PEVL       Y     D WS G+ L  ML G+ P+    AD +  
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVG 254

Query: 115 EYLEWKDNRHMQRSPWD-RLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWY 164
            Y +  D+++    P D  +      LI   L      RL    +++IKSH ++
Sbjct: 255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 2/96 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG     ++  ++       GT 
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 53/209 (25%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN-------- 57
           A+ +  +L   VE +H  G  HRD+KP+N+L+D    +K++DFGL T FR          
Sbjct: 103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162

Query: 58  ------------------------GKERPLDKKC-------------GTLPYVAPEVLVR 80
                                    + +PL+++              GT  Y+APEVL+R
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 81  SYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCL 138
           +   +  D WS G+IL  ML G+ P+    P    ++ + W+ + H+   P  +L     
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI--PPQAKLSPEAS 280

Query: 139 SLIRRILAPLPSTRL---NIEKIKSHRWY 164
            LI + L   P  RL     ++IK+H ++
Sbjct: 281 DLIIK-LCRGPEDRLGKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 42/121 (34%), Positives = 59/121 (48%), Gaps = 9/121 (7%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+EYL SK   HRDL   N L+     +KISDFGL+    +   +    K  
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTG 166

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIEYLEWKDN 122
           G LP  ++APE L        +D+WS G++L  +  L G  P+      + +EYL  K  
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL-GATPYPGLSNEEVLEYLR-KGY 224

Query: 123 R 123
           R
Sbjct: 225 R 225

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 42/101 (41%), Positives = 54/101 (53%), Gaps = 23/101 (22%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA----TVFRMNGKERPLDKKC 67
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA    T F M           
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------- 175

Query: 68  GTLPYV------APEVLVRSYLAEPADIWSCGIILVAMLAG 102
              PYV      APEV++     E  DIWS G I+  M+ G
Sbjct: 176 ---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 38/94 (40%), Positives = 54/94 (57%), Gaps = 8/94 (8%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G++Y+HS GI HRDLKP N+ ++    LKI DFGLA   R    E  +     T  
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDE--MTGYVATRW 180

Query: 72  YVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
           Y APE+++    Y  +  DIWS G I+  +L G+
Sbjct: 181 YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 21/183 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+  +W  N+ ++     
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID--QW--NKVIE----- 239

Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+ +   P  S+ N       
Sbjct: 240 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPDVLF--PADSEHNKLKASQA 294

Query: 190 SDL 192
            DL
Sbjct: 295 RDL 297

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           +Q++ G+ YLH++ I HRD+K EN+ ++  D + I D G A   +            GT+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA---QFPVVAPAFLGLAGTV 220

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
              APEVL R      ADIWS GI+L  MLA
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 37/95 (38%), Positives = 60/95 (63%), Gaps = 4/95 (4%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGTLP 71
           ++  + YLHS+G+ HRD+K +++LL L   +K+SDFG  A + +   K + L    GT  
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPY 182

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           ++APEV+ R+      DIWS GI+++ M+ GE P+
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.4 bits (182), Expect = 7e-15
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 2/96 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG     ++  ++       GT 
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 180

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 47/167 (28%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---------- 55
           A+ +  +L   +E +H  G  HRD+KP+N+L+DL   +K++DFGL T FR          
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162

Query: 56  -----------------------------MNGKERPLDKKC------GTLPYVAPEVLVR 80
                                        +  +     ++C      GT  Y+APEVL+R
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 81  SYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHM 125
               +  D WS G+IL  ML G+ P+    PT   ++ + W++  H+
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI 269

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 34/182 (18%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+ + HS+ + HRDLKP+N+L+D +  +K++DFGLA  F +    R    +  TL 
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLW 166

Query: 72  YVAPEVLVRSYL-AEPADIWSCGIILVAMLAGELP-----------------WDKPTADC 113
           Y APEVL+ S   + P DIWS G I   M A + P                    PT D 
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEM-ATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225

Query: 114 ---IEYLE--------WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHR 162
              +  L         WK      RS    LD + L L+ ++L   P+ R++ +K  +H 
Sbjct: 226 WPGVTSLPDYKNTFPKWKKG--SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283

Query: 163 WY 164
           ++
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 5/163 (3%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K+F QL S +E++HSK I HRD+KP NV +     +K+ D GL   F  + K        
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR 127
           GT  Y++PE +  +     +DIWS G +L  M A + P+     +     +  +      
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227

Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
            P D        L+ R + P P  R +I  +      +K M  
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ---VAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 34/185 (18%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  QL+  ++++H  GI HRD+KPEN+L+   D LK++DFG     R    + P  +  
Sbjct: 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILIK-DDILKLADFGSC---RGIYSKPPYTEYI 159

Query: 68  GTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE L+   Y     DIW+ G +   +L+      G    D+          P 
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219

Query: 111 ADCIEYLEWKDNRHMQ-----------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           A+ ++    + +RHM            R          L L++++LA  P  R+  ++  
Sbjct: 220 AEVLKKF--RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277

Query: 160 SHRWY 164
            H ++
Sbjct: 278 RHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 25/168 (14%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I  +E+LH  GI +RD+K EN+LLD +  + ++DFGL+  F    KER     CGT+ 
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCGTIE 171

Query: 72  YVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-------R 123
           Y+APE++  +    +  D WS GI++  +L G  P+          LE + N       R
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT---------LEGERNTQSEVSRR 222

Query: 124 HMQRSPW--DRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWY 164
            ++  P     +      L+ ++L   P  RL        +IK H ++
Sbjct: 223 ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 2/96 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LH+  + HRD+K +NVLL +  ++K++DFG     ++  ++       GT 
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 72.9 bits (180), Expect = 1e-14
 Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 8/124 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G+EYL SK   HRDL   N L+     +KISDFGL+    +   +    +  
Sbjct: 106 QMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKRGG 163

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYLEWKDNR 123
           G LP  ++APE L        +D+WS G++L  +   GE P+      + +E LE  D  
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE--DGY 221

Query: 124 HMQR 127
            + R
Sbjct: 222 RLPR 225

Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 24/179 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +++S ++YLHS  I +RDLK EN++LD    +KI+DFGL        KE   D       
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLC-------KEGITDAATMKTF 155

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   ++    
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP 215

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIVDG---PP 177
           R+    L  +  SL+  +L   P+ RL     + ++I  H +++     D+ D    PP
Sbjct: 216 RT----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 14/183 (7%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV-FRMNGKERPLD 64
           A+ +  ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL       NG      
Sbjct: 98  ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF- 156

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNR 123
             CGT  Y+APEVL +       D W  G +L  ML G  P + + TA+  + +    N+
Sbjct: 157 --CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL---NK 211

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRL----NIEKIKSHRWYSKHMPNDIVDGPPSS 179
            +Q  P   +  +   L+  +L    + RL    +  +IK+H ++S    +D+++   + 
Sbjct: 212 PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITP 269

Query: 180 DFN 182
            FN
Sbjct: 270 PFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 20/161 (12%)

Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 96  EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLR 148

Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW------DKPTAD 112
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+      D P  +
Sbjct: 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
             +YL         R P   L V   S+++  L   P  RL
Sbjct: 209 TEDYLFQVILEKQIRIP-RSLSVKAASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 41/109 (37%), Positives = 62/109 (56%), Gaps = 13/109 (11%)

Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + +LH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 96  EHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC-------KEGIR 148

Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+D
Sbjct: 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 40/115 (34%), Positives = 58/115 (50%), Gaps = 11/115 (9%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F   +  G+EYL  K   HRDL   NVL+      K+SDFGLA       KE    +  
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA-------KEASQGQDS 158

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L     +  +D+WS GI+L  + + G +P+ + P  D + ++E
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE 213

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 36/105 (34%), Positives = 47/105 (44%), Gaps = 12/105 (11%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  QL+ G+ YLH   I HRD+K  N+L+D Q  LKI+DFGLA  +             G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 69  TLPYV---------APEVLV--RSYLAEPADIWSCGIILVAMLAG 102
           T  Y           PE+L+  R Y     DIW  G +   M   
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 22/164 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL        KE     K     
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC-------KEGIEHSKTTSTF 156

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHM 125
           CGT  Y+APEVL +       D W  G +L  ML G  P + + TA+  + +    N+ +
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL---NKPL 213

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL----NIEKIKSHRWYS 165
           +  P   + V+   L+  +L    + RL    +  +IK+H ++S
Sbjct: 214 RLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 10/98 (10%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERPL---D 64
           Q+++GV YLHS  + HRDLKP N+L+      +  +KI D GLA +F  N   +PL   D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADLD 173

Query: 65  KKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLA 101
               T+ Y APE+L+ +     A DIW+ G I   +L 
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.7 bits (175), Expect = 5e-14
 Identities = 32/96 (33%), Positives = 57/96 (59%), Gaps = 2/96 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +++LHS  + HRD+K +N+LL +  ++K++DFG     ++  ++       GT 
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 2/100 (2%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +FF Q++ G+ +LHSK I HRD+K  N+ LD  D +KI D G+A +  ++      +   
Sbjct: 105 RFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIV 162

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           GT  Y++PE+       E +D+W+ G++L     G+ P+D
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 2/97 (2%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q++ G++YLHS GI HRD+KP N+L++    LKI DFGLA V   + + + + ++  
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQEVV 166

Query: 69  TLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGEL 104
           T  Y APE+L+ S +     DIWS G I   +L   +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 5/99 (5%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +K+  Q++ G+E+ HS  I HRD+KPEN+L+     +K+ DFG A    +          
Sbjct: 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDY 160

Query: 67  CGTLPYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGE 103
             T  Y APE+LV    Y     DIW+ G ++  ML GE
Sbjct: 161 VATRWYRAPELLVGDTKY-GRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 52/184 (28%), Positives = 93/184 (50%), Gaps = 16/184 (8%)

Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 97  ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MK 154

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNR 123
             CGT  Y+APEVL  +      D W  G+++  M+ G LP +++      E +  ++ R
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214

Query: 124 HMQR-SPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIVDGPP 177
             +  SP  +      SL+  +L   P  RL     + ++I  H++++  +  D+ +   
Sbjct: 215 FPRTLSPEAK------SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKL 268

Query: 178 SSDF 181
              F
Sbjct: 269 VPPF 272

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 11/146 (7%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +L  G+E L  + I +RDLKPEN+LLD +  ++ISD GLA         R    + GT+ 
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR---GRVGTVG 166

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN----RHMQR 127
           Y+APEV+         D W  G ++  M+ G+ P+ K      E ++ ++     +  Q 
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK----ERVKREEVDRRVKEDQE 222

Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRL 153
              ++   +  S+ R +L   P  RL
Sbjct: 223 EYSEKFSEDAKSICRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 23/174 (13%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPL 63
           A+ +  ++   + +LH +GI +RDLK +NVLLD    +K++D+G+        KE   P 
Sbjct: 98  ARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMC-------KEGLGPG 150

Query: 64  DKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTADCIEY 116
           D     CGT  Y+APE+L         D W+ G+++  M+AG  P+    D P  +  +Y
Sbjct: 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE------KIKSHRWY 164
           L         R P   L V    +++  L   P  RL  +       IKSH ++
Sbjct: 211 LFQVILEKPIRIP-RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 30/175 (17%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN-GKERPLD 64
           A+ +  +L+  +E+LH   I +RDLKPEN+LLD    + + DFGL+   + N    +  +
Sbjct: 98  AKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLS---KANLTDNKTTN 154

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
             CGT  Y+APEVL+  + Y  +  D WS G+++  M  G  P+              D 
Sbjct: 155 TFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCGWSPFYAE-----------DT 202

Query: 123 RHMQRS--------PWDRLDVNCLSLIRRILAPLPSTRL----NIEKIKSHRWYS 165
           + M R+        P + L       ++ +L   P  RL    +  ++K H +++
Sbjct: 203 QQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 6/108 (5%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +W A+ +  +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG        G  R 
Sbjct: 142 KW-ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR- 199

Query: 63  LDKKCGTLPYVAPEVLVRS----YLAEPADIWSCGIILVAMLAGELPW 106
            D   GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 39/93 (41%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA     N    P      T  
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRY 187

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGEL 104
           Y APEV++     E  DIWS G I+  ++ G +
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 36/103 (34%), Positives = 52/103 (50%), Gaps = 4/103 (3%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG----KERPL 63
           K+ +Q++ GV YLH+  + HRD+K  NV+L     +K+ DFG A      G        L
Sbjct: 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
               GT  ++APEV+  S     +DIWS G  +  M  G+ P 
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 16/164 (9%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+E LH + I +RDLKPEN+LLD    ++ISD GLA       + + +  + GT+ 
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVG 166

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEWKDNRHMQR 127
           Y+APEV+         D W+ G +L  M+AG+ P+     K   + +E L     + +Q 
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEVQE 222

Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIE-----KIKSHRWYSK 166
              ++   +  SL + +L   P  RL  +     ++K H  + +
Sbjct: 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++ G+E LH +   +RDLKPEN+LLD    ++ISD GLA         R    + GT+ 
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GRVGTVG 166

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APEVL         D W  G ++  M+ G+ P+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 6/108 (5%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +W A+ +  +++  ++ +HS G+ HRD+KP+N+LLD    LK++DFG        G  R 
Sbjct: 142 KW-AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR- 199

Query: 63  LDKKCGTLPYVAPEVLVRS----YLAEPADIWSCGIILVAMLAGELPW 106
            D   GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 42/114 (36%), Positives = 62/114 (54%), Gaps = 18/114 (15%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD----- 64
           F ++ + +EY+HSKG+ HRDLKP+N+LL L   + I D+G A +F+   +E  LD     
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDE 177

Query: 65  ------------KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
                       K  GT  Y+APE L+    +E  DI++ G+IL  ML    P+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 40/101 (39%), Positives = 54/101 (53%), Gaps = 2/101 (1%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL         E     
Sbjct: 98  ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTST 155

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            CGT  Y+APEVL +       D W  G +L  ML G  P+
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 7/100 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ++SG+ YLH + I HRD+KP N+L++    +KI+DFG++ +  +     P +   GT+
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTI 232

Query: 71  PYVAPEVLVR-----SYLAEPADIWSCGIILVAMLAGELP 105
            Y++PE +       +Y     DIWS G+ ++    G  P
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 5/101 (4%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERP-L 63
           A+ F  QL+ G++Y+HS  + HRDLKP NV ++ +D  LKI DFGLA +   +   +  L
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175

Query: 64  DKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG 102
            +   T  Y +P +L+   +Y  +  D+W+ G I   ML G
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +++     ++++ G++YLHS+   HRD+K  NVLL  Q  +K++DFG+A   ++   +  
Sbjct: 100 EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIK 157

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            +   GT  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 2/101 (1%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++   + +LH  G+ +RDLK +N+LLD +   K++DFG+     +NG        CGT  
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPD 161

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           Y+APE+L         D W+ G+++  M+AG+ P++    D
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 4/93 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +  Q++S V Y+H  GI HRD+K  N+ L     +K+ DFG++ +    G E  + +   
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVV 162

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
           GT  Y++PE+         +DIW+ G +L  +L
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 3/101 (2%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            + F  QL+ G+ + HS  + HRDLKP+N+L++    LK++DFGLA  F +    R    
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCYSA 158

Query: 66  KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELP 105
           +  TL Y  P+VL  + L   + D+WS G I   +     P
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+++  ++Y+H  G+ HRD+K  N+L+     +K+ DFG+A +   N  +R      GT 
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFVGTP 165

Query: 71  PYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV+   + Y  + ADIWS GI +  M  G  P
Sbjct: 166 YWMAPEVITEGKYYDTK-ADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 47/169 (27%), Positives = 84/169 (49%), Gaps = 14/169 (8%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPY 181

Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNL 239

Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPPS 
Sbjct: 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA-------GPPSC 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 37/97 (38%), Positives = 58/97 (59%), Gaps = 2/97 (2%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
            R+++ G++YLHS+   HRD+K  NVLL  Q  +K++DFG+A   ++   +   +   GT
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGT 164

Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
             ++APEV+ +S     ADIWS GI  + +  GE P 
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---MNGKERPL 63
           +K+ RQ++ GV YLHS  I HRD+K  N+L D    +K+ DFG +   +   ++G    +
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG--M 166

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
               GT  +++PEV+        ADIWS G  +V ML  + PW
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 7/100 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ++  + +LHS  + HRDLK  N+LL L   +K++DFG++   +   ++R  D   GT 
Sbjct: 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTP 167

Query: 71  PYVAPEVLV-RSYLAEP----ADIWSCGIILVAMLAGELP 105
            ++APEV+   ++   P    ADIWS GI L+ +   E P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---MNGKERPL 63
           +K+ RQ++ G+ YLHS  I HRD+K  N+L D    +K+ DFG +   +   M+G    +
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG--I 166

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
               GT  +++PEV+        AD+WS G  +V ML  + PW
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 4/95 (4%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  + YLH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPY 183

Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            +APEV+ R       DIWS GI+++ M+ GE P+
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 3/100 (3%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K   Q +  V + H     HRD+KPEN+L+  Q  +K+ DFG A +  + G         
Sbjct: 104 KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYV 161

Query: 68  GTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPW 106
            T  Y APE+LV  +    P D+W+ G +   +L G+  W
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 41/106 (38%), Positives = 59/106 (55%), Gaps = 7/106 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + Q   RQ++  ++YLHS  I HRDLK  NVLL L   +K++DFG++       + R  D
Sbjct: 111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--D 168

Query: 65  KKCGTLPYVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP 105
              GT  ++APEV++   + +      ADIWS GI L+ M   E P
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 183

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 5e-13
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 2/96 (2%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
            R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A   ++   +   +   GT
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 164

Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
             ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 160

Query: 72  YVAPEVLVRSYLAE-PADIWSCGIILVAMLAGELPW 106
           Y+APEVL +    +  AD +S G +L  +L G  P+
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 44/115 (38%), Positives = 61/115 (53%), Gaps = 12/115 (10%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP---LDK 65
           F  QL+ G+ Y+H + I HRDLKP+N+L+     LK++DFGLA       K  P      
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA-----RAKSIPSQTYSS 162

Query: 66  KCGTLPYVAPEVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
           +  TL Y  P+VL+ +  Y +   DIW  G I + ML G+ P     +D  E LE
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQ-PAFPGVSDVFEQLE 215

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 3/95 (3%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G++YL S+   HRDL   N+L++ +D +KISDFGLA V     K+    K+ 
Sbjct: 113 LFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEP 171

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           G  P  + APE L  S  +  +D+WS G+ L  + 
Sbjct: 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---MNGKERPL 63
           +++ RQ++ GV YLHS  I HRD+K  N+L D    +K+ DFG +   +   M+G    +
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--I 166

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
               GT  +++PEV+        AD+WS    +V ML  + PW
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 3/103 (2%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M+    + F  QL+ G+ Y H + I HRDLKP+N+L++ +  LK++DFGLA    +  K 
Sbjct: 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159

Query: 61  RPLDKKCGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAG 102
                +  TL Y  P+VL+ S   + P D+W  G IL  M  G
Sbjct: 160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 9e-13
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPLDKKC 67
           FF Q++  + ++H+K I HRDLK +N+LLD     +KI DFG++ +     K   +    
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV---V 162

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR 127
           GT  Y++PE+       + +DIW+ G +L  + + +  ++   A  +  L  K       
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE---AANLPALVLKIMSGTFA 219

Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
              DR   +   LI  +L   PS R  + +I + 
Sbjct: 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 39/176 (22%)

Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  +EYLHSK  + HRD+KP NVL++    +K+ DFG++  + ++   + +D  C   P
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG-YLVDSVAKTIDAGCK--P 168

Query: 72  YVAPEVL----------VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           Y+APE +          V+S      D+WS GI ++ +  G  P+D           WK 
Sbjct: 169 YMAPERINPELNQKGYDVKS------DVWSLGITMIELATGRFPYDS----------WKT 212

Query: 122 NRHMQRS---------PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
                +          P ++        + + L      R N  ++  H ++  H+
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 11/99 (11%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP---LDK 65
           F  QL+ G+ Y H + + HRDLKP+N+L+  +  LK++DFGLA       K  P      
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA-----RAKSVPSKTYSN 162

Query: 66  KCGTLPYVAPEVLVRS--YLAEPADIWSCGIILVAMLAG 102
           +  TL Y  P+VL+ S  Y +   D+W  G I   M  G
Sbjct: 163 EVVTLWYRPPDVLLGSTEY-STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 40/111 (36%), Positives = 55/111 (49%), Gaps = 22/111 (19%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL----------ATVFR 55
           A+ +  ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL           T F 
Sbjct: 98  ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF- 156

Query: 56  MNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
                      CGT  Y+APEV+ +       D W  G +L  ML G  P+
Sbjct: 157 -----------CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 2/99 (2%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K+F QL S VE++HS+ + HRD+KP NV +     +K+ D GL   F  + K        
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GT  Y++PE +  +     +DIWS G +L  M A + P+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 34/108 (31%), Positives = 58/108 (53%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           ++E    F Q++  ++ +HS+ + HRDLK  N+ L     +K+ DFG +  +  +     
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT 110
               CGT  Y+APE+  R   ++ AD+WS G+IL  +L    P+  P+
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 2/99 (2%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K+F QL S +E++HS+ + HRD+KP NV +     +K+ D GL   F  + K        
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GT  Y++PE +  +     +DIWS G +L  M A + P+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 24/151 (15%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + + +  QLI  + + H   I HRD+KPEN+L+   D LK+ DFG A      G      
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYT 159

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
           +   T  Y +PE+L+ +   +  D+WS G IL     GEL   +P               
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCIL-----GELSDGQPLF------------- 201

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNI 155
               P +  +++ L  I+++L PLP+ ++ +
Sbjct: 202 ----PGES-EIDQLFTIQKVLGPLPAEQMKL 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 160

Query: 72  YVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPW 106
           Y+APEVL + +     AD +S G +L  +L G  P+
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 43/113 (38%), Positives = 62/113 (54%), Gaps = 8/113 (7%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    QL+ G++Y+HS GI HRDLKP NV ++    L+I DFGLA   R    E  +   
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDE--MTGY 175

Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             T  Y APE+++   +  +  DIWS G I+  +L G+  +  P  D I+ L+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF--PGNDYIDQLK 226

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 41/101 (40%), Positives = 55/101 (54%), Gaps = 5/101 (4%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV-FRMNGKERPLDK 65
           Q F  QL+  ++Y+H+  + HRDLKP+N+L +    LKI DFGLA V F           
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 66  KCGTLPYVAPEVLVRSYLAE--PA-DIWSCGIILVAMLAGE 103
              T  Y APE L  S+ ++  PA DIWS G I   +L G+
Sbjct: 166 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 35/156 (22%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR----- 55
           +++   Q +  + +  ++ +H  G  HRD+KP+N+LLD +  +K+SDFGL T  +     
Sbjct: 98  LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Query: 56  ------------------MNGKERPLDKK----------CGTLPYVAPEVLVRSYLAEPA 87
                             MN K +    K           GT  Y+APEV +++   +  
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 88  DIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKD 121
           D WS G+I+  ML G  P+  + P     + + WK+
Sbjct: 218 DWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 15/183 (8%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H  G  HRD+KP+NVLLD    ++++DFG       +G  +    
Sbjct: 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-V 162

Query: 66  KCGTLPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEW 119
             GT  Y++PE+L      +       D WS G+ +  ML GE P + +   +   Y + 
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKI 220

Query: 120 KDNRHMQRSPWDRLDV--NCLSLIRRILAPLPSTRL---NIEKIKSHRWYSKHMPNDIVD 174
            +++   + P D  DV      LIRR++   P TRL    ++  K H ++     ++I +
Sbjct: 221 MNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRN 279

Query: 175 GPP 177
              
Sbjct: 280 STA 282

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 42/206 (20%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK----- 65
            Q+++G+  LH     HRDL P N+ ++ +   KI+DFGLA  +        L K     
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 66  -------KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPWDKPTADCIEYL 117
                  K  TL Y APE+L+ +     A D+WS G I   +L G+  +  P  + I+ L
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--PGENEIDQL 243

Query: 118 -------------EWKDNRHM-------QRSPWDRLDV------NCLSLIRRILAPLPST 151
                         W   + +        R P D   +      + + L++ +L   P  
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303

Query: 152 RLNIEKIKSHRWY-SKHMPNDIVDGP 176
           R++ ++   H ++ S  +P D    P
Sbjct: 304 RISAKEALKHEYFKSDPLPCDPSQLP 329

Length = 335

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 6/98 (6%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+H+ GI HRDLKP N+ ++    LKI DFGLA   R    E  +   
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSE--MTGY 175

Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
             T  Y APEV++   +  +  DIWS G I+  ML G+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 34/193 (17%)

Query: 5   EAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT----------- 52
           E  +F+  +++  +EYLH  GI +RDLKPEN+LL     + +SDF L+            
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 53  -----VFRMNGKERPLD-KKC----------GTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
                  R +    P +              GT  Y+APEV+         D W+ GI+L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222

Query: 97  VAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-- 154
             ML G  P+     D  E       + +       +  +   LIR++L   PS RL   
Sbjct: 223 YEMLYGTTPFKGSNRD--ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280

Query: 155 --IEKIKSHRWYS 165
               +IK H ++ 
Sbjct: 281 RGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 35/156 (22%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR----- 55
           + + E Q +  + +  ++ +H  G  HRD+KP+N+LLD +  +K+SDFGL T  +     
Sbjct: 98  LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157

Query: 56  ------------------MNGKERPLDKK----------CGTLPYVAPEVLVRSYLAEPA 87
                             MN K +    K           GT  Y+APEV +++   +  
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 88  DIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKD 121
           D WS G+I+  ML G  P+  + P     + + WK+
Sbjct: 218 DWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 38/112 (33%), Positives = 53/112 (47%), Gaps = 3/112 (2%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLHS+   HRDL   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDG 170

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             P  + A E L  +  +  +D+WS G+ L  +L        P     E + 
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 14/102 (13%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+HS GI HRDLKP N+ ++    LKI DFGLA         R  D +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---------RHADAE 170

Query: 67  CG----TLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
                 T  Y APEV++   +  +  DIWS G I+  ML G+
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 2/87 (2%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-CGT 69
           RQL+S ++Y+H +GI HRD+K ENVL++  + + + DFG A  F       P      GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGT 325

Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIIL 96
           +   APEVL         DIWS G+++
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVI 352

Length = 461

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 36/103 (34%), Positives = 59/103 (57%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA   F Q++  V ++HSK + HRD+K  N+LL     +K+ DFG + ++     +    
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
             CGT  YVAPE+  R   ++ AD++S G++L  +L  + P+D
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 10/113 (8%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +F   +  G+EYL SK + HRDL   N+L+      K+SDFGLA V  M      +D   
Sbjct: 104 QFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSK 158

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT----ADCIE 115
             + + APE L     +  +D+WS G++L  + + G  P+ K +     +C+E
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 42/115 (36%), Positives = 60/115 (52%), Gaps = 12/115 (10%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--TVFRMNGKERPLD 64
           Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA  T   M G      
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG------ 176

Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 177 -YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 228

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 20/110 (18%)

Query: 14  ISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           +  + YL  K G+ HRD+KP N+LLD    +K+ DFG++    ++ K +   +  G   Y
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK--TRSAGCAAY 180

Query: 73  VAPEVL----------VRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           +APE +          +R      AD+WS GI LV +  G+ P+     +
Sbjct: 181 MAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQFPYKNCKTE 224

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP---LDK 65
           F  QL+ G+ Y+H + I HRDLKP+N+L+     LK++DFGLA       K  P      
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA-----RAKSVPSHTYSN 162

Query: 66  KCGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAG--ELPWDKPTADCIEYL----- 117
           +  TL Y  P+VL+ S   +   D+W  G I V M+ G    P  K   D +E +     
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222

Query: 118 --------------EWKDNRHM------QRSPWDRLDV--NCLSLIRRILAPLPSTRLNI 155
                          +K  R         R  W++L    +   L  ++L   P  RL+ 
Sbjct: 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282

Query: 156 EKIKSHRWYSKHMP 169
           +   SH ++S   P
Sbjct: 283 QAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 8/99 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC--- 67
           R+L+  + YLH +GI HRD+K EN+ LD  +   + DFG A     +    P   +C   
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH----PDTPQCYGW 247

Query: 68  -GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            GTL   +PE+L         DIWS G++L  M    + 
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 20/100 (20%)

Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFG--------LATVFRMNGKERPLDK 65
           + G+ YLHS+ I HRD+KP N+LL  +  +K+ DFG        LA  F           
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF----------- 163

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
             GT  Y+APE +     +  +D+WS G+ L+ +     P
Sbjct: 164 -TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 25/166 (15%)

Query: 6   AQKFFR---QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRM 56
            QKF +   ++  G+ YL +K   HRDL   N ++    T+KI DFG+         +R 
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 57  NGKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADC 113
            GK        G LP  ++APE L        +D+WS G++L  M    E P+   + + 
Sbjct: 178 GGK--------GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE- 228

Query: 114 IEYLEW-KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
            E L++  D  H+     +      L L+R      P  R    +I
Sbjct: 229 -EVLKFVIDGGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 5/113 (4%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
            R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G 
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGK 170

Query: 70  LP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
           +P  + APE +        +D+WS GI++  +++ GE P W+    D I+ +E
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 3/103 (2%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M+    + F  Q++ G+ Y H + + HRDLKP+N+L++ +  LK++DFGLA    +  K 
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160

Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAG 102
                +  TL Y  P+VL+  S  +   D+W  G I   M +G
Sbjct: 161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 11/101 (10%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK---C 67
           R+ + G+ YLH  G  HRD+K  N+LL     +K++DFG++           + K+    
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFI 162

Query: 68  GTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELP 105
           GT  ++APEV     +       DIW+ GI  + +   + P
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 39/102 (38%), Positives = 50/102 (49%), Gaps = 23/102 (22%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFG----------LATVFRMN 57
           ++F QL+ GV Y+H + I HRDLK +N+ L   + LKI DFG          LAT F   
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTF--- 165

Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAM 99
                     GT  Y++PE L        +DIWS G IL  M
Sbjct: 166 ---------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTL 70
           QL   + Y+HSK I HRDLKP+N+L+D    TLK+ DFG A    +   +R +   C   
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF 235

Query: 71  PYVAPEVLVRSY-LAEPADIWSCGIILVAMLAG 102
            Y APE+++ +       D+WS G I+  M+ G
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)

Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 167

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  QL+ G+ Y H + + HRDLKP+N+L++ +  LK++DFGLA    +  K      +  
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVV 166

Query: 69  TLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAG 102
           TL Y  P++L+ S   +   D+W  G I   M  G
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 17/172 (9%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H     HRD+KP+N+L+D+   ++++DFG       +G  +    
Sbjct: 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV 162

Query: 66  KCGTLPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
             GT  Y++PE+L      +       D WS G+ +  ML GE P+    A+ +     K
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGK 219

Query: 121 DNRHMQR--SPWDRLDV--NCLSLIRRILAPLPSTRL---NIEKIKSHRWYS 165
              H +R   P    DV  +   LIRR++      RL    IE  K H +++
Sbjct: 220 IMNHKERFQFPAQVTDVSEDAKDLIRRLICS-REHRLGQNGIEDFKQHPFFT 270

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 2/97 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTL 70
           Q+ +G+ YL SK   HRDL   N+LL   D +KI DFGL      N       +      
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            + APE L     +  +D+W  G+ L  M   GE PW
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 3/87 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL SK   HRDL   N+L++ ++ +KI DFGL  V   + KE    ++ G  P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESP 174

Query: 72  --YVAPEVLVRSYLAEPADIWSCGIIL 96
             + APE L  S  +  +D+WS G++L
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVL 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 21/112 (18%)

Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFG--------LATVFRMNGKERPL 63
           ++ G+ YL  K  I HRD+KP N+L++ +  +K+ DFG        +A  F         
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--------- 158

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
               GT  Y++PE L  ++    +DIWS G+ LV M  G  P   P A  +E
Sbjct: 159 ---VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 10/90 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC--GT 69
           Q+  G+E+L SK   HRDL   NVL+     +KI+DFGLA         R    K   G 
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR----KTTNGR 195

Query: 70  LPY--VAPEVLV-RSYLAEPADIWSCGIIL 96
           LP   +APE L  R Y  + +D+WS G++L
Sbjct: 196 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLL 224

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 13/101 (12%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE---RPLDKKCG 68
           Q+  G+ YL  +   HRDL   N+L+      K++DFGLA +     KE      DKK  
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI----KEDVYLSSDKK-- 165

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            +PY   APE       +  +D+WS GI+L  M   G++P+
Sbjct: 166 -IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 33/112 (29%), Positives = 59/112 (52%), Gaps = 6/112 (5%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            Q+  G+ YL  K + HRDL   NVL+     +KI+DFGLA +  ++  E+    + G +
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LDVDEKEYHAEGGKV 173

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWD-KPTADCIEYLE 118
           P  ++A E ++       +D+WS G+ +  ++  G  P++  P  +  + LE
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           +Q +  + YLH   I HRDLK  N+L  L   +K++DFG++       + R  D   GT 
Sbjct: 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTP 167

Query: 71  PYVAPEVLV------RSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV++      R Y  + AD+WS GI L+ M   E P
Sbjct: 168 YWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 18/93 (19%)

Query: 25  IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL------ 78
           I HRD+KP N+LLD    +K+ DFG++    ++   +  D  C   PY+APE +      
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCR--PYMAPERIDPSARD 185

Query: 79  ---VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              VRS      D+WS GI L  +  G+ P+ K
Sbjct: 186 GYDVRS------DVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 23/171 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
             + G+ YLHS    HRD+K  N+LL    T+K++DFG A++        P +   GT  
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPY 176

Query: 72  YVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELPWDKP------TADCIEYLEWKDN 122
           ++APEV++           D+WS GI  +     EL   KP          + ++   D+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCI-----ELAERKPPLFNMNAMSALYHIAQNDS 231

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
             +  + W     N    +   L  +P  R + E++  HR+  +  P  ++
Sbjct: 232 PTLSSNDWSDYFRN---FVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 37/112 (33%), Positives = 57/112 (50%), Gaps = 6/112 (5%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R + SG++YL      HRDL   N+L++     K+SDFGL+        E     K G +
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE--DSEATYTTKGGKI 170

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
           P  + APE +        +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 1/93 (1%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R ++  ++YLH   I HRD+K EN+ ++    + + DFG A  F ++          GT+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTI 247

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE 103
              APE+L R       DIWS GI+L  M    
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 5/101 (4%)

Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++ G+ YL++   I HRD+KP N+L++ +  +K+ DFG++    +N      D   GT  
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIA---DTFVGTST 167

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           Y++PE +        +D+WS GI ++ +  G+ P+     D
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 5/104 (4%)

Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++ G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 167

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y++PE L  ++ +  +DIWS G+ LV +  G  P   P A  +E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)

Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +W A+     ++  ++ LH +GI  RDL P N+LLD +  ++++ F      R +  E  
Sbjct: 89  RWAAE-----MVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDS 138

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE-LPWDKPTADCIEYLEWKD 121
            D +     Y APEV   S   E  D WS G IL  +L G+ L    P+           
Sbjct: 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------I 189

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWY 164
           N H   +  + +     SL++++L   P+ RL      +E IKSH ++
Sbjct: 190 NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 11/102 (10%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
           R+ + G+ YLH   + HRD+K +N+LL     +K+ DFG+ A +    G+    +   GT
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR---NTFIGT 176

Query: 70  LPY-VAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP 105
            PY +APEV+      +      +D+WS GI  + +  G+ P
Sbjct: 177 -PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT-L 70
           Q+ SG+ YL ++   HRDL   NVL+   +  K++DFGLA V     KE   + + G   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKF 166

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           P  + APE  + +  +  +D+WS GI+L  ++  G +P+
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 8/107 (7%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  +  +H     HRD+KP+NVLLD+   ++++DFG       +G  +    
Sbjct: 104 ARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS-SV 162

Query: 66  KCGTLPYVAPEVL------VRSYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PE+L      +  Y  E  D WS G+ +  ML GE P+
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERP 62
           +    Q++ G+ YLH+  + HRDLKP N+L+      +  +KI+D G A +F  N   +P
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKP 168

Query: 63  ---LDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGE 103
              LD    T  Y APE+L+ + +  +  DIW+ G I   +L  E
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 11/115 (9%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL +    HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 106 KFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 158

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L     +  +D+WS GI+L  + + G +P+ + P  D +  +E
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++ G+ YL S  I HRD+KP N+L++ +  +K+ DFG++T   +N   +      GT  Y
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTY---VGTNAY 159

Query: 73  VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           +APE +        +D+WS GI  + +  G  P+ +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
            R + +G++YL      HRDL   N+L++     K+SDFGL+ V   +  E       G 
Sbjct: 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGK 171

Query: 70  LP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WD 107
           +P  + APE +        +D+WS GI++  +++ GE P WD
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 7/115 (6%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-- 67
            R + +G++YL      HRDL   N+L++     K+SDFGL+  F  +    P       
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSSLG 170

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELP-WDKPTADCIEYLE 118
           G +P  + APE +        +D+WS GI++   M  GE P WD    D I  +E
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERP 62
           +    Q++ G+ YLH+  + HRDLKP N+L+      +  +KI+D G A +F  N   +P
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKP 168

Query: 63  ---LDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGE 103
              LD    T  Y APE+L+ + +  +  DIW+ G I   +L  E
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 1/94 (1%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           K+  Q+  G++YL S+   HRDL   NVL++ +  +KI DFGL      + +   + D  
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
              + + APE L++S     +D+WS G+ L  +L
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 4/93 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +F Q+   ++++H + I HRD+K +N+ L    T+K+ DFG+A V     +   L + C 
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCI 162

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
           GT  Y++PE+         +DIW+ G +L  M 
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 13/102 (12%)

Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-VFRM 56
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA  V  +
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 57  NGKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
           +  ++  +   G LP  ++APE L        +D+WS GI++
Sbjct: 188 DYYKKTSN---GRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 7/112 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPL 63
           E +K  RQL+  +  LH   I H D+K ENVL D  +D + + D+GL    ++ G     
Sbjct: 110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC---KIIGTPSCY 166

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           D   GTL Y +PE +         D W+ G++   +L G+ P+ +   + ++
Sbjct: 167 D---GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215

Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL SK   HRDL   NVLL  +   KISDFG++      G +       G  P
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA-GSDYYRATTAGRWP 161

Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
             + APE +     +  +D+WS G+ L    + G  P+ +   A+ I  LE
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 10/87 (11%)

Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-----VFRMNGKERPLDKKCGT 69
           +G+EYL SK   HRDL   N L+  ++ LKISDFG++      V+   G  + +  K   
Sbjct: 105 AGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK--- 161

Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIIL 96
             + APE L     +  +D+WS GI+L
Sbjct: 162 --WTAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
           R+++ G+ +LH+  + HRD+K +NVLL     +K+ DFG+ A + R  G+        GT
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGT 184

Query: 70  LPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELP 105
             ++APEV+       +     +DIWS GI  + M  G  P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 8/91 (8%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +F Q+  GV+++H K + HRD+K +N+ L     +K+ DFG A +        P    C 
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----TSPGAYACT 159

Query: 68  --GTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
             GT  YV PE+         +DIWS G IL
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCIL 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 4/84 (4%)

Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP--Y 72
           +G+EYL SK   HRDL   N L+   + LKISDFG++      G    +      +P  +
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW 161

Query: 73  VAPEVLVRSYLAEPADIWSCGIIL 96
            APE L        +D+WS GI+L
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILL 185

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 40/115 (34%), Positives = 58/115 (50%), Gaps = 8/115 (6%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKK 66
           F  Q+  G+EYL SK   HRDL   N +LD   T+K++DFGLA    +  KE     +  
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHT 160

Query: 67  CGTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
              LP  ++A E L        +D+WS G++L  ++  G  P+ D  + D   YL
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 30/94 (31%), Positives = 54/94 (57%), Gaps = 2/94 (2%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL SK   HRDL   N L+D Q  +K+SDFGL+     +     +  K   + +  P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPP 170

Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EVL+ S  +  +D+W+ G+++  + + G++P+++
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 35/111 (31%), Positives = 60/111 (54%), Gaps = 6/111 (5%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+   + +KI+DFGLA +  + G E+  +   G +P
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL--LEGDEKEYNADGGKMP 174

Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
             ++A E +        +D+WS G+ +  ++  G  P+D  PT +  + LE
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 4/87 (4%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N  +       G LP
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRLP 202

Query: 72  --YVAPEVLVRSYLAEPADIWSCGIIL 96
             ++APE L        +D+WS G+++
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLM 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 204

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 2/109 (1%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL    + HRDL   NVL+   + +KI+DFGLA +  ++  E   D     + 
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           ++A E ++       +D+WS G+ +  ++  G  P+D  P  +  + LE
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 14/92 (15%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRM------NGKERPLD 64
           Q+  G+ YLH +G+ H+D+   N ++D +  +KI+D  L+  +F M      + + RP+ 
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
                  ++A E LV    +  +D+WS G++L
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLL 209

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL S+   HRDL   NVL+   + +KI+DFGLA  V  ++  ++  +   G L
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN---GRL 198

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC----- 67
           +++ +EY+H  GI+H D+KPEN+++D  +   I D+G+A+ F ++GK     K+      
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHR 194

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GTL Y   +    + +    D+ S G  ++     +LPW
Sbjct: 195 GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233

Length = 294

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 12/91 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           Q+ +G+EYL S    HRDL   N L+    T+KISDFGL      A  +R+  K   L  
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK-SLLPV 190

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
           +     ++ PE ++       +DIWS G++L
Sbjct: 191 R-----WMPPEAILYGKFTTESDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 16/99 (16%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++F Q+   ++YLH K I HRDLK +NV L   + +K+ D G+A         R L+ +C
Sbjct: 106 EWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA---------RVLENQC 156

Query: 68  -------GTLPYVAPEVLVRSYLAEPADIWSCGIILVAM 99
                  GT  Y++PE+         +D+W+ G  +  M
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 13/164 (7%)

Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+ YLHS  + HRD+K  N+LL     +K+ DFG A++        P +   GT  ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWM 178

Query: 74  APEVLV---RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSP 129
           APEV++           D+WS GI  + +   + P ++      + ++   ++  +Q   
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           W     N    +   L  +P  R   E +  HR+  +  P  ++
Sbjct: 239 WSEYFRN---FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 13/164 (7%)

Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+ YLHS  + HRD+K  N+LL     +K++DFG A++        P +   GT  ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWM 188

Query: 74  APEVLV---RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSP 129
           APEV++           D+WS GI  + +   + P ++      + ++   ++  +Q + 
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248

Query: 130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           W     N    +   L  +P  R   E++  H +  +  P  ++
Sbjct: 249 WSDYFRN---FVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 40/122 (32%), Positives = 58/122 (47%), Gaps = 5/122 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+E+L SK   HRDL   NVLL     +KI DFGLA     +     + K   
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGST 299

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +  +     +D+WS GI+L  + + G  P+     D   Y + K    M
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359

Query: 126 QR 127
            +
Sbjct: 360 AK 361

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 16/104 (15%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----C 67
            +   +EYL S G  HRDL   N L+   + +K+SDFGLA           LD +     
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV--------LDDQYTSSQ 159

Query: 68  GT---LPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWD 107
           GT   + +  PEV   S  +  +D+WS G+++  + + G++P++
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 53/207 (25%), Positives = 80/207 (38%), Gaps = 61/207 (29%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRM----NGKERPLDKK- 66
           + +  +E +H  G  HRD+KP+N+L+D    +K+SDFGL+T F         ++ L  K 
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 67  ----------------------------------------CGTLPYVAPEVLVRSYLAEP 86
                                                    GT  Y+APE+ ++    + 
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 87  ADIWSCGIILVAMLAGELPWDKPTADCIE-----YLEWKDNRHMQRSPWD-RLDVNCLSL 140
            D WS G I+   L G  P+      C E     Y +  + R     P D  L V    L
Sbjct: 229 CDWWSLGAIMFECLIGWPPF------CSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282

Query: 141 IRRILAPLPSTRL---NIEKIKSHRWY 164
           IRR++      RL      +IKSH ++
Sbjct: 283 IRRLITN-AENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 170

Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLL 195

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 5/98 (5%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ + G+ YLHSKG  HRD+K  N+LL     +K++DFG++        +R      GT 
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTP 170

Query: 71  PYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV     +    +  DIW+ GI  + +   + P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 1/97 (1%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +   + KE   +     + 
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWD 107
           ++A E ++       +D+WS G+ +  ++  G  P+D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 6/101 (5%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG---KERPLDKKCG 68
           Q+  G++YL  K   HRDL   NVLL  Q   KISDFGL+     +    K R   K   
Sbjct: 103 QVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK--W 160

Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPWDK 108
            L + APE +     +  +D+WS GI +  A   G+ P+ K
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 14/105 (13%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F  Q+  G+ Y+  K   HRDL+  NVL+      KI+DFGLA V   N      G + P
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           +        + APE +        +D+WS GI+L  ++  G++P+
Sbjct: 168 IK-------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 35/95 (36%), Positives = 47/95 (49%), Gaps = 4/95 (4%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +   F  Q+  G+ +L SK   HRDL   NVLL     +KI DFGLA    MN     +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNY-V 198

Query: 64  DKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
            K    LP  ++APE +        +D+WS GI+L
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 233

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 13/91 (14%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERPLDK 65
           Q+  G+ YL S+   HRDL   N+L+      KI+DFGLA +   +      G + P+  
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK- 169

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
                 + APE          +D+WS GI+L
Sbjct: 170 ------WTAPEAANYGRFTIKSDVWSFGILL 194

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 32/120 (26%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMN----GKER 61
           Q   RQ++  ++ LHS GI HRD+KP+N++      + KI D G A   R+      KE 
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317

Query: 62  PLDKKCGTLPYVAPE----------------------VLVRSYLAEPADIWSCGIILVAM 99
            LD +     Y APE                      VL +  L +  DI+S G+I + M
Sbjct: 318 LLDPR-----YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Length = 566

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 13/95 (13%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-----VFRMNG-KER 61
           KF     +G+ YL SK   HRDL   N L+   + LKISDFG++      ++  +G K+ 
Sbjct: 97  KFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIIL 96
           P+        + APE L     +  +D+WS GI+L
Sbjct: 157 PIK-------WTAPEALNYGRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F  Q+  G+ ++  +   HRDL+  N+L+      KI+DFGLA V   N      G + P
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLEWK 120
           +        + APE +        +D+WS GI+L+ ++  G +P+   +  + I  LE  
Sbjct: 167 IK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-- 217

Query: 121 DNRHMQRS 128
               M R 
Sbjct: 218 RGYRMPRP 225

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL   + +KI DFGLA  +++     R  D +   L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PL 245

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 9/101 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
           R+++ G+ +LH   + HRD+K +NVLL     +K+ DFG+ A + R  G+        GT
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGT 174

Query: 70  LPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELP 105
             ++APEV+       +     +D+WS GI  + M  G  P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+ +G+E+L SK   HRDL   NVL+     +KI DFGLA     +     + K   
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISKGST 301

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
            LP  ++APE +  +     +D+WS GI+L
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILL 331

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ + G+ YLHSKG  HRD+K  N+LL     +K++DFG+A        +R      GT 
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTP 170

Query: 71  PYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGEL 104
            ++APEV          +  DIW+ GI  + +   EL
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL--AEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +F   + +G++YL  K   HRDL   NVL+      KI+DFGL+      G+E  + K  
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKTM 177

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
           G LP  ++A E L  S     +D+WS G++L
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 12/102 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           Q++  +   H++GI HRDLKP+N+++    ++   K+ DFG+ T+  + G          
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLT 144

Query: 68  ------GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE 103
                 GT  Y APE L    +   +D+++ G+I +  L G+
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.8 bits (126), Expect = 8e-08
 Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 10/114 (8%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F   +  G++YL  K   HRDL   N+L+      KI+DFGL+      G+E  + K  
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTM 170

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLE 118
           G LP  ++A E L  S     +D+WS G++L  +++ G  P+   T  C E  E
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYE 222

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 5/101 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTL-KISDFGLATVFRMNGKERPLDKKC 67
           +F Q+  G++++H + I HRD+K +N+ L     + K+ DFG+A   R       L   C
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTC 162

Query: 68  -GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
            GT  Y++PE+          DIWS G +L  +   + P++
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 10/121 (8%)

Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+ YLHS  + HRD+K  N+LL     +K++DFG A+         P +   GT  ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWM 184

Query: 74  APEVLV---RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSP 129
           APEV++           D+WS GI  + +   + P ++      + ++   D+  +Q + 
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244

Query: 130 W 130
           W
Sbjct: 245 W 245

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 6/88 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL   + +KI DFGLA  +++     R   K    L
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---KGSARL 238

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE +        +D+WS G++L
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLL 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 3/87 (3%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G++YL      HRDL   NVLL  Q   KISDFGL+     + +     K  G  P
Sbjct: 103 QVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWP 161

Query: 72  --YVAPEVLVRSYLAEPADIWSCGIIL 96
             + APE +     +  +D+WS G+++
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLM 188

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+++LH+  I HRD+K  N+LL  +  +K+ DFG++         R  +   GT  ++AP
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAP 197

Query: 76  EVLV------RSYLAEPADIWSCGIILVAMLAGELP 105
           EV+        SY A   D+WS GI  + +  G+ P
Sbjct: 198 EVIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 21/48 (43%), Positives = 34/48 (70%)

Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV 53
           A K+  ++   ++YLH  GI HRDLKP+N+L+  +  +K++DFGL+ V
Sbjct: 106 AVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 28/85 (32%), Positives = 45/85 (52%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ +G+EYL S    H+DL   N+L+  Q  +KISD GL+         R   K    + 
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++ PE ++    +  +DIWS G++L
Sbjct: 192 WMPPEAIMYGKFSSDSDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F   +  G++YL  K   HRDL   N+L+      KI+DFGL+      G+E  + K  G
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMG 183

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
            LP  ++A E L  S     +D+WS G++L
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL   + +KI DFGLA  +++     R  D +   L
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PL 239

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLL 265

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 15/115 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERPLDK 65
           Q+  G+ ++  K   HRDL+  N+L+      KI+DFGLA +   N      G + P+  
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
                 + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 169 ------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE 217

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 14/105 (13%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
              Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N      G + P
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           +        + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 167 IK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 41/128 (32%), Positives = 59/128 (46%), Gaps = 34/128 (26%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA----TVFRMNGKERPLDKK 66
           RQ+++G+  LH  GI HRD+KPEN+L+ +   +KI DFG A    T    N     LD +
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375

Query: 67  CGTLPYVAPEVLV--RSYLAEPA--------------------DIWSCGIILVAMLAGEL 104
                Y  PE LV  +S    PA                    D ++ G++L+ M   EL
Sbjct: 376 -----YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL 430

Query: 105 PWDKPTAD 112
              +P A+
Sbjct: 431 ---RPVAN 435

Length = 507

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 5/127 (3%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +  +F  Q+  G+++L SK   HRD+   NVLL      KI DFGLA    MN     +
Sbjct: 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVV 270

Query: 64  DKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWK 120
            K    LP  ++APE +        +D+WS GI+L  + + G+ P+     +   Y   K
Sbjct: 271 -KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329

Query: 121 DNRHMQR 127
               M R
Sbjct: 330 RGYQMSR 336

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 22/102 (21%)

Query: 25  IAHRDLKPENVLLDLQDTLKISDFGL-----ATVFRMNGKERPLDKKCGTLPYVAPEVL- 78
           I HRD+KP NVL++    +K+ DFG+     A++ + N          G   Y+APE + 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---------IGCQSYMAPERIK 174

Query: 79  ------VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
                   +Y  + +D+WS G+ ++ M  G  P+   T   I
Sbjct: 175 SGGPNQNPTYTVQ-SDVWSLGLSILEMALGRYPYPPETYANI 215

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   R +     + K   
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY--VVKGNA 276

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
            LP  ++APE +        +D+WS GI+L
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILL 306

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKC 67
           F  Q+  G++YL    + HRDL   NVL+     +KISDFGL+  V+    ++  + +  
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE---EDSYVKRSK 188

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
           G +P  ++A E L        +D+WS G++L
Sbjct: 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 16/103 (15%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----CGT-- 69
           G+EYL      HRDL   N L+     +K+SDFG+            LD +     G   
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV--------LDDEYTSSSGAKF 163

Query: 70  -LPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            + +  PEV   S  +  +D+WS G+++  +   G++P++K +
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 16/127 (12%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERPLDK 65
           Q+ +G+ Y+      HRDL+  N+L+      KI+DFGLA +   N      G + P+  
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRH 124
                 + APE  +       +D+WS GI+L  ++  G +P+  P  +  E LE  +  +
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY--PGMNNREVLEQVERGY 220

Query: 125 MQRSPWD 131
               P D
Sbjct: 221 RMPCPQD 227

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 1/96 (1%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ YL S+   HRDL   N L+     +KI DFG++         R        + 
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           ++ PE ++       +D+WS G+IL  +   G+ PW
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 11/102 (10%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+++LH     HRD+K  N+LL  +  +K+ DFG++         R  +   GT  ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAP 193

Query: 76  EVL-----VRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           EV+     + S      D+WS GI  + +  G    D P AD
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDG----DPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 3/108 (2%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           L SG++YL   G  H+ L    VL++     KIS F      +       +  K   L +
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-W 174

Query: 73  VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            APE +   + +  +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 18/105 (17%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLDK 65
           Q+ SG++YL S    HRDL   N L+    T+KI+DFG++        +R+ G+      
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR------ 190

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIILVAM--LAGELPW 106
               LP  ++A E ++       +D+W+ G+ L  M  L  E P+
Sbjct: 191 --AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 1/107 (0%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + Q +     +Q+ +G+ YL S+   HRDL   N L+     +KI DFG++         
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           R        + ++ PE ++       +D+WS G++L  +   G+ PW
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 30/161 (18%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLDK 65
           Q+ SG+ YL S+   HRDL   N L+     +KI DFG++        +R+ G       
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT----- 184

Query: 66  KCGTLP--YVAPE-VLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKD 121
               LP  ++ PE ++ R +  E +D+WS G++L  +   G+ PW   + +  E +E   
Sbjct: 185 ---MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT 238

Query: 122 NRHMQRSPWDRLDVNCLSLIRRIL----APLPSTRLNIEKI 158
              + + P       C S +  I+       P  R+NI+ I
Sbjct: 239 QGRLLQRPRT-----CPSEVYDIMLGCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 16/93 (17%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+         +R  GK      
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK------ 180

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             G LP  ++APE L        +D+WS G++L
Sbjct: 181 --GLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 36/130 (27%), Positives = 60/130 (46%), Gaps = 7/130 (5%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   + SG+EYL SK   HRDL   N +L+    + ++DFGL+         R    + 
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRI 173

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRH 124
             +P  ++A E L        +D+WS G+ +  +   G+ P+  P  +  E  ++    +
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY--PGVENSEIYDYLRQGN 231

Query: 125 MQRSPWDRLD 134
             + P D LD
Sbjct: 232 RLKQPPDCLD 241

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 14/102 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERPLDK 65
           Q+  G+ Y+      HRDL+  N+L+      KI+DFGLA +   N      G + P+  
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                 + APE  +       +D+WS GI+L  ++  G +P+
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 23/117 (19%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLDK 65
           Q+ SG+ YL S    HRDL   N L+     +KI DFG++        +R+ G+      
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT----- 184

Query: 66  KCGTLP--YVAPE-VLVRSYLAEPADIWSCGIILVAMLA-GELPW----DKPTADCI 114
               LP  ++ PE +L R +  E +DIWS G++L  +   G+ PW    +    +CI
Sbjct: 185 ---MLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 2/96 (2%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL S  + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM-TRFVLDDQYTSSTGTKFPVKWSSP 170

Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
           EV   S  +  +D+WS G+++  + + G+ P++  +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 19/105 (18%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           ++  G+ YL++    HRDL   N ++    T+KI DFG+         +R  GK      
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK------ 180

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPW 106
             G LP  +++PE L        +D+WS G++L  +A LA E P+
Sbjct: 181 --GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-EQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 16/93 (17%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           Q+ +G+E+L S  + H+DL   NVL+  +  +KISD GL      A  +++ G       
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS----- 186

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
               LP  +++PE ++    +  +DIWS G++L
Sbjct: 187 ---LLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 7/103 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +F   + SG+EYL SK   HRDL   N +L+   T+ ++DFGL+         R   + C
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR---QGC 173

Query: 68  GT-LP--YVAPEVLVRSYLAEPADIWSCGIILVA-MLAGELPW 106
            + LP  ++A E L  +     +D+W+ G+ +   M  G+ P+
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 23/90 (25%), Positives = 47/90 (52%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL    + HR+L   N+LL     ++I+DFG+A +   + K+    +    + 
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           ++A E ++       +D+WS G+ +  M++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 31/125 (24%)

Query: 11  RQLISGVEYLHS-------KGIAHRDLKPENVLLDL-----------------QDTLKIS 46
           RQL+  + Y H+       + + HRDLKP+N+ L                   +   KI 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 47  DFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGE 103
           DFGL+   +  G E       GT  Y +PE+L+   +SY  + +D+W+ G I+  + +G+
Sbjct: 185 DFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGK 240

Query: 104 LPWDK 108
            P+ K
Sbjct: 241 TPFHK 245

Length = 1021

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 18/109 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLDK 65
           Q+ SG++YL S    HRDL   N L+    T+KI+DFG++        +R+ G+      
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGR------ 199

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPWDKPT 110
               LP  ++A E ++       +D+W+ G+ L  + ML  E P+ + T
Sbjct: 200 --AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 35/163 (21%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQD-----TLKISDFGLAT------VFRMNGKERPLD 64
           G  YL      HRDL   N L+  +       +KI DFGLA        +R  G+     
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE----- 172

Query: 65  KKCGTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEW-K 120
              G LP  ++APE L+       +D+WS G+++  +L  G+ P+  P  +  E L+   
Sbjct: 173 ---GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQEVLQHVT 227

Query: 121 DNRHMQRSPWDRLDVNC----LSLIRRILAPLPSTRLNIEKIK 159
               +Q+        NC      L+    A  PS R   ++I+
Sbjct: 228 AGGRLQKPE------NCPDKIYQLMTNCWAQDPSERPTFDRIQ 264

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 19/161 (11%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  QL + + YL SK   HRD+   NVL+   D +K+ DFGL+   R    E       
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASK 167

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLEWKDNR 123
           G LP  ++APE +        +D+W  G+ +  +L  G  P+      D I  +E  +  
Sbjct: 168 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-- 225

Query: 124 HMQRSPWDRLDVNC----LSLIRRILAPLPSTRLNIEKIKS 160
              R P   +  NC     SL+ +  A  PS R    ++K+
Sbjct: 226 ---RLP---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 25/95 (26%), Positives = 35/95 (36%), Gaps = 15/95 (15%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            Q +  +  LH +  +   L   + LL L         G         K     +     
Sbjct: 24  LQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSVAF-----KTPEQSR--PDP 68

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            ++APEV+      E ADI+S GI L   L  ELP
Sbjct: 69  YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 16/93 (17%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLDK 65
           Q+ SG++YL S    HRDL   N L+    T+KI+DFG++        +R+ G+      
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGR------ 191

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
               LP  +++ E ++       +D+W+ G+ L
Sbjct: 192 --AVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 7/103 (6%)

Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLD---- 64
            + +++ ++Y+HSKG  HR +K  ++LL     + +S    +     +GK +R +     
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 65  KKCGTLPYVAPEVLVRSYLA--EPADIWSCGIILVAMLAGELP 105
                LP+++PEVL ++     E +DI+S GI    +  G +P
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 19/92 (20%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLA------TVFRMNGKERPLDKK 66
           G +YL      HRD+   N LL         KI+DFG+A      + +R  G+       
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR------- 180

Query: 67  CGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
              LP  ++ PE  +        D+WS G++L
Sbjct: 181 -AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 16/94 (17%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLD 64
           +Q+ +G+ YL  +   HRDL   N L+     +KI+DFGL      A  ++ +  +    
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND---- 192

Query: 65  KKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
                +P  ++ PE +  +     +D+W+ G++L
Sbjct: 193 ----AIPIRWMPPESIFYNRYTTESDVWAYGVVL 222

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 13/102 (12%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL- 63
             Q+   ++ +GV ++H     H DL   N  L    T+K+ D+G+        KE  + 
Sbjct: 100 LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS---RYKEDYIE 156

Query: 64  --DKKCGTLPYVAPEV-------LVRSYLAEPADIWSCGIIL 96
             D KC  L ++APE+       L+ +   +P+++W+ G+ L
Sbjct: 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL 198

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 24/127 (18%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           Q+ SG+ YL S    HRDL   N L+    T+KI+DFG+      +  +R+ G  R    
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG--RAP-- 193

Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPWDK-PTADCIEYLEWK 120
               LP  ++A E ++       +D+W+ G+ L  +  L  E P++       IE     
Sbjct: 194 ----LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG-- 247

Query: 121 DNRHMQR 127
              H  R
Sbjct: 248 ---HFFR 251

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 17/44 (38%), Positives = 26/44 (59%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA 51
           KF   +  G+EYL ++   HRDL   N +L    T+ ++DFGL+
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 27/155 (17%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--------LKISDFGLA-TVFRMNGKER 61
           +QL   + +L  KG+ H ++  +NVLL  ++         +K+SD G++ TV        
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL------- 159

Query: 62  PLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTA--DCIEYLE 118
           P +     +P+V PE +     L+  AD WS G  L  + +G    DKP +  D  + L+
Sbjct: 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG---DKPLSALDSQKKLQ 216

Query: 119 WKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTR 152
           + ++RH   +P W  L     +LI + +   P  R
Sbjct: 217 FYEDRHQLPAPKWTEL----ANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 33/133 (24%)

Query: 6   AQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           AQ  F Q    ++Y H++  + H DLKPEN+L++  DT          V  +  +  P D
Sbjct: 234 AQIIF-QTGVALDYFHTELHLMHTDLKPENILMETSDT---------VVDPVTNRALPPD 283

Query: 65  ----KKC----------------GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGEL 104
               + C                 T  Y +PEV++        D+WS G I+  +  G+L
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343

Query: 105 PWDKPTADCIEYL 117
            +D  T D +E+L
Sbjct: 344 LYD--THDNLEHL 354

Length = 467

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 13/100 (13%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER---PL 63
           Q+   ++  G+ +LH     H DL   N LL    T+KI D+GL+       KE      
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS---HNKYKEDYYVTP 159

Query: 64  DKKCGTLPYVAPEVL--VRSYL-----AEPADIWSCGIIL 96
           D+    L ++APE++  V   L      + +++WS G+ +
Sbjct: 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 32/137 (23%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+++L +    HRDL   N L+  Q  +K+S   L+  V+  N +   L      L
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY--NSEYYKLRNALIPL 182

Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSP 129
            ++APE +     +  +D+WS G+++  +   GELP+   + +  E L       ++   
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQAGKLELPV 240

Query: 130 WDRLDVNCLSLIRRILA 146
            +     C S + +++ 
Sbjct: 241 PE----GCPSRLYKLMT 253

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 11/108 (10%)

Query: 4   WEA-QKFFRQLISGVEYLH---SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           WE  +K    +   + +LH   S  +   +L PE +++D +D   +    L  +   +  
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835

Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
                K   +  YVAPE      + E +DI+  G+IL+ +L G+ P D
Sbjct: 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 14/109 (12%)

Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRM--NGKERPL-----DK 65
           ++  ++Y+H  G  HR +K  ++L+ +   + +S  GL +   M  +G+   +       
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKY 167

Query: 66  KCGTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW-DKPT 110
               LP+++PEVL   ++ Y A+ +DI+S GI    +  G +P+ D P 
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 15/104 (14%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLL-------DLQDTLKISDFGLATVFRMNGKERPL 63
           +QL S + YL  K + H ++  +N+LL            +K+SD G++  F    +E  +
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181

Query: 64  DKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAM-LAGELP 105
           ++    +P++APE +   + L+  AD WS G  L+ +   GE+P
Sbjct: 182 ER----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 7/97 (7%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q+   ++ SG+ +LH     H DL   N  L    ++KI D+GLA            D  
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162

Query: 67  CGTLPYVAPEVL-VRSYLAEPAD------IWSCGIIL 96
              L ++APE++ +R     P D      IWS G+ +
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	407
KOG0598|consensus	357		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0588|consensus	786		100.0
KOG0592|consensus	604		100.0
KOG0033|consensus	355		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
KOG0694|consensus	694		100.0
KOG0581|consensus	364		100.0
KOG0599|consensus	411		100.0
KOG0605|consensus	550		100.0
KOG0198|consensus	313		100.0
KOG0578|consensus	550		100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0661|consensus	538		100.0
KOG0600|consensus	560		100.0
KOG0593|consensus	396		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0585|consensus	576		100.0
KOG0986|consensus	591		99.98
KOG0604|consensus	400		99.98
KOG0660|consensus	359		99.98
KOG0659|consensus	318		99.98
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.98
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.98
KOG0610|consensus	459		99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
KOG0690|consensus	516		99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
KOG0594|consensus	323		99.97
KOG0591|consensus	375		99.97
KOG0696|consensus	683		99.97
KOG0032|consensus	382		99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
KOG0582|consensus	516		99.97
KOG0663|consensus	419		99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
KOG0614|consensus	732		99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
KOG0597|consensus	808		99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
KOG0658|consensus	364		99.97
KOG4717|consensus	864		99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
KOG0595|consensus	429		99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
KOG0612|consensus	1317		99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
KOG0983|consensus	391		99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
KOG0611|consensus	668		99.97
KOG0603|consensus	612		99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
KOG0580|consensus	281		99.97
KOG0201|consensus	467		99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
KOG0192|consensus	362		99.96
KOG0695|consensus	593		99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
KOG0596|consensus	677		99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
KOG0608|consensus	1034		99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
KOG0579|consensus	1187		99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
KOG0589|consensus	426		99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
KOG4279|consensus	1226		99.95
KOG0607|consensus	463		99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
KOG0667|consensus	586		99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
KOG0586|consensus	596		99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
KOG0669|consensus	376		99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
KOG4645|consensus	1509		99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
KOG0193|consensus	678		99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
KOG4721|consensus	904		99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
KOG4236|consensus	888		99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG0666|consensus	438		99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
KOG0665|consensus	369		99.94
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
KOG0671|consensus	415		99.94
KOG2345|consensus	302		99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
KOG1989|consensus	738		99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
KOG0662|consensus	292		99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
KOG0584|consensus	632		99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
KOG1035|consensus	1351		99.93
KOG0197|consensus	468		99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
KOG0577|consensus	948		99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.92
KOG1006|consensus	361		99.92
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
KOG0574|consensus	502		99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.91
KOG1027|consensus	903		99.91
KOG1151|consensus	775		99.91
KOG0590|consensus	601		99.9
KOG0668|consensus	338		99.9
KOG0670|consensus	752		99.9
KOG0664|consensus	449		99.9
KOG1026|consensus	774		99.9
KOG1095|consensus	1025		99.89
KOG1187|consensus	361		99.89
KOG0984|consensus	282		99.88
KOG0587|consensus	953		99.87
KOG4257|consensus	974		99.86
KOG0199|consensus	1039		99.86
KOG0194|consensus	474		99.86
KOG0590|consensus	601		99.85
KOG0200|consensus	609		99.85
KOG1167|consensus	418		99.84
KOG0603|consensus	612		99.83
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.83
KOG1024|consensus	563		99.83
KOG4250|consensus	732		99.83
KOG0196|consensus	996		99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG4278|consensus	1157		99.82
KOG0606|consensus	1205		99.82
KOG1094|consensus	807		99.82
KOG3653|consensus	534		99.81
KOG1345|consensus	378		99.81
KOG1290|consensus	590		99.81
KOG1025|consensus	1177		99.79
KOG1152|consensus	772		99.78
KOG2052|consensus	513		99.77
KOG0576|consensus	829		99.76
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.74
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.71
KOG1164|consensus	322		99.68
KOG1033|consensus	516		99.67
KOG4158|consensus	598		99.66
KOG1240|consensus	1431		99.64
KOG1165|consensus	449		99.46
KOG1023|consensus	484		99.44
KOG1163|consensus	341		99.42
KOG0195|consensus	448		99.36
PRK09188	365	serine/threonine protein kinase; Provisional	99.36
PRK12274	218	serine/threonine protein kinase; Provisional	99.34
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	99.3
KOG0606|consensus	1205		99.25
KOG1166|consensus	974		99.19
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.17
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.14
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.11
KOG2137|consensus	700		99.09
KOG0601|consensus	524		98.86
smart00090	237	RIO RIO-like kinase.	98.86
KOG1266|consensus	458		98.85
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.71
PRK10345	210	hypothetical protein; Provisional	98.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.57
PRK14879	211	serine/threonine protein kinase; Provisional	98.55
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.35
KOG0601|consensus	524		98.32
KOG1243|consensus	690		98.25
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.06
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.93
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.84
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.77
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	97.66
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.62
KOG3741|consensus	655		97.59
KOG3087|consensus	229		97.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.36
PRK09902	216	hypothetical protein; Provisional	97.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.1
KOG1035|consensus	1351		96.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.58
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.49
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	95.89
KOG1826|consensus	2724		95.68
KOG0576|consensus	829		95.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.58
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.54
PRK05231	319	homoserine kinase; Provisional	94.37
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.37
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.93
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.46
PF01636	239	APH: Phosphotransferase enzyme family This family	93.43
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.87
PRK10271	188	thiK thiamine kinase; Provisional	92.82
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	92.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	91.98
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	91.72
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	91.6
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.35
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.21
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.0
KOG2268|consensus	465		90.98
COG2334	331	Putative homoserine kinase type II (protein kinase	90.88
PLN02236	344	choline kinase	90.83
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	87.52
PRK06148	1013	hypothetical protein; Provisional	86.65
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	86.34
PHA03111	444	Ser/Thr kinase; Provisional	86.24
PRK11768	325	serine/threonine protein kinase; Provisional	86.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	85.14
KOG1093|consensus	725		84.88
PRK06149	972	hypothetical protein; Provisional	84.52
COG4499	434	Predicted membrane protein [Function unknown]	83.82
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	80.92

>KOG0598|consensus

Probab=100.00  E-value=1e-38  Score=304.36  Aligned_cols=182  Identities=31%  Similarity=0.497  Sum_probs=155.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|..|+.|+.+|+.||.|||++||+||||||+|||||.+|+++|+|||+++.....+  ....+.|||+.|||||++.+
T Consensus       122 F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~  199 (357)
T KOG0598|consen  122 FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLG  199 (357)
T ss_pred             cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhc
Confidence            5789999999999999999999999999999999999999999999999998643332  34456899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC----CHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL----NIE  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp----s~~  156 (407)
                      ..|+.++|+||||+++|+|++|.+||.+.+.......+....   ...+...++.++++||+++|+.+|++|.    ++.
T Consensus       200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~  276 (357)
T KOG0598|consen  200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAE  276 (357)
T ss_pred             CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChH
Confidence            999999999999999999999999999988765444443332   1222244899999999999999999996    789


Q ss_pred             HHHhCcccccCCCCCCCCCCCCCCCchhHHh
Q psy11119        157 KIKSHRWYSKHMPNDIVDGPPSSDFNSTAKR  187 (407)
Q Consensus       157 eil~hpwf~~~~~~~~~~~~~~~~~~~~~~~  187 (407)
                      +|.+||||....|+....+...++|.+...+
T Consensus       277 ~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~  307 (357)
T KOG0598|consen  277 EIKRHPFFKGINWEKLLAKKLSPPFKPNVTG  307 (357)
T ss_pred             HhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence            9999999999999998888777777765443

>KOG0575|consensus

Probab=100.00  E-value=6.1e-38  Score=314.70  Aligned_cols=162  Identities=35%  Similarity=0.590  Sum_probs=142.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+|+.|++||+.||.|||+++|+|||||..|++++++.++||+|||+|+.+...+  ....+.||||.|+|||++.+
T Consensus       115 ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k  192 (592)
T KOG0575|consen  115 LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNK  192 (592)
T ss_pred             CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhcc
Confidence            6899999999999999999999999999999999999999999999999999886443  33467899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++..+||||+||+||.||.|++||+..+..+....+...  .+..  +..++.++++||.+||.+||.+|||+++|+.
T Consensus       193 ~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--~Y~~--P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  193 SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--EYSM--PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--Cccc--ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999999999999988766543333222  2222  2468999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      |+||++++
T Consensus       269 h~Ff~~g~  276 (592)
T KOG0575|consen  269 HPFFKSGF  276 (592)
T ss_pred             CHhhhCCC
Confidence            99996654

>KOG0615|consensus

Probab=100.00  E-value=5.5e-39  Score=308.89  Aligned_cols=164  Identities=37%  Similarity=0.640  Sum_probs=141.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +.|...+.|++||+.||.|||++||+||||||+|||+..+   -.+||+|||+|+...   ......+.||||.|.|||+
T Consensus       273 l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEV  349 (475)
T KOG0615|consen  273 LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEV  349 (475)
T ss_pred             cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhh
Confidence            3577788999999999999999999999999999999866   569999999998753   3456678999999999999


Q ss_pred             hhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRS---YLAEPADIWSCGIILVAMLAGELPWDKPTADC-IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.++   ++..++|+||+||+||.+|+|.+||.+...+. ....+.+....+..+.|..+++++++||.+||..||++||
T Consensus       350 l~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~  429 (475)
T KOG0615|consen  350 LASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP  429 (475)
T ss_pred             eecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc
Confidence            9865   45568899999999999999999998776554 3344444545555678999999999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      |+.|+|+||||+..
T Consensus       430 s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  430 SADEALNHPWFKDA  443 (475)
T ss_pred             CHHHHhcChhhhcc
Confidence            99999999999864

>KOG0588|consensus

Probab=100.00  E-value=2.1e-37  Score=312.27  Aligned_cols=164  Identities=38%  Similarity=0.696  Sum_probs=143.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+|.++|+||+.||.|||..+|+||||||+|+|||..+++||+|||+|..-.   ....+.+.||+|.|.|||++.+
T Consensus       109 l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G  185 (786)
T KOG0588|consen  109 LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSG  185 (786)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcC
Confidence            6899999999999999999999999999999999999999999999999998633   3356778999999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . |.+.++||||||||||.||+|.+||++.+......+...+  .+.  .+..++.++++||++||..||++|+|.+||+
T Consensus       186 ~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--~f~--MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~  261 (786)
T KOG0588|consen  186 RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--VFE--MPSNISSEAQDLLRRMLDVDPSTRITTEEIL  261 (786)
T ss_pred             CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--ccc--CCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence            8 8999999999999999999999999988766443333222  222  2367999999999999999999999999999


Q ss_pred             hCcccccCCCCC
Q psy11119        160 SHRWYSKHMPND  171 (407)
Q Consensus       160 ~hpwf~~~~~~~  171 (407)
                      +|||+.+.....
T Consensus       262 kHP~l~g~~~~~  273 (786)
T KOG0588|consen  262 KHPFLSGYTSLP  273 (786)
T ss_pred             hCchhhcCCCCC
Confidence            999999875433

>KOG0592|consensus

Probab=100.00  E-value=2.5e-37  Score=306.09  Aligned_cols=171  Identities=33%  Similarity=0.544  Sum_probs=146.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-----------cCCcCccCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-----------RPLDKKCGT   69 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-----------~~~~~~~gt   69 (407)
                      |+|..++.|+.||+.||+|||++|||||||||+|||+|.+|++||+|||.|+.+......           ....+.+||
T Consensus       171 fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGT  250 (604)
T KOG0592|consen  171 FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGT  250 (604)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeee
Confidence            578999999999999999999999999999999999999999999999999987533211           112457899


Q ss_pred             CCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         70 LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        70 ~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                      ..|++||++.....+..+|+|+||||||.|+.|.+||.+.+.    |..++........-..++++.+.+||+++|..||
T Consensus       251 AeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp  326 (604)
T KOG0592|consen  251 AEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDP  326 (604)
T ss_pred             ecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCc
Confidence            999999999999999999999999999999999999998764    3333333334444456789999999999999999


Q ss_pred             CCCCCHHHHHhCcccccCCCCCCCCC
Q psy11119        150 STRLNIEKIKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       150 ~~Rps~~eil~hpwf~~~~~~~~~~~  175 (407)
                      .+|+|+.+|++||||....|.++-..
T Consensus       327 ~~Rlt~~qIk~HpFF~~Vdw~nlw~~  352 (604)
T KOG0592|consen  327 SDRLTSQQIKAHPFFEGVDWENLWQQ  352 (604)
T ss_pred             cccccHHHHhhCcccccCChhhhhhc
Confidence            99999999999999999988775443

>KOG0033|consensus

Probab=100.00  E-value=9.6e-37  Score=276.14  Aligned_cols=163  Identities=33%  Similarity=0.593  Sum_probs=144.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +|..|.++++||++||.|||.+||+|||+||+|+|+-+..   -+||+|||+|..+. +  ........|||.|||||++
T Consensus       108 SEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~--g~~~~G~~GtP~fmaPEvv  184 (355)
T KOG0033|consen  108 SEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D--GEAWHGFAGTPGYLSPEVL  184 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C--ccccccccCCCcccCHHHh
Confidence            6889999999999999999999999999999999996543   59999999998876 2  2345567899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...+++.++|||+||||||-||.|++||.+.+.......+.......+.+.|..+++++++||++||..||.+|+|+.|+
T Consensus       185 rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EA  264 (355)
T KOG0033|consen  185 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEA  264 (355)
T ss_pred             hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence            99999999999999999999999999999877665544555555677778899999999999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      ++|||+.+.
T Consensus       265 L~HpWi~~r  273 (355)
T KOG0033|consen  265 LKHPWICNR  273 (355)
T ss_pred             hCCchhcch
Confidence            999999874

>KOG0583|consensus

Probab=100.00  E-value=1.1e-36  Score=302.98  Aligned_cols=162  Identities=43%  Similarity=0.740  Sum_probs=140.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |.|.+++++|+||++||+|||++||+||||||+|||++.+ +++||+|||++....  .......+.|||+.|+|||++.
T Consensus       117 l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~  194 (370)
T KOG0583|consen  117 LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLS  194 (370)
T ss_pred             CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhC
Confidence            5789999999999999999999999999999999999999 999999999998763  3445678899999999999998


Q ss_pred             cC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 RS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 ~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.  |.+.++|||||||+||.|++|+.||++.+.......  ........+.|.. ++++.+||++||.+||.+|+++.+
T Consensus       195 ~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~  271 (370)
T KOG0583|consen  195 GKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLE  271 (370)
T ss_pred             CCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHH
Confidence            75  567999999999999999999999998766543333  2224445554433 999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      |+.||||+..
T Consensus       272 i~~h~w~~~~  281 (370)
T KOG0583|consen  272 ILEHPWFQKE  281 (370)
T ss_pred             HhhChhhccC
Confidence            9999999984

>KOG0616|consensus

Probab=100.00  E-value=7.7e-37  Score=283.38  Aligned_cols=172  Identities=28%  Similarity=0.462  Sum_probs=147.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|..|+.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+...     ....+.||||.|+|||++..
T Consensus       141 F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~s  215 (355)
T KOG0616|consen  141 FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQS  215 (355)
T ss_pred             CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhc
Confidence            5889999999999999999999999999999999999999999999999998764     23578899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      +.++.++|+|||||++|||+.|.+||...+.......+...  ....  +..+++++++||+++|+.|-.+|.     ..
T Consensus       216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--~v~f--P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~  291 (355)
T KOG0616|consen  216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--KVKF--PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGV  291 (355)
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--cccC--CcccCHHHHHHHHHHHhhhhHhhhcCcCCCc
Confidence            99999999999999999999999999988875433333333  2222  245789999999999999999995     57


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDF  181 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~  181 (407)
                      .+|+.||||+...|..+.......++
T Consensus       292 ~dIk~H~wF~~v~W~~i~~r~ie~P~  317 (355)
T KOG0616|consen  292 EDIKNHPWFKGVDWEAILQRKIEPPF  317 (355)
T ss_pred             cccccCcccccccHHHHhhccccCCC
Confidence            89999999999888776555443333

>KOG0694|consensus

Probab=100.00  E-value=1.7e-36  Score=307.60  Aligned_cols=180  Identities=30%  Similarity=0.507  Sum_probs=156.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|..|+.|++.++.||.|||++||+|||||.+|||||.+|++||+|||+++.-.  +......+.||||.|+|||++.+
T Consensus       465 F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e  542 (694)
T KOG0694|consen  465 FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTE  542 (694)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--CCCCccccccCChhhcChhhhcc
Confidence            5889999999999999999999999999999999999999999999999998643  23345678999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..|+.++|+|||||+|||||.|+.||.+.+.++.-..+...  ...++  ..+|.++.++++++|.+||++|+.     +
T Consensus       543 ~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP--~~ls~ea~~il~~ll~k~p~kRLG~~e~d~  618 (694)
T KOG0694|consen  543 QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYP--RFLSKEAIAIMRRLLRKNPEKRLGSGERDA  618 (694)
T ss_pred             CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCC--CcccHHHHHHHHHHhccCcccccCCCCCCc
Confidence            99999999999999999999999999998877654444333  23333  348999999999999999999995     5


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCCchhHH
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDFNSTAK  186 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~~~~~~  186 (407)
                      ++|+.||||+...|..+..+...++|.+..+
T Consensus       619 ~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~  649 (694)
T KOG0694|consen  619 EDIKKHPFFRSIDWDDLLNRRIKPPFVPTIK  649 (694)
T ss_pred             hhhhhCCccccCCHHHHhhccCCCCCCcccC
Confidence            8999999999999999888888888876443

>KOG0581|consensus

Probab=100.00  E-value=4.1e-36  Score=286.70  Aligned_cols=165  Identities=27%  Similarity=0.460  Sum_probs=139.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      ++|....+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.++.+...    ...+..||..|||||.+.
T Consensus       175 i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~  250 (364)
T KOG0581|consen  175 IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERIS  250 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhc
Confidence            4788999999999999999996 89999999999999999999999999999876533    557789999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPT---ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +..|+.++||||||+.++|+.+|+.||..+.   ..-.......-....+..+-..+|+++++||..||.+||.+|+++.
T Consensus       251 g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~  330 (364)
T KOG0581|consen  251 GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAK  330 (364)
T ss_pred             CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence            9999999999999999999999999998751   1222222222222333333335999999999999999999999999


Q ss_pred             HHHhCcccccCCC
Q psy11119        157 KIKSHRWYSKHMP  169 (407)
Q Consensus       157 eil~hpwf~~~~~  169 (407)
                      |+++|||+++...
T Consensus       331 qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  331 QLLQHPFIKKFED  343 (364)
T ss_pred             HHhcCHHHhhccc
Confidence            9999999998643

>KOG0599|consensus

Probab=100.00  E-value=2.4e-36  Score=277.23  Aligned_cols=164  Identities=33%  Similarity=0.610  Sum_probs=143.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|++++++++||++|++|||.++|+||||||+|||+|.+.++||+|||+|+.+..+.   .+...||||.|+|||.+..
T Consensus       120 lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC  196 (411)
T KOG0599|consen  120 LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKC  196 (411)
T ss_pred             ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheee
Confidence            6899999999999999999999999999999999999999999999999999876543   4566799999999999863


Q ss_pred             ------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         81 ------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                            ..|+..+|+|+||||+|.||.|.+||-.....-....+......+..+.|..++.+.++||.+||..||.+|+|
T Consensus       197 ~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit  276 (411)
T KOG0599|consen  197 SMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT  276 (411)
T ss_pred             ecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc
Confidence                  36788999999999999999999999755433233334444466778889999999999999999999999999


Q ss_pred             HHHHHhCcccccC
Q psy11119        155 IEKIKSHRWYSKH  167 (407)
Q Consensus       155 ~~eil~hpwf~~~  167 (407)
                      ++|++.||||...
T Consensus       277 ake~LaHpff~q~  289 (411)
T KOG0599|consen  277 AKEALAHPFFIQI  289 (411)
T ss_pred             HHHHhcChHHHHH
Confidence            9999999999653

>KOG0605|consensus

Probab=100.00  E-value=3e-35  Score=291.34  Aligned_cols=175  Identities=29%  Similarity=0.431  Sum_probs=149.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC--------------------Cc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG--------------------KE   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~--------------------~~   60 (407)
                      |+|..++.|+.+++.|++-||+.|++||||||+|+|||..|++||+|||+++.+....                    .+
T Consensus       238 L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (550)
T KOG0605|consen  238 LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD  317 (550)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence            6899999999999999999999999999999999999999999999999986442200                    00


Q ss_pred             cC-------------------------CcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH
Q psy11119         61 RP-------------------------LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE  115 (407)
Q Consensus        61 ~~-------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~  115 (407)
                      ..                         ....+|||.|+|||++.+..|+..+|+||||||+||||.|.+||...+.....
T Consensus       318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~  397 (550)
T KOG0605|consen  318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETY  397 (550)
T ss_pred             ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            00                         11358999999999999999999999999999999999999999998887655


Q ss_pred             HHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CHHHHHhCcccccCCCCCCCCCC
Q psy11119        116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYSKHMPNDIVDGP  176 (407)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~eil~hpwf~~~~~~~~~~~~  176 (407)
                      ..+.........+.-..++++++|||.+||. ||.+|+   +++||+.||||+...|+.+-..+
T Consensus       398 rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~  460 (550)
T KOG0605|consen  398 RKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP  460 (550)
T ss_pred             HHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence            5444443455566667788999999999999 999998   59999999999999998876664

>KOG0198|consensus

Probab=100.00  E-value=5.6e-34  Score=274.70  Aligned_cols=167  Identities=31%  Similarity=0.496  Sum_probs=137.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeecc-CCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRM-NGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~-~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+|..++.|.+||++||.|||++||+||||||+|||++. +|.+||+|||++..... ...........||+.|||||++
T Consensus       114 l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi  193 (313)
T KOG0198|consen  114 LPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVI  193 (313)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhh
Confidence            689999999999999999999999999999999999999 79999999999987653 1122234467899999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKP-TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ..+ ....++||||+||++.||+||..||... ......+......  .....+..+|++++++|.+|+..+|++|||+.
T Consensus       194 ~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~  271 (313)
T KOG0198|consen  194 RNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAE  271 (313)
T ss_pred             cCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHH
Confidence            864 3345999999999999999999999873 3333333333332  22244566999999999999999999999999


Q ss_pred             HHHhCcccccCCC
Q psy11119        157 KIKSHRWYSKHMP  169 (407)
Q Consensus       157 eil~hpwf~~~~~  169 (407)
                      ++++|||......
T Consensus       272 eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  272 ELLEHPFLKQNSI  284 (313)
T ss_pred             HHhhChhhhcccc
Confidence            9999999987643

>KOG0578|consensus

Probab=100.00  E-value=2.1e-33  Score=280.07  Aligned_cols=164  Identities=26%  Similarity=0.459  Sum_probs=147.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.....  ...+.+|||.|||||++..
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtr  443 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTR  443 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhh
Confidence            68999999999999999999999999999999999999999999999999987754433  4567899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..|++++||||||++++||+-|++||-..+.-...|.+... +......+..+|+.+++|+.+||..|+.+|+++.++|+
T Consensus       444 k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  444 KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            99999999999999999999999999877766566666554 55666667889999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||+..
T Consensus       523 HpFl~~a  529 (550)
T KOG0578|consen  523 HPFLKMA  529 (550)
T ss_pred             Chhhhhc
Confidence            9999654

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-33  Score=275.08  Aligned_cols=167  Identities=27%  Similarity=0.418  Sum_probs=133.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+..... ......+||+.|+|||++.+
T Consensus       102 ~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  180 (332)
T cd05614         102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRG  180 (332)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcC
Confidence            57889999999999999999999999999999999999999999999999976533222 12234679999999999986


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh--HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC----
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTAD--CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL----  153 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp----  153 (407)
                      . .++.++|||||||++|+|++|..||......  ........  ..........+++.+.++|.+||+.||++||    
T Consensus       181 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  258 (332)
T cd05614         181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP  258 (332)
T ss_pred             CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence            5 5788999999999999999999999643221  11111111  1122223356889999999999999999999    


Q ss_pred             -CHHHHHhCcccccCCCC
Q psy11119        154 -NIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       154 -s~~eil~hpwf~~~~~~  170 (407)
                       +++++++||||+...+.
T Consensus       259 ~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         259 QGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CCHHHHHcCCCcCCCCHH
Confidence             88999999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0661|consensus

Probab=100.00  E-value=2.7e-33  Score=273.71  Aligned_cols=166  Identities=29%  Similarity=0.460  Sum_probs=142.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+....   ..+.+..+.|.+|.|||++..
T Consensus       107 fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S---kpPYTeYVSTRWYRAPEvLLr  183 (538)
T KOG0661|consen  107 FSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS---KPPYTEYVSTRWYRAPEVLLR  183 (538)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc---CCCcchhhhcccccchHHhhh
Confidence            68999999999999999999999999999999999999999999999999997653   346788899999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC--------------------------CCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP--------------------------WDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~  133 (407)
                      . +|+.+.|+|++|||++|+.+-++-|.+.+..+..+++..-.+......                          ....
T Consensus       184 s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~  263 (538)
T KOG0661|consen  184 SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA  263 (538)
T ss_pred             ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence            5 899999999999999999999999988877766666543332222211                          1236


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      +.++.+||.+||.+||.+|||+.++++||||.....
T Consensus       264 s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  264 SSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             CHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            789999999999999999999999999999987643

>KOG0600|consensus

Probab=100.00  E-value=5.4e-33  Score=273.35  Aligned_cols=165  Identities=28%  Similarity=0.489  Sum_probs=146.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..||+||+.||+|||++||+|||||.+|||||.+|++||+|||+|+.+.... ...++..+.|.+|.|||.+.+
T Consensus       215 ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG  293 (560)
T KOG0600|consen  215 FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLG  293 (560)
T ss_pred             cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-CcccccceEEeeccChHHhcC
Confidence            6789999999999999999999999999999999999999999999999999876543 345788899999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCC-------------------------cCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD-------------------------RLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~s  134 (407)
                      . .|+.++|+||+||||.||++|++.|.+.+..+....+++..+......|.                         .++
T Consensus       294 ~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~  373 (560)
T KOG0600|consen  294 ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFP  373 (560)
T ss_pred             CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCC
Confidence            7 89999999999999999999999999998887777776655544443343                         356


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      ..+.+|+..||..||.+|.|+.+++.|+||..
T Consensus       374 ~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  374 ASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             HHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            78999999999999999999999999999944

>KOG0593|consensus

Probab=100.00  E-value=1.3e-33  Score=262.49  Aligned_cols=164  Identities=27%  Similarity=0.489  Sum_probs=140.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++++.+.+|+.|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.+..  .....+..+.|.+|.|||.+.+
T Consensus        98 ~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvG  175 (396)
T KOG0593|consen   98 VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVG  175 (396)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcc
Confidence            47888999999999999999999999999999999999999999999999998764  3345678899999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-------------------C--------CCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-------------------R--------SPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~--------~~~~~  132 (407)
                      . .|+.++||||+||++.||++|++-|.+....+..|.+.+.-+...                   .        ..+..
T Consensus       176 DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~  255 (396)
T KOG0593|consen  176 DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK  255 (396)
T ss_pred             cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc
Confidence            5 999999999999999999999999998877666665533221110                   0        11345


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      ++.-+.+|+++||+.||.+|++.+|++.|+||.+
T Consensus       256 ~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  256 ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             chHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            6778999999999999999999999999999944

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.1e-33  Score=265.92  Aligned_cols=169  Identities=27%  Similarity=0.411  Sum_probs=137.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   .......||+.|+|||++.+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05631          99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVINN  175 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---CeecCCCCCCCccCHhhhcC
Confidence            467889999999999999999999999999999999999999999999999865322   12234579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++||||+||++|+|++|+.||..........................+++++.+||++||+.||.+||+     +
T Consensus       176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~  255 (285)
T cd05631         176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGA  255 (285)
T ss_pred             CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence            88899999999999999999999999875543221111111112222334568999999999999999999997     8


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      +++++||||....+...
T Consensus       256 ~~~~~h~~~~~~~~~~~  272 (285)
T cd05631         256 AGVKQHPIFKNINFKRL  272 (285)
T ss_pred             HHHhcCHhhcCCCHHHH
Confidence            99999999998765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-32  Score=268.62  Aligned_cols=164  Identities=27%  Similarity=0.476  Sum_probs=134.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05620          93 FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQG  170 (316)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcCccCHHHHcC
Confidence            467889999999999999999999999999999999999999999999998743211  122345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-HHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-EKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-~eil  159 (407)
                      ..++.++||||+||++|+|++|..||...+........ .. .....  ...++.++.+||++||..||.+||++ ++++
T Consensus       171 ~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~-~~-~~~~~--~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-RV-DTPHY--PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh-CCCCC--CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            88899999999999999999999999876654322221 11 12222  23478899999999999999999997 5899


Q ss_pred             hCcccccCCCC
Q psy11119        160 SHRWYSKHMPN  170 (407)
Q Consensus       160 ~hpwf~~~~~~  170 (407)
                      +||||....+.
T Consensus       247 ~h~~f~~~~~~  257 (316)
T cd05620         247 GHPFFKTINWT  257 (316)
T ss_pred             cCCCcCCCCHH
Confidence            99999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0585|consensus

Probab=100.00  E-value=5.9e-33  Score=271.17  Aligned_cols=169  Identities=31%  Similarity=0.560  Sum_probs=140.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccC---CCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN---GKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~---~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |++.+|++|++.++.||+|||.+||+||||||+|+||+.+|++||+|||.+..+..+   +....+....|||.|+|||.
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            578999999999999999999999999999999999999999999999999876332   12223445789999999999


Q ss_pred             hhc---C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVR---S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~---~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      ...   . +.+.+.||||+||+||.|+.|+.||-+....+....+..  .....+....+.+.+++||.+||.+||++|+
T Consensus       287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri  364 (576)
T KOG0585|consen  287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI  364 (576)
T ss_pred             hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee
Confidence            876   2 677889999999999999999999988766543333322  3344444456889999999999999999999


Q ss_pred             CHHHHHhCcccccCCCCC
Q psy11119        154 NIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       154 s~~eil~hpwf~~~~~~~  171 (407)
                      ++.+|..|||........
T Consensus       365 ~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  365 TLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             ehhhheecceeccCCCCC
Confidence            999999999999875433

>KOG0986|consensus

Probab=99.98  E-value=8.9e-33  Score=268.45  Aligned_cols=180  Identities=28%  Similarity=0.421  Sum_probs=147.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|..++.|+.+|+.||++||+.+||+|||||+|||+|..|+++|+|+|+|..+..+.   +....+||..|||||++.+
T Consensus       284 F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~n  360 (591)
T KOG0986|consen  284 FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQN  360 (591)
T ss_pred             CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcC
Confidence            5899999999999999999999999999999999999999999999999999876443   3455689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      +.|+...|+||+||+||+|+.|+.||...................+......+|+++++|.+.+|.+||++|.     ++
T Consensus       361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga  440 (591)
T KOG0986|consen  361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGA  440 (591)
T ss_pred             CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCc
Confidence            9899999999999999999999999975432211111111112223333477999999999999999999998     56


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCCch
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDFNS  183 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~~~  183 (407)
                      .++.+||||+..+|.....+-..+++.+
T Consensus       441 ~evk~HpfFk~lnw~rleagml~PPfiP  468 (591)
T KOG0986|consen  441 QEVKEHPFFKDLNWRRLEAGMLEPPFIP  468 (591)
T ss_pred             chhhhCcccccCCHhHHhccCCCCCCCC
Confidence            7999999999988877666654445543

>KOG0604|consensus

Probab=99.98  E-value=8.2e-33  Score=256.85  Aligned_cols=165  Identities=33%  Similarity=0.543  Sum_probs=142.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      ++|.+|..+++||..|+.|||+.+|.||||||+|+|...+   ..+||+|||+|+.-.   ....+.+.|-||.|+|||+
T Consensus       158 fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~---~~~~L~TPc~TPyYvaPev  234 (400)
T KOG0604|consen  158 FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ---EPGDLMTPCFTPYYVAPEV  234 (400)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC---CCccccCCcccccccCHHH
Confidence            5799999999999999999999999999999999999754   469999999998633   2346678899999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh----HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD----CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +....|+...|+||+||++|.||+|.+||......    .....+......++.+.|..+|++++++|+++|..+|.+|+
T Consensus       235 lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl  314 (400)
T KOG0604|consen  235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL  314 (400)
T ss_pred             hCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe
Confidence            98888999999999999999999999999643321    12233334446778889999999999999999999999999


Q ss_pred             CHHHHHhCcccccCC
Q psy11119        154 NIEKIKSHRWYSKHM  168 (407)
Q Consensus       154 s~~eil~hpwf~~~~  168 (407)
                      |+.++++|||+.+..
T Consensus       315 TI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  315 TIEEVMDHPWINQYE  329 (400)
T ss_pred             eHHHhhcCchhcccc
Confidence            999999999998853

>KOG0660|consensus

Probab=99.98  E-value=2e-32  Score=260.58  Aligned_cols=169  Identities=29%  Similarity=0.437  Sum_probs=138.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+++.++.+++||+.||.|+|+.||+||||||.|+|++.+..+||+|||+|+...........+..+.|.+|.|||++..
T Consensus       122 L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  122 LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence            56788999999999999999999999999999999999999999999999998754434455678889999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH----------------------Hhh-cccCCCC----CCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE----------------------WKD-NRHMQRS----PWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~----------------------~~~-~~~~~~~----~~~~  132 (407)
                      . .|+.+.||||+|||+.||++|++-|.+.+.-.....+                      +.. ....+..    .+..
T Consensus       202 ~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~  281 (359)
T KOG0660|consen  202 SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPN  281 (359)
T ss_pred             cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCC
Confidence            5 8899999999999999999999999764432211111                      111 1111111    2456


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .++.+.+|+.+||..||.+|+|++|++.|||+.....
T Consensus       282 a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  282 ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence            8899999999999999999999999999999998643

>KOG0659|consensus

Probab=99.98  E-value=5.4e-32  Score=247.90  Aligned_cols=166  Identities=25%  Similarity=0.403  Sum_probs=138.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+..++..|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+.+.....  ..+..+.|.+|.|||.+.+
T Consensus        98 l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~~~~~V~TRWYRAPELLfG  175 (318)
T KOG0659|consen   98 LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--IQTHQVVTRWYRAPELLFG  175 (318)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--ccccceeeeeccChHHhcc
Confidence            46788999999999999999999999999999999999999999999999998764433  3344488999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCC------------------------CcCCH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPW------------------------DRLDV  135 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~s~  135 (407)
                      . .|+..+|+||.|||+.||+-|.+-|.+.+.-+....++..-+......|                        ...+.
T Consensus       176 sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~  255 (318)
T KOG0659|consen  176 SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASS  255 (318)
T ss_pred             chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccH
Confidence            6 8999999999999999999999888877665544444433333222222                        33567


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        136 NCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       136 ~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++.+|+.+|+..||.+|+++.|+++|+||+...
T Consensus       256 d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  256 DALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            889999999999999999999999999999743

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.98  E-value=6.2e-32  Score=264.11  Aligned_cols=164  Identities=28%  Similarity=0.458  Sum_probs=135.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  ......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05592          93 FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKG  170 (316)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcC
Confidence            4788899999999999999999999999999999999999999999999997643222  23345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-HHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-EKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-~eil  159 (407)
                      ..++.++||||+||++|+|++|..||.+.+........ .. ..  ......++.++.+||.+||..+|.+||++ .+++
T Consensus       171 ~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~-~~--~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LN-DR--PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hc-CC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            88899999999999999999999999877654332222 11 11  11224578899999999999999999986 5889


Q ss_pred             hCcccccCCCC
Q psy11119        160 SHRWYSKHMPN  170 (407)
Q Consensus       160 ~hpwf~~~~~~  170 (407)
                      +||||....+.
T Consensus       247 ~h~~~~~~~~~  257 (316)
T cd05592         247 QHPFFRGIDWE  257 (316)
T ss_pred             cCcccCCCCHH
Confidence            99999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.98  E-value=2.3e-32  Score=267.77  Aligned_cols=166  Identities=29%  Similarity=0.464  Sum_probs=138.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        92 ~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  169 (323)
T cd05571          92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED  169 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhcC
Confidence            478899999999999999999999999999999999999999999999998753222  122345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........  .  ......+++++.+||++||..||++||     ++
T Consensus       170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (323)
T cd05571         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDA  245 (323)
T ss_pred             CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--C--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence            88899999999999999999999999876654333222222  1  122346899999999999999999999     89


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      .++++||||....+...
T Consensus       246 ~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         246 KEIMEHRFFASINWQDV  262 (323)
T ss_pred             HHHHcCCCcCCCCHHHH
Confidence            99999999988765443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0610|consensus

Probab=99.98  E-value=4.3e-32  Score=261.63  Aligned_cols=171  Identities=28%  Similarity=0.402  Sum_probs=145.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeecc------------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRM------------------------   56 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~------------------------   56 (407)
                      |+|..|+.|+.+++.||+|||-.|||+||||||||||.++|++-|+||.++.....                        
T Consensus       176 fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~  255 (459)
T KOG0610|consen  176 FSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQP  255 (459)
T ss_pred             cchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccc
Confidence            68999999999999999999999999999999999999999999999998753210                        


Q ss_pred             ---------CCC---------------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCC
Q psy11119         57 ---------NGK---------------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW  106 (407)
Q Consensus        57 ---------~~~---------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf  106 (407)
                               ...                     .......+||-.|+|||++.+..++.++|+|+|||++||||.|..||
T Consensus       256 s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  256 SCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             cccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence                     000                     00112457999999999999999999999999999999999999999


Q ss_pred             CCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC----HHHHHhCcccccCCCCCCC
Q psy11119        107 DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN----IEKIKSHRWYSKHMPNDIV  173 (407)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps----~~eil~hpwf~~~~~~~~~  173 (407)
                      .+.+.......+......++..  ..++..++|||+++|.+||.+|+.    +.||++||||++..|.-+.
T Consensus       336 KG~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir  404 (459)
T KOG0610|consen  336 KGSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIR  404 (459)
T ss_pred             CCCCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhee
Confidence            9998887776666554444333  367889999999999999999997    9999999999999987543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=6.2e-32  Score=259.51  Aligned_cols=161  Identities=28%  Similarity=0.414  Sum_probs=131.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+
T Consensus       107 ~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  183 (290)
T cd07862         107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQ  183 (290)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhC
Confidence            467889999999999999999999999999999999999999999999999765432   23345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-----------------------CCCCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-----------------------SPWDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~s~~~  137 (407)
                      ..++.++||||+||++|+|++|.+||.+.+.................                       .....+++.+
T Consensus       184 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (290)
T cd07862         184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  263 (290)
T ss_pred             CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHH
Confidence            88899999999999999999999999876654322222111000000                       0113467889


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .+||.+||+.+|++|||+.++++||||
T Consensus       264 ~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         264 KDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=2.9e-32  Score=267.20  Aligned_cols=165  Identities=27%  Similarity=0.385  Sum_probs=135.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05604          93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRK  170 (325)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHcC
Confidence            578899999999999999999999999999999999999999999999998643211  222345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----E  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~----~  156 (407)
                      ..++.++||||+||++|+|++|..||...+........ .. ..  ......++..+.++|++||..+|.+||++    .
T Consensus       171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~-~~-~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI-LH-KP--LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH-Hc-CC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            88899999999999999999999999876654322222 21 11  11223578899999999999999999976    6


Q ss_pred             HHHhCcccccCCCCC
Q psy11119        157 KIKSHRWYSKHMPND  171 (407)
Q Consensus       157 eil~hpwf~~~~~~~  171 (407)
                      ++++||||....+..
T Consensus       247 ~i~~h~~f~~~~~~~  261 (325)
T cd05604         247 EIQEHPFFESLSWTD  261 (325)
T ss_pred             HHhcCCCcCCCCHHH
Confidence            999999998765433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=1e-31  Score=257.65  Aligned_cols=169  Identities=28%  Similarity=0.350  Sum_probs=136.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....  .......||+.|+|||++.+
T Consensus        94 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  171 (280)
T cd05608          94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQG  171 (280)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcC
Confidence            4788999999999999999999999999999999999999999999999997654322  12234579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|+.||..........................+++++.+++.+||+.||++||     ++
T Consensus       172 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  251 (280)
T cd05608         172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC  251 (280)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence            8889999999999999999999999976543211111111111112223356889999999999999999999     88


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      +++++||||+...+..
T Consensus       252 ~~~l~h~~~~~~~~~~  267 (280)
T cd05608         252 DGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHHhcChhhhcCCHhH
Confidence            9999999998865443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=4.2e-32  Score=266.36  Aligned_cols=170  Identities=30%  Similarity=0.437  Sum_probs=137.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...... ......||+.|+|||++. 
T Consensus        99 l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~  177 (330)
T cd05601          99 FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT  177 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcc
Confidence            578899999999999999999999999999999999999999999999999875433221 223457999999999987 


Q ss_pred             -----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         80 -----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        80 -----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                           ...++.++||||+||++|+|++|..||...+.................+....++.++.+||.+||. +|.+||+
T Consensus       178 ~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t  256 (330)
T cd05601         178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLG  256 (330)
T ss_pred             ccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCC
Confidence                 3467789999999999999999999998766543322222222222333334688999999999998 9999999


Q ss_pred             HHHHHhCcccccCCCCCC
Q psy11119        155 IEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~~  172 (407)
                      +++++.||||....+...
T Consensus       257 ~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         257 YEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             HHHHhCCCCcCCCCHHHH
Confidence            999999999998655443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.2e-31  Score=262.31  Aligned_cols=166  Identities=25%  Similarity=0.436  Sum_probs=137.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......  ......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05591          93 FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQE  170 (321)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcC
Confidence            4678899999999999999999999999999999999999999999999987543222  22345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-------  153 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-------  153 (407)
                      ..++.++||||+||++|+|++|+.||...+...........  ...  ....++.++.++|.+||..+|.+|+       
T Consensus       171 ~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~  246 (321)
T cd05591         171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQG  246 (321)
T ss_pred             CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence            88899999999999999999999999887755433322222  222  2234789999999999999999999       


Q ss_pred             CHHHHHhCcccccCCCCCC
Q psy11119        154 NIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       154 s~~eil~hpwf~~~~~~~~  172 (407)
                      ++.++++||||....+...
T Consensus       247 ~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         247 GEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             CHHHHhcCCccCCCCHHHH
Confidence            9999999999987655443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.7e-31  Score=261.61  Aligned_cols=164  Identities=30%  Similarity=0.501  Sum_probs=136.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......  ......+||+.|+|||++.+
T Consensus        98 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  175 (324)
T cd05587          98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAY  175 (324)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcC
Confidence            4688899999999999999999999999999999999999999999999986532211  22345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++|+||+||++|+|++|+.||...+...........    ....+..++.++.++|++||.++|.+|++.     
T Consensus       176 ~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  251 (324)
T cd05587         176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH----NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGE  251 (324)
T ss_pred             CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence            88899999999999999999999999877654333222221    122234578999999999999999999976     


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||....+.
T Consensus       252 ~~~~~hp~~~~~~~~  266 (324)
T cd05587         252 RDIREHAFFRRIDWE  266 (324)
T ss_pred             HHHhcCCCcCCCCHH
Confidence            899999999986554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0690|consensus

Probab=99.97  E-value=2.6e-32  Score=255.87  Aligned_cols=178  Identities=27%  Similarity=0.445  Sum_probs=154.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|+.++.|-.+|++||.|||+++|++||||.+|+|+|.+|++||+|||+++.-...  .....+.||||.|+|||++..
T Consensus       265 FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleD  342 (516)
T KOG0690|consen  265 FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLED  342 (516)
T ss_pred             ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc--cceeccccCChhhcCchhhcc
Confidence            578899999999999999999999999999999999999999999999999764322  234578899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..|+.++|+|.+||++|||++|++||...+.+..-..+......++    ..++++++.|+..+|.++|.+|.     .+
T Consensus       343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktLLsGLL~kdP~kRLGgGpdDa  418 (516)
T KOG0690|consen  343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDA  418 (516)
T ss_pred             ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHHHHHHhhcChHhhcCCCchhH
Confidence            9999999999999999999999999998877655444444433333    45899999999999999999998     68


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCCchh
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDFNST  184 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~~~~  184 (407)
                      .+|++|+||....|.+.......++|.+.
T Consensus       419 kEi~~h~FF~~v~W~~~~~Kki~PPfKPq  447 (516)
T KOG0690|consen  419 KEIMRHRFFASVDWEATYRKKIEPPFKPQ  447 (516)
T ss_pred             HHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence            99999999999999888887777777664

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.1e-31  Score=258.52  Aligned_cols=162  Identities=30%  Similarity=0.469  Sum_probs=129.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ........|++.|+|||++.+
T Consensus       100 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  177 (288)
T cd07871         100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TKTYSNEVVTLWYRPPDVLLG  177 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--CccccCceecccccChHHhcC
Confidence            467889999999999999999999999999999999999999999999998764322  122344578999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-----------------CC---------CCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-----------------QR---------SPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------~~---------~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|..||...+...............                 ..         .....+
T Consensus       178 ~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (288)
T cd07871         178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRL  257 (288)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCC
Confidence            4 68899999999999999999999998766543322221110000                 00         012346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +.++++||++||..||.+|||++|+++||||
T Consensus       258 ~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            7899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=1.1e-31  Score=267.19  Aligned_cols=171  Identities=26%  Similarity=0.390  Sum_probs=135.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....                     
T Consensus        98 l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (363)
T cd05628          98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN  177 (363)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence            57889999999999999999999999999999999999999999999999875432110                     


Q ss_pred             ------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC
Q psy11119         60 ------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR  127 (407)
Q Consensus        60 ------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  127 (407)
                                  .......+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.................
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  257 (363)
T cd05628         178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF  257 (363)
T ss_pred             cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccC
Confidence                        00113458999999999999888899999999999999999999999877655433322222222333


Q ss_pred             CCCCcCCHHHHHHHHHhccCCCC---CCCCHHHHHhCcccccCCCCCC
Q psy11119        128 SPWDRLDVNCLSLIRRILAPLPS---TRLNIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       128 ~~~~~~s~~~~~LI~~~L~~~P~---~Rps~~eil~hpwf~~~~~~~~  172 (407)
                      ++...+++++++||.+|+. +|.   .||++++|++||||....+...
T Consensus       258 p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         258 PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence            4444578999999999765 444   4689999999999998766554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0594|consensus

Probab=99.97  E-value=1.2e-31  Score=255.56  Aligned_cols=164  Identities=32%  Similarity=0.535  Sum_probs=138.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+...  .+..+..++|.+|.|||++.+.
T Consensus       118 ~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs  195 (323)
T KOG0594|consen  118 PPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGS  195 (323)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCC
Confidence            45679999999999999999999999999999999999999999999999865432  3346777899999999999987


Q ss_pred             -CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCC--------------------------cCC
Q psy11119         82 -YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD--------------------------RLD  134 (407)
Q Consensus        82 -~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~s  134 (407)
                       .|+...||||+|||++||++++.-|.+....+....++...+......|+                          ..+
T Consensus       196 ~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~  275 (323)
T KOG0594|consen  196 TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLD  275 (323)
T ss_pred             CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccC
Confidence             89999999999999999999999998887766555554433332222222                          223


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++..+++.+||..+|.+|.|++.++.||||...
T Consensus       276 ~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  276 PDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            578999999999999999999999999999875

>KOG0591|consensus

Probab=99.97  E-value=5.9e-32  Score=249.34  Aligned_cols=151  Identities=26%  Similarity=0.350  Sum_probs=129.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS--KG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~--~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      ++|..+++|+.||+.||.+||+  ..  |+||||||.||+|+.+|.+||+|||+++.+....  ...++.+|||.||+||
T Consensus       121 ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE  198 (375)
T KOG0591|consen  121 IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPE  198 (375)
T ss_pred             CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHH
Confidence            5899999999999999999999  44  9999999999999999999999999999876432  3456789999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      ++...+|+.++||||+||++|||+.-+.||.+.+.......+  .++..+.-+-..+|.++..||..|+..||+.||+.
T Consensus       199 ~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI--~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  199 RIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI--EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH--HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            999999999999999999999999999999998655433333  33344333336789999999999999999999985

>KOG0696|consensus

Probab=99.97  E-value=3.9e-32  Score=261.22  Aligned_cols=225  Identities=26%  Similarity=0.375  Sum_probs=171.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      .|..|..|+.+|+-||-|||++||++||||.+|||+|.+|++||+|||+++.-...  .....+.||||.|+|||++..+
T Consensus       448 KEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~Yq  525 (683)
T KOG0696|consen  448 KEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQ  525 (683)
T ss_pred             CCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEec
Confidence            46788999999999999999999999999999999999999999999998753222  2344678999999999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----H
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----E  156 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----~  156 (407)
                      +|+..+|+||+||+||||+.|++||++.+.++.-..+ .+ .  ....+..+|.++.++++.+|.+.|.+|+..     .
T Consensus       526 PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-~e-h--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~  601 (683)
T KOG0696|consen  526 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-ME-H--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGER  601 (683)
T ss_pred             ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HH-c--cCcCcccccHHHHHHHHHHhhcCCccccCCCCcccc
Confidence            9999999999999999999999999998876543333 22 2  223335689999999999999999999853     7


Q ss_pred             HHHhCcccccCCCCCCCCCCCCCCCchhHHhhhcchHHHhhhcCCCCCCCccCCCCCccccCCCCCccccCCccccccCC
Q psy11119        157 KIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVEPHLFSFSQP  236 (407)
Q Consensus       157 eil~hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~a~~~~SfSqp  236 (407)
                      +|..||||+...|..+......+++.+..+--++...     ....|....+.-.|.+..  .-+...++.|.++||.+|
T Consensus       602 di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eN-----FD~~Ft~~~~~lTPpD~~--v~~nldq~eF~gFsfvNp  674 (683)
T KOG0696|consen  602 DIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAEN-----FDKFFTREPTDLTPPDKL--VMMNLDQSEFEGFSFVNP  674 (683)
T ss_pred             chhhCcchhhccHHHHhhccCCCCCCCccccCCchhh-----hhHHHhcCCCCCCCchHH--HHhcCchhhcCceeeeCh
Confidence            8999999999999998888888888765433222111     101111111111221110  112234688999999998


Q ss_pred             CCc
Q psy11119        237 THL  239 (407)
Q Consensus       237 ~~~  239 (407)
                      .-+
T Consensus       675 efv  677 (683)
T KOG0696|consen  675 EFV  677 (683)
T ss_pred             hhc
Confidence            644

>KOG0032|consensus

Probab=99.97  E-value=1.7e-31  Score=266.05  Aligned_cols=164  Identities=35%  Similarity=0.582  Sum_probs=149.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC----CcEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~----g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      ++|.++..++.|++.|+.|||+.||+||||||+|+|+...    +.+|++|||++.....   .......|||+.|+|||
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APE  208 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPE  208 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCch
Confidence            5799999999999999999999999999999999999643    4799999999988654   34567889999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++....++..+|+||+||++|.|++|..||.+.+..............+..++|..++..++++|++||..||.+|+|+.
T Consensus       209 vl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~  288 (382)
T KOG0032|consen  209 VLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAA  288 (382)
T ss_pred             hhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHH
Confidence            99988999999999999999999999999999887766666666667788899999999999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      ++++|||++..
T Consensus       289 ~~L~HpWi~~~  299 (382)
T KOG0032|consen  289 QALQHPWIKSI  299 (382)
T ss_pred             HHhcCccccCC
Confidence            99999999875

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.6e-31  Score=260.43  Aligned_cols=165  Identities=32%  Similarity=0.494  Sum_probs=136.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  174 (323)
T cd05584          97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMR  174 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccC
Confidence            4678899999999999999999999999999999999999999999999987543222  22344679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........  .  ......+++++.+||++||.++|++||     ++
T Consensus       175 ~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  250 (323)
T cd05584         175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--K--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDA  250 (323)
T ss_pred             CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCH
Confidence            88899999999999999999999999877654332222221  1  222345789999999999999999999     89


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      +++++||||....+..
T Consensus       251 ~~l~~h~~~~~~~~~~  266 (323)
T cd05584         251 AEVQSHPFFRHVNWDD  266 (323)
T ss_pred             HHHhcCCCcCCCCHHH
Confidence            9999999998865543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2.2e-31  Score=260.71  Aligned_cols=167  Identities=27%  Similarity=0.469  Sum_probs=138.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  ......+||+.|+|||++.+
T Consensus        98 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05616          98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcC
Confidence            4788999999999999999999999999999999999999999999999987543221  22345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ..  .....++.++.+||.+||..+|.+|++     .
T Consensus       176 ~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~  251 (323)
T cd05616         176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE  251 (323)
T ss_pred             CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCH
Confidence            88899999999999999999999999887655433322221  11  222457899999999999999999997     4


Q ss_pred             HHHHhCcccccCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIV  173 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~  173 (407)
                      .++++||||+...|....
T Consensus       252 ~~i~~h~~~~~~~~~~~~  269 (323)
T cd05616         252 RDIKEHAFFRYIDWEKLE  269 (323)
T ss_pred             HHHhcCCCcCCCCHHHHH
Confidence            899999999986654433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=2.4e-31  Score=254.98  Aligned_cols=163  Identities=26%  Similarity=0.388  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ........|++.|+|||++.+
T Consensus        97 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  175 (287)
T cd07848          97 VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLG  175 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccccccccccccCCcHHHcC
Confidence            4678899999999999999999999999999999999999999999999998653222 222334578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh--------------cc---cCCCC-----------CCCc
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD--------------NR---HMQRS-----------PWDR  132 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~--------------~~---~~~~~-----------~~~~  132 (407)
                      ..++.++|+||+||++|+|++|+.||...+...........              ..   ....+           .+..
T Consensus       176 ~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07848         176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGI  255 (287)
T ss_pred             CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcc
Confidence            88899999999999999999999999876543222111100              00   00000           0123


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++.++.+||++||++||++|||++++++||||
T Consensus       256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            67889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-31  Score=263.27  Aligned_cols=165  Identities=28%  Similarity=0.397  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....     .....+||+.|+|||++.+
T Consensus        98 l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~  172 (333)
T cd05600          98 LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG  172 (333)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcC
Confidence            47889999999999999999999999999999999999999999999999876432     2345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCC----CcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPW----DRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ..++.++||||+||++|+|++|..||...+.................+.+    ..+++++.+||.+||..+|.+||++.
T Consensus       173 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~  252 (333)
T cd05600         173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLE  252 (333)
T ss_pred             CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHH
Confidence            88899999999999999999999999877654432222111111111211    25689999999999999999999999


Q ss_pred             HHHhCcccccCCCC
Q psy11119        157 KIKSHRWYSKHMPN  170 (407)
Q Consensus       157 eil~hpwf~~~~~~  170 (407)
                      ++++||||....+.
T Consensus       253 ~ll~h~~~~~~~~~  266 (333)
T cd05600         253 DIKNHPFFKEVDWN  266 (333)
T ss_pred             HHHhCcccCCCCHH
Confidence            99999999986543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=1.9e-31  Score=261.13  Aligned_cols=164  Identities=28%  Similarity=0.481  Sum_probs=136.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......+  ......+||+.|+|||++.+
T Consensus        93 l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (320)
T cd05590          93 FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQE  170 (320)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcC
Confidence            5788999999999999999999999999999999999999999999999987532221  22345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++|+||+||++|+|++|+.||...+..........  ....  ....++.++.+||++||+.||.+||++     
T Consensus       171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  246 (320)
T cd05590         171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVV--YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGG  246 (320)
T ss_pred             CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCC
Confidence            8889999999999999999999999987765533222221  1222  223478999999999999999999998     


Q ss_pred             -HHHHhCcccccCCCC
Q psy11119        156 -EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 -~eil~hpwf~~~~~~  170 (407)
                       ++++.||||....+.
T Consensus       247 ~~~~~~h~~f~~~~~~  262 (320)
T cd05590         247 EEAILRHPFFKELDWE  262 (320)
T ss_pred             HHHHHcCCCcCCCCHH
Confidence             999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=262.14  Aligned_cols=169  Identities=29%  Similarity=0.455  Sum_probs=138.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC----------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG----------------------   58 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~----------------------   58 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......                      
T Consensus        98 l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (350)
T cd05573          98 FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR  177 (350)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence            5788999999999999999999999999999999999999999999999997654332                      


Q ss_pred             -----CccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcC
Q psy11119         59 -----KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRL  133 (407)
Q Consensus        59 -----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (407)
                           .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....................+....+
T Consensus       178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  257 (350)
T cd05573         178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPV  257 (350)
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCC
Confidence                 011233457999999999999888999999999999999999999999877654333322221122333334457


Q ss_pred             CHHHHHHHHHhccCCCCCCCC-HHHHHhCcccccCCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLN-IEKIKSHRWYSKHMPN  170 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps-~~eil~hpwf~~~~~~  170 (407)
                      ++++.+||.+||. +|.+|++ ++++++||||....+.
T Consensus       258 ~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence            9999999999997 9999999 9999999999876544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=3e-31  Score=259.40  Aligned_cols=164  Identities=30%  Similarity=0.507  Sum_probs=136.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+|++.|+|||++.+
T Consensus        93 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  170 (318)
T cd05570          93 FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSY  170 (318)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcC
Confidence            5788999999999999999999999999999999999999999999999986532221  22334579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++|+||+||++|+|++|..||...............  ..  .....++.++.+||++||..||.+||++     
T Consensus       171 ~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~  246 (318)
T cd05570         171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGE  246 (318)
T ss_pred             CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence            88899999999999999999999999876654332222211  11  1224578999999999999999999999     


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      .++++||||+...+.
T Consensus       247 ~~ll~~~~~~~~~~~  261 (318)
T cd05570         247 QDIKGHPFFREIDWD  261 (318)
T ss_pred             HHHhcCCCcCCCCHH
Confidence            999999999886553

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.4e-31  Score=260.46  Aligned_cols=166  Identities=30%  Similarity=0.416  Sum_probs=136.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (323)
T cd05575          93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRK  170 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhcC
Confidence            468889999999999999999999999999999999999999999999998653221  223345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----E  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~----~  156 (407)
                      ..++.++|||||||++|+|++|..||...+...........    .......++..+.++|++||+.+|.+||++    .
T Consensus       171 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (323)
T cd05575         171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK----PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFL  246 (323)
T ss_pred             CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHH
Confidence            88899999999999999999999999876654332222211    122234578999999999999999999987    6


Q ss_pred             HHHhCcccccCCCCCC
Q psy11119        157 KIKSHRWYSKHMPNDI  172 (407)
Q Consensus       157 eil~hpwf~~~~~~~~  172 (407)
                      ++++||||....+...
T Consensus       247 ~il~~~~~~~~~~~~~  262 (323)
T cd05575         247 EIKNHVFFSSINWDDL  262 (323)
T ss_pred             HHHcCCCcCCCCHHHH
Confidence            9999999988665443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=3.6e-31  Score=258.83  Aligned_cols=164  Identities=27%  Similarity=0.476  Sum_probs=134.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05619          93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLG  170 (316)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcC
Confidence            4678899999999999999999999999999999999999999999999987532211  22345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE-KIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~-eil  159 (407)
                      ..++.++|+||+||++|+|++|..||...+........ .. .....+  ..++.++.++|.+||..+|.+||++. +++
T Consensus       171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-RM-DNPCYP--RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh-CCCCCC--ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            88899999999999999999999999877654322221 11 112222  34788999999999999999999996 899


Q ss_pred             hCcccccCCCC
Q psy11119        160 SHRWYSKHMPN  170 (407)
Q Consensus       160 ~hpwf~~~~~~  170 (407)
                      .||||....+.
T Consensus       247 ~h~~~~~~~~~  257 (316)
T cd05619         247 QHPFFREIDWS  257 (316)
T ss_pred             cCcccCCCCHH
Confidence            99999986654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=256.82  Aligned_cols=160  Identities=32%  Similarity=0.507  Sum_probs=133.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......     ....+|++.|+|||++.+
T Consensus        98 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~  172 (291)
T cd05612          98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQS  172 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcC
Confidence            467889999999999999999999999999999999999999999999998765321     234579999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........  ..  .....+++.+++||++||..||.+|++     +
T Consensus       173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  248 (291)
T cd05612         173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGA  248 (291)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--Cc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCH
Confidence            88899999999999999999999999877654332222211  11  122346889999999999999999995     9


Q ss_pred             HHHHhCcccccCCC
Q psy11119        156 EKIKSHRWYSKHMP  169 (407)
Q Consensus       156 ~eil~hpwf~~~~~  169 (407)
                      +++++||||....+
T Consensus       249 ~~~l~h~~~~~~~~  262 (291)
T cd05612         249 DDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHhcCccccCCCH
Confidence            99999999987544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=2.1e-31  Score=261.78  Aligned_cols=161  Identities=30%  Similarity=0.446  Sum_probs=134.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......     ....+||+.|+|||++.+
T Consensus       115 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~  189 (329)
T PTZ00263        115 FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQS  189 (329)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcC
Confidence            468889999999999999999999999999999999999999999999999765321     234579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|||||||++|+|++|..||.+.......... .. .....  ...++..+.+||.+||..||.+|++     +
T Consensus       190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-~~-~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  265 (329)
T PTZ00263        190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-LA-GRLKF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGV  265 (329)
T ss_pred             CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-hc-CCcCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence            88899999999999999999999999876654322222 11 22222  2347889999999999999999996     7


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||.+..+.
T Consensus       266 ~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        266 ADVKNHPYFHGANWD  280 (329)
T ss_pred             HHHhcCCccCCCCHH
Confidence            999999999875443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=2e-31  Score=261.88  Aligned_cols=164  Identities=28%  Similarity=0.461  Sum_probs=135.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        92 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  169 (328)
T cd05593          92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLED  169 (328)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcC
Confidence            578899999999999999999999999999999999999999999999998753221  122345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........    .......+++++.+||++||.+||.+|+     ++
T Consensus       170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (328)
T cd05593         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDA  245 (328)
T ss_pred             CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCH
Confidence            88899999999999999999999999876654332222211    1222346889999999999999999997     89


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      .++++||||....+.
T Consensus       246 ~~il~h~~~~~~~~~  260 (328)
T cd05593         246 KEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HHHhcCCCcCCCCHH
Confidence            999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582|consensus

Probab=99.97  E-value=2.2e-31  Score=258.66  Aligned_cols=172  Identities=26%  Similarity=0.457  Sum_probs=142.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cC-CcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RP-LDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~-~~~~~gt~~Y~APE~l   78 (407)
                      |+|..+..+.+++++||.|||.+|.+|||||+.||||+.+|.+||+|||.+..+...+.. .. ..+..|||.|||||++
T Consensus       123 l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  123 LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence            678899999999999999999999999999999999999999999999998776555431 11 2677999999999996


Q ss_pred             hcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc------CCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         79 VRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH------MQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        79 ~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      ..+  .|+.|+||||||++..||.+|..||....+.........+...      ........++..++.+|..||.+||.
T Consensus       203 ~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~  282 (516)
T KOG0582|consen  203 MQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPS  282 (516)
T ss_pred             hhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcc
Confidence            554  8899999999999999999999999987776555555444321      12222345667899999999999999


Q ss_pred             CCCCHHHHHhCcccccCCCCCC
Q psy11119        151 TRLNIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       151 ~Rps~~eil~hpwf~~~~~~~~  172 (407)
                      +|||++++++|+||++....+.
T Consensus       283 kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  283 KRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             cCCCHHHHhccHHHhhccchhh
Confidence            9999999999999998755443

>KOG0663|consensus

Probab=99.97  E-value=3.5e-31  Score=249.24  Aligned_cols=166  Identities=28%  Similarity=0.408  Sum_probs=142.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+..  .....+..+.|.+|.|||.+.+
T Consensus       174 F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs--p~k~~T~lVVTLWYRaPELLLG  251 (419)
T KOG0663|consen  174 FLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS--PLKPYTPLVVTLWYRAPELLLG  251 (419)
T ss_pred             CchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC--CcccCcceEEEeeecCHHHhcC
Confidence            46789999999999999999999999999999999999999999999999998653  3455677889999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCc---------------------------
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDR---------------------------  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------  132 (407)
                      . .|+++.|+||+|||+.||+++.+-|.+....+....++...+......|++                           
T Consensus       252 ~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~  331 (419)
T KOG0663|consen  252 AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL  331 (419)
T ss_pred             CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccc
Confidence            7 899999999999999999999999998877666666555444333333322                           


Q ss_pred             -CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 -LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 -~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                       +++...+|+..+|..||.+|.|++|.++|.||....
T Consensus       332 ~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  332 SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence             457789999999999999999999999999999854

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=3.9e-31  Score=259.07  Aligned_cols=164  Identities=29%  Similarity=0.444  Sum_probs=136.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....  .......+|++.|+|||++.+
T Consensus        98 l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~  175 (324)
T cd05589          98 FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTE  175 (324)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccCHhHhcC
Confidence            578899999999999999999999999999999999999999999999998643221  122345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ..  .....++.++.++|.+||..||.+||     ++
T Consensus       176 ~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  251 (324)
T cd05589         176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDA  251 (324)
T ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence            88899999999999999999999999887655433322222  11  12245789999999999999999999     79


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      .++++||||+...+.
T Consensus       252 ~~l~~~~~f~~~~~~  266 (324)
T cd05589         252 EDVKKQPFFRDINWD  266 (324)
T ss_pred             HHHhhCCCcCCCCHH
Confidence            999999999876443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=4.4e-31  Score=255.90  Aligned_cols=166  Identities=27%  Similarity=0.374  Sum_probs=129.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......  .......+|++.|+|||++.+
T Consensus       100 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  177 (303)
T cd07869         100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLG  177 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--CccCCCCcccCCCCChHHHcC
Confidence            467889999999999999999999999999999999999999999999998754322  123345678999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCC--------------CC--------------CC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQ--------------RS--------------PW  130 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~--------------~~--------------~~  130 (407)
                      . .++.++||||+||++|+|++|..||.+.............. ....              ..              ..
T Consensus       178 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (303)
T cd07869         178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK  257 (303)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhc
Confidence            4 67889999999999999999999998654321111111000 0000              00              00


Q ss_pred             CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 ~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ..+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       258 ~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         258 LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            12456889999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=258.03  Aligned_cols=161  Identities=29%  Similarity=0.477  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  ......+||+.|+|||++.+
T Consensus        90 ~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  167 (312)
T cd05585          90 FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG  167 (312)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcC
Confidence            4688899999999999999999999999999999999999999999999987532221  22345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEK  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~e  157 (407)
                      ..++.++||||+||++|+|++|..||..............    .....+..+++++.+||.+||..||.+||   ++.+
T Consensus       168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----CCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            8889999999999999999999999987665432222211    12223356889999999999999999997   5899


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      ++.||||.+.
T Consensus       244 ~l~hp~~~~~  253 (312)
T cd05585         244 IKNHPFFSQL  253 (312)
T ss_pred             HHcCCCcCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.9e-31  Score=258.75  Aligned_cols=168  Identities=28%  Similarity=0.374  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+||+.|+|||++.
T Consensus       100 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  179 (338)
T cd07859         100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG  179 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence            57889999999999999999999999999999999999999999999999976432222 12224567999999999987


Q ss_pred             c--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH----------------------H----hhcc-cCCCCCC
Q psy11119         80 R--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE----------------------W----KDNR-HMQRSPW  130 (407)
Q Consensus        80 ~--~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~----------------------~----~~~~-~~~~~~~  130 (407)
                      +  ..++.++||||+||++|+|++|+.||...+........                      .    .... ......+
T Consensus       180 ~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  259 (338)
T cd07859         180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF  259 (338)
T ss_pred             ccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc
Confidence            6  57789999999999999999999999765432111000                      0    0000 0001112


Q ss_pred             CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 ~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ..+++.+.++|.+||..+|++|||++++++||||+...
T Consensus       260 ~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         260 PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            35678899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4.9e-31  Score=252.76  Aligned_cols=161  Identities=28%  Similarity=0.447  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   .......||+.|+|||++.+
T Consensus       105 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  181 (288)
T cd07863         105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQ  181 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc---ccCCCccccccccCchHhhC
Confidence            478899999999999999999999999999999999999999999999999765422   22234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc----------------CC-------CCCCCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH----------------MQ-------RSPWDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~----------------~~-------~~~~~~~s~~~  137 (407)
                      ..++.++||||+||++|+|++|..||..................                ..       ......++..+
T Consensus       182 ~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (288)
T cd07863         182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESG  261 (288)
T ss_pred             CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHH
Confidence            88899999999999999999999999766543322211110000                00       00123467889


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .+||.+||.+||.+|||+.+++.||||
T Consensus       262 ~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         262 AQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=4.5e-31  Score=264.65  Aligned_cols=170  Identities=31%  Similarity=0.505  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....                     
T Consensus        98 ~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (381)
T cd05626          98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW  177 (381)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence            57888999999999999999999999999999999999999999999999764321100                     


Q ss_pred             ------------------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH
Q psy11119         60 ------------------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE  115 (407)
Q Consensus        60 ------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~  115 (407)
                                              .......+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  257 (381)
T cd05626         178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ  257 (381)
T ss_pred             ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH
Confidence                                    00112457999999999998888899999999999999999999999877655433


Q ss_pred             HHHHhhcccCCCCCCCcCCHHHHHHHHHhc--cCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRIL--APLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L--~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                      ............+.+..+++++.+||.+|+  ..+|..|+++.+++.||||....+.
T Consensus       258 ~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         258 LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            333222233344455568999999999955  5566669999999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=3e-31  Score=262.29  Aligned_cols=161  Identities=30%  Similarity=0.447  Sum_probs=135.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       128 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~  202 (340)
T PTZ00426        128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLN  202 (340)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhC
Confidence            57888999999999999999999999999999999999999999999999986532     1235679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+........ .. ...  .....+++.+.++|++||+.+|.+|+     ++
T Consensus       203 ~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-~~-~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  278 (340)
T PTZ00426        203 VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-LE-GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGA  278 (340)
T ss_pred             CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-hc-CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCH
Confidence            88899999999999999999999999876654322222 22 111  12345789999999999999999996     89


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||....|.
T Consensus       279 ~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        279 QNVKEHPWFGNIDWV  293 (340)
T ss_pred             HHHHcCCCcCCCCHH
Confidence            999999999876543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=263.17  Aligned_cols=168  Identities=28%  Similarity=0.432  Sum_probs=136.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--------------------   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--------------------   60 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......                    
T Consensus        98 l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (364)
T cd05599          98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK  177 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence            578999999999999999999999999999999999999999999999998764321100                    


Q ss_pred             ----------------cCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc
Q psy11119         61 ----------------RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH  124 (407)
Q Consensus        61 ----------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  124 (407)
                                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..............
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~  257 (364)
T cd05599         178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET  257 (364)
T ss_pred             cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc
Confidence                            0112357999999999998888899999999999999999999999877654332222222222


Q ss_pred             CCCCCCCcCCHHHHHHHHHhccCCCCCCCC---HHHHHhCcccccCCC
Q psy11119        125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLN---IEKIKSHRWYSKHMP  169 (407)
Q Consensus       125 ~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps---~~eil~hpwf~~~~~  169 (407)
                      ...+....+++++.+||++|+. +|.+|++   +.+++.||||+...+
T Consensus       258 ~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         258 LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            3333344678999999999997 9999998   999999999987654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=4.2e-31  Score=257.30  Aligned_cols=164  Identities=27%  Similarity=0.461  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE----ecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl----d~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~AP   75 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.+..... .......+||+.|+||
T Consensus       105 l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCC
Confidence            4678899999999999999999999999999999999    4567899999999987543221 1223456789999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhH---------HHHHH-----------Hhhccc----------
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADC---------IEYLE-----------WKDNRH----------  124 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~---------~~~~~-----------~~~~~~----------  124 (407)
                      |++.+. .++.++|+||+||++|+|++|..||.......         .....           +.....          
T Consensus       185 E~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (317)
T cd07868         185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD  264 (317)
T ss_pred             HHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhh
Confidence            999874 68899999999999999999999996433210         00000           000000          


Q ss_pred             -----CC--------CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        125 -----MQ--------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       125 -----~~--------~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                           ..        .......+.++.+||.+||..||.+|||++|+++||||
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         265 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                 00        00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=6.9e-31  Score=262.54  Aligned_cols=168  Identities=27%  Similarity=0.434  Sum_probs=137.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......+. ......+||+.|+|||++.+
T Consensus       139 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  217 (370)
T cd05596         139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhcc
Confidence            46788999999999999999999999999999999999999999999999976543221 12245679999999999865


Q ss_pred             C----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC--CCC
Q psy11119         81 S----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST--RLN  154 (407)
Q Consensus        81 ~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~--Rps  154 (407)
                      .    .++.++|+||+||++|+|++|..||.....................+....++.++.+||++||..+|.+  |++
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s  297 (370)
T cd05596         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG  297 (370)
T ss_pred             CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC
Confidence            3    4788999999999999999999999877654332222222223333444568999999999999999987  999


Q ss_pred             HHHHHhCcccccCCC
Q psy11119        155 IEKIKSHRWYSKHMP  169 (407)
Q Consensus       155 ~~eil~hpwf~~~~~  169 (407)
                      ++++++||||+...+
T Consensus       298 ~~ell~h~~~~~~~~  312 (370)
T cd05596         298 VDEIKSHPFFKNDQW  312 (370)
T ss_pred             HHHHhcCcccCCCCh
Confidence            999999999997644

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=3.8e-31  Score=272.26  Aligned_cols=164  Identities=26%  Similarity=0.331  Sum_probs=127.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCC----------------cEEEEecCCceeeccCCCccCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQD----------------TLKISDFGLATVFRMNGKERPL   63 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g----------------~lkL~DFGla~~~~~~~~~~~~   63 (407)
                      +++.+++.++.||+.||+|||+ .||+||||||+|||++.++                .+||+|||.+....     ...
T Consensus       228 l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~  302 (467)
T PTZ00284        228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSR  302 (467)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----ccc
Confidence            4678899999999999999998 5999999999999998766                49999999875421     223


Q ss_pred             cCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-----------------
Q psy11119         64 DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-----------------  126 (407)
Q Consensus        64 ~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------------  126 (407)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...............+                 
T Consensus       303 ~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~  382 (467)
T PTZ00284        303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYN  382 (467)
T ss_pred             ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhh
Confidence            456899999999999988899999999999999999999999987654322211110000000                 


Q ss_pred             -------CC------------CC--CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        127 -------RS------------PW--DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       127 -------~~------------~~--~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                             ..            .+  ...++.+.+||.+||..||.+|||++|+++||||.+..+
T Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        383 SAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence                   00            00  011356789999999999999999999999999987643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=3.7e-31  Score=259.36  Aligned_cols=164  Identities=28%  Similarity=0.466  Sum_probs=136.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .......+||+.|+|||++.+
T Consensus        92 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  169 (323)
T cd05595          92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED  169 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCcccccC
Confidence            478899999999999999999999999999999999999999999999998753221  122334679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+.............    .....+++++.+||.+||..||.+|+     ++
T Consensus       170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (323)
T cd05595         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  245 (323)
T ss_pred             CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCH
Confidence            8889999999999999999999999987765433332222211    22346789999999999999999998     89


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      .++++||||.+..+.
T Consensus       246 ~~~l~h~~~~~~~~~  260 (323)
T cd05595         246 KEVMEHRFFLSINWQ  260 (323)
T ss_pred             HHHHcCCCcCCCCHH
Confidence            999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=6.7e-31  Score=263.28  Aligned_cols=168  Identities=31%  Similarity=0.488  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....                     
T Consensus        98 ~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (382)
T cd05625          98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW  177 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence            47889999999999999999999999999999999999999999999999754321000                     


Q ss_pred             ------------------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH
Q psy11119         60 ------------------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE  115 (407)
Q Consensus        60 ------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~  115 (407)
                                              .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~  257 (382)
T cd05625         178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ  257 (382)
T ss_pred             cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHH
Confidence                                    00112357999999999998888899999999999999999999999877654433


Q ss_pred             HHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC---HHHHHhCcccccCCC
Q psy11119        116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN---IEKIKSHRWYSKHMP  169 (407)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps---~~eil~hpwf~~~~~  169 (407)
                      ............+....+++++.++|.+|+ .+|.+|++   +.++++||||+...+
T Consensus       258 ~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         258 MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            333322233344455678999999999986 59999997   999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0614|consensus

Probab=99.97  E-value=2.3e-31  Score=261.33  Aligned_cols=178  Identities=30%  Similarity=0.506  Sum_probs=154.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+..+++|++|||++||++|||||+|+++|.+|-+||.|||+|+.+..+   ...++.||||.|+|||++.+
T Consensus       517 Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILn  593 (732)
T KOG0614|consen  517 FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILN  593 (732)
T ss_pred             cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC---CceeeecCCcccccchhhhc
Confidence            467789999999999999999999999999999999999999999999999987544   45678999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      +.+..++|.||||+++||||+|.+||.+.+.......+.+.......+  ..++..+.+||+++...+|.+|..     +
T Consensus       594 KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI  671 (732)
T KOG0614|consen  594 KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGI  671 (732)
T ss_pred             cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHHHhcCcHhhhccccCCh
Confidence            999999999999999999999999999998876555555554333333  668899999999999999999995     8


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCCch
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDFNS  183 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~~~  183 (407)
                      .+|.+|.||..-.|.........+++.+
T Consensus       672 ~DIkkH~Wf~gfdweglr~~~L~pPi~~  699 (732)
T KOG0614|consen  672 NDIKKHRWFEGFDWEGLRSRTLPPPIIP  699 (732)
T ss_pred             HHHHhhhhhhcCChhhhhhccCCCCccc
Confidence            9999999999988877666655555543

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=261.43  Aligned_cols=164  Identities=27%  Similarity=0.445  Sum_probs=133.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (330)
T cd05586          93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLD  170 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCccCccCCccccCHHHHcC
Confidence            578899999999999999999999999999999999999999999999998753222  122345689999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC----CH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL----NI  155 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp----s~  155 (407)
                      . .++.++||||+||++|+|++|..||...+...........  .... +...+++++.+||++||.++|.+||    ++
T Consensus       171 ~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  247 (330)
T cd05586         171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDA  247 (330)
T ss_pred             CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCH
Confidence            5 5789999999999999999999999877654332222211  1111 2234789999999999999999998    79


Q ss_pred             HHHHhCcccccCCC
Q psy11119        156 EKIKSHRWYSKHMP  169 (407)
Q Consensus       156 ~eil~hpwf~~~~~  169 (407)
                      .++++||||....+
T Consensus       248 ~~ll~h~~~~~~~~  261 (330)
T cd05586         248 VELKEHPFFADIDW  261 (330)
T ss_pred             HHHhcCccccCCCH
Confidence            99999999987543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=6.9e-31  Score=260.93  Aligned_cols=166  Identities=26%  Similarity=0.363  Sum_probs=130.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....   ........||+.|+|||++.+
T Consensus       120 ~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~  196 (359)
T cd07876         120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILG  196 (359)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc---CccCCCCcccCCCCCchhccC
Confidence            46788899999999999999999999999999999999999999999999875322   122345678999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH---------------------Hhhc-ccCCC-----------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE---------------------WKDN-RHMQR-----------  127 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~---------------------~~~~-~~~~~-----------  127 (407)
                      ..++.++||||+||++|+|++|..||...+........                     +... .....           
T Consensus       197 ~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (359)
T cd07876         197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWI  276 (359)
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccc
Confidence            88899999999999999999999999866532211100                     0000 00000           


Q ss_pred             -----CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        128 -----SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       128 -----~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                           ......+.++++||.+||..||++|||+.|+++||||..++.
T Consensus       277 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         277 FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             cccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence                 001124577899999999999999999999999999987553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=3.6e-31  Score=259.50  Aligned_cols=164  Identities=29%  Similarity=0.490  Sum_probs=135.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.......  ......+||+.|+|||++.
T Consensus        92 l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  169 (325)
T cd05594          92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLE  169 (325)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHc
Confidence            5788999999999999999998 799999999999999999999999999987532221  2233467999999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----C
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----N  154 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s  154 (407)
                      +..++.++||||+||++|+|++|..||...+...........  .  ......+++++.+||.+||..||.+|+     +
T Consensus       170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  245 (325)
T cd05594         170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDD  245 (325)
T ss_pred             cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--C--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCC
Confidence            888899999999999999999999999877654433332222  1  122345789999999999999999997     9


Q ss_pred             HHHHHhCcccccCCCC
Q psy11119        155 IEKIKSHRWYSKHMPN  170 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~  170 (407)
                      +.++++||||....+.
T Consensus       246 ~~~il~h~~~~~~~~~  261 (325)
T cd05594         246 AKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHHHhcCCCcCCCCHH
Confidence            9999999999875443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.5e-30  Score=260.10  Aligned_cols=167  Identities=27%  Similarity=0.447  Sum_probs=134.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.+
T Consensus       139 ~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~  217 (370)
T cd05621         139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhc
Confidence            46888999999999999999999999999999999999999999999999987543221 12245689999999999975


Q ss_pred             C----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC--CCC
Q psy11119         81 S----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST--RLN  154 (407)
Q Consensus        81 ~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~--Rps  154 (407)
                      .    +++.++|+||+||++|+|++|..||...+.................+....++..++++|.+||..++.+  |++
T Consensus       218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~  297 (370)
T cd05621         218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG  297 (370)
T ss_pred             cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC
Confidence            4    4788999999999999999999999877654333222222223333444567999999999999865543  899


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      +.++++||||+...
T Consensus       298 ~~e~l~hp~~~~~~  311 (370)
T cd05621         298 VEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=4.8e-31  Score=269.60  Aligned_cols=164  Identities=24%  Similarity=0.311  Sum_probs=130.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+....   .....+||+.|+|||++.
T Consensus       167 l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~  243 (440)
T PTZ00036        167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELML  243 (440)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhc
Confidence            46788999999999999999999999999999999999765 69999999998654322   223457899999999987


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------CCC--------CCCCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------MQR--------SPWDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~~~  133 (407)
                      +. .++.++||||+||++|+|++|.+||.+................                 .+.        ......
T Consensus       244 ~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~  323 (440)
T PTZ00036        244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT  323 (440)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCC
Confidence            65 7899999999999999999999999876544332222111000                 000        001236


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++++.+||.+||.++|.+|||+.|++.||||...
T Consensus       324 ~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        324 PDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            7899999999999999999999999999999764

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=4.2e-31  Score=262.68  Aligned_cols=171  Identities=27%  Similarity=0.431  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....                     
T Consensus        98 l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (360)
T cd05627          98 LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN  177 (360)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence            57889999999999999999999999999999999999999999999999875422110                     


Q ss_pred             ------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC
Q psy11119         60 ------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR  127 (407)
Q Consensus        60 ------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  127 (407)
                                  .......+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.................
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~  257 (360)
T cd05627         178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF  257 (360)
T ss_pred             cccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceec
Confidence                        00112457999999999999888899999999999999999999999877655433222221122233


Q ss_pred             CCCCcCCHHHHHHHHHhccCCCCCCC---CHHHHHhCcccccCCCCCC
Q psy11119        128 SPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       128 ~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~eil~hpwf~~~~~~~~  172 (407)
                      ++...+++++++||.+|+. +|.+|+   ++.++++||||....|...
T Consensus       258 p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         258 PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence            3334578999999999874 999998   5899999999998766544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=6.4e-31  Score=258.45  Aligned_cols=164  Identities=27%  Similarity=0.464  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......  ......+||+.|+|||++.+
T Consensus        93 l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05618          93 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcC
Confidence            5788999999999999999999999999999999999999999999999987532221  22345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPT--------ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ..++.++|+||+||++|+|++|..||....        ........... .  ....+..++..+.+||++||+.||.+|
T Consensus       171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~--~~~~p~~~~~~~~~ll~~~L~~dP~~R  247 (329)
T cd05618         171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-K--QIRIPRSLSVKAASVLKSFLNKDPKER  247 (329)
T ss_pred             CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-C--CCCCCCCCCHHHHHHHHHHhcCCHHHc
Confidence            888999999999999999999999995211        01111111111 1  122234678999999999999999999


Q ss_pred             CC------HHHHHhCcccccCCC
Q psy11119        153 LN------IEKIKSHRWYSKHMP  169 (407)
Q Consensus       153 ps------~~eil~hpwf~~~~~  169 (407)
                      |+      +.++++||||+...+
T Consensus       248 ~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         248 LGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCCCCH
Confidence            98      589999999987644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.1e-30  Score=255.99  Aligned_cols=166  Identities=29%  Similarity=0.410  Sum_probs=136.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05602          93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHK  170 (325)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccCCccccCHHHHcC
Confidence            467888999999999999999999999999999999999999999999998753221  122345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE----  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~----  156 (407)
                      ..++.++||||+||++|+|++|..||...+...........    .......++..+.++|.+||..+|.+|+++.    
T Consensus       171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC----CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            88899999999999999999999999876654322222111    1222346889999999999999999999765    


Q ss_pred             HHHhCcccccCCCCCC
Q psy11119        157 KIKSHRWYSKHMPNDI  172 (407)
Q Consensus       157 eil~hpwf~~~~~~~~  172 (407)
                      ++++|+||....|.+.
T Consensus       247 ~i~~~~~~~~~~~~~~  262 (325)
T cd05602         247 EIKNHIFFSPINWDDL  262 (325)
T ss_pred             HHhcCcccCCCCHHHH
Confidence            8999999987665443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=7.5e-31  Score=257.87  Aligned_cols=164  Identities=27%  Similarity=0.443  Sum_probs=131.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        93 l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05588          93 LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHcC
Confidence            578899999999999999999999999999999999999999999999998642211  122345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTA--------DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ..++.++|+||+||++|+|++|..||+....        .......... ..  ......++.++.++|++||+.||.+|
T Consensus       171 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~p~~~~~~~~~li~~~L~~dP~~R  247 (329)
T cd05588         171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQ--IRIPRSLSVKASSVLKGFLNKDPKER  247 (329)
T ss_pred             CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CC--CCCCCCCCHHHHHHHHHHhccCHHHc
Confidence            8889999999999999999999999963211        1111111111 11  12234578999999999999999999


Q ss_pred             CC------HHHHHhCcccccCCC
Q psy11119        153 LN------IEKIKSHRWYSKHMP  169 (407)
Q Consensus       153 ps------~~eil~hpwf~~~~~  169 (407)
                      ++      ++++++||||....+
T Consensus       248 ~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         248 LGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCCCCH
Confidence            97      799999999976543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0597|consensus

Probab=99.97  E-value=6e-31  Score=261.34  Aligned_cols=162  Identities=27%  Similarity=0.457  Sum_probs=140.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+|+....  .....+...|||.|||||++.+
T Consensus        97 lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e  174 (808)
T KOG0597|consen   97 LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEE  174 (808)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999987654  3345667789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      +.|+..+|+||+|||+|||++|++||........-..+    ...+..++...+..+..|+..+|.+||.+|++..+++.
T Consensus       175 ~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I----~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  175 QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI----LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH----hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            99999999999999999999999999865433222222    22233344578999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      |||+++..
T Consensus       251 HpF~k~~~  258 (808)
T KOG0597|consen  251 HPFWKGKI  258 (808)
T ss_pred             ChHHhhhh
Confidence            99998865

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=250.33  Aligned_cols=167  Identities=27%  Similarity=0.429  Sum_probs=136.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......   .....+|++.|+|||++.+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  175 (285)
T cd05605          99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcC
Confidence            5788999999999999999999999999999999999999999999999987653221   2234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|+.||.......................+..++..+.+||.+||..||.+||     ++
T Consensus       176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  255 (285)
T cd05605         176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGA  255 (285)
T ss_pred             CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCH
Confidence            8889999999999999999999999987654322111111111222223456889999999999999999999     89


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||....+.
T Consensus       256 ~~l~~~~~~~~~~~~  270 (285)
T cd05605         256 EEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHhcCcCccCCCHH
Confidence            999999999875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=8.1e-31  Score=257.43  Aligned_cols=165  Identities=27%  Similarity=0.429  Sum_probs=133.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        93 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (327)
T cd05617          93 LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRG  170 (327)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcccCCHHHHCC
Confidence            578899999999999999999999999999999999999999999999998753221  122345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCC------hhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPT------ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ..++.++||||+||++|+|++|..||....      .....+.....   .....+..++..+.++|++||..||.+|++
T Consensus       171 ~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  247 (327)
T cd05617         171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---KPIRIPRFLSVKASHVLKGFLNKDPKERLG  247 (327)
T ss_pred             CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---CCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            888999999999999999999999996321      11111222211   122223457899999999999999999997


Q ss_pred             ------HHHHHhCcccccCCCC
Q psy11119        155 ------IEKIKSHRWYSKHMPN  170 (407)
Q Consensus       155 ------~~eil~hpwf~~~~~~  170 (407)
                            ++++++||||....+.
T Consensus       248 ~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         248 CQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             CCCCCCHHHHHcCCCCCCCCHH
Confidence                  5799999999986543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=3.3e-30  Score=256.58  Aligned_cols=165  Identities=26%  Similarity=0.336  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   ........||+.|+|||++.+
T Consensus       123 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~  199 (364)
T cd07875         123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILG  199 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhC
Confidence            46778899999999999999999999999999999999999999999999975422   222345578999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc----------------------cCC------------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR----------------------HMQ------------  126 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~----------------------~~~------------  126 (407)
                      ..++.++|||||||++|+|++|..||...+.............                      ...            
T Consensus       200 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (364)
T cd07875         200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL  279 (364)
T ss_pred             CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccc
Confidence            8889999999999999999999999986654322111111000                      000            


Q ss_pred             ----CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        127 ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       127 ----~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                          .......+..+++||.+||..||.+|||+.++++||||..+.
T Consensus       280 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         280 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             ccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                000112346789999999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=5.6e-31  Score=257.22  Aligned_cols=164  Identities=33%  Similarity=0.527  Sum_probs=136.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+|++.|+|||++.+
T Consensus        95 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  172 (318)
T cd05582          95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNR  172 (318)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcC
Confidence            5788999999999999999999999999999999999999999999999987643221  22345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++||||+||++|+|++|..||...............  ..  .....+++++.+||++||+.||.+||+     +
T Consensus       173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~  248 (318)
T cd05582         173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KL--GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGV  248 (318)
T ss_pred             CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence            88899999999999999999999999877654333322222  11  222457899999999999999999999     7


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      .+++.||||....+.
T Consensus       249 ~~~~~~~~~~~~~~~  263 (318)
T cd05582         249 EEIKRHPFFSTIDWN  263 (318)
T ss_pred             HHHhCCCCcCCCCHH
Confidence            889999999876543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=3.5e-30  Score=255.35  Aligned_cols=165  Identities=26%  Similarity=0.350  Sum_probs=130.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   ........||+.|+|||++.+
T Consensus       116 l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~  192 (355)
T cd07874         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILG  192 (355)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcC
Confidence            46788899999999999999999999999999999999999999999999975422   222345678999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh---------------------hc-ccC-------------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK---------------------DN-RHM-------------  125 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~---------------------~~-~~~-------------  125 (407)
                      ..++.++||||+||++|+|++|..||.+............                     .. ...             
T Consensus       193 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (355)
T cd07874         193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  272 (355)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccc
Confidence            8889999999999999999999999986653322111100                     00 000             


Q ss_pred             ---CCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        126 ---QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       126 ---~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                         ........+.++++||.+||..||++|||+.|+++||||....
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence               0001122356789999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0658|consensus

Probab=99.97  E-value=5.2e-31  Score=251.31  Aligned_cols=165  Identities=31%  Similarity=0.484  Sum_probs=135.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |+.-+++-|+.||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|+.+..+.   +..+...|..|.|||.+.
T Consensus       122 mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELif  198 (364)
T KOG0658|consen  122 MPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIF  198 (364)
T ss_pred             CceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHc
Confidence            3555788999999999999999999999999999999976 899999999999886543   335677899999999998


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc--------------------cCCCCC-----CCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR--------------------HMQRSP-----WDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~--------------------~~~~~~-----~~~~  133 (407)
                      +. .|+.+.||||+||++.||+.|++-|.+.+..+....+.+.-+                    .....+     ....
T Consensus       199 ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~  278 (364)
T KOG0658|consen  199 GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRL  278 (364)
T ss_pred             CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCC
Confidence            87 899999999999999999999999987665544333222111                    111112     2457


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++++.+|+.++|..+|.+|.++.|++.||||....
T Consensus       279 ~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  279 PPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             CHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            89999999999999999999999999999998643

>KOG4717|consensus

Probab=99.97  E-value=1e-30  Score=257.14  Aligned_cols=164  Identities=30%  Similarity=0.560  Sum_probs=142.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |.|+.+++||+||+.|+.|||+..||||||||+|+.+- .-|-+||.|||++..+..+   ..+++.||+..|-|||++.
T Consensus       115 l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  115 LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILL  191 (864)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhh
Confidence            57899999999999999999999999999999999875 4589999999999887644   4567889999999999999


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +. |..+++||||||||||.|++|++||+..+..+....+...    .+..+..++.++++||..||..+|.+|.+.++|
T Consensus       192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI  267 (864)
T KOG4717|consen  192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEI  267 (864)
T ss_pred             cCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc----cccCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence            87 8889999999999999999999999988776554443222    233346689999999999999999999999999


Q ss_pred             HhCcccccCCCCC
Q psy11119        159 KSHRWYSKHMPND  171 (407)
Q Consensus       159 l~hpwf~~~~~~~  171 (407)
                      ..|+|++...+..
T Consensus       268 ~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  268 VSTSWLQAGDRGL  280 (864)
T ss_pred             hccccccCCCCCc
Confidence            9999999876543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=9.3e-31  Score=261.62  Aligned_cols=167  Identities=30%  Similarity=0.473  Sum_probs=134.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....                     
T Consensus        98 ~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (376)
T cd05598          98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW  177 (376)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence            47888999999999999999999999999999999999999999999999754321000                     


Q ss_pred             --------------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q psy11119         60 --------------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW  119 (407)
Q Consensus        60 --------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~  119 (407)
                                          .......+||+.|+|||++.+..++.++||||+||++|+|++|..||.............
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  257 (376)
T cd05598         178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI  257 (376)
T ss_pred             cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHh
Confidence                                001123579999999999998888999999999999999999999998876554333322


Q ss_pred             hhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CHHHHHhCcccccCC
Q psy11119        120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYSKHM  168 (407)
Q Consensus       120 ~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~eil~hpwf~~~~  168 (407)
                      ........+.+..+++++.++|.+|+ .+|.+|+   ++.++++||||+...
T Consensus       258 ~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         258 NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            22223333445568999999999977 5999999   999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=3.1e-30  Score=255.78  Aligned_cols=165  Identities=24%  Similarity=0.421  Sum_probs=130.7

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc-
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR-   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-   80 (407)
                      ++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  .......||+.|+|||++.. 
T Consensus       166 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  243 (353)
T PLN00034        166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTD  243 (353)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCccccccc
Confidence            567788999999999999999999999999999999999999999999998754221  12344579999999999743 


Q ss_pred             ----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 ----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                          .+.+.++|||||||++|+|++|+.||..........................++.++.+||.+||..||++|||+.
T Consensus       244 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~  323 (353)
T PLN00034        244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAM  323 (353)
T ss_pred             cccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence                3556789999999999999999999974332222111111111122223356789999999999999999999999


Q ss_pred             HHHhCcccccCC
Q psy11119        157 KIKSHRWYSKHM  168 (407)
Q Consensus       157 eil~hpwf~~~~  168 (407)
                      |+++||||.+..
T Consensus       324 ell~hp~~~~~~  335 (353)
T PLN00034        324 QLLQHPFILRAQ  335 (353)
T ss_pred             HHhcCcccccCC
Confidence            999999999864

>KOG0595|consensus

Probab=99.97  E-value=8.8e-31  Score=252.42  Aligned_cols=164  Identities=31%  Similarity=0.525  Sum_probs=140.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC------CcEEEEecCCceeeccCCCccCCcCccCCCCCCc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ------DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVA   74 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~------g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A   74 (407)
                      ++|+.++.++.||+.||++||+++|+||||||+||||+..      -.+||+|||+|+.+..+   ....+.||+|.|||
T Consensus       106 l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMA  182 (429)
T KOG0595|consen  106 LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMA  182 (429)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccC
Confidence            5899999999999999999999999999999999999865      35899999999987633   34567899999999


Q ss_pred             hhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         75 PEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        75 PE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ||++..+.|+.|+|+||+|+|||+|++|..||+..+..+..... +............+++...+|+...+..+|.+|.+
T Consensus       183 PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~  261 (429)
T KOG0595|consen  183 PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS  261 (429)
T ss_pred             HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-hccccccCchhhhccCchhhhhhHHHhcCccccCc
Confidence            99999999999999999999999999999999998887654433 33233334444567778889999999999999999


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      ..+-..|++.....
T Consensus       262 ~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  262 FEDFFDHPFLAANP  275 (429)
T ss_pred             hHHhhhhhhcccCc
Confidence            99999999887654

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-30  Score=254.67  Aligned_cols=163  Identities=27%  Similarity=0.404  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       115 l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcC
Confidence            57889999999999999999999999999999999999999999999999976432     2234578999999999977


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-----------------------cCCC----CCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-----------------------HMQR----SPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------------~~~~----~~~~~  132 (407)
                       ..++.++||||+||++|+|++|..||.................                       ....    ..+..
T Consensus       190 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07878         190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG  269 (343)
T ss_pred             CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccC
Confidence             4788999999999999999999999976543321111100000                       0000    01234


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      .++.+.+||.+||..||.+|||+.+++.||||....
T Consensus       270 ~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         270 ANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            567789999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=260.57  Aligned_cols=168  Identities=26%  Similarity=0.381  Sum_probs=132.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--------------------   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--------------------   60 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......                    
T Consensus        98 ~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (377)
T cd05629          98 FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN  177 (377)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence            578889999999999999999999999999999999999999999999998643211000                    


Q ss_pred             -------------------------cCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH
Q psy11119         61 -------------------------RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE  115 (407)
Q Consensus        61 -------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~  115 (407)
                                               ......+||+.|+|||++.+..++.++||||+||++|+|++|..||.........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~  257 (377)
T cd05629         178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETY  257 (377)
T ss_pred             ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHH
Confidence                                     0001357999999999998888899999999999999999999999876654322


Q ss_pred             HHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC---CCHHHHHhCcccccCCC
Q psy11119        116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR---LNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R---ps~~eil~hpwf~~~~~  169 (407)
                      ............+....++.++.+||.+||. +|.+|   +++.+++.||||+...+
T Consensus       258 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         258 RKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            2222211223333444678999999999997 77765   59999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=2.8e-30  Score=253.18  Aligned_cols=166  Identities=28%  Similarity=0.499  Sum_probs=136.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......+  ......+||+.|+|||++.+
T Consensus        98 l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05615          98 FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcC
Confidence            5788999999999999999999999999999999999999999999999987532221  12334579999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|+||+||++|+|++|..||...............  .  ...+..++.++.+++.+||..+|.+|++     .
T Consensus       176 ~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  251 (323)
T cd05615         176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--N--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGE  251 (323)
T ss_pred             CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCH
Confidence            88899999999999999999999999877654333222221  1  1223457899999999999999999997     5


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      +++++||||....+...
T Consensus       252 ~~i~~h~~f~~~~~~~~  268 (323)
T cd05615         252 RDIREHAFFRRIDWDKL  268 (323)
T ss_pred             HHHhcCcccCCCCHHHH
Confidence            79999999998665433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=3.9e-30  Score=257.21  Aligned_cols=167  Identities=27%  Similarity=0.445  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......+. ......+||+.|+|||++.+
T Consensus       139 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~  217 (371)
T cd05622         139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKS  217 (371)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhc
Confidence            46788999999999999999999999999999999999999999999999986543221 12345689999999999975


Q ss_pred             C----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC--CCC
Q psy11119         81 S----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST--RLN  154 (407)
Q Consensus        81 ~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~--Rps  154 (407)
                      .    .++.++||||+||++|+|++|..||...+.................+....++..+++||.+||..++.+  |++
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~  297 (371)
T cd05622         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG  297 (371)
T ss_pred             cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCC
Confidence            4    3788999999999999999999999887654332222222223334444578999999999999854443  789


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      ++++++|+||+...
T Consensus       298 ~~ei~~h~~~~~~~  311 (371)
T cd05622         298 VEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=2.4e-30  Score=253.10  Aligned_cols=164  Identities=30%  Similarity=0.380  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        93 ~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05603          93 FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRK  170 (321)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcC
Confidence            467889999999999999999999999999999999999999999999998753211  222345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----E  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~----~  156 (407)
                      ..++.++|||||||++|+|++|..||...+...........    ........+.++.++|.+||+.+|.+|+++    .
T Consensus       171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (321)
T cd05603         171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFL  246 (321)
T ss_pred             CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHH
Confidence            88899999999999999999999999877654332222211    122224568899999999999999999865    5


Q ss_pred             HHHhCcccccCCCC
Q psy11119        157 KIKSHRWYSKHMPN  170 (407)
Q Consensus       157 eil~hpwf~~~~~~  170 (407)
                      ++++|+||....+.
T Consensus       247 ~~~~~~~~~~~~~~  260 (321)
T cd05603         247 EIKNHVFFSPINWD  260 (321)
T ss_pred             HHhCCCCcCCCCHH
Confidence            99999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.7e-30  Score=261.60  Aligned_cols=170  Identities=25%  Similarity=0.328  Sum_probs=132.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++................||+.|+|||++.+
T Consensus       182 l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  261 (392)
T PHA03207        182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL  261 (392)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC
Confidence            57889999999999999999999999999999999999999999999999976543332223345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--HHHH-HHh-------------------------hcccCCCC--C-
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADC--IEYL-EWK-------------------------DNRHMQRS--P-  129 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--~~~~-~~~-------------------------~~~~~~~~--~-  129 (407)
                      ..++.++||||+||++|+|++|..||.+.....  .... ...                         ........  . 
T Consensus       262 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (392)
T PHA03207        262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV  341 (392)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccch
Confidence            888999999999999999999999996543211  0000 000                         00000000  0 


Q ss_pred             --CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        130 --WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       130 --~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                        ...++.++.++|++||..+|.+|||+.+++.||||.+..++
T Consensus       342 ~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        342 IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence              02356788999999999999999999999999999886543

>KOG0612|consensus

Probab=99.97  E-value=2.3e-30  Score=273.81  Aligned_cols=173  Identities=28%  Similarity=0.421  Sum_probs=145.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +||+-|++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+...|... ....+|||.|++||++..
T Consensus       172 ~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  172 LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHh
Confidence            6899999999999999999999999999999999999999999999999988776555433 356789999999999963


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-  154 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-  154 (407)
                           +.|+..+|+||+||++|||+.|..||.........-.+..-......|.-..+|+++++||.+++. +|+.|.. 
T Consensus       251 ~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgr  329 (1317)
T KOG0612|consen  251 QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGR  329 (1317)
T ss_pred             hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhccc
Confidence                 468999999999999999999999999876654433333222344444456699999999999886 5778887 


Q ss_pred             --HHHHHhCcccccCCCCCCCCC
Q psy11119        155 --IEKIKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       155 --~~eil~hpwf~~~~~~~~~~~  175 (407)
                        ++++..||||.+..|..+.+.
T Consensus       330 ngiedik~HpFF~g~~W~~iR~~  352 (1317)
T KOG0612|consen  330 NGIEDIKNHPFFEGIDWDNIRES  352 (1317)
T ss_pred             ccHHHHHhCccccCCChhhhhhc
Confidence              999999999999999766555

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=3.4e-30  Score=246.68  Aligned_cols=168  Identities=26%  Similarity=0.389  Sum_probs=132.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......   ......|++.|+|||++.+
T Consensus        92 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  168 (277)
T cd05607          92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKE  168 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHcc
Confidence            3567788999999999999999999999999999999999999999999987654221   2234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~----  155 (407)
                      ..++.++|+||+||++|+|++|..||................ ..........+++++.+||.+||+.||.+||++    
T Consensus       169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence            889999999999999999999999997543321111111111 111111234678999999999999999999999    


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      ++++.||||+...+..
T Consensus       249 ~~~~~h~~f~~~~~~~  264 (277)
T cd05607         249 DDPRKHEFFKTINFPR  264 (277)
T ss_pred             hhhhcChhhcCCCHHH
Confidence            6788999998865433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0983|consensus

Probab=99.97  E-value=2.8e-30  Score=237.49  Aligned_cols=165  Identities=24%  Similarity=0.393  Sum_probs=138.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +||..+-++..-+++||.||-++ ||+|||+||+|||+|+.|++|+||||++..+...   ...+...|.+.|||||.+.
T Consensus       188 iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERid  264 (391)
T KOG0983|consen  188 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERID  264 (391)
T ss_pred             chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc---cccccccCCccccCccccC
Confidence            46777888999999999999976 8999999999999999999999999999776433   2334567999999999986


Q ss_pred             cC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 RS---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 ~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      -.   .|...+||||||+.|+||.||+.||.+.+.+.....+..+......+.-.++|+.+.+|+..||.+|+.+||.+.
T Consensus       265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~  344 (391)
T KOG0983|consen  265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYN  344 (391)
T ss_pred             CCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchH
Confidence            43   678899999999999999999999998766654444444434444444456999999999999999999999999


Q ss_pred             HHHhCcccccCC
Q psy11119        157 KIKSHRWYSKHM  168 (407)
Q Consensus       157 eil~hpwf~~~~  168 (407)
                      ++++|||+....
T Consensus       345 ~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  345 KLLEHPFIKRYE  356 (391)
T ss_pred             HHhcCcceeecc
Confidence            999999998764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.3e-30  Score=267.09  Aligned_cols=164  Identities=24%  Similarity=0.368  Sum_probs=137.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+............+||+.|+|||++.+
T Consensus       140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  219 (496)
T PTZ00283        140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR  219 (496)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence            46788999999999999999999999999999999999999999999999987643322333445689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||...+...........  . ..+....+++++.+||.+||+.+|.+||++.++++
T Consensus       220 ~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        220 KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--R-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            88899999999999999999999999877654333222221  1 11223567899999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      |||++..
T Consensus       297 ~p~~~~~  303 (496)
T PTZ00283        297 MPICKLF  303 (496)
T ss_pred             CHHHHHh
Confidence            9998764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=2.6e-30  Score=251.18  Aligned_cols=165  Identities=27%  Similarity=0.459  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  178 (309)
T cd07872         101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLG  178 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhC
Confidence            4678899999999999999999999999999999999999999999999987643221  22234568999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------cCC-------CCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------HMQ-------RSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~-------~~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|+.||...+.............                   ...       ......+
T Consensus       179 ~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (309)
T cd07872         179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRL  258 (309)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCC
Confidence            4 678999999999999999999999987654332211111000                   000       0112347


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++++.+||.+||..||.+|||+.|+++||||+..
T Consensus       259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             CHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            8899999999999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.5e-30  Score=258.56  Aligned_cols=166  Identities=25%  Similarity=0.343  Sum_probs=127.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+||+.|+|||++.+
T Consensus       179 l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~  257 (391)
T PHA03212        179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLAR  257 (391)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcC
Confidence            4678899999999999999999999999999999999999999999999986532211 122345689999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh------hHHHH-H-------------------------HHhhc-c--cC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTA------DCIEY-L-------------------------EWKDN-R--HM  125 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~------~~~~~-~-------------------------~~~~~-~--~~  125 (407)
                      ..++.++||||+||++|+|++|..||-....      ..... .                         ..... .  ..
T Consensus       258 ~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (391)
T PHA03212        258 DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPG  337 (391)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCC
Confidence            8889999999999999999999987643210      00000 0                         00000 0  00


Q ss_pred             CCCCC---CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        126 QRSPW---DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       126 ~~~~~---~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ..+.|   ..++.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       338 ~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        338 SRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             CCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            01111   1356789999999999999999999999999999874

>KOG0611|consensus

Probab=99.97  E-value=1.4e-30  Score=249.98  Aligned_cols=160  Identities=33%  Similarity=0.615  Sum_probs=136.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++++|+||++|+.|||.++|+|||||.+|||+|.|+++||+|||++..+..   ...+.++||+|.|.+||++.+
T Consensus       150 LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG  226 (668)
T KOG0611|consen  150 LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNG  226 (668)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---ccHHHHhcCCcccCCccccCC
Confidence            68999999999999999999999999999999999999999999999999988753   356788999999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . |-++.+|.|||||+||.|+.|..||++.+.... ...+.. +.+..+.   -+.++.-||+.||-.||++|.|+.+|.
T Consensus       227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-vrQIs~-GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiA  301 (668)
T KOG0611|consen  227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-VRQISR-GAYREPE---TPSDASGLIRWMLMVNPERRATIEDIA  301 (668)
T ss_pred             CCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-HHHhhc-ccccCCC---CCchHHHHHHHHHhcCcccchhHHHHh
Confidence            8 778999999999999999999999998776532 222222 2222221   355789999999999999999999999


Q ss_pred             hCcccccCC
Q psy11119        160 SHRWYSKHM  168 (407)
Q Consensus       160 ~hpwf~~~~  168 (407)
                      .|=|+.=++
T Consensus       302 sHWWvNwgy  310 (668)
T KOG0611|consen  302 SHWWVNWGY  310 (668)
T ss_pred             hhheeeccc
Confidence            998876443

>KOG0603|consensus

Probab=99.97  E-value=2.3e-30  Score=261.66  Aligned_cols=151  Identities=33%  Similarity=0.548  Sum_probs=129.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE-ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCC
Q psy11119          4 WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL-DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl-d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~   82 (407)
                      .++..|++||+.|+.|||++||+||||||+|||+ +..|+++|+|||.++.....     ..+.|-|..|.|||++....
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~  489 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQE  489 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCC
Confidence            4677899999999999999999999999999999 58899999999999865432     45678899999999999889


Q ss_pred             CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCc
Q psy11119         83 LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHR  162 (407)
Q Consensus        83 ~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hp  162 (407)
                      +++++||||||++||+||+|+.||.........+...   ......  ..+|.++++||++||+.+|.+|+++.++..||
T Consensus       490 yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  490 YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            9999999999999999999999998766552222211   111111  55899999999999999999999999999999


Q ss_pred             cc
Q psy11119        163 WY  164 (407)
Q Consensus       163 wf  164 (407)
                      ||
T Consensus       565 w~  566 (612)
T KOG0603|consen  565 WF  566 (612)
T ss_pred             ch
Confidence            99

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=3.8e-30  Score=247.49  Aligned_cols=165  Identities=28%  Similarity=0.441  Sum_probs=132.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......   ......|++.|+|||++.+
T Consensus        99 l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05630          99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcC
Confidence            4678899999999999999999999999999999999999999999999987543221   2234579999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|+||+||++|+|++|..||..........................+++++.+||.+||+.||.+|||     +
T Consensus       176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  255 (285)
T cd05630         176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGA  255 (285)
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCch
Confidence            88899999999999999999999999865432111110000011112233557889999999999999999999     9


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      +++++||||++..
T Consensus       256 ~~~~~h~~~~~~~  268 (285)
T cd05630         256 REVKEHPLFKQIN  268 (285)
T ss_pred             HHHHcChhhhccC
Confidence            9999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=5.6e-30  Score=249.02  Aligned_cols=164  Identities=27%  Similarity=0.470  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE----ecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl----d~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~AP   75 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.+..... ........||+.|+||
T Consensus       105 l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCc
Confidence            4678899999999999999999999999999999999    4567899999999986543221 1223455789999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH--------HHHH------------Hhhc---c--------
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCI--------EYLE------------WKDN---R--------  123 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~--------~~~~------------~~~~---~--------  123 (407)
                      |++.+. .++.++||||+||++|+|++|..||.....+..        ....            |...   .        
T Consensus       185 E~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (317)
T cd07867         185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKD  264 (317)
T ss_pred             HHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhh
Confidence            999764 678999999999999999999999975332100        0000            0000   0        


Q ss_pred             ----cCC--------CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        124 ----HMQ--------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       124 ----~~~--------~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                          ...        .......+..+.+||.+||..||.+|||++|+++||||
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         265 FRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                000        00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0580|consensus

Probab=99.97  E-value=2.2e-30  Score=234.23  Aligned_cols=159  Identities=28%  Similarity=0.524  Sum_probs=137.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|..+..|++|++.||.|||..+|+||||||+|+|++..|.+|++|||.+..-.    .....+.|||..|.+||...+
T Consensus       121 f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~  196 (281)
T KOG0580|consen  121 FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEG  196 (281)
T ss_pred             ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCC
Confidence            4678899999999999999999999999999999999999999999999986532    234567899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++..+|+|++|++.||++.|.+||+..... ..|..... .....+  ..++.++.+||.+|+..+|.+|....|+++
T Consensus       197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k-~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRK-VDLKFP--STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             CCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHH-ccccCC--cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            99999999999999999999999999987744 34444333 222222  678999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      |||+...
T Consensus       273 hpwI~a~  279 (281)
T KOG0580|consen  273 HPWIVAN  279 (281)
T ss_pred             hHHHHhc
Confidence            9999764

>KOG0201|consensus

Probab=99.97  E-value=5.7e-31  Score=255.51  Aligned_cols=162  Identities=27%  Similarity=0.416  Sum_probs=137.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +|.++.-++++++.||.|||+++.+|||||+.|||+..+|.+||+|||++..+.....  ...+..|||.|||||++...
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~  186 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQS  186 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhccc
Confidence            5667778899999999999999999999999999999999999999999987654332  23788999999999999988


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                      .|+.++||||||++.+||++|.+||.+..+....+.+-+.   .+...-..+++.+++||..||++||+.||++.++++|
T Consensus       187 ~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  187 GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            9999999999999999999999999877664333332222   1222223688999999999999999999999999999


Q ss_pred             cccccCC
Q psy11119        162 RWYSKHM  168 (407)
Q Consensus       162 pwf~~~~  168 (407)
                      +|++...
T Consensus       264 ~FIk~a~  270 (467)
T KOG0201|consen  264 KFIKRAK  270 (467)
T ss_pred             HHHHhcC
Confidence            9998843

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=1.1e-29  Score=249.57  Aligned_cols=163  Identities=25%  Similarity=0.427  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......    ......|++.|+|||++.
T Consensus       100 ~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~  175 (331)
T cd06649         100 IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhc
Confidence            46788999999999999999986 6999999999999999999999999998765322    223457999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH----------------------------------------
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW----------------------------------------  119 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~----------------------------------------  119 (407)
                      +..++.++||||+||++|+|++|+.||.............                                        
T Consensus       176 ~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T cd06649         176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFE  255 (331)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHH
Confidence            8888999999999999999999999997655432211100                                        


Q ss_pred             ----hhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        120 ----KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       120 ----~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                          ......+..+...+++++.+||.+||..||++|||+.++++||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         256 LLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             HHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                000001111123478899999999999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1.1e-29  Score=253.65  Aligned_cols=167  Identities=28%  Similarity=0.422  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ........+++.|+|||++.+
T Consensus       100 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcC
Confidence            4688899999999999999999999999999999999999999999999998653222 222344568999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh---------------------hcccCCC-------CCCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK---------------------DNRHMQR-------SPWD  131 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~---------------------~~~~~~~-------~~~~  131 (407)
                      . .++.++||||+||++|+|++|+.||...+..........                     .......       ....
T Consensus       179 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (372)
T cd07853         179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS  258 (372)
T ss_pred             CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCC
Confidence            5 578999999999999999999999987654322111100                     0000000       1123


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ..++++.+||.+||..||.+|||+.++++||||.+..
T Consensus       259 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         259 QATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             CCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            4578999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0192|consensus

Probab=99.96  E-value=1.3e-29  Score=250.70  Aligned_cols=156  Identities=33%  Similarity=0.465  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG-IAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g-IvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++......  ...+...||+.|||||++
T Consensus       139 l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~  216 (362)
T KOG0192|consen  139 LPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVL  216 (362)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhh
Confidence            567788999999999999999999 99999999999999998 99999999998754322  233346899999999999


Q ss_pred             h--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         79 V--RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        79 ~--~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      .  ...++.++||||+|++||||+||+.||.........+...........  ...+++.+..||.+||+.||..||++.
T Consensus       217 ~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~~~~l~~l~~~CW~~dp~~RP~f~  294 (362)
T KOG0192|consen  217 RGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKECPPHLSSLMERCWLVDPSRRPSFL  294 (362)
T ss_pred             cCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence            9  558999999999999999999999999988775444444433222222  233889999999999999999999999


Q ss_pred             HHHh
Q psy11119        157 KIKS  160 (407)
Q Consensus       157 eil~  160 (407)
                      +|+.
T Consensus       295 ei~~  298 (362)
T KOG0192|consen  295 EIVS  298 (362)
T ss_pred             HHHH
Confidence            9876

>KOG0695|consensus

Probab=99.96  E-value=5e-30  Score=241.30  Aligned_cols=228  Identities=23%  Similarity=0.365  Sum_probs=166.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |||+.|+.|-.+|+.||.|||++||++||||.+|+|+|..|++||+|+|+.+.-.  +......+.||||.|+|||++.+
T Consensus       348 lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  348 LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcc
Confidence            6899999999999999999999999999999999999999999999999987532  23345678999999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCC-----C--ChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDK-----P--TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~-----~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      ..|+..+|+|+|||+++||+.|+.||+-     +  +.++..+.....   .....+..+|-.+..+++..|++||.+|.
T Consensus       426 eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---kqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  426 EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---KQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh---hcccccceeehhhHHHHHHhhcCCcHHhc
Confidence            9999999999999999999999999962     1  222223332222   12223345777889999999999999997


Q ss_pred             ------CHHHHHhCcccccCCCCCCCCCCCCCCCchhHHhhhcchHHHhhhcCCCCCCCccCCCCCccccCCCCCccccC
Q psy11119        154 ------NIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFALRGPMSVCEVE  227 (407)
Q Consensus       154 ------s~~eil~hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~a  227 (407)
                            .+.++..|+||+...|.........+++.+....-+.     .......|.+..+--.|+..+  .-....+..
T Consensus       503 gc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~-----l~~fd~qft~e~~qltpdd~d--~i~ridqse  575 (593)
T KOG0695|consen  503 GCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYG-----LDNFDTQFTSEPVQLTPDDED--AIKRIDQSE  575 (593)
T ss_pred             CCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccC-----ccccccccccCCcccCCCCHH--HHHhcchhh
Confidence                  5789999999999888877777666666543221110     111112222222222232111  111224678


Q ss_pred             CccccccCCCCcc
Q psy11119        228 PHLFSFSQPTHLD  240 (407)
Q Consensus       228 ~~~~SfSqp~~~~  240 (407)
                      |+++-+.+|+.++
T Consensus       576 fegfeyinpl~ms  588 (593)
T KOG0695|consen  576 FEGFEYINPLLMS  588 (593)
T ss_pred             cCcceecchhhcc
Confidence            8999999988654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=1.1e-29  Score=262.17  Aligned_cols=163  Identities=24%  Similarity=0.399  Sum_probs=136.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+............+||+.|+|||++.+
T Consensus       166 l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  245 (478)
T PTZ00267        166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER  245 (478)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC
Confidence            46788999999999999999999999999999999999999999999999987644332233455689999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||................  . .+....++.++.++|.+||..+|++||++.+++.
T Consensus       246 ~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        246 KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--Y-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            888999999999999999999999998776544333322221  1 1223457899999999999999999999999999


Q ss_pred             Cccccc
Q psy11119        161 HRWYSK  166 (407)
Q Consensus       161 hpwf~~  166 (407)
                      |+|++.
T Consensus       323 ~~~~~~  328 (478)
T PTZ00267        323 TEFLKY  328 (478)
T ss_pred             CHHHHH
Confidence            999875

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1.5e-29  Score=241.82  Aligned_cols=162  Identities=31%  Similarity=0.499  Sum_probs=128.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++......  ........+++.|+|||++.+
T Consensus        98 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  175 (285)
T cd07861          98 MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLG  175 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcC
Confidence            468889999999999999999999999999999999999999999999998754322  122234467899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------------cCCCCCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------------HMQRSPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~s  134 (407)
                      . .++.++|+||+||++|+|++|+.||.................                         .........++
T Consensus       176 ~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (285)
T cd07861         176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD  255 (285)
T ss_pred             CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCC
Confidence            5 578899999999999999999999986654322221111000                         00011134578


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +++.++|++||..||.+|||+.+|++||||
T Consensus       256 ~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         256 EDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.6e-29  Score=259.06  Aligned_cols=165  Identities=25%  Similarity=0.366  Sum_probs=128.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+
T Consensus       257 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence            56888999999999999999999999999999999999999999999999987643322222334679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCC--------ChhHHHHHHHhhcc----------------------------c
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKP--------TADCIEYLEWKDNR----------------------------H  124 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~--------~~~~~~~~~~~~~~----------------------------~  124 (407)
                      ..++.++|||||||+||+|++|..|+-..        ...... .......                            .
T Consensus       337 ~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~-~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  415 (461)
T PHA03211        337 DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL-RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA  415 (461)
T ss_pred             CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH-HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence            88899999999999999999987654211        111111 1110000                            0


Q ss_pred             CCCCCC---CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        125 MQRSPW---DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       125 ~~~~~~---~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      .....|   ..++.++.+||.+||..||.+|||+.|+++||||+.
T Consensus       416 ~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        416 YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            011112   245678999999999999999999999999999975

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=2.1e-29  Score=242.13  Aligned_cols=166  Identities=25%  Similarity=0.406  Sum_probs=135.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......   .......|++.|+|||++.+
T Consensus        99 ~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~~~aPE~~~~  175 (285)
T cd05632          99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNN  175 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---CcccCCCCCcCccChHHhcC
Confidence            468889999999999999999999999999999999999999999999998764322   12234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|+||+||++|+|++|..||..........................+++++.+|+.+||..+|.+||+     +
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  255 (285)
T cd05632         176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGA  255 (285)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccCh
Confidence            88899999999999999999999999876543222222111122222334567889999999999999999999     8


Q ss_pred             HHHHhCcccccCCC
Q psy11119        156 EKIKSHRWYSKHMP  169 (407)
Q Consensus       156 ~eil~hpwf~~~~~  169 (407)
                      .+++.|+||+....
T Consensus       256 ~~l~~~~~~~~~~~  269 (285)
T cd05632         256 GEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHHcChhhhcCCH
Confidence            99999999988643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=2.8e-29  Score=246.95  Aligned_cols=158  Identities=22%  Similarity=0.315  Sum_probs=126.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  250 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD  250 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence            45678899999999999999999999999999999999999999999999976532222112223456788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||..................  ......+++++.+||.+||..+|.+|||+.+++
T Consensus       251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~  328 (338)
T cd05102         251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR--MRAPENATPEIYRIMLACWQGDPKERPTFSALV  328 (338)
T ss_pred             CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999997 99999875543322222222111  222346788999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       329 ~  329 (338)
T cd05102         329 E  329 (338)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=5.4e-29  Score=234.24  Aligned_cols=159  Identities=23%  Similarity=0.384  Sum_probs=133.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......  .......+++.|+|||++.+
T Consensus        99 l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  176 (257)
T cd08223          99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSN  176 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcC
Confidence            4788899999999999999999999999999999999999999999999998764322  22345578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  .. ......+++.+.++|.+||+.+|.+||++.++++
T Consensus       177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            88889999999999999999999999876654333322221  11 1223457899999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       254 ~~~~  257 (257)
T cd08223         254 QPYI  257 (257)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.4e-29  Score=236.40  Aligned_cols=162  Identities=27%  Similarity=0.432  Sum_probs=132.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++........ .......|++.|+|||++.
T Consensus       101 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (263)
T cd06625         101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS  180 (263)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceec
Confidence            467888999999999999999999999999999999999999999999998765332111 1113456889999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+|+++|+|++|..||..............  ..........++..+.++|++||..+|.+|||+.+++
T Consensus       181 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  258 (263)
T cd06625         181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL  258 (263)
T ss_pred             cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            88889999999999999999999999987654332222211  1122223356789999999999999999999999999


Q ss_pred             hCccc
Q psy11119        160 SHRWY  164 (407)
Q Consensus       160 ~hpwf  164 (407)
                      +||||
T Consensus       259 ~~~~~  263 (263)
T cd06625         259 RHFFV  263 (263)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=8.8e-30  Score=239.53  Aligned_cols=162  Identities=33%  Similarity=0.553  Sum_probs=129.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+...  ...........+++.|+|||++. 
T Consensus        95 ~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~  172 (260)
T PF00069_consen   95 LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQ  172 (260)
T ss_dssp             BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence            467889999999999999999999999999999999999999999999998764  12223445667899999999998 


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH---hhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW---KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +...+.++|+||||+++|+|++|..||.............   ..............+..+.++|.+||+.+|++||++.
T Consensus       173 ~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~  252 (260)
T PF00069_consen  173 GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAE  252 (260)
T ss_dssp             TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHH
Confidence            7788999999999999999999999999773222222111   1111111111122247899999999999999999999


Q ss_pred             HHHhCccc
Q psy11119        157 KIKSHRWY  164 (407)
Q Consensus       157 eil~hpwf  164 (407)
                      ++++||||
T Consensus       253 ~l~~~~~~  260 (260)
T PF00069_consen  253 ELLKHPWF  260 (260)
T ss_dssp             HHHTSGGG
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=3.3e-29  Score=237.95  Aligned_cols=160  Identities=24%  Similarity=0.333  Sum_probs=130.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......  .......|++.|+|||++..
T Consensus       108 l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  185 (272)
T cd06637         108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC  185 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhcc
Confidence            4678899999999999999999999999999999999999999999999987653221  22345678999999999862


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           ..++.++|+||+||++|+|++|..||..............  ..........++.++.+||.+||..+|.+|||+
T Consensus       186 ~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  263 (272)
T cd06637         186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT  263 (272)
T ss_pred             ccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence                 3577899999999999999999999976554333322221  122222334578899999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .++++||||
T Consensus       264 ~~il~~~~~  272 (272)
T cd06637         264 EQLMKHPFI  272 (272)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=3.3e-29  Score=242.35  Aligned_cols=165  Identities=25%  Similarity=0.429  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  178 (301)
T cd07873         101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLG  178 (301)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhC
Confidence            4678899999999999999999999999999999999999999999999987543221  22234467899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-----------------cCCC---------CCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-----------------HMQR---------SPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------~~~~---------~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|+.||...+.............                 ....         .....+
T Consensus       179 ~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (301)
T cd07873         179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRL  258 (301)
T ss_pred             CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCC
Confidence            5 678899999999999999999999987664322111110000                 0000         011346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++++.+||.+||+.||.+|||++++++||||..-
T Consensus       259 ~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         259 DSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            8889999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0596|consensus

Probab=99.96  E-value=1.9e-29  Score=250.34  Aligned_cols=161  Identities=27%  Similarity=0.501  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC--
Q psy11119          4 WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS--   81 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--   81 (407)
                      ..++.|.+|++.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..........+.+||+.||+||.+...  
T Consensus       460 ~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s  538 (677)
T KOG0596|consen  460 WFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSS  538 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccc
Confidence            46889999999999999999999999999999998 799999999999988776666667788999999999998642  


Q ss_pred             ---------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         82 ---------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        82 ---------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                               ..+.++||||||||||+|+.|+.||..-............. ....++.... ..++.++++.||..||.+
T Consensus       539 ~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkk  617 (677)
T KOG0596|consen  539 SRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKK  617 (677)
T ss_pred             cccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCccc
Confidence                     25678999999999999999999997543221122222221 1122222221 234899999999999999


Q ss_pred             CCCHHHHHhCccccc
Q psy11119        152 RLNIEKIKSHRWYSK  166 (407)
Q Consensus       152 Rps~~eil~hpwf~~  166 (407)
                      ||++.++|+|||..-
T Consensus       618 R~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  618 RWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCcHHHhcCccccc
Confidence            999999999999976

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=3.2e-29  Score=246.53  Aligned_cols=169  Identities=22%  Similarity=0.406  Sum_probs=132.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...+. ......+||+.|+|||++..
T Consensus        99 l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  177 (332)
T cd05623          99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA  177 (332)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhc
Confidence            46788999999999999999999999999999999999999999999999876532221 12234579999999999862


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-CCCCCcCCHHHHHHHHHhccCCCCC--C
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-RSPWDRLDVNCLSLIRRILAPLPST--R  152 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~LI~~~L~~~P~~--R  152 (407)
                           ..++.++||||+||++|+|++|+.||.................... ......+++++.+||++||..++.+  |
T Consensus       178 ~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r  257 (332)
T cd05623         178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQ  257 (332)
T ss_pred             cccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCC
Confidence                 3678899999999999999999999987665433322222211111 1223467999999999999665544  6


Q ss_pred             CCHHHHHhCcccccCCCC
Q psy11119        153 LNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       153 ps~~eil~hpwf~~~~~~  170 (407)
                      ++++++++||||....+.
T Consensus       258 ~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         258 NGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             CCHHHHhCCCCcCCCCHH
Confidence            899999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.2e-29  Score=250.41  Aligned_cols=163  Identities=28%  Similarity=0.381  Sum_probs=124.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+
T Consensus       154 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  230 (357)
T PHA03209        154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLAR  230 (357)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCC
Confidence            468899999999999999999999999999999999999999999999998743211   12234579999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhHHH---------HHHHhhcc----cCC--------------------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIE---------YLEWKDNR----HMQ--------------------  126 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~P-f~~~~~~~~~---------~~~~~~~~----~~~--------------------  126 (407)
                      ..++.++||||+||++|+|+++..| |.........         ........    ...                    
T Consensus       231 ~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (357)
T PHA03209        231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ  310 (357)
T ss_pred             CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCC
Confidence            8889999999999999999985444 4432211000         00000000    000                    


Q ss_pred             -C-----CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        127 -R-----SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       127 -~-----~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                       .     .....++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        311 PYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             cccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence             0     001235667888999999999999999999999999975

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=5.3e-29  Score=237.29  Aligned_cols=160  Identities=23%  Similarity=0.402  Sum_probs=132.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......      ....|++.|+|||++.
T Consensus       106 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~  179 (267)
T PHA03390        106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIK  179 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhc
Confidence            57889999999999999999999999999999999999998 9999999998764321      2346889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-HHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-IEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-~~ei  158 (407)
                      +..++.++|+||+|+++|+|++|..||............+..........+..+++.+.++|.+||+++|.+||+ ++++
T Consensus       180 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  259 (267)
T PHA03390        180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEI  259 (267)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence            888889999999999999999999999865443322222222222223344568999999999999999999996 6999


Q ss_pred             HhCccccc
Q psy11119        159 KSHRWYSK  166 (407)
Q Consensus       159 l~hpwf~~  166 (407)
                      ++||||+.
T Consensus       260 l~h~~~~~  267 (267)
T PHA03390        260 IKHPFLKI  267 (267)
T ss_pred             hcCCcccC
Confidence            99999963

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=4.4e-29  Score=238.74  Aligned_cols=162  Identities=26%  Similarity=0.412  Sum_probs=125.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....  .......+++.|+|||++.+
T Consensus        96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  173 (284)
T cd07839          96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFG  173 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhC
Confidence            4788999999999999999999999999999999999999999999999987653221  22234567899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-c--------------cc---CC--------CCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-N--------------RH---MQ--------RSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~--------------~~---~~--------~~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|..||............... .              ..   ..        ......+
T Consensus       174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (284)
T cd07839         174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL  253 (284)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence            5 5789999999999999999998886432221111111100 0              00   00        0112346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++++.+||.+||..||.+|||++++++||||
T Consensus       254 ~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         254 NSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            8899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.3e-29  Score=244.39  Aligned_cols=168  Identities=24%  Similarity=0.423  Sum_probs=131.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... ......+||+.|+|||++..
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05597          99 LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQA  177 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhh
Confidence            57889999999999999999999999999999999999999999999999876543222 11223579999999999973


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-CCCCCcCCHHHHHHHHHhccCCCC--CC
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-RSPWDRLDVNCLSLIRRILAPLPS--TR  152 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~LI~~~L~~~P~--~R  152 (407)
                           ..++.++||||+||++|+|++|+.||.................... ......++++++++|++||...+.  .|
T Consensus       178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r  257 (331)
T cd05597         178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGR  257 (331)
T ss_pred             ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCC
Confidence                 3578899999999999999999999987655433222222111111 122345799999999998865444  37


Q ss_pred             CCHHHHHhCcccccCCC
Q psy11119        153 LNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       153 ps~~eil~hpwf~~~~~  169 (407)
                      +++.++++||||....+
T Consensus       258 ~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         258 NGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CCHHHHhcCCCCCCCCH
Confidence            89999999999987644

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.6e-29  Score=239.24  Aligned_cols=163  Identities=28%  Similarity=0.422  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......    ......|++.|+|||.+..
T Consensus        94 l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  169 (279)
T cd05633          94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK  169 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcC
Confidence            578899999999999999999999999999999999999999999999998754322    1233478999999999864


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----C
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----N  154 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s  154 (407)
                       ..++.++|+||+||++|+|++|..||............... .......+..+++++.++|.+||..||.+|+     +
T Consensus       170 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  248 (279)
T cd05633         170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG  248 (279)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence             46789999999999999999999999754332222111111 1122223355789999999999999999999     6


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      +.++++||||+...
T Consensus       249 ~~~~~~h~~~~~~~  262 (279)
T cd05633         249 AQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHhCccccCCC
Confidence            99999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.6e-29  Score=234.11  Aligned_cols=163  Identities=31%  Similarity=0.452  Sum_probs=133.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++.....      .....|++.|+|||.+.+
T Consensus        94 ~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~  167 (260)
T cd05611          94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILG  167 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcC
Confidence            47888999999999999999999999999999999999999999999999875432      223468889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEK  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~e  157 (407)
                      ..++.++|+||+|+++|+|++|..||...+......................++.++.++|.+||..+|++||   +++|
T Consensus       168 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            8889999999999999999999999987665433222222212222233346789999999999999999999   5589


Q ss_pred             HHhCcccccCCC
Q psy11119        158 IKSHRWYSKHMP  169 (407)
Q Consensus       158 il~hpwf~~~~~  169 (407)
                      ++.||||++..|
T Consensus       248 ~l~~~~~~~~~~  259 (260)
T cd05611         248 IKSHPFFKSINW  259 (260)
T ss_pred             HHcChHhhcCCC
Confidence            999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=6.3e-29  Score=234.66  Aligned_cols=163  Identities=27%  Similarity=0.469  Sum_probs=132.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l   78 (407)
                      +++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..+......  .......|++.|+|||++
T Consensus        99 ~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~  178 (267)
T cd06610          99 LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM  178 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHH
Confidence            467889999999999999999999999999999999999999999999998776543322  123445789999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC---CCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR---SPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ... .++.++|+||+||++|+|++|..||...+........... .....   ..+..+++.+.+++.+||..||++||+
T Consensus       179 ~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  257 (267)
T cd06610         179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT  257 (267)
T ss_pred             ccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcC
Confidence            877 7889999999999999999999999876543222222111 11111   112467899999999999999999999


Q ss_pred             HHHHHhCccc
Q psy11119        155 IEKIKSHRWY  164 (407)
Q Consensus       155 ~~eil~hpwf  164 (407)
                      +.+++.||||
T Consensus       258 ~~~ll~~p~~  267 (267)
T cd06610         258 AEELLKHKFF  267 (267)
T ss_pred             HHHHhhCCCC
Confidence            9999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=1.3e-28  Score=235.73  Aligned_cols=165  Identities=23%  Similarity=0.347  Sum_probs=132.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......  ........+++.|+|||++. 
T Consensus       100 l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  177 (282)
T cd06643         100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMC  177 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccccccccccccCHhhccc
Confidence            467889999999999999999999999999999999999999999999998754321  12233457899999999984 


Q ss_pred             ----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 ----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                          +..++.++|+||+||++|+|++|..||...+........ .............++.++.++|.+||+.+|.+||++
T Consensus       178 ~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  256 (282)
T cd06643         178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT  256 (282)
T ss_pred             cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-hhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence                235678999999999999999999999876543322222 221111222234578899999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .++++||||+...
T Consensus       257 ~~il~~~~~~~~~  269 (282)
T cd06643         257 TQLLQHPFVTVNS  269 (282)
T ss_pred             HHHhcCCCEeccC
Confidence            9999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=9.2e-29  Score=236.88  Aligned_cols=166  Identities=28%  Similarity=0.402  Sum_probs=134.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+...    .....+|++.|+|||++.+
T Consensus        94 l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  169 (278)
T cd05606          94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK  169 (278)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcC
Confidence            578899999999999999999999999999999999999999999999998754322    1234579999999999975


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----C
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----N  154 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s  154 (407)
                      + .++.++|+||+||++|+|++|..||............... .......+..++.++.++|.+||..+|.+||     +
T Consensus       170 ~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~  248 (278)
T cd05606         170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG  248 (278)
T ss_pred             CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCC
Confidence            5 6789999999999999999999999866332222111111 1112222345689999999999999999999     9


Q ss_pred             HHHHHhCcccccCCCCC
Q psy11119        155 IEKIKSHRWYSKHMPND  171 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~  171 (407)
                      +.++++||||+...+..
T Consensus       249 ~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         249 AQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             HHHHHhCccccCCCchH
Confidence            99999999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.4e-28  Score=238.81  Aligned_cols=166  Identities=29%  Similarity=0.428  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+
T Consensus       105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  182 (309)
T cd07845         105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLG  182 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhhcC
Confidence            4688899999999999999999999999999999999999999999999998764322  12233456788999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-------------------CCCCC-------CCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-------------------MQRSP-------WDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~  133 (407)
                      . .++.++|+||+||++|+|++|+.||...+..............                   ....+       ...+
T Consensus       183 ~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T cd07845         183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWL  262 (309)
T ss_pred             CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcccc
Confidence            4 6789999999999999999999999876654332221111000                   00000       1225


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++.+.+||.+||.+||++|||+.+++.||||++..
T Consensus       263 ~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         263 SEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            78899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=9.8e-29  Score=238.95  Aligned_cols=165  Identities=25%  Similarity=0.412  Sum_probs=135.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  .......|++.|+|||.+.+
T Consensus       113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  190 (296)
T cd06654         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR  190 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcC
Confidence            4677889999999999999999999999999999999999999999999987543221  12234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|+.||.........+..... ..........++..+.++|.+||.++|.+||++.++++
T Consensus       191 ~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            88889999999999999999999999877654333332222 22222233567889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||....
T Consensus       270 ~~~~~~~~  277 (296)
T cd06654         270 HQFLKIAK  277 (296)
T ss_pred             ChhhhccC
Confidence            99998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=8e-29  Score=237.10  Aligned_cols=163  Identities=23%  Similarity=0.418  Sum_probs=132.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......    .....+|++.|+|||++.+
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  167 (279)
T cd06619          92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG  167 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecC
Confidence            467888999999999999999999999999999999999999999999998765322    2334579999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH-----HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADC-----IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      ..++.++|+||+||++|+|++|..||.......     ...............+...+++++.++|.+||..+|.+||++
T Consensus       168 ~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  247 (279)
T cd06619         168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAP  247 (279)
T ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCH
Confidence            888999999999999999999999996432111     011111111122222334578899999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      +++++||||...
T Consensus       248 ~eil~~~~~~~~  259 (279)
T cd06619         248 ENLMDHPFIVQY  259 (279)
T ss_pred             HHHhcCcccccc
Confidence            999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.1e-28  Score=244.52  Aligned_cols=168  Identities=27%  Similarity=0.365  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......   .......+++.|+|||.+.+
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  191 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG  191 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC---CCCCCCcccccccCHHHHhC
Confidence            467889999999999999999999999999999999999999999999999764322   22334568899999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh---------------------hccc-CCC-----------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK---------------------DNRH-MQR-----------  127 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~---------------------~~~~-~~~-----------  127 (407)
                      ..++.++||||+||++|+|++|..||...+..........                     .... ...           
T Consensus       192 ~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (353)
T cd07850         192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVL  271 (353)
T ss_pred             CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccc
Confidence            8889999999999999999999999976543211110000                     0000 000           


Q ss_pred             ------CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCCC
Q psy11119        128 ------SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       128 ------~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~~  171 (407)
                            ......++.+.++|.+||..||++|||+.+++.||||+.+....
T Consensus       272 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         272 FPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             cCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence                  00123456789999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=1.1e-28  Score=238.62  Aligned_cols=165  Identities=25%  Similarity=0.402  Sum_probs=136.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......  .......|++.|+|||.+.+
T Consensus       112 l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  189 (296)
T cd06655         112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR  189 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCCCcCCCccccCcchhcC
Confidence            4788999999999999999999999999999999999999999999999987653322  12234578899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||............... .......+..+++.+.++|++||..+|.+||++.+++.
T Consensus       190 ~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            88899999999999999999999999877654433332222 22222334568899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||+...
T Consensus       269 ~~~~~~~~  276 (296)
T cd06655         269 HPFLKLAK  276 (296)
T ss_pred             ChHhhhcc
Confidence            99998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.7e-28  Score=236.01  Aligned_cols=163  Identities=29%  Similarity=0.448  Sum_probs=128.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..+....  .......+++.|+|||++.
T Consensus       107 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhh
Confidence            478899999999999999999999999999999999998 8899999999987653221  1223346788999999987


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC------------------------CCCCcCC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR------------------------SPWDRLD  134 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~s  134 (407)
                      +. .++.++|+||+|+++|+|++|..||...+.................                        .....++
T Consensus       185 ~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (295)
T cd07837         185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLS  264 (295)
T ss_pred             CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccC
Confidence            54 6789999999999999999999999865543322211111000000                        0013478


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYS  165 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~  165 (407)
                      .++.++|.+||.+||.+||++.+++.||||+
T Consensus       265 ~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         265 PEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            8999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=1.5e-28  Score=232.84  Aligned_cols=161  Identities=26%  Similarity=0.471  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc----cCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE----RPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~----~~~~~~~gt~~Y~APE   76 (407)
                      +++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++........    .......|++.|+|||
T Consensus       103 l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe  182 (267)
T cd06628         103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE  182 (267)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChh
Confidence            467888999999999999999999999999999999999999999999998876422111    1122346889999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      .+.+..++.++|+||+||++|+|++|..||...+....... ...  .........++..+.++|++||+++|.+||++.
T Consensus       183 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06628         183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGE--NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAA  259 (267)
T ss_pred             HhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH-Hhc--cCCCcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence            99888888999999999999999999999987654322221 111  111222345789999999999999999999999


Q ss_pred             HHHhCccc
Q psy11119        157 KIKSHRWY  164 (407)
Q Consensus       157 eil~hpwf  164 (407)
                      ++++||||
T Consensus       260 ~il~~~~~  267 (267)
T cd06628         260 ELLKHPFL  267 (267)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=8.8e-29  Score=237.37  Aligned_cols=165  Identities=24%  Similarity=0.364  Sum_probs=130.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......   .......|++.|+|||++.
T Consensus       104 l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERID  180 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC---CccccccCccCccCHHHhc
Confidence            46788999999999999999985 9999999999999999999999999998754322   1223346889999999997


Q ss_pred             cC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc--ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         80 RS---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN--RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        80 ~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      +.   .++.++|+||+||++|+|++|..||................  .......+..++.++.+||.+||+++|++|||
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  260 (288)
T cd06616         181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK  260 (288)
T ss_pred             cccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC
Confidence            65   68899999999999999999999997654221111111111  11111222457899999999999999999999


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      +++|+.||||+...
T Consensus       261 ~~~i~~~~~~~~~~  274 (288)
T cd06616         261 YKELLEHPFIKDYE  274 (288)
T ss_pred             HHHHhcChhhhchh
Confidence            99999999998753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=1.1e-28  Score=235.67  Aligned_cols=168  Identities=29%  Similarity=0.412  Sum_probs=134.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......   .......++..|+|||++.+
T Consensus        92 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~~PE~~~~  168 (277)
T cd05577          92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQG  168 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---CccccccCCCCcCCHHHhcC
Confidence            478889999999999999999999999999999999999999999999998764321   22234467889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|+.||..........................+++.+.++|++||..+|.+||     ++
T Consensus       169 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  248 (277)
T cd05577         169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA  248 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccH
Confidence            7788999999999999999999999976543211111111111222233345789999999999999999999     88


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      .+++.||||.+..+..
T Consensus       249 ~~ll~h~~~~~~~~~~  264 (277)
T cd05577         249 DEVREHPLFKDLNWRR  264 (277)
T ss_pred             HHHHhChhhhcCChhh
Confidence            9999999998765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=241.92  Aligned_cols=169  Identities=28%  Similarity=0.429  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .......+|++.|+|||.+.
T Consensus       103 l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh
Confidence            57888999999999999999999999999999999999999999999999876533221 11223457899999999876


Q ss_pred             c-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh----------------------hcc-cCCCC----CCC
Q psy11119         80 R-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK----------------------DNR-HMQRS----PWD  131 (407)
Q Consensus        80 ~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~----------------------~~~-~~~~~----~~~  131 (407)
                      + ..++.++||||+||++|+|++|+.||.+.+..........                      ... .....    ...
T Consensus       183 ~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T cd07849         183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP  262 (336)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhc
Confidence            5 4688999999999999999999999976543211100000                      000 00000    113


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .+++++.++|.+||+.+|++|||+.++++||||+....
T Consensus       263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         263 NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             ccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            45788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=9.2e-29  Score=243.25  Aligned_cols=169  Identities=24%  Similarity=0.398  Sum_probs=132.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.+
T Consensus        99 l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624          99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhc
Confidence            47888999999999999999999999999999999999999999999999976543221 12234579999999999875


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-CCCCCcCCHHHHHHHHHhccCCCCC--C
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-RSPWDRLDVNCLSLIRRILAPLPST--R  152 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~LI~~~L~~~P~~--R  152 (407)
                           ..++.++|+||+||++|+|++|+.||.................... ...+..+++++.++|.+||...+.+  |
T Consensus       178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~  257 (331)
T cd05624         178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQ  257 (331)
T ss_pred             cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCC
Confidence                 4578899999999999999999999987665433222222211121 1223457899999999999876654  5


Q ss_pred             CCHHHHHhCcccccCCCC
Q psy11119        153 LNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       153 ps~~eil~hpwf~~~~~~  170 (407)
                      ++++++++||||....|.
T Consensus       258 ~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         258 NGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             CCHHHHhcCCCcCCCCHH
Confidence            699999999999875543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=1.4e-28  Score=242.23  Aligned_cols=163  Identities=26%  Similarity=0.461  Sum_probs=129.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++......    ......|++.|+|||++.
T Consensus       100 ~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~  175 (333)
T cd06650         100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQ  175 (333)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhc
Confidence            46778899999999999999985 7999999999999999999999999998754322    223457899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH-----------------------------------------
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-----------------------------------------  118 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~-----------------------------------------  118 (407)
                      +..++.++|+||+||++|+|++|+.||............                                         
T Consensus       176 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (333)
T cd06650         176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL  255 (333)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHH
Confidence            888899999999999999999999999765433221110                                         


Q ss_pred             -HhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        119 -WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       119 -~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                       .......+..+...++.++++||.+||..||++|||+.+++.||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         256 DYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             HHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence             0000000111112367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=1.7e-28  Score=237.19  Aligned_cols=164  Identities=26%  Similarity=0.435  Sum_probs=126.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..+......  .......++..|+|||.+
T Consensus       116 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHh
Confidence            478899999999999999999999999999999999999999999999999765433221  122345678899999998


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-------------------CC---------C
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-------------------RS---------P  129 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~---------~  129 (407)
                      .+. .++.++|+||+|+++|+|++|+.||...+...............+                   ..         .
T Consensus       196 ~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  275 (310)
T cd07865         196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK  275 (310)
T ss_pred             cCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc
Confidence            765 468899999999999999999999976654322111111000000                   00         0


Q ss_pred             CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       130 ~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ....+..+.+||.+||..||.+|||++++++||||
T Consensus       276 ~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         276 PYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2.2e-28  Score=231.14  Aligned_cols=167  Identities=32%  Similarity=0.533  Sum_probs=134.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus        90 l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~  166 (262)
T cd05572          90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN  166 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcC
Confidence            4678899999999999999999999999999999999999999999999987654322   2234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|+||+|+++|+|++|..||.....+.....................++++.++|.+||..+|.+||+     +
T Consensus       167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  246 (262)
T cd05572         167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGI  246 (262)
T ss_pred             CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCH
Confidence            78889999999999999999999999876522122111111111122222345889999999999999999999     9


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +|+++||||+...|+
T Consensus       247 ~~l~~~~~~~~~~~~  261 (262)
T cd05572         247 KDIKKHKWFNGFDWE  261 (262)
T ss_pred             HHHhcChhhhCCCCC
Confidence            999999999976543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.4e-28  Score=237.80  Aligned_cols=169  Identities=29%  Similarity=0.403  Sum_probs=136.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--------------------   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--------------------   60 (407)
                      +++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.........                    
T Consensus       100 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (316)
T cd05574         100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE  179 (316)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence            467889999999999999999999999999999999999999999999998654322110                    


Q ss_pred             -------cCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcC
Q psy11119         61 -------RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRL  133 (407)
Q Consensus        61 -------~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (407)
                             .......|+..|+|||++.+..++.++||||+|+++|+|++|..||...+..........  .....+....+
T Consensus       180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~  257 (316)
T cd05574         180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPV  257 (316)
T ss_pred             hhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhc--CCccCCCcccc
Confidence                   011234688999999999888889999999999999999999999987765433322221  22223333347


Q ss_pred             CHHHHHHHHHhccCCCCCCCC----HHHHHhCcccccCCCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLN----IEKIKSHRWYSKHMPND  171 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps----~~eil~hpwf~~~~~~~  171 (407)
                      +.++.++|.+||..+|++||+    +++++.||||+...+..
T Consensus       258 ~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             CHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            899999999999999999999    99999999998865443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=2.5e-28  Score=233.33  Aligned_cols=162  Identities=28%  Similarity=0.501  Sum_probs=129.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........  ......++..|+|||++.+
T Consensus        97 ~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  174 (286)
T cd07847          97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVG  174 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhC
Confidence            47889999999999999999999999999999999999999999999999987543321  2233467889999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------cCCC--------CCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------HMQR--------SPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~--------~~~~~  132 (407)
                      . .++.++|+||+||++|+|++|..||.+....+..........                   ..+.        ..+..
T Consensus       175 ~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07847         175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN  254 (286)
T ss_pred             CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhcc
Confidence            4 678899999999999999999999987654433222111000                   0000        01235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++..+.+||.+||.++|++||++.+++.||||
T Consensus       255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         255 ISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            67889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=2.1e-28  Score=229.92  Aligned_cols=161  Identities=25%  Similarity=0.373  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........  ......|+..|+|||++.+
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  173 (256)
T cd06612          96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQE  173 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhc
Confidence            46888999999999999999999999999999999999999999999999876543321  2233458889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||............... ..........++.++.++|.+||+.+|.+|||+.+++.
T Consensus       174 ~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            88899999999999999999999999876543322221111 11111222346789999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       253 ~~~~  256 (256)
T cd06612         253 HPFI  256 (256)
T ss_pred             CCCC
Confidence            9997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=2e-28  Score=236.47  Aligned_cols=166  Identities=25%  Similarity=0.410  Sum_probs=134.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  192 (292)
T cd06658         115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISR  192 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHcc
Confidence            4678899999999999999999999999999999999999999999999987543221  22234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||......... ................++..+.++|.+||..+|.+|||++++++
T Consensus       193 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            88889999999999999999999999866543222 12222112222223457889999999999999999999999999


Q ss_pred             CcccccCCC
Q psy11119        161 HRWYSKHMP  169 (407)
Q Consensus       161 hpwf~~~~~  169 (407)
                      ||||....+
T Consensus       272 ~~~~~~~~~  280 (292)
T cd06658         272 HPFLKLAGP  280 (292)
T ss_pred             ChhhhccCC
Confidence            999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=1.8e-28  Score=234.48  Aligned_cols=160  Identities=23%  Similarity=0.327  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......  .......|++.|+|||.+..
T Consensus       118 ~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~  195 (282)
T cd06636         118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC  195 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCc
Confidence            4677889999999999999999999999999999999999999999999987543211  12234578999999999862


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           ..++.++|+|||||++|+|++|..||........... ... ..........++.++.+||.+||..||.+||++
T Consensus       196 ~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (282)
T cd06636         196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPR-NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST  273 (282)
T ss_pred             ccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-Hhh-CCCCCCcccccCHHHHHHHHHHhCCChhhCcCH
Confidence                 3577899999999999999999999976543322221 111 111222234578999999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .+|++||||
T Consensus       274 ~ell~~~~~  282 (282)
T cd06636         274 EQLLKHPFI  282 (282)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=1.7e-28  Score=234.43  Aligned_cols=164  Identities=28%  Similarity=0.502  Sum_probs=129.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ .......|+..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  174 (286)
T cd07832          96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYG  174 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeec
Confidence            47889999999999999999999999999999999999999999999999886543321 22345578999999999865


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-------------------CCC-------CCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-------------------MQR-------SPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------------~~~-------~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|.+||..................                   ...       ......
T Consensus       175 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07832         175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA  254 (286)
T ss_pred             cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence            4 5689999999999999999998888765543221111110000                   000       011345


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS  165 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~  165 (407)
                      +.++.+||.+||..+|.+||+++++++||||.
T Consensus       255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         255 SPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            78899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0608|consensus

Probab=99.96  E-value=5.7e-29  Score=249.62  Aligned_cols=170  Identities=29%  Similarity=0.491  Sum_probs=140.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------c-----------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------E-----------   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------~-----------   60 (407)
                      |+|+.|++|+.+|.+|+++.|..|+|||||||+|||||.+|++||+|||+++-++-...         .           
T Consensus       726 FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~  805 (1034)
T KOG0608|consen  726 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW  805 (1034)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence            57899999999999999999999999999999999999999999999999875531100         0           


Q ss_pred             --------------------cCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q psy11119         61 --------------------RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK  120 (407)
Q Consensus        61 --------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  120 (407)
                                          ...+..+||+.|+|||++....++..+|+||.|||||||+.|+.||...+.....+....
T Consensus       806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n  885 (1034)
T KOG0608|consen  806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN  885 (1034)
T ss_pred             ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee
Confidence                                011235899999999999999999999999999999999999999988777666555433


Q ss_pred             hcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CHHHHHhCcccccCCCCC
Q psy11119        121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       121 ~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~~eil~hpwf~~~~~~~  171 (407)
                      -......++-..++.++.+||.+++. .++.|+   ..++|+.||||+...+.+
T Consensus       886 w~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  886 WRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             hhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence            33344555667899999999998654 577887   467899999999987654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=2.6e-28  Score=231.10  Aligned_cols=163  Identities=25%  Similarity=0.386  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC----CccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG----KERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~APE   76 (407)
                      +++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......    .........|++.|+|||
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe  178 (265)
T cd06631          99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE  178 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChh
Confidence            4678899999999999999999999999999999999999999999999987542211    112223456899999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++|+||+||++|+|++|..||............ .............++.++.++|++||.++|.+||++.
T Consensus       179 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  257 (265)
T cd06631         179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSAL  257 (265)
T ss_pred             hhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-hhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence            998888889999999999999999999999865543222221 1111122223356789999999999999999999999


Q ss_pred             HHHhCccc
Q psy11119        157 KIKSHRWY  164 (407)
Q Consensus       157 eil~hpwf  164 (407)
                      +++.||||
T Consensus       258 ~~l~~~~~  265 (265)
T cd06631         258 QLLRHDFL  265 (265)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=2.9e-28  Score=232.37  Aligned_cols=160  Identities=24%  Similarity=0.390  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++|++||||+|+||+++. +.+||+|||++.......   ......+++.|+|||.+..
T Consensus        97 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  172 (282)
T cd07831          97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---PYTEYISTRWYRAPECLLT  172 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---CcCCCCCCcccCChhHhhc
Confidence            478899999999999999999999999999999999999 999999999997653222   2233468899999998754


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc----------------ccCCCC---------CCCcCC
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN----------------RHMQRS---------PWDRLD  134 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~----------------~~~~~~---------~~~~~s  134 (407)
                       ..++.++|+||+||++|+|++|..||...+............                .....+         ....++
T Consensus       173 ~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07831         173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS  252 (282)
T ss_pred             CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccccc
Confidence             467889999999999999999999998765432211110000                000000         012467


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .++.++|.+||.++|++||+++++++||||
T Consensus       253 ~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         253 AEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0579|consensus

Probab=99.96  E-value=1.1e-28  Score=247.26  Aligned_cols=166  Identities=25%  Similarity=0.353  Sum_probs=140.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |.|.+++-+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+.....  ......+++|||.|||||++..
T Consensus       127 LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmC  204 (1187)
T KOG0579|consen  127 LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMC  204 (1187)
T ss_pred             cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheee
Confidence            67899999999999999999999999999999999999999999999999865322  2233467899999999999863


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           .+|..++||||||+.|.+|.-+.+|....+.......+.+. ..+....+..++..+.+++++||.+||..||++
T Consensus       205 ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~a  283 (1187)
T KOG0579|consen  205 ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPA  283 (1187)
T ss_pred             ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCCccCCCH
Confidence                 47899999999999999999999999887776555444443 233333446778899999999999999999999


Q ss_pred             HHHHhCcccccCCC
Q psy11119        156 EKIKSHRWYSKHMP  169 (407)
Q Consensus       156 ~eil~hpwf~~~~~  169 (407)
                      +++++||||.....
T Consensus       284 aqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  284 AQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHhhCcccccCCc
Confidence            99999999986543

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=4.7e-28  Score=227.51  Aligned_cols=159  Identities=25%  Similarity=0.366  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....  .......|++.|+|||++.+
T Consensus        98 ~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08529          98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCED  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcC
Confidence            4677889999999999999999999999999999999999999999999988654322  12234578899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+|||||++|+|++|..||...+........ .. .... .....++.++.++|.+||+.+|++||++.++++
T Consensus       176 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~-~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IR-GVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hc-CCCC-CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            88899999999999999999999999877643322221 11 1111 122367889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      |||+
T Consensus       253 ~~~~  256 (256)
T cd08529         253 NPSL  256 (256)
T ss_pred             CCCC
Confidence            9995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=3.4e-28  Score=235.13  Aligned_cols=159  Identities=20%  Similarity=0.335  Sum_probs=125.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCCCchh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPYVAPE   76 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE   76 (407)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+|+.+...+..     .......||+.|+|||
T Consensus       124 ~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape  203 (294)
T PHA02882        124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD  203 (294)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence            56778899999999999999999999999999999999999999999999876433221     1123346999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHH----HHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL----EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ++.+..++.++||||+||++|+|++|..||...........    .+..............+..+.+++..|+..+|.+|
T Consensus       204 ~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r  283 (294)
T PHA02882        204 AHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEK  283 (294)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCC
Confidence            99988899999999999999999999999986632211111    01111111111234467889999999999999999


Q ss_pred             CCHHHHHh
Q psy11119        153 LNIEKIKS  160 (407)
Q Consensus       153 ps~~eil~  160 (407)
                      |+++++++
T Consensus       284 p~~~~l~~  291 (294)
T PHA02882        284 PDYDALIK  291 (294)
T ss_pred             CCHHHHHH
Confidence            99999975

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.7e-28  Score=231.32  Aligned_cols=164  Identities=26%  Similarity=0.412  Sum_probs=134.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++......  .......+++.|+|||.+.+
T Consensus        95 ~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  172 (274)
T cd06609          95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQ  172 (274)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhcc
Confidence            5788999999999999999999999999999999999999999999999998765332  22234578899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ..+......++.++.++|.+||..+|++|||++++++
T Consensus       173 ~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc--CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            88899999999999999999999999876543322221111  1111122227889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||.+..
T Consensus       251 ~~~~~~~~  258 (274)
T cd06609         251 HKFIKKAK  258 (274)
T ss_pred             ChhhcCCC
Confidence            99998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.4e-28  Score=233.29  Aligned_cols=164  Identities=24%  Similarity=0.446  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..+...   .......|+..|+|||.+.
T Consensus       100 ~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617         100 IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcC
Confidence            47889999999999999999998 9999999999999999999999999998765322   1223356889999999986


Q ss_pred             c----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 R----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ~----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      +    ..++.++|+||+||++|+|++|..||............... ......+...++.++.++|.+||..+|.+||++
T Consensus       177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~  255 (283)
T cd06617         177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY  255 (283)
T ss_pred             CcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence            5    34678999999999999999999999754322222222222 111122224578999999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .+++.||||.+..
T Consensus       256 ~~il~~~~~~~~~  268 (283)
T cd06617         256 PELLQHPFFELHL  268 (283)
T ss_pred             HHHhcCchhhhcc
Confidence            9999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=1.9e-28  Score=237.05  Aligned_cols=166  Identities=25%  Similarity=0.422  Sum_probs=135.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+
T Consensus       112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  189 (297)
T cd06656         112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR  189 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcC
Confidence            4678899999999999999999999999999999999999999999999987653322  12234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||...+.....+..... ..........++..+.+||.+||..+|.+||++.++++
T Consensus       190 ~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            88899999999999999999999999766543322222211 12222233557888999999999999999999999999


Q ss_pred             CcccccCCC
Q psy11119        161 HRWYSKHMP  169 (407)
Q Consensus       161 hpwf~~~~~  169 (407)
                      ||||....+
T Consensus       269 ~~~~~~~~~  277 (297)
T cd06656         269 HPFLKLAKP  277 (297)
T ss_pred             Cchhccccc
Confidence            999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=3.3e-28  Score=232.59  Aligned_cols=158  Identities=23%  Similarity=0.331  Sum_probs=129.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       121 l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (283)
T cd05048         121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY  200 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc
Confidence            35678889999999999999999999999999999999999999999999976543322223344567889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||.+.............  . .......+++++.+|+.+||+.+|.+||++.+|+
T Consensus       201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~--~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~  277 (283)
T cd05048         201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR--Q-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIH  277 (283)
T ss_pred             CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--C-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999998 99999876655433322211  1 1122356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       278 ~~  279 (283)
T cd05048         278 TR  279 (283)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=4.5e-28  Score=233.29  Aligned_cols=166  Identities=29%  Similarity=0.397  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  ........+++.|+|||++..
T Consensus       107 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  184 (292)
T cd06644         107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMC  184 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeecc
Confidence            468889999999999999999999999999999999999999999999998753221  112234568899999999853


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           ..++.++|+||+||++|+|++|..||...+... ..................++.++.++|.+||..+|++||++
T Consensus       185 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  263 (292)
T cd06644         185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSA  263 (292)
T ss_pred             ccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCH
Confidence                 346778999999999999999999997665432 22222221221222234578899999999999999999999


Q ss_pred             HHHHhCcccccCCC
Q psy11119        156 EKIKSHRWYSKHMP  169 (407)
Q Consensus       156 ~eil~hpwf~~~~~  169 (407)
                      +++++||||....+
T Consensus       264 ~~il~~~~~~~~~~  277 (292)
T cd06644         264 AQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHhcCcccccccc
Confidence            99999999987544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=2.7e-28  Score=233.32  Aligned_cols=162  Identities=27%  Similarity=0.455  Sum_probs=127.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......  .......+++.|+|||++.+
T Consensus        97 l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  174 (284)
T cd07860          97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG  174 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEec
Confidence            4678899999999999999999999999999999999999999999999987543221  22234457889999998876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-------------------------CCCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-------------------------RSPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s  134 (407)
                      . .++.++|+||+||++|+|++|..||....................                         ......++
T Consensus       175 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (284)
T cd07860         175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLD  254 (284)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCC
Confidence            4 568899999999999999999999976654332222111100000                         00123467


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++++++|.+||..||.+|||+++++.||||
T Consensus       255 ~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         255 EDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2e-28  Score=254.17  Aligned_cols=164  Identities=26%  Similarity=0.388  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~   82 (407)
                      ..+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+..... ......+||+.|+|||++.+..
T Consensus       266 ~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~  344 (501)
T PHA03210        266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDG  344 (501)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCC
Confidence            456788999999999999999999999999999999999999999999987643222 2223467999999999999888


Q ss_pred             CCCcchhhhHHHHHHHHHhCCC-CCCCCChh-HHHHHHHhhcc---------------------cCCCC--------CCC
Q psy11119         83 LAEPADIWSCGIILVAMLAGEL-PWDKPTAD-CIEYLEWKDNR---------------------HMQRS--------PWD  131 (407)
Q Consensus        83 ~~~~sDiwSlGviL~elltG~~-Pf~~~~~~-~~~~~~~~~~~---------------------~~~~~--------~~~  131 (407)
                      ++.++|||||||++|+|++|.. ||...... ...........                     .....        ...
T Consensus       345 ~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  424 (501)
T PHA03210        345 YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL  424 (501)
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc
Confidence            8999999999999999999875 44332211 01111100000                     00000        012


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      .++.++.++|.+||..||.+|||+.|++.||||...
T Consensus       425 ~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             CCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            356778899999999999999999999999999875

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=3.7e-28  Score=230.32  Aligned_cols=161  Identities=25%  Similarity=0.349  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......  ........|++.|+|||++. 
T Consensus       103 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  180 (267)
T cd06645         103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAV  180 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhcc
Confidence            578899999999999999999999999999999999999999999999998765322  12223457899999999985 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-CCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-QRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                        ...++.++|+||+||++|+|++|..||................... .......++..+.++|.+||..+|++||+++
T Consensus       181 ~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  260 (267)
T cd06645         181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAE  260 (267)
T ss_pred             ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence              3467889999999999999999999996544332222211111111 1111224678899999999999999999999


Q ss_pred             HHHhCcc
Q psy11119        157 KIKSHRW  163 (407)
Q Consensus       157 eil~hpw  163 (407)
                      ++++|||
T Consensus       261 ~ll~~~~  267 (267)
T cd06645         261 KLLQHPF  267 (267)
T ss_pred             HHhcCCC
Confidence            9999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=5.7e-28  Score=232.88  Aligned_cols=167  Identities=26%  Similarity=0.398  Sum_probs=130.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||++||.|||++||+|+||+|+||+++.+|.++|+|||++.......  .......+++.|+|||.+.+
T Consensus        99 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  176 (298)
T cd07841          99 LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFG  176 (298)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--ccccccccceeeeCHHHHhC
Confidence            5788899999999999999999999999999999999999999999999998754322  22233456888999999865


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC------------------------CCCCCCcCCH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM------------------------QRSPWDRLDV  135 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~s~  135 (407)
                      . .++.++|+||+||++|+|++|.+||...................                        ....+...+.
T Consensus       177 ~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (298)
T cd07841         177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD  256 (298)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccH
Confidence            4 67889999999999999999988887655432211111100000                        0001234578


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        136 NCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       136 ~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .+.++|.+||.++|.+|||+.++++|+||++...
T Consensus       257 ~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         257 DALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            8999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-28  Score=230.62  Aligned_cols=161  Identities=22%  Similarity=0.315  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......  .......|++.|+|||++..
T Consensus       110 ~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  187 (275)
T cd06608         110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIAC  187 (275)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcc
Confidence            4678899999999999999999999999999999999999999999999987643222  22234568999999999854


Q ss_pred             C-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 S-----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~-----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .     .++.++|+||+||++|+|++|..||............ .............++.++.+||.+||..||++|||+
T Consensus       188 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~  266 (275)
T cd06608         188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI-PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM  266 (275)
T ss_pred             cccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh-hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence            2     4677899999999999999999999765433222222 221111222223367899999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .+++.|||+
T Consensus       267 ~~ll~~~~~  275 (275)
T cd06608         267 EELLEHPFI  275 (275)
T ss_pred             HHHhcCCCC
Confidence            999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=4.1e-28  Score=234.84  Aligned_cols=165  Identities=24%  Similarity=0.434  Sum_probs=135.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+....  ......+|++.|+|||++.+
T Consensus       114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  191 (297)
T cd06659         114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISR  191 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHcc
Confidence            4678899999999999999999999999999999999999999999999987543222  12234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||......... .............+..++..+.++|.+||..+|.+||+++++++
T Consensus       192 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            88899999999999999999999999866543222 22222222222334567889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||.+..
T Consensus       271 ~~~~~~~~  278 (297)
T cd06659         271 HPFLLQTG  278 (297)
T ss_pred             ChhhccCC
Confidence            99998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0589|consensus

Probab=99.95  E-value=1.1e-28  Score=244.39  Aligned_cols=162  Identities=24%  Similarity=0.335  Sum_probs=143.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|+.++.||.||+.||.|||++.|+|||||+.||+++.++.+||+|||+|+.+....  ....+..|||.|+.||++.+
T Consensus       103 f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d  180 (426)
T KOG0589|consen  103 FPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSD  180 (426)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCC
Confidence            5899999999999999999999999999999999999999999999999999865332  25567889999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..|+.++|||||||++|||++-+.+|...+.......+....   ..+....++.+++.||+.||..+|..||++.+++.
T Consensus       181 ~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~  257 (426)
T KOG0589|consen  181 IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLR  257 (426)
T ss_pred             CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence            999999999999999999999999999988776555544432   33444668999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      +|.....
T Consensus       258 ~P~l~~~  264 (426)
T KOG0589|consen  258 RPHLLRY  264 (426)
T ss_pred             ChhhhhH
Confidence            9987643

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=4.3e-28  Score=234.48  Aligned_cols=164  Identities=27%  Similarity=0.415  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc---------cCCcCccCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE---------RPLDKKCGTLP   71 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~---------~~~~~~~gt~~   71 (407)
                      +++.++..++.||++||.|||++||+|+||||+||+++.++.++|+|||++.........         .......+++.
T Consensus       112 ~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (311)
T cd07866         112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW  191 (311)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccC
Confidence            578899999999999999999999999999999999999999999999998765332211         11233457888


Q ss_pred             CCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC---------------------C--
Q psy11119         72 YVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ---------------------R--  127 (407)
Q Consensus        72 Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------------~--  127 (407)
                      |+|||.+.+. .++.++||||+||++|+|++|.+||.+.+........+.......                     .  
T Consensus       192 y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (311)
T cd07866         192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR  271 (311)
T ss_pred             cCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCc
Confidence            9999998764 678899999999999999999999987665432222111100000                     0  


Q ss_pred             ---CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        128 ---SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       128 ---~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                         ..+..+++.+.++|.+||..+|.+|||+.+++.||||
T Consensus       272 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence               0113355788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.95  E-value=6.1e-28  Score=232.03  Aligned_cols=165  Identities=25%  Similarity=0.419  Sum_probs=133.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++........  ......|++.|+|||.+.+
T Consensus       112 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  189 (285)
T cd06648         112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISR  189 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcC
Confidence            46788899999999999999999999999999999999999999999998765432211  2233568999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||...+...... ...............++..+.++|.+||..+|.+||++.++++
T Consensus       190 ~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            888899999999999999999999997665432222 2222111112222347889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||++..
T Consensus       269 ~~~~~~~~  276 (285)
T cd06648         269 HPFLAKAG  276 (285)
T ss_pred             CcccccCC
Confidence            99998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.5e-28  Score=231.50  Aligned_cols=164  Identities=25%  Similarity=0.379  Sum_probs=131.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........  ......|++.|+|||++..
T Consensus       100 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  177 (280)
T cd06611         100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVAC  177 (280)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhh
Confidence            57889999999999999999999999999999999999999999999998865432211  2234568999999999853


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           ..++.++|+||+||++|+|++|..||......... ................++.++.++|.+||..+|.+||++
T Consensus       178 ~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  256 (280)
T cd06611         178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-LKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTA  256 (280)
T ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-HHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCH
Confidence                 34677899999999999999999999876543322 222221222222234678899999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      .++++||||...
T Consensus       257 ~~il~~~~~~~~  268 (280)
T cd06611         257 AELLKHPFVSDQ  268 (280)
T ss_pred             HHHhcChhhccc
Confidence            999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=5.4e-28  Score=232.40  Aligned_cols=162  Identities=20%  Similarity=0.284  Sum_probs=128.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........  ......|++.|+|||++..
T Consensus       125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  202 (291)
T cd06639         125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC  202 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcC
Confidence            46788999999999999999999999999999999999999999999999876432221  1233568899999999864


Q ss_pred             C-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 S-----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~-----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .     .++.++|+||+||++|+|++|+.||.......... ...............++..+.+||.+||..+|++||++
T Consensus       203 ~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  281 (291)
T cd06639         203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV  281 (291)
T ss_pred             CCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCH
Confidence            3     36789999999999999999999998655432222 22221111111223467789999999999999999999


Q ss_pred             HHHHhCcccc
Q psy11119        156 EKIKSHRWYS  165 (407)
Q Consensus       156 ~eil~hpwf~  165 (407)
                      .+++.||||+
T Consensus       282 ~~il~~~~~~  291 (291)
T cd06639         282 THLLEHPFIK  291 (291)
T ss_pred             HHHhcCcccC
Confidence            9999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=6e-28  Score=227.20  Aligned_cols=166  Identities=33%  Similarity=0.536  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC------ccCCcCccCCCCCCc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK------ERPLDKKCGTLPYVA   74 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~------~~~~~~~~gt~~Y~A   74 (407)
                      +++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........      ........+++.|+|
T Consensus        90 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (265)
T cd05579          90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA  169 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccC
Confidence            47888999999999999999999999999999999999999999999999875433211      112234568889999


Q ss_pred             hhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         75 PEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        75 PE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ||.+.....+.++|+||+|+++|+|++|..||........... ... .....+....++..+.++|.+||+.+|.+|||
T Consensus       170 Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt  247 (265)
T cd05579         170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-ILN-GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG  247 (265)
T ss_pred             HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhc-CCcCCCccccCCHHHHHHHHHHhcCCHhhcCC
Confidence            9999888888999999999999999999999987665432222 221 22222222235899999999999999999999


Q ss_pred             H---HHHHhCcccccCC
Q psy11119        155 I---EKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~---~eil~hpwf~~~~  168 (407)
                      +   .++++||||++..
T Consensus       248 ~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         248 AKSIEEIKNHPFFKGID  264 (265)
T ss_pred             CccHHHHhcCccccCCC
Confidence            9   9999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=5e-28  Score=229.63  Aligned_cols=162  Identities=24%  Similarity=0.392  Sum_probs=128.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ........++..|+|||.+.
T Consensus       103 l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC
Confidence            46778889999999999999999999999999999999999999999999876532211 11223346889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+||++|+|++|+.||............ .. ..........+++.+.++| +||..+|++||++++|+
T Consensus       183 ~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil  259 (266)
T cd06651         183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-AT-QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL  259 (266)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-hc-CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence            888899999999999999999999999866443222211 11 1111122244678889999 57778999999999999


Q ss_pred             hCcccc
Q psy11119        160 SHRWYS  165 (407)
Q Consensus       160 ~hpwf~  165 (407)
                      +||||+
T Consensus       260 ~hp~~~  265 (266)
T cd06651         260 RHPFAQ  265 (266)
T ss_pred             cCcccc
Confidence            999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=7.3e-28  Score=230.76  Aligned_cols=164  Identities=21%  Similarity=0.364  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..+...    ......+++.|+|||.+.
T Consensus        99 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~  174 (286)
T cd06622          99 IPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIK  174 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhc
Confidence            5688999999999999999997 59999999999999999999999999998765322    223456888999999986


Q ss_pred             cC------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         80 RS------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        80 ~~------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.      .++.++|+||+||++|+|++|..||.......................+..++.++.++|.+||..+|.+||
T Consensus       175 ~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  254 (286)
T cd06622         175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRP  254 (286)
T ss_pred             CCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCC
Confidence            54      347899999999999999999999976543322111111111112222345889999999999999999999


Q ss_pred             CHHHHHhCcccccCC
Q psy11119        154 NIEKIKSHRWYSKHM  168 (407)
Q Consensus       154 s~~eil~hpwf~~~~  168 (407)
                      ++++++.||||....
T Consensus       255 ~~~~l~~~~~~~~~~  269 (286)
T cd06622         255 TYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHhcChhhhhcc
Confidence            999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=3e-28  Score=236.33  Aligned_cols=164  Identities=29%  Similarity=0.462  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec----CCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL----QDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~----~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~AP   75 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.    ++.+||+|||++........ .......++++.|+||
T Consensus       105 ~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCH
Confidence            467889999999999999999999999999999999999    89999999999886543322 1223345788999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--------HHHHHH---------------------hhc-cc
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADC--------IEYLEW---------------------KDN-RH  124 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--------~~~~~~---------------------~~~-~~  124 (407)
                      |++.+. .++.++|+||+||++|+|++|+.||.......        ......                     ... ..
T Consensus       185 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (316)
T cd07842         185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD  264 (316)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhh
Confidence            998764 67899999999999999999999997654322        000000                     000 00


Q ss_pred             CCCCC------------CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        125 MQRSP------------WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       125 ~~~~~------------~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .....            +...+.++.++|.+||.+||++|||+.+++.||||
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         265 FKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             ccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00001            11466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=8.4e-28  Score=228.45  Aligned_cols=164  Identities=27%  Similarity=0.423  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++................|+..|+|||.+..
T Consensus       105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  184 (272)
T cd06629         105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS  184 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhcc
Confidence            46788899999999999999999999999999999999999999999999876432222222334568899999999876


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc--CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH--MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      .  .++.++|+||+|+++|+|++|..||..................  ........++.++.++|.+||.++|.+||+++
T Consensus       185 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHH
Confidence            5  3788999999999999999999999755443222221111111  11122345788999999999999999999999


Q ss_pred             HHHhCccc
Q psy11119        157 KIKSHRWY  164 (407)
Q Consensus       157 eil~hpwf  164 (407)
                      ++++||||
T Consensus       265 ~il~~~~~  272 (272)
T cd06629         265 ELLQHPFI  272 (272)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.95  E-value=3.2e-28  Score=229.99  Aligned_cols=163  Identities=25%  Similarity=0.454  Sum_probs=129.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+........    ....++..|+|||.+.
T Consensus        97 ~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~  172 (265)
T cd06605          97 IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQ  172 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHc
Confidence            4678889999999999999999 9999999999999999999999999999875532211    1267889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPT---ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +..++.++|+||+|+++|+|++|..||....   ..................+...++.++.++|.+||..+|.+|||+.
T Consensus       173 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  252 (265)
T cd06605         173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK  252 (265)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHH
Confidence            8888999999999999999999999997542   1111111111111111112222788999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      +++.||||++.
T Consensus       253 ~ll~~~~~~~~  263 (265)
T cd06605         253 ELLEHPFIKKY  263 (265)
T ss_pred             HHhhCchhhcc
Confidence            99999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=4.8e-28  Score=232.99  Aligned_cols=162  Identities=31%  Similarity=0.433  Sum_probs=128.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..+....  .......+++.|+|||.+.+
T Consensus       103 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  180 (293)
T cd07843         103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLG  180 (293)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcC
Confidence            4788999999999999999999999999999999999999999999999988654322  22334567889999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------c---C----CCCCCCc-
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------H---M----QRSPWDR-  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~---~----~~~~~~~-  132 (407)
                      . .++.++|+||+|+++|+|++|..||.................                   .   .    ....+.. 
T Consensus       181 ~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (293)
T cd07843         181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL  260 (293)
T ss_pred             CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc
Confidence            5 568899999999999999999999987654322211110000                   0   0    0011111 


Q ss_pred             -CCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 -LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 -~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                       +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         261 SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=5.3e-28  Score=237.11  Aligned_cols=167  Identities=17%  Similarity=0.332  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~AP   75 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+......+..     .......++..|+||
T Consensus        98 l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227          98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence            467889999999999999999999999999999999999999999999865433221111     011223567889999


Q ss_pred             hhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------------
Q psy11119         76 EVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------------  124 (407)
Q Consensus        76 E~l~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------------  124 (407)
                      |++.+.  .++.++||||+||++|+|++|..||..................                             
T Consensus       178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T cd08227         178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES  257 (327)
T ss_pred             HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence            999763  5789999999999999999999999764432211111110000                             


Q ss_pred             -------------CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        125 -------------MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       125 -------------~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                                   ...+....+++.+.+||.+||..||++|||++++++||||++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                         0000112356789999999999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279|consensus

Probab=99.95  E-value=2e-28  Score=247.69  Aligned_cols=163  Identities=27%  Similarity=0.446  Sum_probs=135.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      .|...-.|.+||++||.|||++.|||||||.+|+|++ ..|.+||+|||-++.+..  -.....+..||..|||||++..
T Consensus       673 NEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDq  750 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQ  750 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhcc
Confidence            4677889999999999999999999999999999997 578999999999987643  2334457789999999999986


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +  .|+.++|||||||.+.||.||++||...........+. .......+.+..++.+++.+|.+|+.++|.+||++.++
T Consensus       751 G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~L  829 (1226)
T KOG4279|consen  751 GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDL  829 (1226)
T ss_pred             CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHh
Confidence            5  89999999999999999999999997654332222111 11233344557789999999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      +.+||+...
T Consensus       830 L~DpFlq~~  838 (1226)
T KOG4279|consen  830 LQDPFLQHN  838 (1226)
T ss_pred             ccCcccccC
Confidence            999999876

>KOG0607|consensus

Probab=99.95  E-value=2.7e-28  Score=228.47  Aligned_cols=172  Identities=28%  Similarity=0.558  Sum_probs=138.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCC-----ccCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGK-----ERPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y   72 (407)
                      ++|.+|..+.+.|+.||.|||.+||.||||||+|||....+.   +|||||.+..-....+.     ...+.+.+|+..|
T Consensus       173 F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf  252 (463)
T KOG0607|consen  173 FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF  252 (463)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence            579999999999999999999999999999999999976553   89999988765433222     2345678999999


Q ss_pred             Cchhhhh---c--CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh------------h--HHHHHHHhh-cccCCCCCCCc
Q psy11119         73 VAPEVLV---R--SYLAEPADIWSCGIILVAMLAGELPWDKPTA------------D--CIEYLEWKD-NRHMQRSPWDR  132 (407)
Q Consensus        73 ~APE~l~---~--~~~~~~sDiwSlGviL~elltG~~Pf~~~~~------------~--~~~~~~~~~-~~~~~~~~~~~  132 (407)
                      ||||+..   +  .+|..+.|.||||||||-||+|++||.+.-.            .  ...+..+.+ ...++...|..
T Consensus       253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah  332 (463)
T KOG0607|consen  253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH  332 (463)
T ss_pred             cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHH
Confidence            9999874   2  2788999999999999999999999953211            1  112222222 24566677999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~~~  172 (407)
                      +|.++++||+.+|..++.+|.++.++++|||+....++..
T Consensus       333 IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka  372 (463)
T KOG0607|consen  333 ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA  372 (463)
T ss_pred             hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence            9999999999999999999999999999999998765543

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.6e-28  Score=227.75  Aligned_cols=161  Identities=24%  Similarity=0.343  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........  ......++..|+|||.+..
T Consensus        98 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~  175 (262)
T cd06613          98 LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAV  175 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcc
Confidence            57889999999999999999999999999999999999999999999999876543221  2234568889999999976


Q ss_pred             C---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 S---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      .   .++.++|+||+||++|+|++|..||.................. ........++.++.++|++||..+|.+|||+.
T Consensus       176 ~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  255 (262)
T cd06613         176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTAT  255 (262)
T ss_pred             cccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence            6   7788999999999999999999999876644333322222111 11112234678899999999999999999999


Q ss_pred             HHHhCcc
Q psy11119        157 KIKSHRW  163 (407)
Q Consensus       157 eil~hpw  163 (407)
                      +++.|+|
T Consensus       256 ~il~~~~  262 (262)
T cd06613         256 KLLQHPF  262 (262)
T ss_pred             HHhcCCC
Confidence            9999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=1e-27  Score=226.15  Aligned_cols=164  Identities=28%  Similarity=0.492  Sum_probs=131.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccC--CcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP--LDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~--~~~~~gt~~Y~APE~l   78 (407)
                      +++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++...........  .....+++.|+|||++
T Consensus        96 ~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626          96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence            46788899999999999999999999999999999999999999999999887643322111  2235688999999999


Q ss_pred             hcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         79 VRSY---LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        79 ~~~~---~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      ....   .+.++|+||+|+++|+|++|+.||.....................+.+..+++.+.++|.+||+.+|.+||++
T Consensus       176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  255 (264)
T cd06626         176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA  255 (264)
T ss_pred             cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCH
Confidence            8765   7899999999999999999999997553222221111222233334445568999999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .+++.|||+
T Consensus       256 ~~i~~~~~~  264 (264)
T cd06626         256 SELLQHPFV  264 (264)
T ss_pred             HHHhcCCCC
Confidence            999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=7.5e-28  Score=240.98  Aligned_cols=158  Identities=25%  Similarity=0.341  Sum_probs=125.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  288 (374)
T cd05106         209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD  288 (374)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence            46788999999999999999999999999999999999999999999999976543222111222345677999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||.................  .......+++++.++|.+||+.+|.+|||+.+++
T Consensus       289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~  366 (374)
T cd05106         289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS  366 (374)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999997 9999986554332222222211  1122234689999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       367 ~  367 (374)
T cd05106         367 Q  367 (374)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=8.6e-28  Score=236.28  Aligned_cols=169  Identities=27%  Similarity=0.429  Sum_probs=132.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l   78 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.........  .......|+..|+|||.+
T Consensus       104 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHh
Confidence            578899999999999999999999999999999999999999999999999765433221  122345789999999998


Q ss_pred             hc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH-----------------------hhcccCCCCC----C
Q psy11119         79 VR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW-----------------------KDNRHMQRSP----W  130 (407)
Q Consensus        79 ~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~-----------------------~~~~~~~~~~----~  130 (407)
                      .+ ..++.++|+||+||++|+|++|+.||...+.........                       .........+    .
T Consensus       184 ~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (334)
T cd07855         184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF  263 (334)
T ss_pred             cCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHc
Confidence            66 367899999999999999999999997654321111000                       0000011111    2


Q ss_pred             CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       131 ~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ..+++++.++|++||+.+|.+||++++++.||||.+...
T Consensus       264 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            346889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=6.2e-28  Score=230.68  Aligned_cols=162  Identities=30%  Similarity=0.486  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......  .......+++.|+|||++.+
T Consensus        96 ~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  173 (283)
T cd07835          96 LDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG  173 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeec
Confidence            4688899999999999999999999999999999999999999999999987543221  12233456889999998876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------------cCCCCCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------------HMQRSPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~s  134 (407)
                      . .++.++|+||+|+++|+|++|..||.................                         .........++
T Consensus       174 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (283)
T cd07835         174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLD  253 (283)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCC
Confidence            5 578899999999999999999999987654332222111000                         00011124567


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ..+.++|.+||+++|.+|||+++++.||||
T Consensus       254 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         254 EDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=8.2e-28  Score=231.40  Aligned_cols=161  Identities=32%  Similarity=0.467  Sum_probs=133.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..+..++.||+.||.|||++||+|+||+|.||+++.++.+||+|||++......     ....+|++.|+|||.+.+
T Consensus        98 l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  172 (290)
T cd05580          98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILS  172 (290)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcC
Confidence            578889999999999999999999999999999999999999999999998765322     234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ...+.++|+||+|+++|+|++|..||............. . ...  .....++..+.++|.+||..+|.+|+     ++
T Consensus       173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~-~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~  248 (290)
T cd05580         173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-E-GKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGV  248 (290)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-c-CCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCH
Confidence            888899999999999999999999998766432222221 1 111  22244689999999999999999999     99


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||....|.
T Consensus       249 ~~l~~~~~~~~~~~~  263 (290)
T cd05580         249 NDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHHHcCcccccCCHH
Confidence            999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=8.8e-28  Score=232.99  Aligned_cols=168  Identities=33%  Similarity=0.529  Sum_probs=132.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC-------------CccCCcCcc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG-------------KERPLDKKC   67 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~-------------~~~~~~~~~   67 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......             .........
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (305)
T cd05609          98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC  177 (305)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence            4688899999999999999999999999999999999999999999999886321100             000112346


Q ss_pred             CCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccC
Q psy11119         68 GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAP  147 (407)
Q Consensus        68 gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~  147 (407)
                      |+..|+|||.+.+..++.++|+||+||++|+|++|..||.+.................+... ..++.++.++|.+||+.
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~  256 (305)
T cd05609         178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQ  256 (305)
T ss_pred             cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhcc
Confidence            78899999999888889999999999999999999999987665433332222211122221 25788999999999999


Q ss_pred             CCCCCCC---HHHHHhCcccccCCC
Q psy11119        148 LPSTRLN---IEKIKSHRWYSKHMP  169 (407)
Q Consensus       148 ~P~~Rps---~~eil~hpwf~~~~~  169 (407)
                      +|++||+   +.++++||||....+
T Consensus       257 ~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         257 NPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             ChhhccCccCHHHHHhCccccCCCH
Confidence            9999997   799999999987543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=8.9e-28  Score=237.05  Aligned_cols=159  Identities=22%  Similarity=0.313  Sum_probs=126.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.............++..|+|||++.+
T Consensus       170 l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  249 (337)
T cd05054         170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD  249 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence            46788999999999999999999999999999999999999999999999986543322222233456778999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... ... .......++++.+++.+||+.+|++||++.+++
T Consensus       250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell  327 (337)
T cd05054         250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTR-MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV  327 (337)
T ss_pred             CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            889999999999999999998 99999765433222222222 111 112245688999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       328 ~~  329 (337)
T cd05054         328 EI  329 (337)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=228.33  Aligned_cols=161  Identities=29%  Similarity=0.466  Sum_probs=129.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++..+....   ......+++.|+|||++.+
T Consensus       104 l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~  180 (287)
T cd07838         104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQ  180 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc---ccccccccccccChHHhcc
Confidence            5788999999999999999999999999999999999999999999999987754322   2233457889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-------------------CCCC----CCCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-------------------MQRS----PWDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------------~~~~----~~~~~s~~~  137 (407)
                      ..++.++|+||+||++|+|++|..||..................                   ....    ....+++.+
T Consensus       181 ~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (287)
T cd07838         181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG  260 (287)
T ss_pred             CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHH
Confidence            88899999999999999999999999876644322221111000                   0000    012356788


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .++|.+||+.+|.+||++.+++.||||
T Consensus       261 ~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         261 LDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.1e-27  Score=236.62  Aligned_cols=165  Identities=25%  Similarity=0.384  Sum_probs=131.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......     .....+++.|+|||.+.+
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhC
Confidence            578899999999999999999999999999999999999999999999998764321     234568899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------CCC----CCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------MQR----SPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------~~~----~~~~~  132 (407)
                      . .++.++||||+||++|+|++|+.||..................                       ...    ..+..
T Consensus       190 ~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07851         190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSG  269 (343)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhcc
Confidence            4 7789999999999999999999999766543221111110000                       000    01234


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                      +++++.++|.+||+.+|.+|||+.+|+.||||.+....
T Consensus       270 ~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         270 ANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             CCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            68899999999999999999999999999999986443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=228.06  Aligned_cols=162  Identities=29%  Similarity=0.487  Sum_probs=129.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......  .......++..|+|||.+.+
T Consensus        95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~  172 (283)
T cd05118          95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLG  172 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhc
Confidence            4678899999999999999999999999999999999999999999999987764332  12233467889999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC--------------------------CCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ--------------------------RSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~  133 (407)
                      . .++.++|+||+|+++|+|++|+.||...+................                          ...+..+
T Consensus       173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd05118         173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA  252 (283)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence            6 788999999999999999999999977654332211111000000                          0112346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +.++.++|.+||.++|.+||++.+++.||||
T Consensus       253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         253 SPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             CHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            7899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.1e-27  Score=234.52  Aligned_cols=168  Identities=27%  Similarity=0.386  Sum_probs=133.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ........+++.|+|||++.
T Consensus       100 l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeee
Confidence            56888999999999999999999999999999999999999999999999987644321 11234456889999999998


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-----------------------C----CCCC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-----------------------R----SPWD  131 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------------------~----~~~~  131 (407)
                      +. .++.++|+||+|+++|+|++|..||...+................                       .    ....
T Consensus       180 ~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (330)
T cd07834         180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP  259 (330)
T ss_pred             cccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcc
Confidence            87 889999999999999999999999987664332111111000000                       0    0113


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      .++.++.++|.+||.++|.+||++++++.||||++..
T Consensus       260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         260 GASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            3678899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=1.2e-27  Score=227.25  Aligned_cols=158  Identities=23%  Similarity=0.318  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  188 (272)
T cd05075         109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD  188 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence            46788999999999999999999999999999999999999999999999987543322112223356778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||........ ...... ... ......++..+.++|.+||+.+|.+|||+.+++
T Consensus       189 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~  265 (272)
T cd05075         189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-YDYLRQ-GNR-LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR  265 (272)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHc-CCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            888999999999999999999 8999976554322 222222 111 122345788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       266 ~~  267 (272)
T cd05075         266 CE  267 (272)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=227.56  Aligned_cols=164  Identities=26%  Similarity=0.448  Sum_probs=132.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....  .......|++.|+|||.+.+
T Consensus        98 l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  175 (277)
T cd06917          98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITE  175 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhcc
Confidence            4688899999999999999999999999999999999999999999999998764332  22234568999999999875


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . .++.++|+||+||++|+|++|..||..........  .......+......++.++.++|.+||..+|.+||++.+++
T Consensus       176 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il  253 (277)
T cd06917         176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELL  253 (277)
T ss_pred             CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence            4 67889999999999999999999998765432211  11111112222234788999999999999999999999999


Q ss_pred             hCcccccCC
Q psy11119        160 SHRWYSKHM  168 (407)
Q Consensus       160 ~hpwf~~~~  168 (407)
                      .|+||++..
T Consensus       254 ~~~~~~~~~  262 (277)
T cd06917         254 KSKWIKAHS  262 (277)
T ss_pred             hChHhhccc
Confidence            999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.2e-27  Score=228.79  Aligned_cols=162  Identities=28%  Similarity=0.468  Sum_probs=128.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||++.+
T Consensus        97 ~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  174 (286)
T cd07846          97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVG  174 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhcc
Confidence            4678899999999999999999999999999999999999999999999987654332  22334568899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-------------------CC--------CCCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-------------------MQ--------RSPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~  132 (407)
                      . .++.++||||+||++|+|++|..||..................                   ..        ...+..
T Consensus       175 ~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07846         175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK  254 (286)
T ss_pred             ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCC
Confidence            4 5788999999999999999999999765532221111100000                   00        001245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++..+.+|+.+||..+|.+||++.+++.||||
T Consensus       255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         255 LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            78899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=1.1e-27  Score=235.35  Aligned_cols=168  Identities=27%  Similarity=0.420  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.....  ........|++.|+|||++
T Consensus       102 ~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence            46888999999999999999999999999999999999999999999999986543222  1122345789999999988


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh-----------------------hcccCC----CCCC
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK-----------------------DNRHMQ----RSPW  130 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~-----------------------~~~~~~----~~~~  130 (407)
                      .+. .++.++|+||+||++|+|++|..||..............                       ......    ...+
T Consensus       182 ~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (332)
T cd07857         182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF  261 (332)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence            664 678999999999999999999999976542211100000                       000000    0112


Q ss_pred             CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 ~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ..++..+.++|.+||+.+|.+|||+.+++.|||+.++.
T Consensus       262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         262 PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            34678899999999999999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0667|consensus

Probab=99.95  E-value=5.1e-28  Score=245.51  Aligned_cols=163  Identities=24%  Similarity=0.317  Sum_probs=127.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC--cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g--~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+...++.++.||+.||.+||+.||||+|||||||||...+  .+||+|||.|+...     ....+.+.+..|.|||++
T Consensus       286 lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~-----q~vytYiQSRfYRAPEVI  360 (586)
T KOG0667|consen  286 LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES-----QRVYTYIQSRFYRAPEVI  360 (586)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC-----Ccceeeeeccccccchhh
Confidence            56788999999999999999999999999999999997544  69999999998643     122367889999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-----------------------------------
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-----------------------------------  123 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------------------------  123 (407)
                      .+..|+.+.|+||||||++||++|.+.|.+.+..+....+..-.+                                   
T Consensus       361 LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~  440 (586)
T KOG0667|consen  361 LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRG  440 (586)
T ss_pred             ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeeccccc
Confidence            999999999999999999999999888876655433221110000                                   


Q ss_pred             ---------------cCCCC----CC----C-cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        124 ---------------HMQRS----PW----D-RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       124 ---------------~~~~~----~~----~-~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                     ....+    .+    . .-...+.++|++||..||.+|+|..++++|||+...-
T Consensus       441 ~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  441 TKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             ccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence                           00000    00    0 1123578999999999999999999999999999643

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=1.2e-27  Score=231.02  Aligned_cols=164  Identities=23%  Similarity=0.397  Sum_probs=129.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..+....   ......+++.|+|||.+.
T Consensus       111 l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERID  187 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcC
Confidence            4678889999999999999997 599999999999999999999999999987653222   122345788999999987


Q ss_pred             cC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 RS----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ~~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      +.    .++.++|+||+|+++|+|++|+.||.....................+....++.++.+||.+||..+|.+||++
T Consensus       188 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~  267 (296)
T cd06618         188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY  267 (296)
T ss_pred             CCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            54    37789999999999999999999997643322222222221212222223478899999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      ++++.||||...
T Consensus       268 ~~il~~~~~~~~  279 (296)
T cd06618         268 RELLQHPFIRRY  279 (296)
T ss_pred             HHHhcChhhhcc
Confidence            999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=1e-27  Score=230.15  Aligned_cols=179  Identities=23%  Similarity=0.407  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..+..... ......+|++.|+|||.+.+
T Consensus       102 ~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  180 (288)
T cd05583         102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRG  180 (288)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcC
Confidence            46788999999999999999999999999999999999999999999999876543321 11233568999999999876


Q ss_pred             CC--CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC---H
Q psy11119         81 SY--LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN---I  155 (407)
Q Consensus        81 ~~--~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps---~  155 (407)
                      ..  .+.++|+||+|+++|+|++|..||.....................+....++.++.++|.+||+.+|++|||   +
T Consensus       181 ~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~  260 (288)
T cd05583         181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA  260 (288)
T ss_pred             CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence            53  788999999999999999999999643221111111111111122233457889999999999999999998   5


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSD  180 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~  180 (407)
                      .++++||||+...|.....++...+
T Consensus       261 ~~~l~~~~~~~~~~~~~~~~~~~~~  285 (288)
T cd05583         261 DEIKNHPFFQGIDWDDLAAKRIPAP  285 (288)
T ss_pred             HHHhcCcccccCCHHHHhhhccCCC
Confidence            6779999999987766555544433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1.2e-27  Score=235.59  Aligned_cols=165  Identities=28%  Similarity=0.418  Sum_probs=130.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  .......++..|+|||.+..
T Consensus       105 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  182 (337)
T cd07858         105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLN  182 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhc
Confidence            4788999999999999999999999999999999999999999999999987653322  22334568899999999875


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH----------------------hhc-ccCC----CCCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW----------------------KDN-RHMQ----RSPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~----------------------~~~-~~~~----~~~~~~  132 (407)
                       ..++.++|+||+||++|+|++|..||...+.........                      ... ....    ...+..
T Consensus       183 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (337)
T cd07858         183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH  262 (337)
T ss_pred             CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence             468899999999999999999999997654321111000                      000 0000    011245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +++++.+||++||+.+|++|||++++++||||...
T Consensus       263 ~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            78899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=229.10  Aligned_cols=163  Identities=29%  Similarity=0.486  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ .......+++.|+|||++.+
T Consensus        97 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~  175 (288)
T cd07833          97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVG  175 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcC
Confidence            46788999999999999999999999999999999999999999999999877543322 13344678899999999988


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc--------------cc-----CCC---------CCCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN--------------RH-----MQR---------SPWD  131 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~--------------~~-----~~~---------~~~~  131 (407)
                      . .++.++|+||+|+++|+|++|..||................              ..     ...         ....
T Consensus       176 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (288)
T cd07833         176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG  255 (288)
T ss_pred             CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCC
Confidence            8 88999999999999999999999998654432211111000              00     000         0112


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      .++.++.+||++||..+|++||+++++++||||
T Consensus       256 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         256 KVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=228.15  Aligned_cols=163  Identities=26%  Similarity=0.481  Sum_probs=128.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+
T Consensus        97 ~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~  175 (287)
T cd07840          97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLG  175 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEc
Confidence            46788999999999999999999999999999999999999999999999987643321 12334567889999998765


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC--------------------------CCCc-
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS--------------------------PWDR-  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~-  132 (407)
                      . .++.++||||+|+++|+|++|..||...+..................                          .... 
T Consensus       176 ~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07840         176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHL  255 (287)
T ss_pred             cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhccc
Confidence            4 67899999999999999999999998766443222211110000000                          0111 


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++..+.++|++||..+|.+||++++++.||||
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         256 IDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=1.5e-27  Score=228.25  Aligned_cols=158  Identities=22%  Similarity=0.339  Sum_probs=126.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       121 ~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (283)
T cd05091         121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY  200 (283)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc
Confidence            35677889999999999999999999999999999999999999999999876543322222334456788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||.+.......... .. .. ..+....++..+.+|+.+||+.+|.+||++.+|+
T Consensus       201 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i-~~-~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~  277 (283)
T cd05091         201 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI-RN-RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIH  277 (283)
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-Hc-CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            888999999999999999998 88899876554332222 12 11 1122356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ..
T Consensus       278 ~~  279 (283)
T cd05091         278 SR  279 (283)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=229.41  Aligned_cols=162  Identities=27%  Similarity=0.426  Sum_probs=124.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+
T Consensus       100 ~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  177 (291)
T cd07844         100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLG  177 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhc
Confidence            4678899999999999999999999999999999999999999999999986532211  12233457889999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHH-HHhhcccC-----------------C---------CCCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL-EWKDNRHM-----------------Q---------RSPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~-~~~~~~~~-----------------~---------~~~~~~  132 (407)
                      . .++.++||||+||++|+|++|..||........... .+......                 .         ......
T Consensus       178 ~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd07844         178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR  257 (291)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC
Confidence            4 678899999999999999999999976552211111 11000000                 0         000112


Q ss_pred             CC--HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        133 LD--VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       133 ~s--~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ++  .++.++|.+||+.+|.+|||+.+++.||||
T Consensus       258 ~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         258 LDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            34  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=1.6e-27  Score=229.39  Aligned_cols=164  Identities=28%  Similarity=0.472  Sum_probs=127.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......  ........+++.|+|||++.+
T Consensus       100 ~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~  177 (294)
T PLN00009        100 NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLG  177 (294)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhC
Confidence            56778899999999999999999999999999999985 457999999998754322  122234467889999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC----------------C---------CCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR----------------S---------PWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------~---------~~~~~s  134 (407)
                      . .++.++|+||+||++|+|++|..||.....................                +         ....++
T Consensus       178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (294)
T PLN00009        178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLE  257 (294)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCC
Confidence            4 6788999999999999999999999876543322222111000000                0         013467


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +++.++|.+||+.+|++||++.++++||||...
T Consensus       258 ~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        258 PAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            889999999999999999999999999999864

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=1.8e-27  Score=228.83  Aligned_cols=157  Identities=23%  Similarity=0.362  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+
T Consensus       117 l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  196 (288)
T cd05093         117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  196 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence            47788999999999999999999999999999999999999999999999876533222222233446788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||............ .. ... ......++.++.+|+.+||+.||.+|||+.+++
T Consensus       197 ~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-~~-~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQ-GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc-CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            888999999999999999998 99999876654332222 11 111 122245788999999999999999999999985


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       274 ~  274 (288)
T cd05093         274 S  274 (288)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=2.3e-27  Score=222.51  Aligned_cols=158  Identities=23%  Similarity=0.324  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+................+++.|+|||.+..
T Consensus       102 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (262)
T cd00192         102 LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD  181 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence            47889999999999999999999999999999999999999999999999987654332223345567889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||............ ..  .........++.++.+++.+||..+|.+|||+.+++
T Consensus       182 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~  258 (262)
T cd00192         182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RK--GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV  258 (262)
T ss_pred             CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-Hc--CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence            888999999999999999999 69999877554332222 11  112222345689999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       259 ~~  260 (262)
T cd00192         259 ER  260 (262)
T ss_pred             Hh
Confidence            75

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=1.8e-27  Score=227.77  Aligned_cols=161  Identities=22%  Similarity=0.314  Sum_probs=127.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  .......|++.|+|||++..
T Consensus       121 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  198 (286)
T cd06638         121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIAC  198 (286)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhch
Confidence            4677889999999999999999999999999999999999999999999987654322  12234568999999999853


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 -----SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 -----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                           ..++.++|+||+||++|+|++|..||.......... ...............++.++.+||.+||+.+|.+|||+
T Consensus       199 ~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  277 (286)
T cd06638         199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV  277 (286)
T ss_pred             hhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCH
Confidence                 346889999999999999999999997654322211 11111111111123357789999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .++++|+||
T Consensus       278 ~ell~~~~~  286 (286)
T cd06638         278 SDLLQHVFI  286 (286)
T ss_pred             HHHhhcccC
Confidence            999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=2e-27  Score=225.34  Aligned_cols=158  Identities=20%  Similarity=0.292  Sum_probs=127.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+
T Consensus       110 ~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05035         110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  189 (273)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence            46778899999999999999999999999999999999999999999999987643332222223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||........... ... .. .......++..+.++|.+||+.||.+||++.+++
T Consensus       190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~-~~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~  266 (273)
T cd05035         190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-LRH-GN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLR  266 (273)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc-CC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999999 9999977654432221 121 11 1222345788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       267 ~~  268 (273)
T cd05035         267 EV  268 (273)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.6e-27  Score=235.43  Aligned_cols=165  Identities=27%  Similarity=0.392  Sum_probs=130.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....     ......+++.|+|||++.+
T Consensus       114 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcC
Confidence            46788999999999999999999999999999999999999999999999875321     2234567889999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-----------------------ccCCCC----CCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-----------------------RHMQRS----PWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-----------------------~~~~~~----~~~~  132 (407)
                      . .++.++|+||+||++|+|++|+.||...+............                       ......    .+..
T Consensus       189 ~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (342)
T cd07879         189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK  268 (342)
T ss_pred             ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcC
Confidence            4 67889999999999999999999998765332211111100                       000000    1234


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                      .+..+.+||.+||+.||.+||++++++.||||....+.
T Consensus       269 ~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         269 ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            67889999999999999999999999999999886543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=1.3e-27  Score=228.44  Aligned_cols=162  Identities=28%  Similarity=0.494  Sum_probs=127.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......  .......+++.|++||++.+
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  174 (284)
T cd07836          97 LDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLG  174 (284)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcC
Confidence            4788999999999999999999999999999999999999999999999987543221  12234567889999999866


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc--------------cCC--CC---------CCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR--------------HMQ--RS---------PWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~--------------~~~--~~---------~~~~~s  134 (407)
                      . .++.++|+||+||++|+|++|..||...+.............              ...  .+         ....++
T Consensus       175 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (284)
T cd07836         175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD  254 (284)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcC
Confidence            4 678899999999999999999999987664432221111000              000  00         012457


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ..+.++|.+||+.+|.+||++.++++||||
T Consensus       255 ~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         255 PLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.6e-27  Score=229.08  Aligned_cols=162  Identities=27%  Similarity=0.491  Sum_probs=124.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++......  .......+++.|+|||.+.+
T Consensus       100 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  177 (291)
T cd07870         100 LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLG  177 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeec
Confidence            3567889999999999999999999999999999999999999999999987543222  12234467899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-cc--------------cC---------C---CCCCC-
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-NR--------------HM---------Q---RSPWD-  131 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~~--------------~~---------~---~~~~~-  131 (407)
                      . .++.++|+||+||++|+|++|..||............... ..              ..         .   ...+. 
T Consensus       178 ~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd07870         178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR  257 (291)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence            4 5788999999999999999999999765432111111000 00              00         0   00011 


Q ss_pred             -cCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        132 -RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       132 -~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                       ..+.++.+++.+|+..||++|||+.+++.||||
T Consensus       258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=1.7e-27  Score=231.48  Aligned_cols=168  Identities=19%  Similarity=0.366  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-----ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-----ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~AP   75 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+......+.     ........++..|+||
T Consensus        98 ~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (314)
T cd08216          98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP  177 (314)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence            46788999999999999999999999999999999999999999999998875532221     1112334577889999


Q ss_pred             hhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------------
Q psy11119         76 EVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------------  124 (407)
Q Consensus        76 E~l~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------------  124 (407)
                      |++...  .++.++|+||+||++|+|++|..||..................                             
T Consensus       178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (314)
T cd08216         178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD  257 (314)
T ss_pred             HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhh
Confidence            999764  5788999999999999999999999865433222111110000                             


Q ss_pred             -CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        125 -MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       125 -~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                       ........++.++.+||.+||..||++|||++++++||||+...
T Consensus       258 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         258 SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence             00000112346788999999999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.8e-27  Score=231.42  Aligned_cols=163  Identities=25%  Similarity=0.442  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++......    .....+|++.|+|||++.
T Consensus        96 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~  171 (308)
T cd06615          96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQ  171 (308)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhc
Confidence            4678899999999999999998 59999999999999999999999999998654322    223457899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh----------------------------------cccC
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD----------------------------------NRHM  125 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~----------------------------------~~~~  125 (407)
                      +..++.++|+||+||++|+|++|..||...+...........                                  ....
T Consensus       172 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (308)
T cd06615         172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPP  251 (308)
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCC
Confidence            878889999999999999999999999754432211111000                                  0000


Q ss_pred             CCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       126 ~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +..+...++.++.+||.+||..+|++||++.++++||||.+.
T Consensus       252 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         252 PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            111122367889999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=2.4e-27  Score=226.02  Aligned_cols=157  Identities=21%  Similarity=0.341  Sum_probs=126.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+
T Consensus       119 l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05049         119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY  198 (280)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence            35778899999999999999999999999999999999999999999999876432222122233456788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||............. . ... ......++..+.++|.+||..||.+||++.|++
T Consensus       199 ~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil  275 (280)
T cd05049         199 RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q-GRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH  275 (280)
T ss_pred             CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c-CCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            888999999999999999998 999997766543322222 1 122 222346789999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       276 ~  276 (280)
T cd05049         276 E  276 (280)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=2.3e-27  Score=220.85  Aligned_cols=159  Identities=26%  Similarity=0.421  Sum_probs=130.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+
T Consensus        95 ~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~  171 (253)
T cd05122          95 LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVING  171 (253)
T ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcC
Confidence            46788999999999999999999999999999999999999999999999876543321   344578899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+|+++|+|++|..||...+........... ..........++..+.++|.+||..+|.+|||+.++++
T Consensus       172 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            88889999999999999999999999876443333222221 11122222234789999999999999999999999999


Q ss_pred             Ccc
Q psy11119        161 HRW  163 (407)
Q Consensus       161 hpw  163 (407)
                      |||
T Consensus       251 ~~~  253 (253)
T cd05122         251 HPF  253 (253)
T ss_pred             CCC
Confidence            998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0586|consensus

Probab=99.95  E-value=1.5e-28  Score=247.45  Aligned_cols=163  Identities=37%  Similarity=0.623  Sum_probs=141.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |.|.+|+.+|.|+++|++|||+++|+|||||.+||||+.+.++||+|||++..+..+   ....+.||++.|.|||++.+
T Consensus       152 ~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g  228 (596)
T KOG0586|consen  152 MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNG  228 (596)
T ss_pred             chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcC
Confidence            457889999999999999999999999999999999999999999999999988633   45678899999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . +.++.+|+||+|++||.|+.|.+||++.+..............    ....++.++.+||+++|..+|.+|+++++|+
T Consensus       229 ~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim  304 (596)
T KOG0586|consen  229 KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM  304 (596)
T ss_pred             cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec----ccceeechhHHHHHHhhccCccccCCHHHhh
Confidence            7 8899999999999999999999999987765443333222222    2234788999999999999999999999999


Q ss_pred             hCcccccCCCC
Q psy11119        160 SHRWYSKHMPN  170 (407)
Q Consensus       160 ~hpwf~~~~~~  170 (407)
                      +|.|.......
T Consensus       305 ~~~W~n~~~~~  315 (596)
T KOG0586|consen  305 KDRWRNDLLEA  315 (596)
T ss_pred             hhcccchhhhh
Confidence            99999876654

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=2e-27  Score=224.96  Aligned_cols=165  Identities=27%  Similarity=0.442  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~   77 (407)
                      +++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++.........  .......|+..|+|||.
T Consensus       100 ~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~  179 (268)
T cd06630         100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV  179 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhH
Confidence            46788999999999999999999999999999999998876 5999999998765433211  11223468899999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh-hcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK-DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++|+||+||++|+|++|..||.............. ............+++++.+++.+||..+|.+||++.
T Consensus       180 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  259 (268)
T cd06630         180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR  259 (268)
T ss_pred             hccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHH
Confidence            9888888999999999999999999999975443221111111 111122223345788999999999999999999999


Q ss_pred             HHHhCcccc
Q psy11119        157 KIKSHRWYS  165 (407)
Q Consensus       157 eil~hpwf~  165 (407)
                      ++++||||+
T Consensus       260 ~ll~~~~~~  268 (268)
T cd06630         260 ELLKHPVFR  268 (268)
T ss_pred             HHhcCcccC
Confidence            999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=2.4e-27  Score=225.05  Aligned_cols=160  Identities=28%  Similarity=0.442  Sum_probs=125.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.......  .......|++.|+|||++..
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  183 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDK  183 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhcc
Confidence            56778889999999999999999999999999999986 6799999999987653222  12233468899999999865


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .  .++.++|+||+|+++|+|++|..||............... ..........+++++.+++.+||+.+|.+|||+.++
T Consensus       184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  262 (268)
T cd06624         184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL  262 (268)
T ss_pred             ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            4  4788999999999999999999999754332211111111 111112234578899999999999999999999999


Q ss_pred             HhCccc
Q psy11119        159 KSHRWY  164 (407)
Q Consensus       159 l~hpwf  164 (407)
                      +.||||
T Consensus       263 l~~~~~  268 (268)
T cd06624         263 LQDPFL  268 (268)
T ss_pred             HhCCCC
Confidence            999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=2.8e-27  Score=228.55  Aligned_cols=166  Identities=24%  Similarity=0.406  Sum_probs=134.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~  190 (292)
T cd06657         113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISR  190 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcC
Confidence            4678899999999999999999999999999999999999999999999987553222  12234568899999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||......... ................+++.+.++|.+||..+|.+||++.+++.
T Consensus       191 ~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            77889999999999999999999999865543221 11222122222233457889999999999999999999999999


Q ss_pred             CcccccCCC
Q psy11119        161 HRWYSKHMP  169 (407)
Q Consensus       161 hpwf~~~~~  169 (407)
                      ||||.+...
T Consensus       270 ~~~~~~~~~  278 (292)
T cd06657         270 HPFLAKAGP  278 (292)
T ss_pred             ChHHhccCC
Confidence            999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=2.2e-27  Score=223.33  Aligned_cols=159  Identities=20%  Similarity=0.353  Sum_probs=130.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........  ......|++.|+|||++.+
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~  175 (256)
T cd08218          98 FPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICEN  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCC
Confidence            36788899999999999999999999999999999999999999999999976533221  1223458889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+||++|+|++|..||...............  .. ......++.++.++|.+||+.+|.+||++.++++
T Consensus       176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            88889999999999999999999999866544322222111  11 1223457889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       253 ~~~~  256 (256)
T cd08218         253 KNFI  256 (256)
T ss_pred             CcCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=2.5e-27  Score=229.49  Aligned_cols=159  Identities=21%  Similarity=0.276  Sum_probs=123.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++.++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||++...
T Consensus       136 ~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (304)
T cd05096         136 SYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG  215 (304)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence            45678899999999999999999999999999999999999999999999765433222222334567889999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHH---hhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         82 YLAEPADIWSCGIILVAMLA--GELPWDKPTADCIEYLEW---KDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~---~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .++.++|||||||++|+|++  +..||.............   ... ..........++..+.+||.+||..+|.+|||+
T Consensus       216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            88999999999999999987  667887655433221111   010 111111224578899999999999999999999


Q ss_pred             HHHHh
Q psy11119        156 EKIKS  160 (407)
Q Consensus       156 ~eil~  160 (407)
                      .+|.+
T Consensus       296 ~~i~~  300 (304)
T cd05096         296 SDIHA  300 (304)
T ss_pred             HHHHH
Confidence            99954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=3.3e-27  Score=220.67  Aligned_cols=163  Identities=27%  Similarity=0.452  Sum_probs=132.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+..
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606          98 LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence            46788999999999999999999999999999999999999999999999987654432112344578899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+|+++|+|++|..||............... ..........++..+.++|.+||..+|.+||++.+++.
T Consensus       178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            88899999999999999999999999876522222221111 11222233456899999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       257 ~~~~  260 (260)
T cd06606         257 HPFL  260 (260)
T ss_pred             CCCC
Confidence            9997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=4.1e-27  Score=221.54  Aligned_cols=159  Identities=21%  Similarity=0.349  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........  ......|++.|+|||.+.+
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~  175 (256)
T cd08221          98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQG  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCC
Confidence            46788999999999999999999999999999999999999999999999986543321  2344578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||..............  .... +....++.++.++|.+||..+|.+||++.++++
T Consensus       176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~  252 (256)
T cd08221         176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLD  252 (256)
T ss_pred             CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence            7788999999999999999999999987655433222221  1111 122557899999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      |+|+
T Consensus       253 ~~~l  256 (256)
T cd08221         253 QPLL  256 (256)
T ss_pred             CcCC
Confidence            9985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=2.3e-27  Score=223.73  Aligned_cols=159  Identities=29%  Similarity=0.484  Sum_probs=131.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.......   ......|+..|+|||++.+
T Consensus        97 l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~  173 (258)
T cd05578          97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCR  173 (258)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcc
Confidence            4678899999999999999999999999999999999999999999999987654322   2234568899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH--HH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE-YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI--EK  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~--~e  157 (407)
                      ..++.++|+||+|+++|+|++|..||......... ......  .........++.++.++|.+||..+|.+||++  .+
T Consensus       174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~  251 (258)
T cd05578         174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD  251 (258)
T ss_pred             cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--cccccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence            88899999999999999999999999876642111 111111  12222334578999999999999999999999  99


Q ss_pred             HHhCccc
Q psy11119        158 IKSHRWY  164 (407)
Q Consensus       158 il~hpwf  164 (407)
                      +++||||
T Consensus       252 l~~~~~~  258 (258)
T cd05578         252 LKNHPYF  258 (258)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=2.6e-27  Score=227.90  Aligned_cols=153  Identities=18%  Similarity=0.183  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....     .....|++.|+|||++.
T Consensus       119 ~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLN  193 (283)
T ss_pred             CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhh
Confidence            45678899999999999999985 9999999999999999999999999998754321     12456889999999997


Q ss_pred             c--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 R--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 ~--~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +  ..++.++|||||||++|+|++|..||...+...............  ......++.+.+||.+||+.||.+|||+.+
T Consensus       194 ~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  271 (283)
T PHA02988        194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--KLPLDCPLEIKCIVEACTSHDSIKRPNIKE  271 (283)
T ss_pred             hccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--CCCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence            6  578999999999999999999999999776554333222222222  222357899999999999999999999999


Q ss_pred             HHh
Q psy11119        158 IKS  160 (407)
Q Consensus       158 il~  160 (407)
                      +++
T Consensus       272 ll~  274 (283)
T PHA02988        272 ILY  274 (283)
T ss_pred             HHH
Confidence            986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=2.3e-27  Score=231.30  Aligned_cols=158  Identities=20%  Similarity=0.353  Sum_probs=127.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.............++..|+|||.+.+
T Consensus       106 ~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~  185 (316)
T cd05108         106 IGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH  185 (316)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc
Confidence            35677889999999999999999999999999999999999999999999987643322222223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.+........ .......  .+....++.++.++|.+||..+|.+||++.+++
T Consensus       186 ~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~  262 (316)
T cd05108         186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELI  262 (316)
T ss_pred             CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999998 999998766543222 1222112  222345678899999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       263 ~~  264 (316)
T cd05108         263 IE  264 (316)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0669|consensus

Probab=99.95  E-value=2.1e-27  Score=216.27  Aligned_cols=167  Identities=28%  Similarity=0.468  Sum_probs=135.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+..++.+++++|+.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.....  ....+..+.|.+|.+||.+
T Consensus       121 ~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEll  200 (376)
T KOG0669|consen  121 FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELL  200 (376)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHh
Confidence            46678999999999999999999999999999999999999999999999987754322  2335667789999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCc-------------------------
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDR-------------------------  132 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------  132 (407)
                      .+. .++++.|+|..|||+.+|++|.+-+.+.+.......+..-.+......|+.                         
T Consensus       201 LG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n  280 (376)
T KOG0669|consen  201 LGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKN  280 (376)
T ss_pred             hcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhh
Confidence            876 889999999999999999999999887765544333322222222222221                         


Q ss_pred             ------CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        133 ------LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       133 ------~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                            -++++.+|+.++|..||.+|+++.++++|.||.+.
T Consensus       281 ~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  281 RLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             hcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                  13578999999999999999999999999999875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=3.1e-27  Score=227.53  Aligned_cols=158  Identities=22%  Similarity=0.331  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       120 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  199 (291)
T cd05094         120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  199 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence            46778999999999999999999999999999999999999999999999876433222222234456788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||...........  ....... .....++..+.+++.+||.++|.+||++.+++
T Consensus       200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~  276 (291)
T cd05094         200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--ITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY  276 (291)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            888999999999999999999 9999977655432221  1111111 12344688999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       277 ~~  278 (291)
T cd05094         277 KI  278 (291)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=3.5e-27  Score=221.92  Aligned_cols=159  Identities=25%  Similarity=0.354  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH-----SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH-----~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP   75 (407)
                      +++.+++.++.||+.||.|||     +.+++|+||||+||+++.++.+||+|||++........  ......+++.|+||
T Consensus       102 l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccCh
Confidence            467889999999999999999     89999999999999999999999999999987643321  12345789999999


Q ss_pred             hhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         76 EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        76 E~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      |++.+..++.++|+||||+++|+|++|..||.........  ........ ......++..+.+++.+||..+|.+||++
T Consensus       180 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~  256 (265)
T cd08217         180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA--SKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPST  256 (265)
T ss_pred             hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH--HHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCH
Confidence            9998888889999999999999999999999877643222  22221221 12234678899999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      .+|++|||+
T Consensus       257 ~~il~~~~~  265 (265)
T cd08217         257 EELLQLPLI  265 (265)
T ss_pred             HHHhhCCCC
Confidence            999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=1.8e-27  Score=225.65  Aligned_cols=161  Identities=25%  Similarity=0.356  Sum_probs=125.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........  ......|++.|+|||.+..
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  180 (267)
T cd06646         103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAV  180 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHccc
Confidence            46788999999999999999999999999999999999999999999999986542211  1234568899999999853


Q ss_pred             ---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-CCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 ---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-RSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                         ..++.++|+||+||++|+|++|..||.................... ......++..+.+||++||..+|++||+++
T Consensus       181 ~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  260 (267)
T cd06646         181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE  260 (267)
T ss_pred             ccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHH
Confidence               3567899999999999999999999965443221111111111111 111234688999999999999999999999


Q ss_pred             HHHhCcc
Q psy11119        157 KIKSHRW  163 (407)
Q Consensus       157 eil~hpw  163 (407)
                      +|++|+|
T Consensus       261 ~il~~l~  267 (267)
T cd06646         261 RLLTHLF  267 (267)
T ss_pred             HHhcCCC
Confidence            9999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=3.7e-27  Score=236.05  Aligned_cols=159  Identities=24%  Similarity=0.340  Sum_probs=126.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||++.+
T Consensus       211 l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  290 (375)
T cd05104         211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN  290 (375)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence            46788999999999999999999999999999999999999999999999986543322222222345677999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||..................  ...+...+.++.+||.+||+.||++||++.+|+
T Consensus       291 ~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  368 (375)
T cd05104         291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR--MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV  368 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            888999999999999999998 89999866544333333222211  112234678999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       369 ~~  370 (375)
T cd05104         369 QL  370 (375)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=4.1e-27  Score=232.47  Aligned_cols=167  Identities=28%  Similarity=0.426  Sum_probs=127.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........ ........++..|+|||++
T Consensus       111 l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHH
Confidence            578899999999999999999999999999999999984 55789999999876532211 1112334678899999987


Q ss_pred             hc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh----------------------cccCCCC----CCC
Q psy11119         79 VR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD----------------------NRHMQRS----PWD  131 (407)
Q Consensus        79 ~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~----------------------~~~~~~~----~~~  131 (407)
                      .. ..++.++|+||+||++|+|++|+.||...+...........                      .......    ...
T Consensus       191 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (342)
T cd07854         191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLP  270 (342)
T ss_pred             hCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHcc
Confidence            65 46788999999999999999999999766543221111100                      0000000    113


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      .++.++.+||.+||..+|.+|||+.+++.||||+..
T Consensus       271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            477889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.8e-27  Score=212.03  Aligned_cols=151  Identities=23%  Similarity=0.238  Sum_probs=120.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.++.||+.||.|||++|      ||+|||++.++.+|+  ||++......       ...||+.|+|||++.+
T Consensus        14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~   78 (176)
T smart00750       14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQG   78 (176)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcC
Confidence            689999999999999999999999      999999999999999  9998765321       2268999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC----CCCCCcCCH--HHHHHHHHhccCCCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ----RSPWDRLDV--NCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~--~~~~LI~~~L~~~P~~Rps  154 (407)
                      ..++.++||||+||++|+|++|+.||....................    ......++.  ++.++|.+||..+|.+||+
T Consensus        79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~  158 (176)
T smart00750       79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA  158 (176)
T ss_pred             CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC
Confidence            8889999999999999999999999976543322222222211111    011222333  6899999999999999999


Q ss_pred             HHHHHhCccccc
Q psy11119        155 IEKIKSHRWYSK  166 (407)
Q Consensus       155 ~~eil~hpwf~~  166 (407)
                      +.++++|+|+..
T Consensus       159 ~~~ll~~~~~~~  170 (176)
T smart00750      159 ANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHHHHHHH
Confidence            999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=4.1e-27  Score=221.11  Aligned_cols=159  Identities=26%  Similarity=0.421  Sum_probs=129.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......   ......|++.|+|||.+..
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~  175 (258)
T cd06632          99 FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQ  175 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcC
Confidence            4678889999999999999999999999999999999999999999999987653322   2234568899999999877


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. ++.++|+||+||++|+|++|..||........... ..... .....+..+++.+.++|++||..+|.+||++.+++
T Consensus       176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l  253 (258)
T cd06632         176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSK-ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL  253 (258)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcc-cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence            65 88999999999999999999999976653222221 11111 11222345789999999999999999999999999


Q ss_pred             hCccc
Q psy11119        160 SHRWY  164 (407)
Q Consensus       160 ~hpwf  164 (407)
                      .|||+
T Consensus       254 ~~~~~  258 (258)
T cd06632         254 EHPFV  258 (258)
T ss_pred             cCCCC
Confidence            99996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=4.7e-27  Score=225.88  Aligned_cols=163  Identities=22%  Similarity=0.323  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~   82 (407)
                      ...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..
T Consensus       118 ~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  197 (288)
T cd05061         118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV  197 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC
Confidence            45678899999999999999999999999999999999999999999987543222212222334577899999998888


Q ss_pred             CCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh-
Q psy11119         83 LAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS-  160 (407)
Q Consensus        83 ~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~-  160 (407)
                      ++.++|+||+||++|+|++ |..||............... ...  ......++.+.+++.+||+.+|.+|||+.++++ 
T Consensus       198 ~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  274 (288)
T cd05061         198 FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL  274 (288)
T ss_pred             CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999998 79999876654322222111 111  112346789999999999999999999999987 


Q ss_pred             -----CcccccCC
Q psy11119        161 -----HRWYSKHM  168 (407)
Q Consensus       161 -----hpwf~~~~  168 (407)
                           ||||....
T Consensus       275 l~~~~~~~~~~~~  287 (288)
T cd05061         275 LKDDLHPSFPEVS  287 (288)
T ss_pred             HHhhcCCCCCCCC
Confidence                 89988653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=2.4e-27  Score=227.76  Aligned_cols=170  Identities=26%  Similarity=0.432  Sum_probs=132.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++....... ........|+..|+|||.+..
T Consensus       102 l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  180 (290)
T cd05613         102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRG  180 (290)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccC
Confidence            4678889999999999999999999999999999999999999999999987654322 122334578999999999875


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----  153 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----  153 (407)
                      .  .++.++|+||+|+++|+|++|..||.....................+....+++.+.+++++||..+|.+||     
T Consensus       181 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~  260 (290)
T cd05613         181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPS  260 (290)
T ss_pred             CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence            3  567899999999999999999999974322111111111111111122345788999999999999999997     


Q ss_pred             CHHHHHhCcccccCCCCC
Q psy11119        154 NIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       154 s~~eil~hpwf~~~~~~~  171 (407)
                      ++.+++.||||.+..+++
T Consensus       261 ~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         261 DADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CHHHHHcCcccccCCHHH
Confidence            899999999999876544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645|consensus

Probab=99.95  E-value=2.5e-28  Score=261.37  Aligned_cols=164  Identities=30%  Similarity=0.527  Sum_probs=135.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +|...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+.....  ........|||.|||||++.
T Consensus      1332 dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1332 DEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhc
Confidence            4667788999999999999999999999999999999999999999999988765532  23355678999999999997


Q ss_pred             cC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 RS---YLAEPADIWSCGIILVAMLAGELPWDKPTADC-IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      +.   +.+-++||||+||++.||.||+.||..-+.+- +.|....  +..+. .+..++.+.+++|..||..||.+|.++
T Consensus      1412 ~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--gh~Pq-~P~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1412 GTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--GHKPQ-IPERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred             ccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--cCCCC-CchhhhHhHHHHHHHHHhcCchhhhHH
Confidence            64   67889999999999999999999998665543 2333222  22222 234599999999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .|+++|.|-+...
T Consensus      1489 ~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1489 SQLLEHAFGKSCT 1501 (1509)
T ss_pred             HHHHHhhcccccc
Confidence            9999999887654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=3.6e-27  Score=227.50  Aligned_cols=163  Identities=28%  Similarity=0.477  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+
T Consensus       113 ~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~  191 (302)
T cd07864         113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLG  191 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcC
Confidence            46789999999999999999999999999999999999999999999999976543322 22233456788999998865


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC--------------------------CCCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM--------------------------QRSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|+.||...................                          ....+..+
T Consensus       192 ~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (302)
T cd07864         192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI  271 (302)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC
Confidence            4 57889999999999999999999998654332111111100000                          00113357


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +..+.++|.+||..+|.+||++++++.||||
T Consensus       272 ~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         272 PTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=4.3e-27  Score=224.82  Aligned_cols=158  Identities=21%  Similarity=0.365  Sum_probs=126.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       106 ~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05109         106 IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH  185 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc
Confidence            46788999999999999999999999999999999999999999999999987643322211222345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||........... ... . ...+....++.++.++|.+||..||++||++.+++
T Consensus       186 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~-~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~  262 (279)
T cd05109         186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEK-G-ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV  262 (279)
T ss_pred             CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHC-C-CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999998 9999986654432221 112 1 12223355788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       263 ~~  264 (279)
T cd05109         263 DE  264 (279)
T ss_pred             HH
Confidence            53

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=1.9e-27  Score=229.60  Aligned_cols=166  Identities=25%  Similarity=0.420  Sum_probs=134.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........  ......|++.|+|||.+.+
T Consensus       112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  189 (293)
T cd06647         112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR  189 (293)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhcc
Confidence            46778899999999999999999999999999999999999999999999876543322  2234468899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|++++|..||...+........... .......+..++..+.++|++||..+|.+||++.+++.
T Consensus       190 ~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            88889999999999999999999999866543222211111 22223334557888999999999999999999999999


Q ss_pred             CcccccCCC
Q psy11119        161 HRWYSKHMP  169 (407)
Q Consensus       161 hpwf~~~~~  169 (407)
                      |+||+...+
T Consensus       269 h~~~~~~~~  277 (293)
T cd06647         269 HPFLKIAKP  277 (293)
T ss_pred             CHHHhcCcc
Confidence            999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=2.7e-27  Score=223.07  Aligned_cols=165  Identities=26%  Similarity=0.464  Sum_probs=132.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++........  ......++..|+|||.+.
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~  173 (264)
T cd06623          96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQ  173 (264)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhC
Confidence            4788899999999999999999 9999999999999999999999999999886543222  123456889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...++.++|+||||+++|+|++|..||..... .....................++..+.++|.+||.++|++||++.++
T Consensus       174 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            88889999999999999999999999977641 11111111111111222222278899999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      ++|||++..
T Consensus       254 l~~~~~~~~  262 (264)
T cd06623         254 LQHPFIKKA  262 (264)
T ss_pred             HhCHHHHhc
Confidence            999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=6e-27  Score=224.31  Aligned_cols=158  Identities=17%  Similarity=0.321  Sum_probs=127.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+
T Consensus       106 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  185 (279)
T cd05111         106 LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF  185 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc
Confidence            46788999999999999999999999999999999999999999999999986543332223334557788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||.+.......... .. .. ........+.++.+++.+||..+|++|||+.+++
T Consensus       186 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~  262 (279)
T cd05111         186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EK-GE-RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELA  262 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HC-CC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            888999999999999999998 99999876554322221 11 11 1122234677899999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       263 ~~  264 (279)
T cd05111         263 NE  264 (279)
T ss_pred             HH
Confidence            73

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=3.9e-27  Score=223.24  Aligned_cols=162  Identities=27%  Similarity=0.452  Sum_probs=129.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++........ ........|+..|+|||++.
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         103 LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhc
Confidence            46778899999999999999999999999999999999999999999999876532211 11223456899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+||++|+|++|+.||.......... .... .......+..++..+.++|++|+. +|.+||++++++
T Consensus       183 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il  259 (265)
T cd06652         183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIAT-QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL  259 (265)
T ss_pred             CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhc-CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence            8888899999999999999999999998664332222 1111 111122234577889999999995 999999999999


Q ss_pred             hCcccc
Q psy11119        160 SHRWYS  165 (407)
Q Consensus       160 ~hpwf~  165 (407)
                      +|||+.
T Consensus       260 ~~~~~~  265 (265)
T cd06652         260 RHTFVH  265 (265)
T ss_pred             cCcccC
Confidence            999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=6.1e-27  Score=223.08  Aligned_cols=162  Identities=30%  Similarity=0.493  Sum_probs=128.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+
T Consensus        95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  172 (282)
T cd07829          95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYTHEVVTLWYRAPEILLG  172 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccCccccCcCcCChHHhcC
Confidence            5788999999999999999999999999999999999999999999999987654322  12334456788999999877


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc------------------ccC-------CCCCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN------------------RHM-------QRSPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~------------------~~~-------~~~~~~~~s  134 (407)
                      . .++.++|+||+||++|+|++|..||................                  ...       .......++
T Consensus       173 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07829         173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD  252 (282)
T ss_pred             CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence            6 78899999999999999999999998765432211110000                  000       001123457


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ..+.++|++||..+|++||++.+++.||||
T Consensus       253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.2e-27  Score=232.77  Aligned_cols=165  Identities=25%  Similarity=0.386  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....     ......+++.|+|||++.+
T Consensus       117 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhC
Confidence            46788999999999999999999999999999999999999999999999875321     2234568899999999876


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh----------------------c-ccCCC----CCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD----------------------N-RHMQR----SPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~----------------------~-~~~~~----~~~~~  132 (407)
                       ..++.++|+||+||++|+|++|+.||...............                      . .....    ..+..
T Consensus       192 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (345)
T cd07877         192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  271 (345)
T ss_pred             ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCC
Confidence             46788999999999999999999999765432211110000                      0 00000    01123


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                      .++++.++|.+||..+|.+||++.+++.||||.+....
T Consensus       272 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         272 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             CCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            57889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0193|consensus

Probab=99.95  E-value=7e-28  Score=241.73  Aligned_cols=160  Identities=28%  Similarity=0.388  Sum_probs=129.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |.....+.|++||++|+.|||.++|+|||||..||++.+++.+||+|||+++.-..-..........|...|||||++..
T Consensus       485 fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm  564 (678)
T KOG0193|consen  485 FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM  564 (678)
T ss_pred             hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh
Confidence            34567889999999999999999999999999999999999999999999986543334445566778999999999975


Q ss_pred             C---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC-CCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         81 S---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ-RSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        81 ~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +   +|+..+||||+||++|||++|.+||.....+.+.+..-....... .......+.++++|+..||+.++++||.+.
T Consensus       565 qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  565 QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHH
Confidence            4   899999999999999999999999995555443332211111111 122345667999999999999999999999


Q ss_pred             HHHh
Q psy11119        157 KIKS  160 (407)
Q Consensus       157 eil~  160 (407)
                      +|+.
T Consensus       645 ~il~  648 (678)
T KOG0193|consen  645 QLLS  648 (678)
T ss_pred             HHHH
Confidence            9987

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=5.3e-27  Score=227.71  Aligned_cols=160  Identities=24%  Similarity=0.377  Sum_probs=130.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....      .....+++.|+|||++. 
T Consensus       112 l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~  185 (307)
T cd06607         112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILA  185 (307)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeec
Confidence            46788999999999999999999999999999999999999999999999865421      12346888999999874 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                        ...++.++||||+|+++|+|++|..||.........+.....  .........++..+.++|.+||..+|.+||++.+
T Consensus       186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  263 (307)
T cd06607         186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE  263 (307)
T ss_pred             cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence              346788999999999999999999999876654433322211  1111222346788999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      |+.||||....
T Consensus       264 il~~~~~~~~~  274 (307)
T cd06607         264 LLKHRFVLRER  274 (307)
T ss_pred             HhcChhhcccC
Confidence            99999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=1.5e-27  Score=223.26  Aligned_cols=151  Identities=26%  Similarity=0.405  Sum_probs=123.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.++++|||.+......     .....++..|+|||.+.+
T Consensus        82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~  156 (237)
T cd05576          82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGI  156 (237)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCC
Confidence            578889999999999999999999999999999999999999999999987654321     223456778999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++|+||+||++|+|++|+.|+.......      ......  .....+++.+.++|.+||+.||.+||++     
T Consensus       157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  228 (237)
T cd05576         157 SEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV  228 (237)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cccccc--CCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence            778899999999999999999998876432110      000111  1223478899999999999999999985     


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      +++++||||
T Consensus       229 ~~~~~h~~~  237 (237)
T cd05576         229 EDIKSHPFF  237 (237)
T ss_pred             HHHHcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=5.1e-27  Score=223.48  Aligned_cols=157  Identities=24%  Similarity=0.314  Sum_probs=126.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+.
T Consensus       117 ~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05032         117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (277)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence            56788999999999999999999999999999999999999999999998765433222223344577889999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|+|||||++|+|++ |..||...+........ .. .. .......++.++.++|.+||..+|++|||+.++++
T Consensus       197 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         197 VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-ID-GG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH-hc-CC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            88999999999999999998 99999876654332222 22 11 11223446899999999999999999999999976


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      .
T Consensus       274 ~  274 (277)
T cd05032         274 S  274 (277)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=5.6e-27  Score=220.16  Aligned_cols=158  Identities=25%  Similarity=0.374  Sum_probs=129.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||.|||++||+|+||+|+||+++.++ .+||+|||++.......   ......|++.|+|||.+.
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~  174 (256)
T cd08220          98 LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCE  174 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhcc
Confidence            46788999999999999999999999999999999998654 58999999998654322   223356889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+|+++|+|++|..||...+........ ..  .........++.++.++|.+||.++|.+|||+.+++
T Consensus       175 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll  251 (256)
T cd08220         175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MS--GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM  251 (256)
T ss_pred             CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-Hh--cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            888889999999999999999999999876554322222 11  111222345788999999999999999999999999


Q ss_pred             hCccc
Q psy11119        160 SHRWY  164 (407)
Q Consensus       160 ~hpwf  164 (407)
                      .||||
T Consensus       252 ~~p~~  256 (256)
T cd08220         252 AQPIC  256 (256)
T ss_pred             hCCCC
Confidence            99996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=5e-27  Score=231.04  Aligned_cols=167  Identities=28%  Similarity=0.403  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc---cCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE---RPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~---~~~~~~~gt~~Y~APE~   77 (407)
                      +++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.........   .......|++.|+|||.
T Consensus       104 ~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (337)
T cd07852         104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI  183 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCcee
Confidence            356778899999999999999999999999999999999999999999999866433221   22334568999999998


Q ss_pred             hhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc---------------------------ccCCCCC
Q psy11119         78 LVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN---------------------------RHMQRSP  129 (407)
Q Consensus        78 l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~  129 (407)
                      +.+. .++.++|+||+||++|+|++|+.||................                           .......
T Consensus       184 ~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (337)
T cd07852         184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL  263 (337)
T ss_pred             eeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh
Confidence            7654 67889999999999999999999997654332111110000                           0000111


Q ss_pred             CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       130 ~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ...++.++.++|.+||+.+|.+|||+.++++|||+++.
T Consensus       264 ~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            23368899999999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=5.2e-27  Score=224.67  Aligned_cols=158  Identities=23%  Similarity=0.320  Sum_probs=127.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+
T Consensus       121 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (283)
T cd05090         121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY  200 (283)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence            35677889999999999999999999999999999999999999999999986543332222334456778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||............. .  ....+.+..+++.+.++|.+||+++|.+||++.+|+
T Consensus       201 ~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~  277 (283)
T cd05090         201 GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-K--RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH  277 (283)
T ss_pred             CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c--CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            888999999999999999998 999997765433222221 1  112223456789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       278 ~~  279 (283)
T cd05090         278 TR  279 (283)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=4.7e-27  Score=224.32  Aligned_cols=157  Identities=21%  Similarity=0.302  Sum_probs=124.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+.
T Consensus       117 ~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05062         117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  196 (277)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence            35677889999999999999999999999999999999999999999998754322221122234567889999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|+|||||++|+|++ |..||............ .. ... ......++..+.++|.+||..+|++|||+.++++
T Consensus       197 ~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~-~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  273 (277)
T cd05062         197 VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-ME-GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  273 (277)
T ss_pred             CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-Hc-CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            88999999999999999999 79999876654322221 11 111 1223457889999999999999999999999987


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      +
T Consensus       274 ~  274 (277)
T cd05062         274 S  274 (277)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=5.6e-27  Score=221.98  Aligned_cols=158  Identities=26%  Similarity=0.403  Sum_probs=127.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....  .......|++.|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~  180 (267)
T cd08229         103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE  180 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcC
Confidence            4678899999999999999999999999999999999999999999999987654322  22234578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||......................++..++.++.++|.+||+.+|.+|||+.+|++
T Consensus       181 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            88889999999999999999999999765443222222222222233334567889999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=4.9e-27  Score=219.83  Aligned_cols=159  Identities=24%  Similarity=0.374  Sum_probs=131.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++|+||+|+||+++.+++++|+|||++.......  .......|++.|+|||.+.+
T Consensus       100 ~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~  177 (258)
T cd08215         100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQN  177 (258)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhcc
Confidence            4678899999999999999999999999999999999999999999999998754332  12334578999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||............ .. .. .......++.++.++|.+||..+|.+||++.++++
T Consensus       178 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LK-GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH-hc-CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            88889999999999999999999999876643322222 11 11 12222367889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       255 ~~~~  258 (258)
T cd08215         255 SPFI  258 (258)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=6.8e-27  Score=229.72  Aligned_cols=168  Identities=22%  Similarity=0.367  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC------------CccCCcCccC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG------------KERPLDKKCG   68 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~------------~~~~~~~~~g   68 (407)
                      +++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......            .........+
T Consensus       116 ~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (335)
T PTZ00024        116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV  195 (335)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccccc
Confidence            4678899999999999999999999999999999999999999999999997654111            1112233457


Q ss_pred             CCCCCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC--------------------
Q psy11119         69 TLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR--------------------  127 (407)
Q Consensus        69 t~~Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------------  127 (407)
                      ++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.................                    
T Consensus       196 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (335)
T PTZ00024        196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP  275 (335)
T ss_pred             ccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCc
Confidence            8899999998765 5788999999999999999999999876654322211111000000                    


Q ss_pred             ----CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        128 ----SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       128 ----~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                          ......+.++.++|.+||..+|++||++++++.||||+...
T Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence                00123578899999999999999999999999999998753

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=3.1e-27  Score=225.50  Aligned_cols=163  Identities=26%  Similarity=0.392  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+....  .......|+..|+|||.+.+
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  175 (277)
T cd06642          98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCc
Confidence            4678899999999999999999999999999999999999999999999987654322  11223468889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||............ .. .. .......++.++.++|.+||..+|.+||++.+++.
T Consensus       176 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PK-NS-PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hc-CC-CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            88889999999999999999999999765443222211 11 11 11122356788999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||....
T Consensus       253 ~~~~~~~~  260 (277)
T cd06642         253 HKFITRYT  260 (277)
T ss_pred             hHHHHHHh
Confidence            99998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=4.3e-27  Score=222.76  Aligned_cols=159  Identities=26%  Similarity=0.402  Sum_probs=128.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....  .......|++.|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~  180 (267)
T cd08228         103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE  180 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhcc
Confidence            4678899999999999999999999999999999999999999999999988654322  12234568899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+|+++|+|++|..||...................+..+...++..+.++|.+||..+|++||++.++++
T Consensus       181 ~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            88889999999999999999999999765433223322222222222233457789999999999999999999999987


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      .
T Consensus       261 ~  261 (267)
T cd08228         261 I  261 (267)
T ss_pred             H
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=4.9e-27  Score=225.77  Aligned_cols=158  Identities=25%  Similarity=0.381  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||++.+
T Consensus       129 l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  208 (293)
T cd05053         129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD  208 (293)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence            46778899999999999999999999999999999999999999999999986543322222223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||.......... ......  ........+..+.+|+.+||..+|.+|||+.+++
T Consensus       209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil  285 (293)
T cd05053         209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGY--RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV  285 (293)
T ss_pred             CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-HHHcCC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            888999999999999999998 999998766543222 222211  1122345688999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       286 ~~  287 (293)
T cd05053         286 ED  287 (293)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=7e-27  Score=220.68  Aligned_cols=158  Identities=20%  Similarity=0.327  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... .......+++.|+|||.+.
T Consensus        92 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05116          92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN  171 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence            467889999999999999999999999999999999999999999999998765432211 1112234467899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...++.++|+|||||++|+|++ |..||............ .. .. ..+.+..+++++.++|.+||++||.+||++.+|
T Consensus       172 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~-~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ES-GE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HC-CC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence            7788899999999999999998 99999876554332222 22 11 122334688999999999999999999999998


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      ...
T Consensus       249 ~~~  251 (257)
T cd05116         249 ELR  251 (257)
T ss_pred             HHH
Confidence            763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=5.7e-27  Score=224.74  Aligned_cols=165  Identities=27%  Similarity=0.442  Sum_probs=133.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       113 l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  190 (286)
T cd06614         113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKR  190 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcC
Confidence            46778899999999999999999999999999999999999999999998865432221  2233457889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||............. ............++.++.++|.+||+.+|.+||++.++++
T Consensus       191 ~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            888999999999999999999999998765443222221 2122222233447889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      |+||.+..
T Consensus       270 ~~~~~~~~  277 (286)
T cd06614         270 HPFLKKAC  277 (286)
T ss_pred             ChHhhccC
Confidence            99999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=8.4e-27  Score=230.43  Aligned_cols=165  Identities=26%  Similarity=0.383  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....     ......+++.|+|||.+.+
T Consensus       115 l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhC
Confidence            47889999999999999999999999999999999999999999999999875432     1234467899999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-----------------------cCC----CCCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-----------------------HMQ----RSPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------------~~~----~~~~~~  132 (407)
                      . .++.++|+||+||++|+|++|..||...+.............                       ...    ...+..
T Consensus       190 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07880         190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN  269 (343)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccC
Confidence            3 678899999999999999999999986654322111111000                       000    011245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN  170 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~  170 (407)
                      +++.+.++|.+||..||.+|||+.+++.||||+.....
T Consensus       270 ~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         270 ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             CChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            67889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=7.4e-27  Score=224.70  Aligned_cols=161  Identities=20%  Similarity=0.258  Sum_probs=125.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       127 ~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (296)
T cd05051         127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL  206 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence            46788999999999999999999999999999999999999999999999876543322222334456788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHHhh----cccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLA--GELPWDKPTADCIEYLEWKD----NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ..++.++||||+||++|+|++  |..||...+...........    ......+....++.++.++|.+||+.+|.+|||
T Consensus       207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt  286 (296)
T cd05051         207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT  286 (296)
T ss_pred             CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence            888999999999999999998  78898765543322111111    011111223456789999999999999999999


Q ss_pred             HHHHHhC
Q psy11119        155 IEKIKSH  161 (407)
Q Consensus       155 ~~eil~h  161 (407)
                      +.+|++.
T Consensus       287 ~~el~~~  293 (296)
T cd05051         287 FREIHLF  293 (296)
T ss_pred             HHHHHHH
Confidence            9999653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=6.4e-27  Score=224.06  Aligned_cols=157  Identities=22%  Similarity=0.324  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++................+++.|+|||.+.+
T Consensus       119 l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05092         119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  198 (280)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence            45778899999999999999999999999999999999999999999999876533222122223345788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||............. . .. .......+++.+.++|.+||..+|.+||++++|+
T Consensus       199 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~-~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~  275 (280)
T cd05092         199 RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q-GR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH  275 (280)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-c-Cc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            888999999999999999998 999997665443222221 1 11 1222345789999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       276 ~  276 (280)
T cd05092         276 S  276 (280)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=6.9e-27  Score=223.32  Aligned_cols=158  Identities=20%  Similarity=0.342  Sum_probs=124.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||+|||++|++||||||+||+++.++   .+||+|||+++................+..|+|||+
T Consensus       113 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05036         113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA  192 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHH
Confidence            46778899999999999999999999999999999998765   599999999986532211111122234567999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++||||+||++|+|++ |..||...+........ .....  ......++..+.+++.+||..+|++||++.
T Consensus       193 ~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~  269 (277)
T cd05036         193 FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFA  269 (277)
T ss_pred             HhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            988889999999999999999997 99999876654332221 11111  122345789999999999999999999999


Q ss_pred             HHHhC
Q psy11119        157 KIKSH  161 (407)
Q Consensus       157 eil~h  161 (407)
                      ++++|
T Consensus       270 ~vl~~  274 (277)
T cd05036         270 TILER  274 (277)
T ss_pred             HHHHH
Confidence            99987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=6.9e-27  Score=219.70  Aligned_cols=159  Identities=22%  Similarity=0.338  Sum_probs=128.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc-EEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~-lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||.+.......  .......|++.|+|||++.
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~  175 (257)
T cd08225          98 FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQ  175 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--ccccccCCCccccCHHHHc
Confidence            467889999999999999999999999999999999998864 6999999987654322  1223346899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+|+++|+|++|..||...+...........  . .......++.++.++|.+||..+|++|||+.+++
T Consensus       176 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll  252 (257)
T cd08225         176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--Y-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSIL  252 (257)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--c-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence            888889999999999999999999999866544322221111  1 1112245788999999999999999999999999


Q ss_pred             hCccc
Q psy11119        160 SHRWY  164 (407)
Q Consensus       160 ~hpwf  164 (407)
                      +||||
T Consensus       253 ~~~~~  257 (257)
T cd08225         253 KRPFL  257 (257)
T ss_pred             hCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4721|consensus

Probab=99.94  E-value=6.1e-28  Score=239.95  Aligned_cols=155  Identities=28%  Similarity=0.469  Sum_probs=132.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      .......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||-++.....   .....++||..|||||++.+.
T Consensus       210 tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrne  286 (904)
T KOG4721|consen  210 TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNE  286 (904)
T ss_pred             CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcC
Confidence            34566789999999999999999999999999999999999999999998876433   234568999999999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-cccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      +.++|+|||||||+|||||||+.||.+-+...+   +|-. ......+.+..+++.++-||+.||+..|..||++.+|+.
T Consensus       287 PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~  363 (904)
T KOG4721|consen  287 PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILL  363 (904)
T ss_pred             CcccccceehhHHHHHHHHhcCCCccccchhee---EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHH
Confidence            999999999999999999999999986554322   2322 133444556778999999999999999999999999998


Q ss_pred             Cc
Q psy11119        161 HR  162 (407)
Q Consensus       161 hp  162 (407)
                      |-
T Consensus       364 Hl  365 (904)
T KOG4721|consen  364 HL  365 (904)
T ss_pred             HH
Confidence            85

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.3e-27  Score=217.93  Aligned_cols=159  Identities=24%  Similarity=0.410  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........  ......++..|+|||...+
T Consensus        96 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~  173 (254)
T cd06627          96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEM  173 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcC
Confidence            47888999999999999999999999999999999999999999999999987643322  1234568899999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+|+++|+|++|..||............. .  .........++..+.++|.+||..+|++||++.+++.
T Consensus       174 ~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-Q--DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-c--cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            778899999999999999999999998665432222221 1  1222233567899999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       251 ~~~~  254 (254)
T cd06627         251 HPWI  254 (254)
T ss_pred             CCCC
Confidence            9997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=8.6e-27  Score=223.95  Aligned_cols=164  Identities=26%  Similarity=0.432  Sum_probs=129.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+
T Consensus       102 l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~  177 (287)
T cd06621         102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQG  177 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcC
Confidence            4677889999999999999999999999999999999999999999999986543221    123467889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhcccC---CCCCC--CcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTA---DCIEYLEWKDNRHM---QRSPW--DRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~---~~~~~--~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ..++.++|+||+||++|+|++|..||.....   .......+......   .....  ..+++.+.++|.+||..+|.+|
T Consensus       178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  257 (287)
T cd06621         178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR  257 (287)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccC
Confidence            8889999999999999999999999986521   11222222221111   11111  2346789999999999999999


Q ss_pred             CCHHHHHhCcccccCC
Q psy11119        153 LNIEKIKSHRWYSKHM  168 (407)
Q Consensus       153 ps~~eil~hpwf~~~~  168 (407)
                      ||+.|+++||||++..
T Consensus       258 pt~~eil~~~~~~~~~  273 (287)
T cd06621         258 PTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCHHHHHhCccccccc
Confidence            9999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=7.1e-27  Score=223.23  Aligned_cols=162  Identities=27%  Similarity=0.435  Sum_probs=132.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||++.+
T Consensus        98 l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~  175 (277)
T cd06640          98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQ  175 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhcc
Confidence            4677889999999999999999999999999999999999999999999997654322  12233468889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+||++|+|++|..||............  . ..........++..+.++|.+||..+|.+||++.+++.
T Consensus       176 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--P-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--h-cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            88899999999999999999999999866543322211  1 11112223456788999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      |+||...
T Consensus       253 ~~~~~~~  259 (277)
T cd06640         253 HKFIVKN  259 (277)
T ss_pred             ChHhhhc
Confidence            9999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4236|consensus

Probab=99.94  E-value=3e-28  Score=240.27  Aligned_cols=162  Identities=30%  Similarity=0.522  Sum_probs=141.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |+|...+.++.||+.||.|||-++|+|+||||+|||+....   .+||||||+|+.+...   ....+.+|||.|+|||+
T Consensus       661 L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRrsVVGTPAYLaPEV  737 (888)
T KOG4236|consen  661 LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRRSVVGTPAYLAPEV  737 (888)
T ss_pred             chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh---hhhhhhcCCccccCHHH
Confidence            57888899999999999999999999999999999998664   6999999999987543   33456789999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.++.|...-|+||.|||+|.-|+|..||.....  +...+.....-++..+|..+++++.+||..+|+..-++|.|+++
T Consensus       738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             HhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence            9999999999999999999999999999986432  22223233356677889999999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      .+.|||++..
T Consensus       816 ~lsh~Wlq~y  825 (888)
T KOG4236|consen  816 SLSHPWLQDY  825 (888)
T ss_pred             hccchhhhcc
Confidence            9999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=4.8e-27  Score=246.40  Aligned_cols=165  Identities=24%  Similarity=0.330  Sum_probs=118.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC-
Q psy11119          4 WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS-   81 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-   81 (407)
                      ..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+.... .......++++.|+|||.+... 
T Consensus       255 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccC
Confidence            456789999999999999999999999999999996 5799999999998654322 2233456899999999976432 


Q ss_pred             ---------------------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH--------HHHhhcccCC------
Q psy11119         82 ---------------------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY--------LEWKDNRHMQ------  126 (407)
Q Consensus        82 ---------------------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~--------~~~~~~~~~~------  126 (407)
                                           .++.++||||+||+||+|+++..|++.........        ..|.......      
T Consensus       334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  413 (566)
T PLN03225        334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLR  413 (566)
T ss_pred             CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhh
Confidence                                 13345699999999999999887765322111000        0111100000      


Q ss_pred             --CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        127 --RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       127 --~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                        .......+....+||.+||..||++|||+.++++||||.+...
T Consensus       414 ~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             hhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence              0001112334568999999999999999999999999987644

>KOG0666|consensus

Probab=99.94  E-value=3.2e-27  Score=220.64  Aligned_cols=168  Identities=27%  Similarity=0.430  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC----CcEEEEecCCceeeccCCCcc-CCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRMNGKER-PLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~----g~lkL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~AP   75 (407)
                      +|...++.++.||+.|+.|||++=|+||||||.|||+..+    |.+||+|||+++.+...-... .....+.|.+|.||
T Consensus       129 lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  129 LPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             CCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecCh
Confidence            4667899999999999999999999999999999999987    899999999999886543322 34556789999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------HHHHHHHhhcccCCCCCC---------------
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTAD---------CIEYLEWKDNRHMQRSPW---------------  130 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~---------------  130 (407)
                      |.+.+. .|+.+.|+|+.|||+.||++-++-|.+....         +....++.-.+......|               
T Consensus       209 ELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~  288 (438)
T KOG0666|consen  209 ELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSD  288 (438)
T ss_pred             HHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHH
Confidence            999987 8899999999999999999988777432111         111111111111111111               


Q ss_pred             ------------------CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 ------------------DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 ------------------~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                        ..-++.+.+|+.+||..||-+|+|++++++|+||.+..
T Consensus       289 f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  289 FRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             hHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence                              11245589999999999999999999999999999863

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=6.5e-27  Score=222.41  Aligned_cols=160  Identities=33%  Similarity=0.568  Sum_probs=131.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc------------------cC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE------------------RP   62 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~------------------~~   62 (407)
                      +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........                  ..
T Consensus        99 l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (280)
T cd05581          99 LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR  178 (280)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccc
Confidence            578899999999999999999999999999999999999999999999998765433211                  12


Q ss_pred             CcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHH
Q psy11119         63 LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIR  142 (407)
Q Consensus        63 ~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~  142 (407)
                      .....++..|+|||++.....+.++|+||+|++++++++|+.||....... .+....   .........+++.+.++|.
T Consensus       179 ~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~li~  254 (280)
T cd05581         179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKIL---KLEYSFPPNFPPDAKDLIE  254 (280)
T ss_pred             cccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH---hcCCCCCCccCHHHHHHHH
Confidence            233467889999999988888999999999999999999999998776332 222211   1122233456889999999


Q ss_pred             HhccCCCCCCCCH----HHHHhCccc
Q psy11119        143 RILAPLPSTRLNI----EKIKSHRWY  164 (407)
Q Consensus       143 ~~L~~~P~~Rps~----~eil~hpwf  164 (407)
                      +||+.+|.+||++    +++++||||
T Consensus       255 ~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         255 KLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            9999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=1.3e-26  Score=226.06  Aligned_cols=160  Identities=23%  Similarity=0.372  Sum_probs=130.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....      ......|+..|+|||++. 
T Consensus       118 l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~  191 (313)
T cd06633         118 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILA  191 (313)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccc
Confidence            4678889999999999999999999999999999999999999999999875421      223457889999999984 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                        ...++.++|+||+||++|+|++|..||...............  ..+......++..+.+||.+||+.+|.+||++.+
T Consensus       192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~  269 (313)
T cd06633         192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE  269 (313)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence              346788999999999999999999999876544333322222  2222223456788999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      ++.||||+...
T Consensus       270 ~l~~~~~~~~~  280 (313)
T cd06633         270 LLRHDFVRRDR  280 (313)
T ss_pred             HhcCcccCCCc
Confidence            99999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.94  E-value=4.4e-27  Score=230.65  Aligned_cols=167  Identities=19%  Similarity=0.337  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-----CCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-----PLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~AP   75 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.++++||+.+......+...     ......++..|+||
T Consensus        98 ~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (328)
T cd08226          98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP  177 (328)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence            4678889999999999999999999999999999999999999999998654322211110     01112356779999


Q ss_pred             hhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc------------------------------
Q psy11119         76 EVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR------------------------------  123 (407)
Q Consensus        76 E~l~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~------------------------------  123 (407)
                      |++.+.  .++.++|+||+||++|+|++|..||.................                              
T Consensus       178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (328)
T cd08226         178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES  257 (328)
T ss_pred             hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccc
Confidence            999764  468899999999999999999999986554322211111000                              


Q ss_pred             -------------cCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        124 -------------HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       124 -------------~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                                   ....+....+++.+.+||++||..||++|||+.++++||||...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                         00011122356789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=2.6e-27  Score=258.57  Aligned_cols=162  Identities=17%  Similarity=0.198  Sum_probs=118.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-------------------CcEEEEecCCceeeccCCC--
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-------------------DTLKISDFGLATVFRMNGK--   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-------------------g~lkL~DFGla~~~~~~~~--   59 (407)
                      +++.++..|++||+.||.|||++||+||||||+||||+..                   +.+|++|||+++.......  
T Consensus        77 ~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~  156 (793)
T PLN00181         77 VDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR  156 (793)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence            5788999999999999999999999999999999999654                   4456666666543211000  


Q ss_pred             ------------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC
Q psy11119         60 ------------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR  127 (407)
Q Consensus        60 ------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  127 (407)
                                  .......+||+.|+|||++.+..++.++|||||||+||||++|..|+......   ...... ...+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~-~~~~-  231 (793)
T PLN00181        157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRH-RVLP-  231 (793)
T ss_pred             hhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHH-hhcC-
Confidence                        00011246899999999998888899999999999999999999887643211   111111 1111 


Q ss_pred             CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       128 ~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +.+....+...+++.+||.++|.+||++.++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        232 PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            1111124567899999999999999999999999999763

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=1.3e-26  Score=217.90  Aligned_cols=157  Identities=24%  Similarity=0.309  Sum_probs=122.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++................++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  170 (252)
T cd05084          91 LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY  170 (252)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC
Confidence            46788999999999999999999999999999999999999999999999875432111111111123456999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||..............   .........++..+.+|+.+||..+|++|||+.+++
T Consensus       171 ~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  247 (252)
T cd05084         171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ---GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVH  247 (252)
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc---CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999998 9999976654432222211   111223345788999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       248 ~  248 (252)
T cd05084         248 Q  248 (252)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=1.5e-26  Score=224.06  Aligned_cols=157  Identities=23%  Similarity=0.358  Sum_probs=126.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +..++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+.
T Consensus       135 ~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  214 (304)
T cd05101         135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR  214 (304)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence            55678899999999999999999999999999999999999999999999876433322222334567789999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++||||||+++|+|++ |..||...+....... .....  .......++.++.+||.+||..+|.+||++.++++
T Consensus       215 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         215 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGH--RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCC--cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            88999999999999999998 8899987665433222 22211  11223457899999999999999999999999987


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      .
T Consensus       292 ~  292 (304)
T cd05101         292 D  292 (304)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=1.4e-26  Score=222.58  Aligned_cols=157  Identities=22%  Similarity=0.313  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+
T Consensus       124 l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  203 (290)
T cd05045         124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD  203 (290)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence            35678899999999999999999999999999999999999999999999876533322212233456778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||.+........ ....  .........++.++.++|.+||+.+|.+||++.+++
T Consensus       204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-LLKT--GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhC--CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            888999999999999999999 999998766543222 1111  122223456789999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       281 ~  281 (290)
T cd05045         281 K  281 (290)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0665|consensus

Probab=99.94  E-value=3e-27  Score=221.74  Aligned_cols=172  Identities=27%  Similarity=0.356  Sum_probs=133.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +.+...+++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+.-   +.....+..+.|..|.|||++.+-
T Consensus       116 DH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e---~~~~~mtpyVvtRyyrapevil~~  192 (369)
T KOG0665|consen  116 DHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE---DTDFMMTPYVVTRYYRAPEVILGM  192 (369)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc---CcccccCchhheeeccCchheecc
Confidence            45678899999999999999999999999999999999999999999999753   233456777899999999999998


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-------------------------------cccCCCCCC
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-------------------------------NRHMQRSPW  130 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~  130 (407)
                      .+.+.+||||+||++.||++|..-|.+.+.-+...+....                               ....+...|
T Consensus       193 ~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f  272 (369)
T KOG0665|consen  193 GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLF  272 (369)
T ss_pred             CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccc
Confidence            8999999999999999999999988654433211111000                               000111111


Q ss_pred             C-------cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCCCCCCCC
Q psy11119        131 D-------RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP  176 (407)
Q Consensus       131 ~-------~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~~~~~~~  176 (407)
                      .       .-+..+++|+.+||..||++|.+++++++|||++-++..+.+..+
T Consensus       273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap  325 (369)
T KOG0665|consen  273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAP  325 (369)
T ss_pred             cccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCC
Confidence            1       112458899999999999999999999999999966555444443

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.94  E-value=1.9e-26  Score=224.25  Aligned_cols=159  Identities=24%  Similarity=0.373  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....      .....|++.|+|||.+.+
T Consensus       112 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~  185 (308)
T cd06634         112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILA  185 (308)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhh
Confidence            46788999999999999999999999999999999999999999999999876432      233468899999999853


Q ss_pred             ---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         81 ---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        81 ---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                         ...+.++|||||||++|+|++|..||.........+.....  .........++..+.+||++||..+|.+||++.+
T Consensus       186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  263 (308)
T cd06634         186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (308)
T ss_pred             cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc--CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence               45778999999999999999999999766544333322221  2222223457888999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++|||+...
T Consensus       264 ll~~~~~~~~  273 (308)
T cd06634         264 LLKHRFVLRE  273 (308)
T ss_pred             HhhCcccccc
Confidence            9999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=1.2e-26  Score=218.43  Aligned_cols=156  Identities=25%  Similarity=0.376  Sum_probs=127.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||++......+.  ......|++.|+|||++.+
T Consensus        97 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  174 (255)
T cd08219          97 FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWEN  174 (255)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHcc
Confidence            46788999999999999999999999999999999999999999999999976643222  2234568899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||...+...........  .. .+....++..+.+||.+||+.+|.+||++.+++.
T Consensus       175 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--SY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--CC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            88899999999999999999999999876654332222111  11 1223457889999999999999999999999986


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      -
T Consensus       252 ~  252 (255)
T cd08219         252 R  252 (255)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=220.02  Aligned_cols=161  Identities=27%  Similarity=0.411  Sum_probs=126.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......   ......++..|+|||++.+
T Consensus        96 ~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~  172 (283)
T cd07830          96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILLR  172 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccCceeeec
Confidence            4678899999999999999999999999999999999999999999999997654322   2234568889999998854


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-----------------C---------CCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-----------------Q---------RSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------~---------~~~~~~~  133 (407)
                      . .++.++|+||+|+++|+|++|..||...................                 .         .......
T Consensus       173 ~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd07830         173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA  252 (283)
T ss_pred             CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence            4 67889999999999999999999997665433222111000000                 0         0001123


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +.++.++|++||..+|++|||++|++.||||
T Consensus       253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         253 SPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            6789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=2.6e-26  Score=216.23  Aligned_cols=158  Identities=25%  Similarity=0.370  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..+...... .......++..|+|||.+.
T Consensus        94 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040          94 FLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             CcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhc
Confidence            467889999999999999999999999999999999999999999999999876432221 1112345778899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|+||+||++|+|++ |..||...+...........  .........++..+.+++.+||..+|++||++.++
T Consensus       174 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--GERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            8888999999999999999999 99999876655433322221  11122224578899999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       252 ~~  253 (257)
T cd05040         252 RE  253 (257)
T ss_pred             HH
Confidence            76

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=1.7e-26  Score=218.91  Aligned_cols=158  Identities=22%  Similarity=0.314  Sum_probs=126.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+.............+++.|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  182 (266)
T cd05033         103 FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY  182 (266)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc
Confidence            46788999999999999999999999999999999999999999999999987642222111222345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||||+++|+|++ |..||............ ..  ....+....++..+.+++.+||+.+|++||++.+++
T Consensus       183 ~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~  259 (266)
T cd05033         183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-ED--GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIV  259 (266)
T ss_pred             CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-Hc--CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            888999999999999999998 99999766544322222 11  112223356789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       260 ~~  261 (266)
T cd05033         260 ST  261 (266)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=251.49  Aligned_cols=163  Identities=25%  Similarity=0.371  Sum_probs=130.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCcEEEec-----------------CCcEEEEecCCceeecc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-------GIAHRDLKPENVLLDL-----------------QDTLKISDFGLATVFRM   56 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-------gIvHrDLkp~NILld~-----------------~g~lkL~DFGla~~~~~   56 (407)
                      |++..++.|+.||+.||.|||+.       +|+||||||+||||+.                 .+.+||+|||++..+..
T Consensus       115 L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~  194 (1021)
T PTZ00266        115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI  194 (1021)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc
Confidence            57889999999999999999995       4999999999999964                 23489999999976532


Q ss_pred             CCCccCCcCccCCCCCCchhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCC
Q psy11119         57 NGKERPLDKKCGTLPYVAPEVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLD  134 (407)
Q Consensus        57 ~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  134 (407)
                      .   ......+||+.|+|||++.+.  .++.++|||||||+||+|++|..||...............   .+..+....+
T Consensus       195 ~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~---~p~lpi~~~S  268 (1021)
T PTZ00266        195 E---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR---GPDLPIKGKS  268 (1021)
T ss_pred             c---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc---CCCCCcCCCC
Confidence            2   122345799999999998653  5789999999999999999999999765543322222222   1222334578


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .++.+||..||..+|.+||++.+++.|+|+....+
T Consensus       269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        269 KELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            99999999999999999999999999999986543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.1e-26  Score=214.35  Aligned_cols=158  Identities=35%  Similarity=0.572  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+
T Consensus        90 l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~  167 (250)
T cd05123          90 FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLG  167 (250)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCC
Confidence            4788899999999999999999999999999999999999999999999987654322  12344568889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH---HH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI---EK  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~---~e  157 (407)
                      ...+.++|+||+|+++|+|++|..||........ ......   ........++..+.++|++||..+|.+||++   ++
T Consensus       168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~  243 (250)
T cd05123         168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEKILK---DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEE  243 (250)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhc---CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHH
Confidence            8888999999999999999999999976654322 222111   2222334568899999999999999999999   99


Q ss_pred             HHhCccc
Q psy11119        158 IKSHRWY  164 (407)
Q Consensus       158 il~hpwf  164 (407)
                      +++||||
T Consensus       244 l~~~~~f  250 (250)
T cd05123         244 IKAHPFF  250 (250)
T ss_pred             HHhCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=2.3e-26  Score=217.29  Aligned_cols=158  Identities=28%  Similarity=0.420  Sum_probs=126.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+....  .......+++.|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~  180 (267)
T cd08224         103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE  180 (267)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhcc
Confidence            4678899999999999999999999999999999999999999999999987654322  12234568899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+||++|+|++|..||......................+...++..+.++|.+||..+|.+|||+.+|++
T Consensus       181 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            88899999999999999999999999765433222222222122222233367889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=2.5e-26  Score=223.82  Aligned_cols=158  Identities=23%  Similarity=0.373  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       131 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (314)
T cd05099         131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD  210 (314)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence            35677889999999999999999999999999999999999999999999976532221111222334567999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||............ .. .. .......++.++.++|.+||..+|.+||++.+++
T Consensus       211 ~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll  287 (314)
T cd05099         211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL-RE-GH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV  287 (314)
T ss_pred             CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc-CC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            888999999999999999999 89999876554322222 11 11 1122345788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       288 ~~  289 (314)
T cd05099         288 EA  289 (314)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=2.3e-26  Score=217.64  Aligned_cols=158  Identities=23%  Similarity=0.341  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......... .......+++.|+|||.+.
T Consensus        92 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05115          92 ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN  171 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc
Confidence            478899999999999999999999999999999999999999999999998765332221 1112223457899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...++.++|+|||||++|+|++ |..||............ .....  .......++++.++|.+||..+|++||++.+|
T Consensus       172 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            8888999999999999999996 99999876654332222 11111  12234568899999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      .+.
T Consensus       249 ~~~  251 (257)
T cd05115         249 EER  251 (257)
T ss_pred             HHH
Confidence            763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=2.9e-26  Score=217.20  Aligned_cols=157  Identities=22%  Similarity=0.315  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+
T Consensus       101 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  179 (263)
T cd05052         101 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAY  179 (263)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhcc
Confidence            467788999999999999999999999999999999999999999999998765432211 1112234667999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||........ ......  .........++.++.++|.+||..+|++||++.+++
T Consensus       180 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~  256 (263)
T cd05052         180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEK--GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIH  256 (263)
T ss_pred             CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHC--CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            888999999999999999998 9999987655432 222222  122233356789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       257 ~~  258 (263)
T cd05052         257 QA  258 (263)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=2.1e-26  Score=222.48  Aligned_cols=155  Identities=23%  Similarity=0.316  Sum_probs=123.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   ........+..|+|||++.+
T Consensus       116 l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  192 (297)
T cd05089         116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNY  192 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhcc
Confidence            356788999999999999999999999999999999999999999999998632111   01111233557999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.......... ....  .........++..+.+||.+||..+|.+||++++++
T Consensus       193 ~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  269 (297)
T cd05089         193 SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-KLPQ--GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQIS  269 (297)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999997 999998766543222 2211  112223345789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       270 ~~  271 (297)
T cd05089         270 VQ  271 (297)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=1.5e-26  Score=224.49  Aligned_cols=158  Identities=23%  Similarity=0.355  Sum_probs=125.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+
T Consensus       137 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (307)
T cd05098         137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  216 (307)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence            35678899999999999999999999999999999999999999999999876532211111122234578999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||.......... .... . ........++.++.+||.+||..+|.+||++.+++
T Consensus       217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl  293 (307)
T cd05098         217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKE-G-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  293 (307)
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHHc-C-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            888999999999999999998 899998765543222 2222 1 12223345788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       294 ~~  295 (307)
T cd05098         294 ED  295 (307)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=2.3e-26  Score=217.20  Aligned_cols=155  Identities=22%  Similarity=0.339  Sum_probs=125.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+.
T Consensus       101 ~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~  179 (261)
T cd05072         101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG  179 (261)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccC
Confidence            5677889999999999999999999999999999999999999999999987543221 112233456789999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|+||+||++|+|++ |..||............ ..  ....+....++.++.++|.+||..+|++||+++++.+
T Consensus       180 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QR--GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-Hc--CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            88899999999999999998 99999876554332222 11  1222334567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.94  E-value=3.2e-26  Score=214.76  Aligned_cols=157  Identities=30%  Similarity=0.430  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......    ......+++.|+|||.+.+
T Consensus       100 ~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~  175 (256)
T cd08530         100 IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKG  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCC
Confidence            467788999999999999999999999999999999999999999999998765432    2233568899999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||...+........  ....... ....++.++.++|.+||..+|.+||++.+++.
T Consensus       176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--QRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCCCCC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            88889999999999999999999999877654332222  1122221 22367889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||++
T Consensus       253 ~p~~  256 (256)
T cd08530         253 SPAV  256 (256)
T ss_pred             CCCC
Confidence            9974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.5e-26  Score=215.75  Aligned_cols=157  Identities=22%  Similarity=0.332  Sum_probs=125.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-CCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-PLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05060          92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN  171 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhc
Confidence            4678899999999999999999999999999999999999999999999998764332211 111122356799999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|+|||||++|+|++ |..||...+......  ..... ...+....++..+.++|.+||.++|.+||++.++
T Consensus       172 ~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA--MLESG-ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH--HHHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            8888999999999999999998 999998766543222  12211 1223335678899999999999999999999998


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       249 ~~  250 (257)
T cd05060         249 ES  250 (257)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=2.6e-26  Score=216.50  Aligned_cols=152  Identities=22%  Similarity=0.339  Sum_probs=123.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......     .....++..|+|||++.+
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  173 (256)
T cd05082          99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE  173 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-----CCCCccceeecCHHHHcc
Confidence            367788999999999999999999999999999999999999999999998754321     123345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............ ..  .........+++.+.++|.+||..+|++|||+.+++
T Consensus       174 ~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  250 (256)
T cd05082         174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EK--GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLR  250 (256)
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hc--CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            888899999999999999998 99999876554322221 11  112223356789999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       251 ~  251 (256)
T cd05082         251 E  251 (256)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=2.6e-26  Score=222.71  Aligned_cols=158  Identities=24%  Similarity=0.352  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+|+||||+||+++.++.++++|||++..+.............+++.|+|||.+.+
T Consensus       138 l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  217 (302)
T cd05055         138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN  217 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc
Confidence            46788999999999999999999999999999999999999999999999876543322111223346788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... . .........++++.+++.+||+++|++|||+.+++
T Consensus       218 ~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell  295 (302)
T cd05055         218 CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-G-YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV  295 (302)
T ss_pred             CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-C-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            888999999999999999998 99999876544322222222 1 11222345688999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       296 ~  296 (302)
T cd05055         296 Q  296 (302)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=3.6e-26  Score=219.12  Aligned_cols=163  Identities=21%  Similarity=0.382  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......    .....+|+..|+|||++.
T Consensus       100 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~  175 (284)
T cd06620         100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHc
Confidence            4678889999999999999997 59999999999999999999999999998654222    122457899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH---------HH-HHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADC---------IE-YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                      +..++.++|+||+||++|+|++|..||.......         .. ...... ......+...++.++.+||.+||.+||
T Consensus       176 ~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp  254 (284)
T cd06620         176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSDFPEDLRDFVDACLLKDP  254 (284)
T ss_pred             cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCCchhcCHHHHHHHHHHhcCCc
Confidence            8888899999999999999999999998544310         00 011111 111111223377889999999999999


Q ss_pred             CCCCCHHHHHhCcccccCC
Q psy11119        150 STRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       150 ~~Rps~~eil~hpwf~~~~  168 (407)
                      .+|||+.++++|+||.+..
T Consensus       255 ~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         255 TERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             ccCcCHHHHhcCccccccc
Confidence            9999999999999997754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=4.5e-26  Score=222.49  Aligned_cols=161  Identities=24%  Similarity=0.379  Sum_probs=131.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....      .....|++.|+|||.+. 
T Consensus       122 l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~  195 (317)
T cd06635         122 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILA  195 (317)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhc
Confidence            46788899999999999999999999999999999999999999999998865321      23456889999999984 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                        .+.++.++|+||+||++|+|++|..||...............  .........+++.+.++|.+||+.+|.+||++.+
T Consensus       196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  273 (317)
T cd06635         196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEE  273 (317)
T ss_pred             CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc--cCCCCCCccccHHHHHHHHHHccCCcccCcCHHH
Confidence              346788999999999999999999999776544333332222  1122223456788999999999999999999999


Q ss_pred             HHhCcccccCCC
Q psy11119        158 IKSHRWYSKHMP  169 (407)
Q Consensus       158 il~hpwf~~~~~  169 (407)
                      +++|+|+....+
T Consensus       274 il~~~~~~~~~~  285 (317)
T cd06635         274 LLKHMFVLRERP  285 (317)
T ss_pred             HHhChhhhccCc
Confidence            999999977544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0671|consensus

Probab=99.94  E-value=3.2e-27  Score=226.05  Aligned_cols=163  Identities=29%  Similarity=0.439  Sum_probs=124.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--------------------CCcEEEEecCCceeeccCCCc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--------------------QDTLKISDFGLATVFRMNGKE   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--------------------~g~lkL~DFGla~~~~~~~~~   60 (407)
                      +|-+.++.+.+||+++++|||+.+++|-||||+|||+..                    +-.++|+|||.|+.-..    
T Consensus       189 fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----  264 (415)
T KOG0671|consen  189 FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----  264 (415)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc----
Confidence            456789999999999999999999999999999999842                    23589999999986321    


Q ss_pred             cCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH-HHHHh-h-----------------
Q psy11119         61 RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE-YLEWK-D-----------------  121 (407)
Q Consensus        61 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~-~-----------------  121 (407)
                       ..+..+.|..|.|||++.+-+++.++||||+||||+|+++|...|......+.. ..+.. +                 
T Consensus       265 -~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~  343 (415)
T KOG0671|consen  265 -HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFR  343 (415)
T ss_pred             -CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhh
Confidence             225667899999999999999999999999999999999999999765422211 10000 0                 


Q ss_pred             cccCCC----------------CCC-------CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        122 NRHMQR----------------SPW-------DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       122 ~~~~~~----------------~~~-------~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ......                .+.       ...-.++.+||++||..||.+|+|+.|++.||||....
T Consensus       344 ~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  344 RGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            000000                000       00113578999999999999999999999999998753

>KOG2345|consensus

Probab=99.94  E-value=3.2e-27  Score=214.71  Aligned_cols=159  Identities=29%  Similarity=0.418  Sum_probs=124.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-------CCcCccCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-------PLDKKCGTLP   71 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-------~~~~~~gt~~   71 (407)
                      ++|.++..||.+|++||++||+..  ++||||||.|||+...+.+++.|||.++.....-...       .......|..
T Consensus       124 ~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~p  203 (302)
T KOG2345|consen  124 VSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIP  203 (302)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCc
Confidence            589999999999999999999998  9999999999999999999999999987643221110       1122356899


Q ss_pred             CCchhhhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         72 YVAPEVLVRS---YLAEPADIWSCGIILVAMLAGELPWDKPTA--DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        72 Y~APE~l~~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      |.|||.+.-+   ..++++|||||||+||+|+.|..||+....  ....+.  ........+.-..+|+.+.++|+.||.
T Consensus       204 yRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--v~n~q~s~P~~~~yse~l~~lik~mlq  281 (302)
T KOG2345|consen  204 YRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--VQNAQISIPNSSRYSEALHQLIKSMLQ  281 (302)
T ss_pred             ccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--eeccccccCCCCCccHHHHHHHHHHhc
Confidence            9999998644   678999999999999999999999973211  001111  111233334445589999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .||.+||++.+++.+
T Consensus       282 vdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  282 VDPNQRPTIPELLSK  296 (302)
T ss_pred             CCcccCCCHHHHHHH
Confidence            999999999999874

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.1e-26  Score=217.12  Aligned_cols=161  Identities=25%  Similarity=0.425  Sum_probs=129.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++....... ........|+..|+|||.+.
T Consensus       103 l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (264)
T cd06653         103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS  182 (264)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhc
Confidence            46788899999999999999999999999999999999999999999999976532211 11223456889999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +...+.++|+||+||++|+|++|+.||............ .. .......+..+++++.++|.+||. +|..||++.+++
T Consensus       183 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~-~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~  259 (264)
T cd06653         183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI-AT-QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL  259 (264)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH-Hc-CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence            888889999999999999999999999876543322221 11 122222345688999999999999 579999999999


Q ss_pred             hCccc
Q psy11119        160 SHRWY  164 (407)
Q Consensus       160 ~hpwf  164 (407)
                      .|||.
T Consensus       260 ~~~~~  264 (264)
T cd06653         260 RHPFV  264 (264)
T ss_pred             cCCCC
Confidence            99984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.3e-26  Score=215.98  Aligned_cols=157  Identities=20%  Similarity=0.335  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+
T Consensus        97 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~  175 (256)
T cd05059          97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDY  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccCCCCCCccccCHHHhcc
Confidence            46788899999999999999999999999999999999999999999999876432211 11112224457999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |..||.......... ....  ..........+.++.+++.+||..+|++|||+.+++
T Consensus       176 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l  252 (256)
T cd05059         176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-SVSA--GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL  252 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-HHHc--CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            888999999999999999999 899998665443222 2221  111222345789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       253 ~~  254 (256)
T cd05059         253 SQ  254 (256)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=3e-26  Score=219.40  Aligned_cols=160  Identities=24%  Similarity=0.303  Sum_probs=123.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-CCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-PLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.
T Consensus       104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            5788999999999999999999999999999999999999999999999988654322111 112234566799999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh------------cccCCCCCCCcCCHHHHHHHHHhccC
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD------------NRHMQRSPWDRLDVNCLSLIRRILAP  147 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~------------~~~~~~~~~~~~s~~~~~LI~~~L~~  147 (407)
                      +..++.++||||||+++|+|++|..||...............            ......+....++.++.+++.+||++
T Consensus       184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  263 (283)
T cd05080         184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET  263 (283)
T ss_pred             ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            888899999999999999999999998754322111110000            00111112345688999999999999


Q ss_pred             CCCCCCCHHHHHh
Q psy11119        148 LPSTRLNIEKIKS  160 (407)
Q Consensus       148 ~P~~Rps~~eil~  160 (407)
                      +|++|||++++++
T Consensus       264 ~p~~Rps~~~i~~  276 (283)
T cd05080         264 EAKFRPTFRSLIP  276 (283)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=4.9e-26  Score=215.08  Aligned_cols=156  Identities=21%  Similarity=0.305  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+..... .......++..|+|||.+.+
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  177 (260)
T cd05070          99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhc
Confidence            46778999999999999999999999999999999999999999999999986543221 11122335667999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||||+++|+|++ |..||...+....... ...  ....+.....+..+.+|+.+||.++|.+|||++++.
T Consensus       178 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VER--GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHc--CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            888999999999999999999 9999987654432222 111  112223345788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       255 ~  255 (260)
T cd05070         255 S  255 (260)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=4.3e-26  Score=215.25  Aligned_cols=158  Identities=27%  Similarity=0.377  Sum_probs=127.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~  179 (260)
T cd08222         103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKH  179 (260)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHcc
Confidence            467889999999999999999999999999999999974 679999999987653322  22234568899999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||............ .. . ........++.++.++|.+||..+|++||++.++++
T Consensus       180 ~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~-~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VE-G-PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-Hc-C-CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            77888999999999999999999999765543222221 11 1 111223457889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       257 ~~~~  260 (260)
T cd08222         257 NPFI  260 (260)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=3.4e-26  Score=226.09  Aligned_cols=159  Identities=24%  Similarity=0.338  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  255 (343)
T cd05103         176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  255 (343)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence            35677889999999999999999999999999999999999999999999876532222112223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||.....................  ....++++.+++.+||+.+|.+||++.+|+
T Consensus       256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~cl~~~p~~Rps~~eil  333 (343)
T cd05103         256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELV  333 (343)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999997 99999765433222222222112111  233678899999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       334 ~~  335 (343)
T cd05103         334 EH  335 (343)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=3e-26  Score=218.89  Aligned_cols=157  Identities=20%  Similarity=0.297  Sum_probs=125.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.+.............++..|+|||++.+
T Consensus       114 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  193 (280)
T cd05043         114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN  193 (280)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence            46788999999999999999999999999999999999999999999999976533222112223346778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|++++ |..||...+.... .......  ........+++++.+++.+||..+|++|||+.+++
T Consensus       194 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  270 (280)
T cd05043         194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYLKDG--YRLAQPINCPDELFAVMACCWALDPEERPSFSQLV  270 (280)
T ss_pred             CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-HHHHHcC--CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            888999999999999999999 9999987654332 2222221  12222345788999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       271 ~  271 (280)
T cd05043         271 Q  271 (280)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=2.4e-26  Score=222.94  Aligned_cols=155  Identities=23%  Similarity=0.329  Sum_probs=123.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   .......++..|+|||.+.+
T Consensus       121 l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  197 (303)
T cd05088         121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNY  197 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhc
Confidence            467789999999999999999999999999999999999999999999998632111   11112234667999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||...+.... +.....  ......+..+++++.+||.+||+.+|.+||++.+++
T Consensus       198 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  274 (303)
T cd05088         198 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  274 (303)
T ss_pred             cCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-HHHHhc--CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999998 9999986654432 222111  111222345788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       275 ~~  276 (303)
T cd05088         275 VS  276 (303)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1989|consensus

Probab=99.94  E-value=5e-27  Score=244.94  Aligned_cols=159  Identities=28%  Similarity=0.374  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-------cCCcCccCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-------RPLDKKCGTLP   71 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-------~~~~~~~gt~~   71 (407)
                      |+|.++.+||.|+++||++||...  |||||||-|||||+.+|+.||||||.|+-.......       ...-....|+.
T Consensus       141 lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~  220 (738)
T KOG1989|consen  141 LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQ  220 (738)
T ss_pred             CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcc
Confidence            689999999999999999999998  999999999999999999999999998753222110       00112357999


Q ss_pred             CCchhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         72 YVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        72 Y~APE~l~---~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      |+|||++.   +...++|+|||+|||+||-|+....||+....-.      .....+..++...++..+.+||+.||.+|
T Consensus       221 YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~n  294 (738)
T KOG1989|consen  221 YRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ILNGNYSFPPFPNYSDRLKDLIRTMLQPN  294 (738)
T ss_pred             ccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------EEeccccCCCCccHHHHHHHHHHHHhccC
Confidence            99999984   4589999999999999999999999998763221      12245666676789999999999999999


Q ss_pred             CCCCCCHHHHHhCcccc
Q psy11119        149 PSTRLNIEKIKSHRWYS  165 (407)
Q Consensus       149 P~~Rps~~eil~hpwf~  165 (407)
                      |.+||++.|++.+-+-.
T Consensus       295 P~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  295 PDERPNIYQVLEEIFEL  311 (738)
T ss_pred             cccCCCHHHHHHHHHHH
Confidence            99999999998765443

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=4.3e-26  Score=215.50  Aligned_cols=157  Identities=20%  Similarity=0.305  Sum_probs=124.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||+.|++|+||||.||+++.++.+||+|||.++....... .......++..|+|||.+.+
T Consensus        97 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~  175 (256)
T cd05113          97 FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLY  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhc
Confidence            46788999999999999999999999999999999999999999999999876532211 11112335677999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||...+........... ..  .......+..+.+++.+||..+|.+||++.+|+
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll  252 (256)
T cd05113         176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LR--LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL  252 (256)
T ss_pred             CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CC--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            888899999999999999998 99999876654322222111 11  112234678999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       253 ~~  254 (256)
T cd05113         253 SS  254 (256)
T ss_pred             Hh
Confidence            75

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=5.7e-26  Score=214.81  Aligned_cols=156  Identities=22%  Similarity=0.311  Sum_probs=125.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~  177 (260)
T cd05069          99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhcc
Confidence            35678899999999999999999999999999999999999999999999976533221 11222345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ...+.++|+||+|+++|+|++ |..||.......... ....  ....+.+..++..+.+++++||.++|.+||++++++
T Consensus       178 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  254 (260)
T cd05069         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QVER--GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQ  254 (260)
T ss_pred             CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHc--CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            888999999999999999999 999998765543222 2222  122223346788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       255 ~  255 (260)
T cd05069         255 S  255 (260)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=4e-26  Score=216.90  Aligned_cols=156  Identities=19%  Similarity=0.248  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++|++||||||+||+++.++.+|++|||.+........ .......++..|+|||++.+
T Consensus       104 l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  182 (266)
T cd05064         104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQY  182 (266)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhh
Confidence            47888999999999999999999999999999999999999999999998764321111 11112345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|++++ |..||........... ... . ...+.+..++..+.+++.+||+.+|.+||++.+|+
T Consensus       183 ~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~-~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~  259 (266)
T cd05064         183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VED-G-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIH  259 (266)
T ss_pred             CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHC-C-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence            888999999999999999775 9999987665432222 122 1 12233456789999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       260 ~  260 (266)
T cd05064         260 S  260 (266)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.94  E-value=5.4e-26  Score=215.48  Aligned_cols=157  Identities=22%  Similarity=0.332  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-----cEEEEecCCceeeccCCCccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP   75 (407)
                      +++.++..++.||+.||.|||+.|++|+||||+||+++.++     .++|+|||++................++..|+||
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence            35678889999999999999999999999999999999887     8999999998765332222222233557889999


Q ss_pred             hhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         76 EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        76 E~l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      |++.+..++.++|||||||++|+|++ |..||...+.......  .... ........++..+.++|.+||.++|.+||+
T Consensus       183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  259 (269)
T cd05044         183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH--VTAG-GRLQKPENCPDKIYQLMTNCWAQDPSERPT  259 (269)
T ss_pred             HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH--HhcC-CccCCcccchHHHHHHHHHHcCCCcccCCC
Confidence            99988888999999999999999998 9999986654332211  1111 122233557889999999999999999999


Q ss_pred             HHHHHh
Q psy11119        155 IEKIKS  160 (407)
Q Consensus       155 ~~eil~  160 (407)
                      +.++++
T Consensus       260 ~~~i~~  265 (269)
T cd05044         260 FDRIQE  265 (269)
T ss_pred             HHHHHH
Confidence            999876

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=6.1e-26  Score=214.54  Aligned_cols=156  Identities=22%  Similarity=0.334  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........ .......+..|+|||++.+
T Consensus       100 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  178 (261)
T cd05068         100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALY  178 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCcccccc
Confidence            467889999999999999999999999999999999999999999999999876422111 1111223457999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||||+++|+|++ |+.||...+....... ....  ...+....++..+.+++.+||+.+|.+||++.+++
T Consensus       179 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~  255 (261)
T cd05068         179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-VDQG--YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQ  255 (261)
T ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcC--CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            888999999999999999999 9999987665432222 2221  12222345788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       256 ~  256 (261)
T cd05068         256 W  256 (261)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=4.6e-26  Score=220.88  Aligned_cols=158  Identities=20%  Similarity=0.338  Sum_probs=126.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+
T Consensus       106 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (303)
T cd05110         106 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY  185 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc
Confidence            46778899999999999999999999999999999999999999999999986543322222233456778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.+........  ..... ...+.+...+..+.+++.+||..+|++||++++++
T Consensus       186 ~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~  262 (303)
T cd05110         186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD--LLEKG-ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELA  262 (303)
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999997 999998765432222  12211 12222345678999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       263 ~~  264 (303)
T cd05110         263 AE  264 (303)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=6.1e-26  Score=218.98  Aligned_cols=159  Identities=20%  Similarity=0.299  Sum_probs=123.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++.+.............+++.|+|||+..+.
T Consensus       128 ~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  207 (296)
T cd05095         128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG  207 (296)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence            46689999999999999999999999999999999999999999999998765332221222233456789999998888


Q ss_pred             CCCCcchhhhHHHHHHHHHh--CCCCCCCCChhHHHHHH---Hhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         82 YLAEPADIWSCGIILVAMLA--GELPWDKPTADCIEYLE---WKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt--G~~Pf~~~~~~~~~~~~---~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .++.++|+|||||++|+|++  |..||............   .... .....+....+++.+.+|+.+||..||.+||++
T Consensus       208 ~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         208 KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            88999999999999999998  78899765443322111   0010 111122234577899999999999999999999


Q ss_pred             HHHHh
Q psy11119        156 EKIKS  160 (407)
Q Consensus       156 ~eil~  160 (407)
                      .+|.+
T Consensus       288 ~~i~~  292 (296)
T cd05095         288 QEIHA  292 (296)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0662|consensus

Probab=99.94  E-value=2e-26  Score=200.69  Aligned_cols=165  Identities=27%  Similarity=0.473  Sum_probs=136.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+.+.++.++.|++.||.|||++++.||||||+|+||+.+|.+|++|||+++.+...  .+-....+.|.+|.+|.++.+
T Consensus        98 ~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfg  175 (292)
T KOG0662|consen   98 LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_pred             CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeee
Confidence            467889999999999999999999999999999999999999999999999876432  223445678999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCc-------------------------C
Q psy11119         81 S-YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDR-------------------------L  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~  133 (407)
                      . -|+...|+||.|||+.|+.. |++.|.+.+.++....++...+......|+.                         +
T Consensus       176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l  255 (292)
T KOG0662|consen  176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL  255 (292)
T ss_pred             eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence            6 78899999999999999987 8888888887766655554433333333322                         2


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +..-++|++++|.-+|.+|+++++.++||||...
T Consensus       256 ns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  256 NSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            3456899999999999999999999999999864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=7.3e-26  Score=214.66  Aligned_cols=156  Identities=21%  Similarity=0.296  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+..+..... .......++..|+|||++.+
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~  177 (262)
T cd05071          99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY  177 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhcc
Confidence            36778899999999999999999999999999999999999999999999976543221 11223346678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||............ ..  ....+....++..+.++|.+|++++|++||++++++
T Consensus       178 ~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~  254 (262)
T cd05071         178 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ  254 (262)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hc--CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            888999999999999999999 89999876554332222 11  111222345788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       255 ~  255 (262)
T cd05071         255 A  255 (262)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=5e-26  Score=229.82  Aligned_cols=158  Identities=25%  Similarity=0.393  Sum_probs=127.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       234 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  313 (400)
T cd05105         234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD  313 (400)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence            46778899999999999999999999999999999999999999999999986543322222234457788999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.........+.......  .......++.++.++|.+||+.+|++||++.++.
T Consensus       314 ~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  391 (400)
T cd05105         314 NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS  391 (400)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence            888999999999999999997 9999986554333333322221  1222346788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       392 ~  392 (400)
T cd05105         392 D  392 (400)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=6e-26  Score=213.99  Aligned_cols=156  Identities=18%  Similarity=0.317  Sum_probs=123.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....... .......++..|+|||++.+
T Consensus        97 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd05114          97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNF  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhccc
Confidence            46788999999999999999999999999999999999999999999999875432211 11122335668999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |+.||...+........ ......  ......+..+.+++.+||..+|.+||++++++
T Consensus       176 ~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i-~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~  252 (256)
T cd05114         176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-SRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELL  252 (256)
T ss_pred             CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            888999999999999999999 99999876654332222 221111  11234678899999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       253 ~  253 (256)
T cd05114         253 R  253 (256)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=5.1e-26  Score=223.67  Aligned_cols=158  Identities=23%  Similarity=0.347  Sum_probs=125.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +..++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||++.+.
T Consensus       132 ~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  211 (334)
T cd05100         132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR  211 (334)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC
Confidence            45677889999999999999999999999999999999999999999999765432222222233445779999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|||||||++|+|++ |..||...+........ ...  ........++.++.++|.+||+.+|.+||++.++++
T Consensus       212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEG--HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcC--CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            88999999999999999998 89999876654332222 221  112223457889999999999999999999999998


Q ss_pred             Cc
Q psy11119        161 HR  162 (407)
Q Consensus       161 hp  162 (407)
                      +-
T Consensus       289 ~l  290 (334)
T cd05100         289 DL  290 (334)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=6.4e-26  Score=214.00  Aligned_cols=155  Identities=21%  Similarity=0.329  Sum_probs=125.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ......+++.|+|||.+.+
T Consensus       101 ~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~  178 (261)
T cd05148         101 LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASH  178 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHcc
Confidence            45778899999999999999999999999999999999999999999999876532211  1223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||||+++|+|++ |..||.......... ....  ....+....+++.+.++|.+||..+|.+|||+.+++
T Consensus       179 ~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~  255 (261)
T cd05148         179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD-QITA--GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR  255 (261)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHHh--CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            888999999999999999998 899998765433222 2222  112223356789999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       256 ~  256 (261)
T cd05148         256 E  256 (261)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=4.7e-26  Score=216.35  Aligned_cols=158  Identities=22%  Similarity=0.358  Sum_probs=125.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...............+++.|++||.+..
T Consensus       110 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05074         110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD  189 (273)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence            36678899999999999999999999999999999999999999999999886533222112223345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||...+.... +.........  ......+..+.+++.+||+.+|.+||++.+++
T Consensus       190 ~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~  266 (273)
T cd05074         190 NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-YNYLIKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR  266 (273)
T ss_pred             CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-HHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999999 8999986654332 2222221111  11234678999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       267 ~~  268 (273)
T cd05074         267 DQ  268 (273)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=6.6e-26  Score=214.04  Aligned_cols=157  Identities=24%  Similarity=0.289  Sum_probs=121.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~   79 (407)
                      ++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++........  .......+++.|+|||.+.
T Consensus        96 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (262)
T cd05058          96 TVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ  175 (262)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence            45667889999999999999999999999999999999999999999998754322110  1112334577899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|||||||++|+|++ |.+||...........  ..... .......++..+.+++.+||..+|++||++.++
T Consensus       176 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  252 (262)
T cd05058         176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY--LLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL  252 (262)
T ss_pred             cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            8888999999999999999999 5667765544322221  11111 112223468899999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      ++.
T Consensus       253 l~~  255 (262)
T cd05058         253 VSR  255 (262)
T ss_pred             HHH
Confidence            874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=6.4e-26  Score=215.36  Aligned_cols=159  Identities=19%  Similarity=0.261  Sum_probs=119.7

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc-
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR-   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-   80 (407)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................+++.|+|||++.. 
T Consensus        98 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05042          98 QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR  177 (269)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence            4567889999999999999999999999999999999999999999999865322211111233346778999999753 


Q ss_pred             ------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcc-cCCC-CCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         81 ------SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR-HMQR-SPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        81 ------~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                            ..++.++||||+||++|+|++ |..||................. .... .....++..+.+++..|+ .+|++
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~  256 (269)
T cd05042         178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPET  256 (269)
T ss_pred             cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCccc
Confidence                  356789999999999999999 8899987654433222222211 1111 122457888899999998 59999


Q ss_pred             CCCHHHHHhC
Q psy11119        152 RLNIEKIKSH  161 (407)
Q Consensus       152 Rps~~eil~h  161 (407)
                      |||+++|++-
T Consensus       257 Rpt~~~v~~~  266 (269)
T cd05042         257 RPTAEEVHEL  266 (269)
T ss_pred             ccCHHHHHHH
Confidence            9999999763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=5.1e-26  Score=217.33  Aligned_cols=162  Identities=26%  Similarity=0.420  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+....  .......++..|+|||.+..
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  175 (277)
T cd06641          98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhcc
Confidence            4678899999999999999999999999999999999999999999999987654321  12233568889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+||++|+|++|..||............ .. .. .......++.++.++|.+||..+|.+||++.+++.
T Consensus       176 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PK-NN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hc-CC-CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            78889999999999999999999999865543222211 11 11 11122457889999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||.+.
T Consensus       253 ~~~~~~~  259 (277)
T cd06641         253 HKFIVRF  259 (277)
T ss_pred             CHHHhhh
Confidence            9999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.3e-26  Score=212.39  Aligned_cols=158  Identities=23%  Similarity=0.288  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................++..|+|||.+.+
T Consensus        90 ~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  169 (251)
T cd05041          90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY  169 (251)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence            35678889999999999999999999999999999999999999999999875432211111122334567999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||............ ..  .........++.++.++|.+||..+|.+||++.+++
T Consensus       170 ~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell  246 (251)
T cd05041         170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ES--GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY  246 (251)
T ss_pred             CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hc--CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            888999999999999999999 89999776644322222 11  112223356788999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       247 ~~  248 (251)
T cd05041         247 NE  248 (251)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.2e-26  Score=218.40  Aligned_cols=159  Identities=22%  Similarity=0.293  Sum_probs=123.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+.
T Consensus       127 ~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  206 (295)
T cd05097         127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG  206 (295)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence            46678899999999999999999999999999999999999999999998765333222222334457789999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHH---hhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         82 YLAEPADIWSCGIILVAMLA--GELPWDKPTADCIEYLEW---KDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~---~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .++.++|+|||||++|+|++  |..||...+.........   ... ..........+++.+.+||.+||..+|.+||++
T Consensus       207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            88999999999999999988  678887665433221111   110 111112233468899999999999999999999


Q ss_pred             HHHHh
Q psy11119        156 EKIKS  160 (407)
Q Consensus       156 ~eil~  160 (407)
                      ++|++
T Consensus       287 ~~i~~  291 (295)
T cd05097         287 NKIHH  291 (295)
T ss_pred             HHHHH
Confidence            99965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=6.2e-26  Score=215.94  Aligned_cols=154  Identities=23%  Similarity=0.309  Sum_probs=121.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......   ........++.|+|||++..
T Consensus       109 l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~  185 (270)
T cd05047         109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNY  185 (270)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHcc
Confidence            357788999999999999999999999999999999999999999999998532111   11112234567999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||...+..... .....  .........++.++.+|+.+||..+|.+|||+.+++
T Consensus       186 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  262 (270)
T cd05047         186 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  262 (270)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HHHhC--CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence            888999999999999999997 99999766543322 21111  112222345788999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       263 ~  263 (270)
T cd05047         263 V  263 (270)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0584|consensus

Probab=99.94  E-value=1.5e-26  Score=233.38  Aligned_cols=159  Identities=26%  Similarity=0.448  Sum_probs=133.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +...++.|++||++||.|||++.  |+|||||-+||+|+.+ |.+||+|+|+|+..+..    .....+|||.|||||+.
T Consensus       141 n~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~aksvIGTPEFMAPEmY  216 (632)
T KOG0584|consen  141 NIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----HAKSVIGTPEFMAPEMY  216 (632)
T ss_pred             CHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----ccceeccCccccChHHH
Confidence            45678999999999999999995  9999999999999865 89999999999986533    22346899999999998


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      . ..|.+.+||||||+++.||+|+..||..-......|++......+.... .--+++++++|.+||.. .++|+|+.|+
T Consensus       217 E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~-kV~dPevr~fIekCl~~-~~~R~sa~eL  293 (632)
T KOG0584|consen  217 E-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS-KVKDPEVREFIEKCLAT-KSERLSAKEL  293 (632)
T ss_pred             h-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh-ccCCHHHHHHHHHHhcC-chhccCHHHH
Confidence            7 5668999999999999999999999998877777777765533222111 12268899999999999 9999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      |.||||...
T Consensus       294 L~d~Ff~~d  302 (632)
T KOG0584|consen  294 LKDPFFDED  302 (632)
T ss_pred             hhChhhccc
Confidence            999999875

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=8.3e-26  Score=216.90  Aligned_cols=157  Identities=23%  Similarity=0.398  Sum_probs=123.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++|++||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       127 l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (288)
T cd05050         127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY  206 (288)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence            35677899999999999999999999999999999999999999999999875432221111222345677999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||........... ... ... .+....++.++.+||.+||+.+|.+|||+.|++
T Consensus       207 ~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~-~~~-~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~  283 (288)
T cd05050         207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY-VRD-GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN  283 (288)
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hhc-CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            888999999999999999998 8889976655432222 121 111 112235788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       284 ~  284 (288)
T cd05050         284 R  284 (288)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1035|consensus

Probab=99.93  E-value=3e-26  Score=244.40  Aligned_cols=159  Identities=33%  Similarity=0.555  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeec----------------cCCCccCCcCc
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR----------------MNGKERPLDKK   66 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~----------------~~~~~~~~~~~   66 (407)
                      -.+++++|+||++||.|+|++|||||||||.||++|+++++||+|||+|+...                .+......+..
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~  775 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ  775 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence            35789999999999999999999999999999999999999999999998721                11122356778


Q ss_pred             cCCCCCCchhhhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC--CCCcCCHHHHHHH
Q psy11119         67 CGTLPYVAPEVLVRS---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS--PWDRLDVNCLSLI  141 (407)
Q Consensus        67 ~gt~~Y~APE~l~~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~LI  141 (407)
                      +||.-|+|||++.+.   .|+.|+|+||||+||+||+.   ||...-.........+ ....+.+  -+..--+.-..+|
T Consensus       776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLI  851 (1351)
T ss_pred             cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHH
Confidence            999999999999865   48999999999999999984   5654332221122222 2223322  1222234567899


Q ss_pred             HHhccCCCCCCCCHHHHHhCcccc
Q psy11119        142 RRILAPLPSTRLNIEKIKSHRWYS  165 (407)
Q Consensus       142 ~~~L~~~P~~Rps~~eil~hpwf~  165 (407)
                      ++||+.||++|||+.|++++.||-
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhhccCCC
Confidence            999999999999999999999997

>KOG0197|consensus

Probab=99.93  E-value=4.1e-26  Score=227.09  Aligned_cols=155  Identities=25%  Similarity=0.372  Sum_probs=125.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      .-.+...++.||++|++||+++++|||||...|||+++++.+||+|||+|+....+ ........--...|.|||.+...
T Consensus       301 ~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~  379 (468)
T KOG0197|consen  301 NLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYG  379 (468)
T ss_pred             chHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhC
Confidence            44677899999999999999999999999999999999999999999999943322 22222222334569999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.+||||||||+||||+| |+.||.+.+..+...... .  ....+.+..+|+++.+++..||+.+|++|||++.+..
T Consensus       380 ~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~--GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  380 KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-R--GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-c--cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            99999999999999999999 999999887654333222 2  2233344679999999999999999999999986644

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=6.3e-26  Score=215.38  Aligned_cols=150  Identities=23%  Similarity=0.314  Sum_probs=118.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc-------EEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-------LKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~-------lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||++.....      .....++..|+
T Consensus       102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~  175 (262)
T cd05077         102 LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWI  175 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------ccccccccccc
Confidence            467888999999999999999999999999999999987664       89999999865421      12345788999


Q ss_pred             chhhhhc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         74 APEVLVR-SYLAEPADIWSCGIILVAML-AGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        74 APE~l~~-~~~~~~sDiwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                      |||++.. ..++.++||||+||++|+|+ +|..||.........  ......   .......+.++.+||.+||+.+|.+
T Consensus       176 aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~  250 (262)
T cd05077         176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--RFYEGQ---CMLVTPSCKELADLMTHCMNYDPNQ  250 (262)
T ss_pred             ChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--HHHhcC---ccCCCCChHHHHHHHHHHcCCChhh
Confidence            9999874 57889999999999999998 589998765543221  111111   1112234678999999999999999


Q ss_pred             CCCHHHHHhC
Q psy11119        152 RLNIEKIKSH  161 (407)
Q Consensus       152 Rps~~eil~h  161 (407)
                      ||++.+|+++
T Consensus       251 Rp~~~~il~~  260 (262)
T cd05077         251 RPFFRAIMRD  260 (262)
T ss_pred             CcCHHHHHHh
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.2e-25  Score=207.46  Aligned_cols=161  Identities=36%  Similarity=0.583  Sum_probs=131.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+.......   ......++..|++||.+..
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~  160 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLG  160 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHcc
Confidence            3678889999999999999999999999999999999999999999999998764332   3345568889999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ...+.++|+||+|+++|+|++|..||.......................+..++.++.+++.+||..+|++||++.++++
T Consensus       161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            77888999999999999999999999873332222222222222222222227889999999999999999999999999


Q ss_pred             Cccc
Q psy11119        161 HRWY  164 (407)
Q Consensus       161 hpwf  164 (407)
                      ||||
T Consensus       241 ~~~~  244 (244)
T smart00220      241 HPFF  244 (244)
T ss_pred             CCCC
Confidence            9997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=1.4e-25  Score=210.46  Aligned_cols=156  Identities=24%  Similarity=0.349  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........... ....+++.|+|||.+.+
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~  178 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKD  178 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhcc
Confidence            46888999999999999999999999999999999999999999999999987643321111 12236789999999987


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |..||...+........... ..  ......++.++.+++.+||..+|.+|||+.+++
T Consensus       179 ~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll  255 (258)
T smart00219      179 GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YR--LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELV  255 (258)
T ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CC--CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence            788999999999999999998 89999876544332222111 11  122244789999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       256 ~  256 (258)
T smart00219      256 E  256 (258)
T ss_pred             h
Confidence            6

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=1.3e-25  Score=213.43  Aligned_cols=157  Identities=22%  Similarity=0.326  Sum_probs=125.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++........ .......+++.|+|||.+..
T Consensus       104 ~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  182 (270)
T cd05056         104 LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINF  182 (270)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhcc
Confidence            46788899999999999999999999999999999999999999999999876543311 11123345568999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+|||||++|+|++ |..||.......... ......  ..+.+..++..+.++|.+|+..+|.+|||+.+++
T Consensus       183 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~  259 (270)
T cd05056         183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGE--RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK  259 (270)
T ss_pred             CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999996 999998766543222 222211  2233456789999999999999999999999987


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       260 ~~  261 (270)
T cd05056         260 AQ  261 (270)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=1.3e-25  Score=212.11  Aligned_cols=156  Identities=23%  Similarity=0.359  Sum_probs=125.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .......++..|+|||++..
T Consensus        99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~  177 (260)
T cd05067          99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhcc
Confidence            46778899999999999999999999999999999999999999999999876542211 11123345678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |+.||...+...... ....  ....+.....+.++.++|.+||+.+|++||++++++
T Consensus       178 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05067         178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLER--GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLR  254 (260)
T ss_pred             CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHc--CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            888899999999999999999 999998765443222 2222  112233355788999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       255 ~  255 (260)
T cd05067         255 S  255 (260)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.5e-25  Score=214.21  Aligned_cols=157  Identities=21%  Similarity=0.359  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...............++..|+|||.+..
T Consensus       106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05057         106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH  185 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc
Confidence            46888999999999999999999999999999999999999999999999987543222111222234568999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|++++ |..||............ .....  .+.....+..+.+++.+||..+|..||++.+++
T Consensus       186 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EKGER--LPQPPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            888999999999999999998 99999887655433222 22111  222234678899999999999999999999986


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       263 ~  263 (279)
T cd05057         263 N  263 (279)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=2.1e-25  Score=209.14  Aligned_cols=157  Identities=24%  Similarity=0.326  Sum_probs=124.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+++.|+|||++..
T Consensus        90 ~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  168 (250)
T cd05085          90 LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNY  168 (250)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhcc
Confidence            4678889999999999999999999999999999999999999999999987533221 111122345677999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|++++ |..||............ ..  .........++..+.+++.+||+.+|++||++.+++
T Consensus       169 ~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  245 (250)
T cd05085         169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EK--GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ  245 (250)
T ss_pred             CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-Hc--CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            888999999999999999998 99999876554332222 11  111122345789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       246 ~~  247 (250)
T cd05085         246 KE  247 (250)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=1.7e-25  Score=210.61  Aligned_cols=153  Identities=26%  Similarity=0.442  Sum_probs=124.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......     ......+..|+|||.+.+
T Consensus        97 ~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~  171 (254)
T cd05083          97 VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKH  171 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhcc
Confidence            367788999999999999999999999999999999999999999999998754221     122234567999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||............. .  .........+++.+.++|.+||+.+|.+||++++++
T Consensus       172 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  248 (254)
T cd05083         172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-K--GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLR  248 (254)
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-C--CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888899999999999999998 999998776543332221 1  122223456789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ..
T Consensus       249 ~~  250 (254)
T cd05083         249 EK  250 (254)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=1.8e-25  Score=211.98  Aligned_cols=157  Identities=20%  Similarity=0.332  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccC-CcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~-~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........... ......++.|+|||++.
T Consensus       104 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh
Confidence            46788999999999999999999999999999999999999999999999876543221111 11122345799999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|+||+||++|+|++ |..||............ ..  ....+....++..+.+++.+||..+|.+||++.+|
T Consensus       184 ~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-~~--~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-ND--GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hc--CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            8888999999999999999998 99999766543322222 22  12222334578899999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       261 ~~  262 (268)
T cd05063         261 VN  262 (268)
T ss_pred             HH
Confidence            76

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=2e-25  Score=212.07  Aligned_cols=158  Identities=19%  Similarity=0.281  Sum_probs=119.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+.
T Consensus        98 ~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05087          98 DPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV  177 (269)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence            34567789999999999999999999999999999999999999999998653322211222345678889999998643


Q ss_pred             -------CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhc-ccCCCC-CCCcCCHHHHHHHHHhccCCCCC
Q psy11119         82 -------YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN-RHMQRS-PWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        82 -------~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~-~~~~~~-~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                             .++.++|+||+||++|+|++ |..||................ .....+ .....+..+.+++.+|+ .+|.+
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~  256 (269)
T cd05087         178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQ  256 (269)
T ss_pred             cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCccc
Confidence                   35789999999999999996 999998765544332222221 111111 12246788999999998 68999


Q ss_pred             CCCHHHHHh
Q psy11119        152 RLNIEKIKS  160 (407)
Q Consensus       152 Rps~~eil~  160 (407)
                      |||+++|..
T Consensus       257 Rpt~~~l~~  265 (269)
T cd05087         257 RPSAEEVHL  265 (269)
T ss_pred             CCCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.3e-25  Score=215.25  Aligned_cols=160  Identities=23%  Similarity=0.333  Sum_probs=123.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.+...... .......++..|+|||++.
T Consensus       106 ~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            467889999999999999999999999999999999999999999999999865433221 1122345677899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH-------------HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADC-------------IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +..++.++|+||+||++|+|+++..|+..+....             ........ .....+.+..++..+.+||.+||+
T Consensus       186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  264 (284)
T cd05079         186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKCWE  264 (284)
T ss_pred             cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHcc
Confidence            8888899999999999999999877653321110             00001111 111223345688999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .+|.+||++.+++++
T Consensus       265 ~~p~~Rpt~~~il~~  279 (284)
T cd05079         265 FQPSKRTTFQNLIEG  279 (284)
T ss_pred             CCcccCcCHHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=7e-26  Score=214.86  Aligned_cols=157  Identities=27%  Similarity=0.417  Sum_probs=123.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+...++.||+.||.|||+++++|+||++.||+++.++.+||+|||++................+...|+|||.+..
T Consensus       100 ~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  179 (259)
T PF07714_consen  100 LSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD  179 (259)
T ss_dssp             SBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            46788999999999999999999999999999999999999999999999987532222222334456778999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||||+++|||++ |..||...+........ .....  ......++..+.++|.+||+.+|.+||++.+|+
T Consensus       180 ~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~  256 (259)
T PF07714_consen  180 GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL  256 (259)
T ss_dssp             SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccc-ccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999999 78999877655433332 22222  223345789999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       257 ~  257 (259)
T PF07714_consen  257 Q  257 (259)
T ss_dssp             H
T ss_pred             h
Confidence            5

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=1.4e-25  Score=220.36  Aligned_cols=163  Identities=27%  Similarity=0.434  Sum_probs=127.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||++||.|||++||+||||+|.||+++.++.++|+|||.+.....     ......+++.|+|||.+.+
T Consensus       105 ~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         105 LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeec
Confidence            35677889999999999999999999999999999999999999999999875321     1233467889999999866


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH-----------------------hhcc-cCCC---CCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW-----------------------KDNR-HMQR---SPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~-----------------------~~~~-~~~~---~~~~~  132 (407)
                       ..++.++|+||+||++|+|++|..||.............                       .... ....   .....
T Consensus       180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (328)
T cd07856         180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN  259 (328)
T ss_pred             cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence             478899999999999999999999997654321100000                       0000 0000   01134


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++.+.++|++||..+|++||++++++.||||....
T Consensus       260 ~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         260 ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            678999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0577|consensus

Probab=99.93  E-value=5.1e-26  Score=227.11  Aligned_cols=162  Identities=25%  Similarity=0.403  Sum_probs=140.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |.|.++.-++.+.+.||+|||+.+.||||||..|||+++.|.+||+|||.|....      +.++++|||.|||||++..
T Consensus       123 lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILA  196 (948)
T KOG0577|consen  123 LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILA  196 (948)
T ss_pred             chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHhee
Confidence            4577889999999999999999999999999999999999999999999997653      4467899999999999863


Q ss_pred             ---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         81 ---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        81 ---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                         +.|+-++||||||+++.||.-.++|+-..+.....|.+..+....  ..-+.++..++.|+..||.+-|.+|||.++
T Consensus       197 MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~~F~~Fvd~CLqKipqeRptse~  274 (948)
T KOG0577|consen  197 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYFRNFVDSCLQKIPQERPTSEE  274 (948)
T ss_pred             ccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence               478889999999999999999999998888887788776654322  223456889999999999999999999999


Q ss_pred             HHhCcccccCCCC
Q psy11119        158 IKSHRWYSKHMPN  170 (407)
Q Consensus       158 il~hpwf~~~~~~  170 (407)
                      +++|+|+.+..+.
T Consensus       275 ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  275 LLKHRFVLRERPP  287 (948)
T ss_pred             HhhcchhccCCCc
Confidence            9999999876543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.6e-25  Score=209.44  Aligned_cols=153  Identities=23%  Similarity=0.372  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......     ....++..|+|||.+..
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~  173 (256)
T cd05039          99 ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALRE  173 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcC
Confidence            4678899999999999999999999999999999999999999999999987652211     12344567999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |..||...+........ ..  .........+++.+.++|.+||..+|.+||++.+++
T Consensus       174 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~  250 (256)
T cd05039         174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EK--GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLR  250 (256)
T ss_pred             CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hc--CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            888899999999999999997 99999877654332222 11  111222345789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       251 ~~  252 (256)
T cd05039         251 EQ  252 (256)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=2e-25  Score=209.96  Aligned_cols=150  Identities=22%  Similarity=0.327  Sum_probs=119.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-------cEEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------TLKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-------~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||++.....      .....++..|+
T Consensus        98 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~  171 (259)
T cd05037          98 VSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWI  171 (259)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCcc
Confidence            46778899999999999999999999999999999999888       799999999876432      12345677899


Q ss_pred             chhhhhcC--CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         74 APEVLVRS--YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        74 APE~l~~~--~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      |||++...  .++.++|+||+||++|+|++ |..||........ ...+........    .....+.++|.+||..+|.
T Consensus       172 aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~  246 (259)
T cd05037         172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQDQHRLPM----PDCAELANLINQCWTYDPT  246 (259)
T ss_pred             ChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHhcCCCCCC----CCchHHHHHHHHHhccChh
Confidence            99999876  78899999999999999999 6888876643221 111221111111    1237899999999999999


Q ss_pred             CCCCHHHHHhC
Q psy11119        151 TRLNIEKIKSH  161 (407)
Q Consensus       151 ~Rps~~eil~h  161 (407)
                      +||++.++++.
T Consensus       247 ~Rpt~~~il~~  257 (259)
T cd05037         247 KRPSFRAILRD  257 (259)
T ss_pred             hCCCHHHHHHh
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=2.7e-25  Score=224.51  Aligned_cols=159  Identities=23%  Similarity=0.331  Sum_probs=127.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  315 (401)
T cd05107         236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN  315 (401)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence            46678899999999999999999999999999999999999999999999986533222122233467889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+||++|+|++ |..||.................  ....+..++.++.+||.+||..+|.+||++.+|+
T Consensus       316 ~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell  393 (401)
T cd05107         316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV  393 (401)
T ss_pred             CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            888999999999999999998 8999976554333222222211  1223345789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       394 ~~  395 (401)
T cd05107         394 HL  395 (401)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=2.2e-25  Score=211.74  Aligned_cols=158  Identities=20%  Similarity=0.340  Sum_probs=124.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCcc---CCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC---GTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~---gt~~Y~APE~   77 (407)
                      +++.+++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++................   .+..|+|||.
T Consensus       103 ~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (269)
T cd05065         103 FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA  182 (269)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhH
Confidence            4677889999999999999999999999999999999999999999999987654322211111111   2457999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++||||+||++|+|++ |..||............  . .....+....++..+.+++.+||..+|.+||++.
T Consensus       183 ~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i--~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI--E-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFG  259 (269)
T ss_pred             hccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH--H-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            988888999999999999999886 99999876544322221  1 1222333456788999999999999999999999


Q ss_pred             HHHhC
Q psy11119        157 KIKSH  161 (407)
Q Consensus       157 eil~h  161 (407)
                      +|+..
T Consensus       260 ~i~~~  264 (269)
T cd05065         260 QIVST  264 (269)
T ss_pred             HHHHH
Confidence            99763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.7e-25  Score=209.71  Aligned_cols=156  Identities=22%  Similarity=0.316  Sum_probs=124.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+..... .......++..|+|||.+.+
T Consensus       100 ~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~  178 (261)
T cd05034         100 LRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANY  178 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhcc
Confidence            46788899999999999999999999999999999999999999999999876543211 11112234568999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ...+.++|+||+||++|+|++ |+.||...+....... ...  ....+.....+.++.+++.+||..+|.+||+++++.
T Consensus       179 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ-VER--GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc--CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            888999999999999999999 9999977654432222 221  112222344688999999999999999999999987


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       256 ~  256 (261)
T cd05034         256 S  256 (261)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.93  E-value=2.9e-25  Score=208.93  Aligned_cols=157  Identities=18%  Similarity=0.303  Sum_probs=123.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+
T Consensus        97 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~  175 (256)
T cd05112          97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSF  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhcc
Confidence            46788999999999999999999999999999999999999999999999876532211 11122335678999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|+||+|+++|+|++ |..||............ ....  ........+..+.+|+.+||+.+|.+||++.+++
T Consensus       176 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l  252 (256)
T cd05112         176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGF--RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLL  252 (256)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-hCCC--CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence            888899999999999999998 99999876543322211 1111  1112234688999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       253 ~~  254 (256)
T cd05112         253 HQ  254 (256)
T ss_pred             Hh
Confidence            74

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=4.5e-25  Score=208.64  Aligned_cols=155  Identities=23%  Similarity=0.355  Sum_probs=124.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||.+..+..... .......++..|+|||++...
T Consensus       100 ~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~  178 (260)
T cd05073         100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG  178 (260)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccC
Confidence            5677889999999999999999999999999999999999999999999876543221 111223456779999999888


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|+||+||++|++++ |..||............ ..  ....+....++.++.+++.+||+++|++||++.++++
T Consensus       179 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hC--CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            88999999999999999999 99999876544332221 11  2222334567889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.93  E-value=1.9e-25  Score=240.77  Aligned_cols=157  Identities=29%  Similarity=0.433  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC----------------ccCCcCc
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK----------------ERPLDKK   66 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~----------------~~~~~~~   66 (407)
                      ...+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||++........                .......
T Consensus       112 v~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~  191 (932)
T PRK13184        112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI  191 (932)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCC
Confidence            456788999999999999999999999999999999999999999999986521110                0011234


Q ss_pred             cCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         67 CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        67 ~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +||+.|+|||++.+..++.++||||+||++|+|++|..||............... ......++..+++.+.+++.+||.
T Consensus       192 vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~  270 (932)
T PRK13184        192 VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL-SPIEVAPYREIPPFLSQIAMKALA  270 (932)
T ss_pred             CCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhcc-ChhhccccccCCHHHHHHHHHHcc
Confidence            7999999999999888899999999999999999999999875543322221111 112223345788999999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .||++|++..+.+.
T Consensus       271 ~DP~kR~ss~eeLl  284 (932)
T PRK13184        271 VDPAERYSSVQELK  284 (932)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999987655544

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=5.4e-25  Score=209.35  Aligned_cols=158  Identities=19%  Similarity=0.304  Sum_probs=118.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++...............+++..|+|||++...
T Consensus        97 ~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (268)
T cd05086          97 QLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF  176 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence            34567889999999999999999999999999999999999999999987542221111222345788999999998532


Q ss_pred             -------CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcc-cCC-CCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         82 -------YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR-HMQ-RSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        82 -------~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~-~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                             .++.++||||+||++|+|++ |..||................. ... ......+++.+.+++..|+ .+|.+
T Consensus       177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~  255 (268)
T cd05086         177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEK  255 (268)
T ss_pred             cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCccc
Confidence                   34678999999999999997 5778876554332222222211 111 1122347888999999999 67999


Q ss_pred             CCCHHHHHh
Q psy11119        152 RLNIEKIKS  160 (407)
Q Consensus       152 Rps~~eil~  160 (407)
                      ||++++|++
T Consensus       256 Rp~~~~i~~  264 (268)
T cd05086         256 RATAEEVHR  264 (268)
T ss_pred             CCCHHHHHH
Confidence            999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=3.8e-25  Score=209.98  Aligned_cols=157  Identities=22%  Similarity=0.344  Sum_probs=124.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-CCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-PLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+....... ......++..|+|||.+.
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc
Confidence            4677889999999999999999999999999999999999999999999998654332111 111223456899999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|+||+||++|++++ |..||.......... .... . ...+....+++.+.+++.+||+++|.+||++.++
T Consensus       183 ~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (267)
T cd05066         183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK-AIEE-G-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI  259 (267)
T ss_pred             cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH-HHhC-C-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence            8888999999999999999887 999998765433222 1122 1 1222334578899999999999999999999998


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       260 ~~  261 (267)
T cd05066         260 VS  261 (267)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=4.2e-25  Score=209.53  Aligned_cols=156  Identities=27%  Similarity=0.432  Sum_probs=126.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.+.......   ......|+..|+|||.+.
T Consensus       110 ~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~  186 (269)
T cd08528         110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVK  186 (269)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhc
Confidence            4678899999999999999996 689999999999999999999999999997654322   334557899999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++|+||+|+++|+|++|..||............ .. ..........+++.+.++|.+||..||++||++.++.
T Consensus       187 ~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~  264 (269)
T cd08528         187 NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-VE-AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS  264 (269)
T ss_pred             CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH-hh-ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence            888899999999999999999999999876544322221 11 1122222235788999999999999999999999987


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       265 ~~  266 (269)
T cd08528         265 AM  266 (269)
T ss_pred             HH
Confidence            64

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=4.5e-25  Score=210.03  Aligned_cols=158  Identities=20%  Similarity=0.307  Sum_probs=125.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++...... .........+++.|+|||.+.+
T Consensus       114 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~  192 (275)
T cd05046         114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQE  192 (275)
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcc-cccccCCceeEEeecChhhhcc
Confidence            467889999999999999999999999999999999999999999999998643221 1112233456778999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ...+.++||||+|+++|+|++ |..||...........  .............++..+.++|.+||..+|.+||++.+++
T Consensus       193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l  270 (275)
T cd05046         193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR--LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV  270 (275)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH--HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            878899999999999999999 8899976544332222  2212222233346789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       271 ~~  272 (275)
T cd05046         271 SA  272 (275)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=4.6e-25  Score=208.52  Aligned_cols=150  Identities=22%  Similarity=0.295  Sum_probs=117.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc--------EEEEecCCceeeccCCCccCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--------LKISDFGLATVFRMNGKERPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~--------lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y   72 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++.....      .....+++.|
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y  170 (258)
T cd05078          97 INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPW  170 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCc
Confidence            467788899999999999999999999999999999987765        69999998765321      2234688899


Q ss_pred             CchhhhhcC-CCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         73 VAPEVLVRS-YLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        73 ~APE~l~~~-~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      +|||++.+. .++.++|+||+||++|+|++| ..||.......... .......    .....+.++.+||.+||+.+|.
T Consensus       171 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~li~~~l~~~p~  245 (258)
T cd05078         171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQ----LPAPKWTELANLINQCMDYEPD  245 (258)
T ss_pred             cCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcccc----CCCCCcHHHHHHHHHHhccChh
Confidence            999999864 678899999999999999998 56766544332211 1111111    1223567899999999999999


Q ss_pred             CCCCHHHHHhC
Q psy11119        151 TRLNIEKIKSH  161 (407)
Q Consensus       151 ~Rps~~eil~h  161 (407)
                      +|||+++|++.
T Consensus       246 ~Rps~~~il~~  256 (258)
T cd05078         246 FRPSFRAIIRD  256 (258)
T ss_pred             hCCCHHHHHHh
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=5.7e-25  Score=210.47  Aligned_cols=160  Identities=23%  Similarity=0.369  Sum_probs=121.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccC-CcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~-~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........... .....++..|+|||++.
T Consensus       105 l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (284)
T cd05081         105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT  184 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence            46788899999999999999999999999999999999999999999999986543222111 11122345699999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--------------HHHHhhcccCCCCCCCcCCHHHHHHHHHhc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--------------YLEWKDNRHMQRSPWDRLDVNCLSLIRRIL  145 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L  145 (407)
                      +..++.++|+||+||++|+|++|..|+.........              ...... .....+....++.++.+||.+||
T Consensus       185 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl  263 (284)
T cd05081         185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK-NNGRLPAPPGCPAEIYAIMKECW  263 (284)
T ss_pred             cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHc
Confidence            888899999999999999999998776543321110              000111 11122233557889999999999


Q ss_pred             cCCCCCCCCHHHHHhC
Q psy11119        146 APLPSTRLNIEKIKSH  161 (407)
Q Consensus       146 ~~~P~~Rps~~eil~h  161 (407)
                      ..+|++|||+.+|++.
T Consensus       264 ~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         264 NNDPSQRPSFSELALQ  279 (284)
T ss_pred             cCChhhCCCHHHHHHH
Confidence            9999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1006|consensus

Probab=99.92  E-value=2.6e-26  Score=210.60  Aligned_cols=163  Identities=23%  Similarity=0.350  Sum_probs=130.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      ++|...-++..-.+.||.||-.. .|+|||+||+|||+|..|.+||||||++..+...   ...+...|..+|||||.+.
T Consensus       164 ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~  240 (361)
T KOG1006|consen  164 IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERID  240 (361)
T ss_pred             CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccC
Confidence            46666777777788999999876 8999999999999999999999999998654322   2234457889999999996


Q ss_pred             cC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC----CCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         80 RS--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR----SPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        80 ~~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      ..  .|..++|+||||++|||+.||..||...+........... +.++.    ..-..++..+..+|..||.+|-+.||
T Consensus       241 p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~-gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp  319 (361)
T KOG1006|consen  241 PSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI-GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP  319 (361)
T ss_pred             CccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc-CCCCeecCcccccccCHHHHHHHHHHhhcccccCc
Confidence            54  6889999999999999999999999877654333332222 22221    11234788999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      .+.+++++||++..
T Consensus       320 ky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  320 KYDDLKKFPFYRMY  333 (361)
T ss_pred             chhhhhcCchhhhh
Confidence            99999999999875

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=5.6e-25  Score=209.76  Aligned_cols=159  Identities=25%  Similarity=0.362  Sum_probs=123.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus       106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            467788999999999999999999999999999999999999999999999875422111 1111234456799999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH-------------HHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI-------------EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      ...++.++|+||+|+++|+|++|..|+........             ....... .....+....++.++.+++.+||.
T Consensus       186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~  264 (284)
T cd05038         186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWE  264 (284)
T ss_pred             cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhc
Confidence            88889999999999999999999999875433211             0111111 112222334567899999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      ++|.+||++.+|++
T Consensus       265 ~~p~~Rpt~~ei~~  278 (284)
T cd05038         265 AEPQDRPSFADLIL  278 (284)
T ss_pred             cChhhCCCHHHHHH
Confidence            99999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.4e-25  Score=224.81  Aligned_cols=165  Identities=27%  Similarity=0.362  Sum_probs=123.7

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+++.|+|||.+...
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCC
Confidence            456788999999999999999999999999999999999999999999997543221 1111223458999999998542


Q ss_pred             C----------------------CCCcchhhhHHHHHHHHHhCCC-CCCCCChhHHHH-------HHHh--hcccCCCCC
Q psy11119         82 Y----------------------LAEPADIWSCGIILVAMLAGEL-PWDKPTADCIEY-------LEWK--DNRHMQRSP  129 (407)
Q Consensus        82 ~----------------------~~~~sDiwSlGviL~elltG~~-Pf~~~~~~~~~~-------~~~~--~~~~~~~~~  129 (407)
                      .                      ...+.|+||+||++|+|++|.+ ||.....-..+.       ..|.  .......+.
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~  465 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL  465 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccc
Confidence            1                      1134799999999999999886 775322111111       1111  112344556


Q ss_pred             CCcCCHHHHHHHHHhccCCC---CCCCCHHHHHhCcccccC
Q psy11119        130 WDRLDVNCLSLIRRILAPLP---STRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       130 ~~~~s~~~~~LI~~~L~~~P---~~Rps~~eil~hpwf~~~  167 (407)
                      +...++.+++|+.+||..+|   .+|+|++|+++||||...
T Consensus       466 ~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        466 LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            77789999999999999866   689999999999999753

>KOG0574|consensus

Probab=99.92  E-value=1.8e-26  Score=214.73  Aligned_cols=165  Identities=24%  Similarity=0.353  Sum_probs=138.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+...  ....++..|||.|||||++..
T Consensus       126 L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~E  203 (502)
T KOG0574|consen  126 LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEE  203 (502)
T ss_pred             ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHH
Confidence            678999999999999999999999999999999999999999999999999765422  223467899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      -.|..++||||||+...||.-|++||.+.......+.+-.. .......+...+.++-++|++||.++|++|-|+-++++
T Consensus       204 IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  204 IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            89999999999999999999999999876544322222111 22223334557889999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      |||++...
T Consensus       283 H~FiknA~  290 (502)
T KOG0574|consen  283 HTFIKNAP  290 (502)
T ss_pred             hhhhcCCC
Confidence            99998753

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.7e-24  Score=206.94  Aligned_cols=150  Identities=24%  Similarity=0.366  Sum_probs=117.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-------cEEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------TLKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-------~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++..+       .+|++|||++.....      .....++..|+
T Consensus       114 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~  187 (274)
T cd05076         114 VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWI  187 (274)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCccc
Confidence            46788899999999999999999999999999999998654       389999998754321      12235788899


Q ss_pred             chhhhhc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         74 APEVLVR-SYLAEPADIWSCGIILVAML-AGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        74 APE~l~~-~~~~~~sDiwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                      |||.+.+ ..++.++|+||+||++|+|+ +|..||........... .......    ....++++.++|.+||+.+|++
T Consensus       188 aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~li~~cl~~~p~~  262 (274)
T cd05076         188 APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEKKHRL----PEPSCKELATLISQCLTYEPTQ  262 (274)
T ss_pred             CchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHhccCC----CCCCChHHHHHHHHHcccChhh
Confidence            9999876 46789999999999999985 69999987654332111 1111111    1234678999999999999999


Q ss_pred             CCCHHHHHhC
Q psy11119        152 RLNIEKIKSH  161 (407)
Q Consensus       152 Rps~~eil~h  161 (407)
                      |||+.+|+++
T Consensus       263 Rps~~~il~~  272 (274)
T cd05076         263 RPSFRTILRD  272 (274)
T ss_pred             CcCHHHHHHh
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.91  E-value=2.2e-24  Score=231.01  Aligned_cols=100  Identities=24%  Similarity=0.391  Sum_probs=81.0

Q ss_pred             cCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         67 CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        67 ~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +||+.|+|||++.+..++.++||||+||+||||++|..||.+.................... ...++..+.+++.+||.
T Consensus       541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~-~~~~~~~~~~~l~~lL~  619 (669)
T cd05610         541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEG-EEKLSVNAQNAIEILLT  619 (669)
T ss_pred             eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcc-cccCCHHHHHHHHHHcc
Confidence            46899999999998888999999999999999999999998776554433333222222211 23578889999999999


Q ss_pred             CCCCCCCCHHHHHhCcccccC
Q psy11119        147 PLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       147 ~~P~~Rps~~eil~hpwf~~~  167 (407)
                      .+|.+||++.++++||||...
T Consensus       620 ~dP~~R~ta~e~l~h~~~~~~  640 (669)
T cd05610         620 MDPTKRAGLKELKQHPLFHGV  640 (669)
T ss_pred             cChhHCcCHHHHHhCHhhcCC
Confidence            999999999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1027|consensus

Probab=99.91  E-value=3.5e-25  Score=228.95  Aligned_cols=159  Identities=29%  Similarity=0.421  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CC--cEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhh
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QD--TLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g--~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l   78 (407)
                      ..+....|+++||++||+.+|+||||||+||||+.   ++  .++|+|||+++.+..+... .......||-.|+|||++
T Consensus       607 ~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  607 DPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             cHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence            45788999999999999999999999999999986   34  5899999999987655432 225567899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      .....+.++||+|+||++|+.++| ..||.+....+  ..+........... .....++.+||.+|++++|..||++.+
T Consensus       687 ~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RPsa~~  763 (903)
T KOG1027|consen  687 REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRPSATD  763 (903)
T ss_pred             hccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCCCHHH
Confidence            988778899999999999999995 99998765432  22222222111111 011128999999999999999999999


Q ss_pred             HHhCccccc
Q psy11119        158 IKSHRWYSK  166 (407)
Q Consensus       158 il~hpwf~~  166 (407)
                      ++.||+|-.
T Consensus       764 VL~HPlFW~  772 (903)
T KOG1027|consen  764 VLNHPLFWD  772 (903)
T ss_pred             HhCCCccCC
Confidence            999999965

>KOG1151|consensus

Probab=99.91  E-value=8.8e-25  Score=212.19  Aligned_cols=171  Identities=26%  Similarity=0.456  Sum_probs=139.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCcEEEe---cCCcEEEEecCCceeeccCCCc-----cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK--GIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~--gIvHrDLkp~NILld---~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~   70 (407)
                      |+|.+|+.|+.||+.||.||.+.  -|+|.||||.|||+-   ..|.+||+|||+++++......     .......||.
T Consensus       565 mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTY  644 (775)
T KOG1151|consen  565 MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTY  644 (775)
T ss_pred             hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCcee
Confidence            68999999999999999999987  499999999999995   3478999999999987654322     2345668999


Q ss_pred             CCCchhhhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--HHHHHHhhcccCCCCCCCcCCHHHHHHHHHh
Q psy11119         71 PYVAPEVLVRS----YLAEPADIWSCGIILVAMLAGELPWDKPTADC--IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRI  144 (407)
Q Consensus        71 ~Y~APE~l~~~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~  144 (407)
                      +|++||.+.-+    ..+.++||||+|||+|.++.|+.||.......  ..+..+........++-+.++.+++++|++|
T Consensus       645 WYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRC  724 (775)
T KOG1151|consen  645 WYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRC  724 (775)
T ss_pred             eecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHH
Confidence            99999998633    57789999999999999999999998654322  2222233334556666677999999999999


Q ss_pred             ccCCCCCCCCHHHHHhCcccccCCCCC
Q psy11119        145 LAPLPSTRLNIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       145 L~~~P~~Rps~~eil~hpwf~~~~~~~  171 (407)
                      |++..++|..+.++..||||.-+....
T Consensus       725 LaYRKeDR~DV~qLA~dpyllPh~rrs  751 (775)
T KOG1151|consen  725 LAYRKEDRIDVQQLACDPYLLPHIRRS  751 (775)
T ss_pred             HHhhhhhhhhHHHHccCccccchhhhc
Confidence            999999999999999999998765443

>KOG0590|consensus

Probab=99.90  E-value=1.3e-24  Score=228.18  Aligned_cols=168  Identities=37%  Similarity=0.627  Sum_probs=142.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l   78 (407)
                      |...++..+++||+.||.|+|+.||.||||||+|++++.+|.+||+|||.+..+......  ......+|+.+|+|||++
T Consensus       417 ~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~  496 (601)
T KOG0590|consen  417 LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVL  496 (601)
T ss_pred             cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence            456789999999999999999999999999999999999999999999999988776665  566788999999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH-----HHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY-----LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      .+. +.....||||+|+++..|.+|+.||..+...+..+     ..+..........+..++...+.+|.+||+++|.+|
T Consensus       497 ~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R  576 (601)
T KOG0590|consen  497 TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKR  576 (601)
T ss_pred             cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhe
Confidence            877 77778999999999999999999998665543321     122222233344566788899999999999999999


Q ss_pred             CCHHHHHhCcccccCC
Q psy11119        153 LNIEKIKSHRWYSKHM  168 (407)
Q Consensus       153 ps~~eil~hpwf~~~~  168 (407)
                      .|+++|++.+||+...
T Consensus       577 ~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  577 ITIEQILNDEWIRSIE  592 (601)
T ss_pred             ecHHHHhhChHhhhcc
Confidence            9999999999999753

>KOG0668|consensus

Probab=99.90  E-value=1.5e-23  Score=188.97  Aligned_cols=164  Identities=24%  Similarity=0.471  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |+.-+++.|+.||+.||.|||++||.|||+||.|++||.. -.++|+|+|+|..+..+.   ..+..+.+..|--||.+.
T Consensus       129 l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLV  205 (338)
T KOG0668|consen  129 LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLV  205 (338)
T ss_pred             hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchhee
Confidence            3456789999999999999999999999999999999965 569999999998765432   234556777789999987


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCC-CCChhHHHHHHHh-----------hc-------------ccCCCCCCC--
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWD-KPTADCIEYLEWK-----------DN-------------RHMQRSPWD--  131 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~-~~~~~~~~~~~~~-----------~~-------------~~~~~~~~~--  131 (407)
                      .- .+...-|+||+||+|..|+..+.||- +.+..+....+.+           ..             ......+|.  
T Consensus       206 dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~F  285 (338)
T KOG0668|consen  206 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRF  285 (338)
T ss_pred             echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHh
Confidence            64 78889999999999999999988873 2222211111100           00             011112221  


Q ss_pred             -------cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        132 -------RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       132 -------~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                             -.++++.+|+.++|..|-.+|+|+.|++.||||...
T Consensus       286 i~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  286 INSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                   246899999999999999999999999999999754

>KOG0670|consensus

Probab=99.90  E-value=1.5e-24  Score=214.12  Aligned_cols=160  Identities=24%  Similarity=0.425  Sum_probs=124.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ...++.|++||+.||..|-..||+|.||||+|||++++. .+||||||.|.....    ...+.+..+..|.|||++.+.
T Consensus       535 ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~  610 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE----NEITPYLVSRFYRAPEIILGL  610 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc----ccccHHHHHHhccCcceeecC
Confidence            457899999999999999999999999999999999765 489999999976432    233445567789999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHH--HHhhc--------cc-----CCC-------------------
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL--EWKDN--------RH-----MQR-------------------  127 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~--------~~-----~~~-------------------  127 (407)
                      .|....|+||.||+||||+||..-|.+.+.......  ..+..        ..     +..                   
T Consensus       611 ~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~  690 (752)
T KOG0670|consen  611 PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRT  690 (752)
T ss_pred             cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEE
Confidence            999999999999999999999999987765532211  11100        00     000                   


Q ss_pred             -----CC----------CCcCC-------HHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        128 -----SP----------WDRLD-------VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       128 -----~~----------~~~~s-------~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                           .|          ...++       ..+++|+.+||..||++|.|+.++|.||||..
T Consensus       691 vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  691 VMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             EecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                 00          00011       35889999999999999999999999999975

>KOG0664|consensus

Probab=99.90  E-value=6.1e-24  Score=195.68  Aligned_cols=166  Identities=26%  Similarity=0.448  Sum_probs=127.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+.+-+.-+.+||+.||.|||+.||.||||||.|+|+++|..+||||||+++..... .....+..+.|-.|.|||++.+
T Consensus       153 Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~~hMTqEVVTQYYRAPEiLMG  231 (449)
T KOG0664|consen  153 LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DRLNMTHEVVTQYYRAPELLMG  231 (449)
T ss_pred             CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hhhhhHHHHHHHHhccHHHhhc
Confidence            345667788999999999999999999999999999999999999999999875433 3344556677888999999988


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh---------------------cccCCCC---CC-----
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD---------------------NRHMQRS---PW-----  130 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~---------------------~~~~~~~---~~-----  130 (407)
                      . .|+.+.||||.|||+.||+..+..|...+.......+..-                     ......+   ..     
T Consensus       232 aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS  311 (449)
T KOG0664|consen  232 ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIAS  311 (449)
T ss_pred             chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecC
Confidence            6 8899999999999999999998888654433221111000                     0000001   00     


Q ss_pred             -CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        131 -DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       131 -~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                       ..-..+...++.+++.++|.+|.+.++.+.|++..+.
T Consensus       312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence             1223467889999999999999999999999998764

>KOG1026|consensus

Probab=99.90  E-value=1.4e-23  Score=218.58  Aligned_cols=157  Identities=22%  Similarity=0.338  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+..+...++.||+.|++||-++.+|||||-..|+||.++-.+||+|||+++..-.....+......-..+|||||.|..
T Consensus       600 L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly  679 (774)
T KOG1026|consen  600 LSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY  679 (774)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence            56778899999999999999999999999999999999999999999999987543333333323345678999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +.++++|||||+||+|||+++ |..||.+-..++.......  +.. .+.+...|.++.+|+..||+.+|.+||++.||-
T Consensus       680 ~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~--g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  680 GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA--GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc--CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            999999999999999999999 9999998776654443322  333 445577899999999999999999999999985


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       757 ~  757 (774)
T KOG1026|consen  757 S  757 (774)
T ss_pred             H
Confidence            4

>KOG1095|consensus

Probab=99.89  E-value=2.6e-23  Score=223.51  Aligned_cols=157  Identities=24%  Similarity=0.355  Sum_probs=129.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+..+...++.||++|+.||+++++|||||...|+||+....+||+|||+|+.+......+......-...|||||.+..
T Consensus       799 L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d  878 (1025)
T KOG1095|consen  799 LSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD  878 (1025)
T ss_pred             CCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh
Confidence            46778899999999999999999999999999999999999999999999995433322222111123457999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +.++.++|||||||+|||+++ |..||...+..+.... +....  ..+++..+++.+.+++..||+.+|++||++..|+
T Consensus       879 ~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~  955 (1025)
T KOG1095|consen  879 GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-VLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV  955 (1025)
T ss_pred             cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-HHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence            999999999999999999999 9999988776544332 33333  3444567899999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       956 ~  956 (1025)
T KOG1095|consen  956 E  956 (1025)
T ss_pred             h
Confidence            8

>KOG1187|consensus

Probab=99.89  E-value=3.6e-23  Score=205.60  Aligned_cols=159  Identities=28%  Similarity=0.458  Sum_probs=118.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCc-cCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG---IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-CGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g---IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~-~gt~~Y~APE   76 (407)
                      |++....+|+.+++.||+|||...   |+||||||+|||||++.+.||+|||+|+.....  ....... .||..|+|||
T Consensus       171 L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PE  248 (361)
T KOG1187|consen  171 LDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPE  248 (361)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChh
Confidence            578899999999999999999964   999999999999999999999999999654321  1122222 7999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhHHHHHHH-----hhc--ccCCCCCC--CcCC-----HHHHHHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT-ADCIEYLEW-----KDN--RHMQRSPW--DRLD-----VNCLSLI  141 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~-~~~~~~~~~-----~~~--~~~~~~~~--~~~s-----~~~~~LI  141 (407)
                      ++..+..+.++||||+||+|.||++|+.|.+... ........|     ...  .....+..  ...+     ..+..+.
T Consensus       249 y~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a  328 (361)
T KOG1187|consen  249 YASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELA  328 (361)
T ss_pred             hhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHH
Confidence            9998889999999999999999999999887532 111111111     110  11111111  2223     2255788


Q ss_pred             HHhccCCCCCCCCHHHHHhC
Q psy11119        142 RRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       142 ~~~L~~~P~~Rps~~eil~h  161 (407)
                      .+|+..+|..||++.++++.
T Consensus       329 ~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  329 LRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HHHcCcCCCcCcCHHHHHHH
Confidence            89999999999999998554

>KOG0984|consensus

Probab=99.88  E-value=5e-23  Score=183.03  Aligned_cols=118  Identities=26%  Similarity=0.472  Sum_probs=97.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +||...=+++.-++.||.|||++ .|+|||+||.||||+..|++|+||||.+..+.+.-   ..+-..|...|||||.+.
T Consensus       145 ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~  221 (282)
T KOG0984|consen  145 IPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERIN  221 (282)
T ss_pred             CchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcC
Confidence            47788889999999999999998 89999999999999999999999999998764321   122246888999999986


Q ss_pred             cC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q psy11119         80 RS----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD  121 (407)
Q Consensus        80 ~~----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  121 (407)
                      .+    .|+.++||||||+.++||.+++.||+..............
T Consensus       222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            43    7889999999999999999999999877655544444333

>KOG0587|consensus

Probab=99.87  E-value=2.2e-22  Score=209.32  Aligned_cols=164  Identities=23%  Similarity=0.310  Sum_probs=138.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.+||+|||++..+...  .....+.+|||.|||||++..
T Consensus       120 l~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac  197 (953)
T KOG0587|consen  120 LKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIAC  197 (953)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeec
Confidence            568888999999999999999999999999999999999999999999999876433  234567899999999999975


Q ss_pred             C-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 S-----YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~-----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .     .|...+|+||||++..||.-|.+|+-+.......+.+- .+.......|...+.++.++|..||.+|-.+||+.
T Consensus       198 ~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~  276 (953)
T KOG0587|consen  198 DESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST  276 (953)
T ss_pred             ccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CCCCccccchhhHHHHHHHHHHHHHhhccccCcch
Confidence            3     46778999999999999999999998877654443332 22333344467788999999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      .++++|||+++.
T Consensus       277 ~~ll~hpFi~e~  288 (953)
T KOG0587|consen  277 EELLKHPFITEQ  288 (953)
T ss_pred             hhhccCCccccc
Confidence            999999999854

>KOG4257|consensus

Probab=99.86  E-value=4.1e-22  Score=200.40  Aligned_cols=156  Identities=21%  Similarity=0.308  Sum_probs=124.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+......|+.||+.||.|||+..++||||-..|||+.+...+||+|||+++.+....... .+...-...|||||.+.-
T Consensus       488 L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINf  566 (974)
T KOG4257|consen  488 LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINF  566 (974)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh-ccccccceeecCccccch
Confidence            3455677899999999999999999999999999999999999999999999876543221 122223456999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||.|||++||++. |..||.+-...+......+   ....+.++.+++.+..|+.+||+.+|.+||++.+|.
T Consensus       567 RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn---GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  567 RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN---GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999988 9999987654433222211   122333467899999999999999999999988775


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      .
T Consensus       644 ~  644 (974)
T KOG4257|consen  644 A  644 (974)
T ss_pred             H
Confidence            4

>KOG0199|consensus

Probab=99.86  E-value=1.1e-21  Score=199.46  Aligned_cols=161  Identities=23%  Similarity=0.332  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCC-cCccCCCCCCchhhhhcC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~   81 (407)
                      ....+.|+.||+.|+.||.+++.|||||-..|+|+-....+||+|||+.+-+..+...... ....-...|+|||.+...
T Consensus       211 v~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~  290 (1039)
T KOG0199|consen  211 VSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR  290 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc
Confidence            4567899999999999999999999999999999999999999999999877544332221 122335569999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++|+|++||++|||++ |+.||-+.....+...+. ....  .+....+++++.++++.||+.+|.+|||+..|.+
T Consensus       291 kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~er--LpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  291 KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGER--LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cccc--CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            99999999999999999999 999999887765444333 2122  2333558999999999999999999999999976


Q ss_pred             Cccccc
Q psy11119        161 HRWYSK  166 (407)
Q Consensus       161 hpwf~~  166 (407)
                      .-+..+
T Consensus       368 ~~~l~e  373 (1039)
T KOG0199|consen  368 DLVLAE  373 (1039)
T ss_pred             hHHHHh
Confidence            554443

>KOG0194|consensus

Probab=99.86  E-value=7.2e-22  Score=199.23  Aligned_cols=155  Identities=25%  Similarity=0.357  Sum_probs=125.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCc-CccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD-KKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~-~~~gt~~Y~APE~l~   79 (407)
                      ++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-.   ...... ...-...|+|||.+.
T Consensus       259 v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~  335 (474)
T KOG0194|consen  259 LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLN  335 (474)
T ss_pred             CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhc
Confidence            4567889999999999999999999999999999999999999999999986432   111111 112456799999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...++.++||||+||++||+.+ |..||.+................  .+.....+.++..++.+|+..+|++||++.++
T Consensus       336 ~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r--~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i  413 (474)
T KOG0194|consen  336 TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR--MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTI  413 (474)
T ss_pred             cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc--CCCCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence            9999999999999999999999 88999988876554444333222  22334678889999999999999999999998


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      .+
T Consensus       414 ~~  415 (474)
T KOG0194|consen  414 KK  415 (474)
T ss_pred             HH
Confidence            76

>KOG0590|consensus

Probab=99.85  E-value=9.7e-23  Score=214.07  Aligned_cols=362  Identities=30%  Similarity=0.434  Sum_probs=234.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEecCC-cEEEEecCCceeecc-CCCccCCcCccC-CCCCCchhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLH-SKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRM-NGKERPLDKKCG-TLPYVAPEV   77 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH-~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~-~~~~~~~~~~~g-t~~Y~APE~   77 (407)
                      ++..+..|+.|+..++.|+| ..|+.||||||+|.+++..+ +++++|||+|+.+.. .+........+| ++.|+|||.
T Consensus       121 ~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~  200 (601)
T KOG0590|consen  121 SSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH  200 (601)
T ss_pred             CCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence            45678899999999999999 99999999999999999999 999999999999887 677777888899 999999999


Q ss_pred             hhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-cCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         78 LVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        78 l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      ..+. +.+...|+||+|+++..+++|..||+.+......+..|.... .....+|..++....+++.+++..+|..|.+.
T Consensus       201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~  280 (601)
T KOG0590|consen  201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSI  280 (601)
T ss_pred             ccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccc
Confidence            9884 888999999999999999999999998877666666666553 34577899999999999999999999999999


Q ss_pred             HHHHhCccccc-CCCCCCCCCCCCCCCchhHHhhhcchHHHh---hhcC-CCCC-------CCccCCCCCc--cccCCCC
Q psy11119        156 EKIKSHRWYSK-HMPNDIVDGPPSSDFNSTAKRMRSDLETEA---NRAC-PTFD-------DRACVSQPEP--FALRGPM  221 (407)
Q Consensus       156 ~eil~hpwf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~-------~~~~~~~p~~--~~~~~~~  221 (407)
                      +++..++|+.. .......+  +..+....++....-.+.-.   .... ..+.       .......|..  .....+.
T Consensus       281 ~~~~~d~~~~~~~~~~~~~n--~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~  358 (601)
T KOG0590|consen  281 EELKLDNWLSSKRNGFSKSN--PCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPT  358 (601)
T ss_pred             cccccccccccccccccccc--ccccccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCc
Confidence            99999999998 21111111  00000000000000000000   0000 0000       0000000100  0000000


Q ss_pred             Cc-------cccCCc-cccccCCCCcccccccccccCCCCCCCcccCcccccchHHHHHhhhCCCCccccccccccchhh
Q psy11119        222 SV-------CEVEPH-LFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLL  293 (407)
Q Consensus       222 ~~-------~~~a~~-~~SfSqp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (407)
                      ..       .-..+- ..+|++|.-.+.+....+..                          +-.|. -+.         
T Consensus       359 ~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--------------------------~~~~~-mE~---------  402 (601)
T KOG0590|consen  359 ESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--------------------------GILQS-MEY---------  402 (601)
T ss_pred             ccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--------------------------cchhh-hhc---------
Confidence            00       000010 12344444433332222111                          11111 000         


Q ss_pred             hhhhhhcccCCcee--eEEecCHHHHHHHHH---HHHHHhCCeeeecCceEEEEEeecCCCCeeEEEEEEEEec--C--e
Q psy11119        294 VAILFSCHIRRMTR--FFVKYTAEEAVEKLC---MMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLD--N--Q  364 (407)
Q Consensus       294 ~~~~~~~~~~r~tR--F~s~~~~~~i~~~l~---~~~~~l~~~~~~~~~~~v~i~~~d~rk~~l~~~~~i~~~~--~--~  364 (407)
                      +...   +..++||  |++..++...+..|.   .-++.+|+..+......+.+.-..-.|----|..+||.++  .  .
T Consensus       403 ~~~D---lf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  403 CPYD---LFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             ccHH---HHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            0000   2235566  999999999999999   6678889988765544443321111122223678888886  3  6


Q ss_pred             EEEEEEeccC-------CchHHHHHHHHHHHh---hhhhhhcCCCcccccc
Q psy11119        365 TLLDFRLSKG-------CGIEFKTRFLCIKRA---LAEDIINKPISWSVAI  405 (407)
Q Consensus       365 ~~v~f~k~~G-------d~lE~~~~f~~~~~~---l~~~v~~~~~~~~~~~  405 (407)
                      ..++|..+++       |+.||+.+|..|..+   +-.++.. .--|.+|.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~-~~~Wk~a~  529 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG-RFPWKVAK  529 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC-CCcccccc
Confidence            7799999999       999999999999888   4444444 66676653

>KOG0200|consensus

Probab=99.85  E-value=7.3e-21  Score=201.55  Aligned_cols=157  Identities=24%  Similarity=0.377  Sum_probs=123.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccC--CCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG--TLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~APE~l   78 (407)
                      |+..+...++.||+.|++||++..++||||-..|||+..+..+||+|||+|+.......... ....|  ...|||||.+
T Consensus       415 L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl  493 (609)
T KOG0200|consen  415 LTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESL  493 (609)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHh
Confidence            45678899999999999999999999999999999999999999999999986543332211 11122  2349999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      ....++.++||||+||+|||+.+ |..||.+-......+. +...+.. ...+..+++++.++++.||+.+|++||++.+
T Consensus       494 ~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l~~G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~  571 (609)
T KOG0200|consen  494 FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FLKEGNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSE  571 (609)
T ss_pred             ccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HHhcCCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence            99999999999999999999999 9999987442222233 2332222 2223556899999999999999999999999


Q ss_pred             HHh
Q psy11119        158 IKS  160 (407)
Q Consensus       158 il~  160 (407)
                      +.+
T Consensus       572 ~~~  574 (609)
T KOG0200|consen  572 CVE  574 (609)
T ss_pred             HHH
Confidence            876

>KOG1167|consensus

Probab=99.84  E-value=4.9e-21  Score=185.82  Aligned_cols=166  Identities=30%  Similarity=0.498  Sum_probs=121.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCC------------------C--
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNG------------------K--   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~------------------~--   59 (407)
                      ++-.+++.|++.++.||.++|.+||+||||||.|+|.+. .+.-.|+|||+|.......                  .  
T Consensus       129 l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~  208 (418)
T KOG1167|consen  129 LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDV  208 (418)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcc
Confidence            345688999999999999999999999999999999985 4678999999997211000                  0  


Q ss_pred             ----------------------ccCCcCccCCCCCCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH
Q psy11119         60 ----------------------ERPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY  116 (407)
Q Consensus        60 ----------------------~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~  116 (407)
                                            ........||+.|.|||++.+- ..++++||||.|||+..++++..||-....+....
T Consensus       209 ~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al  288 (418)
T KOG1167|consen  209 HCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADAL  288 (418)
T ss_pred             cccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchH
Confidence                                  0001134699999999999865 67889999999999999999999983221110000


Q ss_pred             H----------------------HHh-------------------hccc------CCCCCC-CcCCHHHHHHHHHhccCC
Q psy11119        117 L----------------------EWK-------------------DNRH------MQRSPW-DRLDVNCLSLIRRILAPL  148 (407)
Q Consensus       117 ~----------------------~~~-------------------~~~~------~~~~~~-~~~s~~~~~LI~~~L~~~  148 (407)
                      .                      .|.                   ....      .....| ..++..+.+|+.+||..|
T Consensus       289 ~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~n  368 (418)
T KOG1167|consen  289 AEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELN  368 (418)
T ss_pred             HHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCC
Confidence            0                      000                   0000      001111 224457899999999999


Q ss_pred             CCCCCCHHHHHhCccccc
Q psy11119        149 PSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       149 P~~Rps~~eil~hpwf~~  166 (407)
                      |.+|+|++++|+||||..
T Consensus       369 p~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  369 PQKRITAEDALKHPFFDE  386 (418)
T ss_pred             hhhcccHHHHhcCcCCcc
Confidence            999999999999999984

>KOG0603|consensus

Probab=99.83  E-value=2e-21  Score=196.98  Aligned_cols=167  Identities=29%  Similarity=0.463  Sum_probs=139.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      .+..+..|...++-|++++|+.||+|||+|++||+++.+|++++.|||+++......      ..|||..|||||++.  
T Consensus        95 ~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--  166 (612)
T KOG0603|consen   95 DELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--  166 (612)
T ss_pred             HHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--
Confidence            467788999999999999999999999999999999999999999999998754322      229999999999998  


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----HH
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----IE  156 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~~  156 (407)
                      .+..++|+||+|+++++|++|..||..    +....+.+.    ....+..++..+++++..++..+|..|..     +.
T Consensus       167 gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~----~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~  238 (612)
T KOG0603|consen  167 GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA----ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVD  238 (612)
T ss_pred             ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh----ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhH
Confidence            667899999999999999999999987    222222222    12223457889999999999999999984     58


Q ss_pred             HHHhCcccccCCCCCCCCCCCCCCCchh
Q psy11119        157 KIKSHRWYSKHMPNDIVDGPPSSDFNST  184 (407)
Q Consensus       157 eil~hpwf~~~~~~~~~~~~~~~~~~~~  184 (407)
                      ++++|++|....|+........+++.+.
T Consensus       239 eik~h~f~~~i~~~~l~~r~~~~~fkp~  266 (612)
T KOG0603|consen  239 EIKQHEFFQSIDWNELEARSRPPPFKPG  266 (612)
T ss_pred             HHhccchheeeeHhhHhhcCCCCCCCCc
Confidence            9999999999999877777666666653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.83  E-value=8.7e-21  Score=211.58  Aligned_cols=154  Identities=22%  Similarity=0.302  Sum_probs=113.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH---SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH---~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++.+++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.......      .....||+.|+|||+
T Consensus       777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~  849 (968)
T PLN00113        777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPET  849 (968)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCccc
Confidence            467888999999999999999   6699999999999999998888776 665433211      123368899999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc----c------cCCC----CCCCcCCHHHHHHHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN----R------HMQR----SPWDRLDVNCLSLIRR  143 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~----~------~~~~----~~~~~~s~~~~~LI~~  143 (407)
                      +.+..++.++||||+||++|||++|+.||+...........+...    .      ....    ........++.+++.+
T Consensus       850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  929 (968)
T PLN00113        850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH  929 (968)
T ss_pred             ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHh
Confidence            988889999999999999999999999996432111111111100    0      0000    0001112356789999


Q ss_pred             hccCCCCCCCCHHHHHhC
Q psy11119        144 ILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       144 ~L~~~P~~Rps~~eil~h  161 (407)
                      ||+.+|++||++.++++.
T Consensus       930 Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        930 CTATDPTARPCANDVLKT  947 (968)
T ss_pred             hCcCCchhCcCHHHHHHH
Confidence            999999999999999875

>KOG1024|consensus

Probab=99.83  E-value=3.8e-20  Score=177.89  Aligned_cols=155  Identities=21%  Similarity=0.305  Sum_probs=126.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~   82 (407)
                      ..+...++.|++.|++|||++||+|.||-..|.+||+.-.+||+|=.+++.+-................||+||.+.+..
T Consensus       395 t~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~  474 (563)
T KOG1024|consen  395 TIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH  474 (563)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh
Confidence            34567889999999999999999999999999999999999999999988764443322223334456799999999999


Q ss_pred             CCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         83 LAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        83 ~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ++.++|+|||||+||||+| |..||.+-++.+... ..++......  +..+|+++..++.-||+..|++||+++|+..
T Consensus       475 yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkdGyRlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  475 YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKDGYRLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhccceecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999999999999999 999998877654333 3333222222  2568999999999999999999999999865

>KOG4250|consensus

Probab=99.83  E-value=8e-21  Score=194.31  Aligned_cols=104  Identities=34%  Similarity=0.603  Sum_probs=93.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--CC--cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--QD--TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--~g--~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      |+|.+...+...+..||.|||++||+||||||.||++-.  +|  -.||+|||.|+.+..+   ....+..||+.|.+||
T Consensus       117 LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPe  193 (732)
T KOG4250|consen  117 LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPE  193 (732)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC---CeeeeecCchhhcChH
Confidence            689999999999999999999999999999999999853  24  3799999999987543   3667889999999999


Q ss_pred             hhhc-CCCCCcchhhhHHHHHHHHHhCCCCCC
Q psy11119         77 VLVR-SYLAEPADIWSCGIILVAMLAGELPWD  107 (407)
Q Consensus        77 ~l~~-~~~~~~sDiwSlGviL~elltG~~Pf~  107 (407)
                      +... ++++..+|.||+||++|++.||..||.
T Consensus       194 l~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  194 LYERQKKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             HHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence            9985 799999999999999999999999995

>KOG0196|consensus

Probab=99.82  E-value=7.7e-21  Score=195.56  Aligned_cols=154  Identities=23%  Similarity=0.376  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccC--CCCCCchhhhhcC
Q psy11119          4 WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG--TLPYVAPEVLVRS   81 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~   81 (407)
                      -+..-+.+.|+.|+.||-++|+|||||...|||++.+-.+|++|||+++.+..+. +...++.-|  ..+|.|||.+...
T Consensus       731 iQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~R  809 (996)
T KOG0196|consen  731 IQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYR  809 (996)
T ss_pred             ehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhc
Confidence            3556788999999999999999999999999999999999999999999775443 223333333  3569999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++||||+|++|||.++ |+.||-+....+....+  + ..+..+++.++|..+..|+..||+++-.+||.+.||+.
T Consensus       810 KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI--e-~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  810 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI--E-QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ccCchhhccccceEEEEecccCCCcccccchHHHHHHH--H-hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            99999999999999999887 99998776654433322  2 33445566779999999999999999999999999987


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      +
T Consensus       887 ~  887 (996)
T KOG0196|consen  887 T  887 (996)
T ss_pred             H
Confidence            4

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=9.7e-20  Score=163.40  Aligned_cols=125  Identities=42%  Similarity=0.722  Sum_probs=110.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........  ......+...|++||.+.
T Consensus        89 ~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~  166 (215)
T cd00180          89 LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLL  166 (215)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhc
Confidence            367788999999999999999999999999999999999 89999999999986543321  123456788899999998


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .. ..+.+.|+|++|+++++|                                   ..+.+++.+|+..+|.+||++.++
T Consensus       167 ~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l  211 (215)
T cd00180         167 GKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDPEKRPSAKEI  211 (215)
T ss_pred             ccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCcccCcCHHHH
Confidence            87 888999999999999998                                   578999999999999999999999


Q ss_pred             HhCc
Q psy11119        159 KSHR  162 (407)
Q Consensus       159 l~hp  162 (407)
                      ++|+
T Consensus       212 ~~~~  215 (215)
T cd00180         212 LEHL  215 (215)
T ss_pred             hhCC
Confidence            9875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4278|consensus

Probab=99.82  E-value=5.3e-20  Score=185.07  Aligned_cols=152  Identities=22%  Similarity=0.330  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCC
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLA   84 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~   84 (407)
                      ....++.||.+|++||..+++|||||-..|+|+.++..+|++|||+++.+..+... ......-...|.|||.+..+.++
T Consensus       366 vLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFS  444 (1157)
T KOG4278|consen  366 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFS  444 (1157)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccc
Confidence            45678899999999999999999999999999999999999999999987533211 11111224569999999999999


Q ss_pred             CcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         85 EPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        85 ~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++|||+|||+|||+.| |-.||.+.+.... |.....  .+....+.++++.+.+|++.||+++|.+||++.||-.
T Consensus       445 iKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEk--gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  445 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEK--GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             cchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhc--cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999999999 9999988765532 222222  2333445789999999999999999999999998744

>KOG0606|consensus

Probab=99.82  E-value=1.6e-20  Score=199.05  Aligned_cols=158  Identities=34%  Similarity=0.519  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC-------------CccCCcCccCCCCCCchhhh
Q psy11119         12 QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG-------------KERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus        12 QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~-------------~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++|||+.||+|||+||+|++|+.-|++|++|||+++......             ....-...||||.|.|||++
T Consensus       151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            34789999999999999999999999999999999999986431110             01112345999999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC---CH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NI  155 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp---s~  155 (407)
                      ..+.|+..+|+|++|+|+|+.+.|..||.+.+.++..-........++.. ...++++++++|.++|..+|..|.   .+
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga  309 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGA  309 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence            99999999999999999999999999999998876543333333333333 345788999999999999999997   67


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      -+++.|+||..-.|.
T Consensus       310 ~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  310 LEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhhhhccceeecccc
Confidence            889999999988776

>KOG1094|consensus

Probab=99.82  E-value=4.5e-20  Score=184.77  Aligned_cols=156  Identities=23%  Similarity=0.331  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCCC
Q psy11119          6 AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAE   85 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~   85 (407)
                      ...++.||++|++||.+.+++||||.+.|+|++.++++||+|||+++-+-.+...+.....+-..+|||||.+..+.+++
T Consensus       639 ~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtt  718 (807)
T KOG1094|consen  639 GVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTT  718 (807)
T ss_pred             hHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccc
Confidence            45699999999999999999999999999999999999999999998654333333333344567899999999999999


Q ss_pred             cchhhhHHHHHHHHHh--CCCCCCCCChhHHHHHH--Hh-hc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         86 PADIWSCGIILVAMLA--GELPWDKPTADCIEYLE--WK-DN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        86 ~sDiwSlGviL~ellt--G~~Pf~~~~~~~~~~~~--~~-~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ++|+|++|+++||+++  .+.||...+.+..-...  .. .. .......+.-++.++.+||.+||..+..+||+++++.
T Consensus       719 aSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  719 ASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             hhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            9999999999999865  78899877655332211  11 11 1111223456788999999999999999999999986


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       799 ~~  800 (807)
T KOG1094|consen  799 LF  800 (807)
T ss_pred             HH
Confidence            54

>KOG3653|consensus

Probab=99.81  E-value=8.7e-20  Score=179.19  Aligned_cols=160  Identities=26%  Similarity=0.379  Sum_probs=120.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK---------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP   71 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~---------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~   71 (407)
                      +++.+.++++.-++.||+|||+.         .|+|||||..|||+..++..-|+|||+|..+............+||.+
T Consensus       304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R  383 (534)
T KOG3653|consen  304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR  383 (534)
T ss_pred             ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence            46788999999999999999973         599999999999999999999999999999887766666667899999


Q ss_pred             CCchhhhhcC-CCC-----CcchhhhHHHHHHHHHhCC------------CCCC-----CCChhHHHHHHHhhc-ccCCC
Q psy11119         72 YVAPEVLVRS-YLA-----EPADIWSCGIILVAMLAGE------------LPWD-----KPTADCIEYLEWKDN-RHMQR  127 (407)
Q Consensus        72 Y~APE~l~~~-~~~-----~~sDiwSlGviL~elltG~------------~Pf~-----~~~~~~~~~~~~~~~-~~~~~  127 (407)
                      |||||++.+. ...     .+.||||+|.+||||++..            +||+     .++.++......... +....
T Consensus       384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p  463 (534)
T KOG3653|consen  384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP  463 (534)
T ss_pred             hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence            9999999875 222     3579999999999999853            2343     223222222222221 22222


Q ss_pred             CCCCcC--CHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119        128 SPWDRL--DVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus       128 ~~~~~~--s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..|..-  ...+++.+..||+.||+.|+|+.=+.+
T Consensus       464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  464 DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence            334322  245789999999999999999865544

>KOG1345|consensus

Probab=99.81  E-value=2.6e-20  Score=171.76  Aligned_cols=161  Identities=29%  Similarity=0.516  Sum_probs=122.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC--CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~--g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      .|....+++.|+++|+.|+|++++||||||.+||||-..  ..+||||||..+...     ......-.+..|.+||+..
T Consensus       119 gE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-----~tV~~~~~~~~y~~pe~~~  193 (378)
T KOG1345|consen  119 GEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-----TTVKYLEYVNNYHAPELCD  193 (378)
T ss_pred             cHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-----ceehhhhhhcccCCcHHHh
Confidence            466778999999999999999999999999999999533  479999999986532     1122233567799999874


Q ss_pred             cC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH---HHHHHhhcccC-CCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         80 RS-----YLAEPADIWSCGIILVAMLAGELPWDKPTADCI---EYLEWKDNRHM-QRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        80 ~~-----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~---~~~~~~~~~~~-~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      ..     ...+.+|+|.||+++|.+|||.+||......+.   ++..|...... ....+..+++.+..+.++-|.++|+
T Consensus       194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~  273 (378)
T KOG1345|consen  194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFK  273 (378)
T ss_pred             hccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccc
Confidence            32     345678999999999999999999986544433   44455544332 2334677899999999999999999


Q ss_pred             CC---CCHHHHHhCcccccC
Q psy11119        151 TR---LNIEKIKSHRWYSKH  167 (407)
Q Consensus       151 ~R---ps~~eil~hpwf~~~  167 (407)
                      +|   -++++.....|....
T Consensus       274 drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  274 DRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             ccchhHHHHHHHHHHHHHhh
Confidence            99   566666677777653

>KOG1290|consensus

Probab=99.81  E-value=3.7e-20  Score=182.28  Aligned_cols=104  Identities=22%  Similarity=0.344  Sum_probs=73.4

Q ss_pred             CccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-----h-HHHHHH--Hhh--------ccc----
Q psy11119         65 KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-----D-CIEYLE--WKD--------NRH----  124 (407)
Q Consensus        65 ~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~-----~-~~~~~~--~~~--------~~~----  124 (407)
                      ..+.|..|.|||++.+..|++.+||||++|++|||+||-..|+....     + +....+  ...        .+.    
T Consensus       410 ~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRd  489 (590)
T KOG1290|consen  410 EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRD  489 (590)
T ss_pred             hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHh
Confidence            33567889999999999999999999999999999999988853211     1 000000  000        000    


Q ss_pred             -----------CCCCCCC---------cCC----HHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        125 -----------MQRSPWD---------RLD----VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       125 -----------~~~~~~~---------~~s----~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                 ....+|.         .++    .++.+|+.-||..+|++|||+.++++|||+....
T Consensus       490 FFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~  557 (590)
T KOG1290|consen  490 FFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA  557 (590)
T ss_pred             hhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence                       0011221         122    3578999999999999999999999999998653

>KOG1025|consensus

Probab=99.79  E-value=4.5e-19  Score=183.28  Aligned_cols=155  Identities=22%  Similarity=0.378  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~   82 (407)
                      ......|..||++|+.|||+++++||||-..|||+.+-.++|+.|||+++.....+.+.........+.|||-|.+....
T Consensus       797 sq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~  876 (1177)
T KOG1025|consen  797 SQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK  876 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccC
Confidence            34667899999999999999999999999999999999999999999999987766655554445567799999999999


Q ss_pred             CCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         83 LAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        83 ~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ++.++||||+||.+||++| |..|+++...+++.....+.. ....+  +..+-++.-++.+||..|+..||+++++..
T Consensus       877 ~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqP--piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  877 YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQP--PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCC--CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999 999999887765544333332 23333  447788999999999999999999988754

>KOG1152|consensus

Probab=99.78  E-value=7.6e-20  Score=183.02  Aligned_cols=104  Identities=42%  Similarity=0.750  Sum_probs=95.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+|..+|+|++.|+++||++||+|||||-+|+.++.+|.+||+|||.|....    ..+.....||..|.|||++.+
T Consensus       667 m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g  742 (772)
T KOG1152|consen  667 MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGG  742 (772)
T ss_pred             cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCC
Confidence            6899999999999999999999999999999999999999999999999987643    356778899999999999998


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDK  108 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~  108 (407)
                      . |.+..-|||++|++||.++..+.||..
T Consensus       743 ~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  743 EKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7 888999999999999999999988853

>KOG2052|consensus

Probab=99.77  E-value=1.9e-18  Score=168.66  Aligned_cols=159  Identities=28%  Similarity=0.391  Sum_probs=117.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLP   71 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~--------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~   71 (407)
                      +-+...+++.-+++||+|||-.        .|.|||||..|||+..+|..-|+|+|+|-.......  ....+..+||.+
T Consensus       306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence            4567889999999999999964        499999999999999999999999999987654432  345678899999


Q ss_pred             CCchhhhhcCC------CCCcchhhhHHHHHHHHHhC----------CCCCCCCChhH---HHHHHH--hhc-ccCCCCC
Q psy11119         72 YVAPEVLVRSY------LAEPADIWSCGIILVAMLAG----------ELPWDKPTADC---IEYLEW--KDN-RHMQRSP  129 (407)
Q Consensus        72 Y~APE~l~~~~------~~~~sDiwSlGviL~elltG----------~~Pf~~~~~~~---~~~~~~--~~~-~~~~~~~  129 (407)
                      |||||++...-      .-..+||||+|+++||+...          ++||.+-...+   .+..+.  ... .......
T Consensus       386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr  465 (513)
T KOG2052|consen  386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR  465 (513)
T ss_pred             ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc
Confidence            99999997531      12458999999999999873          57886432222   122111  111 2222334


Q ss_pred             CCcCC--HHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119        130 WDRLD--VNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus       130 ~~~~s--~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      |...+  ..+..|++.||..||.-|.|+--|.+
T Consensus       466 W~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  466 WKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            44332  24567899999999999999877755

>KOG0576|consensus

Probab=99.76  E-value=1.2e-18  Score=177.01  Aligned_cols=165  Identities=24%  Similarity=0.349  Sum_probs=132.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      |+|.++...++..+.||+|||++|-+|||||-.|||++..|.+|++|||.+..+..  .-.......|||.|||||+.. 
T Consensus       109 lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaav  186 (829)
T KOG0576|consen  109 LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAV  186 (829)
T ss_pred             chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHH
Confidence            57889999999999999999999999999999999999999999999999876532  222335678999999999974 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                        .+.|...+|+|++|+...|+---++|--+.......+..-+.. .........+.++.+-+|++.+|.++|.+||+++
T Consensus       187 erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptae  266 (829)
T KOG0576|consen  187 ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAE  266 (829)
T ss_pred             HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChh
Confidence              3478999999999999999988888865544433333332222 1222233456788899999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      .++.|||....
T Consensus       267 klL~h~fvs~~  277 (829)
T KOG0576|consen  267 KLLQHPFVSQT  277 (829)
T ss_pred             hheeceeeccc
Confidence            99999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=2.4e-17  Score=156.19  Aligned_cols=167  Identities=34%  Similarity=0.501  Sum_probs=129.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCcc----CCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKER----PLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~----~~~~~~gt~~Y~AP   75 (407)
                      +++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+..+.......    .....+|+..|+||
T Consensus        98 ~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515          98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCH
Confidence            46778999999999999999999999999999999999998 79999999998654333221    34677899999999


Q ss_pred             hhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhcccC--CCCCCCcC----CHHHHHHHHH
Q psy11119         76 EVLVR---SYLAEPADIWSCGIILVAMLAGELPWDKPTA---DCIEYLEWKDNRHM--QRSPWDRL----DVNCLSLIRR  143 (407)
Q Consensus        76 E~l~~---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~~----s~~~~~LI~~  143 (407)
                      |.+.+   .......|+||+|++++++++|..||.....   ..............  ........    ...+.+++.+
T Consensus       178 e~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (384)
T COG0515         178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKK  257 (384)
T ss_pred             HHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHH
Confidence            99987   5788999999999999999999999887663   11122211111111  11111111    2578999999


Q ss_pred             hccCCCCCCCCHHHHHhCcccccC
Q psy11119        144 ILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       144 ~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++..+|..|.+..+...++|....
T Consensus       258 ~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         258 LLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             HHhcCchhcCCHHHHhhchHhhCc
Confidence            999999999999999998766654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.74  E-value=1.7e-17  Score=151.82  Aligned_cols=107  Identities=44%  Similarity=0.707  Sum_probs=92.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh-h
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL-V   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l-~   79 (407)
                      +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+........ .......++..|++||.+ .
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~  173 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLG  173 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcC
Confidence            46778899999999999999999999999999999999999999999999987654321 123345688899999998 5


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDK  108 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~  108 (407)
                      ...++.++|+|+||+++++|++|+.||..
T Consensus       174 ~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      174 GKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            55777899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.71  E-value=7.3e-18  Score=161.01  Aligned_cols=133  Identities=26%  Similarity=0.349  Sum_probs=92.4

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC-----
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS-----   81 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----   81 (407)
                      ..+..|++..+++||+.|++|+||+|+|++++.+|.++|+||+......   .....  ...+..|.+||.....     
T Consensus       148 l~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g---~~~~~--~~~~~~~~PPe~~~~~~~~~~  222 (288)
T PF14531_consen  148 LSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAG---TRYRC--SEFPVAFTPPELESCAGQFGQ  222 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETT---EEEEG--GGS-TTTS-HHHHHHHTSCHH
T ss_pred             HHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecC---ceeec--cCCCcccCChhhhhhhcccCc
Confidence            3455999999999999999999999999999999999999998765432   11111  2345779999987542     


Q ss_pred             ---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         82 ---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        82 ---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                         .++.+.|.|+||+++|.|++|..||+..........        .......+++.++.||+.+|++||.+|
T Consensus       223 ~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  223 NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence               467889999999999999999999986654321111        111222688999999999999999988

>KOG1164|consensus

Probab=99.68  E-value=5.4e-16  Score=152.34  Aligned_cols=160  Identities=26%  Similarity=0.329  Sum_probs=120.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-----CcEEEEecCCceeec--cCCC-----ccC-CcCcc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-----DTLKISDFGLATVFR--MNGK-----ERP-LDKKC   67 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-----g~lkL~DFGla~~~~--~~~~-----~~~-~~~~~   67 (407)
                      |+...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+++.+.  ....     .+. .....
T Consensus       119 fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r  198 (322)
T KOG1164|consen  119 FSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR  198 (322)
T ss_pred             cCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence            4667899999999999999999999999999999999865     359999999998332  2211     111 12345


Q ss_pred             CCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH--HHHHHhhcccCCCCCCCcCCHHHHHHHHHhc
Q psy11119         68 GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI--EYLEWKDNRHMQRSPWDRLDVNCLSLIRRIL  145 (407)
Q Consensus        68 gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L  145 (407)
                      ||..|+++.+..+...+.+.|+||++.++.+++.|.+||........  .+........... .....+.++..+...+-
T Consensus       199 GT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  277 (322)
T KOG1164|consen  199 GTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-FGDLKPEEFAKILEYID  277 (322)
T ss_pred             CccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-ccCCChHHHHHHHHHhh
Confidence            99999999999999999999999999999999999999976543211  2222111111111 22334567788888888


Q ss_pred             cCCCCCCCCHHHHHhC
Q psy11119        146 APLPSTRLNIEKIKSH  161 (407)
Q Consensus       146 ~~~P~~Rps~~eil~h  161 (407)
                      ..+...+|....+...
T Consensus       278 ~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  278 SLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccCCcCCCCHHHHHHH
Confidence            8899999998887665

>KOG1033|consensus

Probab=99.67  E-value=2.7e-17  Score=164.24  Aligned_cols=153  Identities=28%  Similarity=0.462  Sum_probs=116.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC----CccCCcCccCCCCCCchhhh
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG----KERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~APE~l   78 (407)
                      ......++.|+..|++|   +|.+|||+||.||+...+..+||.|||+.+......    .....+...||.+||+||.+
T Consensus       358 ~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi  434 (516)
T KOG1033|consen  358 LSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI  434 (516)
T ss_pred             hhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHH
Confidence            34577899999999999   999999999999999999999999999998765443    12234567899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      .++.|+.++||||||+||+||+. -..+++..     ..........++...+...+ .-..|+.+|+.+.|.+||++.+
T Consensus       435 ~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  435 RGQQYSEKVDIYALGLILAELLIQFSTQFERI-----ATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----HhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence            99999999999999999999997 33333211     11111111222222233333 4568999999999999998887


Q ss_pred             HHhCccc
Q psy11119        158 IKSHRWY  164 (407)
Q Consensus       158 il~hpwf  164 (407)
                      .-.|+|.
T Consensus       509 ~~~~~~~  515 (516)
T KOG1033|consen  509 VALHEFL  515 (516)
T ss_pred             Hhhhhhc
Confidence            7777764

>KOG4158|consensus

Probab=99.66  E-value=5e-16  Score=150.14  Aligned_cols=152  Identities=25%  Similarity=0.371  Sum_probs=111.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--C--CcEEEEecCCceeeccCCCc----cCCcCccCCCCCCc
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--Q--DTLKISDFGLATVFRMNGKE----RPLDKKCGTLPYVA   74 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--~--g~lkL~DFGla~~~~~~~~~----~~~~~~~gt~~Y~A   74 (407)
                      -..++-++.|+++|+.|||.+||.|||+|.+|||+.-  +  -.+.|+|||.+---...+-.    ......-|...-||
T Consensus       340 ~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  340 YRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             hHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence            4567788999999999999999999999999999943  3  35899999976322221111    11223457778899


Q ss_pred             hhhhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         75 PEVLVRS------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        75 PE~l~~~------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      ||+....      -.-.++|.|++|.+.||++....||......-.....+.+.  ........+++.+++|+..+|+.|
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--qLPalp~~vpp~~rqlV~~lL~r~  497 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--QLPALPSRVPPVARQLVFDLLKRD  497 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--hCCCCcccCChHHHHHHHHHhcCC
Confidence            9998643      23368999999999999999999998744332232222221  122234668999999999999999


Q ss_pred             CCCCCCHH
Q psy11119        149 PSTRLNIE  156 (407)
Q Consensus       149 P~~Rps~~  156 (407)
                      |++|++..
T Consensus       498 pskRvsp~  505 (598)
T KOG4158|consen  498 PSKRVSPN  505 (598)
T ss_pred             ccccCCcc
Confidence            99999753

>KOG1240|consensus

Probab=99.64  E-value=3.8e-16  Score=166.33  Aligned_cols=155  Identities=23%  Similarity=0.324  Sum_probs=110.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceee--ccCCCc---cCCcCccCCCCCCchh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--RMNGKE---RPLDKKCGTLPYVAPE   76 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~--~~~~~~---~~~~~~~gt~~Y~APE   76 (407)
                      ...+.+.|+.||+.||.-||..||+|||||.+||||+.-+-+.|+||..-+..  ..++..   ....+...-..|+|||
T Consensus       118 ~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE  197 (1431)
T KOG1240|consen  118 VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE  197 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence            35677889999999999999999999999999999999999999999765432  111111   1112222334699999


Q ss_pred             hhhcC----------C-CCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccC-CCCCCCc-CCHHHHHHHH
Q psy11119         77 VLVRS----------Y-LAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM-QRSPWDR-LDVNCLSLIR  142 (407)
Q Consensus        77 ~l~~~----------~-~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~-~s~~~~~LI~  142 (407)
                      .+...          . .+++-||||+||++.||++ |++||+-..     ...++..... ....... -+..++.||.
T Consensus       198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~~~~~~~e~~Le~Ied~~~Rnlil  272 (1431)
T KOG1240|consen  198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRSGNADDPEQLLEKIEDVSLRNLIL  272 (1431)
T ss_pred             hhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhccCccCHHHHHHhCcCccHHHHHH
Confidence            98652          1 4567899999999999999 799986321     1111111000 0000000 1346899999


Q ss_pred             HhccCCCCCCCCHHHHHhC
Q psy11119        143 RILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       143 ~~L~~~P~~Rps~~eil~h  161 (407)
                      .|++.+|++|.++++.++.
T Consensus       273 ~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  273 SMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHccCchhccCHHHHHHh
Confidence            9999999999999999885

>KOG1165|consensus

Probab=99.46  E-value=3.7e-13  Score=127.90  Aligned_cols=156  Identities=21%  Similarity=0.339  Sum_probs=117.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-----cEEEEecCCceeeccCCC-----ccCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-----TLKISDFGLATVFRMNGK-----ERPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-----~lkL~DFGla~~~~~~~~-----~~~~~~~~gt~   70 (407)
                      |+.+.+.-++.|++.-++|+|++.+|+|||||+|+||...+     .+.++|||+|+.+.....     .+......||.
T Consensus       121 FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA  200 (449)
T KOG1165|consen  121 FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA  200 (449)
T ss_pred             ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence            46778999999999999999999999999999999997543     589999999998765432     22344668999


Q ss_pred             CCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--HHHHHHhhccc--CCCCCCCcCCHHHHHHHHHhcc
Q psy11119         71 PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC--IEYLEWKDNRH--MQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        71 ~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~--~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +||+-....+...+...|+-|||-++++.|.|.+||.+...+.  ..|.++-+...  ........+|.++..-++-.-.
T Consensus       201 RYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~  280 (449)
T KOG1165|consen  201 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRR  280 (449)
T ss_pred             eeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHh
Confidence            9999988888888999999999999999999999998754432  22332222111  1112234567777776666666


Q ss_pred             CCCCCCCCHH
Q psy11119        147 PLPSTRLNIE  156 (407)
Q Consensus       147 ~~P~~Rps~~  156 (407)
                      .+-.+-|..+
T Consensus       281 L~F~E~PDYd  290 (449)
T KOG1165|consen  281 LDFFETPDYD  290 (449)
T ss_pred             cCcccCCCHH
Confidence            6666667653

>KOG1023|consensus

Probab=99.44  E-value=2.5e-13  Score=137.87  Aligned_cols=155  Identities=30%  Similarity=0.434  Sum_probs=112.0

Q ss_pred             HHHHHHHHHHHHHHHHHCCC-eecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC---
Q psy11119          6 AQKFFRQLISGVEYLHSKGI-AHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS---   81 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~gI-vHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---   81 (407)
                      ...+++.|+.||+|||+..| +|+.+++.|.++|..-.+||+|||+.................-...|.|||.+...   
T Consensus        50 ~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~  129 (484)
T KOG1023|consen   50 ILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ  129 (484)
T ss_pred             HHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence            45678999999999999865 99999999999999999999999998765321111112222344568999999864   


Q ss_pred             C----CCCcchhhhHHHHHHHHHhCCCCCCCCChh----HHHHHHHhhcccCCCCC---CCcCCHHHHHHHHHhccCCCC
Q psy11119         82 Y----LAEPADIWSCGIILVAMLAGELPWDKPTAD----CIEYLEWKDNRHMQRSP---WDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        82 ~----~~~~sDiwSlGviL~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~---~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      .    .+.+.|+||+|++++|+++...||+.....    +..+...........+.   .....+++..++++||..+|.
T Consensus       130 ~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  130 SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence            1    356789999999999999999999763222    12222212111111111   124566799999999999999


Q ss_pred             CCCCHHHHHh
Q psy11119        151 TRLNIEKIKS  160 (407)
Q Consensus       151 ~Rps~~eil~  160 (407)
                      +||++++|..
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999999866

>KOG1163|consensus

Probab=99.42  E-value=7.4e-13  Score=120.97  Aligned_cols=156  Identities=22%  Similarity=0.305  Sum_probs=117.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCc-----cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y   72 (407)
                      ++...+.-++-|++.-++|+|.++++||||||+|+|+.-+   ..+.++|||+|+.+......     +.-....||..|
T Consensus       108 ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY  187 (341)
T KOG1163|consen  108 FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY  187 (341)
T ss_pred             hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence            3567788899999999999999999999999999999643   46999999999987544321     222345799999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--HHHHhhc--ccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLEWKDN--RHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~--~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      .+-....+...+...|+-|+|.+|..+..|.+||.+.......  +....+.  .........++|.++.-.+.-|-..-
T Consensus       188 ASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~  267 (341)
T KOG1163|consen  188 ASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLG  267 (341)
T ss_pred             hhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcC
Confidence            9888777777788999999999999999999999986654322  2221111  11112224567888888888887777


Q ss_pred             CCCCCCHH
Q psy11119        149 PSTRLNIE  156 (407)
Q Consensus       149 P~~Rps~~  156 (407)
                      -++-|+..
T Consensus       268 F~E~Pdy~  275 (341)
T KOG1163|consen  268 FEEKPDYM  275 (341)
T ss_pred             CCCCCcHH
Confidence            77777653

>KOG0195|consensus

Probab=99.36  E-value=2.7e-12  Score=119.08  Aligned_cols=147  Identities=21%  Similarity=0.267  Sum_probs=111.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEE--ecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKIS--DFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +..+|.+++..++.|++|||+..  |.---|....+++|++-..+|.  |--++  +..       ......|.|++||.
T Consensus       287 d~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fqe-------~gr~y~pawmspea  357 (448)
T KOG0195|consen  287 DHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQE-------VGRAYSPAWMSPEA  357 (448)
T ss_pred             ecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--eec-------cccccCcccCCHHH
Confidence            34688999999999999999974  4445688899999998776654  32222  111       12345789999999


Q ss_pred             hhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         78 LVRSY---LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        78 l~~~~---~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ++.++   .-.++|+|||++++|||.|.+.||.+....+.-.++..+...  ...+++++..+..|+.-|++.||.+||.
T Consensus       358 lqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~hm~klm~icmnedpgkrpk  435 (448)
T KOG0195|consen  358 LQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRHMNKLMNICMNEDPGKRPK  435 (448)
T ss_pred             HhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHHHHHHHHHHhcCCCCcCCC
Confidence            98763   346789999999999999999999887766555544444333  2334678999999999999999999999


Q ss_pred             HHHHH
Q psy11119        155 IEKIK  159 (407)
Q Consensus       155 ~~eil  159 (407)
                      +..|+
T Consensus       436 fdmiv  440 (448)
T KOG0195|consen  436 FDMIV  440 (448)
T ss_pred             cceeh
Confidence            87664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.36  E-value=8.2e-13  Score=131.20  Aligned_cols=75  Identities=33%  Similarity=0.480  Sum_probs=63.5

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCC-CCCcEEEecCCcEEEEecCCceeeccCCCcc------CCcCccCCCCCCchhhhh
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDL-KPENVLLDLQDTLKISDFGLATVFRMNGKER------PLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDL-kp~NILld~~g~lkL~DFGla~~~~~~~~~~------~~~~~~gt~~Y~APE~l~   79 (407)
                      ..++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+.+...+...      .....++++.|+|||.+.
T Consensus       114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            578999999999999999999999 9999999999999999999999876544222      224667899999999986


Q ss_pred             cC
Q psy11119         80 RS   81 (407)
Q Consensus        80 ~~   81 (407)
                      ..
T Consensus       194 ~~  195 (365)
T PRK09188        194 PR  195 (365)
T ss_pred             hh
Confidence            43

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.34  E-value=1.6e-12  Score=118.87  Aligned_cols=103  Identities=18%  Similarity=0.122  Sum_probs=79.2

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCC-CCCcEEEecCCcEEEEecCCceeeccCCCc------cC-----CcCccCCCCCCc
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDL-KPENVLLDLQDTLKISDFGLATVFRMNGKE------RP-----LDKKCGTLPYVA   74 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDL-kp~NILld~~g~lkL~DFGla~~~~~~~~~------~~-----~~~~~gt~~Y~A   74 (407)
                      ..++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......+..      +.     ......++.|+.
T Consensus        94 ~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~  173 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT  173 (218)
T ss_pred             HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            468899999999999999999999 799999999999999999999865433310      00     011236788889


Q ss_pred             hhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCC
Q psy11119         75 PEVLVRS--YLAEPADIWSCGIILVAMLAGELPWDKP  109 (407)
Q Consensus        75 PE~l~~~--~~~~~sDiwSlGviL~elltG~~Pf~~~  109 (407)
                      |+...--  ..-...++++.|+-+|.++|+..|.-..
T Consensus       174 ~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        174 PVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            8765432  2225678999999999999999886443

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=99.30  E-value=2e-12  Score=94.35  Aligned_cols=61  Identities=28%  Similarity=0.322  Sum_probs=47.0

Q ss_pred             ccccCCccccccCCCCcccccccccccCCCCCCCcccCcccccchHHHHHhhhCCCCccccccccccchhhhhhhhhccc
Q psy11119        223 VCEVEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHI  302 (407)
Q Consensus       223 ~~~~a~~~~SfSqp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (407)
                      ..+|||++||||++++|++||...+-                                                   ...
T Consensus         3 ~~lNAFdiIS~S~G~DLSgLFe~~~~---------------------------------------------------~~~   31 (63)
T PF03822_consen    3 KSLNAFDIISLSSGFDLSGLFEEKDK---------------------------------------------------SSV   31 (63)
T ss_dssp             EE--HHHHHCTSTTTSCGGGGGCG-S----------------------------------------------------SS
T ss_pred             ccccHHHHHHhccCCChHHhcCcccc---------------------------------------------------ccc
Confidence            46799999999999999998873221                                                   035


Q ss_pred             CCceeeEEecCHHHHHHHHHHHHHHhCCeeee
Q psy11119        303 RRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRS  334 (407)
Q Consensus       303 ~r~tRF~s~~~~~~i~~~l~~~~~~l~~~~~~  334 (407)
                      +|.|||+|+.++++|+++||++++.+|+.|++
T Consensus        32 ~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen   32 KRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             ---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             cccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            78899999999999999999999999999975

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>KOG0606|consensus

Probab=99.25  E-value=6.4e-12  Score=134.37  Aligned_cols=172  Identities=26%  Similarity=0.375  Sum_probs=134.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccC-------CC---------------
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN-------GK---------------   59 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~-------~~---------------   59 (407)
                      +++-++.++..+..+++|||+..+.|+|++|.|+++..+|+.+++|||........       +.               
T Consensus       902 saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~  981 (1205)
T KOG0606|consen  902 SAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERR  981 (1205)
T ss_pred             ccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccc
Confidence            35567889999999999999999999999999999999999999999843221100       00               


Q ss_pred             -------ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCc
Q psy11119         60 -------ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDR  132 (407)
Q Consensus        60 -------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (407)
                             .+......||+.|.+||...+...+..+|+|+.|+++++.++|..||...+....-..+......+ ......
T Consensus       982 ~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~-p~g~~~ 1060 (1205)
T KOG0606|consen  982 PQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW-PEGPEE 1060 (1205)
T ss_pred             cccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC-CCCccc
Confidence                   011234578999999999999999999999999999999999999999887764332222221111 112345


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHH---HHHhCcccccCCCCCCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIE---KIKSHRWYSKHMPNDIVD  174 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~---eil~hpwf~~~~~~~~~~  174 (407)
                      .+.++++++.+++..+|.+|..+.   ++..|++|+...|..+..
T Consensus      1061 ~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             cChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence            788999999999999999999887   899999999988776543

>KOG1166|consensus

Probab=99.19  E-value=2.9e-11  Score=131.07  Aligned_cols=103  Identities=25%  Similarity=0.300  Sum_probs=89.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-------CCcEEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-------~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      |+|..+.++..|++..|++||..||||+||||+|+||..       +-.++|+|||.+-.+..-.........++|-.+-
T Consensus       791 m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~  870 (974)
T KOG1166|consen  791 MDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFD  870 (974)
T ss_pred             CCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccch
Confidence            678889999999999999999999999999999999953       2359999999986654333334566778899999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCC
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGE  103 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~  103 (407)
                      .+|+..+..+++.+|.|.++.+++.||.|+
T Consensus       871 C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  871 CIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             hHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            999999999999999999999999999984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.17  E-value=3.8e-11  Score=109.10  Aligned_cols=53  Identities=23%  Similarity=0.333  Sum_probs=48.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          1 MAQWEAQKFFRQLISGVEYL-HSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~L-H~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      +++.++..++.|++.+|.|+ |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus       114 ~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         114 LSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            46788999999999999999 799999999999999999 588999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.14  E-value=7e-11  Score=107.21  Aligned_cols=54  Identities=24%  Similarity=0.380  Sum_probs=49.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeec
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFR   55 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~   55 (407)
                      +++.++..++.|++.+|.++|+ +||+||||||+||+++ ++.++|+|||+++...
T Consensus       114 ~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         114 LEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            3567889999999999999999 9999999999999999 8999999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.11  E-value=3.4e-11  Score=112.06  Aligned_cols=78  Identities=15%  Similarity=0.192  Sum_probs=59.6

Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCCCcc
Q psy11119          8 KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPA   87 (407)
Q Consensus         8 ~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s   87 (407)
                      ....+++.+|..||+.|++|||+||.||+++.+| ++|+|||..........              ...++....+..++
T Consensus       139 ~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~  203 (232)
T PRK10359        139 DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKN  203 (232)
T ss_pred             HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccc
Confidence            3567999999999999999999999999999988 99999998765321110              01133344455899


Q ss_pred             hhhhHHHHHHHHH
Q psy11119         88 DIWSCGIILVAML  100 (407)
Q Consensus        88 DiwSlGviL~ell  100 (407)
                      |+|+||+.+..+.
T Consensus       204 di~~lg~~~~~~~  216 (232)
T PRK10359        204 EIKDLGYYLLIYK  216 (232)
T ss_pred             cccceeEeehHHH
Confidence            9999999887553

>KOG2137|consensus

Probab=99.09  E-value=5.4e-11  Score=123.00  Aligned_cols=157  Identities=16%  Similarity=0.277  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC------ccCC-cCccCCCCCCchhhhhcCC
Q psy11119         11 RQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK------ERPL-DKKCGTLPYVAPEVLVRSY   82 (407)
Q Consensus        11 ~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~------~~~~-~~~~gt~~Y~APE~l~~~~   82 (407)
                      .+.+.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++........      +... .-..-...|.|||++....
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455788999987 899999999999999999999999998754322111      0000 0112356799999999988


Q ss_pred             CCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         83 LAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        83 ~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .+.++|+||+||++|.+.. |..-+...... ..+...... .......-..++.++++-+.+++..++..||++..+..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            8999999999999999995 55445433222 122111111 11111222678999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      .|||....
T Consensus       265 ~~ff~D~~  272 (700)
T KOG2137|consen  265 IPFFSDPG  272 (700)
T ss_pred             ccccCCch
Confidence            99998753

>KOG0601|consensus

Probab=98.86  E-value=1.8e-09  Score=110.26  Aligned_cols=163  Identities=20%  Similarity=0.237  Sum_probs=122.6

Q ss_pred             CCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCC---cCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLIS----GVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPL---DKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~----aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~---~~~~gt~~Y   72 (407)
                      +++..++.++.+...    ||.++|+.+++|-|+||+||++..+ ...+++|||+...+....-....   ...-|...|
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y  294 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY  294 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence            467888999999999    9999999999999999999999999 88999999999887655422211   122567789


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ++||...+ -++...|+|++|.++.+..+|..+...........   ......+.......+..+...+..|+..+|..|
T Consensus       295 ~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~  370 (524)
T KOG0601|consen  295 AAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLR  370 (524)
T ss_pred             eChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---cccccCchhhhcCcchhhhhHHHHhcCcchhhh
Confidence            99999865 44789999999999999888766543321111110   011122222334456677779999999999999


Q ss_pred             CCHHHHHhCcccccC
Q psy11119        153 LNIEKIKSHRWYSKH  167 (407)
Q Consensus       153 ps~~eil~hpwf~~~  167 (407)
                      ++.+.++.|+++...
T Consensus       371 ~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  371 LTAQILTALNVIHSK  385 (524)
T ss_pred             hHHHHHhccccccch
Confidence            999999999998753

>smart00090 RIO RIO-like kinase

Probab=98.86  E-value=3e-09  Score=100.05  Aligned_cols=50  Identities=20%  Similarity=0.366  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKG-IAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~g-IvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      +.++..++.||+.+|.+||++| |+||||||+||+++ ++.++|+|||.+..
T Consensus       147 ~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      147 EEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            4557899999999999999999 99999999999999 88999999999864

>KOG1266|consensus

Probab=98.85  E-value=4.4e-09  Score=100.37  Aligned_cols=158  Identities=18%  Similarity=0.175  Sum_probs=106.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceee--ccCCCccCCcCccCCCCCCchhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVF--RMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~--~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      .+..-.+|+.||++||.|||+..  |+|+++.-+.|++..+|-+|+.--.....-  .............+-+.|.+||.
T Consensus       174 ~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s  253 (458)
T KOG1266|consen  174 FQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES  253 (458)
T ss_pred             hHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence            45667899999999999999984  999999999999999998888542211110  00011111122346778999998


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD-CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      =.....+.++|||++|....+|..|+.--...... ..+....    ......   -.+--+++|.+|+...|..||++.
T Consensus       254 g~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia----~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar  326 (458)
T KOG1266|consen  254 GTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIA----NVIIGL---ENGLQRGSITKCLEGEPNGRPDAR  326 (458)
T ss_pred             CcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhh----hheeec---cCccccCcCcccccCCCCCCcchh
Confidence            65556778899999999999998887542221111 1111110    011000   112236789999999999999999


Q ss_pred             HHHhCccccc
Q psy11119        157 KIKSHRWYSK  166 (407)
Q Consensus       157 eil~hpwf~~  166 (407)
                      +++.||..-+
T Consensus       327 ~llfHpllfe  336 (458)
T KOG1266|consen  327 LLLFHPLLFE  336 (458)
T ss_pred             hhhcCceeee
Confidence            9999997543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.78  E-value=1e-08  Score=93.40  Aligned_cols=51  Identities=20%  Similarity=0.334  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeec
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR   55 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~   55 (407)
                      .+..++.+|+.++.++|+.||+||||||+||+++.++.++|+|||.+....
T Consensus       126 ~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            456789999999999999999999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.74  E-value=1.2e-08  Score=96.02  Aligned_cols=45  Identities=24%  Similarity=0.435  Sum_probs=42.0

Q ss_pred             HHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          9 FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         9 i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus       147 ~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        147 QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            467999999999999999999999999999999999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.71  E-value=1.8e-08  Score=90.39  Aligned_cols=50  Identities=24%  Similarity=0.383  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          4 WEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      .+++.++.|++.++.++|. .||+||||||+||+++ ++.++++|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            4678999999999999999 9999999999999999 999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.70  E-value=2e-08  Score=92.63  Aligned_cols=45  Identities=27%  Similarity=0.290  Sum_probs=37.7

Q ss_pred             HHHHHHHHHHH-HHHHHCCCeecCCCCCcEEEecC----CcEEEEecCCc
Q psy11119          7 QKFFRQLISGV-EYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLA   51 (407)
Q Consensus         7 ~~i~~QL~~aL-~~LH~~gIvHrDLkp~NILld~~----g~lkL~DFGla   51 (407)
                      ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+||+.+
T Consensus       107 ~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            35688888887 99999999999999999999743    37999995443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.59  E-value=6.9e-08  Score=87.62  Aligned_cols=45  Identities=36%  Similarity=0.607  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          8 KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         8 ~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            6899999999999999999999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.57  E-value=6.8e-07  Score=88.37  Aligned_cols=152  Identities=14%  Similarity=0.150  Sum_probs=109.6

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh---
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV---   79 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~---   79 (407)
                      +.-+.+..+.|+.+.+-||+.|.+-+|++++|+|+..++.+.|.|-..-..-   ......--.+|.+.|.+||.-.   
T Consensus       116 w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~s  192 (637)
T COG4248         116 WDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPS  192 (637)
T ss_pred             cHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec---cCCceEecccCccccCCHHHhcccc
Confidence            3456788999999999999999999999999999999999999986543332   2223334457899999999865   


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhC-CCCCCCC-------ChhH--HH---HHHHhhc-----ccCCCCCCCcCCHHHHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAG-ELPWDKP-------TADC--IE---YLEWKDN-----RHMQRSPWDRLDVNCLS  139 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG-~~Pf~~~-------~~~~--~~---~~~~~~~-----~~~~~~~~~~~s~~~~~  139 (407)
                        +..-+...|.|.||++++++|.| +.||.+.       +..+  +.   +....+.     ......+|.-+++.+..
T Consensus       193 f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA  272 (637)
T COG4248         193 FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA  272 (637)
T ss_pred             ccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHH
Confidence              22445678999999999999996 9999642       1111  10   0001111     12223456778899999


Q ss_pred             HHHHhccCC--CCCCCCHHH
Q psy11119        140 LIRRILAPL--PSTRLNIEK  157 (407)
Q Consensus       140 LI~~~L~~~--P~~Rps~~e  157 (407)
                      |..+|+..-  +.-|||++.
T Consensus       273 lF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         273 LFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             HHHHHhcccCCCCCCCCHHH
Confidence            999999764  568998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.55  E-value=1.1e-07  Score=87.02  Aligned_cols=48  Identities=38%  Similarity=0.535  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      +...++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            4568999999999999999999999999999999 88999999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.46  E-value=1.6e-07  Score=98.62  Aligned_cols=47  Identities=34%  Similarity=0.527  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          6 AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ...++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       430 ~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            56789999999999999999999999999999 588999999999865

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.35  E-value=8.1e-07  Score=80.92  Aligned_cols=52  Identities=19%  Similarity=0.211  Sum_probs=45.6

Q ss_pred             CHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          2 AQWEAQKFFRQLISGVEYL-HSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~L-H~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      ++.++..++.|++.+|..+ |..||+|+||++.||+++ ++.+.|+|||.+...
T Consensus       122 ~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         122 NDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            3456678889999999999 899999999999999997 578999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=98.32  E-value=3e-07  Score=94.18  Aligned_cols=153  Identities=19%  Similarity=0.209  Sum_probs=109.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCC-chhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYV-APEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~-APE~l   78 (407)
                      |++...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.+.-.     .....+.-++. .+|++
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~  437 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEIL  437 (524)
T ss_pred             cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-----cccccccccccccchhh
Confidence            4677889999999999999999999999999999999876 78899999988642211     11122333344 24554


Q ss_pred             h-cCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         79 V-RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        79 ~-~~~~~~~sDiwSlGviL~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      . ...+..++|++|+|.-+++..+|..- +....        +........+.......++..+.+.++.+++..|+.+.
T Consensus       438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~  509 (524)
T KOG0601|consen  438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAV  509 (524)
T ss_pred             ccccccccccccccccccccccccCcccCccccc--------ceeeecccccCCCchHHhhhhhhhhhcCCccccchhhh
Confidence            4 44788999999999999999988643 22211        11111222222233447888999999999999999999


Q ss_pred             HHHhCccccc
Q psy11119        157 KIKSHRWYSK  166 (407)
Q Consensus       157 eil~hpwf~~  166 (407)
                      ++..|.=|..
T Consensus       510 ~l~~~~~~~~  519 (524)
T KOG0601|consen  510 ELSLHSEFYR  519 (524)
T ss_pred             hhcccchhhh
Confidence            9888765543

>KOG1243|consensus

Probab=98.25  E-value=5.8e-06  Score=86.04  Aligned_cols=96  Identities=16%  Similarity=0.242  Sum_probs=71.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          3 QWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      +..+..-+.||+.||.|||. .+++|++|.-+.|+++..|..||++|.++......+.  ......---.|..|+.+...
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            45677889999999999985 5899999999999999999999999988765432221  11111122235666654322


Q ss_pred             CCCCcchhhhHHHHHHHHHhC
Q psy11119         82 YLAEPADIWSCGIILVAMLAG  102 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG  102 (407)
                      .  -..|.|.|||++++++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.23  E-value=1.8e-06  Score=73.23  Aligned_cols=50  Identities=32%  Similarity=0.374  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          4 WEAQKFFRQLISGVEYLHSK---GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~---gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .....++.+++.++.++|..   +++|+|++|.||+++..+.++++|||.+..
T Consensus        86 ~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            45577899999999999995   799999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.06  E-value=6.4e-06  Score=72.36  Aligned_cols=45  Identities=31%  Similarity=0.459  Sum_probs=40.6

Q ss_pred             HHHHHHHHHHHHHHHHCCC-----eecCCCCCcEEEecCCcEEEEecCCce
Q psy11119          7 QKFFRQLISGVEYLHSKGI-----AHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gI-----vHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      ..++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4567899999999999985     9999999999999 7789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.96  E-value=1.3e-05  Score=73.61  Aligned_cols=52  Identities=29%  Similarity=0.476  Sum_probs=46.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCcee
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATV   53 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~   53 (407)
                      +......++.+++..+.-||.+||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            3556788999999999999999999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.93  E-value=1.7e-05  Score=75.90  Aligned_cols=50  Identities=26%  Similarity=0.334  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-------CCcEEEEecCCce
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDTLKISDFGLAT   52 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-------~g~lkL~DFGla~   52 (407)
                      +.....++.+++..+.-||..||+|+|+++.|||++.       ++.+.++||+.+.
T Consensus       137 ~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        137 PRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            3466789999999999999999999999999999985       4679999999775

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.84  E-value=2.9e-05  Score=79.60  Aligned_cols=48  Identities=21%  Similarity=0.357  Sum_probs=41.2

Q ss_pred             HHHHHHHHH-HHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          7 QKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         7 ~~i~~QL~~-aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      ..++.+++. .+..+|..|++|+|+||.||+++.+|.++++|||++..+
T Consensus       259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            345666665 478899999999999999999999999999999998654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.77  E-value=4.3e-05  Score=68.38  Aligned_cols=45  Identities=33%  Similarity=0.519  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          8 KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         8 ~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++..+=.-+.-||..||+|+||.++||++... ++.++|||++..
T Consensus        96 ~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          96 DLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            466777778899999999999999999999854 499999999863

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.66  E-value=0.00018  Score=49.74  Aligned_cols=43  Identities=23%  Similarity=0.228  Sum_probs=36.9

Q ss_pred             CCeeEEEEEEEEec--CeEEEEEEeccCCchHHHHHHHHHHHhhh
Q psy11119        349 KAQLVFKASVLTLD--NQTLLDFRLSKGCGIEFKTRFLCIKRALA  391 (407)
Q Consensus       349 k~~l~~~~~i~~~~--~~~~v~f~k~~Gd~lE~~~~f~~~~~~l~  391 (407)
                      +..+.|+++|+++.  +++.|+|+|.+||...|++++.+|-..|+
T Consensus         2 ~~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~   46 (47)
T PF02149_consen    2 KEVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR   46 (47)
T ss_dssp             CC-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred             CcceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence            35689999999996  99999999999999999999999877664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.62  E-value=6.2e-05  Score=68.21  Aligned_cols=50  Identities=32%  Similarity=0.471  Sum_probs=39.0

Q ss_pred             HHHHHHHHHHHHHHHH-HHHCCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          4 WEAQKFFRQLISGVEY-LHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~-LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      ++...++.+++..+.. +|..||+|+||.+.||+++.+ .+.++|||.+...
T Consensus       106 ~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             hhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            3466788889886655 579999999999999999976 9999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741|consensus

Probab=97.59  E-value=0.00075  Score=68.87  Aligned_cols=131  Identities=15%  Similarity=0.209  Sum_probs=95.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      .+|+..|.|+.||..||.++|+.|+.-+-|.|.+||++.+..++|+.-|.......+.         +     +  -+..
T Consensus       390 ~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-----~--~le~  453 (655)
T KOG3741|consen  390 APEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------T-----E--PLES  453 (655)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC---------C-----c--chhH
Confidence            4789999999999999999999999999999999999988889988888766543221         0     1  1111


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                         ..+-|.-.||.+++.|.||..- |....... .....         ....++.+++++|.-+...++++ -++.+++
T Consensus       454 ---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~~---------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll  519 (655)
T KOG3741|consen  454 ---QQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLTR---------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLL  519 (655)
T ss_pred             ---HhhhhHHHHHHHHHHHhhcccccccccchHH-HHHHH---------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence               1356999999999999998543 22211111 10111         11336788999999999999987 7888887


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      .+
T Consensus       520 p~  521 (655)
T KOG3741|consen  520 PM  521 (655)
T ss_pred             HH
Confidence            75

>KOG3087|consensus

Probab=97.51  E-value=0.00015  Score=64.79  Aligned_cols=47  Identities=32%  Similarity=0.489  Sum_probs=41.8

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCcee
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATV   53 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~   53 (407)
                      ..++++|=+.+.-||.++|+|+||..+||++..+|+   +.++|||++..
T Consensus       116 ~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            578888889999999999999999999999987764   58999999864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.36  E-value=0.00016  Score=75.63  Aligned_cols=36  Identities=22%  Similarity=0.512  Sum_probs=31.8

Q ss_pred             HHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeec
Q psy11119         20 LHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFR   55 (407)
Q Consensus        20 LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~   55 (407)
                      ++..|++|+|+||.||+++.+|    .++++|||++..+.
T Consensus       276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            3468999999999999999888    99999999987653

>PRK09902 hypothetical protein; Provisional

Probab=97.26  E-value=0.00051  Score=63.13  Aligned_cols=51  Identities=10%  Similarity=0.098  Sum_probs=45.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc--EEEEecCCce
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLAT   52 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~--lkL~DFGla~   52 (407)
                      ++.+...++.+++..+.-||..|+.|+|+.+.||+++.+|.  ++++||.-++
T Consensus       126 ~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        126 SDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             chHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            34455789999999999999999999999999999987777  9999998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.10  E-value=0.00088  Score=61.94  Aligned_cols=43  Identities=23%  Similarity=0.421  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119          9 FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus         9 i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      +...|.+++.-+|+.|++|+|.+|.|++++. +.++++||+..+
T Consensus       140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcccc
Confidence            4567888999999999999999999999994 559999997653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035|consensus

Probab=96.98  E-value=0.0018  Score=71.84  Aligned_cols=151  Identities=21%  Similarity=0.238  Sum_probs=102.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC---cEEEecCCcEEEE--ecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPE---NVLLDLQDTLKIS--DFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~---NILld~~g~lkL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +.+.++.+..++++||.|+|+....|.-+...   +--.+..+...++  ||+.+..+.......   ....+..+.+||
T Consensus       284 ~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e  360 (1351)
T KOG1035|consen  284 PLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADE  360 (1351)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCcccccccc
Confidence            56778899999999999999996655554444   3344555667766  888877654433221   223345577888


Q ss_pred             hhhcCCCC--CcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         77 VLVRSYLA--EPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        77 ~l~~~~~~--~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ........  ...|+|++|..+..+..|..+-......    ..+..         ........++..+|+..++++|++
T Consensus       361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~----~~~l~---------~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP----VSLLD---------VLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             ccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch----hhhhc---------cccchhhhhhhhhhcchhhhhccc
Confidence            87666333  3469999999999998876542211100    00000         001115788999999999999999


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      +.+++.|+|.+-..
T Consensus       428 ~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  428 ALELLTHPFLRFPT  441 (1351)
T ss_pred             hhhhhhchhccccc
Confidence            99999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.58  E-value=0.004  Score=59.12  Aligned_cols=49  Identities=20%  Similarity=0.341  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119          4 WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      +.+..++..|++-+.-+-..||+|+|+++-||+++++|.+.++||--+.
T Consensus       202 en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            4455677777777777779999999999999999999999999997554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.49  E-value=0.0052  Score=55.93  Aligned_cols=31  Identities=32%  Similarity=0.534  Sum_probs=26.3

Q ss_pred             CCCeecCCCCCcEEEec--CCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDL--QDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~--~g~lkL~DFGla~~   53 (407)
                      ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            35799999999999998  56789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.39  E-value=0.007  Score=56.83  Aligned_cols=50  Identities=24%  Similarity=0.351  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119          4 WEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus         4 ~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      +++..+..++++.+.-|-. .|+||+||+.-|||+. +|.+.++|||-|...
T Consensus       166 ~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         166 EEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             hhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            3788899999999988887 8999999999999999 899999999988654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=95.89  E-value=0.07  Score=48.32  Aligned_cols=52  Identities=23%  Similarity=0.156  Sum_probs=46.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          2 AQWEAQKFFRQLISGVEYLHS---KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~---~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ++....+++.++++.+.+++.   ..+.-.|++|+|+-++.+|.+|++|...+..
T Consensus        57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            567888999999999999998   3578899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826|consensus

Probab=95.68  E-value=0.0027  Score=72.19  Aligned_cols=155  Identities=12%  Similarity=-0.069  Sum_probs=100.5

Q ss_pred             HHHHHHHHHHHHHHHHHC-C----CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          6 AQKFFRQLISGVEYLHSK-G----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~-g----IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +....++.+.+..-+|+. +    .+|++||+-|.+|..+.++|++++|+.+...+  .........+++.|+.|++...
T Consensus      1337 v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1337 VHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred             HHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHH
Confidence            344445556777777765 1    68999999999999999999999999984221  1122344567888999999888


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      -.++.++|+|..|+.+|+...|..+|-.-...  .......+... .......|.++-.....+|-.+-..||.-..++.
T Consensus      1415 ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~--~Lkgiidn~tf-~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP--ALKGIIDNHTF-FSIEKLKPGDANVEALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred             HhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH--HHcCccccccc-ccccccCCCcccHHHHHHHHHHhhhcchhhhhcc
Confidence            88888899999999999999998876321110  00000010111 1111112334444555556666678887777777


Q ss_pred             Ccccc
Q psy11119        161 HRWYS  165 (407)
Q Consensus       161 hpwf~  165 (407)
                      -+.|.
T Consensus      1492 ~d~~a 1496 (2724)
T KOG1826|consen 1492 RDHFA 1496 (2724)
T ss_pred             ccccc
Confidence            66554

>KOG0576|consensus

Probab=95.16  E-value=0.0055  Score=64.23  Aligned_cols=150  Identities=21%  Similarity=0.184  Sum_probs=101.1

Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCCCcc
Q psy11119          8 KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPA   87 (407)
Q Consensus         8 ~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s   87 (407)
                      ...+.-..+++|+|+.-=+|+|    ||+.. ++..+..||+....+....   ...+..+++.++|||+.....+....
T Consensus       340 ~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p  411 (829)
T KOG0576|consen  340 YPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCP  411 (829)
T ss_pred             hhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCC
Confidence            3445556789999998778888    77766 4788999999886654322   34567899999999999988888999


Q ss_pred             hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119         88 DIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus        88 DiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      |.|++|+--.++.-|.+|-..+.......-.-........ ..|.....  .++...|+...|..|+....+..|.+|.+
T Consensus       412 ~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~--~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  412 DSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFH--RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             CccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccc--cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            9999998777777777775432211000000000000000 11211111  24778899999999999999999999987


Q ss_pred             C
Q psy11119        167 H  167 (407)
Q Consensus       167 ~  167 (407)
                      .
T Consensus       490 C  490 (829)
T KOG0576|consen  490 C  490 (829)
T ss_pred             C
Confidence            4

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.58  E-value=0.033  Score=51.90  Aligned_cols=30  Identities=30%  Similarity=0.347  Sum_probs=25.4

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .+++|+|+.|.||+++.++..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            358999999999999966556799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.54  E-value=0.06  Score=52.33  Aligned_cols=30  Identities=40%  Similarity=0.637  Sum_probs=27.0

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .+++|+|+++.||+++.++...|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=94.37  E-value=0.078  Score=51.68  Aligned_cols=30  Identities=33%  Similarity=0.474  Sum_probs=25.8

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .|++|+|++|.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999966556899999764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.37  E-value=0.088  Score=50.96  Aligned_cols=29  Identities=31%  Similarity=0.566  Sum_probs=25.4

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .+++|+|+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999997 778999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.93  E-value=0.057  Score=50.02  Aligned_cols=29  Identities=24%  Similarity=0.455  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEec-CCcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDL-QDTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~-~g~lkL~DFGla~   52 (407)
                      +++|+|+.+.|||++. ++.+.++||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            6899999999999997 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.62  E-value=0.11  Score=50.06  Aligned_cols=30  Identities=37%  Similarity=0.553  Sum_probs=26.6

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999987777999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.54  E-value=0.13  Score=49.81  Aligned_cols=29  Identities=34%  Similarity=0.458  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEecC----CcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDLQ----DTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~~----g~lkL~DFGla~   52 (407)
                      +++|+|+.|.||+++.+    +.+.++||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            68999999999999975    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.46  E-value=0.078  Score=55.41  Aligned_cols=35  Identities=29%  Similarity=0.533  Sum_probs=31.3

Q ss_pred             HHHCCCeecCCCCCcEEEecCCcEEEEecCCceee
Q psy11119         20 LHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF   54 (407)
Q Consensus        20 LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~   54 (407)
                      +-..|++|.|.+|-||+++.+|.+.+.|||+...+
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            34489999999999999999999999999998654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.43  E-value=0.047  Score=49.79  Aligned_cols=31  Identities=35%  Similarity=0.483  Sum_probs=21.8

Q ss_pred             CCCeecCCCCCcEEEe-cCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLD-LQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld-~~g~lkL~DFGla~~   53 (407)
                      .+++|+|+.|.||+++ .++.+-|+||+.+..
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             cEEEEeccccccceeeeccceeEEEecccceE
Confidence            4699999999999999 667778999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.87  E-value=0.2  Score=49.82  Aligned_cols=50  Identities=32%  Similarity=0.534  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          3 QWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+++..++.+.+..+.-+..+ ..-|||+.-.||||+ +|++.|+||-+++.
T Consensus       320 ~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         320 SEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            467889999998877777766 688999999999999 99999999999884

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.82  E-value=0.095  Score=47.39  Aligned_cols=28  Identities=21%  Similarity=0.309  Sum_probs=24.8

Q ss_pred             CeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         25 IAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        25 IvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+|+|+.|.|++++.+| ++++||+.|..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            59999999999998777 99999998853

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.54  E-value=0.17  Score=48.54  Aligned_cols=47  Identities=28%  Similarity=0.379  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHHHHHC--CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          7 QKFFRQLISGVEYLHSK--GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~--gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ++.+..+-.++.-.|..  -++|+|+.|+|++.+..|.++|+||..|..
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            33444455555555554  589999999999999989999999988753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=92.13  E-value=0.11  Score=48.47  Aligned_cols=28  Identities=18%  Similarity=0.122  Sum_probs=25.3

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .++|+|+.|.||+++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=91.98  E-value=0.22  Score=48.52  Aligned_cols=29  Identities=21%  Similarity=0.184  Sum_probs=27.1

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      |++|+|+.++|+|++.++.+.++||..++
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=91.72  E-value=0.12  Score=48.27  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=26.4

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      ..++|+|+.|.|||++.++...|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            358999999999999987778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=91.60  E-value=0.13  Score=48.47  Aligned_cols=29  Identities=28%  Similarity=0.370  Sum_probs=25.6

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.35  E-value=0.17  Score=47.12  Aligned_cols=37  Identities=30%  Similarity=0.359  Sum_probs=32.1

Q ss_pred             HHHHHHHHHC--CCeecCCCCCcEEEecCCcEEEEecCC
Q psy11119         14 ISGVEYLHSK--GIAHRDLKPENVLLDLQDTLKISDFGL   50 (407)
Q Consensus        14 ~~aL~~LH~~--gIvHrDLkp~NILld~~g~lkL~DFGl   50 (407)
                      +.+|.-.|+.  +.+|+|..|+||+-|..|.+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            4668888953  799999999999999999999999763

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.21  E-value=0.13  Score=47.09  Aligned_cols=30  Identities=33%  Similarity=0.585  Sum_probs=21.5

Q ss_pred             CCeecCCCCCcEEE-ecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLL-DLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILl-d~~g~lkL~DFGla~~   53 (407)
                      .++|+|+.|.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 8889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.00  E-value=0.4  Score=43.48  Aligned_cols=30  Identities=27%  Similarity=0.524  Sum_probs=25.3

Q ss_pred             CCCeecCCCCCcEEEecCC-----cEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQD-----TLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g-----~lkL~DFGla~   52 (407)
                      ..++|||+.+.||++..++     .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4689999999999998654     58999998764

subfamily of choline kinases

>KOG2268|consensus

Probab=90.98  E-value=0.42  Score=46.99  Aligned_cols=46  Identities=20%  Similarity=0.400  Sum_probs=39.6

Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCc
Q psy11119          6 AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA   51 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla   51 (407)
                      +..+...|+.-+--|-.+|+||+|..--||+++.++.++++||--.
T Consensus       204 ~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  204 PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHh
Confidence            4456677777788889999999999999999999999999999543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.88  E-value=0.31  Score=48.12  Aligned_cols=28  Identities=43%  Similarity=0.569  Sum_probs=25.2

Q ss_pred             CeecCCCCCcEEEecCCc-EEEEecCCce
Q psy11119         25 IAHRDLKPENVLLDLQDT-LKISDFGLAT   52 (407)
Q Consensus        25 IvHrDLkp~NILld~~g~-lkL~DFGla~   52 (407)
                      +||+|+.|.||+++.+.. ..++|||-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 8999998653

>PLN02236 choline kinase

Probab=90.83  E-value=0.28  Score=48.70  Aligned_cols=29  Identities=31%  Similarity=0.614  Sum_probs=25.6

Q ss_pred             CCeecCCCCCcEEEec-CCcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDL-QDTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~-~g~lkL~DFGla~   52 (407)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4679999998775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=87.52  E-value=0.4  Score=46.05  Aligned_cols=30  Identities=30%  Similarity=0.479  Sum_probs=25.3

Q ss_pred             CCeecCCCCCcEEEecCCc-EEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDT-LKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~-lkL~DFGla~~   53 (407)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK06148 hypothetical protein; Provisional

Probab=86.65  E-value=1.2  Score=50.77  Aligned_cols=31  Identities=32%  Similarity=0.520  Sum_probs=26.1

Q ss_pred             CCCeecCCCCCcEEEecCC--cEE-EEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQD--TLK-ISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g--~lk-L~DFGla~~   53 (407)
                      +++||+|++++|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  554 999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=86.34  E-value=1  Score=44.42  Aligned_cols=28  Identities=32%  Similarity=0.520  Sum_probs=24.8

Q ss_pred             CeecCCCCCcEEEec-CCcEEEEecCCce
Q psy11119         25 IAHRDLKPENVLLDL-QDTLKISDFGLAT   52 (407)
Q Consensus        25 IvHrDLkp~NILld~-~g~lkL~DFGla~   52 (407)
                      ++|.|+.+.|||++. ++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4789999999874

>PHA03111 Ser/Thr kinase; Provisional

Probab=86.24  E-value=1.7  Score=42.91  Aligned_cols=37  Identities=27%  Similarity=0.277  Sum_probs=26.5

Q ss_pred             HHHHHHHHHHHHHHHHHH----CCCeecCCCCCcEEEecCC
Q psy11119          5 EAQKFFRQLISGVEYLHS----KGIAHRDLKPENVLLDLQD   41 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~----~gIvHrDLkp~NILld~~g   41 (407)
                      -++.++.|++--.-.+-+    ...+|-||||+|||+-...
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            467888888655434433    3699999999999995443

>PRK11768 serine/threonine protein kinase; Provisional

Probab=86.04  E-value=1  Score=44.28  Aligned_cols=28  Identities=25%  Similarity=0.222  Sum_probs=23.7

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .|++|+|+.+.|||++ + .+.|+||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4799999999999995 4 57899999664

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=85.14  E-value=0.62  Score=45.74  Aligned_cols=30  Identities=30%  Similarity=0.534  Sum_probs=27.8

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|+++.|++++.++-+-|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            589999999999999998899999999875

>KOG1093|consensus

Probab=84.88  E-value=0.53  Score=48.90  Aligned_cols=84  Identities=17%  Similarity=0.123  Sum_probs=56.0

Q ss_pred             CCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC---------CCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         84 AEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS---------PWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        84 ~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      ++++||||+|.++.++.-|..-|.............+- ...+..         ..-.++....++..+|+-..|..||.
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~-~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY-YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh-ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence            36999999999999999987776543332111111110 000000         00124556788999999999999999


Q ss_pred             HHHHHhCcccccCC
Q psy11119        155 IEKIKSHRWYSKHM  168 (407)
Q Consensus       155 ~~eil~hpwf~~~~  168 (407)
                      ..++++++-|....
T Consensus       188 ~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  188 PMELSKRCSFTEVY  201 (725)
T ss_pred             hhHHhcCccHHHHH
Confidence            99999999988753

>PRK06149 hypothetical protein; Provisional

Probab=84.52  E-value=1.1  Score=50.90  Aligned_cols=31  Identities=23%  Similarity=0.245  Sum_probs=25.4

Q ss_pred             HCCCeecCCCCCcEEEecCC--c---EEEEecCCce
Q psy11119         22 SKGIAHRDLKPENVLLDLQD--T---LKISDFGLAT   52 (407)
Q Consensus        22 ~~gIvHrDLkp~NILld~~g--~---lkL~DFGla~   52 (407)
                      ..|+||+|++++||+++.++  .   .-|+|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            35899999999999998653  3   4799999764

>COG4499 Predicted membrane protein [Function unknown]

Probab=83.82  E-value=2.3  Score=42.18  Aligned_cols=79  Identities=20%  Similarity=0.259  Sum_probs=56.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCC-CchhhhhcC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY-VAPEVLVRS   81 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y-~APE~l~~~   81 (407)
                      ....++++.|.+..|.-+ .+.-.|-=+.|+||+++.++.+.+.-+|+-..+               |+| +.||.+.. 
T Consensus        84 k~~Klr~a~~~I~~l~e~-~~tr~~~~laPeNilf~~~l~p~~vH~Glk~~l---------------pPye~tee~f~~-  146 (434)
T COG4499          84 KTRKLRLALQNIATLSEL-NNTRYTFFLAPENILFDGGLTPFFVHRGLKNSL---------------PPYEMTEERFLK-  146 (434)
T ss_pred             HHHHHHHHHHHHHHHHHh-hccceeEEecchheEEcCCCceEEEecchhccC---------------CCCCCCHHHHHH-
Confidence            344566688888888763 444567778999999999999999999975332               223 56666543 


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCC
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWD  107 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~  107 (407)
                               ++-+++..++.|..+|+
T Consensus       147 ---------~ykA~~~~~fn~k~~Fe  163 (434)
T COG4499         147 ---------EYKALAIYAFNGKFSFE  163 (434)
T ss_pred             ---------HHHHHHHHHHcCCccHH
Confidence                     34567778888988885

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=80.92  E-value=2.2  Score=42.30  Aligned_cols=49  Identities=24%  Similarity=0.303  Sum_probs=32.0

Q ss_pred             HHHHHHHHHHHHHHHHH----HCCCeecCCCCCcEEEecCC------------------cEEEEecCCcee
Q psy11119          5 EAQKFFRQLISGVEYLH----SKGIAHRDLKPENVLLDLQD------------------TLKISDFGLATV   53 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH----~~gIvHrDLkp~NILld~~g------------------~lkL~DFGla~~   53 (407)
                      -++.++.|++--.--+-    ....+|-||||+|||+-...                  .++|.||.++..
T Consensus       276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            35677888754331132    23689999999999994332                  356677777654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	407
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-54
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-54
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-53
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-53
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-53
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-53
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-53
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-53
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-53
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-53
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-53
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-53
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-53
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-53
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-53
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-53
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-52
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-52
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-52
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-52
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-51
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-27
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-27
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-26
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-26
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-26
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-26
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-25
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-25
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-25
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-25
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-25
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-25
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-25
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-24
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-24
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-20
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-20
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-20
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-20
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-20
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-19
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-19
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-17
3soa_A	444	Full-Length Human Camkii Length = 444		1e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-16
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-14
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-14
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-14
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-14
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-14
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-14
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-14
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-14
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-14
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-12
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-10
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-09
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		9e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-08
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-08
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		9e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		2e-07
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-07
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-06

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  207 bits (527), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 103/199 (51%), Positives = 138/199 (69%), Gaps = 7/199 (3%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 279
Query: 175 GPPSSDFNSTAKRMRSDLE 193
           G  S   +  +K ++S+L+
Sbjct: 280 GGVSESPSGFSKHIQSNLD 298

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  207 bits (527), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 103/199 (51%), Positives = 138/199 (69%), Gaps = 7/199 (3%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280
Query: 175 GPPSSDFNSTAKRMRSDLE 193
           G  S   +  +K ++S+L+
Sbjct: 281 GGVSESPSGFSKHIQSNLD 299

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 220 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 98/167 (58%), Positives = 125/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 97/167 (58%), Positives = 124/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K  GTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 222 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 97/167 (58%), Positives = 124/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K  GTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 97/167 (58%), Positives = 124/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K  GTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 97/167 (58%), Positives = 124/167 (74%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K  GTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 96/167 (57%), Positives = 123/167 (73%), Gaps = 2/167 (1%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K  GTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+    EY +W
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K
Sbjct: 221 KEKK-TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 112/203 (55%), Gaps = 23/203 (11%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNG 58
            ++ EA+ FF+QL+SGV Y HS  I HRDLK EN LLD      LKI DFG +    ++ 
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 59  KERPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           + +      GT  Y+APEVL+R  Y  + AD+WSCG+ L  ML G  P++ P        
Sbjct: 173 QPK---STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE------- 222
Query: 118 EWKDNRH-MQR-------SPWD-RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
           E +D R  +QR        P D R+   C  LI RI    P+TR++I +IK+H W+ K++
Sbjct: 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282
Query: 169 PNDIVD-GPPSSDFNSTAKRMRS 190
           P D+++     S F    + M+S
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQS 305

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 69/171 (40%), Positives = 99/171 (57%), Gaps = 8/171 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + E ++FF+Q+I  +EY H   I HRDLKPEN+LLD    +KI+DFGL+ +   +G  
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNF 163
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP-ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+     A P  D+WSCGI+L  ML G LP+D    + I  L  
Sbjct: 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD---EFIPNLFK 218
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           K N  +   P D L     SLIRR++   P  R+ I++I+   W++ ++P+
Sbjct: 219 KVNSCVYVMP-DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 103/181 (56%), Gaps = 20/181 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QLISGV Y H+  +AHRDLK EN LLD      LKI+DFG +    ++ + + 
Sbjct: 116 EARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPK- 174
Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKP--------TADC 113
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P        T   
Sbjct: 175 --SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           I  +++    ++  SP       C  LI RI    P+ R++I +I++H W+ K++P D++
Sbjct: 233 ILNVQYAIPDYVHISP------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLM 286
Query: 174 D 174
           +
Sbjct: 287 N 287

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 96/172 (55%), Gaps = 8/172 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F + GK 
Sbjct: 108 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 166
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 167 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
           +  R   R P+  +  +C +L++R L   P  R  +E+I   RW +     D
Sbjct: 222 RVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 272

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 95/172 (55%), Gaps = 8/172 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F + GK 
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG  PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 224
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
           +  R   R P+  +  +C +L++R L   P  R  +E+I   RW +     D
Sbjct: 225 RVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 94/164 (57%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 168
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD+ CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 169 --LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 223
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 93/164 (56%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 168
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 169 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 223
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 93/164 (56%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 168
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 169 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 223
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 266

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 93/164 (56%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 168
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 169 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 223
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 92/164 (56%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 168
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG  PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 169 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 223
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 224 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 93/164 (56%), Gaps = 8/164 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K 
Sbjct: 103 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK- 161
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 162 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 216
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  R   R P+  +  +C +L+++ L   PS R  +E+I   RW
Sbjct: 217 RVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRW 259

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/181 (37%), Positives = 101/181 (55%), Gaps = 20/181 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QLISGV Y H+  + HRDLK EN LLD      LKI DFG +    ++ + + 
Sbjct: 115 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 173
Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKP--------TADC 113
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P        T   
Sbjct: 174 --STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 231
Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           I  +++    ++  SP       C  LI RI    P+ R++I +I++H W+ K++P D++
Sbjct: 232 ILNVQYAIPDYVHISP------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLM 285
Query: 174 D 174
           +
Sbjct: 286 N 286

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/181 (37%), Positives = 101/181 (55%), Gaps = 20/181 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QLISGV Y H+  + HRDLK EN LLD      LKI DFG +    ++ + + 
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 174
Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKP--------TADC 113
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P        T   
Sbjct: 175 --STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           I  +++    ++  SP       C  LI RI    P+ R++I +I++H W+ K++P D++
Sbjct: 233 ILNVQYAIPDYVHISP------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLM 286
Query: 174 D 174
           +
Sbjct: 287 N 287

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/178 (37%), Positives = 99/178 (55%), Gaps = 10/178 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M++ EA++FF+Q+IS VEY H   I HRDLKPEN+LLD    +KI+DFGL+ +   +G  
Sbjct: 100 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNF 158
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP-ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+     A P  D+WSCG+IL  ML   LP+D  +   +    +
Sbjct: 159 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----F 212
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPP 177
           K+  +   +    L      LI+R+L   P  R++I +I    W+   +P  ++  PP
Sbjct: 213 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL--PP 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 67/178 (37%), Positives = 99/178 (55%), Gaps = 10/178 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M++ EA++FF+Q+IS VEY H   I HRDLKPEN+LLD    +KI+DFGL+ +   +G  
Sbjct: 104 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNF 162
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP-ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+     A P  D+WSCG+IL  ML   LP+D  +   +    +
Sbjct: 163 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----F 216
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPP 177
           K+  +   +    L      LI+R+L   P  R++I +I    W+   +P  ++  PP
Sbjct: 217 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL--PP 272

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 96/175 (54%), Gaps = 8/175 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M++ EA++FF+Q+IS VEY H   I HRDLKPEN+LLD    +KI+DFGL+ +       
Sbjct: 110 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DG 166
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP-ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+     A P  D+WSCG+IL  ML   LP+D  +   +    +
Sbjct: 167 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----F 222
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
           K+  +   +    L      LI+R+L   P  R++I +I    W+   +P  +++
Sbjct: 223 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 64/170 (37%), Positives = 93/170 (54%), Gaps = 8/170 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M++ EA++FF+Q+IS VEY H   I HRDLKPEN+LLD    +KI+DFGL+ +       
Sbjct: 109 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DG 165
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP-ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+     A P  D+WSCG+IL  ML   LP+D  +   +    +
Sbjct: 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----F 221
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
           K+  +   +    L      LI+R+L   P  R++I +I    W+   +P
Sbjct: 222 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 271

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 62/160 (38%), Positives = 89/160 (55%), Gaps = 8/160 (5%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F    K   LD
Sbjct: 114 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LD 170
Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
             CG  PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  +  R
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLR 227
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
              R P+     +C +L+++ L   PS R  +E+I   RW
Sbjct: 228 GKYRIPF-YXSTDCENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 69/185 (37%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + E+++ F+Q++SGV+Y H   + HRDLKPENVLLD     KI+DFGL+    M    
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDG 169
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+  R Y     DIWS G+IL A+L G LP+D    D +  L  
Sbjct: 170 EFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD---DHVPTLFK 226
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
           K    +  +P   L+ + +SL++ +L   P  R  I+ I+ H W+ + +P  +    PS 
Sbjct: 227 KICDGIFYTP-QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS- 284
Query: 180 DFNST 184
            ++ST
Sbjct: 285 -YSST 288

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/171 (36%), Positives = 93/171 (54%), Gaps = 8/171 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA++ F+Q++S V+Y H   + HRDLKPENVLLD     KI+DFGL+    M    
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDG 164
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+  R Y     DIWSCG+IL A+L G LP+D      +    +
Sbjct: 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----F 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           K  R       + L+ +  +L+  +L   P  R  I+ I+ H W+ + +P+
Sbjct: 221 KKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/171 (36%), Positives = 93/171 (54%), Gaps = 8/171 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA++ F+Q++S V+Y H   + HRDLKPENVLLD     KI+DFGL+    M    
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDG 164
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+  R Y     DIWSCG+IL A+L G LP+D      +    +
Sbjct: 165 EFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----F 220
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           K  R       + L+ +  +L+  +L   P  R  I+ I+ H W+ + +P+
Sbjct: 221 KKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 100/181 (55%), Gaps = 20/181 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QLISGV Y H+  + HRDLK EN LLD      LKI  FG +    ++ + + 
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK- 174
Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKP--------TADC 113
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P        T   
Sbjct: 175 --STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           I  +++    ++  SP       C  LI RI    P+ R++I +I++H W+ K++P D++
Sbjct: 233 ILNVQYAIPDYVHISP------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLM 286
Query: 174 D 174
           +
Sbjct: 287 N 287

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/181 (36%), Positives = 100/181 (55%), Gaps = 20/181 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QLISGV Y H+  + HRDLK EN LLD      LKI  FG +    ++ + + 
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK- 174
Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKP--------TADC 113
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P        T   
Sbjct: 175 --DTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           I  +++    ++  SP       C  LI RI    P+ R++I +I++H W+ K++P D++
Sbjct: 233 ILNVQYAIPDYVHISP------ECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLM 286
Query: 174 D 174
           +
Sbjct: 287 N 287

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 100/184 (54%), Gaps = 9/184 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A +  RQ++SG+ Y+H   I HRDLKPEN+LL+ +     ++I DFGL+T F  +
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEY 116
            K   +  K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++     D ++ 
Sbjct: 183 KK---MKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           +E K     +   W ++  +   LIR++L  +PS R++      H W   +    I    
Sbjct: 239 VE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297
Query: 177 PSSD 180
           PS D
Sbjct: 298 PSLD 301

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 100/184 (54%), Gaps = 9/184 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A +  RQ++SG+ Y+H   I HRDLKPEN+LL+ +     ++I DFGL+T F  +
Sbjct: 146 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEY 116
            K   +  K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++     D ++ 
Sbjct: 206 KK---MKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 261
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           +E K     +   W ++  +   LIR++L  +PS R++      H W   +    I    
Sbjct: 262 VE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 320
Query: 177 PSSD 180
           PS D
Sbjct: 321 PSLD 324

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 100/184 (54%), Gaps = 9/184 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A +  RQ++SG+ Y+H   I HRDLKPEN+LL+ +     ++I DFGL+T F  +
Sbjct: 147 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEY 116
            K   +  K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++     D ++ 
Sbjct: 207 KK---MKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 262
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           +E K     +   W ++  +   LIR++L  +PS R++      H W   +    I    
Sbjct: 263 VE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 321
Query: 177 PSSD 180
           PS D
Sbjct: 322 PSLD 325

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/189 (35%), Positives = 104/189 (55%), Gaps = 10/189 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F +  K 
Sbjct: 111 MKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK- 169
Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             LD  CG+ PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  
Sbjct: 170 --LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE 224
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD--GPP 177
           +  R   R P+  +  +C +L++++L   P  R ++E+I   RW +     + +     P
Sbjct: 225 RVLRGKYRIPF-YMSTDCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEP 283
Query: 178 SSDFNSTAK 186
             DFN T +
Sbjct: 284 DPDFNDTKR 292

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 98/184 (53%), Gaps = 9/184 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A +  RQ++SG+ Y H   I HRDLKPEN+LL+ +     ++I DFGL+T F  +
Sbjct: 123 FSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEY 116
            K +    K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++     D ++ 
Sbjct: 183 KKXKD---KIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           +E K     +   W ++  +   LIR+ L  +PS R++      H W   +    I    
Sbjct: 239 VE-KGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDV 297
Query: 177 PSSD 180
           PS D
Sbjct: 298 PSLD 301

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMN 57
            ++ +A +  +Q+ SG+ Y+H   I HRDLKPEN+LL+ ++    +KI DFGL+T F+ N
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEY 116
            K   +  + GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P + K   D ++ 
Sbjct: 178 TK---MKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
Query: 117 LEWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDG 175
           +E    ++    P W  +  +   LIR++L   PS R+   +   H W  K+      + 
Sbjct: 234 VET--GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS----ET 287
Query: 176 PPSSDFNSTAKRMRSDLETEANR 198
           P  SD  S    M +  + +A +
Sbjct: 288 PTISDLPSLESAMTNIRQFQAEK 310

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 94/171 (54%), Gaps = 9/171 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMN 57
            ++ +A +  +Q+ SG+ Y+H   I HRDLKPEN+LL+ ++    +KI DFGL+T F+ N
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEY 116
            K   +  + GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P + K   D ++ 
Sbjct: 178 TK---MKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +E           W  +  +   LIR++L   PS R+   +   H W  K+
Sbjct: 234 VE-TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 94/171 (54%), Gaps = 9/171 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMN 57
            ++ +A +  +Q+ SG+ Y+H   I HRDLKPEN+LL+ ++    +KI DFGL+T F+ N
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEY 116
            K   +  + GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P + K   D ++ 
Sbjct: 178 TK---MKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +E           W  +  +   LIR++L   PS R+   +   H W  K+
Sbjct: 234 VE-TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 95/167 (56%), Gaps = 9/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A +  RQ++SG+ Y+H   I HRDLKPEN+LL+ +     ++I DFGL+T F  +
Sbjct: 129 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEY 116
            K   +  K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++     D ++ 
Sbjct: 189 KK---MKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 244
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +E K     +   W ++  +   LIR++L  +PS R++      H W
Sbjct: 245 VE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 94/170 (55%), Gaps = 9/170 (5%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTL---KISDFGLATVFRMNGKER 61
           +A    +Q++SG+ YLH   I HRD+KPEN+LL+ +++L   KI DFGL++ F    K+ 
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDY 203
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWK 120
            L  + GT  Y+APEVL + Y  E  D+WSCG+I+  +L G  P+  +   D I+ +E K
Sbjct: 204 KLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-K 261
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
              +   + W  +      LI+ +L    + R   E+  + RW  K+  N
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A    +Q++SG  YLH   I HRDLKPEN+LL+ +     +KI DFGL+  F + 
Sbjct: 101 FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 160
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           GK   + ++ GT  Y+APEVL + Y  E  D+WSCG+IL  +L G  P+   T   I   
Sbjct: 161 GK---MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKR 216
Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
             K         W ++      L++ +L   PS R++ E+  +H W  K
Sbjct: 217 VEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            ++ +A    +Q++SG  YLH   I HRDLKPEN+LL+ +     +KI DFGL+  F + 
Sbjct: 118 FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 177
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           GK   + ++ GT  Y+APEVL + Y  E  D+WSCG+IL  +L G  P+   T   I   
Sbjct: 178 GK---MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKR 233
Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
             K         W ++      L++ +L   PS R++ E+  +H W  K
Sbjct: 234 VEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 7/162 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKER 61
           +A    +Q++SGV YLH   I HRDLKPEN+LL+ ++    +KI DFGL+ VF     ++
Sbjct: 137 DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQK 193
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            + ++ GT  Y+APEVL + Y  E  D+WS G+IL  +LAG  P+   T   I     K 
Sbjct: 194 KMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   W  +      LI+++L      R++ ++   H W
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 82/163 (50%), Gaps = 8/163 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    RQ++  V YLH  GI HRDLKPEN+L   QD    + ISDFGL+   +M GK  
Sbjct: 121 DASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLS---KMEGKGD 177
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            +   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +D+  +   E +  K
Sbjct: 178 VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQI-LK 236
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    WD +  +    IR ++   P+ R   E+   H W
Sbjct: 237 AEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 15/184 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ F RQ I GV+YLH+  + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER 198
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           +     CGT  Y+APEVL +   +   DIWS G IL  +L G+ P++     C++  Y+ 
Sbjct: 199 K--KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYIR 253
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-----HMPNDIV 173
            K N +   S    ++    +LIRR+L   P+ R ++ ++ +  +++       +P   +
Sbjct: 254 IKKNEY---SVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310
Query: 174 DGPP 177
             PP
Sbjct: 311 TVPP 314

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/184 (34%), Positives = 100/184 (54%), Gaps = 15/184 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ F RQ I GV+YLH+  + HRDLK  N+ L+    +KI DFGLAT    +G E
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-E 197
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           R  D  CGT  Y+APEVL +   +   DIWS G IL  +L G+ P++     C++  Y+ 
Sbjct: 198 RKKD-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYIR 253
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-----HMPNDIV 173
            K N +   S    ++    +LIRR+L   P+ R ++ ++ +  +++       +P   +
Sbjct: 254 IKKNEY---SVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310
Query: 174 DGPP 177
             PP
Sbjct: 311 TVPP 314

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 15/184 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ F RQ I GV+YLH+  + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER 198
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           +     CGT  Y+APEVL +   +   DIWS G IL  +L G+ P++     C++  Y+ 
Sbjct: 199 K--KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYIR 253
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-----HMPNDIV 173
            K N +   S    ++    +LIRR+L   P+ R ++ ++ +  +++       +P   +
Sbjct: 254 IKKNEY---SVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 310
Query: 174 DGPP 177
             PP
Sbjct: 311 TVPP 314

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/184 (34%), Positives = 100/184 (54%), Gaps = 15/184 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ F RQ I GV+YLH+  + HRDLK  N+ L+    +KI DFGLAT    +G E
Sbjct: 123 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG-E 181
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           R  D  CGT  Y+APEVL +   +   DIWS G IL  +L G+ P++     C++  Y+ 
Sbjct: 182 RKKD-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYIR 237
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-----HMPNDIV 173
            K N +   S    ++    +LIRR+L   P+ R ++ ++ +  +++       +P   +
Sbjct: 238 IKKNEY---SVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCL 294
Query: 174 DGPP 177
             PP
Sbjct: 295 TVPP 298

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERP 62
           A  + RQ++  + Y H   I HRD+KPENVLL  ++    +K+ DFG+A     +G    
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG--LV 189
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
              + GT  ++APEV+ R    +P D+W CG+IL  +L+G LP+        E +  K  
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI-IKGK 248
Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW--------YSKHMPNDI 172
             M    W  +  +   L+RR+L   P+ R+ + +  +H W        Y  H+P  +
Sbjct: 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV 306

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL-DLQDTL--KISDFGLATVFRMN 57
            ++ EA    R+L+S V ++H  G+ HRDLKPEN+L  D  D L  KI DFG A +   +
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKP--TADCIE 115
              +PL   C TL Y APE+L ++   E  D+WS G+IL  ML+G++P+     +  C  
Sbjct: 163 N--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 116 YLEW-----KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +E      K +   +   W  +      LI+ +L   P+ RL +  ++ + W
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 88/174 (50%), Gaps = 13/174 (7%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ E +   R L+  V +LH+  I HRDLKPEN+LLD    +++SDFG +       K 
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 61  RPLDKKCGTLPYVAPEVLVRSY------LAEPADIWSCGIILVAMLAGELP-WDKPTADC 113
           R L   CGT  Y+APE+L  S         +  D+W+CG+IL  +LAG  P W +     
Sbjct: 257 REL---CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313
Query: 114 IEYLEWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
           +  +   + ++   SP WD        LI R+L   P  RL  E+   H ++ +
Sbjct: 314 LRMI--MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVL---LDLQDTLKISDFGLATVFRMNGKER 61
           +A +   Q++  V+YLH  GI HRDLKPEN+L   LD    + ISDFGL+   +M     
Sbjct: 117 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGS 173
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +D+  A   E +  K
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LK 232
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    WD +  +    IR ++   P  R   E+   H W
Sbjct: 233 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 89/169 (52%), Gaps = 14/169 (8%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER 61
           ++ EA+ F  Q+I+G+ YLHS GI HRDL   N+LL     +KI+DFGLAT  +M     
Sbjct: 110 SENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM----- 164
Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA-DCIEYL 117
           P +K    CGT  Y++PE+  RS     +D+WS G +   +L G  P+D  T  + +  +
Sbjct: 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224
Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
              D       P   L +    LI ++L   P+ RL++  +  H + S+
Sbjct: 225 VLAD----YEMP-SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVL---LDLQDTLKISDFGLATVFRMNGKER 61
           +A +   Q++  V+YLH  GI HRDLKPEN+L   LD    + ISDFGL+   +M     
Sbjct: 117 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGS 173
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +D+  A   E +  K
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LK 232
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    WD +  +    IR ++   P  R   E+   H W
Sbjct: 233 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVL---LDLQDTLKISDFGLATVFRMNGKER 61
           +A +   Q++  V+YLH  GI HRDLKPEN+L   LD    + ISDFGL+   +M     
Sbjct: 117 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGS 173
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +D+  A   E +  K
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LK 232
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    WD +  +    IR ++   P  R   E+   H W
Sbjct: 233 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVL---LDLQDTLKISDFGLATVFRMNGKER 61
           +A +   Q++  V+YLH  GI HRDLKPEN+L   LD    + ISDFGL+   +M     
Sbjct: 117 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGS 173
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +D+  A   E +  K
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LK 232
Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    WD +  +    IR ++   P  R   E+   H W
Sbjct: 233 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/171 (36%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 1   MAQWEAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           M   E  KF+  +L  G+++LHS GI +RDLKPEN+LLD +  +K++DFGL+        
Sbjct: 126 MFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDH 183
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           E+     CGT+ Y+APEV+ R   +  AD WS G+++  ML G LP+          L  
Sbjct: 184 EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           K    M +     L     SL+R +    P+ RL       E+IK H +YS
Sbjct: 244 KAKLGMPQF----LSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYS 290

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 86/163 (52%), Gaps = 9/163 (5%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKER 61
           +A    +Q++S V+YLH  GI HRDLKPEN+L    +    + I+DFGL+ +   NG   
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNG--- 162
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +   CGT  YVAPEVL +   ++  D WS G+I   +L G  P+ + T   + + + K+
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKE 221
Query: 122 NRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +   SP WD +  +    I  +L   P+ R   EK  SH W
Sbjct: 222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 136 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 195
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           + +   CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 196 KKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 250
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 251 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 294

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           + +   CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 198 KKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 252
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 253 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 118 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 177
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           +     CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 178 K--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 232
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 233 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 276

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           + +   CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 172 KKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 226
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 227 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 173
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           +     CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 174 K--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 228
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 229 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 10/167 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G+ 
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 173
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--YLE 118
           +     CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++     C++  YL 
Sbjct: 174 K--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLR 228
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            K N +   S    ++    SLI+++L   P+ R  I ++ +  +++
Sbjct: 229 IKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 93/165 (56%), Gaps = 16/165 (9%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGK 59
           + +  ++ FF Q+++ +++ HS+G+ HRD+K EN+L+DL +   K+ DFG   +      
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---- 191
Query: 60  ERPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
           + P     GT  Y  PE + R  Y A PA +WS GI+L  M+ G++P+++      E LE
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EILE 247
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            + +     SP      +C +LIRR LAP PS+R ++E+I    W
Sbjct: 248 AELHFPAHVSP------DCCALIRRCLAPKPSSRPSLEEILLDPW 286

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRM 56
            ++ EA      +   VEYLHS+G+ HRDLKP N+L   +    + L+I DFG A   R 
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA 177
Query: 57  -NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
            NG    L   C T  +VAPEVL R    E  DIWS GI+L  MLAG  P+    +D  E
Sbjct: 178 ENGL---LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234
Query: 116 YLEWKDNRH---MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
            +  +       +    W+ +      L+ ++L   P  RL  +++  H W ++
Sbjct: 235 EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRM 56
            ++ EA      +   VEYLHS+G+ HRDLKP N+L   +    + L+I DFG A   R 
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA 177
Query: 57  -NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
            NG    L   C T  +VAPEVL R    E  DIWS GI+L  MLAG  P+    +D  E
Sbjct: 178 ENGL---LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234
Query: 116 YLEWKDNRH---MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
            +  +       +    W+ +      L+ ++L   P  RL  +++  H W ++
Sbjct: 235 EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNG 58
           ++ +A     Q++  V ++H   I HRDLKPEN+LL  +     +K++DFGLA    + G
Sbjct: 128 SEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQG 185
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
           +++      GT  Y++PEVL +    +P DIW+CG+IL  +L G  P WD+       Y 
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKL--YQ 243
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +     +LI ++L   P+ R+  ++   H W
Sbjct: 244 QIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  R + + +++LHS  IAHRD+KPEN+L   ++    LK++DFG A     N  + 
Sbjct: 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           P    C T  YVAPEVL      +  D+WS G+I+  +L G  P+   T   I     + 
Sbjct: 189 P----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
Query: 122 NRHMQRS----PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
            R  Q       W  +  +   LIR +L   P+ RL I +  +H W ++ M
Sbjct: 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  R + + +++LHS  IAHRD+KPEN+L   ++    LK++DFG A     N  + 
Sbjct: 110 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 169
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           P    C T  YVAPEVL      +  D+WS G+I+  +L G  P+   T   I     + 
Sbjct: 170 P----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 225
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
            R  Q       W  +  +   LIR +L   P+ RL I +  +H W ++ M
Sbjct: 226 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 80/170 (47%), Gaps = 7/170 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKER 61
           +A    +Q++  V YLH  GI HRDLKPEN+L         LKI+DFGL+ +      + 
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQV 205
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +   CGT  Y APE+L         D+WS GII   +L G  P+     D   +    +
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265
Query: 122 NRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
             +   SP WD + +N   L+R+++   P  RL   +   H W +    N
Sbjct: 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 9/164 (5%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           +A    +Q++  V + H  G+ HRDLKPEN+LL  +     +K++DFGLA    + G ++
Sbjct: 104 DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQ 161
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
                 GT  Y++PEVL +    +P DIW+CG+IL  +L G  P WD+       Y + K
Sbjct: 162 AWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKL--YQQIK 219
Query: 121 DNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
              +   SP WD +     +LI ++L   P+ R+   +   H W
Sbjct: 220 AGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 89/169 (52%), Gaps = 9/169 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNG 58
           ++ +A    +Q++  V + H  G+ HRDLKPEN+LL  +     +K++DFGLA    + G
Sbjct: 119 SEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEG 176
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
           +++      GT  Y++PEVL +    +P D+W+CG+IL  +L G  P WD+       Y 
Sbjct: 177 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ 234
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
           + K   +   SP WD +      LI ++L   PS R+   +   H W S
Sbjct: 235 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 177 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 177 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 1   MAQWEAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           M   E  KF+  +L   +++LHS GI +RDLKPEN+LLD +  +K++DFGL+        
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDH 179
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           E+     CGT+ Y+APEV+ R    + AD WS G+++  ML G LP+          +  
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           K    M +     L     SL+R +    P+ RL      +E+IK H ++S
Sbjct: 240 KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 177 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 118 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 175
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 176 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 234
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 235 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 276

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 125 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 182
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 183 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 241
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 242 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 283

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 1   MAQWEAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           M   E  KF+  +L   +++LHS GI +RDLKPEN+LLD +  +K++DFGL+        
Sbjct: 123 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDH 180
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           E+     CGT+ Y+APEV+ R    + AD WS G+++  ML G LP+          +  
Sbjct: 181 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           K    M +     L     SL+R +    P+ RL      +E+IK H ++S
Sbjct: 241 KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 287

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 12/171 (7%)
Query: 1   MAQWEAQKFF-RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           M   E  KF+  +L   +++LHS GI +RDLKPEN+LLD +  +K++DFGL+        
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDH 179
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           E+     CGT+ Y+APEV+ R    + AD WS G+++  ML G LP+          +  
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           K    M +     L     SL+R +    P+ RL      +E+IK H ++S
Sbjct: 240 KAKLGMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 9/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  V + H  GI HRDLKPEN+LL  +     +K++DFGLA    + G
Sbjct: 101 SEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQG 158
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            ++      GT  Y++PEVL +    +P D+W+CG+IL  +L G  P WD+       Y 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL--YQ 216
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +      LI ++L   P+ R+   +   H W
Sbjct: 217 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 258 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 315
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 316 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 374
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 375 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 416

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 85/156 (54%), Gaps = 4/156 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L     ++ +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 255
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +       L+ ++L    + RL  E+++ +     H
Sbjct: 256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 9/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  V + H  GI HRDLKPEN+LL  +     +K++DFGLA    + G
Sbjct: 101 SEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQG 158
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            ++      GT  Y++PEVL +    +P D+W+CG+IL  +L G  P WD+       Y 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL--YQ 216
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +      LI ++L   P+ R+   +   H W
Sbjct: 217 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERP 62
           A  + RQ++  + Y H   I HRD+KP  VLL  ++    +K+  FG+A     +G    
Sbjct: 134 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LV 191
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
              + GT  ++APEV+ R    +P D+W CG+IL  +L+G LP+        E +  K  
Sbjct: 192 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI-IKGK 250
Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW--------YSKHMPNDI 172
             M    W  +  +   L+RR+L   P+ R+ + +  +H W        Y  H+P  +
Sbjct: 251 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV 308

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDK 65
           +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +       R L  
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 301
Query: 66  KCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKD 121
            CGT  Y+APEVLV    A      D WS G+IL   L+G  P+ +  T   ++      
Sbjct: 302 -CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +     W  +    L L++++L   P  R   E+   H W
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 92/175 (52%), Gaps = 19/175 (10%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ +A+ +F+ LI G+EYLH + I HRD+KP N+L+     +KI+DFG++  F+  G +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSD 191
Query: 61  RPLDKKCGTLPYVAPEVLVRS---YLAEPADIWSCGIILVAMLAGELPWDKPTADCI--- 114
             L    GT  ++APE L  +   +  +  D+W+ G+ L   + G+ P+      C+   
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 115 ---EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
              + LE+ D   +     D        LI R+L   P +R+ + +IK H W ++
Sbjct: 252 IKSQALEFPDQPDIAEDLKD--------LITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERP 62
           A  + RQ++  + Y H   I HRD+KP  VLL  ++    +K+  FG+A     +G    
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LV 189
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
              + GT  ++APEV+ R    +P D+W CG+IL  +L+G LP+        E +  K  
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI-IKGK 248
Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW--------YSKHMPNDI 172
             M    W  +  +   L+RR+L   P+ R+ + +  +H W        Y  H+P  +
Sbjct: 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV 306

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 9/169 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNG 58
           ++ +A    +Q++  V + H  G+ HR+LKPEN+LL  +     +K++DFGLA    + G
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEG 165
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
           +++      GT  Y++PEVL +    +P D+W+CG+IL  +L G  P WD+       Y 
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ 223
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
           + K   +   SP WD +      LI ++L   PS R+   +   H W S
Sbjct: 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 252
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 253 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 253
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 252
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 253 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 255
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 256 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 253
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 253
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 255
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 256 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 4/156 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 145 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG  P+        EYL ++    ++    +
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKIIKLEYDFPE 260
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +       L+ ++L    + RL  E+++ +     H
Sbjct: 261 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 296

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 253
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 4/156 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 255
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +       L+ ++L    + RL  E+++ +     H
Sbjct: 256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 4/156 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 256
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +       L+ ++L    + RL  E+++ +     H
Sbjct: 257 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 292

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 122 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 237
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 238 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 267

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 92/190 (48%), Gaps = 11/190 (5%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +A  +F QLI G+EYLHS+GI H+D+KP N+LL    TLKIS  G+A        +    
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 65  KKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
              G+  +  PE+   + ++     DIWS G+ L  +  G  P++    D I  L     
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE---GDNIYKLFENIG 226
Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY-SKHMPNDI-VDGPPSSD 180
           +     P D        L++ +L   P+ R +I +I+ H W+  KH P +  V  PPS D
Sbjct: 227 KGSYAIPGD-CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285
Query: 181 FNSTAKRMRS 190
              T  R RS
Sbjct: 286 ---TKDRWRS 292

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 4/156 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 256
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           +       L+ ++L    + RL  E+++ +     H
Sbjct: 257 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 292

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 115 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 230
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 231 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 260

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 231
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL--DLQDT-LKISDFGLATVFRMNGKER 61
           +A +  + ++S V Y H   +AHRDLKPEN L   D  D+ LK+ DFGLA  F+     R
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
               K GT  YV+P+VL   Y  E  D WS G+++  +L G  P+  PT   +     + 
Sbjct: 167 ---TKVGTPYYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREG 222
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
                   W  +     SLIRR+L   P  R+   +   H W+ K +
Sbjct: 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL--DLQDT-LKISDFGLATVFRMNGKER 61
           +A +  + ++S V Y H   +AHRDLKPEN L   D  D+ LK+ DFGLA  F+     R
Sbjct: 124 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
               K GT  YV+P+VL   Y  E  D WS G+++  +L G  P+  PT   +     + 
Sbjct: 184 ---TKVGTPYYVSPQVLEGLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREG 239
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
                   W  +     SLIRR+L   P  R+   +   H W+ K +
Sbjct: 240 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 286

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 117 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 232
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 233 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 262

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 118 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           YV+PE+L      + +D+W+ G I+  ++AG LP   P     EYL ++    ++    +
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG-LP---PFRAGNEYLIFQKIIKLEYDFPE 233
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           +       L+ ++L    + RL  E+++ +
Sbjct: 234 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 30/203 (14%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGK 59
           + EA    + + S +++LH+KGIAHRDLKPEN+L +  +    +KI DFGL +  ++NG 
Sbjct: 110 ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD 169
Query: 60  ERPLD-----KKCGTLPYVAPEVLVRSYLAEPA------DIWSCGIILVAMLAGELP--- 105
             P+        CG+  Y+APEV V ++  E +      D+WS G+IL  +L+G  P   
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEV-VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 106 -------WDK----PTADCIEYLEWKDNRH-MQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
                  WD+    P    + +   ++ ++      W  +      LI ++L      RL
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
Query: 154 NIEKIKSHRWYSKHMPNDIVDGP 176
           +  ++  H W     P + +  P
Sbjct: 289 SAAQVLQHPWVQGCAPENTLPTP 311

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA    +N 
Sbjct: 126 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 183
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            E       GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+       Y 
Sbjct: 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA 240
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +     SLI  +L   P  R+  ++     W
Sbjct: 241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA    +N 
Sbjct: 102 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 159
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            E       GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+       Y 
Sbjct: 160 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA 216
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +     SLI  +L   P  R+  ++     W
Sbjct: 217 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 263

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 170 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA    +N 
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 160
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            E       GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+       Y 
Sbjct: 161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA 217
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +     SLI  +L   P  R+  ++     W
Sbjct: 218 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNG 58
           ++ +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA    +N 
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 160
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
            E       GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+       Y 
Sbjct: 161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA 217
Query: 118 EWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           + K   +   SP WD +     SLI  +L   P  R+  ++     W
Sbjct: 218 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 170 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------ 110
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 111 -ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
               + Y E++D      S   +        IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNY-EFEDEYFSNTSALAK------DFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ E +K  R L+  +  LH   I HRDLKPEN+LLD    +K++DFG +       K 
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 61  RPLDKKCGTLPYVAPEVLVRSY------LAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
           R +   CGT  Y+APE++  S         +  D+WS G+I+  +LAG  P+       +
Sbjct: 181 RSV---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237
Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
             +    N       WD        L+ R L   P  R   E+  +H ++ +++  ++
Sbjct: 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 60/95 (63%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           YV+PE+L      + +D+W+ G I+  ++AG  P+
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ E +K  R L+  +  LH   I HRDLKPEN+LLD    +K++DFG +       K 
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 61  RPLDKKCGTLPYVAPEVLVRSY------LAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
           R +   CGT  Y+APE++  S         +  D+WS G+I+  +LAG  P+       +
Sbjct: 181 REV---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237
Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
             +    N       WD        L+ R L   P  R   E+  +H ++ +++  ++
Sbjct: 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 60/95 (63%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 143 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           YV+PE+L      + +D+W+ G I+  ++AG  P+
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 60/95 (63%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           YV+PE+L      + +D+W+ G I+  ++AG  P+
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q++ GV YLHSK IAH DLKPEN++L  ++     +K+ DFG+A     
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 165 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N       +          IRR+L   P  R+ I +   H W
Sbjct: 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q++ GV YLHSK IAH DLKPEN++L  ++     +K+ DFG+A     
Sbjct: 112 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 172 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 228
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N       +          IRR+L   P  R+ I +   H W
Sbjct: 229 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q++ GV YLHSK IAH DLKPEN++L  ++     +K+ DFG+A     
Sbjct: 126 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 185
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             + + +    GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 186 GNEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 242
Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N       +          IRR+L   P  R+ I +   H W
Sbjct: 243 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ E +K  R L+  +  LH   I HRDLKPEN+LLD    +K++DFG +       K 
Sbjct: 108 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 167
Query: 61  RPLDKKCGTLPYVAPEVLVRSY------LAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
           R +   CGT  Y+APE++  S         +  D+WS G+I+  +LAG  P+       +
Sbjct: 168 REV---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 224
Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
             +    N       WD        L+ R L   P  R   E+  +H ++ ++
Sbjct: 225 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP--LDKKCGTLPYV 73
            +EYLHSK I +RDLKPEN+LLD    +KI+DFG A       K  P      CGT  Y+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KYVPDVTYXLCGTPDYI 170
Query: 74  APEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSPWDR 132
           APEV+      +  D WS GI++  MLAG  P +D  T    E +    N  ++  P+  
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---NAELRFPPFFN 227
Query: 133 LDVNCL--SLIRRILAP-LPSTRLNIEKIKSHRWYSK 166
            DV  L   LI R L+  L + +   E +K+H W+ +
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 30/203 (14%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGK 59
           + EA    + + S +++LH+KGIAHRDLKPEN+L +  +    +KI DF L +  ++NG 
Sbjct: 110 ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 60  ERPLD-----KKCGTLPYVAPEVLVRSYLAEPA------DIWSCGIILVAMLAGELP--- 105
             P+        CG+  Y+APEV V ++  E +      D+WS G+IL  +L+G  P   
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEV-VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 106 -------WDK----PTADCIEYLEWKDNRH-MQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
                  WD+    P    + +   ++ ++      W  +      LI ++L      RL
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
Query: 154 NIEKIKSHRWYSKHMPNDIVDGP 176
           +  ++  H W     P + +  P
Sbjct: 289 SAAQVLQHPWVQGCAPENTLPTP 311

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 42/94 (44%), Positives = 58/94 (61%), Gaps = 3/94 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +   RQ + G+++LH+  I HRDLKPEN+L+    T+K++DFGLA   R+   +  LD  
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALDPV 171
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             TL Y APEVL++S  A P D+WS G I   M 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 22/169 (13%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGKERP 62
           +  +Q+++ + Y HS+ + H+DLKPEN+L   QDT     +KI DFGLA +F+ +     
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSPIKIIDFGLAELFKSDEHST- 184
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD- 121
                GT  Y+APEV  R  +    DIWS G+++  +L G LP+   T   +E ++ K  
Sbjct: 185 --NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF---TGTSLEEVQQKAT 238
Query: 122 ----NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
               N  ++  P   L    + L++++L   P  R +  ++  H W+ +
Sbjct: 239 YKEPNYAVECRP---LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 21/173 (12%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A  F  Q++ G+++ H   I HRD+KP+N+L+D   TLKI DFG+A         +  + 
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NH 171
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
             GT+ Y +PE        E  DI+S GI+L  ML GE P++  TA  I        +H+
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI------KHI 225
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----EKIKSHRWYS-KHMPNDI 172
           Q S       N  + +R+    +P +  N+     EK K++R+ + + M +D+
Sbjct: 226 QDSVP-----NVTTDVRK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 11/171 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRM 56
            ++ EA      +   VEYLH++G+ HRDLKP N+L   +    ++++I DFG A   R 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 57  -NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
            NG    L   C T  +VAPEVL R       DIWS G++L  ML G  P+     D  E
Sbjct: 173 ENGL---LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229
Query: 116 YLEWK---DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +  +       +    W+ +      L+ ++L   P  RL    +  H W
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKER 61
           EA +  R + + +++LH+KGIAHRDLKPEN+L +  +    +KI DF L +  ++N    
Sbjct: 112 EASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 62  P-----LDKKCGTLPYVAPEVL-----VRSYLAEPADIWSCGIILVAMLAGELP------ 105
           P     L   CG+  Y+APEV+       ++  +  D+WS G++L  ML+G  P      
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCG 231
Query: 106 ----WDKPTADCIEYLEWKDNRHMQRSP-------WDRLDVNCLSLIRRILAPLPSTRLN 154
               WD+   +     + K    +Q          W  +      LI ++L      RL+
Sbjct: 232 ADCGWDR--GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLS 289
Query: 155 IEKIKSHRWYSKHMPN 170
             ++  H W     P 
Sbjct: 290 AAQVLQHPWVQGQAPE 305

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFGLA   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 7/151 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+++LHSKGI +RDLK +N+LLD    +KI+DFG+     M G  +  ++ CGT  
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKT-NEFCGTPD 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+APE+L+        D WS G++L  ML G+ P+     + + +    DN    R  W 
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W- 241
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIE-KIKSH 161
            L+     L+ ++    P  RL +   I+ H
Sbjct: 242 -LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 271

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +   RQ + G+++LH+  I HRDLKPEN+L+    T+K++DFGLA ++       P+   
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--- 179
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             TL Y APEVL++S  A P D+WS G I   M 
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +   RQ + G+++LH+  I HRDLKPEN+L+    T+K++DFGLA ++       P+   
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV--- 171
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             TL Y APEVL++S  A P D+WS G I   M 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 16/170 (9%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A   FRQL+S V YL  K I HRD+K EN+++    T+K+ DFG A       + +    
Sbjct: 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYT 188
Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
            CGT+ Y APEVL+ + Y     ++WS G+ L  ++  E P          + E ++   
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP----------FCELEETVE 238
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
               P   +    +SL+  +L P+P  R  +EK+ +  W ++  P ++ D
Sbjct: 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLAD 286

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+++LHSKGI +RDLK +N+LLD    +KI+DFG+     M G  +  +  CGT  
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKT-NXFCGTPD 183
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+APE+L+        D WS G++L  ML G+ P+     + + +    DN    R  W 
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W- 240
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIE-KIKSHRWYS----KHMPNDIVDGPPSSDFNSTAK 186
            L+     L+ ++    P  RL +   I+ H  +     + +    +D P      S   
Sbjct: 241 -LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299
Query: 187 RMRSDLETEANRACPTFDDRACVS 210
               D E    +   +F DRA ++
Sbjct: 300 CSNFDKEFLNEKPRLSFADRALIN 323

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 21/176 (11%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD---- 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 ---CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
               + Y ++ +    Q S   +        IR++L      RL I++   H W +
Sbjct: 229 NITAVSY-DFDEEFFSQTSELAK------DFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +   RQ + G+++LH+  I HRDLKPEN+L+    T+K++DFGLA ++       P+   
Sbjct: 115 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV--- 171
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             TL Y APEVL++S  A P D+WS G I   M 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 18/172 (10%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
            A+  A+ +  Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+ 
Sbjct: 138 FAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRT 195
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLE 118
             L   CGT  Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + + 
Sbjct: 196 WXL---CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
            K      R P      +   L+R +L    + R       +  IK+H+W++
Sbjct: 253 GK-----VRFP-SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 21/176 (11%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD---- 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 ---CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
               + Y ++ +    Q S   +        IR++L      RL I++   H W +
Sbjct: 229 NITAVSY-DFDEEFFSQTSELAK------DFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  +K++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 21/176 (11%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD---- 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 ---CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
               + Y ++ +    Q S   +        IR++L      RL I++   H W +
Sbjct: 229 NITAVSY-DFDEEFFSQTSELAK------DFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  ++++DFGLA   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 95/177 (53%), Gaps = 16/177 (9%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             + E Q +  +++  +E+LH  GI +RD+K EN+LLD    + ++DFGL+  F  +  E
Sbjct: 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 61  RPLDKKCGTLPYVAPEVLVR---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           R  D  CGT+ Y+AP++ VR   S   +  D WS G+++  +L G  P+   T D  +  
Sbjct: 216 RAYD-FCGTIEYMAPDI-VRGGDSGHDKAVDWWSLGVLMYELLTGASPF---TVDGEKNS 270
Query: 118 EWKDNRHMQRS--PW-DRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
           + + +R + +S  P+   +      LI+R+L   P  RL     + ++IK H ++ K
Sbjct: 271 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTAD 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+     + T  
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            I  + +  +       +          IR++L      RL I++   H W +
Sbjct: 229 NITSVSYDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL---CGTPE 189
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 244
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 245 -SHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 284

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTAD 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+     + T  
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            I  + +  +       +          IR++L      RL I++   H W +
Sbjct: 229 NITSVSYDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 198
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 253
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 254 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 293

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 7/147 (4%)
Query: 9   FFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           F+   IS G+ +LH +GI +RDLK +NV+LD +  +KI+DFG+     M+G      + C
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTT--REFC 181
Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR 127
           GT  Y+APE++      +  D W+ G++L  MLAG+ P+D    D +     + N    +
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK 241
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLN 154
           S    L    +S+ + ++   P+ RL 
Sbjct: 242 S----LSKEAVSICKGLMTKHPAKRLG 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 196
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 251
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 252 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 224
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 279
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 280 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFA 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 196
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 251
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 252 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILA-----PLPSTRLNIEKIKSHRWYS 165
                 +   L+R +L         + +  +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFA 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 87/167 (52%), Gaps = 18/167 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L  
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL-- 219
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNR 123
            CGT  Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K   
Sbjct: 220 -CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--- 275
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
              R P      +   L+R +L    + R       +  IK+H+W++
Sbjct: 276 --VRFP-SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 245
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 246 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 285

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           +++ EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTAD 112
           +G E       GT  +VAPE++    L   AD+WS G+I   +L+G  P+     + T  
Sbjct: 171 DGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS 165
            I  + +  +       +          IR++L      RL I++   H W +
Sbjct: 229 NITSVSYDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 172
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L + C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 232
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 233 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 278

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 132 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 188
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 248
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 249 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 294

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 124 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 180
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 240
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 241 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 286

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+++D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 309 AHPYLEQYYDPSDEPIAEAP 328

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG    + ++      D  CG
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCG 169
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 224
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 77/171 (45%), Gaps = 11/171 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ----DTLKISDFGLATVFRM 56
            ++ EA      +   VEYLH++G+ HRDLKP N+L   +    ++++I DFG A   R 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 57  -NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
            NG    L   C T  +VAPEVL R       DIWS G++L   L G  P+     D  E
Sbjct: 173 ENGL---LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE 229
Query: 116 YLEWK---DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +  +       +    W+ +      L+ + L   P  RL    +  H W
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPW 280

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 117 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 173
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 233
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 234 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 279

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 122 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 178
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 238
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 239 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 284

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 123 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 179
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 239
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 240 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 285

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 172
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 232
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 233 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 278

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G    L   CGT  
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGATWTL---CGTPE 224
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 279
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 280 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 329 AHPYLEQYYDPSDEPIAEAP 348

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 174
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 234
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 235 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG    + ++      D  CG
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCG 194
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 249
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H + +++  P+D  I + P
Sbjct: 311 AHPYLAQYYDPSDEPIAEAP 330

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 168 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 224
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 284
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 285 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 330

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 38/89 (42%), Positives = 55/89 (61%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++     +  L     TL 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEVL++S  A P D+WS G I   M 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 218
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 38/89 (42%), Positives = 55/89 (61%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++     +  L     TL 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEVL++S  A P D+WS G I   M 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 38/89 (42%), Positives = 55/89 (61%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++     +  L     TL 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEVL++S  A P D+WS G I   M 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG    + ++      D  CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 174
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 234
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 235 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 280

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 62/100 (62%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L   +T+KI DFGLATV          ++  G++
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R   + P    +D+++ GI+L  ++ G+LP+
Sbjct: 175 LWMAPEV-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRD+K  N+ L    T+KI DFGLATV       + +++  G++
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWDK-PTADCIEYLEWKDNRHM 125
            ++APEV +R     P    +D++S GI+L  ++ GELP+      D I ++     R  
Sbjct: 199 LWMAPEV-IRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV---GRGY 254
Query: 126 QRSPWDRLDVNCLSLIRRILA 146
                 +L  NC   ++R++A
Sbjct: 255 ASPDLSKLYKNCPKAMKRLVA 275

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 309 AHPYLEQYYDPSDEPIAEAP 328

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 314 AHPYLEQYYDPSDEPIAEAP 333

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGELPW-------------------D 107
            T  Y APE+++ S    +  DIWS G IL  ML+    +                   +
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPE 246
Query: 108 KPTADCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
           +   +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 307 AHPYLEQYYDPSDEPIAEAP 326

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 42/205 (20%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN---- 122
            T  Y APE+++ S    +  DIWS G IL  ML+     ++P      YL+  ++    
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRPIFPGKHYLDQLNHILGI 245
Query: 123 ------------------------RHMQRSPWDRL----DVNCLSLIRRILAPLPSTRLN 154
                                    H  + PW+RL    D   L L+ ++L   P  R+ 
Sbjct: 246 LGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 305
Query: 155 IEKIKSHRWYSKHM-PND--IVDGP 176
           +E+  +H + +++  P+D  I + P
Sbjct: 306 VEQALAHPYLAQYYDPSDEPIAEAP 330

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 311 AHPYLEQYYDPSDEPIAEAP 330

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 314 AHPYLEQYYDPSDEPIAEAP 333

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 254
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 255 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 314
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 315 AHPYLEQYYDPSDEPIAEAP 334

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 245
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 246 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 305
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 306 AHPYLEQYYDPSDEPIAEAP 325

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 256
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 257 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 316
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 317 AHPYLEQYYDPSDEPIAEAP 336

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 309 AHPYLEQYYDPSDEPIAEAP 328

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 246
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 307 AHPYLEQYYDPSDEPIAEAP 326

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 329 AHPYLEQYYDPSDEPIAEAP 348

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 32/200 (16%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK----------PT 110
            T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+          P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 111 A---DCIEYLEWKDNR----HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIK 159
               +CI  L+ ++      H  + PW+RL    D   L L+ ++L   P  R+ +E+  
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 160 SHRWYSKHM-PND--IVDGP 176
           +H +  ++  P+D  I + P
Sbjct: 313 AHPYLEQYYDPSDEPIAEAP 332

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 204
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 259
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  I +H+W++
Sbjct: 260 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFA 299

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG    + ++      D  CG
Sbjct: 117 YITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCG 172
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           TL Y+ PE++      E  D+WS G++    L G  P++  T         +  R + R 
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ-------ETYRRISRV 225
Query: 129 PW---DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +   D +      LI R+L    S RL + ++  H W
Sbjct: 226 EFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+AP +++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           F +Q+  G+ ++H   I H DLKPEN+L   +D   +KI DFGLA  ++   K   L   
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVN 248
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTADCIEYLEWKDN 122
            GT  ++APEV+   +++ P D+WS G+I   +L+G  P+    D  T + I    W   
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-- 306
Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
             ++   +  +       I ++L    S R++  +   H W S H
Sbjct: 307 --LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 42/205 (20%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN---- 122
            T  Y APE+++ S    +  DIWS G IL  ML+     ++P      YL+  ++    
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRPIFPGKHYLDQLNHILGI 243
Query: 123 ------------------------RHMQRSPWDRL----DVNCLSLIRRILAPLPSTRLN 154
                                    H  + PW+RL    D   L L+ ++L   P  R+ 
Sbjct: 244 LGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 303
Query: 155 IEKIKSHRWYSKHM-PND--IVDGP 176
           +E+  +H +  ++  P+D  I + P
Sbjct: 304 VEQALAHPYLEQYYDPSDEPIAEAP 328

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 3/95 (3%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A + F Q+  GV+Y+HSK + HRDLKP N+ L     +KI DFGL T  + +GK     +
Sbjct: 138 ALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---R 194
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             GTL Y++PE +      +  D+++ G+IL  +L
Sbjct: 195 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  ++IS + +LH KGI +RDLK +NVLLD +   K++DFG+      NG       
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA--T 183
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APE+L         D W+ G++L  ML G  P++    D  +  E   N  +
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILNDEV 241
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLN 154
               W  L  +   +++  +   P+ RL 
Sbjct: 242 VYPTW--LHEDATGILKSFMTKNPTMRLG 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 173
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 228
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 173
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 228
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAAL---CG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 112 ARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 167
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 224
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 225 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 42/205 (20%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDKKC 67
           F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 68  GTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN---- 122
            T  Y APE+++ S    +  DIWS G IL  ML+     ++P      YL+  ++    
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRPIFPGKHYLDQLNHILGI 243
Query: 123 ------------------------RHMQRSPWDRL----DVNCLSLIRRILAPLPSTRLN 154
                                    H  + PW+RL    D   L L+ ++L   P  R+ 
Sbjct: 244 LGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 303
Query: 155 IEKIKSHRWYSKHM-PND--IVDGP 176
           +E+  +H +  ++  P+D  I + P
Sbjct: 304 VEQALAHPYLEQYYDPSDEPIAEAP 328

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 194
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 249
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 185
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 240
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 241 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG    + ++       + CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKX 164
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 110 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 167
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 227
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 228 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 276

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRM--NGKERPLDKK 66
           RQ+ S + YLH++GI HRD+KPEN L     +  +K+ DFGL+  F    NG+   +  K
Sbjct: 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 67  CGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPW 106
            GT  +VAPEVL           D WS G++L  +L G +P+
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 112 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKX 169
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 229
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 230 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 278

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 115 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXL---CG 170
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 225
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 164
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 173
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE +      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 228
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKX 164
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 60/104 (57%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G+I+  M+ G + +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF--PGTDHID 232

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L    GT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---AGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDL---CG 173
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 228
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 117 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 172
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 227
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 228 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDL---CG 169
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 224
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 164
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 60/104 (57%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G+I+  M+ G + +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF--PGTDHID 232

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G    +  
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKX 164
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIV 173
            R+    L     SL+  +L   P  RL     + +++  HR++      D+V
Sbjct: 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAAL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           TL Y+ PE++      E  D+WS G++    L G+ P++  T        +K    ++ +
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDT----YKRISRVEFT 224
Query: 129 PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             D +      LI R+L   PS R  + ++  H W
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAAL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 112 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 167
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 222
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 223 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXL---CG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 58/98 (59%), Gaps = 2/98 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  ++   + +LH KGI +RDLKPEN++L+ Q  +K++DFGL      +G        CG
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCG 183
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           T+ Y+APE+L+RS      D WS G ++  ML G  P+
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 110 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTL---CG 165
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 220
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 221 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 113 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTXL---CG 168
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 223
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---CGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
            +APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 58/98 (59%), Gaps = 2/98 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  ++   + +LH KGI +RDLKPEN++L+ Q  +K++DFGL      +G        CG
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCG 183
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           T+ Y+APE+L+RS      D WS G ++  ML G  P+
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 8/155 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  +L   + Y H + + HRD+KPEN+L+  +  LKI+DFG  +V   + + R +   CG
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRXM---CG 174
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           TL Y+ PE++      E  D+W  G++    L G  P+D P+    E      N  ++  
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDLKFP 232
Query: 129 PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           P+  L      LI ++L   P  RL ++ +  H W
Sbjct: 233 PF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 187
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 244
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 245 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L    GT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXL---XGTPE 203
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEYLEWKDNRHMQRSP 129
           Y+APE+++     +  D W+ G+++  M AG  P+  D+P     + +  K      R P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----VRFP 258
Query: 130 WDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                 +   L+R +L    + R       +  IK+H+W++
Sbjct: 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 8/155 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  +L   + Y H + + HRD+KPEN+L+  +  LKI+DFG  +V   + + R +   CG
Sbjct: 120 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRXM---CG 175
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           TL Y+ PE++      E  D+W  G++    L G  P+D P+    E      N  ++  
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDLKFP 233
Query: 129 PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           P+  L      LI ++L   P  RL ++ +  H W
Sbjct: 234 PF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 200
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 257
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 258 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 172
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 229
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 230 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 200
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 257
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 258 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 186
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 243
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 244 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 219
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 220 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 276
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 277 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 139 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 194
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 251
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 252 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 60/101 (59%), Gaps = 6/101 (5%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  + YLH++G+ HRD+K +++LL L   +K+SDFG         K+ P  K     PY
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPY 206
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW--DKPT 110
            +APEV+ RS  A   DIWS GI+++ M+ GE P+  D P 
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 115 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 170
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 171 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 227
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 228 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 199
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 256
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 257 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 73/166 (43%), Gaps = 10/166 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 162 EASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 218
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D WS G+I   +L G  P+       I       
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTR 278
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R  I +  +H W
Sbjct: 279 IRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPW 324

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 186
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 243
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 244 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 167
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 224
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 225 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 172
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 229
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 230 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 92/183 (50%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +  +  T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPEVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+  +W  N+ ++     
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID--QW--NKVIE----- 239
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N+      
Sbjct: 240 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPD--VLFPADSEHNALKASQA 294
Query: 190 SDL 192
            DL
Sbjct: 295 RDL 297

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 206
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 263
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 264 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 200
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 257
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 258 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 167
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 224
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 225 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 214
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 271
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 272 -------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 214
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 271
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 272 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 187
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 244
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 245 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L   +T+KI DFGLAT           ++  G++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R   + P    +D+++ GI+L  ++ G+LP+
Sbjct: 187 LWMAPEV-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 200
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 257
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 258 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 199
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 256
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 257 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 171
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 228
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 229 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 171
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 228
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 229 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 199
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--- 256
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 257 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L   +T+KI DFGLAT           ++  G++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R   + P    +D+++ GI+L  ++ G+LP+
Sbjct: 187 LWMAPEV-IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 172
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 229
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 230 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 199
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 256
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 257 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 198 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L   CG
Sbjct: 117 YITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-SVHAPSSRRTTL---CG 172
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           TL Y+ PE++      E  D+WS G++    L G  P++  T         +  R + R 
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ-------ETYRRISRV 225
Query: 129 PW---DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +   D +      LI R+L    S RL + ++  H W
Sbjct: 226 EFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 199 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI++FG  +V   + +   L   CG
Sbjct: 115 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-SVHAPSSRRTTL---CG 170
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 225
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 214
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 271
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  PS R   E+I++H W
Sbjct: 272 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 38/194 (19%)
Query: 8   KFFR-QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           K+F+ QL+ G+ + H   I HRDLKP+N+L++ +  LK+ DFGLA  F +         +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSE 168
Query: 67  CGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPWDKPTAD------------ 112
             TL Y AP+VL+  R+Y +   DIWSCG IL  M+ G+ P    T D            
Sbjct: 169 VVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMG 226
Query: 113 --------CIEYLEWKDNRHMQRSPWDR-----------LDVNCLSLIRRILAPLPSTRL 153
                    +  L   +    QR P D            LD N +  +  +L   P  RL
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 154 NIEKIKSHRWYSKH 167
           + ++   H W++++
Sbjct: 287 SAKQALHHPWFAEY 300

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 176 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 113 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 173 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 75/141 (53%), Gaps = 9/141 (6%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWDK-PTADCIEYLEWKDNRHM 125
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+      D I ++     R  
Sbjct: 176 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV---GRGY 231
Query: 126 QRSPWDRLDVNCLSLIRRILA 146
                 ++  NC   ++R++A
Sbjct: 232 LSPDLSKVRSNCPKAMKRLMA 252

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 42/195 (21%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ F  QL++G+ Y H + + HRDLKP+N+L++ +  LKI+DFGLA  F +    R    
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTH 159
Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAG---------------------- 102
           +  TL Y AP+VL+ S   +   DIWS G I   M+ G                      
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 103 ----------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR 152
                     ELP   P     E L W+       S    LD + + L+ ++L   P+ R
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWE-------SFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 153 LNIEKIKSHRWYSKH 167
           +  ++   H ++ ++
Sbjct: 273 ITAKQALEHAYFKEN 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 42/195 (21%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ F  QL++G+ Y H + + HRDLKP+N+L++ +  LKI+DFGLA  F +    R    
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTH 159
Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAG---------------------- 102
           +  TL Y AP+VL+ S   +   DIWS G I   M+ G                      
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGT 219
Query: 103 ----------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR 152
                     ELP   P     E L W+       S    LD + + L+ ++L   P+ R
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWE-------SFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 153 LNIEKIKSHRWYSKH 167
           +  ++   H ++ ++
Sbjct: 273 ITAKQALEHAYFKEN 287

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNG 58
           M++ EA ++ RQ+  G+ ++H     H DLKPEN++   +  + LK+ DFGL        
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---D 202
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTADCI 114
            ++ +    GT  + APEV     +    D+WS G++   +L+G  P+    D  T   +
Sbjct: 203 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262
Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  +W    +M  S +  +  +    IR++L   P+TR+ I +   H W
Sbjct: 263 KSCDW----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 307

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 171 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNG 58
           M++ EA ++ RQ+  G+ ++H     H DLKPEN++   +  + LK+ DFGL        
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---D 308
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW----DKPTADCI 114
            ++ +    GT  + APEV     +    D+WS G++   +L+G  P+    D  T   +
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368
Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  +W    +M  S +  +  +    IR++L   P+TR+ I +   H W
Sbjct: 369 KSCDW----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLR 205
Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW------DKPTAD 112
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+      D P  +
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
             +YL         R P   L V   S+++  L   P  RL
Sbjct: 266 TEDYLFQVILEKQIRIPR-SLSVKAASVLKSFLNKDPKERL 305

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/98 (41%), Positives = 59/98 (60%), Gaps = 3/98 (3%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ F  QL++G+ Y H + + HRDLKP+N+L++ +  LKI+DFGLA  F +    R    
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTH 159
Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAG 102
           +  TL Y AP+VL+ S   +   DIWS G I   M+ G
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          ++  G++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 171 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI++FG  +V   + +   L   CG
Sbjct: 116 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-SVHAPSSRRTTL---CG 171
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 226
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 13/109 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-------VFRMN 57
           E  + FRQ++  + Y+HS+GI HRDLKP N+ +D    +KI DFGLA        + +++
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  GKERP-----LDKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIILVAML 100
            +  P     L    GT  YVA EVL    +  E  D++S GII   M+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 59/109 (54%), Gaps = 13/109 (11%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-------VFRMN 57
           E  + FRQ++  + Y+HS+GI HRDLKP N+ +D    +KI DFGLA        + +++
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  GKERP-----LDKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIILVAML 100
            +  P     L    GT  YVA EVL    +  E  D++S GII   M+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 112 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 169
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +   
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 229
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 230 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 111 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 168
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +   
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 228
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 229 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 270

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNG 58
           M++ E   + RQ   G++++H   I H D+KPEN++ + +   ++KI DFGLAT  ++N 
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNP 203
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
            E  +     T  + APE++ R  +    D+W+ G++   +L+G  P+     D +E L+
Sbjct: 204 DEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--AGEDDLETLQ 260
Query: 119 WKDNRHMQRSPWDRLDVNCLS--------LIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
                +++R  W+  D +  S         I+ +L   P  RL +     H W      N
Sbjct: 261 -----NVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
Query: 171 DIVDGPPSSDFNSTAKRMR 189
            +    PSS +N   ++++
Sbjct: 315 -LTSRIPSSRYNKIRQKIK 332

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 3/95 (3%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A + F Q+  GV+Y+HSK + +RDLKP N+ L     +KI DFGL T  + +GK     +
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX---R 180
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
             GTL Y++PE +      +  D+++ G+IL  +L
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 110 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 167
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +   
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 227
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 228 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 269

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 106 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLR 158
Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW------DKPTAD 112
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+      D P  +
Sbjct: 159 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 218
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
             +YL         R P   L V   S+++  L   P  RL
Sbjct: 219 TEDYLFQVILEKQIRIP-RSLSVKAASVLKSFLNKDPKERL 258

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID 232

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 191
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+  +W  N+ ++     
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID--QW--NKVIE----- 240
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+ +   P  S+ N       
Sbjct: 241 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPDVLF--PADSEHNKLKASQA 295
Query: 190 SDL 192
            DL
Sbjct: 296 RDL 298

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+  +W  N+ ++     
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID--QW--NKVIE----- 239
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N       
Sbjct: 240 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPD--VLFPADSEHNKLKASQA 294
Query: 190 SDL 192
            DL
Sbjct: 295 RDL 297

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 110 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLR 162
Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW------DKPTAD 112
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+      D P  +
Sbjct: 163 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
             +YL         R P   L V   S+++  L   P  RL
Sbjct: 223 TEDYLFQVILEKQIRIPR-SLSVKAASVLKSFLNKDPKERL 262

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID 232

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 5   EAQKFFRQLIS-GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--R 61
           E  +F+   IS  + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE  R
Sbjct: 121 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLR 173
Query: 62  PLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW------DKPTAD 112
           P D     CGT  Y+APE+L         D W+ G+++  M+AG  P+      D P  +
Sbjct: 174 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 233
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL 153
             +YL         R P   + V   S+++  L   P  RL
Sbjct: 234 TEDYLFQVILEKQIRIPR-SMSVKAASVLKSFLNKDPKERL 273

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 307
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +   
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 368 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLD 64
           A+ FF Q++  V + H+ G+ HRD+K EN+L+DL +  LK+ DFG   +     K+    
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 187
Query: 65  KKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + ++   
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--- 244
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                   R+   C  LIR  LA  P  R   E+I++H W
Sbjct: 245 -------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPW 277

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 6   AQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           A+ +  +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL      +G    + 
Sbjct: 253 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 310
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +   
Sbjct: 311 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 370
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 371 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 412

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID 232

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG          +R   +  GT 
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTP 180
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+ +L SKGI +RDLK +NV+LD +  +KI+DFG+      +G        CGT  
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPD 507
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           Y+APE++      +  D W+ G++L  MLAG+ P++    D
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 93/183 (50%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    ++ +  T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+  ++ +  P  D I+  +W  N+ ++     
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILF--PGRDYID--QW--NKVIE----- 239
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C + ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N       
Sbjct: 240 QLGTPCPAFMKKL---QPTVRNYVENRPKYAGYSFEKLFPD--VLFPADSEHNKLKASQA 294
Query: 190 SDL 192
            DL
Sbjct: 295 RDL 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 2/96 (2%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG          +R      GT 
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTP 180
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 2/96 (2%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG          +R      GT 
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTP 180
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 2/96 (2%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG          +R      GT 
Sbjct: 124 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTP 181
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/91 (43%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
           Y APEV++     E  DIWS G I+  M+ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/91 (43%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
           Y APEV++     E  DIWS G I+  M+ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+ +L SKGI +RDLK +NV+LD +  +KI+DFG+      +G        CGT  
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPD 186
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           Y+APE++      +  D W+ G++L  MLAG+ P++    D
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL------ 63
           F Q+   VE+LHSKG+ HRDLKP N+   + D +K+ DFGL T    + +E+ +      
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 64  ----DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
                 + GT  Y++PE +  +  +   DI+S G+IL  +L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMVPFVVTRY 192
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  DIWS G I+  M+ G + +  P  D I+  +W  N+ +     +
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHID--QW--NKVI-----E 241
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+ +   P  S+ N       
Sbjct: 242 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPDVLF--PADSEHNKLKASQA 296
Query: 190 SDL 192
            DL
Sbjct: 297 RDL 299

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLAT           ++  G++
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 199 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL------ 63
           F Q+   VE+LHSKG+ HRDLKP N+   + D +K+ DFGL T    + +E+ +      
Sbjct: 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 64  ----DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
                 + GT  Y++PE +  +  +   DI+S G+IL  +L
Sbjct: 230 YATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG  +V   + +   L    G
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXL---XG 173
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRHMQR 127
           TL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    ++ 
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF 228
Query: 128 SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +  D +      LI R+L   PS R  + ++  H W
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 5/100 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLAT           ++  G++
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPW 106
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+
Sbjct: 191 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 74/141 (52%), Gaps = 9/141 (6%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLAT           ++  G++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWDK-PTADCIEYLEWKDNRHM 125
            ++APEV +R     P    +D+++ GI+L  ++ G+LP+      D I ++     R  
Sbjct: 171 LWMAPEV-IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV---GRGY 226
Query: 126 QRSPWDRLDVNCLSLIRRILA 146
                 ++  NC   ++R++A
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMA 247

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    ++ +  T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  D+WS G I+  M+  ++ +  P  D I+  +W  N+ ++     
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF--PGRDYID--QW--NKVIE----- 239
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N       
Sbjct: 240 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPD--VLFPADSEHNKLKASQA 294
Query: 190 SDL 192
            DL
Sbjct: 295 RDL 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKC 67
           + +Q++ G++YLH   I HRD+K +NVL++     LKISDFG  T  R+ G     +   
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFT 184
Query: 68  GTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW 106
           GTL Y+APE++    R Y  + ADIWS G  ++ M  G+ P+
Sbjct: 185 GTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRY 183
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G I+  M+  ++ +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYID 232

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL    + N +      
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC---KENIEHNSTTS 197
Query: 66  K-CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNR 123
             CGT  Y+APEVL +       D W  G +L  ML G  P + + TA+  + +    N+
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL---NK 254
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE----KIKSHRWYSKHMPNDIVDGPPSS 179
            +Q  P   +  +   L+  +L    + RL  +    +IKSH ++S    +D+++   + 
Sbjct: 255 PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP 312
Query: 180 DFN 182
            FN
Sbjct: 313 PFN 315

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG        G  R  D 
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDT 228
Query: 66  KCGTLPYVAPEVLVR----SYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG +          P  ++  
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSC-------HAPSSRRTT 166
Query: 68  --GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE-WKDNRH 124
             GTL Y+ PE++      E  D+WS G++    L G+ P++  T     Y E +K    
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISR 221
Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           ++ +  D +      LI R+L   PS R  + ++  H W
Sbjct: 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG        G  R  D 
Sbjct: 175 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDT 233
Query: 66  KCGTLPYVAPEVLVR----SYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP--LDKK 66
           F  QL+ G++Y+HS  + HRDLKP N+L++    LKI DFG+A     +  E    + + 
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE----------------LPWDKP 109
             T  Y APE+++  +   +  D+WS G I   MLA                  +    P
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282
Query: 110 TADCIEYLEWKDNRHMQRS-------PWDRL----DVNCLSLIRRILAPLPSTRLNIEKI 158
           +   I+ +  +  R   +S       PW+ +    D   LSL+ R+L   PS R++    
Sbjct: 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342
Query: 159 KSHRWYSK-HMPNDIVDGPPSSDF 181
             H + +K H P+D  D  P  DF
Sbjct: 343 LRHPFLAKYHDPDDEPDCAPPFDF 366

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG        G  R  D 
Sbjct: 175 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDT 233
Query: 66  KCGTLPYVAPEVLVR----SYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKC 67
           + +Q++ G++YLH   I HRD+K +NVL++     LKISDFG  T  R+ G     +   
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFT 170
Query: 68  GTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW 106
           GTL Y+APE++    R Y  + ADIWS G  ++ M  G+ P+
Sbjct: 171 GTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF 211

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
           Y APEV++     E  DIWS G I+  M+  ++ +  P  D I+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYID 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP--LDKK 66
           F  QL+ G++Y+HS  + HRDLKP N+L++    LKI DFG+A     +  E    + + 
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE----------------LPWDKP 109
             T  Y APE+++  +   +  D+WS G I   MLA                  +    P
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 283
Query: 110 TADCIEYLEWKDNRHMQRS-------PWDRL----DVNCLSLIRRILAPLPSTRLNIEKI 158
           +   I+ +  +  R   +S       PW+ +    D   LSL+ R+L   PS R++    
Sbjct: 284 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 159 KSHRWYSK-HMPNDIVDGPPSSDF 181
             H + +K H P+D  D  P  DF
Sbjct: 344 LRHPFLAKYHDPDDEPDCAPPFDF 367

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 41/206 (19%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP----LD 64
           F  Q++ G++Y+HS  + HRDLKP N+L++    LKI DFGLA   R+   E      L 
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA---RIADPEHDHTGFLT 205
Query: 65  KKCGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLA------GELPWDK--------- 108
           +   T  Y APE+++ S    +  DIWS G IL  ML+      G+   D+         
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 265
Query: 109 -PTA---DCIEYLEWKDNRHMQRSP------WDRL----DVNCLSLIRRILAPLPSTRLN 154
            P+    +CI  +  K   ++Q  P      W +L    D   L L+ R+L   P+ R+ 
Sbjct: 266 SPSQEDLNCI--INMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRIT 323
Query: 155 IEKIKSHRWYSKHMPNDIVDGPPSSD 180
           +E+  +H +  ++   D  D P + +
Sbjct: 324 VEEALAHPYLEQYY--DPTDEPVAEE 347

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 2/96 (2%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HR++K +N+LL +  ++K++DFG          +R      GT 
Sbjct: 124 RECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTP 181
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            ++APEV+ R       DIWS GI+ + M+ GE P+
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           +++     ++++ G++YLHS+   HRD+K  NVLL  Q  +K++DFG+A   ++   +  
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIK 176
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            +   GT  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA     N    P      T  
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY---VVTRY 188
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGEL 104
           Y APEV++     E  DIWS G I+  ++ G +
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKPEN+L++ +  +K++DFGLA  F +    R    +
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHE 164
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++SG+E+LH + I +RDLKPENVLLD    ++ISD GLA    +   +       GT  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPG 354
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           ++APE+L+        D ++ G+ L  M+A   P+
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++SG+E+LH + I +RDLKPENVLLD    ++ISD GLA    +   +       GT  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPG 354
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           ++APE+L+        D ++ G+ L  M+A   P+
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 228
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKPEN+L++ +  +K++DFGLA  F +    R    +
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHE 165
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            QK+  Q+I+G+ + HS  I HRD+KPEN+L+     +K+ DFG A      G+    D 
Sbjct: 126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDD 183
Query: 66  KCGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE 103
           +  T  Y APE+LV      +  D+W+ G ++  M  GE
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+E LH + I +RDLKPEN+LLD    ++ISD GLA V    G+   +  + GT+ 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQT--IKGRVGTVG 350
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+APEV+         D W+ G +L  M+AG+ P+ +           +  + +     +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410
Query: 132 RLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
           R      SL  ++L   P+ RL     +  ++K H  + K
Sbjct: 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++SG+E+LH + I +RDLKPENVLLD    ++ISD GLA    +   +       GT  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPG 354
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           ++APE+L+        D ++ G+ L  M+A   P+
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKPEN+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+E LH + I +RDLKPEN+LLD    ++ISD GLA V    G+   +  + GT+ 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQT--IKGRVGTVG 350
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+APEV+         D W+ G +L  M+AG+ P+ +           +  + +     +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410
Query: 132 RLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
           R      SL  ++L   P+ RL     +  ++K H  + K
Sbjct: 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKPEN+L++ +  +K++DFGLA  F +    R    +
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHE 164
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 228
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++SG+E+LH + I +RDLKPENVLLD    ++ISD GLA    +   +       GT  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPG 354
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           ++APE+L+        D ++ G+ L  M+A   P+
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  D+WS G I+  M+  ++ +  P  D I+  +W  N+ ++     
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF--PGRDYID--QW--NKVIE----- 233
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N       
Sbjct: 234 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPD--VLFPADSEHNKLKASQA 288
Query: 190 SDL 192
            DL
Sbjct: 289 RDL 291

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKPEN+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 195
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y APEV++     E  D+WS G I+  M+  ++ +  P  D I+  +W  N+ ++     
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILF--PGRDYID--QW--NKVIE----- 244
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS--KHMPNDIVDGPPSSDFNSTAKRMR 189
           +L   C   ++++    P+ R  +E    +  YS  K  P+  V  P  S+ N       
Sbjct: 245 QLGTPCPEFMKKL---QPTVRTYVENRPKYAGYSFEKLFPD--VLFPADSEHNKLKASQA 299
Query: 190 SDL 192
            DL
Sbjct: 300 RDL 302

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 191
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 13/105 (12%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT-------VFRMN 57
           E  + FRQ++  + Y+HS+GI HR+LKP N+ +D    +KI DFGLA        + +++
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  GKERP-----LDKKCGTLPYVAPEVL-VRSYLAEPADIWSCGIIL 96
            +  P     L    GT  YVA EVL    +  E  D +S GII 
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIF 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 189
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 191
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 134 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 190
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 191 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 248
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 249 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA-------GPPAS 290

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 183
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/89 (43%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +     T  
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAML 100
           Y APEV++     E  DIWS G I+  M+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 136 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 192
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 193 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 250
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 251 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-------AGPPAS 292

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 129 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 185
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 243
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 244 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-------AGPPAS 285

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 235
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 293
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-------AGPPAS 335

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 256 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 312
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 370
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA-------GPPAS 412

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 58/96 (60%), Gaps = 2/96 (2%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
            R+++ G++YLHS+   HRD+K  NVLL  Q  +K++DFG+A   ++   +   +   GT
Sbjct: 122 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGT 179
Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
             ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  +  LH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 125 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPY 181
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPW 130
            +APE++ R       DIWS GI+++ M+ GE P+ ++P    ++ +  +DN   +    
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNL 239
Query: 131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
            ++  +    + R+L   P+ R    ++  H + +K        GPP+S
Sbjct: 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-------AGPPAS 281

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 163
Query: 67  CGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 113 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 170
Query: 67  CGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 171 VVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 64/113 (56%), Gaps = 8/113 (7%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    QL+ G++Y+HS GI HRDLKP NV ++    L+I DFGLA   R   +E  +   
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEE--MTGY 188
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             T  Y APE+++   +  +  DIWS G I+  +L G+  +  P +D I+ L+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLK 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +HS G+ HRD+KP+N+LLD    LK++DFG        G     D 
Sbjct: 176 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH-CDT 234
Query: 66  KCGTLPYVAPEVLVR----SYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PEVL       Y     D WS G+ L  ML G+ P+
Sbjct: 235 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 64/113 (56%), Gaps = 8/113 (7%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    QL+ G++Y+HS GI HRDLKP NV ++    L+I DFGLA   R   +E  +   
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEE--MTGY 188
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             T  Y APE+++   +  +  DIWS G I+  +L G+  +  P +D I+ L+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLK 239

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 4/95 (4%)
Query: 13  LISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPY 72
           ++  + YLH++G+ HRD+K +++LL     +K+SDFG         KE P  K     PY
Sbjct: 150 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPY 206
Query: 73  -VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
            +APEV+ R       DIWS GI+++ M+ GE P+
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 164
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/91 (42%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA     N    P      T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRY 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
           Y APEV++    A   DIWS G I+  ++ G
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 113 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 170
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 171 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 164
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-- 62
           E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F +    +P  
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGII---------------------LVAM 99
              +  TL Y  PE+L+  R Y   P D+W  G I                     L++ 
Sbjct: 186 YXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 100 LAGEL-PWDKPTADCIE-YLEWKDNRHMQRSPWDRL-----DVNCLSLIRRILAPLPSTR 152
           L G + P   P  D  E Y + +  +  +R   DRL     D   L LI ++L   P+ R
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304
Query: 153 LNIEKIKSHRWY-SKHMPNDI 172
           ++ +   +H ++ S  MP+D+
Sbjct: 305 IDSDDALNHDFFWSDPMPSDL 325

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 164
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 165
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 110 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHE 167
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 165
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 165
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG---KERPLDK 65
             R+++ G+EYLH  G  HRD+K  N+LL    +++I+DFG++      G   + +    
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 66  KCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
             GT  ++APEV+  VR Y  + ADIWS GI  + +  G  P+ K
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 163
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 162
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 166
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 3/96 (3%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +    R    +
Sbjct: 110 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHE 167
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLA 101
             TL Y APE+L+   Y +   DIWS G I   M+ 
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-- 62
           E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F +    +P  
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGII---------------------LVAM 99
              +  TL Y  PE+L+  R Y   P D+W  G I                     L++ 
Sbjct: 186 YXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 100 LAGEL-PWDKPTADCIE-YLEWKDNRHMQRSPWDRL-----DVNCLSLIRRILAPLPSTR 152
           L G + P   P  D  E Y + +  +  +R   DRL     D   L LI ++L   P+ R
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304
Query: 153 LNIEKIKSHRWY-SKHMPNDI 172
           ++ +   +H ++ S  MP+D+
Sbjct: 305 IDSDDALNHDFFWSDPMPSDL 325

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  QL+ GV + H   I HRDLKP+N+L++    LK++DFGLA  F +    R    +  
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVV 181
Query: 69  TLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGE 103
           TL Y AP+VL+ S   +   DIWS G I   M+ G+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 2/97 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A        +R  +   G
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVG 181
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           T  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG---KERPLDK 65
             R+++ G+EYLH  G  HRD+K  N+LL    +++I+DFG++      G   + +    
Sbjct: 121 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 66  KCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
             GT  ++APEV+  VR Y  + ADIWS GI  + +  G  P+ K
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-- 62
           E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F +    +P  
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGII---------------------LVAM 99
              +  TL Y  PE+L+  R Y   P D+W  G I                     L++ 
Sbjct: 186 YXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 100 LAGEL-PWDKPTADCIE-YLEWKDNRHMQRSPWDRL-----DVNCLSLIRRILAPLPSTR 152
           L G + P   P  D  E Y + +  +  +R   DRL     D   L LI ++L   P+ R
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304
Query: 153 LNIEKIKSHRWY-SKHMPNDI 172
           ++ +   +H ++ S  MP+D+
Sbjct: 305 IDSDDALNHDFFWSDPMPSDL 325

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-- 62
           E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F +    +P  
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGII---------------------LVAM 99
              +  TL Y  PE+L+  R Y   P D+W  G I                     L++ 
Sbjct: 185 YXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 100 LAGEL-PWDKPTADCIE-YLEWKDNRHMQRSPWDRL-----DVNCLSLIRRILAPLPSTR 152
           L G + P   P  D  E Y + +  +  +R   DRL     D   L LI ++L   P+ R
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303
Query: 153 LNIEKIKSHRWY-SKHMPNDI 172
           ++ +   +H ++ S  MP+D+
Sbjct: 304 IDSDDALNHDFFWSDPMPSDL 324

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  QL+ GV + H   I HRDLKP+N+L++    LK++DFGLA  F +    R    +  
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVV 181
Query: 69  TLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGE 103
           TL Y AP+VL+ S   +   DIWS G I   M+ G+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A   ++   +   +   G
Sbjct: 109 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVG 166
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           T  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A   ++   +   +   G
Sbjct: 109 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVG 166
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           T  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A   ++   +   +   G
Sbjct: 129 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVG 186
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           T  ++APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLD----LQDTLKISDFGLATVFRMNGKERPL 63
           +  +Q++ GV YLH   I H DLKP+N+LL     L D +KI DFG++   R  G    L
Sbjct: 135 RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD-IKIVDFGMS---RKIGHACEL 190
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE-YLEWKD- 121
            +  GT  Y+APE+L    +    D+W+ GII   +L    P+     D  E YL     
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF--VGEDNQETYLNISQV 248
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           N       +  +       I+ +L   P  R   E   SH W
Sbjct: 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   ++  GT  
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFVGTRS 171
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y++PE L  ++ +  +DIWS G+ LV M  G  P  +P     E L++  N    + P  
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP--RPPMAIFELLDYIVNEPPPKLPSA 229
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
              +     + + L   P+ R +++++  H +  +
Sbjct: 230 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 264

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 64/113 (56%), Gaps = 8/113 (7%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    QL+ G++Y+HS GI HRDLKP NV ++    L+I DFGLA   R   +E  +   
Sbjct: 126 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEE--MTGY 180
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             T  Y APE+++   +  +  DIWS G I+  +L G+  +  P +D I+ L+
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLK 231

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K+F QL S +E++HS+ + HRD+KP NV +     +K+ D GL   F  + K        
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 197
Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GT  Y++PE +  +     +DIWS G +L  M A + P+
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/100 (42%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-----TLKISDFGLATVFRMNGKER 61
           + F  QLI+GV + HS+   HRDLKP+N+LL + D      LKI DFGLA  F +    R
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIR 192
Query: 62  PLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAML 100
               +  TL Y  PE+L+ S + +   DIWS   I   ML
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 50/85 (58%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YLH++ I HRD+K  N+LLD     KI+DFG++      G+        GTL Y+ P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 76  EVLVRSYLAEPADIWSCGIILVAML 100
           E  ++  L E +D++S G++L  +L
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 355
Query: 72  YVAPEVLVRSYLAE-PADIWSCGIILVAMLAGELPW 106
           Y+APEVL +    +  AD +S G +L  +L G  P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 299 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 354
Query: 72  YVAPEVLVRSYLAE-PADIWSCGIILVAMLAGELPW 106
           Y+APEVL +    +  AD +S G +L  +L G  P+
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 355
Query: 72  YVAPEVLVRSYLAE-PADIWSCGIILVAMLAGELPW 106
           Y+APEVL +    +  AD +S G +L  +L G  P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 5/96 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F    K++P     GT  
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKP-HASVGTHG 355
Query: 72  YVAPEVLVRSYLAE-PADIWSCGIILVAMLAGELPW 106
           Y+APEVL +    +  AD +S G +L  +L G  P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 7/179 (3%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+++   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   + D + Y   +++     +  + L  
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSA 248
Query: 136 NCLSLIRRILAPLPSTR------LNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRM 188
           +  +++ + LA  P  R      +  + ++ H       P  + D   +S  +S A  +
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVA 74
           +G+ +LH     HRD+K  N+LLD   T KISDFGLA       +     +  GT  Y+A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 75  PEVLVRSYLAEPADIWSCGIILVAMLAG 102
           PE L R  +   +DI+S G++L+ ++ G
Sbjct: 204 PEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  +L+  ++YL ++ I HRD+KP+N+LLD    + I+DF +A    M  +E  +    G
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAG 176
Query: 69  TLPYVAPEVLVRSYLAE---PADIWSCGIILVAMLAGELPWD-KPTADCIEYLE-WKDNR 123
           T PY+APE+      A      D WS G+    +L G  P+  + +    E +  ++   
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLN 154
               S W +     +SL++++L P P  R +
Sbjct: 237 VTYPSAWSQ---EMVSLLKKLLEPNPDQRFS 264

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 42/211 (19%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLD 64
           Q F  Q +  V+ LH   + HRDLKP N+L++    LK+ DFGLA +   +  +   P  
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 65  KKCGTLPYV------APEVLVRSY-LAEPADIWSCGIILVAMLAGE-------------- 103
           ++ G   YV      APEV++ S   +   D+WSCG IL  +                  
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 104 ------LPWDKPTADCIEYLEWKDNRHMQRSP----------WDRLDVNCLSLIRRILAP 147
                  P       CIE    ++  +++  P          + R++   + L++R+L  
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRARE--YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 148 LPSTRLNIEKIKSHRWY-SKHMPNDIVDGPP 177
            P+ R+  ++   H +  + H PND  +G P
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVA 74
           +G+ +LH     HRD+K  N+LLD   T KISDFGLA       +     +  GT  Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 75  PEVLVRSYLAEPADIWSCGIILVAMLAG 102
           PE L R  +   +DI+S G++L+ ++ G
Sbjct: 195 PEAL-RGEITPKSDIYSFGVVLLEIITG 221

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVA 74
           +G+ +LH     HRD+K  N+LLD   T KISDFGLA       +     +  GT  Y+A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 75  PEVLVRSYLAEPADIWSCGIILVAMLAG 102
           PE L R  +   +DI+S G++L+ ++ G
Sbjct: 204 PEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVA 74
           +G+ +LH     HRD+K  N+LLD   T KISDFGLA       +     +  GT  Y+A
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 75  PEVLVRSYLAEPADIWSCGIILVAMLAG 102
           PE L R  +   +DI+S G++L+ ++ G
Sbjct: 198 PEAL-RGEITPKSDIYSFGVVLLEIITG 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + Q   RQ++  + +LHSK I HRDLK  NVL+ L+  ++++DFG++       ++R  D
Sbjct: 118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--D 175
Query: 65  KKCGTLPYVAPEVLVRSYLAE-----PADIWSCGIILVAMLAGELP 105
              GT  ++APEV++   + +      ADIWS GI L+ M   E P
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + Q   RQ++  + +LHSK I HRDLK  NVL+ L+  ++++DFG++       ++R  D
Sbjct: 110 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--D 167
Query: 65  KKCGTLPYVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP 105
              GT  ++APEV++   + +      ADIWS GI L+ M   E P
Sbjct: 168 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 42/211 (19%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--------RMNG 58
           Q F  Q +  V+ LH   + HRDLKP N+L++    LK+ DFGLA +            G
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 59  KERPLDKKCGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE-------------- 103
           ++  + +   T  Y APEV++ S   +   D+WSCG IL  +                  
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 104 ------LPWDKPTADCIEYLEWKDNRHMQRSP----------WDRLDVNCLSLIRRILAP 147
                  P       CIE    ++  +++  P          + R++   + L++R+L  
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRARE--YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 148 LPSTRLNIEKIKSHRWY-SKHMPNDIVDGPP 177
            P+ R+  ++   H +  + H PND  +G P
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 7/157 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 187
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD--CIEYLEWKDNRHMQRSP 129
           Y++PE L  ++ +  +DIWS G+ LV M  G  P    +      E L++  N    + P
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLP 247
Query: 130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
                +     + + L   P+ R +++++  H +  +
Sbjct: 248 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+HS G+ HRDLKP N+ ++    LKI DFGLA        +  +   
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGY 183
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
             T  Y APEV++   +  +  DIWS G I+  ML G+
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGLA V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLD 64
           Q F  Q +  V+ LH   + HRDLKP N+L++    LK+ DFGLA +   +  +   P  
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 65  KKCGTLPYV------APEVLVRSY-LAEPADIWSCGIILVAMLAGE-------------- 103
           ++ G + +V      APEV++ S   +   D+WSCG IL  +                  
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 104 ------LPWDKPTADCIEYLEWKDNRHMQRSP----------WDRLDVNCLSLIRRILAP 147
                  P       CIE    ++  +++  P          + R++   + L++R+L  
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRARE--YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 148 LPSTRLNIEKIKSHRWY-SKHMPNDIVDGPP 177
            P+ R+  ++   H +  + H PND  +G P
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD--------CIEYLEWKDNR 123
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A           E L++  N 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE 228
Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
              + P     +     + + L   P+ R +++++  H +  +
Sbjct: 229 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+HS G+ HRDLKP N+ ++    LKI DFGLA        +  +   
Sbjct: 147 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGY 201
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
             T  Y APEV++   +  +  DIWS G I+  ML G+
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTG 183
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 133 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTG 187
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/88 (42%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+EYLH   I HRDLKP N+LLD    LK++DFGLA  F      R    +  T  Y 
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYR 179
Query: 74  APEVLVRSYL-AEPADIWSCGIILVAML 100
           APE+L  + +     D+W+ G IL  +L
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 181
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 235

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 166
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 181
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTG 186
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 238

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 185
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 138 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTG 192
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 244

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTG 186
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 238

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 198
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 252

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--TVFRMNGKERPL 63
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA  T   M G     
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----- 188
Query: 64  DKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 189 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++ + +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 12/91 (13%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC------GT 69
           G+ YLH++ I HRD+K  N+LLD     KI+DFG++       K   LD+        GT
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK------KGTELDQTHLXXVVKGT 204
Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIILVAML 100
           L Y+ PE  ++  L E +D++S G++L  +L
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 208
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 262

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--TVFRMNGKERPL 63
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA  T   M G     
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----- 188
Query: 64  DKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 189 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 240

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 107 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 165
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 166 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 221

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 111 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 169
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 170 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 225

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            + F  QL+ G+ + HS+ + HRDLKP+N+L++    LK++DFGLA  F +    R    
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRCYSA 160
Query: 66  KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELP 105
           +  TL Y  P+VL  + L   + D+WS G I   +     P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--TVFRMNGKERPL 63
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA  T   M G     
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----- 188
Query: 64  DKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 189 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 240

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVK 185
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL   G  HRDL   N+L++     K+SDFGL  V   +  E     + G
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + +PE +        +D+WS GI+L  +++ GE P W+    D I+ ++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 7/179 (3%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+L+   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 129 LNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   +   + Y   +++     +  + L  
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 136 NCLSLIRRILAPLPSTR------LNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRM 188
           +  +++ + LA  P  R      +  + ++ H       P  + D   +S  +S A  +
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL      HRDL   N+L++     K+SDFG++ V   +  E     + G
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGG 179
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +        +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 180 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 233

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 60/106 (56%), Gaps = 3/106 (2%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           + +  A+ F  QL+ G++Y+HS  + HRDLKP N+ ++ +D  LKI DFGLA +   +  
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 60  ERP-LDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
            +  L +   T  Y +P +L+  +   +  D+W+ G I   ML G+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 126 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 180
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 15/106 (14%)
Query: 12  QLISGVEYLHSKGIA---HRDLKPENVLL-------DLQD-TLKISDFGLATVFRMNGKE 60
           Q+  G+ YLH + I    HRDLK  N+L+       DL +  LKI+DFGLA  +    K 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
                  G   ++APEV+  S  ++ +D+WS G++L  +L GE+P+
Sbjct: 173 ----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 132 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 186
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 132 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 186
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL      HRDL   N+L++     K+SDFG++ V   +  E     + G
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGG 173
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +        +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 174 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 147 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXG 201
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 253

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 137 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 191
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 243

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG++YL      HRDL   N+L++     K+SDFG++ V   +  E     + G
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGG 194
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +        +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 195 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 248

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 176
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 193
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 245

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 193
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 245

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 124 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 178
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 176
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 131 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 185
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 238

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 123 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 177
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 230

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 133 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 187
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 186
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 183
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 235

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 126 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 180
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 176
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 229

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 126 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 180
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 123 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MT 177
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 193
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 245

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 150 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXG 204
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 256

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G+ YL   G  HRDL   NVL+D     K+SDFGL+ V   +  +       G
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGG 214
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +     +  +D+WS G+++  +LA GE P W+    D I  +E
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 188
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 138 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 192
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 244

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 146 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 200
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 252

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 147 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 201
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 253

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 147 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 201
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 253

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 150 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 204
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 256

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 183
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 80/179 (44%), Gaps = 7/179 (3%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+++   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   +   + Y   +++     +  + L  
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 136 NCLSLIRRILAPLPSTR------LNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRM 188
           +  +++ + LA  P  R      +  + ++ H       P  + D   +S  +S A  +
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 146 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 200
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 252

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 80/179 (44%), Gaps = 7/179 (3%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+++   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   +   + Y   +++     +  + L  
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 136 NCLSLIRRILAPLPSTR------LNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRM 188
           +  +++ + LA  P  R      +  + ++ H       P  + D   +S  +S A  +
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 183
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 235

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 80/179 (44%), Gaps = 7/179 (3%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+++   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   +   + Y   +++     +  + L  
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 136 NCLSLIRRILAPLPSTR------LNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRM 188
           +  +++ + LA  P  R      +  + ++ H       P  + D   +S  +S A  +
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 11  RQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-- 67
           + +++   Y+H+ K I HRD+KP N+L+D    +K+SDFG +        E  +DKK   
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES--------EYMVDKKIKG 209
Query: 68  --GTLPYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGELPW 106
             GT  ++ PE      SY     DIWS GI L  M    +P+
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 179
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G+ YL   G  HRDL   NVL+D     K+SDFGL+ V   +  +       G
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAXTTTGG 214
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +     +  +D+WS G+++  +LA GE P W+    D I  +E
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H     HRD+KP+N+L+D+   ++++DFG       +G  +    
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV 235
Query: 66  KCGTLPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
             GT  Y++PE+L      +       D WS G+ +  ML GE P+    A+ +     K
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGK 292
Query: 121 DNRHMQR--SPWDRLDV--NCLSLIRRILAPLPS--TRLNIEKIKSHRWYS 165
              H +R   P    DV  N   LIRR++        +  IE  K H ++S
Sbjct: 293 IMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 123 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 181
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 125 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 183
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G++YL   G  HRDL   N+L++     K+SDFGL+ V   +  E     + G
Sbjct: 129 MLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGG 187
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +        +D+WS GI++  +++ GE P W+    D I+ +E
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE 241

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 179
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 207
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 124 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 182
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 176
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 179
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 117 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 175
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 116 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 174
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 176
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 194
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 122 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 180
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 136 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEP 194
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 195
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGL    R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  QL+ G+ Y H + + HRDLKP+N+L++ +  LK++DFGLA    +  K    D +  
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVV 162
Query: 69  TLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAG 102
           TL Y  P++L+ S   +   D+W  G I   M  G
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+ +   LK+ DFG+A   + +      
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK 213
Query: 64  DKKCGTLPYVAPEVL-----------VRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           D + G + Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 5/114 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G+ YL   G  HRDL   N+L++     K+SDFGL+ V   +  E       G
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGG 208
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            +P  + APE +        +D+WS GI++  +++ GE P WD    D I+ +E
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 230
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  + 
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MA 176
Query: 65  KKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
               T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 177 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 229

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MAG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MAG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            + F  QL+ G+ + HS+ + HRDLKP+N+L++    LK+++FGLA  F +    R    
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSA 160
Query: 66  KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELP 105
           +  TL Y  P+VL  + L   + D+WS G I   +     P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  + YL  K G+ HRD+KP N+LLD +  +K+ DFG++        ++  D+  G   
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAA 189
Query: 72  YVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELPWDKPTAD 112
           Y+APE +      +P     AD+WS GI LV +  G+ P+     D
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G+ Y+H+ GI HRDLKP N+ ++    LKI DFGLA        +  +   
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMXGX 185
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGE 103
             T  Y APEV++      +  DIWS G I+  M+ G+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI D+GLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 12/103 (11%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLAT--VFRMNGKERPLD------KKC 67
           G+E +H+KG AHRDLKP N+LL  +    + D G        + G  + L       ++C
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 68  GTLPYVAPEVL-VRSY--LAEPADIWSCGIILVAMLAGELPWD 107
            T+ Y APE+  V+S+  + E  D+WS G +L AM+ GE P+D
Sbjct: 206 -TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +L   + Y H K + HRD+KPEN+LL L+  LKI+DFG    + ++         CGTL 
Sbjct: 131 ELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLD 186
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD 131
           Y+ PE++      E  D+W  G++   +L G  P++  + +       K +     S   
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS--- 243
Query: 132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +      LI ++L   PS RL + ++ +H W
Sbjct: 244 -VPTGAQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA   R    E  +  
Sbjct: 156 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTG 210
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +     DIWS G I+  +L G   +  P  D I  L+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLF--PGTDHINQLQ 262

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 58/117 (49%), Gaps = 20/117 (17%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF------------ 54
           Q    QLI  ++YLHS G+ HRD+KP N+LL+ +  +K++DFGL+  F            
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 55  RMNGKERPLDKK-------CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE 103
            +N      D           T  Y APE+L+ S    +  D+WS G IL  +L G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q +  V + H     HRD+KPEN+L+     +K+ DFG A +  + G     D +  T  
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDYYDDEVATRW 167
Query: 72  YVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPW 106
           Y +PE+LV  +    P D+W+ G +   +L+G   W
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 6   AQKFFRQLISGVEYLHS---KGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKER 61
           A  +  Q   GV YLHS   K + HRDLKP N+LL    T LKI DFG A   + +    
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +    G+  ++APEV   S  +E  D++S GIIL  ++    P+D+        + W  
Sbjct: 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAV 217
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           +   +      L     SL+ R  +  PS R ++E+I
Sbjct: 218 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 6   AQKFFRQLISGVEYLHS---KGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKER 61
           A  +  Q   GV YLHS   K + HRDLKP N+LL    T LKI DFG A   + +    
Sbjct: 105 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 160
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +    G+  ++APEV   S  +E  D++S GIIL  ++    P+D+        + W  
Sbjct: 161 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAV 218
Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           +   +      L     SL+ R  +  PS R ++E+I
Sbjct: 219 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 255

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 1/137 (0%)
Query: 17  VEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLPYVAP 75
           + + H  GI HRD+KP N+++   + +K+ DFG+A     +G          GT  Y++P
Sbjct: 146 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 205
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           E      +   +D++S G +L  +L GE P+   +   + Y   +++     +  + L  
Sbjct: 206 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 265
Query: 136 NCLSLIRRILAPLPSTR 152
           +  +++ + LA  P  R
Sbjct: 266 DLDAVVLKALAKNPENR 282

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEP 176
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 72/166 (43%), Gaps = 7/166 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNG 58
           + + E   +  Q+   +++LHS  I H D++PEN++   +   T+KI +FG A   +   
Sbjct: 99  LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 59  KERPLDKKCGTLP-YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
             R L     T P Y APEV     ++   D+WS G ++  +L+G  P+   T   I   
Sbjct: 159 NFRLL----FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                       +  + +  +  + R+L     +R+   +   H W
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 45/77 (58%), Gaps = 2/77 (2%)
Query: 25  IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLA 84
           + HRDLKP NV LD +  +K+ DFGLA +  +N  E    +  GT  Y++PE + R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQMNRMSYN 194
Query: 85  EPADIWSCGIILVAMLA 101
           E +DIWS G +L  + A
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPL---D 64
           +  Q + G+EYLHS+ I H D+K +NVLL    +   + DFG A   + +G  + L   D
Sbjct: 190 YLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              GT  ++APEV++        D+WS   +++ ML G  PW +
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 217
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K    ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 277 TREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 336 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 370

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           ++  Q+  G+EYL +K   HR+L   N+L++ ++ +KI DFGL  V   + KE    K+ 
Sbjct: 119 QYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKEP 177
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           G  P  + APE L  S  +  +D+WS G++L  +  
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 195
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 254
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 255 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 314 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 348

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++ G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   +   GT  
Sbjct: 123 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 178
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYL 117
           Y+APE L  ++ +  +DIWS G+ LV +  G  P   P A  +E +
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAI 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 211
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 212 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 270
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K    ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 271 TREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 330 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 364

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 262
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 263 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 321
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 322 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 381 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 415

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 243 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 302 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 184
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 185 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 243
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 244 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 303 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 337

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 202
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 203 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 261
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 262 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 321 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 355

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 243 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 302 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 243 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 302 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 221
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 222 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 280
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K    ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 281 TREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 340 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 374

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 191
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 192 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 250
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 251 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 310 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 344

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 217
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K    ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 277 TREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 336 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 370

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 187
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 188 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 246
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 247 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 306 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 340

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI  FGLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 195
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 254
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 255 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 314 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 348

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 188
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 189 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 247
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 248 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 307 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 341

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 243 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 302 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 5/115 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + SG+ YL      HRDL   N+L++     K+SDFGL+     N  +       G
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 69  T---LPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
               + + APE +        +D WS GI++  +++ GE P WD    D I  +E
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 219
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 220 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 278
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K    ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 279 TREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 338 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 372

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPL---D 64
           +  Q + G+EYLHS+ I H D+K +NVLL    +   + DFG A   + +G  + L   D
Sbjct: 171 YLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              GT  ++APEV++        D+WS   +++ ML G  PW +
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 8/100 (8%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  +E+LHSK  + HRD+KP NVL++    +K+ DFG++  + ++   + +D  C   P
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTIDAGCK--P 218
Query: 72  YVAPE----VLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           Y+APE     L +   +  +DIWS GI ++ +     P+D
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A      G++ 
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGEK- 174
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
             DK C                    D+WS G+I+  +L G  P+       I       
Sbjct: 175 -YDKSC--------------------DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213
Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            R  Q       W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 196
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 197 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 255
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 256 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 315 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 349

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDK--------------P 109
           C    Y APE++  +       D+WS G +L  +L G+   P D               P
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 110 TADCI-----EYLEWKDNRHMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           T + I      Y E+K  + ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 243 TREQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 160 SHRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           +H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 302 AHSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HSKGI HRD+KP NV++D Q   L++ D+GLA  +     
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH---P 185
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
            +  + +  +  +  PE+LV   + + + D+WS G +L +M+    P+
Sbjct: 186 AQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + + Q   +Q +  + YLH   I HRDLK  N+L  L   +K++DFG++       + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 61  RPLDKKCGTLPYVAPEVLV------RSYLAEPADIWSCGIILVAMLAGELP 105
           R  D   GT  ++APEV++      R Y  + AD+WS GI L+ M   E P
Sbjct: 192 R--DSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPP 239

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
             R + SG+ YL      HRDL   N+L++     K+SDFGL+     N  + P +    
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTETSSL 181
Query: 68  -GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            G +P  + APE +        +D WS GI++  +++ GE P WD    D I  +E
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE 237

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HSKGI HRD+KP NV++D Q   L++ D+GLA  +     
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH---P 190
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
            +  + +  +  +  PE+LV   + + + D+WS G +L +M+    P+
Sbjct: 191 AQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 55/91 (60%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL S+   HRDL   N+L++ +  +KI+DFGLA +  ++ K+  + ++ G  P
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDXXVVREPGQSP 177
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAML 100
             + APE L  +  +  +D+WS G++L  + 
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 2/102 (1%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E     +  + G+EYLH     HRD+K  N+LL+ +   K++DFG+A        +R  +
Sbjct: 126 EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--N 183
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
              GT  ++APEV+        ADIWS GI  + M  G+ P+
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DF LA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI D GLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 57/126 (45%), Gaps = 26/126 (20%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV--FRMNG 58
           + +   +     L+ GV+Y+HS GI HRDLKP N L++   ++K+ DFGLA    +  NG
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 59  KE------RPLDKKCGTLP-----------------YVAPE-VLVRSYLAEPADIWSCGI 94
                   R  D    T P                 Y APE +L++    E  D+WS G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 95  ILVAML 100
           I   +L
Sbjct: 273 IFAELL 278

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 55/91 (60%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL S+   HRDL   N+L++ +  +KI+DFGLA +  ++ K+  + ++ G  P
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 180
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAML 100
             + APE L  +  +  +D+WS G++L  + 
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPL---D 64
           +  Q + G+EYLH++ I H D+K +NVLL    +   + DFG A   + +G  + L   D
Sbjct: 155 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              GT  ++APEV++        DIWS   +++ ML G  PW +
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + + Q   +Q +  + YLH   I HRDLK  N+L  L   +K++DFG++       + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 61  RPLDKKCGTLPYVAPEVLV------RSYLAEPADIWSCGIILVAMLAGELP 105
           R  D   GT  ++APEV++      R Y  + AD+WS GI L+ M   E P
Sbjct: 192 R--DSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPP 239

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 55/91 (60%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL S+   HRDL   N+L++ +  +KI+DFGLA +  ++ K+  + ++ G  P
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 193
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAML 100
             + APE L  +  +  +D+WS G++L  + 
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPL---D 64
           +  Q + G+EYLH++ I H D+K +NVLL    +   + DFG A   + +G  + L   D
Sbjct: 169 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              GT  ++APEV++        DIWS   +++ ML G  PW +
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSXI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDKPTADCIEYL------ 117
           C    Y APE++  +       D+WS G +L  +L G+   P D      +E +      
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 118 ------EWKDNR------HMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
                 E   N        ++  PW      R     ++L  R+L   P+ RL   +  +
Sbjct: 243 TREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 161 HRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 303 HSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 55/91 (60%), Gaps = 3/91 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+EYL S+   HRDL   N+L++ +  +KI+DFGLA +  ++ K+  + ++ G  P
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 181
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAML 100
             + APE L  +  +  +D+WS G++L  + 
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + + Q   +Q +  + YLH   I HRDLK  N+L  L   +K++DFG++       + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 61  RPLDKKCGTLPYVAPEVLV------RSYLAEPADIWSCGIILVAMLAGELP 105
           R  D   GT  ++APEV++      R Y  + AD+WS GI L+ M   E P
Sbjct: 192 R--DXFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPP 239

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLH++   HRDL   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEXYRVREDG 197
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAML 100
             P  + APE L        +D+WS G+ L  +L
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPL---D 64
           +  Q + G+EYLH++ I H D+K +NVLL    +   + DFG A   + +G  + L   D
Sbjct: 171 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
              GT  ++APEV++        DIWS   +++ ML G  PW +
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H  G  HRD+KP+N+LLD    ++++DFG     R +G  R L  
Sbjct: 164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-V 222
Query: 66  KCGTLPYVAPEVL-------VRSYLAEPADIWSCGIILVAMLAGELPW--DKPTADCIEY 116
             GT  Y++PE+L                D W+ G+    M  G+ P+  D       + 
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
Query: 117 LEWKDNRHMQRSPWDR-LDVNCLSLIRRILAPLPSTRLN 154
           + +K+  H+     D  +       I+R+L P P TRL 
Sbjct: 283 VHYKE--HLSLPLVDEGVPEEARDFIQRLLCP-PETRLG 318

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI D GLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
            Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI D GLA   R    E  +  
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDE--MTG 181
Query: 66  KCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
              T  Y APE+++   +  +  DIWS G I+  +L G   +  P  D I+ L+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 11/115 (9%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 112 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 164
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L  +  +  +D+WS GI+L  + + G +P+ + P  D +  +E
Sbjct: 165 GKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 8/100 (8%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  +E+LHSK  + HRD+KP NVL++    +K+ DFG++  + ++   + +D  C   P
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCK--P 174
Query: 72  YVAPE----VLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           Y+APE     L +   +  +DIWS GI ++ +     P+D
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKK 66
           +  QL   + Y+HS GI HRD+KP+N+LLD  DT  LK+ DFG A   ++   E  +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLD-PDTAVLKLCDFGSAK--QLVRGEPNVSYI 183
Query: 67  CGTLPYVAPEVLVRSY-LAEPADIWSCGIILVAMLAGE--LPWDKPTADCIEYL------ 117
           C    Y APE++  +       D+WS G +L  +L G+   P D      +E +      
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 118 ------EWKDNR------HMQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
                 E   N        ++  PW      R     ++L  R+L   P+ RL   +  +
Sbjct: 243 TREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 161 HRWYSK-HMPNDIVDGPPSSD----FNSTAKRMRSD 191
           H ++ +   PN  V  P   D    FN T + + S+
Sbjct: 303 HSFFDELRDPN--VKLPNGRDTPALFNFTTQELSSN 336

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERP---LD 64
           Q++ G+ YLH+  + HRDLKP N+L+      +  +KI+D G A +F  N   +P   LD
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLD 193
Query: 65  KKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGE 103
               T  Y APE+L+ + +  +  DIW+ G I   +L  E
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLHS+   HR+L   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDG 180
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
             P  + APE L        +D+WS G+ L  +L 
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 11/115 (9%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 173
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L     +  +D+WS GI+L  + + G +P+ + P  D +  +E
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 11/115 (9%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 345
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L     +  +D+WS GI+L  + + G +P+ + P  D +  +E
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H     HRD+KP+NVLLD+   ++++DFG       +G  +    
Sbjct: 177 ARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS-SV 235
Query: 66  KCGTLPYVAPEVL------VRSYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PE+L      +  Y  E  D WS G+ +  ML GE P+
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPF 281

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 49/177 (27%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-------------------LKISD 47
           +K   Q+   V +LHS  + H DLKPEN+L    D                    +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 48  FGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           FG AT       +        T  Y APEV++    ++P D+WS G IL+    G   + 
Sbjct: 181 FGSATY-----DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF- 234
Query: 108 KPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY 164
            PT D  E+                     L+++ RIL PLP  +  I+K +  +++
Sbjct: 235 -PTHDSKEH---------------------LAMMERILGPLP--KHMIQKTRKRKYF 267

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           A+ +  +++  ++ +H     HRD+KP+NVLLD+   ++++DFG       +G  +    
Sbjct: 193 ARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS-SV 251
Query: 66  KCGTLPYVAPEVL------VRSYLAEPADIWSCGIILVAMLAGELPW 106
             GT  Y++PE+L      +  Y  E  D WS G+ +  ML GE P+
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPF 297

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 11/115 (9%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 106 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 158
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           G LP  + APE L     +  +D+WS GI+L  + + G +P+ + P  D +  +E
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+ YLHS  + HRD+K  N+LL     +K+ DFG A++        P +   GT  ++
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWM 217
Query: 74  APEVLV---RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSP 129
           APEV++           D+WS GI  + +   + P ++      + ++   ++  +Q   
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277
Query: 130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           W     N    +   L  +P  R   E +  HR+  +  P  ++
Sbjct: 278 WSEYFRN---FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +  QL+  + Y+HS GI HRD+KP+N+LLD     LK+ DFG A +  +   E  +   C
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI--LIAGEPNVSXIC 203
Query: 68  GTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGE--LPWDKPTADCIEYLE------ 118
               Y APE++   +      DIWS G ++  ++ G+   P +      +E ++      
Sbjct: 204 SRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262
Query: 119 ----------WKDNRHMQRSPW-------DRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                     + +++  Q  P         R   + + LI R+L   PS RL   +   H
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 162 RWYSK------HMPNDIVDGPPSSDFNSTAKRMRSDL 192
            ++ +       MPN   + PP  ++      +R DL
Sbjct: 323 PFFDELRTGEARMPNG-RELPPLFNWTKEELSVRPDL 358

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +   +   G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NVL+D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 16  GVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-CGTLPY 72
           G+ YLH++   I HRDLK  N+L+D + T+K+ DFGL+   R+        K   GT  +
Sbjct: 149 GMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS---RLKASXFLXSKXAAGTPEW 205
Query: 73  VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           +APEVL      E +D++S G+IL  +   + PW
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 14  ISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYV 73
           + G+ YLHS  + HRD+K  N+LL     +K+ DFG A++        P +   GT  ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWM 178
Query: 74  APEVLV---RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSP 129
           APEV++           D+WS GI  + +   + P ++      + ++   ++  +Q   
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIV 173
           W     N    +   L  +P  R   E +  HR+  +  P  ++
Sbjct: 239 WSEYFRN---FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 1/95 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           K+  Q+  G++YL S+   HRDL   NVL++ +  +KI DFGL      + +   + D +
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
              + + APE L++S     +D+WS G+ L  +L 
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 1/95 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           K+  Q+  G++YL S+   HRDL   NVL++ +  +KI DFGL      + +   + D +
Sbjct: 118 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
              + + APE L++S     +D+WS G+ L  +L 
Sbjct: 178 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKC 67
           +  QL   V ++HS GI HRD+KP+N+L++ +D TLK+ DFG A   ++   E  +   C
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK--KLIPSEPSVAXIC 203
Query: 68  GTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE 103
               Y APE+++ +    P+ D+WS G +   ++ G+
Sbjct: 204 SRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKK-- 66
           Q+I+ VE++HSK   HRD+KP+N L+ L    + + I DFGLA  +R     + +  +  
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 67  ---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
               GT  Y +    +    +   D+ S G +L+  L G LPW
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 25  IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLA 84
           + HRDLKP NV LD +  +K+ DFGLA +  +N          GT  Y++PE + R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194
Query: 85  EPADIWSCGIILVAMLA 101
           E +DIWS G +L  + A
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLH++   HR+L   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDG 180
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
             P  + APE L        +D+WS G+ L  +L 
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 184
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/77 (40%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 25  IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLA 84
           + HRDLKP NV LD +  +K+ DFGLA +  +N          GT  Y++PE + R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYN 194
Query: 85  EPADIWSCGIILVAMLA 101
           E +DIWS G +L  + A
Sbjct: 195 EKSDIWSLGCLLYELCA 211

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 185
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 185
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 186
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 187 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  F   G+
Sbjct: 133 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQ 191
Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV   + + + D+WS G +L +M+  + P+
Sbjct: 192 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DIN 195
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 236

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 200
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+  + ++ +E         +
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPV 185
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 197
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 238

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 254
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + +KI+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 5/115 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G++YL      HRDL   N+L++     K+SDFGL+     +  +       G
Sbjct: 140 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 69  T---LPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
               + + APE +        +D+WS GI++  +++ GE P WD    D I  +E
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 254

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 86/230 (37%), Gaps = 65/230 (28%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQD-------------------TLKISDFGLAT 52
           QL   V++LH   + H DLKPEN+L    D                    +++ DFG AT
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 53  VFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
                           T  Y APEV++    ++P D+WS G I+     G          
Sbjct: 205 F-----DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG---------- 249
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
                +  DNR              L+++ RIL P+PS    I K +  +++ +      
Sbjct: 250 -FTLFQTHDNREH------------LAMMERILGPIPSRM--IRKTRKQKYFYR------ 288
Query: 173 VDGPPSSDFNSTAKR--------MRSDLETEANRACPTFDDRACVSQPEP 214
             G    D N++A R        +R  L +EA      FD    + + EP
Sbjct: 289 --GRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEP 336

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 57/181 (31%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-------------------LKISD 47
           +K   Q+   V +LHS  + H DLKPEN+L    D                    +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 48  FGLATVFRMNGKERPLDKKCGTL----PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE 103
           FG AT           D+   TL     Y APEV++    ++P D+WS G IL+    G 
Sbjct: 181 FGSATY---------DDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
Query: 104 LPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +  PT D  E+                     L+++ RIL PLP  +  I+K +  ++
Sbjct: 232 TVF--PTHDSKEH---------------------LAMMERILGPLP--KHMIQKTRKRKY 266
Query: 164 Y 164
           +
Sbjct: 267 F 267

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 23/157 (14%)
Query: 6   AQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDT------LKISDFGLATVFRMNG 58
            ++  +QL+ G++Y+H + GI H D+KPENVL+++ D+      +KI+D G A  +    
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---- 188
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-----------D 107
            +        T  Y +PEVL+ +     ADIWS   ++  ++ G+  +           D
Sbjct: 189 -DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 108 KPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRI 144
              A  IE L    +  ++   + R   N   L+R I
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G++YL +    HRDL   N+L++     K+SDFGL+ V   +  E       G
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGG 210
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
            +P  + APE +        +D+WS GI++   M  GE P+
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 23/157 (14%)
Query: 6   AQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDT------LKISDFGLATVFRMNG 58
            ++  +QL+ G++Y+H + GI H D+KPENVL+++ D+      +KI+D G A  +    
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---- 188
Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-----------D 107
            +        T  Y +PEVL+ +     ADIWS   ++  ++ G+  +           D
Sbjct: 189 -DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 108 KPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRI 144
              A  IE L    +  ++   + R   N   L+R I
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI 284

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLH++   HR L   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDG 175
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
             P  + APE L        +D+WS G+ L  +L 
Sbjct: 176 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F +Q+  G+ YLH++   HR L   NVLLD    +KI DFGLA      G E    ++ G
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDG 174
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA 101
             P  + APE L        +D+WS G+ L  +L 
Sbjct: 175 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 6/103 (5%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+   R    +     +    
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSRGSKF 168
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
           P  +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 169 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN---GRL 214
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 16  GVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK-CGTLPY 72
           G+ YLH++   I HR+LK  N+L+D + T+K+ DFGL+   R+        K   GT  +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS---RLKASTFLSSKSAAGTPEW 205
Query: 73  VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           +APEVL      E +D++S G+IL  +   + PW
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+     +     +  K   +
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 169
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 170 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+     +     +  K   +
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 165
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+     +     +  K   +
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 170
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 171 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 211

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 13  LISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  +E+LHSK  + HRD+KP NVL++    +K  DFG++  + ++   + +D  C   P
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISG-YLVDDVAKDIDAGCK--P 201
Query: 72  YVAPE----VLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           Y APE     L +   +  +DIWS GI  + +     P+D
Sbjct: 202 YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 1/106 (0%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +A   A    RQ+ S ++  H+ G  HRD+KPEN+L+   D   + DFG+A+    + K 
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKL 189
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
             L    GTL Y APE    S+    ADI++   +L   L G  P+
Sbjct: 190 TQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+     +     +  K   +
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 176
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 177 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 5   EAQKFFRQLIS-------GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN 57
           E Q  F+ L+S       G+EYL S+   HRDL   NVL+   + ++I+DFGLA    +N
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DIN 208
Query: 58  GKERPLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             +       G LP  ++APE L        +D+WS G+++
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 181
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 182 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 182
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 183 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 181
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 182 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 2/101 (1%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+     +     +  K   +
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 185
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
            +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 143 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 201
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 202 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK 59
           +  ++ + +  +L+  ++Y HS+GI HRD+KP NV++D +   L++ D+GLA  F   GK
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGK 180
Query: 60  ERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELPW 106
           E   + +  +  +  PE+LV  + Y     D+WS G +   M+  + P+
Sbjct: 181 E--YNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL-----DLQDTLKISDFGLATVF-----RMNGKER 61
           QLIS +EY+HSK + +RD+KPEN L+       Q  + I DFGLA  +     + +   R
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYR 172
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
                 GT  Y++    +    +   D+ + G + +  L G LPW    AD ++
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 147 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 203
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 204 PVKWMAPEALFDRIYTHQSDVWSFGVLL 231

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 199
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLL 227

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 151 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 207
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 208 PVKWMAPEALFDRIYTHQSDVWSFGVLL 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 214
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 214
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 174
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 184
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 150 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 206
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 207 PVKWMAPEALFDRIYTHQSDVWSFGVLL 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 63/116 (54%), Gaps = 13/116 (11%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL---ATVFRMNGKERPLDKKC 67
           ++++ G+ YLH+KGI H+DLK +NV  D    + I+DFGL   + V +   +E  L  + 
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 68  GTLPYVAPEVLVRSY---------LAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
           G L ++APE++ +            ++ +D+++ G I   + A E P+    A+ I
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 2/109 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+   + +KI+DFGLA +   + KE   D     + 
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           ++A E +        +D+WS G+ +  ++  G  P+D  PT +  + LE
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 158 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 214
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 1/116 (0%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL    + HRDL   NVL+   + +KI+DFGLA +  ++  E   D     + 
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 186
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQ 126
           ++A E ++R      +D+WS G+ +  ++  G  P+D   A  I  L  K  R  Q
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 242

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFR-----MNGKERPL 63
           Q+IS +EY+HSK   HRD+KP+N L+ L    + + I DFGLA  +R      +   R  
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA 111
               GT  Y +    +    +   D+ S G +L+    G LPW    A
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFR-----MNGKERPL 63
           Q+IS +EY+HSK   HRD+KP+N L+ L    + + I DFGLA  +R      +   R  
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA 111
               GT  Y +    +    +   D+ S G +L+    G LPW    A
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFR-----MNGKERPL 63
           Q+IS +EY+HSK   HRD+KP+N L+ L    + + I DFGLA  +R      +   R  
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA 111
               GT  Y +    +    +   D+ S G +L+    G LPW    A
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 6/88 (6%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA  +  ++  ++  +   G L
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN---GRL 255
Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL 96
           P  ++APE L        +D+WS G++L
Sbjct: 256 PVKWMAPEALFDRIYTHQSDVWSFGVLL 283

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 2/101 (1%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL-DKK 66
           ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + + +
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                + APE L     +  +D W  G+ L  M   G+ PW
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 135 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 192
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 247

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 189
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 244

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 131 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 188
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 243

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 9   FFRQLISGVEYLH--SKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDK 65
           F  QLI  +  LH  S  + HRD+KP NVL++  D TLK+ DFG A   +++  E  +  
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAY 191
Query: 66  KCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGE 103
            C    Y APE++    +     DIWS G I   M+ GE
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 16  GVEYLHSK---GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLP 71
           G+ YLH      I HRD+K  N+LLD +    + DFGLA +  M+ K+  +     GT+ 
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXXAVRGTIG 208
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           ++APE L     +E  D++  G++L+ ++ G+  +D
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 185
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 240

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 190 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 242

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 217 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 269

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 189
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 244

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 183
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 238

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 183
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 238

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 184
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 185
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 240

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 207
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 262

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 189
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 122 QIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 179
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 234

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 185
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 240

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 216
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 271

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 176
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 184
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 2/109 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+   + +KI+DFGLA +   + KE   D     + 
Sbjct: 148 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK-PTADCIEYLE 118
           ++A E +        +D+WS G+ +  ++  G  P+D  PT +  + LE
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 256

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 185
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 240

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K   
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 216 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 268

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +  +  +E+    + G +P
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP 186
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 10/87 (11%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-----TVFRMNGKERPLDKKCGT 69
           +G+EYL SK   HRDL   N L+  ++ LKISDFG++      V+  +G  R +  K   
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--- 280
Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIIL 96
             + APE L     +  +D+WS GI+L
Sbjct: 281 --WTAPEALNYGRYSSESDVWSFGILL 305

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 203 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 255

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLK-----ISDFGLATVF-----RMNGKER 61
           QL+S +EY+HSK + +RD+KPEN L+  Q   K     I DFGLA  +     + +   R
Sbjct: 105 QLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYR 164
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
                 GT  Y++    +    +   D+ + G + +  L G LPW    AD ++
Sbjct: 165 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 218

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 5/115 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             R + +G++YL      HR L   N+L++     K+SDFGL+     +  +       G
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 69  T---LPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
               + + APE +        +D+WS GI++  +++ GE P WD    D I  +E
Sbjct: 174 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL   + +KI DFGLA  +++     R  D +   L
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL-PL 265
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +     +  +D+WS G++L
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLL 291

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 8   KFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATV------FRMNGK 59
           K F Q    V+++H +   I HRDLK EN+LL  Q T+K+ DFG AT       +  + +
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 60  ERPLDKK---CGTLP-YVAPEV--LVRSY-LAEPADIWSCGIILVAMLAGELPWDKPTAD 112
            R L ++     T P Y  PE+  L  ++ + E  DIW+ G IL  +   + P++     
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
            I       N      P D       SLIR +L   P  RL+I ++
Sbjct: 260 RI------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K   
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
            LP  ++A E L        +D+WS G++L  ++  G  P+ D  T D   YL
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-G 68
           F Q+   ++++H + I HRD+K +N+ L    T+++ DFG+A V     +   L + C G
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIG 187
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAM 99
           T  Y++PE+         +DIW+ G +L  +
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
           R+++ G+ +LH   + HRD+K +NVLL     +K+ DFG+ A + R  G+        GT
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGT 192
Query: 70  LPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELP 105
             ++APEV+       +     +D+WS GI  + M  G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 28/136 (20%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLAT----------- 52
           E +++   L   ++ +H  GI HRD+KP N L + +     + DFGLA            
Sbjct: 118 EVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 53  -VFRMNGKERPLDKKC--------------GTLPYVAPEVLVRSYLAEPA-DIWSCGIIL 96
            V     +ER    KC              GT  + APEVL +      A D+WS G+I 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 97  VAMLAGELPWDKPTAD 112
           +++L+G  P+ K + D
Sbjct: 238 LSLLSGRYPFYKASDD 253

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 29/128 (22%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDT------LKISDFG 49
           ++      RQ+ SGV +LHS  I HRDLKP+N+L+         Q T      + ISDFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 50  L-------ATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY---LAEPADIWSCGIILVAM 99
           L          FR N     L+   GT  + APE+L  S    L    DI+S G +   +
Sbjct: 192 LCKKLDSGQXXFRXN-----LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 100 LA-GELPW 106
           L+ G+ P+
Sbjct: 247 LSKGKHPF 254

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 29/128 (22%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDT------LKISDFG 49
           ++      RQ+ SGV +LHS  I HRDLKP+N+L+         Q T      + ISDFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 50  L-------ATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY---LAEPADIWSCGIILVAM 99
           L          FR N     L+   GT  + APE+L  S    L    DI+S G +   +
Sbjct: 192 LCKKLDSGQXXFRXN-----LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 100 LA-GELPW 106
           L+ G+ P+
Sbjct: 247 LSKGKHPF 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F  Q+  G+ Y+  K   HRDL+  NVL+      KI+DFGLA V   N      G + P
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           +        + APE +        +D+WS GI+L  ++  G++P+
Sbjct: 175 IK-------WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPL 63
            +KF   ++  ++ LH   I H DLKPEN+LL  Q    +K+ DFG +       + + +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRV 256
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
                +  Y APEV++ +    P D+WS G IL  +L G
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPL 63
            +KF   ++  ++ LH   I H DLKPEN+LL  Q    +K+ DFG +       + + +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRV 256
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
                +  Y APEV++ +    P D+WS G IL  +L G
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 6   AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPL 63
            +KF   ++  ++ LH   I H DLKPEN+LL  Q    +K+ DFG +       + + +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRV 256
Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAG 102
                +  Y APEV++ +    P D+WS G IL  +L G
Sbjct: 257 YXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 25  IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL----VR 80
           I HRD+KP N+LLD    +K+ DFG++    ++   +  D  C   PY+APE +     R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCR--PYMAPERIDPSASR 203
Query: 81  SYLAEPADIWSCGIILVAMLAGELPWDK 108
                 +D+WS GI L  +  G  P+ K
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPK 231

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL-PL 210
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLL 236

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL-----DLQDTLKISDFGLATVF-----RMNGKER 61
           QLIS +EY+HSK + +RD+KPEN L+       Q  + I DF LA  +     + +   R
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
                 GT  Y++    +    +   D+ + G + +  L G LPW    AD ++
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL-----DLQDTLKISDFGLATVF-----RMNGKER 61
           QLIS +EY+HSK + +RD+KPEN L+       Q  + I DF LA  +     + +   R
Sbjct: 134 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 193
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
                 GT  Y++    +    +   D+ + G + +  L G LPW    AD ++
Sbjct: 194 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL-PL 214
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLL 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 205
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 205
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 257
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLL 283

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R +          
Sbjct: 115 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH- 173
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 473 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 531
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 16  GVEYLHSK---GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-GTLP 71
           G+ YLH      I HRD+K  N+LLD +    + DFGLA +  M+ K+  +     G + 
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXXAVRGXIG 200
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           ++APE L     +E  D++  G++L+ ++ G+  +D
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 264
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLL 290

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 210
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLL 236

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 474 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 532
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F   +  G++YL  K   HRDL   N+L+      KI+DFGL+      G+E  + K  G
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMG 191
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            LP  ++A E L  S     +D+WS G++L  +++ G  P+
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F   +  G++YL  K   HRDL   N+L+      KI+DFGL+      G+E  + K  G
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMG 201
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            LP  ++A E L  S     +D+WS G++L  +++ G  P+
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 21/121 (17%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA--------- 51
           + +   +     L+ G  ++H  GI HRDLKP N LL+   ++K+ DFGLA         
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 52  -TVFRMNGKERP----------LDKKCGTLPYVAPE-VLVRSYLAEPADIWSCGIILVAM 99
             V  +   E P          L     T  Y APE +L++    +  DIWS G I   +
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 100 L 100
           L
Sbjct: 246 L 246

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 169
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 259
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLL 285

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 109 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 167
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 214
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLL 240

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 266
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLL 292

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 115 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 173
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 131 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 189
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 131 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 189
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 184
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-----TVFRMNGKERPLDKKCGT 69
           +G+EYL SK   HRDL   N L+  ++ LKISDFG++      V   +G  R +  K   
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK--- 280
Query: 70  LPYVAPEVLVRSYLAEPADIWSCGIIL 96
             + APE L     +  +D+WS GI+L
Sbjct: 281 --WTAPEALNYGRYSSESDVWSFGILL 305

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 158 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 216
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLL 242

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 129 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 187
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R + +     +  
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTH 179
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL-VAMLAGELPW 106
           G  P  + APE +     +  +D+WS G+++  A   G+ P+
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 5   EAQ--KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
           EAQ   + R  +  + +LHS+G+ H D+KP N+ L  +   K+ DFGL       G    
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG-- 213
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILV 97
            + + G   Y+APE+L  SY    AD++S G+ ++
Sbjct: 214 -EVQEGDPRYMAPELLQGSY-GTAADVFSLGLTIL 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  +++     R  D +   L
Sbjct: 193 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PL 251
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLL 277

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 184
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 184
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 239

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 189
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 244

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 62/132 (46%), Gaps = 33/132 (25%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDT------LKISDFG 49
           ++      RQ+ SGV +LHS  I HRDLKP+N+L+         Q T      + ISDFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 50  L-------ATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY-------LAEPADIWSCGII 95
           L        + FR N     L+   GT  + APE+L  S        L    DI+S G +
Sbjct: 174 LCKKLDSGQSSFRTN-----LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 96  LVAMLA-GELPW 106
              +L+ G+ P+
Sbjct: 229 FYYILSKGKHPF 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 2/99 (2%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ ++  +   HRDL+  N+L+      KI+DFGLA V   N        K  
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF- 347
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            + + APE +        +D+WS GI+L+ ++  G +P+
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 182
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ YL  + + HRDL   NVL+     +KI+DFG A +  +  +E+    + G +P
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEGGKVP 186
Query: 72  --YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
             ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 241

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 39/180 (21%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLA---TVFRMNGKE 60
             +Q  SG+ +LHS  I HRDLKP N+L+ + +        ISDFGL     V R +   
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPA---DIWSCGIILVAMLA-GELPWDKP------- 109
           R      GT  ++APE+L       P    DI+S G +   +++ G  P+ K        
Sbjct: 183 R--SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 110 -----TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY 164
                + DC+              P    DV    LI +++A  P  R + + +  H ++
Sbjct: 241 LLGACSLDCLH-------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +    P   K   + 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIK 179
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +    P   K   + 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIK 178
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLL 203

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F  Q+  G+ ++  +   HRDL+  N+L+      KI+DFGLA V   N      G + P
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           +        + APE +        +D+WS GI+L+ ++  G +P+
Sbjct: 176 IK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ ++  +   HRDL+  N+L+      KI+DFGLA V    G + P+     
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV----GAKFPIK---- 334
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
              + APE +        +D+WS GI+L+ ++  G +P+
Sbjct: 335 ---WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL-----DLQDTLKISDFGLATVF-----RMNGKER 61
           QLI+ +EY+H+K + +RD+KPEN L+       Q  + I DFGLA  +     + +   R
Sbjct: 108 QLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYR 167
Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
                 GT  Y++    +    +   D+ + G + +  L G LPW    AD ++
Sbjct: 168 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 221

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 15/117 (12%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERP 62
           F  Q+  G+ Y+  K   HRDL+  NVL+      KI+DFGLA V   N      G + P
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYL 117
           +        + APE +        +++WS GI+L  ++  G++P+  +  AD +  L
Sbjct: 174 IK-------WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 33/132 (25%)
Query: 3   QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------QDT------LKISDFG 49
           ++      RQ+ SGV +LHS  I HRDLKP+N+L+         Q T      + ISDFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 50  L-------ATVFRMNGKERPLDKKCGTLPYVAPEVLVRSY-------LAEPADIWSCGII 95
           L          FR N     L+   GT  + APE+L  S        L    DI+S G +
Sbjct: 174 LCKKLDSGQXXFRXN-----LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 96  LVAMLA-GELPW 106
              +L+ G+ P+
Sbjct: 229 FYYILSKGKHPF 240

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 46/85 (54%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ +G+EYL S  + H+DL   NVL+  +  +KISD GL          + L      + 
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++APE ++    +  +DIWS G++L
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVL 237

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 46/85 (54%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ +G+EYL S  + H+DL   NVL+  +  +KISD GL          + L      + 
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++APE ++    +  +DIWS G++L
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVL 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 24/124 (19%)
Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN--- 57
           + +   +     L+ G +++H  GI HRDLKP N LL+   ++KI DFGLA     +   
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDI 187
Query: 58  --------------------GKERPLDKKCGTLPYVAPE-VLVRSYLAEPADIWSCGIIL 96
                                 ++ L     T  Y APE +L++       DIWS G I 
Sbjct: 188 HIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIF 247
Query: 97  VAML 100
             +L
Sbjct: 248 AELL 251

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  + +     R  D +   L
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PL 205
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  + +     R  D +   L
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PL 205
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA    +      + K   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--HIKNDSNYVVKGNA 230
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI L  + + G  P+     D   Y   K+   M
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 290
Query: 126 ---QRSPWDRLDV 135
              + +P +  D+
Sbjct: 291 LSPEHAPAEMYDI 303

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  + +     R  D +   L
Sbjct: 156 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PL 214
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLL 240

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL  K   HRDL   NVLL  +   KISDFGL+     +       +  
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-RSA 172
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           G  P  + APE +     +  +D+WS G+ +   L+ G+ P+ K
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 26/154 (16%)
Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA  +  +++  + YLHS G+ + DLKPEN++L  ++ LK+ D G   V R+N       
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLG--AVSRINS----FG 235
Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
              GT  + APE+ VR+      DI++ G  L A     L  D PT         ++ R+
Sbjct: 236 YLYGTPGFQAPEI-VRTGPTVATDIYTVGRTLAA-----LTLDLPT---------RNGRY 280
Query: 125 MQRSPWDRLDVNCLS----LIRRILAPLPSTRLN 154
           +   P D   +        L+RR + P P  R  
Sbjct: 281 VDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  + +     R  D +   L
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PL 214
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLL 240

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 12/105 (11%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--------RMNGKE 60
           F + + SG+ YLHS  I HRDL   N L+     + ++DFGLA +          +   +
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 61  RPLDKKCGTL---PY-VAPEVLVRSYLAEPADIWSCGIILVAMLA 101
           +P  KK  T+   PY +APE++      E  D++S GI+L  ++ 
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 20/101 (19%)
Query: 14  ISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER--PL 63
           +SG+ +LH++         IAHRDLK +N+L+    T  I+D GLA  F  +  E   P 
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 64  DKKCGTLPYVAPEVL--------VRSYLAEPADIWSCGIIL 96
           + + GT  Y+ PEVL         +SY+   AD++S G+IL
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIM--ADMYSFGLIL 242

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-TVFRMNGKERPLDKKCGTL 70
           Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA  + +     R  D +   L
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PL 214
Query: 71  PYVAPEVLVRSYLAEPADIWSCGIIL 96
            ++APE +        +D+WS G++L
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLL 240

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F   +  G++YL  K   HR+L   N+L+      KI+DFGL+      G+E  + K  G
Sbjct: 144 FAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMG 198
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
            LP  ++A E L  S     +D+WS G++L  +++ G  P+
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +     + K   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNA 207
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI L  + + G  P+     D   Y   K+   M
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 126 ---QRSPWDRLDV 135
              + +P +  D+
Sbjct: 268 LSPEHAPAEMYDI 280

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 226
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 287 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 319

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 226
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 287 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 319

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKERPLDKKC---- 67
           S + YLH   I HRDLKPEN++L     +   KI D G A       KE    + C    
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA-------KELDQGELCTEFV 185
Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GTL Y+APE+L +       D WS G +    + G  P+
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 15  SGVEYLHSKGIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKERPLDKKC---- 67
           S + YLH   I HRDLKPEN++L     +   KI D G A       KE    + C    
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA-------KELDQGELCTEFV 184
Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GTL Y+APE+L +       D WS G +    + G  P+
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +     + K   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNA 223
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI L  + + G  P+     D   Y   K+   M
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 283
Query: 126 ---QRSPWDRLDV 135
              + +P +  D+
Sbjct: 284 LSPEHAPAEMYDI 296

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 228
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 288
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 289 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 321

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 42/88 (47%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+E+L  K   HRDL   NVL+     +KI DFGLA     +           
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIIL 96
            + ++APE L        +D+WS GI+L
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILL 264

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERPLDK 65
            R ++ G+ +L   GI HR++KP N++     D Q   K++DFG A   R    +     
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVS 174
Query: 66  KCGTLPYVAPEVLVRSYL--------AEPADIWSCGIILVAMLAGELPW 106
             GT  Y+ P++  R+ L            D+WS G+       G LP+
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +     + K   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNA 230
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI L  + + G  P+     D   Y   K+   M
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 290
Query: 126 ---QRSPWDRLDV 135
              + +P +  D+
Sbjct: 291 LSPEHAPAEMYDI 303

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +     + K   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNA 225
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI L  + + G  P+     D   Y   K+   M
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 285
Query: 126 ---QRSPWDRLDV 135
              + +P +  D+
Sbjct: 286 LSPEHAPAEMYDI 298

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 163 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 220
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 221 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 280
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 281 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 313

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 165 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 222
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 283 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 315

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA    MN     + K   
Sbjct: 157 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNY-IVKGNA 214
Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHM 125
            LP  ++APE +        +D+WS GI+L  + + G  P+     +   Y   KD   M
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
            +  +     N  S+++   A  P+ R   ++I S
Sbjct: 275 AQPAF--APKNIYSIMQACWALEPTHRPTFQQICS 307

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 173
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 346
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 346
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 346
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 429
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/70 (40%), Positives = 38/70 (54%)
Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  + I G++  H   I+HRD+K +NVLL    T  I+DFGLA  F           + G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 69  TLPYVAPEVL 78
           T  Y+APEVL
Sbjct: 196 TRRYMAPEVL 205

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ YL S+   HRDL   N L+     +KI DFG++         R        + 
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW----DKPTADCIEYLEWKDNRHMQ 126
           ++ PE ++       +D+WS G+IL  +   G+ PW    +    +CI        R ++
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-----TQGRVLE 255
Query: 127 RS---PWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           R    P +  DV      R      P  RLNI++I
Sbjct: 256 RPRVCPKEVYDVMLGCWQRE-----PQQRLNIKEI 285

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 10  FRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERPLDK 65
            R ++ G+ +L   GI HR++KP N++     D Q   K++DFG A   R    +     
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVX 174
Query: 66  KCGTLPYVAPEVLVRSYL--------AEPADIWSCGIILVAMLAGELPW 106
             GT  Y+ P++  R+ L            D+WS G+       G LP+
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 42/85 (49%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+          R   K    + 
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++APE L        +D+WS G++L
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVL 219

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 42/85 (49%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+          R   K    + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++APE L        +D+WS G++L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 176
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+         +R  GK      
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGK------ 191
Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             G LP  ++APE L        +D+WS G++L
Sbjct: 192 --GLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 183
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 232

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 42/85 (49%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+          R   K    + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           ++APE L        +D+WS G++L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 184
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 233

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIK 181
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 230

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F   ++ G+  LH  G+ HRDL P N+LL   + + I DF LA   R +  +      
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHY 193
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAML 100
                Y APE++++     +  D+WS G ++  M 
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIK 170
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F   ++ G+  LH  G+ HRDL P N+LL   + + I DF LA   R +  +      
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHY 193
Query: 67  CGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAML 100
                Y APE++++     +  D+WS G ++  M 
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIK 181
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 230

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 229

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIK 185
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 234

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 176
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 174
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N        K   + 
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIK 170
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 219

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 4/121 (3%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ +G+ Y+      HRDL+  N+L+      KI+DFGLA +   N        K   + 
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIK 171
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPW 130
           + APE  +       +D+WS GI+L  ++  G +P+  P  +  E LE  +  +    P 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY--PGMNNREVLEQVERGYRMPCPQ 229
Query: 131 D 131
           D
Sbjct: 230 D 230

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 173
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 171
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 173
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 14/102 (13%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMN------GKERPLDK 65
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N      G + P+  
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 66  KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
                 + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 178 ------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+         +R  GK      
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK------ 191
Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             G LP  ++APE L        +D+WS G++L
Sbjct: 192 --GLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 11  RQLISGVEYLHSKG--IAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKC 67
           RQ++ G+++LH++   I HRDLK +N+ +     ++KI D GLAT+ R +  +  +    
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---- 191
Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
           GT  + APE     Y  E  D+++ G   +     E P+
Sbjct: 192 GTPEFXAPEXYEEKY-DESVDVYAFGXCXLEXATSEYPY 229

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 169
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 170 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 180
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N        K   + 
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIK 171
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 49/174 (28%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL------------------DLQDT-LKISDFGLAT 52
           QL   + +LH   + H DLKPEN+L                    +++T ++++DFG AT
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 53  VFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
                           T  Y  PEV++    A+P D+WS G IL     G          
Sbjct: 223 F-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG---------- 267
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
                +  +NR              L ++ +IL P+PS    I + +  +++ K
Sbjct: 268 -FTLFQTHENREH------------LVMMEKILGPIPSHM--IHRTRKQKYFYK 306

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL------ATVFRMNGKERPLDK 65
           ++  G+ YL++K   HRDL   N ++    T+KI DFG+         +R  GK      
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK------ 190
Query: 66  KCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             G LP  ++APE L        +D+WS G++L
Sbjct: 191 --GLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 221

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
           G+ YL    + HRDL   N L+     +K+SDFG+ T F ++ +          + + +P
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASP 193
Query: 76  EVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           EV   S  +  +D+WS G+++  + + G++P++ 
Sbjct: 194 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 49/174 (28%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL------------------DLQDT-LKISDFGLAT 52
           QL   + +LH   + H DLKPEN+L                    +++T ++++DFG AT
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 53  VFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
                           T  Y  PEV++    A+P D+WS G IL     G          
Sbjct: 191 F-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG---------- 235
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
                +  +NR              L ++ +IL P+PS    I + +  +++ K
Sbjct: 236 -FTLFQTHENREH------------LVMMEKILGPIPSHM--IHRTRKQKYFYK 274

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 49/174 (28%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLL------------------DLQDT-LKISDFGLAT 52
           QL   + +LH   + H DLKPEN+L                    +++T ++++DFG AT
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 53  VFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
                           T  Y  PEV++    A+P D+WS G IL     G          
Sbjct: 200 F-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG---------- 244
Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
                +  +NR              L ++ +IL P+PS    I + +  +++ K
Sbjct: 245 -FTLFQTHENREH------------LVMMEKILGPIPSHM--IHRTRKQKYFYK 283

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF-PIK 196
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLL 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 2/96 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ SG+ Y+      HRDL+  N+L+      K++DFGL  +   N        K   + 
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIK 347
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW 106
           + APE  +       +D+WS GI+L  +   G +P+
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +   Q+  G++YL  K   HR+L   NVLL  +   KISDFGL+     +       +  
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSA 498
Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDK 108
           G  P  + APE +     +  +D+WS G+ +   L+ G+ P+ K
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLL 200

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLL 200

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIK 182
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   + +    +     + 
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIK 175
Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT-ADCIEYLE 118
           + APE +        +D+WS GI+L  ++  G +P+   T  + I+ LE
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIK 178
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLL 203

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 179
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 182
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 181
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLL 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 182
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 182
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 179
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 182
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 190
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLL 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K   + 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 177
Query: 72  YVAPEVLVRSYLAEPADIWSCGIIL 96
           + APE L  +  +  +D+W+ G++L
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLL 202
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	407
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-81
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-81
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-62
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-59
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-58
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-58
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-58
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-58
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-57
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-56
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-56
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-56
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-55
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-55
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-54
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-54
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-51
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-51
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-50
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-49
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-46
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-46
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-46
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-45
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-45
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-45
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-44
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-43
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-43
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-43
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-43
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-42
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-42
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-42
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-41
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-41
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-41
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-40
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-40
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-40
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-39
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-39
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-39
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-38
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-38
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-38
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-37
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-36
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-33
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-31
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-28
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-27
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-27
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-27
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-27
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-26
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-26
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-26
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-25
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-25
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-24
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-21
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-21
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-12
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-12
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-12
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-12
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-12
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-11
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-11
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-10
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-09
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-09
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-08
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-05
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	3e-04

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  252 bits (645), Expect = 1e-81
 Identities = 103/199 (51%), Positives = 137/199 (68%), Gaps = 7/199 (3%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND-----IVD 174
           K  +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +        +  
Sbjct: 222 K-EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280

Query: 175 GPPSSDFNSTAKRMRSDLE 193
           G  S   +  +K ++S+L+
Sbjct: 281 GGVSESPSGFSKHIQSNLD 299

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  250 bits (640), Expect = 2e-81
 Identities = 98/173 (56%), Positives = 125/173 (72%), Gaps = 2/173 (1%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L  R + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
           K  +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K +    
Sbjct: 222 K-EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  202 bits (515), Expect = 3e-62
 Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 8/192 (4%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
               +A  +F QLI G+EYLHS+GI H+D+KP N+LL    TLKIS  G+A        +
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

Query: 61  RPLDKKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                  G+  +  PE+   + ++     DIWS G+ L  +  G  P++      I  L 
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLF 222

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI--VDGP 176
               +     P          L++ +L   P+ R +I +I+ H W+ K  P     V  P
Sbjct: 223 ENIGKGSYAIP-GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281

Query: 177 PSSDFNSTAKRM 188
           PS D     + M
Sbjct: 282 PSPDTKDRWRSM 293

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  196 bits (499), Expect = 2e-59
 Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERP 62
           EA+ FF+QL+SGV Y HS  I HRDLK EN LLD      LKI DFG +    ++ +   
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 173

Query: 63  LDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
                GT  Y+APEVL+ + Y  + AD+WSCG+ L  ML G  P++ P          K 
Sbjct: 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE---EPRDYRKT 230

Query: 122 NRHMQRS-----PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
            + +           R+   C  LI RI    P+TR++I +IK+H W+ K++P D+++  
Sbjct: 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNES 290

Query: 177 PSSDFNSTAKRMRSDLET 194
            +       ++    L+T
Sbjct: 291 NTGSQFQEPEQPMQSLDT 308

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  191 bits (488), Expect = 2e-58
 Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 9/166 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +A+ +F+ LI G+EYLH + I HRD+KP N+L+     +KI+DFG++  F+  G +  L 
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSDALLS 195

Query: 65  KKCGTLPYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
              GT  ++APE L    + +  +  D+W+ G+ L   + G+ P+       I  L  K 
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER---IMCLHSKI 252

Query: 122 NRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
                  P    +  +   LI R+L   P +R+ + +IK H W ++
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  190 bits (484), Expect = 5e-58
 Identities = 63/166 (37%), Positives = 91/166 (54%), Gaps = 8/166 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA++ F+Q++S V+Y H   + HRDLKPENVLLD     KI+DFGL+ +         L 
Sbjct: 112 EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LR 168

Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
             CG+  Y APEV+  R Y     DIWSCG+IL A+L G LP+D      +  L  K   
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRG 225

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
            +   P + L+ +  +L+  +L   P  R  I+ I+ H W+ + +P
Sbjct: 226 GVFYIP-EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  191 bits (488), Expect = 7e-58
 Identities = 67/171 (39%), Positives = 96/171 (56%), Gaps = 8/171 (4%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + E ++FF+Q+I  +EY H   I HRDLKPEN+LLD    +KI+DFGL+ +       
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163

Query: 61  RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
             L   CG+  Y APEV+  + Y     D+WSCGI+L  ML G LP+D      I  L  
Sbjct: 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF---IPNLFK 218

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           K N  +   P D L     SLIRR++   P  R+ I++I+   W++ ++P+
Sbjct: 219 KVNSCVYVMP-DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  189 bits (483), Expect = 2e-57
 Identities = 64/171 (37%), Positives = 93/171 (54%), Gaps = 8/171 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA+  FRQ++S V+Y H K I HRDLK EN+LLD    +KI+DFG +  F + GK   LD
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LD 171

Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
             CG  PY APE+   + Y     D+WS G+IL  +++G LP+D      ++ L  +  R
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLR 228

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
              R P   +  +C +L++R L   P  R  +E+I   RW +     D + 
Sbjct: 229 GKYRIP-FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  187 bits (478), Expect = 1e-56
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 16/169 (9%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPL 63
            ++ FF Q+++ +++ HS+G+ HRD+K EN+L+DL+    K+ DFG   +      + P 
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPY 195

Query: 64  DKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
               GT  Y  PE +    Y A PA +WS GI+L  M+ G++P++          E    
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-------RDQEIL-- 246

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
                 P   +  +C +LIRR LAP PS+R ++E+I    W      + 
Sbjct: 247 EAELHFP-AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  187 bits (476), Expect = 3e-56
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 14/179 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A   FRQL+S V YL  K I HRD+K EN+++    T+K+ DFG A             
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FY 187

Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
             CGT+ Y APEVL+   Y     ++WS G+ L  ++  E P+        E  E     
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-------ELEETV--E 238

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFN 182
                P+  +    +SL+  +L P+P  R  +EK+ +  W ++ +             N
Sbjct: 239 AAIHPPY-LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVN 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  191 bits (486), Expect = 3e-56
 Identities = 65/177 (36%), Positives = 96/177 (54%), Gaps = 8/177 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E+++ F+Q++SGV+Y H   + HRDLKPENVLLD     KI+DFGL+ +         L 
Sbjct: 117 ESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LR 173

Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
             CG+  Y APEV+  R Y     DIWS G+IL A+L G LP+D      +  L  K   
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICD 230

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
            +  +P   L+ + +SL++ +L   P  R  I+ I+ H W+ + +P  +    PS  
Sbjct: 231 GIFYTP-QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYS 286

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  182 bits (464), Expect = 5e-55
 Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 14/175 (8%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            EA+ F  Q+I+G+ YLHS GI HRDL   N+LL     +KI+DFGLAT  +M   E+  
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EK-H 169

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEW 119
              CGT  Y++PE+  RS     +D+WS G +   +L G  P+D    K T + +   ++
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
           +    +  S           LI ++L   P+ RL++  +  H + S++      D
Sbjct: 230 EMPSFL--SI------EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  183 bits (467), Expect = 5e-55
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 17/178 (9%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPL 63
            A+ FF Q++  V + H+ G+ HRD+K EN+L+DL    LK+ DFG   +     K+   
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVY 205

Query: 64  DKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
               GT  Y  PE +    Y    A +WS GI+L  M+ G++P++            +  
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EII 256

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-HMPNDIVDGPPSS 179
           R        R+   C  LIR  LA  PS R   E+I++H W     +P +  +    S
Sbjct: 257 RGQVFFR-QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  182 bits (464), Expect = 2e-54
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 19/194 (9%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           + + EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G E
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEY 116
           R     CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++    K T   I+ 
Sbjct: 197 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH-----MPND 171
            E+   +H+  +P         SLI+++L   P+ R  I ++ +  +++       +P  
Sbjct: 256 NEYSIPKHI--NP------VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 307

Query: 172 IVDGPPSSDFNSTA 185
            +  PP      ++
Sbjct: 308 CLTIPPRFSIAPSS 321

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  180 bits (460), Expect = 3e-54
 Identities = 59/186 (31%), Positives = 95/186 (51%), Gaps = 19/186 (10%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA+ + RQ++ G +YLH   + HRDLK  N+ L+    +KI DFGLAT    +G ER   
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ER-KK 173

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEWK 120
             CGT  Y+APEVL +   +   D+WS G I+  +L G+ P++    K T   I+  E+ 
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 233

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH-----MPNDIVDG 175
             +H+  +P         SLI+++L   P+ R  I ++ +  +++       +P   +  
Sbjct: 234 IPKHI--NP------VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTI 285

Query: 176 PPSSDF 181
           PP    
Sbjct: 286 PPRFSI 291

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  181 bits (462), Expect = 6e-54
 Identities = 42/193 (21%), Positives = 75/193 (38%), Gaps = 27/193 (13%)

Query: 1   MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           +     +   + +++   Y+H+ K I HRD+KP N+L+D    +K+SDFG +  + ++ K
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKK 206

Query: 60  ERPLDKKCGTLPYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGELPWDK--------- 108
              +    GT  ++ PE      SY     DIWS GI L  M    +P+           
Sbjct: 207 ---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263

Query: 109 ---------PTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK 159
                    P           + +    + +  L    +  ++  L   P+ R+  E   
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF--LSNEDIDFLKLFLRKNPAERITSEDAL 321

Query: 160 SHRWYSKHMPNDI 172
            H W +     D+
Sbjct: 322 KHEWLADTNIEDL 334

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  172 bits (439), Expect = 3e-51
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 16/170 (9%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
                +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG +            
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRR 164

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC----IEYLEW 119
              CGTL Y+ PE++      E  D+WS G++    L G+ P++  T       I  +E+
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
                +  +           LI R+L   PS R  + ++  H W + +  
Sbjct: 225 TFPDFV--TE------GARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  172 bits (438), Expect = 3e-51
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 22/177 (12%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             +  +  F  +L   + Y H + + HRD+KPEN+L+  +  LKI+DFG +         
Sbjct: 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-------VH 163

Query: 61  RPLDKK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC---- 113
            P  ++   CGTL Y+ PE++      E  D+W  G++    L G  P+D P+       
Sbjct: 164 APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223

Query: 114 IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           I  ++ K    +  S           LI ++L   P  RL ++ +  H W   +   
Sbjct: 224 IVNVDLKFPPFL--SD------GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  169 bits (431), Expect = 9e-50
 Identities = 43/188 (22%), Positives = 85/188 (45%), Gaps = 13/188 (6%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+     LK+ DFG+A   + +      
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 185

Query: 64  DKKCGTLPYVAPEVLV-----------RSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +   +
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-N 244

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
            I  L    + + +    D  + +   +++  L   P  R++I ++ +H +         
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

Query: 173 VDGPPSSD 180
                +++
Sbjct: 305 QMAKGTTE 312

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  169 bits (431), Expect = 2e-49
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 19/224 (8%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+     LK+ DFG+A   + +      
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166

Query: 64  DKKCGTLPYVAPEVLV-----------RSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           D + GT+ Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +   +
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-N 225

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
            I  L    + + +    D  + +   +++  L   P  R++I ++ +H +         
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH--- 282

Query: 173 VDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFA 216
              P +     T + M+  L        P    +A  +  E ++
Sbjct: 283 ---PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYS 323

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  168 bits (428), Expect = 1e-48
 Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 19/224 (8%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
           WE + +++ ++  V  +H  GI H DLKP N L+     LK+ DFG+A   + +      
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213

Query: 64  DKKCGTLPYVAPEVLV-----------RSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
           D + G + Y+ PE +            +S ++  +D+WS G IL  M  G+ P+ +   +
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-N 272

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
            I  L    + + +    D  + +   +++  L   P  R++I ++ +H +         
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH--- 329

Query: 173 VDGPPSSDFNSTAKRMRSDLETEANRACPTFDDRACVSQPEPFA 216
              P +     T + M+  L        P    +A  +  E ++
Sbjct: 330 ---PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYS 370

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  161 bits (410), Expect = 1e-46
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
             + +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +    G+  
Sbjct: 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171

Query: 62  PLDKKCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLAGELP-WDKPTADCI--- 114
            +   CGT  Y+APEVLV    A      D WS G+IL   L+G  P  +  T   +   
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231

Query: 115 ----EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
               +Y       +     W  +    L L++++L   P  R   E+   H W       
Sbjct: 232 ITSGKY-------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

Query: 171 DIVDGPPSSDFNSTAKRMRSDLETEANR 198
                   S+ N +    +   +   +R
Sbjct: 285 RKFQ-DLLSEENESTALPQVLAQPSTSR 311

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  159 bits (405), Expect = 2e-46
 Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 7/169 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A +  + ++S V Y H   +AHRDLKPEN L         LK+ DFGLA  F+     +
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGK 163

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +  K GT  YV+P+VL   Y     D WS G+++  +L G  P+  PT   +     + 
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG 222

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
                   W  +     SLIRR+L   P  R+   +   H W+ K + +
Sbjct: 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  159 bits (405), Expect = 9e-46
 Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 10/174 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL--DLQDTLKISDFGLATVFRM--NGKE 60
                 RQ+ S + YLH++GI HRD+KPEN L   +    +K+ DFGL+  F    NG+ 
Sbjct: 169 LISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 61  RPLDKKCGTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEY 116
             +  K GT  +VAPEVL     SY     D WS G++L  +L G +P      AD I  
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ 287

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
           +        +   ++ L      L+  +L      R +  +   H W S+    
Sbjct: 288 VL-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  159 bits (405), Expect = 6e-45
 Identities = 57/182 (31%), Positives = 82/182 (45%), Gaps = 26/182 (14%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
             + +F Q++  V+YLH  GI HRDLKPENVLL  Q+    +KI+DFG + +    G+  
Sbjct: 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 296

Query: 62  PLDKKCGTLPYVAPEVLV----RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCI-- 114
            +   CGT  Y+APEVLV      Y     D WS G+IL   L+G  P  +  T   +  
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355

Query: 115 -----EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
                +Y       +     W  +    L L++++L   P  R   E+   H W      
Sbjct: 356 QITSGKY-------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408

Query: 170 ND 171
             
Sbjct: 409 KR 410

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  156 bits (397), Expect = 7e-45
 Identities = 40/203 (19%), Positives = 71/203 (34%), Gaps = 40/203 (19%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKE 60
           E     R ++ G+ +L   GI HR++KP N++     D Q   K++DFG A     + + 
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP--------ADIWSCGIILVAMLAGELPWDKPT-- 110
                  GT  Y+ P++  R+ L +          D+WS G+       G LP+      
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 111 ---------------ADCIEYLEWKDNRHMQRS----PWDRLDVNCLSLIRRILAPL--- 148
                          +  I  ++  +N  +  S        L      L+  +LA +   
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 149 -PSTRLNIEKIKSHRWYSKHMPN 170
                   ++  +      H  N
Sbjct: 290 DQEKCWGFDQFFAETSDILHRGN 312

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  158 bits (401), Expect = 8e-45
 Identities = 27/180 (15%), Positives = 61/180 (33%), Gaps = 25/180 (13%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +      +   Q+I  +  LH  G+ H  L+P +++LD +  + ++ F        +G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRDGAR 259

Query: 61  RPLDKKCGTLPYVAPEVLV-----------RSYLAEPADIWSCGIILVAMLAGELPWDKP 109
                   +  +  PE+             R+ +    D W+ G+++  +   +LP  K 
Sbjct: 260 VVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316

Query: 110 TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
            A       ++  +++             +L+   L      RL   +      Y +   
Sbjct: 317 AALGGSEWIFRSCKNI--PQP------VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (396), Expect = 9e-45
 Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 23/187 (12%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF---------- 54
           E  + FRQ++  + Y+HS+GI HRDLKP N+ +D    +KI DFGLA             
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 55  --RMNGKERPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTA 111
              + G    L    GT  YVA EVL    +  E  D++S GII   M+         + 
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------FST 230

Query: 112 DCIEYLEWKDNRHMQRSP----WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
                   K  R +         D        +IR ++   P+ R     + +  W    
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

Query: 168 MPNDIVD 174
             ++++ 
Sbjct: 291 HQDEVIK 297

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  155 bits (394), Expect = 1e-44
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 8/162 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
              +  +Q+++ + Y HS+ + H+DLKPEN+L         +KI DFGLA +F+    + 
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDE 181

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
                 GT  Y+APEV  R       DIWS G+++  +L G LP+   + + +   +   
Sbjct: 182 HSTNAAGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-QQKATY 239

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                      L    + L++++L   P  R +  ++  H W
Sbjct: 240 KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  153 bits (389), Expect = 6e-44
 Identities = 58/171 (33%), Positives = 91/171 (53%), Gaps = 9/171 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A +  +Q+ SG+ Y+H   I HRDLKPEN+LL+ ++    +KI DFGL+T F    +  
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNT 178

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            +  + GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P + K   D ++ +E  
Sbjct: 179 KMKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-T 236

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
                    W  +  +   LIR++L   PS R+   +   H W  K+   +
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  152 bits (386), Expect = 2e-43
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 11/175 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E +K  R L+  +  LH   I HRDLKPEN+LLD    +K++DFG +           L 
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLR 181

Query: 65  KKCGTLPYVAPEVLVRSYLA------EPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
           + CGT  Y+APE++  S         +  D+WS G+I+  +LAG  P W +     +  +
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
               N       WD        L+ R L   P  R   E+  +H ++ +++  ++
Sbjct: 242 M-SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  156 bits (397), Expect = 2e-43
 Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 8/189 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A +  +Q+ SG+ Y+H   I HRDLKPEN+LL+ ++    +KI DFGL+T F+   +  
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNT 178

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +  + GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P+       I       
Sbjct: 179 KMKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
                   W  +  +   LIR++L   PS R+   +   H W  K+           S  
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSL- 296

Query: 182 NSTAKRMRS 190
            S    +R 
Sbjct: 297 ESAMTNIRQ 305

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  156 bits (396), Expect = 3e-43
 Identities = 62/189 (32%), Positives = 96/189 (50%), Gaps = 9/189 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A +  RQ++SG+ Y+H   I HRDLKPEN+LL+ +     ++I DFGL+T F      +
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASK 183

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +  K GT  Y+APEVL  +Y  E  D+WS G+IL  +L+G  P++      I     K 
Sbjct: 184 KMKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
               +   W ++  +   LIR++L  +PS R++      H W   +    I    PS D 
Sbjct: 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLD- 301

Query: 182 NSTAKRMRS 190
            +    +R 
Sbjct: 302 -NAILNIRQ 309

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  156 bits (396), Expect = 4e-43
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 8/189 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++SGV YLH   I HRDLKPEN+LL+ ++    +KI DFGL+ VF     ++
Sbjct: 137 DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQK 193

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            + ++ GT  Y+APEVL + Y  E  D+WS G+IL  +LAG  P+   T   I     K 
Sbjct: 194 KMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
                   W  +      LI+++L      R++ ++   H W  +            S  
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL- 311

Query: 182 NSTAKRMRS 190
            +  + MR 
Sbjct: 312 ANAIENMRK 320

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  155 bits (394), Expect = 8e-43
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 9/189 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++SG+ YLH   I HRD+KPEN+LL+ ++    +KI DFGL++ F    K+ 
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDY 203

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L  + GT  Y+APEVL + Y  E  D+WSCG+I+  +L G  P+       I     K 
Sbjct: 204 KLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
             +   + W  +      LI+ +L    + R   E+  + RW  K+  N   +       
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI--NKSDQKTL 320

Query: 182 NSTAKRMRS 190
                 MR 
Sbjct: 321 CGALSNMRK 329

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  150 bits (381), Expect = 1e-42
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 8/171 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA          
Sbjct: 106 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSE 162

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
                 GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+        ++  
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-A 221

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
                    WD +     SLI  +L   P  R+  ++     W        
Sbjct: 222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  151 bits (382), Expect = 3e-42
 Identities = 31/172 (18%), Positives = 46/172 (26%), Gaps = 12/172 (6%)

Query: 2   AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER 61
                     QLI     L SKG+ H    P+N+ +     L + D          G   
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL---WKVGTRG 248

Query: 62  PLDKKCGTLPYVAPEVLVRSYLA--EPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           P       + Y   E L  S        + W  G+ +  +    LP+   T       + 
Sbjct: 249 PAS--SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306

Query: 120 KDNRHMQRSPWDRLDVNCLS-----LIRRILAPLPSTRLNIEKIKSHRWYSK 166
              R              L      LI R L      RL   +      + +
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  150 bits (380), Expect = 6e-42
 Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 31/179 (17%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E +   R L+  V +LH+  I HRDLKPEN+LLD    +++SDFG +           L 
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLR 257

Query: 65  KKCGTLPYVAPEVLVRSYLA------EPADIWSCGIILVAMLAGELP-WDKPTADCIEYL 117
           + CGT  Y+APE+L  S         +  D+W+CG+IL  +LAG  P W +         
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--------- 308

Query: 118 EWKDNRHMQR----------SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
             +    ++             WD        LI R+L   P  RL  E+   H ++ +
Sbjct: 309 --RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  148 bits (377), Expect = 1e-41
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 22/201 (10%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA    R+L+S V ++H  G+ HRDLKPEN+L   ++    +KI DFG A +   + +  
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
           PL   C TL Y APE+L ++   E  D+WS G+IL  ML+G++P      +         
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----CTS 220

Query: 121 DNRHMQR----------SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH--M 168
               M++            W  +      LI+ +L   P+ RL +  ++ + W      +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 169 PNDIVDGPPSSDFNSTAKRMR 189
            ++ +  P     +  A    
Sbjct: 281 SSNPLMTPDILGSSGAAVHTC 301

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  148 bits (377), Expect = 1e-41
 Identities = 53/166 (31%), Positives = 74/166 (44%), Gaps = 9/166 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKE 60
           EA      +   VEYLH++G+ HRDLKP N+L        ++++I DFG A   R   + 
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AEN 174

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLE- 118
             L   C T  +VAPEVL R       DIWS G++L  ML G  P  + P     E L  
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234

Query: 119 -WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                  +    W+ +      L+ ++L   P  RL    +  H W
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  149 bits (379), Expect = 2e-41
 Identities = 38/201 (18%), Positives = 68/201 (33%), Gaps = 40/201 (19%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKE 60
           E     R ++ G+ +L   GI HR++KP N++     D Q   K++DFG A     + + 
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEP--------ADIWSCGIILVAMLAGELPWDKPT-- 110
                  GT  Y+ P++  R+ L +          D+WS G+       G LP+      
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 111 ---------------ADCIEYLEWKDNRHMQRS----PWDRLDVNCL----SLIRRILAP 147
                          +  I  ++  +N  +  S        L          ++  IL  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 148 LPSTRLNIEKIKSHRWYSKHM 168
                   ++  +      H 
Sbjct: 290 DQEKCWGFDQFFAETSDILHR 310

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  147 bits (373), Expect = 2e-41
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 28/200 (14%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA    + + S +++LH+KGIAHRDLKPEN+L +  +    +KI DF L +  ++NG   
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 62  P-----LDKKCGTLPYVAPEVLVRSYLA-----EPADIWSCGIILVAMLAGELP-WDKPT 110
           P     L   CG+  Y+APEV+           +  D+WS G+IL  +L+G  P   +  
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

Query: 111 ADCIEYLEWKDNRHMQR--------------SPWDRLDVNCLSLIRRILAPLPSTRLNIE 156
           +DC                              W  +      LI ++L      RL+  
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291

Query: 157 KIKSHRWYSKHMPNDIVDGP 176
           ++  H W     P + +  P
Sbjct: 292 QVLQHPWVQGCAPENTLPTP 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  153 bits (388), Expect = 3e-41
 Identities = 41/187 (21%), Positives = 64/187 (34%), Gaps = 32/187 (17%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
             +     + S + YLH   I HRDLKPEN++L         KI D G A          
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-- 179

Query: 62  PLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWD------------- 107
              +  GTL Y+APE+L  + Y     D WS G +    + G  P+              
Sbjct: 180 -CTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 108 KPTADCIEYLEWKDNRHMQRSPWDRLDVNCLS---------LIRRILAPLPSTRLNIEKI 158
           + + + I    + D     +        N LS          ++ +L      R    + 
Sbjct: 238 EKSNEHIVV--YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295

Query: 159 KSHRWYS 165
            +   + 
Sbjct: 296 PNVGCFQ 302

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  147 bits (374), Expect = 5e-41
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 17/191 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
            A  + RQ++  + Y H   I HRD+KP  VLL  ++    +K+  FG+A     +G   
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV- 189

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP---WDKPTADCIEYLE 118
               + GT  ++APEV+ R    +P D+W CG+IL  +L+G LP     +   + I    
Sbjct: 190 -AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII--- 245

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPS 178
            K    M    W  +  +   L+RR+L   P+ R+ + +  +H W  +            
Sbjct: 246 -KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER-----DRYAYK 299

Query: 179 SDFNSTAKRMR 189
                T +++R
Sbjct: 300 IHLPETVEQLR 310

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  147 bits (374), Expect = 6e-41
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 13/189 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++  + Y HS GI HR+LKPEN+LL  +     +K++DFGLA          
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSE 185

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
                 GT  Y++PEVL +   ++P DIW+CG+IL  +L G  P WD+        ++  
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-A 244

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
                    WD +     SLI  +L   P  R+  ++     W              +  
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV-----ASAIH 299

Query: 181 FNSTAKRMR 189
              T   ++
Sbjct: 300 RQDTVDCLK 308

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  148 bits (375), Expect = 2e-40
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 7/167 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++  V + H  G+ HR+LKPEN+LL  +     +K++DFGLA       +  
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-- 168

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
                 GT  Y++PEVL +    +P D+W+CG+IL  +L G  P WD+      + ++  
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-A 227

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
                    WD +      LI ++L   PS R+   +   H W S  
Sbjct: 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  145 bits (368), Expect = 2e-40
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 11/166 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  R + + +++LHS  IAHRD+KPEN+L   ++    LK++DFG A        + 
Sbjct: 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQN 184

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P +          ++ +
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244

Query: 121 DNR---HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                       W  +  +   LIR +L   P+ RL I +  +H W
Sbjct: 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  144 bits (365), Expect = 3e-40
 Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 9/171 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++S V+YLH  GI HRDLKPEN+L    +    + I+DFGL+ +     +  
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNG 162

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            +   CGT  YVAPEVL +   ++  D WS G+I   +L G  P +++  +   E ++ +
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-E 221

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
                +   WD +  +    I  +L   P+ R   EK  SH W   +    
Sbjct: 222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  144 bits (365), Expect = 7e-40
 Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 7/174 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A    +Q++  V YLH  GI HRDLKPEN+L         LKI+DFGL+ +      + 
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQV 205

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            +   CGT  Y APE+L         D+WS GII   +L G  P+     D   +    +
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265

Query: 122 NRH-MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
             +      WD + +N   L+R+++   P  RL   +   H W +    N +  
Sbjct: 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM 319

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  144 bits (366), Expect = 1e-39
 Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 13/193 (6%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKER 61
            +   F +Q+  G+ ++H   I H DLKPEN+L   +D   +KI DFGLA  +       
Sbjct: 187 LDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPRE 243

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEYL 117
            L    GT  ++APEV+   +++ P D+WS G+I   +L+G  P     D  T + I   
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303

Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPP 177
            W     ++   +  +       I ++L    S R++  +   H W S H  +  +    
Sbjct: 304 RWD----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359

Query: 178 SSDFNSTAKRMRS 190
             +  S A+   +
Sbjct: 360 KKNRGSDAQDFVT 372

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (361), Expect = 1e-39
 Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 11/173 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER--- 61
           +       +  G+E +H+KG AHRDLKP N+LL  +    + D G      ++ +     
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 62  ----PLDKKCGTLPYVAPEVL-VRSYLA--EPADIWSCGIILVAMLAGELPWDKPTADCI 114
                   +  T+ Y APE+  V+S+    E  D+WS G +L AM+ GE P+D       
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-G 253

Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           + +       +      R       L+  ++   P  R +I  + S     + 
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  141 bits (358), Expect = 2e-39
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 15/176 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKE 60
           EA +F +Q++ GV YLHSK IAH DLKPEN++L  ++     +K+ DFG+A         
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAG 165

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEY 116
                  GT  +VAPE++    L   AD+WS G+I   +L+G  P      + T   I  
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
           + +          +          IRR+L   P  R+ I +   H W       ++
Sbjct: 226 VNYD----FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  143 bits (363), Expect = 3e-39
 Identities = 51/173 (29%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A          
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHN 218

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWK 120
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P +          +   
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--- 275

Query: 121 DNRHMQR----------SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                 R            W  +      LIR +L   P+ R+ I +  +H W
Sbjct: 276 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  141 bits (358), Expect = 5e-39
 Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 18/193 (9%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKE 60
           EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA         
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDG 172

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEY 116
                  GT  +VAPE++    L   AD+WS G+I   +L+G  P      + T   I  
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           + +          +          IR++L      RL I++   H W +       +   
Sbjct: 233 VSYD----FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

Query: 177 PSSDFNSTAKRMR 189
            S       +  R
Sbjct: 289 ESV---VNLENFR 298

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  140 bits (355), Expect = 1e-38
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 15/178 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKE 60
           EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA         
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEY 116
                  GT  +VAPE++    L   AD+WS G+I   +L+G  P      + T   +  
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
           + ++     +   +          IRR+L   P  R+ I+    H W         + 
Sbjct: 232 VNYE----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  141 bits (356), Expect = 1e-38
 Identities = 48/190 (25%), Positives = 73/190 (38%), Gaps = 21/190 (11%)

Query: 5   EAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP 62
              K F Q    V+++H +   I HRDLK EN+LL  Q T+K+ DFG AT          
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 63  LDK----------KCGTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPWDKP 109
             +          +  T  Y  PE++       + E  DIW+ G IL  +   + P++  
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

Query: 110 TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
               I   ++    H  +           SLIR +L   P  RL+I ++           
Sbjct: 257 AKLRIVNGKYSIPPHDTQYT------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

Query: 170 NDIVDGPPSS 179
           N     P + 
Sbjct: 311 NVNPKSPITE 320

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  140 bits (355), Expect = 1e-38
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 15/203 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +  +  +Q++ GV YLH   I H DLKP+N+LL        +KI DFG++      G   
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHAC 188

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEYL 117
            L +  GT  Y+APE+L    +    D+W+ GII   +L    P     ++ T   I  +
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248

Query: 118 EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH-MPNDIVDGP 176
                       +  +       I+ +L   P  R   E   SH W  +    N      
Sbjct: 249 NVD----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304

Query: 177 PSSDFNSTAKRMRSDLETEANRA 199
            SS   +    +RS  +  +  +
Sbjct: 305 TSSSSQTQDHSVRSSEDKTSKSS 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  141 bits (356), Expect = 6e-38
 Identities = 47/183 (25%), Positives = 69/183 (37%), Gaps = 24/183 (13%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------------TLKISDFGLA 51
                 RQ+ SGV +LHS  I HRDLKP+N+L+                  + ISDFGL 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 52  TVFR--MNGKERPLDKKCGTLPYVAPEVLVRS-------YLAEPADIWSCGIILVAML-A 101
                  +     L+   GT  + APE+L  S        L    DI+S G +   +L  
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 102 GELPWDKPTADCIEYLEWK-DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
           G+ P+    +     +        M+      L      LI +++   P  R    K+  
Sbjct: 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

Query: 161 HRW 163
           H  
Sbjct: 296 HPL 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  139 bits (352), Expect = 6e-38
 Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 15/194 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKE 60
           EA  F +Q++ GV YLH+K IAH DLKPEN++L  ++     +K+ DFGLA         
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDG 172

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEY 116
                  GT  +VAPE++    L   AD+WS G+I   +L+G  P      + T   I  
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGP 176
           + +          + +        IR++L      RL I++   H W +       +   
Sbjct: 233 VSYD----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288

Query: 177 PSSDFNSTAKRMRS 190
            S       K+   
Sbjct: 289 ESVVNLENFKKQYV 302

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  138 bits (349), Expect = 3e-37
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 13/191 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERP 62
           E   + RQ   G++++H   I H D+KPEN++ + +   ++KI DFGLAT       +  
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEI 206

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEYLE 118
           +     T  + APE++ R  +    D+W+ G++   +L+G  P     D  T   ++  +
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 266

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPS 178
           W          +  +       I+ +L   P  RL +     H W      N     P S
Sbjct: 267 W----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322

Query: 179 SDFNSTAKRMR 189
                  K   
Sbjct: 323 RYNKIRQKIKE 333

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  136 bits (344), Expect = 5e-37
 Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 13/165 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERP 62
           E   +  Q+   +++LHS  I H D++PEN++   +   T+KI +FG A   +       
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDN 159

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEYLE 118
                    Y APEV     ++   D+WS G ++  +L+G  P     ++   + I   E
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +          +  + +  +  + R+L     +R+   +   H W
Sbjct: 220 Y----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  138 bits (348), Expect = 4e-36
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 16/192 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERP 62
           EA ++ RQ+  G+ ++H     H DLKPEN++   +  + LK+ DFGL         ++ 
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQS 312

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-W---DKPTADCIEYLE 118
           +    GT  + APEV     +    D+WS G++   +L+G  P     D  T   ++  +
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW---YSKHMPNDIVDG 175
           W     M  S +  +  +    IR++L   P+TR+ I +   H W    +    +  +  
Sbjct: 373 WN----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 428

Query: 176 PPSSDFNSTAKR 187
              +    + K 
Sbjct: 429 SRYTKIRDSIKT 440

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  134 bits (337), Expect = 2e-35
 Identities = 27/185 (14%), Positives = 62/185 (33%), Gaps = 15/185 (8%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +      +   Q+I  +  LH  G+ H  L+P +++LD +  + ++ F    V       
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAV 266

Query: 61  RPLDKKCGTLPYVAPEVL-----VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE 115
            P+ +        A  +L       + +    D W+ G+ +  +   +LP     A    
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDG 175
              ++  +++             +L+   L      RL   +      Y + +  ++   
Sbjct: 327 EWIFRSCKNI--PQP------VRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAA 377

Query: 176 PPSSD 180
            P   
Sbjct: 378 LPLYQ 382

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (338), Expect = 2e-35
 Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 11/169 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGK 59
           E     +Q  SG+ +LHS  I HRDLKP N+L+ + +        ISDFGL     +   
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178

Query: 60  E-RPLDKKCGTLPYVAPEVLVRSYLA---EPADIWSCGIILVAMLA-GELPWDKPTADCI 114
                    GT  ++APE+L            DI+S G +   +++ G  P+ K      
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQ 237

Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
             +           P    DV    LI +++A  P  R + + +  H +
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (317), Expect = 2e-33
 Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 13/164 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +   + R  +  + +LHS+G+ H D+KP N+ L  +   K+ DFGL       G     +
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GE 214

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
            + G   Y+APE+L  SY    AD++S G+ ++ +                   W+  R 
Sbjct: 215 VQEGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELPH-------GGEGWQQLRQ 266

Query: 125 MQRSP--WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
               P     L     S++  +L P P  R   E + +     +
Sbjct: 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  126 bits (319), Expect = 5e-33
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +L+  ++YL ++ I HRD+KP+N+LLD    + I+DF +A +     +E  +    GT P
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKP 179

Query: 72  YVAPEVLVRSYLAE---PADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS 128
           Y+APE+      A      D WS G+    +L G  P+   ++   +  E          
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFETTVV 237

Query: 129 PW-DRLDVNCLSLIRRILAPLPSTRL-NIEKIKSHRWYS 165
            +        +SL++++L P P  R   +  +++  + +
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (312), Expect = 8e-33
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 11/165 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A + F Q+  GV+Y+HSK + +RDLKP N+ L     +KI DFGL T  + +GK     
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RT 179

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
           +  GTL Y++PE +      +  D+++ G+IL  +L         TA       + D R 
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFETSKF-FTDLR- 232

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
                 D  D    +L++++L+  P  R N  +I       K  P
Sbjct: 233 -DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  120 bits (304), Expect = 2e-31
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 22/167 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+   +   GT  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEY-----LEWKDNRHM 125
           YV+PE+L      + +D+W+ G I+  ++AG  P          +       ++ +    
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--- 254

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL------NIEKIKSHRWYSK 166
                         L+ ++L    + RL          +K+H ++  
Sbjct: 255 -------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (306), Expect = 2e-31
 Identities = 38/183 (20%), Positives = 65/183 (35%), Gaps = 16/183 (8%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL-----------DLQDTLKISDFG 49
           M Q     F  +++  +E +H   I H D+KP+N +L           DL   L + D G
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 50  LATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKP 109
            +   ++  K      KC T  +   E+L         D +     +  ML G       
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---K 285

Query: 110 TADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
             +  E  E K     +R P   +      ++  I        L++ + K  + + +H  
Sbjct: 286 VKN--EGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

Query: 170 NDI 172
           N I
Sbjct: 344 NKI 346

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  120 bits (303), Expect = 3e-31
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 17/173 (9%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV----------F 54
                F Q+   VE+LHSKG+ HRDLKP N+   + D +K+ DFGL T            
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

Query: 55  RMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
                      + GT  Y++PE +  +  +   DI+S G+IL  +L         T    
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMER 279

Query: 115 EYLEWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK 166
             +   D R+++    + +       +++ +L+P P+ R     I  +  +  
Sbjct: 280 VRI-ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (299), Expect = 4e-31
 Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 12/170 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKG-----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
              +   QL   ++  H +      + HRDLKP NV LD +  +K+ DFGLA +  +N  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHD 169

Query: 60  ERPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                   GT  Y++PE +   SY  E +DIWS G +L  + A   P+    A   + L 
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFT---AFSQKELA 225

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
            K      R    R       +I R+L      R ++E+I  +    +H 
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  118 bits (298), Expect = 1e-30
 Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 36/204 (17%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG            
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------- 166

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLE-- 118
                       A E     Y  +  D+WS G+I+  +L G  P +          ++  
Sbjct: 167 ------------AKETTGEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 119 -WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM--PNDIVDG 175
                       W  +      LIR +L   P+ R+ I +  +H W  +    P   +  
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH- 272

Query: 176 PPSSDFNSTAKRMRSDLETEANRA 199
             +S      K    D++ E   A
Sbjct: 273 --TSRVLKEDKERWEDVKEEMTSA 294

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (298), Expect = 3e-30
 Identities = 41/196 (20%), Positives = 82/196 (41%), Gaps = 9/196 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +   +F Q+   ++++H + I HRD+K +N+ L    T+++ DFG+A V  +N       
Sbjct: 126 QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELAR 183

Query: 65  KKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
              GT  Y++PE+   + Y    +DIW+ G +L  +   +  ++   A  ++ L  K   
Sbjct: 184 ACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKIIS 239

Query: 124 HMQRSPW-DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFN 182
                P       +  SL+ ++    P  R ++  I    + +K +   +     + +F 
Sbjct: 240 -GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFC 298

Query: 183 STAKRMRSDLETEANR 198
                        A R
Sbjct: 299 LKTFSKFGSQPIPAKR 314

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  117 bits (294), Expect = 3e-30
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 20/176 (11%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATV----------FRMN 57
             F Q+   VE+LHSKG+ HRDLKP N+   + D +K+ DFGL T               
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 58  GKERPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
                   + GT  Y++PE +   SY  +  DI+S G+IL  +L         +      
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY------PFSTQMERV 234

Query: 117 LEWKDNRHMQRSP-WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-HMPN 170
               D R+++  P + +       +++ +L+P P  R     I  +  +     P 
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  114 bits (288), Expect = 5e-28
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 18/164 (10%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----C 67
           ++  G+E LH + I +RDLKPEN+LLD    ++ISD GLA          P  +      
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRV 346

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQ 126
           GT+ Y+APEV+         D W+ G +L  M+AG+ P+  +      E +E       +
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
               +R      SL  ++L   P+ RL     +  ++K H  + 
Sbjct: 407 EYS-ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  112 bits (283), Expect = 8e-28
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 19/168 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++  ++ +H  G  HRD+KP+N+LLD    ++++DFG     R +G  R      GT  
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS-LVAVGTPD 228

Query: 72  YVAPEVLVRSYLAE-------PADIWSCGIILVAMLAGELPWD----KPTADCIEYLEWK 120
           Y++PE+L                D W+ G+    M  G+ P+       T   I  + +K
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYK 286

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYS 165
           ++  +     + +       I+R+L P P TRL        ++H ++ 
Sbjct: 287 EHLSLPLVD-EGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFFF 332

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (277), Expect = 8e-28
 Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 5/101 (4%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ   G++YLH+K I HRDLK  N+ L   +T+KI DFGLAT           ++  G++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 71  PYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWD 107
            ++APEV+ R   + P    +D+++ GI+L  ++ G+LP+ 
Sbjct: 187 LWMAPEVI-RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  110 bits (278), Expect = 1e-27
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 29/173 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++   + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE           
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTF 170

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE+L         D W+ G+++  M+AG  P+D   +            ++ 
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--TEDYLF 228

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL------NIEKIKSHRWYS 165
           +         P   L V   S+++  L   P  RL          I+ H ++ 
Sbjct: 229 QVILEKQIRIP-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 2e-27
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 19/165 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK---KCG 68
           ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA        +    K     G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVG 352

Query: 69  TLPYVAPEVLVR--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           T  Y+APEVL +  +Y    AD +S G +L  +L G  P+ +        ++        
Sbjct: 353 THGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
             P D       SL+  +L    + RL       +++K   ++  
Sbjct: 412 ELP-DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  111 bits (279), Expect = 2e-27
 Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 13/163 (7%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++  ++ +HS G  HRD+KP+N+LLD    LK++DFG        G  R  D   GT  
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPD 234

Query: 72  YVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELP-WDKPTADCIEY-LEWKDNRHM 125
           Y++PEVL             D WS G+ L  ML G+ P +           +  K++   
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYS 165
                  +     +LI   L      RL    +E+IK H ++ 
Sbjct: 295 PDDND--ISKEAKNLICAFLTD-REVRLGRNGVEEIKRHLFFK 334

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  109 bits (276), Expect = 2e-27
 Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 37/173 (21%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +L   +++LHS GI +RDLKPEN+LLD +  +K++DFGL+       KE    +K     
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEKKAYSF 186

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT+ Y+APEV+ R    + AD WS G+++  ML G LP+             KD +   
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-----------KDRKETM 235

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
                     P   L     SL+R +    P+ RL      +E+IK H ++S 
Sbjct: 236 TMILKAKLGMP-QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  112 bits (283), Expect = 2e-27
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 19/165 (11%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           Q++SG+E+LH + I +RDLKPENVLLD    ++ISD GLA        E    +      
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-------VELKAGQTKTKGY 349

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHM 125
            GT  ++APE+L+        D ++ G+ L  M+A   P+  +      + L+ +     
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
              P D+           +L   P  RL     + + +++H  + 
Sbjct: 410 VTYP-DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  110 bits (278), Expect = 3e-27
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 29/173 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++   + YLH +GI +RDLK +NVLLD +  +K++D+G+        KE           
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTF 213

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE+L         D W+ G+++  M+AG  P+D   +            ++ 
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--TEDYLF 271

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL------NIEKIKSHRWYS 165
           +         P   L V   S+++  L   P  RL          I+ H ++ 
Sbjct: 272 QVILEKQIRIP-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  109 bits (274), Expect = 3e-27
 Identities = 53/172 (30%), Positives = 76/172 (44%), Gaps = 40/172 (23%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----C 67
           ++   +EYLHSK I +RDLKPEN+LLD    +KI+DFG A       K   +       C
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KY--VPDVTYTLC 164

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-MQ 126
           GT  Y+APEV+      +  D WS GI++  MLAG  P+            +  N     
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF------------YDSNTMKTY 212

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                     P    + +   L+ R++    S RL       E +K+H W+ 
Sbjct: 213 EKILNAELRFP-PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  109 bits (275), Expect = 4e-27
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 26/165 (15%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   R+ G+   L   CGT  
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL---CGTPE 203

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI------EYLEWKDNRHM 125
            +APE+++     +  D W+ G+++  M AG  P+       I        + +  +   
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--- 260

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
                     +   L+R +L    + R       +  IK+H+W++
Sbjct: 261 -------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  108 bits (273), Expect = 5e-27
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 37/173 (21%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++   + +LH KGI +RDLKPEN++L+ Q  +K++DFGL        KE   D       
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHDGTVTHTF 181

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT+ Y+APE+L+RS      D WS G ++  ML G  P+             ++ +   
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-----------ENRKKTI 230

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
                     P   L      L++++L    ++RL     +  ++++H ++  
Sbjct: 231 DKILKCKLNLP-PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  108 bits (272), Expect = 1e-26
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 36/176 (20%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +++  +E+LH  GI +RD+K EN+LLD    + ++DFGL+       KE   D+      
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVADETERAYD 219

Query: 67  -CGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
            CGT+ Y+AP+++    S   +  D WS G+++  +L G  P+                 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-------NSQA 272

Query: 124 HMQRS--------PWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSK 166
            + R         P   +      LI+R+L   P  RL     + ++IK H ++ K
Sbjct: 273 EISRRILKSEPPYP-QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (266), Expect = 3e-26
 Identities = 40/104 (38%), Positives = 61/104 (58%), Gaps = 7/104 (6%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDK 65
             + +Q++ G++YLH   I HRD+K +NVL++     LKISDFG +   R+ G     + 
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTET 182

Query: 66  KCGTLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPW 106
             GTL Y+APE++    R Y  + ADIWS G  ++ M  G+ P+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  106 bits (267), Expect = 3e-26
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 12/161 (7%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           K+F QL S +E++HS+ + HRD+KP NV +     +K+ D GL      + K        
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 197

Query: 68  GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR 127
           GT  Y++PE +  +     +DIWS G +L  M A + P+     +    L  K    +++
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKK----IEQ 252

Query: 128 SPWDRLDVNCLS-----LIRRILAPLPSTRLNIEKIKSHRW 163
             +  L  +  S     L+   + P P  R ++  +     
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  108 bits (271), Expect = 3e-26
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 11/163 (6%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLP 71
           +++  ++ +H     HRD+KP+N+L+D+   ++++DFG       +G  +      GT  
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPD 241

Query: 72  YVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHM 125
           Y++PE+L      +       D WS G+ +  ML GE P + +   +    +     R  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL---NIEKIKSHRWYS 165
             +    +  N   LIRR++      RL    IE  K H ++S
Sbjct: 302 FPTQVTDVSENAKDLIRRLICS-REHRLGQNGIEDFKKHPFFS 343

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  106 bits (268), Expect = 4e-26
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 21/164 (12%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL        KE   D       
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKTF 165

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +     
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
           R+    L     SL+  +L   P  RL     + +++  HR++ 
Sbjct: 226 RT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 4e-26
 Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 13/109 (11%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFR---MNGKERPLDKKC 67
           ++++ G+ YLH+KGI H+DLK +NV  D    + I+DFGL ++        +E  L  + 
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 68  GTLPYVAPEVLVRSYLAEP---------ADIWSCGIILVAMLAGELPWD 107
           G L ++APE++ +               +D+++ G I   + A E P+ 
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  106 bits (266), Expect = 7e-26
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 25/164 (15%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++I G+++LHSKGI +RDLK +N+LLD    +KI+DFG+        KE  L        
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGDAKTNTF 178

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEWKDN 122
           CGT  Y+APE+L+        D WS G++L  ML G+ P+     +     I      DN
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MDN 234

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-NIEKIKSHRWYS 165
               R     L+     L+ ++    P  RL     I+ H  + 
Sbjct: 235 PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  106 bits (266), Expect = 9e-26
 Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 36/171 (21%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++ S + YLHS  I +RDLKPEN+LLD Q  + ++DFGL        KE           
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNSTTSTF 199

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APEVL +       D W  G +L  ML G  P+             ++   M 
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-----------RNTAEMY 248

Query: 127 RS--------PWDRLDVNCLSLIRRILAPLPSTRL----NIEKIKSHRWYS 165
            +            +  +   L+  +L    + RL    +  +IKSH ++S
Sbjct: 249 DNILNKPLQLK-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (265), Expect = 9e-26
 Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 45/225 (20%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVF--RMNGKERP 62
           E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F    N +   
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 63  LDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG------------------ 102
              +  TL Y  PE+L+  R Y   P D+W  G I+  M                     
Sbjct: 185 YTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243

Query: 103 --------------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPL 148
                              +     +E ++ +  +   R      D   L LI ++L   
Sbjct: 244 LCGSITPEVWPNVDNYELYEK----LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299

Query: 149 PSTRLNIEKIKSHRWYSKH-MPNDIVDGP---PSSDFNSTAKRMR 189
           P+ R++ +   +H ++    MP+D+        +S F   A   R
Sbjct: 300 PAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  105 bits (264), Expect = 2e-25
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 22/165 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++IS + +LH KGI +RDLK +NVLLD +   K++DFG+        KE   +       
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGVTTATF 184

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE+L         D W+ G++L  ML G  P++    D +      D     
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL------NIEKIKSHRWYS 165
                 L  +   +++  +   P+ RL          I  H ++ 
Sbjct: 245 TW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (262), Expect = 2e-25
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDK 65
             +  Q + G+EYLH++ I H D+K +NVLL        + DFG A   + +G  + L  
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212

Query: 66  K---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPW 106
                GT  ++APEV++        DIWS   +++ ML G  PW
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  103 bits (258), Expect = 2e-25
 Identities = 26/105 (24%), Positives = 46/105 (43%), Gaps = 12/105 (11%)

Query: 8   KFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDK 65
           KF   +  G+ +LH+    I    L   +V++D   T +IS   +   F+  G       
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------- 167

Query: 66  KCGTLPYVAPEVLVRS---YLAEPADIWSCGIILVAMLAGELPWD 107
           +     +VAPE L +         AD+WS  ++L  ++  E+P+ 
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  104 bits (261), Expect = 4e-25
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 29/168 (17%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++  G+ +L SKGI +RDLK +NV+LD +  +KI+DFG+        KE   D       
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTF 181

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----KPTADCIEYLEWKDN 122
           CGT  Y+APE++      +  D W+ G++L  MLAG+ P++          I     + N
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHN 237

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
               +S    +    +++ + ++   P  RL         IK H ++ 
Sbjct: 238 VAYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (258), Expect = 5e-25
 Identities = 51/189 (26%), Positives = 79/189 (41%), Gaps = 26/189 (13%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             +   RQ + G+++LH+  I HRDLKPEN+L+    T+K++DFGLA ++     +  L 
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE--LPWDK-------------- 108
               TL Y APEVL++S  A P D+WS G I   M   +     +               
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237

Query: 109 PTADC---IEYLEWKDNRHMQRSPWD----RLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           P  D       L           P       ++ +   L+  +L   P  R++  +   H
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297

Query: 162 RWYSKHMPN 170
            +  K   N
Sbjct: 298 SYLHKDEGN 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  102 bits (257), Expect = 7e-25
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 11  RQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
             +  G+ YLH++   I HR+LK  N+L+D + T+K+ DFGL+ +              G
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAG 201

Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           T  ++APEVL      E +D++S G+IL  +   + PW 
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 8e-25
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 26/180 (14%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +    QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++     +  L   
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 179

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE--LPWDK--------------PT 110
             TL Y APEVL++S  A P D+WS G I   M   +                     P 
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 111 ADC---IEYLEWKDNRHMQRSPWD----RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
            +       L  +        P +     +D     L+ + L   P+ R++     SH +
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  104 bits (260), Expect = 1e-24
 Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 22/165 (13%)

Query: 12  QLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK---- 66
           +++S ++YLHS K + +RDLK EN++LD    +KI+DFGL        KE   D      
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMKT 308

Query: 67  -CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
            CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +  L   +    
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368

Query: 126 QRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
            R+    L     SL+  +L   P  RL     + ++I  HR+++
Sbjct: 369 PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (259), Expect = 3e-24
 Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 21/164 (12%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK----- 66
           ++  G+ +L SKGI +RDLK +NV+LD +  +KI+DFG+        KE   D       
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTF 502

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
           CGT  Y+APE++      +  D W+ G++L  MLAG+ P++    +  + L      H  
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIMEHNV 559

Query: 127 RSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYS 165
             P   +    +++ + ++   P  RL         IK H ++ 
Sbjct: 560 AYP-KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (251), Expect = 4e-24
 Identities = 39/96 (40%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 16  GVEYLHS---KGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPLDKKCGTLP 71
           GV YLHS   K + HRDLKP N+LL    T LKI DFG A        +  +    G+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAA 168

Query: 72  YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
           ++APEV   S  +E  D++S GIIL  ++    P+D
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 13/162 (8%)

Query: 7   QKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPL 63
           + + RQ++ G+++LH++   I HRDLK +N+ +     ++KI D GLAT+ R +  +  +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 191

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD--KPTADCIEYLEWKD 121
               GT  ++APE+    Y  E  D+++ G+ ++ M   E P+   +  A     +    
Sbjct: 192 ----GTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--- 243

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +     S           +I   +      R +I+ + +H +
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.6 bits (249), Expect = 9e-24
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 5/99 (5%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +    Q +  V + H     HRD+KPEN+L+     +K+ DFG A +    G     D +
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDE 162

Query: 67  CGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
             T  Y +PE+LV    Y   P D+W+ G +   +L+G 
Sbjct: 163 VATRWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGV 200

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 26/158 (16%)

Query: 16  GVEYLHSKG--IAHRDLKPENVLLDLQD-----TLKISDFGLATVFRMNGKERPLDKKCG 68
           G+EY+ ++   I HRDL+  N+ L   D       K++DFGL+           +    G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188

Query: 69  TLPYVAPEVLVRSYLA--EPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ 126
              ++APE +     +  E AD +S  +IL  +L GE P+D+ +   I+++       + 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247

Query: 127 RSPWDRLDV--NC----LSLIRRILAPLPSTRLNIEKI 158
                R  +  +C     ++I    +  P  R +   I
Sbjct: 248 -----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 5/101 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + + +  QL+ GV + H   I HRDLKP+N+L++    LK++DFGLA  F      R   
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYT 177

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
            +  TL Y AP+VL+  + Y +   DIWS G I   M+ G+
Sbjct: 178 HEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 44/193 (22%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A+ F  QL++G+ Y H + + HRDLKP+N+L++ +  LKI+DFGLA  F      R   
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYT 158

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG-------------------- 102
            +  TL Y AP+VL+  + Y +   DIWS G I   M+ G                    
Sbjct: 159 HEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

Query: 103 ------------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS 150
                       ELP   P      +  ++            LD + + L+ ++L   P+
Sbjct: 218 GTPNSKNWPNVTELPKYDPN-----FTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPN 270

Query: 151 TRLNIEKIKSHRW 163
            R+  ++   H +
Sbjct: 271 QRITAKQALEHAY 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           QK+  Q+I+G+ + HS  I HRD+KPEN+L+     +K+ DFG A            D +
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDE 184

Query: 67  CGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
             T  Y APE+LV    Y  +  D+W+ G ++  M  GE
Sbjct: 185 VATRWYRAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGE 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 45/200 (22%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +     + F  QL+ G+ + H   I HRDLKP+N+L++ +  LK+ DFGLA  F      
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPV 162

Query: 61  RPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG---------------- 102
                +  TL Y AP+VL+  R+Y +   DIWSCG IL  M+ G                
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 103 ----------------ELPWDKPTADCIEYLEWKDN---RHMQRSPWDRLDVNCLSLIRR 143
                           +LP   P        +       + +Q    + LD N +  +  
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPN-----IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG 276

Query: 144 ILAPLPSTRLNIEKIKSHRW 163
           +L   P  RL+ ++   H W
Sbjct: 277 LLQLNPDMRLSAKQALHHPW 296

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 45/222 (20%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             + F  QL+ G+ Y H + + HRDLKP+N+L++ +  LK++DFGLA     +   +  D
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYD 158

Query: 65  KKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAG-------------------- 102
            +  TL Y  P++L+    Y +   D+W  G I   M  G                    
Sbjct: 159 NEVVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217

Query: 103 ------------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS 150
                            K       Y +++    +  +P  RLD +   L+ ++L     
Sbjct: 218 GTPTEETWPGILSNEEFKT----YNYPKYRAEALLSHAP--RLDSDGADLLTKLLQFEGR 271

Query: 151 TRLNIEKIKSHRWYSKHMPNDIVDGP-PSSDFNSTAKRMRSD 191
            R++ E    H ++   +   I   P  +S F     +++ +
Sbjct: 272 NRISAEDAMKHPFFL-SLGERIHKLPDTTSIFALKEIQLQKE 312

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.6 bits (244), Expect = 3e-23
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 5/103 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             + F  QL+ G+ + HS+ + HRDLKP+N+L++    LK+++FGLA  F      R   
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYS 159

Query: 65  KKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELP 105
            +  TL Y  P+VL   + Y +   D+WS G I   +     P
Sbjct: 160 AEVVTLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRP 201

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 36/185 (19%), Positives = 65/185 (35%), Gaps = 44/185 (23%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-------------------LQDTLKI 45
           E +    Q+  G+ Y+HS  + H D+KP N+ +                     +   KI
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 46  SDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE 103
            D G  T             + G   ++A EVL    ++L   ADI++  + +V     E
Sbjct: 176 GDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAE 228

Query: 104 LPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLS-----LIRRILAPLPSTRLNIEKI 158
                         +W     +++    R+    LS     L++ ++ P P  R +   +
Sbjct: 229 PLPR-------NGDQWH---EIRQGRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMAL 277

Query: 159 KSHRW 163
             H  
Sbjct: 278 VKHSV 282

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 15/108 (13%)

Query: 11  RQLISGVEYLHSKG---IAHRDLKPENVLLD--------LQDTLKISDFGLATVFRMNGK 59
            Q+  G+ YLH +    I HRDLK  N+L+             LKI+DFGLA  +    K
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171

Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
                   G   ++APEV+  S  ++ +D+WS G++L  +L GE+P+ 
Sbjct: 172 MS----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 55/199 (27%), Positives = 77/199 (38%), Gaps = 50/199 (25%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGK 59
             + F  QLI+GV + HS+   HRDLKP+N+LL + D      LKI DFGLA   R  G 
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGI 189

Query: 60  E-RPLDKKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAG-------------- 102
             R    +  TL Y  PE+L   R Y +   DIWS   I   ML                
Sbjct: 190 PIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248

Query: 103 ------------------ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRI 144
                              LP  K +     + +++     +      LD   L L+  +
Sbjct: 249 KIFEVLGLPDDTTWPGVTALPDWKQS-----FPKFRGKTLKRVLG-ALLDDEGLDLLTAM 302

Query: 145 LAPLPSTRLNIEKIKSHRW 163
           L   P  R++ +    H +
Sbjct: 303 LEMDPVKRISAKNALEHPY 321

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 18/117 (15%)

Query: 8   KFFRQLISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
           +    + SG+ +LH +         IAHRDLK +N+L+       I+D GLA +   +  
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 60  ERPLDK--KCGTLPYVAPEVL-------VRSYLAEPADIWSCGIILVAMLAGELPWD 107
           +  +    + GT  Y+APEVL             +  DIW+ G++L  +    +   
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRMVSNG 224

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 17/143 (11%)

Query: 15  SGVEYLHSK----------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            G+ YLH             I+HRD+K +NVLL    T  I+DFGLA  F          
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191

Query: 65  KKCGTLPYVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
            + GT  Y+APEVL  +   +       D+++ G++L  + +     D P  + +   E 
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

Query: 120 KDNRHMQRSPWDRLDVNCLSLIR 142
           +  +H   S  D  +V      R
Sbjct: 252 EIGQHP--SLEDMQEVVVHKKKR 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 35/221 (15%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDK 65
           + +  QL   + Y+HS GI HRD+KP+N+LLD     LK+ DFG A   +   +  P   
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVS 215

Query: 66  KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LPWDK-------------- 108
              +  Y APE++  +     + D+WS G +L  +L G+   P D               
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275

Query: 109 PTADCIEYLEWKDNRH----MQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           PT + I  +           ++  PW      R     ++L  R+L   P+ RL   +  
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335

Query: 160 SHRWYSK-HMPNDIV----DGPPSSDFNSTAKRMRSDLETE 195
           +H ++ +   PN  +    D P   +F +        L T 
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI 376

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 34/206 (16%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F   ++ G+  LH  G+ HRDL P N+LL   + + I DF LA   R +  +      
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHY 193

Query: 67  CGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LP-------WDK-------P 109
                Y APE++++        D+WS G ++  M   +            +K       P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 110 TADCIEYLEWKDNR--------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEK 157
             + +        R        ++    W  +    D   L LI ++L   P  R++ E+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313

Query: 158 IKSHRWYSK-HMPNDIVDGPPSSDFN 182
              H ++     P D +    S  F+
Sbjct: 314 ALRHPYFESLFDPLD-LTEGLSERFH 338

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 50/185 (27%), Positives = 72/185 (38%), Gaps = 33/185 (17%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +    + G+EYLH   I HRDLKP N+LLD    LK++DFGLA  F      R    +
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQ 172

Query: 67  CGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGE--LPWDK-------------- 108
             T  Y APE+L   R Y     D+W+ G IL  +L     LP D               
Sbjct: 173 VVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231

Query: 109 PTA----------DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           PT           D + +  +                + L LI+ +    P  R+   + 
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQGLFLFNPCARITATQA 289

Query: 159 KSHRW 163
              ++
Sbjct: 290 LKMKY 294

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 34/197 (17%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERP-LD 64
           + F  QL+ G++Y+HS  + HRDLKP N+ ++ +D  LKI DFGLA +   +   +  L 
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 65  KKCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE------------------LP 105
           +   T  Y +P +L+       A D+W+ G I   ML G+                  +P
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 106 WDKPTADCIEYLEWKDNRHMQ------RSPWDRL----DVNCLSLIRRILAPLPSTRLNI 155
                 +  + L      +++        P  +L        +  + +IL   P  RL  
Sbjct: 243 --VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 156 EKIKSHRWYSK-HMPND 171
           E+  SH + S    P D
Sbjct: 301 EEALSHPYMSIYSFPMD 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 43/209 (20%), Positives = 84/209 (40%), Gaps = 33/209 (15%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDK 65
             +  QL   V ++HS GI HRD+KP+N+L++ + +TLK+ DFG A   +      P   
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSA---KKLIPSEPSVA 200

Query: 66  KCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE--LPWD-------------- 107
              +  Y APE+++    Y     D+WS G +   ++ G+     +              
Sbjct: 201 YICSRFYRAPELMLGATEY-TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259

Query: 108 KPTADCIEYLEWKDNRH----MQRSPWDRL-----DVNCLSLIRRILAPLPSTRLNIEKI 158
            PT + +  +           ++   W ++         + L+ +IL   P  R+N  + 
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319

Query: 159 KSHRWYSK-HMPNDIVDGPPSSDFNSTAK 186
            +H ++       +      S+  +   +
Sbjct: 320 MAHPFFDHLRNSYESEVKNNSNFPHGVNQ 348

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 7/102 (6%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDK 65
           + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA         +  + 
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNV 189

Query: 66  KCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGELP 105
           +  +  +  PE+LV  + Y     D+WS G +L +M+  + P
Sbjct: 190 RVASRYFKGPELLVDYQMY-DYSLDMWSLGCMLASMIFRKEP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 42/209 (20%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+HS G+ HRDLKP N+ ++    LKI DFGLA         R  D +
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA---------RHADAE 179

Query: 67  ----CGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LP-------WDK---- 108
                 T  Y APEV++         DIWS G I+  ML G+             +    
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

Query: 109 ---PTADCIEYLEWKDNR-------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLN 154
              P  + ++ L  K  +          R  + +L          L+ ++L      RL 
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299

Query: 155 IEKIKSHRWYSK-HMPNDIVDGPPSSDFN 182
             +  +H ++     P +  +     D +
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDS 328

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 32/206 (15%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP-LDK 65
             F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +      L +
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 66  KCGTLPYVAPEVLVRS--YLAEPADIWSCGIILVAMLAGE--LP-------WDK------ 108
              T  Y APE+++ S  Y  +  DIWS G IL  ML+     P        +       
Sbjct: 191 YVATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249

Query: 109 -PTADCIEYLEWKDNR-------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIE 156
            P+ + +  +     R       H  + PW+RL    D   L L+ ++L   P  R+ +E
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309

Query: 157 KIKSHRWYSK-HMPNDIVDGPPSSDF 181
           +  +H +  + + P+D         F
Sbjct: 310 QALAHPYLEQYYDPSDEPIAEAPFKF 335

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 46/219 (21%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q F  Q +  V+ LH   + HRDLKP N+L++    LK+ DFGLA +   +  +      
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 67  CGTL--PYV------APEVLVRS--YLAEPADIWSCGIILVAMLAGE------------- 103
             +    +V      APEV++ S  Y +   D+WSCG IL  +                 
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233

Query: 104 -------LPWDKPTADCI------EYLEWKDNRHMQRSPWDRL----DVNCLSLIRRILA 146
                   P       CI      EY+  K       +P +++    +   + L++R+L 
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYI--KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

Query: 147 PLPSTRLNIEKIKSHRWYSK-HMPND--IVDGPPSSDFN 182
             P+ R+  ++   H +    H PND    +  P S F 
Sbjct: 292 FDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFE 330

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 33/206 (16%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDK 65
           + +  QL+  + Y+HS GI HRD+KP+N+LLD     LK+ DFG A +        P   
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AGEPNVS 200

Query: 66  KCGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LPWDK-------------- 108
              +  Y APE++  +       DIWS G ++  ++ G+   P +               
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260

Query: 109 PTADCIEYLEWKDNRH----MQRSPWD-----RLDVNCLSLIRRILAPLPSTRLNIEKIK 159
           P+ + I+ +      H    ++  P+      R   + + LI R+L   PS RL   +  
Sbjct: 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320

Query: 160 SHRWYSK-HMPND-IVDGPP-SSDFN 182
            H ++ +       + +G      FN
Sbjct: 321 CHPFFDELRTGEARMPNGRELPPLFN 346

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 8/104 (7%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERP 62
           +    Q++ G+ YLH+  + HRDLKP N+L+  +      +KI+D G A +F    K   
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 63  -LDKKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGE 103
            LD    T  Y APE+L   R Y  +  DIW+ G I   +L  E
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSE 233

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 16/98 (16%)

Query: 15  SGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD-- 64
           SG+ +LH++         IAHRDLK +N+L+    T  I+D GLA  F  +  E  +   
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 65  KKCGTLPYVAPEVLVRSYLA------EPADIWSCGIIL 96
            + GT  Y+ PEVL  S           AD++S G+IL
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 12/115 (10%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK- 66
            F + + SG+ YLHS  I HRDL   N L+     + ++DFGLA +      +    +  
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 67  -----------CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT 110
                       G   ++APE++      E  D++S GI+L  ++          
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.1 bits (229), Expect = 9e-21
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 43/215 (20%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
                Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +   
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 186

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE--LP-------WDK-------PT 110
             T  Y APEV++     E  DIWS G I+  M+ G    P       W+K       P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246

Query: 111 ADCIEYLEWKDNRHMQ------RSPWDRL----------------DVNCLSLIRRILAPL 148
            + ++ L+     +++         +++L                      L+ ++L   
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306

Query: 149 PSTRLNIEKIKSHRWYSK-HMPND-IVDGPPSSDF 181
            S R+++++   H + +  + P++     P   D 
Sbjct: 307 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 34/200 (17%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA           +   
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGY 189

Query: 67  CGTLPYVAPEVLVRSYLAEPA-DIWSCGIILVAMLAGE--LP-------WDK-------P 109
             T  Y APE+++         DIWS G I+  +L G    P                 P
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 110 TADCIEYLEWKDNR-------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKI 158
            A+ ++ +  +  R        M +  +  +    +   + L+ ++L      R+   + 
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309

Query: 159 KSHRWYSK-HMPNDIVDGPP 177
            +H ++++ H P+D     P
Sbjct: 310 LAHAYFAQYHDPDDEPVADP 329

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A  F  Q++ G+++ H   I HRD+KP+N+L+D   TLKI DFG+A         +  +
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-N 170

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
              GT+ Y +PE        E  DI+S GI+L  ML GE P++  TA  I        +H
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI------KH 224

Query: 125 MQ 126
           +Q
Sbjct: 225 IQ 226

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 44/205 (21%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    Q++ G+ Y+H+ GI HRDLKP N+ ++    LKI DFGLA         R  D +
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---------RQADSE 181

Query: 67  ----CGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE--LP-------WDK--- 108
                 T  Y APEV++    Y  +  DIWS G I+  M+ G+             +   
Sbjct: 182 MTGYVVTRWYRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240

Query: 109 ----PTADCIEYLEWKDNR-------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRL 153
               P A+ ++ L+  + +        +++  +  +        ++L+ ++L      R+
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300

Query: 154 NIEKIKSHRWYSK-HMPNDIVDGPP 177
              +  +H ++   H   D      
Sbjct: 301 TAGEALAHPYFESLHDTEDEPQVQK 325

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 16/128 (12%)

Query: 8   KFFRQLISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFR--MN 57
           K      SG+ +LH +         IAHRDLK +N+L+    T  I+D GLA       +
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 58  GKERPLDKKCGTLPYVAPEVLVRSYLA------EPADIWSCGIILVAMLAGELPWDKPTA 111
             +   + + GT  Y+APEVL  S         + ADI++ G++   +            
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

Query: 112 DCIEYLEW 119
             + Y + 
Sbjct: 263 YQLPYYDL 270

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 39/97 (40%), Positives = 53/97 (54%), Gaps = 3/97 (3%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
                Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    +   
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 223

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE 103
             T  Y APEV++     E  DIWS G I+  M+  +
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 11/128 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A +        + + H  GI HRD+KP N+++   + +K+ DFG+A    +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA--IADSGNSVT 174

Query: 65  KK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           +     GT  Y++PE      +   +D++S G +L  +L GE P+   +   + Y     
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----- 229

Query: 122 NRHMQRSP 129
            +H++  P
Sbjct: 230 -QHVREDP 236

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.8 bits (220), Expect = 3e-19
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           EA  +  +++  + YLHS G+ + DLKPEN++L  ++ LK+ D G  +  R+N       
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVS--RINSFGYLY- 238

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
              GT  + APE+ VR+      DI++ G  L A+       +
Sbjct: 239 ---GTPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPTRN 277

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 54/242 (22%), Positives = 89/242 (36%), Gaps = 70/242 (28%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           Q    QLI  ++YLHS G+ HRD+KP N+LL+ +  +K++DFGL+  F    +       
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 67  CGTLP-------------YV------APEVLVRS--YLAEPADIWSCGIILVAMLAGE-- 103
                             YV      APE+L+ S  Y  +  D+WS G IL  +L G+  
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGIDMWSLGCILGEILCGKPI 230

Query: 104 ----------------LPWDKPTADCIEYLEWKDNRHMQRS------------------- 128
                           +    P+ + +E ++    + M  S                   
Sbjct: 231 FPGSSTMNQLERIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288

Query: 129 --------PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-HMPNDIVDGPPSS 179
                   P    +   L L+ ++L   P+ R++      H + S  H PN+  +     
Sbjct: 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHII 348

Query: 180 DF 181
             
Sbjct: 349 TI 350

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 40/200 (20%)

Query: 7   QKFFRQLISGVEYLH--SKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPL 63
           + F  QLI  +  LH  S  + HRD+KP NVL++  D TLK+ DFG A   +      P 
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---KKLSPSEPN 188

Query: 64  DKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIILVAMLAGE--LPWD------------ 107
                +  Y APE++   + Y     DIWS G I   M+ GE     D            
Sbjct: 189 VAYICSRYYRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 108 --KPTADCI-----EYLEWKDNRHMQRSPWDRL--------DVNCLSLIRRILAPLPSTR 152
              P+ + +      + +     + +  PW  +              L+  +L  LP  R
Sbjct: 248 LGCPSREVLRKLNPSHTDVDL-YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 153 LNIEKIKSHRWYSK-HMPND 171
           +   +   H ++ + H P  
Sbjct: 307 MKPYEALCHPYFDELHDPAT 326

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 22/111 (19%)

Query: 8   KFFRQLISGVEYLHS---------KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG 58
           +    +  G+ YLH+           I+HRDL   NVL+    T  ISDFGL+     N 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 59  KERPLDK------KCGTLPYVAPEVL-------VRSYLAEPADIWSCGIIL 96
             RP ++      + GT+ Y+APEVL             +  D+++ G+I 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 17/115 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +A   A    RQ+ S ++  H+ G  HRD+KPEN+L+   D   + DFG+A         
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA--------- 181

Query: 61  RPLDKKC--------GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD 107
                +         GTL Y+APE    S+    ADI++   +L   L G  P+ 
Sbjct: 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 42/253 (16%), Positives = 74/253 (29%), Gaps = 79/253 (31%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +     L+ G  ++H  GI HRDLKP N LL+   ++K+ DFGLA           ++  
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 67  CGTLP--------------YV------APEVLVRS--YLAEPADIWSCGIILVAMLAGEL 104
                              +V      APE+++    Y  +  DIWS G I   +L    
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY-TKSIDIWSTGCIFAELLNMLQ 250

Query: 105 PWD--------------------------------------------KPTADCIEYLEWK 120
                                                           PT D ++ +   
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310

Query: 121 DNR-------HMQRSPWDRL----DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-HM 168
           +         H +     +       + ++L+  +L   P+ R+ I++   H +      
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370

Query: 169 PNDIVDGPPSSDF 181
                        
Sbjct: 371 KKLENFSTKKIIL 383

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 47/203 (23%), Positives = 73/203 (35%), Gaps = 44/203 (21%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           +     L+ GV+Y+HS GI HRDLKP N L++   ++K+ DFGLA               
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 67  CG-------------------------TLPYVAPEVLV--RSYLAEPADIWSCGIILVAM 99
                                      T  Y APE+++   +Y  E  D+WS G I   +
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY-TEAIDVWSIGCIFAEL 277

Query: 100 LAGELPWDK---------PTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRIL-APLP 149
           L                 P + C      +   +  +    R + + L++I  IL  P  
Sbjct: 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT-RGNRDQLNVIFNILGTPSE 336

Query: 150 STRLNIEKIKSHRW--YSKHMPN 170
                IE ++      Y +  P 
Sbjct: 337 ED---IEALEKEDAKRYIRIFPK 356

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 40/97 (41%), Positives = 61/97 (62%), Gaps = 6/97 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGL-ATVFRMNGKERPLDKKCGT 69
             ++  + YLH++G+ HRD+K +++LL L   +K+SDFG  A + +   K + L    GT
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGT 204

Query: 70  LPY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
            PY +APEV+ RS  A   DIWS GI+++ M+ GE P
Sbjct: 205 -PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 10/99 (10%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG         +  P   K  T+
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRSTM 176

Query: 71  ---PY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
              PY +APEV+ R       DIWS GI+ + M+ GE P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 13/127 (10%)

Query: 11  RQLISGVEYLHSKG-IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-- 67
             +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++           +D     
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANS 189

Query: 68  --GTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM 125
             GT  Y++PE L  ++ +  +DIWS G+ LV M  G  P   P A  +E +        
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 126 QRSPWDR 132
                 R
Sbjct: 250 AAETPPR 256

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 22/102 (21%), Positives = 44/102 (43%), Gaps = 7/102 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA-----TVFRMNGKERPLDK 65
           + ++  ++Y+H  G  HR +K  ++L+ +   + +S             R          
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 66  KCGTLPYVAPEVLVRSYLA--EPADIWSCGIILVAMLAGELP 105
               LP+++PEVL ++       +DI+S GI    +  G +P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 26/120 (21%), Positives = 57/120 (47%), Gaps = 15/120 (12%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKI--SDFGLATVFRMNGKERPL---DKK 66
           +++  +EY+H     H D+K  N+LL  ++  ++  +D+GL+  +  NG  +      +K
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218

Query: 67  C--GTLPYVAPEVLVRSYL-AEPA---DIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
              GT+ + +    + ++     +   D+   G  ++  L G+LPW++   D +     K
Sbjct: 219 GHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 19/172 (11%)

Query: 11  RQLISGVEYLHSKG-IAHRDLKPENVLLDLQDTLKISDFGLA-----TVFRMNGKERPLD 64
             ++  +E+LHSK  + HRD+KP NVL++    +K+ DFG++      V +        D
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--------D 167

Query: 65  KKCGTLPYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
              G  PY+APE +      +     +DIWS GI ++ +     P+D       + L+  
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQV 226

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
                 + P D+     +    + L      R    ++  H +++ H     
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 4/96 (4%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           +  + G+EYLH     HRD+K  N+LL+ +   K++DFG+A        +R  +   GT 
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGT- 188

Query: 71  PY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           P+ +APEV+        ADIWS GI  + M  G+ P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 38/96 (39%), Positives = 57/96 (59%), Gaps = 4/96 (4%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+++ G++YLHS+   HRD+K  NVLL     +K++DFG+A        +R  +   GT 
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGT- 182

Query: 71  PY-VAPEVLVRSYLAEPADIWSCGIILVAMLAGELP 105
           P+ +APEV+ +S     ADIWS GI  + +  GE P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 21/174 (12%)

Query: 11  RQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
             ++  + YL  K G+ HRD+KP N+LLD +  +K+ DFG++    ++ K +  D+  G 
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAK--DRSAGC 187

Query: 70  LPYVAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             Y+APE +      +P     AD+WS GI LV +  G+ P+     D  E L       
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLT-----K 241

Query: 125 MQRSPWDRLDVNCL------SLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
           + +     L  +        S ++  L      R    K+  H +  ++   ++
Sbjct: 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 8/104 (7%)

Query: 11  RQLISGVEYLHSKG-IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGT 69
              +  + +L     I HRD+KP N+LLD    +K+ DFG++     +  +    +  G 
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT---RDAGC 188

Query: 70  LPYVAPEVLVRSYLAEP----ADIWSCGIILVAMLAGELPWDKP 109
            PY+APE +  S   +     +D+WS GI L  +  G  P+ K 
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK---C 67
           R+++ G+EYLH  G  HRD+K  N+LL    +++I+DFG++      G       +    
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 68  GTLPY-VAPEVLVRS--YLAEPADIWSCGIILVAMLAGELP 105
           GT P  +APEV+ +   Y    ADIWS GI  + +  G  P
Sbjct: 188 GT-PCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAP 226

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 24/112 (21%), Positives = 50/112 (44%), Gaps = 15/112 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKI--SDFGLATVFRMNGKERPL--DKKC 67
           +L+  +E+LH     H ++  EN+ +D +D  ++  + +G A  +  +GK        + 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226

Query: 68  ---GTLPYVAPEVLVRSYL-AEPA---DIWSCGIILVAMLAGELPWDKPTAD 112
              G L +++    +  +    P+   D+ S G  ++  L G LPW     +
Sbjct: 227 PHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 40/101 (39%), Positives = 60/101 (59%), Gaps = 9/101 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           RQ++  + +LHSK I HRDLK  NVL+ L+  ++++DFG++       ++R  D   GT 
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGT- 180

Query: 71  PY-VAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP 105
           PY +APEV++   + +      ADIWS GI L+ M   E P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 28/112 (25%), Positives = 53/112 (47%), Gaps = 15/112 (13%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKI--SDFGLATVFRMNG--KERPLDKK- 66
           +++  +EY+H     H D+K  N+LL+ ++  ++   D+GLA  +   G  K    D K 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219

Query: 67  --CGTLPYVAPEVLVRSYL-AEPA---DIWSCGIILVAMLAGELPWDKPTAD 112
              GT+ + +    + ++    P+   D+   G  ++  L G LPW+    D
Sbjct: 220 CHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 15/100 (15%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-------G 68
           G+ +LH     HRD+K  N+LLD   T KISDFGLA       +      +        G
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA-------RASEKFAQTVMTSRIVG 197

Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK 108
           T  Y+APE L R  +   +DI+S G++L+ ++ G    D+
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 15/112 (13%)

Query: 16  GVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC-------G 68
           G+ YLH++ I HRD+K  N+LLD     KI+DFG++       K+     +        G
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS-------KKGTELDQTHLSTVVKG 203

Query: 69  TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDK-PTADCIEYLEW 119
           TL Y+ PE  ++  L E +D++S G++L  +L       +    + +   EW
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)

Query: 16  GVEYLHSKG---IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK------ 66
           G+ YLH      I HRD+K  N+LLD +    + DFGLA       K             
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-------KLMDYKDTHVTTAV 195

Query: 67  CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD--KPTADCIEYL-EW 119
            GT+ ++APE L     +E  D++  G++L+ ++ G+  +D  +   D    L +W
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 9/101 (8%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R+++ G+ +LH   + HRD+K +NVLL     +K+ DFG++         R  +   GT 
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGT- 192

Query: 71  PY-VAPEVLVRSYLAEP-----ADIWSCGIILVAMLAGELP 105
           PY +APEV+      +      +D+WS GI  + M  G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 17/102 (16%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK---C 67
              + G+ YLHS  + HRD+K  N+LL     +K+ DFG A++         +       
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPANSFV 211

Query: 68  GTLPY-VAPEVLVRSYLAE---PADIWSCGIILVAMLAGELP 105
           GT PY +APEV++     +     D+WS GI  + +   + P
Sbjct: 212 GT-PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 7/114 (6%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
              Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA   R+        ++  
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGA 341

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
             P    APE  +       +D+WS GI+L  +   G +P       + ++ +E
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 29/151 (19%)

Query: 7   QKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQD------TLKISDFGLATVFRMNGK 59
           ++  +QL+ G++Y+H + GI H D+KPENVL+++ D       +KI+D G A        
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188

Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           +        T  Y +PEVL+ +     ADIWS   ++  ++ G         +  E   +
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG-----DFLFEPDEGHSY 243

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPS 150
             +               ++ I  +L  LPS
Sbjct: 244 TKDDDH------------IAQIIELLGELPS 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 7/114 (6%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
              Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA   R+        ++  
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGA 424

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
             P    APE  +       +D+WS GI+L  +   G +P       + ++ +E
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 18/109 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLK-----ISDFGLATVFRM--NGKERPLD 64
           QLIS +EY+HSK + +RD+KPEN L+            I DF LA  +      K  P  
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 65  KK---CGTLPYVAPEVLVRSYLAEPA----DIWSCGIILVAMLAGELPW 106
           +     GT  Y++    + ++L +      D+ + G + +  L G LPW
Sbjct: 173 EHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 7/115 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
               Q+ S +EYL  K   HR+L   N L+     +K++DFGL+   R+   +       
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAG 378

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
              P    APE L  +  +  +D+W+ G++L  +   G  P      +   E LE
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 27/109 (24%), Positives = 53/109 (48%), Gaps = 18/109 (16%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDTLK-----ISDFGLATVFRM--NGKERPLD 64
           Q+++ V+ +H K + +RD+KP+N L+   ++       + DFG+   +R     +  P  
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173

Query: 65  KK---CGTLPYVAPEVLVRSYLAEPA----DIWSCGIILVAMLAGELPW 106
           +K    GT  Y++    + ++L        D+ + G + +  L G LPW
Sbjct: 174 EKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 19/105 (18%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERPLD 64
           +KF   ++  ++ LH   I H DLKPEN+LL  Q    +K+ DFG +        +R   
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRV-- 256

Query: 65  KKCGTLPYV------APEVLVRSYLAEPADIWSCGIILVAMLAGE 103
                  Y+      APEV++ +    P D+WS G IL  +L G 
Sbjct: 257 -----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 16/113 (14%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFR--MNGKERPLDKK 66
           Q+IS +EY+HSK   HRD+KP+N L+ L      + I DFGLA  +R     +  P  + 
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 67  ---CGTLPYVAPEVLVRSYLAEPA----DIWSCGIILVAMLAGELPWDKPTAD 112
               GT  Y +    + ++L        D+ S G +L+    G LPW    A 
Sbjct: 173 KNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 44/239 (18%), Positives = 75/239 (31%), Gaps = 76/239 (31%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------------------TLKISD 47
           +    QL   + +LH   + H DLKPEN+L    +                   +++++D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 48  FGLATVFRMNGKERPLDKKCGTLPYV------APEVLVRSYLAEPADIWSCGIILVAMLA 101
           FG AT    + +             V       PEV++    A+P D+WS G IL     
Sbjct: 186 FGSAT---FDHEHHT--------TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 102 GE----------------------------------------LPWDKPTADCIEYLEWKD 121
           G                                         L WD+ ++D     E   
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSD 180
                        V    L+RR+L   P+ R+ + +   H +++   P +       + 
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 6/116 (5%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G++YL SK   HRDL   N +LD + T+K++DFGLA            +K  
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             LP  ++A E L        +D+WS G++L  +    G  P  D  T D   YL 
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-GAPPYPDVNTFDITVYLL 246

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 9/115 (7%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           F  Q+  G+ ++  +   HRDL+  N+L+      KI+DFGLA   R+        ++  
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGA 345

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             P    APE +        +D+WS GI+L  +    G +P       + I  LE
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY-GRIPYPGMSNPEVIRALE 399

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 13/116 (11%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 345

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           G LP    APE L     +  +D+WS GI+L  +    G +P    P  D +  +E
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF-GRVPYPRIPLKDVVPRVE 400

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 8/116 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +     KE   +   
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-- 178

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           G +P  ++A E ++       +D+WS G+ +  +    G  P    P ++    LE
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF-GSKPYDGIPASEISSILE 233

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 46/238 (19%), Positives = 79/238 (33%), Gaps = 72/238 (30%)

Query: 6   AQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQD----------------------- 41
            +K  +Q++ G++YLH+K  I H D+KPEN+LL + +                       
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 42  --------------------------TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP 75
                                      +KI+D G A         +   +   T  Y + 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-----HKHFTEDIQTRQYRSL 262

Query: 76  EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDV 135
           EVL+ S    PADIWS   +   +  G+  ++  + +       +D  H           
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE----EYTRDEDH----------- 307

Query: 136 NCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLE 193
             ++LI  +L  +P   +   K     +  K     I    P   F    ++     E
Sbjct: 308 --IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 17/108 (15%), Positives = 31/108 (28%), Gaps = 29/108 (26%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A +  + L +  +  H  G+A     P  V + +   + ++                  
Sbjct: 130 GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---------------- 173

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
               T+P   P+           DI   G  L A+L    P  +    
Sbjct: 174 ---ATMPDANPQ----------DDIRGIGASLYALLVNRWPLPEAGVR 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 9/115 (7%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
              Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N       ++  
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA---REGA 170

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             P    APE +        +D+WS GI+L  +    G +P       + I+ LE
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH-GRIPYPGMTNPEVIQNLE 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA     +       K  
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--KGD 254

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL 96
             LP   +APE +        +D+WS G++L
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 8/116 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           +      +G+EYL SK   HRDL   N L+  ++ LKISDFG++              + 
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR- 275

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             +P    APE L     +  +D+WS GI+L     L G  P  +       E++E
Sbjct: 276 -QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL-GASPYPNLSNQQTREFVE 329

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 16/107 (14%)

Query: 12  QLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMN--GKERPLDKK 66
           Q+I+ VE++HSK   HRD+KP+N L+ L    + + I DFGLA  +R     +  P  + 
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 67  ---CGTLPYVAPEVLVRSYLAEPA----DIWSCGIILVAMLAGELPW 106
               GT  Y +    V ++L        D+ S G +L+  L G LPW
Sbjct: 171 KNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 6/116 (5%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   +K  
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             LP  ++A E L        +D+WS G++L  +    G  P  D  T D   YL 
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-GAPPYPDVNTFDITVYLL 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 8/116 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +     KE   +   
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-- 178

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           G +P  ++A E ++       +D+WS G+ +  +    G  P    P ++    LE
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF-GSKPYDGIPASEISSILE 233

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 13/116 (11%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
           KF   +   +EYL      HRDL   NVL+   +  K+SDFGL        KE    +  
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDT 173

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           G LP    APE L     +  +D+WS GI+L  +    G +P    P  D +  +E
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF-GRVPYPRIPLKDVVPRVE 228

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 29/115 (25%), Positives = 53/115 (46%), Gaps = 8/115 (6%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  Q+  G+ YL   G+ HR+L   NVLL     ++++DFG+A +   + K+    +   
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--A 177

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
             P  ++A E +        +D+WS G+ +  +    G  P      A+  + LE
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF-GAEPYAGLRLAEVPDLLE 231

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 63.7 bits (156), Expect = 1e-11
 Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
             +  G+ +L S    HRDL   N L+D    +K+SDFG+    R    ++ +       
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQYVSSVGTKF 167

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P    APEV      +  +D+W+ GI++  V  L G++P      ++ +  + 
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL-GKMPYDLYTNSEVVLKVS 219

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 26/117 (22%), Positives = 41/117 (35%), Gaps = 20/117 (17%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKK 66
           + +  +++  + YL    + H DLKPEN+LLD     K              +       
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 67  C------G--------------TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGE 103
                  G              T  Y APEV++       +D+WS G +L  +  G 
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 33/116 (28%), Positives = 51/116 (43%), Gaps = 9/116 (7%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
               Q+ S +EYL  K   HRDL   N L+     +K++DFGL+ +   +        K 
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK- 173

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
              P    APE L  +  +  +D+W+ G++L  +A   G  P      +   E LE
Sbjct: 174 --FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY-GMSPYPGIDLSQVYELLE 226

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R + +G++YL +    HRDL   N+L++     K+SDFGL+ V   +  E       G +
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKI 212

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P    APE +        +D+WS GI++  V    GE P W+    + ++ + 
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY-GERPYWELSNHEVMKAIN 264

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 46/222 (20%), Positives = 71/222 (31%), Gaps = 76/222 (34%)

Query: 7   QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------------------TLKISD 47
           +K   Q+   V +LHS  + H DLKPEN+L    D                    +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 48  FGLATVFRMNGKERPLDKKCGTLPYV------APEVLVRSYLAEPADIWSCGIILVAMLA 101
           FG AT           D+   T   V      APEV++    ++P D+WS G IL+    
Sbjct: 181 FGSAT---------YDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 102 GE----------------------------------------LPWDKPTADCIEYLEWKD 121
           G                                         L WD+ ++          
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                    D        LI+++L   P+ R+ + +   H +
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 7/113 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R + SG++YL   G  HRDL   N+L++     K+SDFGL  V   +  E     + G +
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKI 212

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P    +PE +        +D+WS GI+L  V    GE P W+    D I+ ++
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-GERPYWEMSNQDVIKAVD 264

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 21/107 (19%)

Query: 7   QKFFRQLISGVEYLHSK--GIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERP 62
           +KF +Q+ + + +L +    I H DLKPEN+LL       +KI DFG +           
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----- 214

Query: 63  LDKKCGTLPYV------APEVLVRSYLAEPADIWSCGIILVAMLAGE 103
                    Y+      +PEVL+        D+WS G ILV M  GE
Sbjct: 215 ------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           R + +G+ YL   G  HRDL   NVL+D     K+SDFGL+ V   +  +       G +
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKI 216

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P    APE +     +  +D+WS G+++  V    GE P W+    D I  +E
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY-GERPYWNMTNRDVISSVE 268

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
             +  G+ YL    + HRDL   N L+     +K+SDFG+    R    ++         
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT---RFVLDDQYTSSTGTKF 167

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P    +PEV   S  +  +D+WS G+++  V    G++P  ++  ++ +E + 
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE-GKIPYENRSNSEVVEDIS 219

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 35/125 (28%), Positives = 52/125 (41%), Gaps = 8/125 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+EYL  +   HRDL   N +LD   T+K++DFGLA              + 
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLEWKDN 122
             LP  + A E L        +D+WS G++L  +    G  P       D   +L     
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR-GAPPYRHIDPFDLTHFLA--QG 244

Query: 123 RHMQR 127
           R + +
Sbjct: 245 RRLPQ 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 33/113 (29%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            QL + + YL SK   HRD+   NVL+   D +K+ DFGL+     +   +    K   L
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK---L 554

Query: 71  P--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P  ++APE +        +D+W  G+ +  + M  G  P       D I  +E
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIE 606

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 9/113 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
           + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+   R    +          
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKF 183

Query: 71  PY--VAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
           P     PEVL+ S  +  +DIW+ G+++  +  L G++P      ++  E++ 
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL-GKMPYERFTNSETAEHIA 235

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 34/114 (29%), Positives = 52/114 (45%), Gaps = 5/114 (4%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + +   
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH-R 184

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPW-DKPTADCIEYLE 118
            +P+   APE L     +  +D W  G+ L  M   G+ PW     +  +  ++
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 21/119 (17%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC--- 67
            QL + + YL SK   HRD+   NVL+   D +K+ DFGL+         R ++      
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---------RYMEDSTYYK 173

Query: 68  ---GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
              G LP  ++APE +        +D+W  G+ +  + M  G  P       D I  +E
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIE 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 9/116 (7%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
              Q+  G++YL  K   HR+L   NVLL  +   KISDFGL+   +  G +        
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARS 497

Query: 68  -GTLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
            G  P    APE +     +  +D+WS G+ +   L+ G+ P       + + ++E
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 9/114 (7%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC--G 68
            Q+  G++YL  K   HRDL   NVLL  +   KISDFGL+   +  G +         G
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARSAG 173

Query: 69  TLPY--VAPEVLVRSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
             P    APE +     +  +D+WS G+ +   L+ G+ P       + + ++E
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 21/119 (17%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC--- 67
            Q+   + YL S    HRD+   N+L+   + +K+ DFGL+         R ++ +    
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS---------RYIEDEDYYK 170

Query: 68  ---GTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
                LP  +++PE +        +D+W   + +  +    G+ P +     D I  LE
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF-GKQPFFWLENKDVIGVLE 228

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 21/121 (17%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD--- 64
            F   +  G++YL  K   HRDL   N+L+      KI+DFGL+         R  +   
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---------RGQEVYV 196

Query: 65  -KKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYL 117
            K  G LP  ++A E L    Y    +D+WS G++L  +  L G  P      A+  E L
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSL-GGTPYCGMTCAELYEKL 254

Query: 118 E 118
            
Sbjct: 255 P 255

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 7/113 (6%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL 70
            Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R +          G  
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH-GKW 182

Query: 71  PY--VAPEVLV-RSYLAEPADIWSCGIILVAMLA-GELP-WDKPTADCIEYLE 118
           P    APE +    + ++ +D+WS G+++    + G+ P      ++    LE
Sbjct: 183 PVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 32/91 (35%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +       K  
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV--KGN 206

Query: 68  GTLPY--VAPEVLVRSYLAEPADIWSCGIIL 96
             LP   +APE +        +D+WS GI L
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 34/170 (20%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
           +   ++  G+ YL++    HRDL   N ++    T+KI DFG+         +R  GK  
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-- 199

Query: 62  PLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIE 115
                 G LP  +++PE L    +    +D+WS G++L  +A L  E P+        + 
Sbjct: 200 ------GLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATL-AEQPYQGLSNEQVLR 251

Query: 116 YLEWKDNRHMQRSPWDRLDVNCLSLIRRIL----APLPSTRLNIEKIKSH 161
           ++   +   + +        NC  ++  ++       P  R +  +I S 
Sbjct: 252 FV--MEGGLLDKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 20/122 (16%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
           +F   +  G+EYL S+   HRDL   N +L    T+ ++DFGL+        +R     +
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200

Query: 62  PLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIEY 116
                   LP  ++A E L  +     +D+W+ G+ +  +    G+ P+     A+   Y
Sbjct: 201 --------LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR-GQTPYAGIENAEIYNY 251

Query: 117 LE 118
           L 
Sbjct: 252 LI 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 15/96 (15%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL        K  P DK+  
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT-------KVLPQDKEFF 171

Query: 68  -----GTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
                G  P  + APE L  S  +  +D+WS G++L
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 17/97 (17%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           +  Q+  G+EYL +K   HRDL   N+L++ ++ +KI DFGL        K  P DK+  
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT-------KVLPQDKEYY 202

Query: 68  -----GTLP--YVAPEVLV-RSYLAEPADIWSCGIIL 96
                G  P  + APE L    +     D+WS G++L
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVAS-DVWSFGVVL 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 30/122 (24%), Positives = 52/122 (42%), Gaps = 20/122 (16%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
           KF   +  G+EYL ++   HRDL   N +L    T+ ++DFGL+        +R     +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 62  PLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEY 116
                   +P  ++A E L        +D+W+ G+ +  +A   G  P       +  +Y
Sbjct: 211 --------MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-GMTPYPGVQNHEMYDY 261

Query: 117 LE 118
           L 
Sbjct: 262 LL 263

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 18/98 (18%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
            F  Q+  G+ +L SK   HRD+   NVLL      KI DFGLA      + + + G  R
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 62  PLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL 96
                   LP  ++APE +    Y  + +D+WS GI+L
Sbjct: 228 --------LPVKWMAPESIFDCVYTVQ-SDVWSYGILL 256

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 22/120 (18%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLD 64
            Q+ +G+EYL S  + H+DL   NVL+  +  +KISD GL         +++ G      
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN----- 189

Query: 65  KKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
                LP  ++APE ++   +  + +DIWS G++L  V    G  P       D +E + 
Sbjct: 190 ---SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSY-GLQPYCGYSNQDVVEMIR 244

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCG 68
           +  Q+  G++YL S+   HRDL   NVL++ +  +KI DFGL      + KE    K   
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEYYTVKDDR 189

Query: 69  TLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
             P  + APE L++S     +D+WS G+ L
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTL 219

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 22/120 (18%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLD 64
            Q+ +G+ YL      HRDL   N L+     +KI DFG++        +R+ G+     
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR----- 219

Query: 65  KKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEYLE 118
                LP  ++ PE ++ R +  E +D+WS G++L  +    G+ P +     + I+ + 
Sbjct: 220 ---TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTY-GKQPWYQLSNTEAIDCIT 274

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 35/96 (36%), Positives = 46/96 (47%), Gaps = 15/96 (15%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC- 67
           F +Q+  G+ YLH++   HRDL   NVLLD    +KI DFGLA       K  P   +  
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA-------KAVPEGHEYY 191

Query: 68  -----GTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
                G  P  + APE L        +D+WS G+ L
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 6/106 (5%)

Query: 9   FFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKC 67
           +  Q+  G+EYL S+   HRDL   N+L++ +  +KI+DFGLA +  ++       +   
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-- 189

Query: 68  GTLP--YVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPT 110
           G  P  + APE L  +  +  +D+WS G++L  +    +       
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 16/97 (16%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
            F  Q+  G+E+L  K   HRDL   NVL+     +KI DFGLA      + + + G  R
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235

Query: 62  PLDKKCGTLP--YVAPEVLVRSYLAEPADIWSCGIIL 96
                   LP  ++APE L        +D+WS GI+L
Sbjct: 236 --------LPVKWMAPESLFEGIYTIKSDVWSYGILL 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
            +  Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA     +       K  
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--KGD 209

Query: 68  GTLP--YVAPEVLV-RSYLAEPADIWSCGIIL 96
             LP  ++APE +  R Y  + +D+WS G++L
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLL 240

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKC 67
               Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA         +      
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK--TTN 252

Query: 68  GTLP--YVAPEVLV-RSYLAEPADIWSCGIIL 96
           G LP  ++APE L  R Y  + +D+WS G++L
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLL 283

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 24/132 (18%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
               QL  G+EYL S+   HRDL   NVL+   + +KI+DFGLA        ++     R
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 62  PLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIE 115
                   LP  ++APE L  R Y  + +D+WS G+++  +  L G  P+   P  +  +
Sbjct: 221 --------LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTL-GGSPYPGIPVEELFK 270

Query: 116 YLEWKDNRHMQR 127
            L  K+   M +
Sbjct: 271 LL--KEGHRMDK 280

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 27/137 (19%), Positives = 55/137 (40%), Gaps = 25/137 (18%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTL--------KISDFGLA-TVFRMNGKER 61
           +QL + + +L    + H ++  +N+LL  ++          K+SD G++ TV   +  + 
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179

Query: 62  PLDKKCGTLPYVAPEVLV--RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTADCIEY 116
                   +P+V PE +   ++      D WS G  L  +    G+ P     +   +++
Sbjct: 180 R-------IPWVPPECIENPKNLNLA-TDKWSFGTTLWEICSG-GDKPLSALDSQRKLQF 230

Query: 117 LEWKDNRHMQRSPWDRL 133
            E  D   +       L
Sbjct: 231 YE--DRHQLPAPKAAEL 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 18/98 (18%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
            F  Q+  G++YL    + HRDL   N+L+     +KISDFGL+        +    + R
Sbjct: 154 SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGR 213

Query: 62  PLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL 96
                   +P  ++A E L    Y  + +D+WS G++L
Sbjct: 214 --------IPVKWMAIESLFDHIYTTQ-SDVWSFGVLL 242

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 24/129 (18%)

Query: 11  RQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKERPLD 64
            Q+ SG+ YL S+   HRDL   N L+     +KI DFG++        +R+ G      
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH----- 194

Query: 65  KKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIEYLE 118
                LP  ++ PE ++ R +  E +D+WS G+IL  +    G+ PW      + IE + 
Sbjct: 195 ---TMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTY-GKQPWFQLSNTEVIECIT 249

Query: 119 WKDNRHMQR 127
               R ++R
Sbjct: 250 --QGRVLER 256

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 24/132 (18%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
               QL  G+EYL S+   HRDL   NVL+   + +KI+DFGLA        ++     R
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266

Query: 62  PLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCIE 115
                   LP  ++APE L  R Y  + +D+WS G+++  +  L G  P+   P  +  +
Sbjct: 267 --------LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTL-GGSPYPGIPVEELFK 316

Query: 116 YLEWKDNRHMQR 127
            L  K+   M +
Sbjct: 317 LL--KEGHRMDK 326

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 31/124 (25%), Positives = 54/124 (43%), Gaps = 24/124 (19%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLA------TVFRMNGKER 61
              RQ+ +G+ YL  +   HRDL   N L+     +KI+DFGL+        ++ +G   
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN-- 235

Query: 62  PLDKKCGTLPYV---APEVLV-RSYLAEPADIWSCGIIL--VAMLAGELPW-DKPTADCI 114
                   +P +    PE +    Y  E +D+W+ G++L  +    G  P+      + I
Sbjct: 236 ------DAIP-IRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSY-GLQPYYGMAHEEVI 286

Query: 115 EYLE 118
            Y+ 
Sbjct: 287 YYVR 290

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 41/173 (23%), Positives = 63/173 (36%), Gaps = 37/173 (21%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLA------TVFRMNG 58
              R +  G +YL      HRD+   N LL         KI DFG+A      + +R  G
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203

Query: 59  KERPLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTAD 112
                      LP  ++ PE  +   + ++  D WS G++L  +  L G +P   K   +
Sbjct: 204 CAM--------LPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSL-GYMPYPSKSNQE 253

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRIL----APLPSTRLNIEKIKSH 161
            +E++       M          NC   + RI+       P  R N   I   
Sbjct: 254 VLEFVT--SGGRMDPPK------NCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 32/126 (25%), Positives = 51/126 (40%), Gaps = 25/126 (19%)

Query: 8   KFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLA------TVFRMNG 58
              R +  G +YL      HRD+   N LL         KI DFG+A        +R  G
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244

Query: 59  KERPLDKKCGTLP--YVAPEVLV-RSYLAEPADIWSCGIIL--VAMLAGELP-WDKPTAD 112
                      LP  ++ PE  +   + ++  D WS G++L  +  L G +P   K   +
Sbjct: 245 CAM--------LPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSL-GYMPYPSKSNQE 294

Query: 113 CIEYLE 118
            +E++ 
Sbjct: 295 VLEFVT 300

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 4e-06
 Identities = 49/301 (16%), Positives = 95/301 (31%), Gaps = 89/301 (29%)

Query: 134 DVNC---LSLIRRILA------------PLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPS 178
           + +C     + + IL+             +  T      + S     + M    V+    
Sbjct: 32  NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS---KQEEMVQKFVEEVLR 88

Query: 179 SDFNSTAKRMRSDLETEANRACPTFDDRACVSQ-------PEPFALRGPMSVCEVEPHLF 231
            ++      ++    TE  +  P+   R  + Q        + FA     +V  ++P+L 
Sbjct: 89  INYKFLMSPIK----TEQRQ--PSMMTRMYIEQRDRLYNDNQVFA---KYNVSRLQPYL- 138

Query: 232 SFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAG 291
                  L   L           +  ++          VL  I G  G  KT        
Sbjct: 139 ------KLRQAL--------LELRPAKN----------VL--IDGVLGSGKTW------- 165

Query: 292 LLVAILFSCHIRRMTRFFV------KYTAEEAV----EKLCMMLDKLGYSWRSYSPAI-V 340
           + + +  S  ++    F +         + E V    +KL   +D    S   +S  I +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 341 TISTVDSRKAQLV----FKASVLTLDN----QTLLDFRLSKGCGIEFKTRFLCIKRALAE 392
            I ++ +   +L+    ++  +L L N    +    F L   C I   TRF  +   L+ 
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL--SCKILLTTRFKQVTDFLSA 283

Query: 393 D 393
            
Sbjct: 284 A 284

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 43.7 bits (102), Expect = 6e-05
 Identities = 12/53 (22%), Positives = 18/53 (33%), Gaps = 1/53 (1%)

Query: 5   EAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRM 56
            A+    QL + +    +     HRDL   NVLL      K+          +
Sbjct: 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 18/106 (16%), Positives = 42/106 (39%), Gaps = 5/106 (4%)

Query: 297 LFSCH---IRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLV 353
           LF      ++R TRF  +    E +  +  + + +G+   + +           +  QL 
Sbjct: 24  LFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQLA 83

Query: 354 FKASVLTL-DNQTLLDFRLSKGCGIEFKTRFLCIKRALAEDIINKP 398
               +  +  +  ++D R + G  +E+   +  +   L E+II + 
Sbjct: 84  VVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL-ENIIWRA 128

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	407
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.98
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.98
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.98
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.98
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.98
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.98
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.98
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.98
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.98
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.88
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.8
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.54
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.33
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.23
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.01
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	98.85
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	98.85
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	98.82
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	98.78
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	98.69
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	98.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.55
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	98.52
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.82
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.19
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.18
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.04
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	94.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.43
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.94
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	91.5
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	90.98
3ats_A	357	Putative uncharacterized protein; hypothetical pro	90.95
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.78
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.44
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	89.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	88.44
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	83.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	81.63

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-41  Score=346.91  Aligned_cols=335  Identities=24%  Similarity=0.444  Sum_probs=210.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......   ......+||+.|+|||++.+
T Consensus       113 l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  189 (476)
T 2y94_A          113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISG  189 (476)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccC
Confidence            578999999999999999999999999999999999999999999999999875432   23456789999999999988


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . +.+.++|||||||++|+|++|..||...+...........  .  ......+++++.+||++||..||.+|||+.+++
T Consensus       190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil  265 (476)
T 2y94_A          190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--I--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIR  265 (476)
T ss_dssp             CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--C--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            7 4578999999999999999999999987655433322222  1  122345789999999999999999999999999


Q ss_pred             hCcccccCCCCCCCCCCCCCCCch-hHHhhhcchHHHhhhcCCCCC-------CCccCCCC-Ccccc------CCCCCcc
Q psy11119        160 SHRWYSKHMPNDIVDGPPSSDFNS-TAKRMRSDLETEANRACPTFD-------DRACVSQP-EPFAL------RGPMSVC  224 (407)
Q Consensus       160 ~hpwf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~p-~~~~~------~~~~~~~  224 (407)
                      +||||++..+.......+...... ....+        ...+..+.       .......+ ++...      .... ..
T Consensus       266 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~-~~  336 (476)
T 2y94_A          266 EHEWFKQDLPKYLFPEDPSYSSTMIDDEAL--------KEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRR-IM  336 (476)
T ss_dssp             TCHHHHTTCCTTTTTSSSCSSCSHHHHHHH--------HSCCCC-------------------------------CC-TT
T ss_pred             hCHHhhhcCccccCCCCcccccccCCHHHH--------HHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchh-hh
Confidence            999999865433222111111100 00000        00000000       00000000 00000      0000 00


Q ss_pred             ccCCccccccCCCC-c-ccccccc--------cccCCCCCCCcccCcccccchHHHHHhhhCCCCccccccccccchhhh
Q psy11119        225 EVEPHLFSFSQPTH-L-DDLLVSS--------QFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLV  294 (407)
Q Consensus       225 ~~a~~~~SfSqp~~-~-~~l~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (407)
                      ..+.+.+-.++|.. . +......        ....+|.......                   |....   ..+.    
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~---~~~~----  390 (476)
T 2y94_A          337 NEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLD-------------------ELNPQ---KSKH----  390 (476)
T ss_dssp             CCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCT-------------------TTSSS---TTTC----
T ss_pred             hhhhccccccCCccccccccccccCCcccCCcccccCCccccccc-------------------ccccc---cccc----
Confidence            00000000000000 0 0000000        0000000000000                   00000   0000    


Q ss_pred             hhhhhcccCCceeeEEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecCC-CCeeEEEEEEEEec-CeEEEEEEec
Q psy11119        295 AILFSCHIRRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSR-KAQLVFKASVLTLD-NQTLLDFRLS  372 (407)
Q Consensus       295 ~~~~~~~~~r~tRF~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~r-k~~l~~~~~i~~~~-~~~~v~f~k~  372 (407)
                        .+....+.+.++.|+.++.+||.+|..||+.|||.|+..+...|+++..... ...+++++++|+++ +.+||||++.
T Consensus       391 --~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~  468 (476)
T 2y94_A          391 --QGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSI  468 (476)
T ss_dssp             --SCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEE
T ss_pred             --cccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeec
Confidence              0111456778899999999999999999999999999999999999875443 45677999999997 7899999999


Q ss_pred             cCCchHH
Q psy11119        373 KGCGIEF  379 (407)
Q Consensus       373 ~Gd~lE~  379 (407)
                      .||.++|
T Consensus       469 ~~~~~~~  475 (476)
T 2y94_A          469 DDEILEV  475 (476)
T ss_dssp             CCC----
T ss_pred             CCCcccc
Confidence            9999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.7e-42  Score=334.60  Aligned_cols=171  Identities=28%  Similarity=0.464  Sum_probs=148.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+..........+.|||+.|||||++.+
T Consensus       129 l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~  208 (311)
T 4aw0_A          129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  208 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC
Confidence            68999999999999999999999999999999999999999999999999998765554455667899999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH---
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK---  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e---  157 (407)
                      ..++.++|||||||++|+|++|+.||.+.+.......+....  .  ..+..+++++++||.+||.+||++|||++|   
T Consensus       209 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            989999999999999999999999999887665444433332  2  223568999999999999999999999887   


Q ss_pred             ---HHhCcccccCCCCCCCCC
Q psy11119        158 ---IKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       158 ---il~hpwf~~~~~~~~~~~  175 (407)
                         |++||||+...|..+...
T Consensus       285 ~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          285 YGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             HHHHHTSGGGTTCCCTTGGGS
T ss_pred             CHHHHCCCCcCCCCHHHhcCC
Confidence               689999999887765443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-41  Score=333.28  Aligned_cols=165  Identities=24%  Similarity=0.401  Sum_probs=143.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+....  ....+.|||+.|||||++.+
T Consensus       167 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~  244 (346)
T 4fih_A          167 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISR  244 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCC
Confidence            6899999999999999999999999999999999999999999999999998764332  23457799999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..|+.++|||||||++|+|++|+.||.+.+........ ..........+..+|+++++||.+||..||++|||++|+++
T Consensus       245 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            88899999999999999999999999887765443332 33334445566789999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||++..
T Consensus       324 Hp~~~~~~  331 (346)
T 4fih_A          324 HPFLAKAG  331 (346)
T ss_dssp             CGGGGGCC
T ss_pred             CHhhcCCC
Confidence            99999764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-41  Score=328.36  Aligned_cols=169  Identities=33%  Similarity=0.511  Sum_probs=142.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....  .....+.+||+.|||||++.+
T Consensus       123 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~  200 (304)
T 3ubd_A          123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNR  200 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--CccccccccCcccCCHHHhcc
Confidence            689999999999999999999999999999999999999999999999999865332  233456799999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++||||+||++|+|++|+.||.+.+...........  .  ...+..+|+++++||++||++||++|||     +
T Consensus       201 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~  276 (304)
T 3ubd_A          201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--K--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGV  276 (304)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTH
T ss_pred             CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--C--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCH
Confidence            99999999999999999999999999988776554444332  2  2234568999999999999999999998     5


Q ss_pred             HHHHhCcccccCCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~  175 (407)
                      +|+++||||+...|.....+
T Consensus       277 ~eil~Hp~f~~idw~~l~~~  296 (304)
T 3ubd_A          277 EEIKRHSFFSTIDWNKLYRR  296 (304)
T ss_dssp             HHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHcCccccCCCHHHHHhC
Confidence            89999999998766544333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-41  Score=320.96  Aligned_cols=162  Identities=38%  Similarity=0.669  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....   ....+.+||+.|+|||++.+
T Consensus       109 l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~  185 (275)
T 3hyh_A          109 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISG  185 (275)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC---CccCCeeECcccCChhhhcC
Confidence            689999999999999999999999999999999999999999999999999865432   23456799999999999988


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . +++.++||||+||++|+|++|+.||.+.+...........  .  ...+..+|+++++||.+||++||++|||++|++
T Consensus       186 ~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil  261 (275)
T 3hyh_A          186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--V--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM  261 (275)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--C--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            7 4578999999999999999999999987765433322222  2  223356899999999999999999999999999


Q ss_pred             hCcccccCCC
Q psy11119        160 SHRWYSKHMP  169 (407)
Q Consensus       160 ~hpwf~~~~~  169 (407)
                      +||||+...+
T Consensus       262 ~hpw~k~~~p  271 (275)
T 3hyh_A          262 QDDWFKVDLP  271 (275)
T ss_dssp             HCHHHHTTCC
T ss_pred             cCcccccCCC
Confidence            9999987544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=333.45  Aligned_cols=165  Identities=24%  Similarity=0.401  Sum_probs=144.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+....  ....+.|||+.|||||++.+
T Consensus       244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~  321 (423)
T 4fie_A          244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISR  321 (423)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCC
Confidence            6899999999999999999999999999999999999999999999999998764332  23457799999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..|+.++|||||||++|+|++|+.||.+.+........ ..........+..+++++++||.+||..||.+|||++|+++
T Consensus       322 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            88999999999999999999999999887765444333 33334445566789999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||++..
T Consensus       401 Hp~~~~~~  408 (423)
T 4fie_A          401 HPFLAKAG  408 (423)
T ss_dssp             CGGGGGCC
T ss_pred             CHHhcCCC
Confidence            99999754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-40  Score=317.20  Aligned_cols=161  Identities=24%  Similarity=0.381  Sum_probs=133.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |++.+++.|+.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+....    ....+.+||+.|||||+
T Consensus       126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~  201 (290)
T 3fpq_A          126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHH
Confidence            578999999999999999999998  999999999999984 79999999999975321    23456799999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++|||||||++|+|+||+.||.+.......+..... ...+...+..+++++.+||.+||.+||++|||++|
T Consensus       202 ~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e  279 (290)
T 3fpq_A          202 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             GGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            875 5789999999999999999999999876544333333332 22222234557899999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||++.
T Consensus       280 ~l~Hp~~~~~  289 (290)
T 3fpq_A          280 LLNHAFFQEE  289 (290)
T ss_dssp             HHTSGGGC--
T ss_pred             HhcCccccCC
Confidence            9999999863

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-40  Score=326.94  Aligned_cols=162  Identities=20%  Similarity=0.341  Sum_probs=140.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...  .......+||+.|||||++.+
T Consensus       122 ~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~  199 (350)
T 4b9d_A          122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICEN  199 (350)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCC
Confidence            478999999999999999999999999999999999999999999999999865322  112345689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|||||||+||+|++|+.||.+.+............  . .+.+..+|+++++||.+||.+||.+|||++|+++
T Consensus       200 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--F-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--C-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            989999999999999999999999999887765544443332  1 2344678999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||++.
T Consensus       277 hp~~~~~  283 (350)
T 4b9d_A          277 KGFIAKR  283 (350)
T ss_dssp             SHHHHTT
T ss_pred             CHHhhcC
Confidence            9999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-39  Score=317.60  Aligned_cols=166  Identities=25%  Similarity=0.339  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCcc---CCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKER---PLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~---~~~~~~gt~~Y~APE   76 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.+...+...   .....+||+.|||||
T Consensus       147 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence            68999999999999999999999999999999999999988 59999999998765433221   223468999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|+.||.+.+............ ......+..+++++.+||.+||.+||.+|||+.
T Consensus       227 ~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-CCchhcCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            9999999999999999999999999999998766554444333332 222233467899999999999999999999999


Q ss_pred             HH-------------HhCcccccC
Q psy11119        157 KI-------------KSHRWYSKH  167 (407)
Q Consensus       157 ei-------------l~hpwf~~~  167 (407)
                      |+             ++|||+.+.
T Consensus       306 el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          306 ELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHHhhhhhccCCCcCCC
Confidence            98             468998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=319.53  Aligned_cols=169  Identities=28%  Similarity=0.387  Sum_probs=138.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC--CccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG--KERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+....  ......+.+||+.|+|||++
T Consensus       155 l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          155 LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence            6899999999999999999999999999999999999999999999999998764322  22345678999999999998


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-----------------------CC----C
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-----------------------SP----W  130 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~----~  130 (407)
                      .+. +++.++||||+||++|+|++|++||.+.+.......+.........                       .+    +
T Consensus       235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (398)
T 4b99_A          235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY  314 (398)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS
T ss_pred             cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC
Confidence            875 7899999999999999999999999988765544433322111110                       01    2


Q ss_pred             CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        131 DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       131 ~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ..+++++.+||.+||..||.+|||++|+++||||++...
T Consensus       315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          315 PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            357899999999999999999999999999999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.9e-39  Score=316.72  Aligned_cols=167  Identities=25%  Similarity=0.481  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCC--------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGK--------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~--------------------   59 (407)
                      |++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......                    
T Consensus       114 l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (361)
T 4f9c_A          114 LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC  193 (361)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccc
Confidence            6889999999999999999999999999999999999977 8999999999986532211                    


Q ss_pred             ------ccCCcCccCCCCCCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH-HHHhh----------
Q psy11119         60 ------ERPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY-LEWKD----------  121 (407)
Q Consensus        60 ------~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~-~~~~~----------  121 (407)
                            .....+.+||+.|+|||++.+. +++.++||||+||++|+|++|+.||.....+.... .+...          
T Consensus       194 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~  273 (361)
T 4f9c_A          194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAA  273 (361)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhh
Confidence                  1123456899999999999875 68999999999999999999999996544321111 11000          


Q ss_pred             ----------------------------------------cccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        122 ----------------------------------------NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       122 ----------------------------------------~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                                                              ........|..+|+++++||++||..||++|||++|+++|
T Consensus       274 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          274 KTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             hhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                                    0011123466789999999999999999999999999999


Q ss_pred             cccccC
Q psy11119        162 RWYSKH  167 (407)
Q Consensus       162 pwf~~~  167 (407)
                      |||++.
T Consensus       354 p~f~~i  359 (361)
T 4f9c_A          354 PFFKDM  359 (361)
T ss_dssp             GGGTTC
T ss_pred             cccCCC
Confidence            999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-39  Score=339.92  Aligned_cols=178  Identities=25%  Similarity=0.329  Sum_probs=145.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...    ...+.|||+.|||||++.+
T Consensus       289 l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~  364 (689)
T 3v5w_A          289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK  364 (689)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHST
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhC
Confidence            689999999999999999999999999999999999999999999999999876432    2356799999999999975


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----  154 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----  154 (407)
                       .+|+.++|||||||++|+|++|.+||.+.+...... ............+..+|+++++||.+||..||.+|++     
T Consensus       365 ~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~g  443 (689)
T 3v5w_A          365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG  443 (689)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSST
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCC
Confidence             488999999999999999999999997643322111 1111122223345678999999999999999999998     


Q ss_pred             HHHHHhCcccccCCCCCCCCCCCCCCCch
Q psy11119        155 IEKIKSHRWYSKHMPNDIVDGPPSSDFNS  183 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~~~~~~~~~~~~~  183 (407)
                      ++||++||||+...|..+......+++.+
T Consensus       444 a~ei~~HpfF~~idW~~l~~~~~~pP~~P  472 (689)
T 3v5w_A          444 AQEVKESPFFRSLDWQMVFLQKYPPPLIP  472 (689)
T ss_dssp             HHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence            79999999999988876655544444443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=298.28  Aligned_cols=163  Identities=26%  Similarity=0.373  Sum_probs=128.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+..............+||+.|||||++.+
T Consensus       129 l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  208 (307)
T 3omv_A          129 FQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM  208 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhc
Confidence            57889999999999999999999999999999999999999999999999987654333344566799999999999975


Q ss_pred             C---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC--CCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 S---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM--QRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .   .++.++|||||||+||||+||+.||.+.+...............  ....+..+++++.+||.+||+.||++|||+
T Consensus       209 ~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  288 (307)
T 3omv_A          209 QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLF  288 (307)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred             cCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCH
Confidence            3   58899999999999999999999998765543333333222111  123356789999999999999999999999


Q ss_pred             HHHHhCcc
Q psy11119        156 EKIKSHRW  163 (407)
Q Consensus       156 ~eil~hpw  163 (407)
                      .+|+++..
T Consensus       289 ~ei~~~Le  296 (307)
T 3omv_A          289 PQILSSIE  296 (307)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99877643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.9e-38  Score=302.20  Aligned_cols=162  Identities=26%  Similarity=0.444  Sum_probs=121.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc----------cCCcCccCCCC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE----------RPLDKKCGTLP   71 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~----------~~~~~~~gt~~   71 (407)
                      ++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+......          ...++.+||+.
T Consensus       116 ~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~  195 (299)
T 4g31_A          116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL  195 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCT
T ss_pred             HHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCcc
Confidence            34568899999999999999999999999999999999999999999999876533221          12345689999


Q ss_pred             CCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         72 YVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        72 Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                      |||||++.+..++.++|||||||++|||++   ||............... .. ..+.+...++.+.+||.+||++||.+
T Consensus       196 YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~-~~-~p~~~~~~~~~~~~li~~~L~~dP~~  270 (299)
T 4g31_A          196 YMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN-LK-FPPLFTQKYPCEYVMVQDMLSPSPME  270 (299)
T ss_dssp             TSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT-TC-CCHHHHHHCHHHHHHHHHHTCSSGGG
T ss_pred             ccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc-CC-CCCCCcccCHHHHHHHHHHcCCChhH
Confidence            999999999999999999999999999996   88643322111111111 11 11223456778899999999999999


Q ss_pred             CCCHHHHHhCcccccCC
Q psy11119        152 RLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       152 Rps~~eil~hpwf~~~~  168 (407)
                      |||+.|+++||||+...
T Consensus       271 Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          271 RPEAINIIENAVFEDLD  287 (299)
T ss_dssp             SCCHHHHHTSGGGCCC-
T ss_pred             CcCHHHHhcCHhhCCCC
Confidence            99999999999998754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.7e-37  Score=321.34  Aligned_cols=168  Identities=27%  Similarity=0.458  Sum_probs=146.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC--CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~--g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+|.+++.|++||+.||.|||++||+||||||+|||++.+  |.+||+|||+|+.+...   ......|||+.|+|||++
T Consensus       252 l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~  328 (573)
T 3uto_A          252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVA  328 (573)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECccccCHHHh
Confidence            4789999999999999999999999999999999999854  89999999999876433   234567999999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||.+.+...................+..+|+++++||++||..||.+|||+.|+
T Consensus       329 ~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~  408 (573)
T 3uto_A          329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA  408 (573)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            99989999999999999999999999999888765555444444445555677899999999999999999999999999


Q ss_pred             HhCcccccCCCCC
Q psy11119        159 KSHRWYSKHMPND  171 (407)
Q Consensus       159 l~hpwf~~~~~~~  171 (407)
                      ++||||+...+..
T Consensus       409 l~Hpw~~~~~~~~  421 (573)
T 3uto_A          409 LEHPWLTPGNAPG  421 (573)
T ss_dssp             HHSTTTSCCCCTT
T ss_pred             hcCcCcCCCCCCC
Confidence            9999999876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.5e-36  Score=292.80  Aligned_cols=158  Identities=20%  Similarity=0.317  Sum_probs=125.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..|+.||+.||+|||+++|+||||||+|||++.++++||+|||+|+..............+||+.|||||++.+
T Consensus       155 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  234 (329)
T 4aoj_A          155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  234 (329)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence            57889999999999999999999999999999999999999999999999987654443344456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||+||||+| |+.||.+.+........... ..  .+.+..+++++.+||.+||+.||++|||+.||+
T Consensus       235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~  311 (329)
T 4aoj_A          235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RE--LERPRACPPEVYAIMRGCWQREPQQRHSIKDVH  311 (329)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred             CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC--CCCcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            999999999999999999999 99999987765443333222 22  233456899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       312 ~~  313 (329)
T 4aoj_A          312 AR  313 (329)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.9e-36  Score=290.03  Aligned_cols=158  Identities=23%  Similarity=0.331  Sum_probs=135.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+..............+||+.|||||++.+
T Consensus       142 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  221 (308)
T 4gt4_A          142 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY  221 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence            57889999999999999999999999999999999999999999999999987654443444566789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +.++.++|||||||+||||+| |..||.+.+........... .  ..+.+..+++++.+||.+||+.||.+|||+.||+
T Consensus       222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~--~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~  298 (308)
T 4gt4_A          222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-Q--VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH  298 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999998 89999987765443333222 2  2233467899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       299 ~~  300 (308)
T 4gt4_A          299 SR  300 (308)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.6e-36  Score=290.82  Aligned_cols=161  Identities=22%  Similarity=0.339  Sum_probs=134.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+..............+||+.|||||++.+
T Consensus       125 l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  204 (299)
T 4asz_A          125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  204 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence            57889999999999999999999999999999999999999999999999986543333333345679999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||+||||+| |+.||.+.+........... ..  .+.+..+|+++.+||.+||+.||++|||+.+| 
T Consensus       205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~-~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i-  280 (299)
T 4asz_A          205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-RV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI-  280 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH-
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHH-
Confidence            999999999999999999999 99999987765544333322 21  22345689999999999999999999999999 


Q ss_pred             hCccccc
Q psy11119        160 SHRWYSK  166 (407)
Q Consensus       160 ~hpwf~~  166 (407)
                       ++|+++
T Consensus       281 -~~~L~~  286 (299)
T 4asz_A          281 -HTLLQN  286 (299)
T ss_dssp             -HHHHHH
T ss_pred             -HHHHHH
Confidence             455543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-36  Score=297.35  Aligned_cols=159  Identities=24%  Similarity=0.333  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+............+||+.|||||++.+
T Consensus       182 l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  261 (353)
T 4ase_A          182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  261 (353)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence            46889999999999999999999999999999999999999999999999987644333333445689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||+||||+| |..||.+.................  +.+..+++++.+||.+||+.||++|||+.+|+
T Consensus       262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            999999999999999999998 999998765443333333332222  23356899999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       340 ~~  341 (353)
T 4ase_A          340 EH  341 (353)
T ss_dssp             HH
T ss_pred             HH
Confidence            97

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-35  Score=298.36  Aligned_cols=177  Identities=25%  Similarity=0.418  Sum_probs=141.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       150 l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          150 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcC
Confidence            578999999999999999999999999999999999999999999999999753222  233456799999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTA--------DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ..++.++|||||||++|+|++|..||.....        ....+..... ..  ...+..+++++.+||++||+.||.+|
T Consensus       228 ~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~li~~lL~~dP~~R  304 (396)
T 4dc2_A          228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ--IRIPRSLSVKAASVLKSFLNKDPKER  304 (396)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CC--CCCCTTSCHHHHHHHHHHTCSCTTTS
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cc--cCCCCcCCHHHHHHHHHHhcCCHhHc
Confidence            8899999999999999999999999964321        1111121111 12  22234589999999999999999999


Q ss_pred             CCH------HHHHhCcccccCCCCCCCCCCCCCCCc
Q psy11119        153 LNI------EKIKSHRWYSKHMPNDIVDGPPSSDFN  182 (407)
Q Consensus       153 ps~------~eil~hpwf~~~~~~~~~~~~~~~~~~  182 (407)
                      |++      ++|++||||+...|.........+++.
T Consensus       305 ~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~  340 (396)
T 4dc2_A          305 LGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK  340 (396)
T ss_dssp             TTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCC
T ss_pred             CCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCc
Confidence            984      899999999988766554443333443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=293.93  Aligned_cols=169  Identities=27%  Similarity=0.444  Sum_probs=138.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       121 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  198 (353)
T 3txo_A          121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQE  198 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcCC
Confidence            578999999999999999999999999999999999999999999999999753222  233456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........  ....  ...+++++.+||++||..||.+||++     
T Consensus       199 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~  274 (353)
T 3txo_A          199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGG  274 (353)
T ss_dssp             HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTC
T ss_pred             CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCC
Confidence            88899999999999999999999999988766544333332  2222  23478999999999999999999998     


Q ss_pred             -HHHHhCcccccCCCCCCCCC
Q psy11119        156 -EKIKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       156 -~eil~hpwf~~~~~~~~~~~  175 (407)
                       ++|++||||+...|......
T Consensus       275 ~~~il~hp~f~~~~w~~l~~~  295 (353)
T 3txo_A          275 EHAILRHPFFKEIDWAQLNHR  295 (353)
T ss_dssp             THHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHhhCCcccCCCHHHHhcC
Confidence             89999999998776554333

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.3e-35  Score=294.72  Aligned_cols=180  Identities=24%  Similarity=0.356  Sum_probs=147.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....+. ......+||+.|+|||++.+
T Consensus       165 ~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~  243 (410)
T 3v8s_A          165 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKS  243 (410)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhc
Confidence            57899999999999999999999999999999999999999999999999987543321 22346789999999999986


Q ss_pred             CC----CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC--CCC
Q psy11119         81 SY----LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST--RLN  154 (407)
Q Consensus        81 ~~----~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~--Rps  154 (407)
                      ..    ++.++|||||||++|+|++|..||...+.................+.+..+++++++||++||..+|.+  |++
T Consensus       244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~  323 (410)
T 3v8s_A          244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG  323 (410)
T ss_dssp             TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred             cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCC
Confidence            54    788999999999999999999999987766544444333333445555678999999999999999988  999


Q ss_pred             HHHHHhCcccccCCCCCCCCCCCCCCC
Q psy11119        155 IEKIKSHRWYSKHMPNDIVDGPPSSDF  181 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~~~~~~~~~~~  181 (407)
                      ++||++||||+...|.........+++
T Consensus       324 ~~ei~~Hp~f~~~~w~~~~~~~~~~p~  350 (410)
T 3v8s_A          324 VEEIKRHLFFKNDQWAWETLRDTVAPV  350 (410)
T ss_dssp             HHHHHTSGGGCCSSCCSTTGGGSCCSC
T ss_pred             HHHHhcCccccCCCHHHHhhcccCCCC
Confidence            999999999998776554433333333

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.6e-35  Score=287.03  Aligned_cols=176  Identities=27%  Similarity=0.464  Sum_probs=143.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       115 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  192 (345)
T 1xjd_A          115 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLG  192 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--CCcccCCCCCcccCChhhhcC
Confidence            578899999999999999999999999999999999999999999999999754322  123456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE-KIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~-eil  159 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ....  ...+++++.+||.+||..||.+||++. +|+
T Consensus       193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~--p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC--CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCC--CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            88899999999999999999999999987765433333222  2222  245899999999999999999999998 999


Q ss_pred             hCcccccCCCCCCCCCCCCCCCc
Q psy11119        160 SHRWYSKHMPNDIVDGPPSSDFN  182 (407)
Q Consensus       160 ~hpwf~~~~~~~~~~~~~~~~~~  182 (407)
                      +||||+...|.........+++.
T Consensus       269 ~hp~f~~~~w~~l~~~~~~~p~~  291 (345)
T 1xjd_A          269 QHPLFREINWEELERKEIDPPFR  291 (345)
T ss_dssp             GSGGGTTCCHHHHHTTCSCC---
T ss_pred             cCccccCCCHHHHhhCCCCCCcC
Confidence            99999988766554443333443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.4e-34  Score=305.83  Aligned_cols=178  Identities=25%  Similarity=0.437  Sum_probs=150.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....+  ......+||+.|+|||++.+
T Consensus       439 ~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~  516 (674)
T 3pfq_A          439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAY  516 (674)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcC
Confidence            5789999999999999999999999999999999999999999999999998643222  23456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI-----  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~-----  155 (407)
                      ..++.++|||||||++|+|++|+.||.+.+.......+...  ..  ..+..+++++.+||++||..||.+||++     
T Consensus       517 ~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~  592 (674)
T 3pfq_A          517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE  592 (674)
T ss_dssp             CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHH
T ss_pred             CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcH
Confidence            88999999999999999999999999987766444333332  22  2234689999999999999999999997     


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCCchh
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDFNST  184 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~~~~  184 (407)
                      ++|++||||+...|.........+++.+.
T Consensus       593 ~ei~~h~ff~~i~w~~l~~~~~~pp~~p~  621 (674)
T 3pfq_A          593 RDIKEHAFFRYIDWEKLERKEIQPPYKPK  621 (674)
T ss_dssp             HHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred             HHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence            99999999999887776666555556553

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-34  Score=279.00  Aligned_cols=168  Identities=58%  Similarity=1.085  Sum_probs=145.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+............+||+.|+|||++.+
T Consensus       102 ~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence            57899999999999999999999999999999999999999999999999987665554445567789999999999987


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. ++.++|||||||++|+|++|+.||.........+..+.. ......++..+++++.+||.+||..||.+|||+.|++
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil  260 (323)
T 3tki_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK  260 (323)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            64 578999999999999999999999877665555555544 2334455678999999999999999999999999999


Q ss_pred             hCcccccCCC
Q psy11119        160 SHRWYSKHMP  169 (407)
Q Consensus       160 ~hpwf~~~~~  169 (407)
                      +||||.+...
T Consensus       261 ~h~~~~~~~~  270 (323)
T 3tki_A          261 KDRWYNKPLK  270 (323)
T ss_dssp             TCTTTTCCCC
T ss_pred             hChhhccccc
Confidence            9999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.3e-34  Score=281.57  Aligned_cols=168  Identities=29%  Similarity=0.488  Sum_probs=141.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       102 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  179 (337)
T 1o6l_A          102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcC
Confidence            578999999999999999999999999999999999999999999999999753322  223456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ..  .....+++++.+||.+||..||.+||     ++
T Consensus       180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~  255 (337)
T 1o6l_A          180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  255 (337)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred             CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence            88899999999999999999999999887765433333222  11  12246899999999999999999999     99


Q ss_pred             HHHHhCcccccCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVD  174 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~  174 (407)
                      ++|++||||....|.....
T Consensus       256 ~ei~~h~~f~~~~~~~~~~  274 (337)
T 1o6l_A          256 KEVMEHRFFLSINWQDVVQ  274 (337)
T ss_dssp             HHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHcCCCcCCCCHHHHHh
Confidence            9999999999876654433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-34  Score=290.75  Aligned_cols=172  Identities=24%  Similarity=0.415  Sum_probs=143.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++. 
T Consensus       172 l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~  250 (437)
T 4aw2_A          172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA  250 (437)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhh
Confidence            57899999999999999999999999999999999999999999999999987543322 2234568999999999997 


Q ss_pred             ----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC-CCCcCCHHHHHHHHHhccCCCCC--C
Q psy11119         80 ----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS-PWDRLDVNCLSLIRRILAPLPST--R  152 (407)
Q Consensus        80 ----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~LI~~~L~~~P~~--R  152 (407)
                          ...++.++||||+||++|+|++|+.||...+.................+ .+..+++++++||++||..+|.+  |
T Consensus       251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r  330 (437)
T 4aw2_A          251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQ  330 (437)
T ss_dssp             HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTT
T ss_pred             cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCC
Confidence                4468899999999999999999999999877665443333322222222 23568999999999999988888  9


Q ss_pred             CCHHHHHhCcccccCCCCCCC
Q psy11119        153 LNIEKIKSHRWYSKHMPNDIV  173 (407)
Q Consensus       153 ps~~eil~hpwf~~~~~~~~~  173 (407)
                      ++++|+++||||+...|....
T Consensus       331 ~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          331 NGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             TTTHHHHTSGGGTTCCTTTGG
T ss_pred             CCHHHHhCCCccCCCCHHHHh
Confidence            999999999999998887653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.7e-34  Score=277.38  Aligned_cols=162  Identities=35%  Similarity=0.605  Sum_probs=137.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......   ......+||+.|+|||++.+
T Consensus       111 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  187 (328)
T 3fe3_A          111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQG  187 (328)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---CccccccCCcceeCcccccC
Confidence            578899999999999999999999999999999999999999999999999765433   23456789999999999988


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. .+.++||||+||++|+|++|..||.+.+...........  ..  ..+..+++++.+||++||..||.+|||++|++
T Consensus       188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil  263 (328)
T 3fe3_A          188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM  263 (328)
T ss_dssp             CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred             CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            75 458999999999999999999999988766544333322  22  22245789999999999999999999999999


Q ss_pred             hCcccccCCC
Q psy11119        160 SHRWYSKHMP  169 (407)
Q Consensus       160 ~hpwf~~~~~  169 (407)
                      +||||+....
T Consensus       264 ~h~~~~~~~~  273 (328)
T 3fe3_A          264 KDRWINAGHE  273 (328)
T ss_dssp             TCTTTTTTCT
T ss_pred             cCHhhcCCCc
Confidence            9999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-34  Score=273.73  Aligned_cols=164  Identities=28%  Similarity=0.432  Sum_probs=135.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||++.+
T Consensus       117 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  193 (308)
T 3g33_A          117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQ  193 (308)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcC
Confidence            578999999999999999999999999999999999999999999999999765322   23456689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC-----------------------CCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP-----------------------WDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~s~~~  137 (407)
                      ..++.++||||+||++|+|++|..||.......................                       ...+++++
T Consensus       194 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (308)
T 3g33_A          194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESG  273 (308)
T ss_dssp             SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHH
T ss_pred             CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHH
Confidence            8899999999999999999999999988776554433332211111111                       13578899


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      .+||.+||+.||.+|||+.|+++||||++.
T Consensus       274 ~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          274 AQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-33  Score=272.27  Aligned_cols=165  Identities=25%  Similarity=0.413  Sum_probs=141.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus       113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  190 (297)
T 3fxz_A          113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR  190 (297)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcC
Confidence            5788999999999999999999999999999999999999999999999998754332  23345689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||...+........... .......+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       191 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            88899999999999999999999999887765444433333 23333445678999999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||+...
T Consensus       270 h~~~~~~~  277 (297)
T 3fxz_A          270 HQFLKIAK  277 (297)
T ss_dssp             CGGGGGCC
T ss_pred             ChhhcccC
Confidence            99998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-34  Score=281.51  Aligned_cols=175  Identities=25%  Similarity=0.422  Sum_probs=143.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       118 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  195 (353)
T 2i0e_A          118 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAY  195 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhcC
Confidence            578999999999999999999999999999999999999999999999999753322  223456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|||||||++|+|++|..||...+...........  ...  .+..+++++.+||.+||..||.+||+     +
T Consensus       196 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~  271 (353)
T 2i0e_A          196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE  271 (353)
T ss_dssp             CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC--CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHH
T ss_pred             CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence            88899999999999999999999999987765443333322  222  22468999999999999999999994     6


Q ss_pred             HHHHhCcccccCCCCCCCCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVDGPPSSDF  181 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~~~~~~~~  181 (407)
                      ++|++||||+...|.........+++
T Consensus       272 ~~i~~h~~f~~~~w~~l~~~~~~~p~  297 (353)
T 2i0e_A          272 RDIKEHAFFRYIDWEKLERKEIQPPY  297 (353)
T ss_dssp             HHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             HHHhcCccccCCCHHHHHhCCCCCCc
Confidence            99999999998776554443333333

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-33  Score=272.25  Aligned_cols=167  Identities=28%  Similarity=0.428  Sum_probs=134.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus       116 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~  193 (311)
T 3niz_A          116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMG  193 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcC
Confidence            578899999999999999999999999999999999999999999999999875322  223345689999999999976


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC--------------------------CCcC
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP--------------------------WDRL  133 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~  133 (407)
                       ..++.++||||+||++|+|++|..||.......................                          ...+
T Consensus       194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (311)
T 3niz_A          194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF  273 (311)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTC
T ss_pred             CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCccc
Confidence             4789999999999999999999999987665543333222111111110                          1346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ++++.+||.+||..||.+|||++|+++||||++..+
T Consensus       274 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          274 CQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            789999999999999999999999999999997643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.5e-34  Score=282.08  Aligned_cols=164  Identities=31%  Similarity=0.478  Sum_probs=139.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++......   ......+||+.|+|||
T Consensus       112 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE  188 (361)
T 2yab_A          112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPE  188 (361)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT---CCCCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC---CccccCCCCccEECch
Confidence            57899999999999999999999999999999999998877    7999999999876432   2345678999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|..||.+.+...................|..+++++++||.+||.+||.+|||+.
T Consensus       189 ~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  268 (361)
T 2yab_A          189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ  268 (361)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence            99988889999999999999999999999988776544333333322333334567899999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      |+++||||...
T Consensus       269 e~l~hp~~~~~  279 (361)
T 2yab_A          269 EALRHPWITPV  279 (361)
T ss_dssp             HHHTSTTTSCS
T ss_pred             HHhcCcCcCCC
Confidence            99999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-34  Score=275.86  Aligned_cols=165  Identities=31%  Similarity=0.471  Sum_probs=140.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       103 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~  177 (318)
T 1fot_A          103 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVST  177 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcC
Confidence            57889999999999999999999999999999999999999999999999986432     2345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|+||+||++|+|++|..||...+...........  ..  .....+++++.+||.+||..||.+||     ++
T Consensus       178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  253 (318)
T 1fot_A          178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT  253 (318)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTT
T ss_pred             CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCH
Confidence            88899999999999999999999999887765433333222  11  12245889999999999999999999     99


Q ss_pred             HHHHhCcccccCCCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDIVD  174 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~~~  174 (407)
                      +++++||||+...|.....
T Consensus       254 ~~i~~hp~f~~~~~~~~~~  272 (318)
T 1fot_A          254 EDVKNHPWFKEVVWEKLLS  272 (318)
T ss_dssp             HHHHTSGGGSSCCHHHHHT
T ss_pred             HHHhcCccccCCCHHHHHh
Confidence            9999999999876654433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=282.52  Aligned_cols=173  Identities=22%  Similarity=0.383  Sum_probs=140.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++....... ......+||+.|+|||++..
T Consensus       159 l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~  237 (412)
T 2vd5_A          159 IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQA  237 (412)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhh
Confidence            57899999999999999999999999999999999999999999999999987643322 12345689999999999973


Q ss_pred             -------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC-CCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 -------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS-PWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 -------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                             ..++.++||||+||++|+|++|+.||...+.................+ ....+++++++||++||. +|.+|
T Consensus       238 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~R  316 (412)
T 2vd5_A          238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR  316 (412)
T ss_dssp             HHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGC
T ss_pred             cccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chhhc
Confidence                   467899999999999999999999999877654433333221122222 235689999999999999 99998


Q ss_pred             ---CCHHHHHhCcccccCCCCCCCCC
Q psy11119        153 ---LNIEKIKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       153 ---ps~~eil~hpwf~~~~~~~~~~~  175 (407)
                         +++++|++||||+...|......
T Consensus       317 lgr~~~~ei~~Hpff~~i~w~~l~~~  342 (412)
T 2vd5_A          317 LGRGGAGDFRTHPFFFGLDWDGLRDS  342 (412)
T ss_dssp             TTTTTHHHHHTSGGGTTCCSTTSTTS
T ss_pred             CCCCCHHHHhcCCCcCCCCHHHHhhc
Confidence               59999999999999888776543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-33  Score=285.60  Aligned_cols=165  Identities=29%  Similarity=0.511  Sum_probs=143.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe---cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld---~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......  ......+||+.|+|||+
T Consensus       107 ~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHH
Confidence            57899999999999999999999999999999999998   45789999999997654322  23355789999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+||++|+|++|..||.+.+...............+.+.|..+++++.+||.+||..||.+|||+.|
T Consensus       185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  264 (444)
T 3soa_A          185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE  264 (444)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            99888899999999999999999999999887766554444444455666677889999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||+..
T Consensus       265 ~L~hp~~~~~  274 (444)
T 3soa_A          265 ALKHPWISHR  274 (444)
T ss_dssp             HHHSCTTHHH
T ss_pred             HhcCccccCC
Confidence            9999999753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-33  Score=268.43  Aligned_cols=165  Identities=30%  Similarity=0.492  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.+
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~  174 (288)
T 1ob3_A           97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMG  174 (288)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeC
Confidence            578899999999999999999999999999999999999999999999999765322  122345678999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-------------------------CCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-------------------------SPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~s  134 (407)
                      . .++.++||||+||++|+|++|..||.....................                         .....++
T Consensus       175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (288)
T 1ob3_A          175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD  254 (288)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcC
Confidence            4 6899999999999999999999999887655433332221111000                         0123578


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +++.+||.+||..||++|||+.|+++||||++.
T Consensus       255 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          255 ESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            999999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-34  Score=282.37  Aligned_cols=168  Identities=27%  Similarity=0.377  Sum_probs=133.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC-------------------Ccc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG-------------------KER   61 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~-------------------~~~   61 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....                   ...
T Consensus       106 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (388)
T 3oz6_A          106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP  185 (388)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccc
Confidence            4678899999999999999999999999999999999999999999999998753211                   112


Q ss_pred             CCcCccCCCCCCchhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC--------------
Q psy11119         62 PLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ--------------  126 (407)
Q Consensus        62 ~~~~~~gt~~Y~APE~l~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------  126 (407)
                      .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+................              
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~  265 (388)
T 3oz6_A          186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKT  265 (388)
T ss_dssp             ----CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence            2345689999999999987 5789999999999999999999999987765443322221100000              


Q ss_pred             -----------------------------CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        127 -----------------------------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       127 -----------------------------~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                                   ..++..+++++.+||.+||..||.+|||++|+++||||+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          266 MIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             HHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred             HHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence                                         011236789999999999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.3e-33  Score=267.21  Aligned_cols=166  Identities=26%  Similarity=0.430  Sum_probs=132.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  .......+||+.|+|||++.+
T Consensus        98 l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~  175 (292)
T 3o0g_A           98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcC
Confidence            578899999999999999999999999999999999999999999999999875422  233455689999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhcccCCC-------------------------CCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQR-------------------------SPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf-~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~  133 (407)
                      . .++.++||||+||++|+|++|..|| ...+.................                         .....+
T Consensus       176 ~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (292)
T 3o0g_A          176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL  255 (292)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred             CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccccc
Confidence            6 4899999999999999999988775 444433322222221111110                         112357


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++++.+||.+||+.||++|||++|+++||||++..
T Consensus       256 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            88999999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-33  Score=270.78  Aligned_cols=169  Identities=30%  Similarity=0.495  Sum_probs=136.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+
T Consensus       105 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhC
Confidence            4678899999999999999999999999999999999999999999999998754222  23345689999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC------------------------------CC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR------------------------------SP  129 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------------------------~~  129 (407)
                      . .++.++||||+||++|+|++|..||...+.................                              ..
T Consensus       183 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (317)
T 2pmi_A          183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT  262 (317)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence            4 6899999999999999999999999887765433332221111000                              01


Q ss_pred             CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCCCC
Q psy11119        130 WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       130 ~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~~~  171 (407)
                      ...+++++.+||.+||..||.+|||+.|+++||||.+..+..
T Consensus       263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            125788999999999999999999999999999999876543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-33  Score=278.11  Aligned_cols=167  Identities=26%  Similarity=0.448  Sum_probs=136.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       107 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  184 (345)
T 3a8x_A          107 LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRG  184 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccCC
Confidence            578999999999999999999999999999999999999999999999999753222  223456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------hHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTA--------DCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      ..++.++||||+||++|+|++|..||.....        ....+..... ...  .....++.++.+||.+||..||.+|
T Consensus       185 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~--~~p~~~s~~~~~li~~lL~~dP~~R  261 (345)
T 3a8x_A          185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQI--RIPRSLSVKAASVLKSFLNKDPKER  261 (345)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCC--CCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred             CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCC--CCCCCCCHHHHHHHHHHhcCCHhHC
Confidence            8889999999999999999999999975211        1111111112 122  2234689999999999999999999


Q ss_pred             CCH------HHHHhCcccccCCCCCC
Q psy11119        153 LNI------EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       153 ps~------~eil~hpwf~~~~~~~~  172 (407)
                      |++      .++++||||+...|...
T Consensus       262 ~~~~~~~~~~~i~~hp~f~~~~w~~~  287 (345)
T 3a8x_A          262 LGCHPQTGFADIQGHPFFRNVDWDMM  287 (345)
T ss_dssp             TTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred             CCCCCcCCHHHHhcCCccCCCCHHHH
Confidence            985      89999999998766443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-33  Score=289.69  Aligned_cols=166  Identities=25%  Similarity=0.328  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....   .......+||+.|+|||++.+
T Consensus       161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~  237 (464)
T 3ttj_A          161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILG  237 (464)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcC
Confidence            57889999999999999999999999999999999999999999999999986532   223456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC----------------------CCCCCC-------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM----------------------QRSPWD-------  131 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------------------~~~~~~-------  131 (407)
                      ..++.++||||+||++|+|++|+.||.+.+...............                      ....+.       
T Consensus       238 ~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (464)
T 3ttj_A          238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  317 (464)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccc
Confidence            889999999999999999999999998876544332222111100                      000000       


Q ss_pred             ---------cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 ---------RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ---------~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                               ..++++++||.+||..||.+|||++|+++||||.....
T Consensus       318 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             cccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                     01567999999999999999999999999999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-33  Score=277.80  Aligned_cols=163  Identities=30%  Similarity=0.546  Sum_probs=140.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++......   ......+||+.|+|||+
T Consensus       125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEV  201 (362)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC---CSCCCSCSCTTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC---cccccCCCCccccCHHH
Confidence            57899999999999999999999999999999999998654   5999999999865422   23345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++|||||||++|+|++|..||...+...............+.+.|..+++++.+||.+||..||.+|||+.+
T Consensus       202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  281 (362)
T 2bdw_A          202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ  281 (362)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99888899999999999999999999999887765444433333344455667789999999999999999999999999


Q ss_pred             HHhCccccc
Q psy11119        158 IKSHRWYSK  166 (407)
Q Consensus       158 il~hpwf~~  166 (407)
                      +++||||..
T Consensus       282 ~l~hp~~~~  290 (362)
T 2bdw_A          282 ALKVPWICN  290 (362)
T ss_dssp             HTTSHHHHT
T ss_pred             HhcCcccCC
Confidence            999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-34  Score=278.29  Aligned_cols=165  Identities=22%  Similarity=0.448  Sum_probs=140.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++..+....   .....+||+.|+|||++
T Consensus        99 ~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~  175 (321)
T 1tki_A           99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHh
Confidence            578999999999999999999999999999999999997  7899999999998764332   23456799999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||...+...................+..+++++.+||.+||..||.+|||+.|+
T Consensus       176 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~  255 (321)
T 1tki_A          176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            98888999999999999999999999999877654444333333333333456789999999999999999999999999


Q ss_pred             HhCcccccCC
Q psy11119        159 KSHRWYSKHM  168 (407)
Q Consensus       159 l~hpwf~~~~  168 (407)
                      ++||||++..
T Consensus       256 l~hp~~~~~~  265 (321)
T 1tki_A          256 LQHPWLKQKI  265 (321)
T ss_dssp             HHSHHHHSCG
T ss_pred             hcChhhccCc
Confidence            9999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-33  Score=279.23  Aligned_cols=175  Identities=29%  Similarity=0.410  Sum_probs=144.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       136 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  213 (373)
T 2r5t_A          136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHK  213 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCC
Confidence            578899999999999999999999999999999999999999999999999753222  223456789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI----E  156 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~----~  156 (407)
                      ..++.++|||||||++|+|++|..||...+...........  ..  .....++.++.+||.+||..||.+||++    .
T Consensus       214 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence            88999999999999999999999999887765433333222  11  2234689999999999999999999986    6


Q ss_pred             HHHhCcccccCCCCCCCCCCCCCCC
Q psy11119        157 KIKSHRWYSKHMPNDIVDGPPSSDF  181 (407)
Q Consensus       157 eil~hpwf~~~~~~~~~~~~~~~~~  181 (407)
                      +|++||||+...|.........+++
T Consensus       290 ~i~~h~~f~~~~w~~l~~~~~~pp~  314 (373)
T 2r5t_A          290 EIKSHVFFSLINWDDLINKKITPPF  314 (373)
T ss_dssp             HHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             HHhCCccccCCCHHHHHhCCCCCCC
Confidence            9999999998877655444333333

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.5e-33  Score=272.25  Aligned_cols=168  Identities=26%  Similarity=0.441  Sum_probs=137.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....  .......+||+.|+|||++
T Consensus       121 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (351)
T 3mi9_A          121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  200 (351)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhh
Confidence            57889999999999999999999999999999999999999999999999987643222  2234556899999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCc-------------------------
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDR-------------------------  132 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------  132 (407)
                      .+. .++.++||||+||++|+|++|..||.......................|..                         
T Consensus       201 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (351)
T 3mi9_A          201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK  280 (351)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHH
T ss_pred             cCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhh
Confidence            764 689999999999999999999999998776544433333222222222222                         


Q ss_pred             ---CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 ---LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ---~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                         .++.+.+||.+||..||.+|||++|+++||||....
T Consensus       281 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          281 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence               267899999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-33  Score=277.12  Aligned_cols=163  Identities=27%  Similarity=0.424  Sum_probs=139.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       138 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~  212 (350)
T 1rdq_E          138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-----CcccccCCccccCHHHhcC
Confidence            57899999999999999999999999999999999999999999999999986532     2245689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|||||||++|+|++|..||...+...........  ..  .....+++++.+||.+||..||.+||+     +
T Consensus       213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  288 (350)
T 1rdq_E          213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCH
Confidence            88899999999999999999999999887765433333222  22  223468999999999999999999998     9


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      ++|++||||....|...
T Consensus       289 ~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          289 NDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             HHHHTSGGGTTCCHHHH
T ss_pred             HHHHhCcCcCCCCHHHH
Confidence            99999999998765443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-33  Score=271.52  Aligned_cols=169  Identities=26%  Similarity=0.434  Sum_probs=141.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++......   ......+||+.|+|||+
T Consensus       128 ~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEI  204 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCee
Confidence            578899999999999999999999999999999999997   789999999999875432   22345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+||++|+|++|..||.......................+..+++.+.+||.+||..||.+|||+++
T Consensus       205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~  284 (327)
T 3lm5_A          205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI  284 (327)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99888999999999999999999999999887766544444444344555556778999999999999999999999999


Q ss_pred             HHhCcccccCCCCCC
Q psy11119        158 IKSHRWYSKHMPNDI  172 (407)
Q Consensus       158 il~hpwf~~~~~~~~  172 (407)
                      +++||||+...+...
T Consensus       285 ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          285 CLSHSWLQQWDFENL  299 (327)
T ss_dssp             HTTCGGGCCCCTTCC
T ss_pred             HhCCHhhcccccccc
Confidence            999999998766543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=267.62  Aligned_cols=162  Identities=29%  Similarity=0.568  Sum_probs=135.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....  ......+||+.|+|||++.+
T Consensus       134 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  211 (298)
T 2zv2_A          134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSE  211 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhcc
Confidence            5789999999999999999999999999999999999999999999999998764322  22345689999999999976


Q ss_pred             CC---CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         81 SY---LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        81 ~~---~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      ..   ++.++||||+||++|+|++|..||..............  .....+....+++++.+||.+||+.||.+|||+.|
T Consensus       212 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          212 TRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             TCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence            53   47789999999999999999999988765443322222  22333344578999999999999999999999999


Q ss_pred             HHhCccccc
Q psy11119        158 IKSHRWYSK  166 (407)
Q Consensus       158 il~hpwf~~  166 (407)
                      +++||||++
T Consensus       290 ~l~hp~~~~  298 (298)
T 2zv2_A          290 IKLHPWVTR  298 (298)
T ss_dssp             HTTCHHHHC
T ss_pred             HhcCccccC
Confidence            999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-33  Score=272.26  Aligned_cols=164  Identities=33%  Similarity=0.507  Sum_probs=138.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.....   ......+||+.|+|||
T Consensus       111 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE  187 (326)
T 2y0a_A          111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPE  187 (326)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT---SCCCCCCSCTTTCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC---CccccccCCcCcCCce
Confidence            57889999999999999999999999999999999999887    7999999999876432   2334568999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|..||.......................+..+++.+.+||.+||..||.+|||+.
T Consensus       188 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  267 (326)
T 2y0a_A          188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ  267 (326)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             eecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHH
Confidence            99888889999999999999999999999988765543333322222222223456889999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      ++++||||+..
T Consensus       268 e~l~hp~~~~~  278 (326)
T 2y0a_A          268 DSLQHPWIKPK  278 (326)
T ss_dssp             HHHHSTTTSCC
T ss_pred             HHhcCCCccCC
Confidence            99999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=279.26  Aligned_cols=168  Identities=23%  Similarity=0.451  Sum_probs=137.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....   ......+||+.|+|||++..
T Consensus       112 l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeecc
Confidence            578999999999999999999999999999999999999999999999999875432   23456789999999999974


Q ss_pred             ---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-HH
Q psy11119         81 ---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-IE  156 (407)
Q Consensus        81 ---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-~~  156 (407)
                         ..++.++||||+||++|+|++|..||............... .......+..+++++.+||.+||..||.+||+ ++
T Consensus       189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~  267 (384)
T 4fr4_A          189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLS  267 (384)
T ss_dssp             CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHH
T ss_pred             CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHH
Confidence               35789999999999999999999999754332221111111 11122223568999999999999999999998 99


Q ss_pred             HHHhCcccccCCCCCC
Q psy11119        157 KIKSHRWYSKHMPNDI  172 (407)
Q Consensus       157 eil~hpwf~~~~~~~~  172 (407)
                      ++++||||....|...
T Consensus       268 ~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          268 DVQNFPYMNDINWDAV  283 (384)
T ss_dssp             HHHTSGGGTTCCHHHH
T ss_pred             HHHcChhhhcCCHHHH
Confidence            9999999998766543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-33  Score=272.40  Aligned_cols=166  Identities=25%  Similarity=0.472  Sum_probs=128.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+............+||+.|+|||++.+
T Consensus       105 ~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence            57889999999999999999999999999999999997 78899999999987654433333456689999999999975


Q ss_pred             -----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         81 -----------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        81 -----------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                                 ..++.++|||||||++|+|++|..||............... ...........+.++.+||.+||..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp  262 (343)
T 3dbq_A          184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDP  262 (343)
T ss_dssp             CC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHcCCCh
Confidence                       57888999999999999999999999875543333322222 222222334567899999999999999


Q ss_pred             CCCCCHHHHHhCcccccCC
Q psy11119        150 STRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       150 ~~Rps~~eil~hpwf~~~~  168 (407)
                      .+|||+.++++||||+...
T Consensus       263 ~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          263 KQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             TTSCCHHHHHTSHHHHSCC
T ss_pred             hHCCCHHHHHhCccccccC
Confidence            9999999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.6e-33  Score=270.46  Aligned_cols=165  Identities=28%  Similarity=0.455  Sum_probs=135.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+
T Consensus       118 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  195 (327)
T 3a62_A          118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMR  195 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcC
Confidence            4788999999999999999999999999999999999999999999999987543222  22345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++||||+||++|+|++|..||...+...........  ..  .....+++++.+||.+||..||.+||     ++
T Consensus       196 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~  271 (327)
T 3a62_A          196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDA  271 (327)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTH
T ss_pred             CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCH
Confidence            88899999999999999999999999987765443333222  11  22245789999999999999999999     89


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      .++++||||+...|..
T Consensus       272 ~e~l~hp~f~~~~~~~  287 (327)
T 3a62_A          272 GEVQAHPFFRHINWEE  287 (327)
T ss_dssp             HHHHHSGGGSSCCHHH
T ss_pred             HHHHcCCcccCCCHHH
Confidence            9999999999865543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.2e-33  Score=262.21  Aligned_cols=167  Identities=59%  Similarity=1.089  Sum_probs=142.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+............+||+.|+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence            57889999999999999999999999999999999999999999999999987654444344556789999999999987


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. ++.++||||+|+++|+|++|..||.........+..+... ......+..+++.+.+||.+||+.||.+|||+.+++
T Consensus       182 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  260 (276)
T 2yex_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK  260 (276)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence            64 5788999999999999999999998776554444444442 233345677899999999999999999999999999


Q ss_pred             hCcccccCC
Q psy11119        160 SHRWYSKHM  168 (407)
Q Consensus       160 ~hpwf~~~~  168 (407)
                      +||||++..
T Consensus       261 ~~~~~~~~~  269 (276)
T 2yex_A          261 KDRWYNKPL  269 (276)
T ss_dssp             TCTTTTCCC
T ss_pred             cCccccChh
Confidence            999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.2e-33  Score=282.57  Aligned_cols=165  Identities=29%  Similarity=0.478  Sum_probs=138.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++.
T Consensus       245 ~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcC
Confidence            5788999999999999999998 99999999999999999999999999999753222  22345678999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----C
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----N  154 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s  154 (407)
                      +..++.++||||+||++|+|++|..||...+.............    .....+++++.+||.+||..||.+||     +
T Consensus       323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t  398 (446)
T 4ejn_A          323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSED  398 (446)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred             CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCC
Confidence            88899999999999999999999999988776544333333221    12345899999999999999999999     9


Q ss_pred             HHHHHhCcccccCCCCC
Q psy11119        155 IEKIKSHRWYSKHMPND  171 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~  171 (407)
                      ++++++||||....+..
T Consensus       399 ~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          399 AKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             HHHHHTSGGGTTCCHHH
T ss_pred             HHHHHhCccccCCCHHH
Confidence            99999999999875543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3e-33  Score=280.78  Aligned_cols=164  Identities=30%  Similarity=0.539  Sum_probs=132.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....   ......+||+.|+|||+
T Consensus       158 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCHhh
Confidence            578899999999999999999999999999999999997   788999999999865322   23456789999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH----HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC----IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.+..++.++|||||||++|+|++|..||.......    ..............+.|..+++++.+||++||..||.+||
T Consensus       235 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  314 (400)
T 1nxk_A          235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM  314 (400)
T ss_dssp             SCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence            988888999999999999999999999997654321    1122222323444556778999999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      |+.++++||||...
T Consensus       315 t~~eil~hp~~~~~  328 (400)
T 1nxk_A          315 TITEFMNHPWIMQS  328 (400)
T ss_dssp             CHHHHHHSHHHHTT
T ss_pred             CHHHHhcCccccCC
Confidence            99999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=268.30  Aligned_cols=167  Identities=25%  Similarity=0.422  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .......+||+.|+|||++.+
T Consensus        97 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A           97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcC
Confidence            467889999999999999999999999999999999999999999999999764322  223345678999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC--------------------------CCcC
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP--------------------------WDRL  133 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~  133 (407)
                       ..++.++||||+||++|+|++|..||.+.+...................                          +..+
T Consensus       175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (324)
T 3mtl_A          175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL  254 (324)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTS
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCC
Confidence             4789999999999999999999999998776544333322211111111                          1346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ++++.+||.+||..||.+|||++|+++||||.+...
T Consensus       255 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          255 DSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             CHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            889999999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-32  Score=260.81  Aligned_cols=165  Identities=30%  Similarity=0.536  Sum_probs=141.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......   .......||+.|+|||+
T Consensus       102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEV  178 (284)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchh
Confidence            578899999999999999999999999999999999987665   999999999765432   22345679999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+|+++|+|++|..||...................+.+.+..+++++.+||.+||++||.+|||+.|
T Consensus       179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  258 (284)
T 3kk8_A          179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ  258 (284)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence            99888899999999999999999999999887766544444444344555566789999999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||....
T Consensus       259 ~l~h~~~~~~~  269 (284)
T 3kk8_A          259 ALKVPWICNRE  269 (284)
T ss_dssp             HTTSHHHHSCC
T ss_pred             HhcCccccCCh
Confidence            99999998754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.6e-33  Score=277.62  Aligned_cols=169  Identities=25%  Similarity=0.429  Sum_probs=125.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE----ecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl----d~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~AP   75 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.+..... .......+||+.|+||
T Consensus       125 l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCc
Confidence            5788899999999999999999999999999999999    6778999999999987643221 1234557899999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------HHHHHHHhhcccCCCCCCC--------------
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTAD---------CIEYLEWKDNRHMQRSPWD--------------  131 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~~--------------  131 (407)
                      |++.+. .++.++||||+||++|+|++|..||......         .................|.              
T Consensus       205 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~  284 (405)
T 3rgf_A          205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD  284 (405)
T ss_dssp             HHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH
T ss_pred             hhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh
Confidence            999874 6899999999999999999999999755432         1111111111111111121              


Q ss_pred             --------------------cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 --------------------RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 --------------------~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                                          ..++.+.+||.+||..||.+|||++|+++||||.....
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          285 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             CCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred             ccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence                                12678999999999999999999999999999987643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5e-33  Score=273.06  Aligned_cols=162  Identities=38%  Similarity=0.680  Sum_probs=135.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....   .......+||+.|+|||++.+
T Consensus       105 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~~~~~~~~gt~~y~aPE~~~~  181 (336)
T 3h4j_B          105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVING  181 (336)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---SBTTCCCTTSTTTSCGGGSCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---CcccccccCCcCcCCHHHHcC
Confidence            57899999999999999999999999999999999999999999999999976432   233456789999999999987


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. .+.++|||||||++|+|++|..||.........    ..........+..+++++.+||++||..||.+|||++|++
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil  257 (336)
T 3h4j_B          182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR  257 (336)
T ss_dssp             SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred             CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            74 478999999999999999999999875433210    1111122223456899999999999999999999999999


Q ss_pred             hCcccccCCC
Q psy11119        160 SHRWYSKHMP  169 (407)
Q Consensus       160 ~hpwf~~~~~  169 (407)
                      +||||+...+
T Consensus       258 ~hp~~~~~~~  267 (336)
T 3h4j_B          258 RDPWFNVNLP  267 (336)
T ss_dssp             TCHHHHTTCC
T ss_pred             hChhhccCCc
Confidence            9999987654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-32  Score=279.34  Aligned_cols=171  Identities=25%  Similarity=0.433  Sum_probs=127.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---------------------   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---------------------   59 (407)
                      |++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......                     
T Consensus       153 l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (458)
T 3rp9_A          153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH  232 (458)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence            57899999999999999999999999999999999999999999999999986542211                     


Q ss_pred             ----ccCCcCccCCCCCCchhhhh-cCCCCCcchhhhHHHHHHHHHh-----------CCCCCCCCChh-----------
Q psy11119         60 ----ERPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLA-----------GELPWDKPTAD-----------  112 (407)
Q Consensus        60 ----~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDiwSlGviL~ellt-----------G~~Pf~~~~~~-----------  112 (407)
                          .......+||+.|+|||++. ...++.++||||+||++|+|++           |.++|.+....           
T Consensus       233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~  312 (458)
T 3rp9_A          233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGND  312 (458)
T ss_dssp             ------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC----------------
T ss_pred             cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccc
Confidence                01345568999999999875 4578999999999999999999           66677543310           


Q ss_pred             ---------HHHHHHH----------------------hhc-----ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119        113 ---------CIEYLEW----------------------KDN-----RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus       113 ---------~~~~~~~----------------------~~~-----~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                               .......                      ...     .......+..+++++.+||++||..||.+|||++
T Consensus       313 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~  392 (458)
T 3rp9_A          313 FKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITIN  392 (458)
T ss_dssp             ----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHH
Confidence                     0000000                      000     0000112345689999999999999999999999


Q ss_pred             HHHhCcccccCCCCC
Q psy11119        157 KIKSHRWYSKHMPND  171 (407)
Q Consensus       157 eil~hpwf~~~~~~~  171 (407)
                      |+++||||+...+..
T Consensus       393 e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          393 ECLAHPFFKEVRIAE  407 (458)
T ss_dssp             HHHHSGGGTTTCCGG
T ss_pred             HHhcCHhhhhcCCCc
Confidence            999999999876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.7e-33  Score=273.67  Aligned_cols=164  Identities=29%  Similarity=0.581  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......  ......+||+.|+|||+
T Consensus       127 ~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~  204 (351)
T 3c0i_A          127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEV  204 (351)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHH
Confidence            478899999999999999999999999999999999987665   9999999998764322  22345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+||++|+|++|..||...... ................|..+++++.+||.+||..||.+|||+.+
T Consensus       205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  283 (351)
T 3c0i_A          205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE  283 (351)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            99888899999999999999999999999875432 22222222222222335678999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||+..
T Consensus       284 ~l~hp~~~~~  293 (351)
T 3c0i_A          284 ALNHPWLKER  293 (351)
T ss_dssp             HHTSHHHHTH
T ss_pred             HhcChhhcCC
Confidence            9999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-32  Score=268.51  Aligned_cols=167  Identities=26%  Similarity=0.377  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...  .......+||+.|+|||++.+
T Consensus       109 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~  186 (346)
T 1ua2_A          109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFG  186 (346)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHhhC
Confidence            467789999999999999999999999999999999999999999999999765322  223455689999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC------------------------CCcCCH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP------------------------WDRLDV  135 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~s~  135 (407)
                      . .++.++||||+||++|+|++|..||.+.....................                        +..+++
T Consensus       187 ~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (346)
T 1ua2_A          187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD  266 (346)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCH
Confidence            4 688999999999999999999999988776544333332211111111                        145678


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        136 NCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       136 ~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ++.+||.+||..||.+|||+.|+++||||.....
T Consensus       267 ~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          267 DLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence            9999999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.9e-33  Score=272.52  Aligned_cols=165  Identities=31%  Similarity=0.527  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-C---cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-D---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||+..+ +   .+||+|||+++......  ......+||+.|+|||
T Consensus       113 ~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE  190 (342)
T 2qr7_A          113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPE  190 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHH
Confidence            5789999999999999999999999999999999998543 3   59999999998764332  2345678999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT---ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      ++.+..++.++||||+||++|+|++|..||....   ...................|..+++++.+||++||..||.+||
T Consensus       191 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  270 (342)
T 2qr7_A          191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL  270 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             HhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc
Confidence            9988778899999999999999999999998632   2222222222223334445678999999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      |+.++++||||..+
T Consensus       271 t~~~il~hp~~~~~  284 (342)
T 2qr7_A          271 TAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHTTSHHHHTG
T ss_pred             CHHHHhcCCeecCc
Confidence            99999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-32  Score=268.46  Aligned_cols=167  Identities=31%  Similarity=0.444  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-----cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-----LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-----~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP   75 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++......  .......+||+.|+||
T Consensus       129 ~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          129 VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPP  206 (329)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCH
Confidence            57889999999999999999999999999999999995     4455999999999765322  2233456789999999


Q ss_pred             hhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCC------------------------
Q psy11119         76 EVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPW------------------------  130 (407)
Q Consensus        76 E~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------  130 (407)
                      |++.+. .++.++||||+||++|+|++|..||.......................|                        
T Consensus       207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
T 3gbz_A          207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV  286 (329)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence            999875 5899999999999999999999999887765544433322111111111                        


Q ss_pred             --CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        131 --DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       131 --~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                        ..+++++.+||.+||..||.+|||+.|+++||||+...+
T Consensus       287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence              116789999999999999999999999999999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-33  Score=269.66  Aligned_cols=167  Identities=28%  Similarity=0.463  Sum_probs=137.7

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC--cEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g--~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~   77 (407)
                      ++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..+.....  ........||+.|+|||+
T Consensus       166 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  245 (345)
T 3hko_A          166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV  245 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence            4677889999999999999999999999999999998776  899999999987643222  123456689999999999


Q ss_pred             hhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         78 LVR--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        78 l~~--~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      +.+  ..++.++|||||||++|+|++|..||.....................+.+..+++++.+||.+||+.||.+||++
T Consensus       246 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            975  578899999999999999999999999887665554444444444445556689999999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .++++||||++..
T Consensus       326 ~~~l~hp~~~~~~  338 (345)
T 3hko_A          326 MRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHSHHHHTTS
T ss_pred             HHHhcChhhccCh
Confidence            9999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-32  Score=275.61  Aligned_cols=166  Identities=23%  Similarity=0.427  Sum_probs=140.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.....   ......+||+.|+|||++
T Consensus       146 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIV  222 (387)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC---cceeeeccCCCccCchhc
Confidence            578899999999999999999999999999999999974  467999999999876432   223445799999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||...+...................+..+++++.+||.+||..||.+|||+.++
T Consensus       223 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el  302 (387)
T 1kob_A          223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA  302 (387)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            98888999999999999999999999999877654433333333334445567789999999999999999999999999


Q ss_pred             HhCcccccCCC
Q psy11119        159 KSHRWYSKHMP  169 (407)
Q Consensus       159 l~hpwf~~~~~  169 (407)
                      ++||||+....
T Consensus       303 l~hp~~~~~~~  313 (387)
T 1kob_A          303 LEHPWLKGDHS  313 (387)
T ss_dssp             HTSTTTSSCCT
T ss_pred             hhCccccCCcc
Confidence            99999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.98  E-value=2.9e-32  Score=265.24  Aligned_cols=164  Identities=25%  Similarity=0.454  Sum_probs=138.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus       138 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  215 (321)
T 2c30_A          138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISR  215 (321)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcC
Confidence            5788999999999999999999999999999999999999999999999998754322  22345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||.......... ...............+++.+.+||.+||..||.+|||+.++++
T Consensus       216 ~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            888999999999999999999999998776543322 2222222223334568999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||.+.
T Consensus       295 hp~~~~~  301 (321)
T 2c30_A          295 HPFLLQT  301 (321)
T ss_dssp             SGGGGGC
T ss_pred             ChhhccC
Confidence            9999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.98  E-value=1.5e-32  Score=275.05  Aligned_cols=166  Identities=27%  Similarity=0.400  Sum_probs=135.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......   .....+||+.|+|||++.
T Consensus       138 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~  214 (394)
T 4e7w_A          138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIF  214 (394)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHc
Confidence            57888999999999999999999999999999999999 79999999999998764332   234567899999999997


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc---------------CC-----CC-----CCCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH---------------MQ-----RS-----PWDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------~~-----~~-----~~~~~  133 (407)
                      +. .++.++||||+||++|+|++|+.||.+.+..............               ..     ..     ....+
T Consensus       215 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (394)
T 4e7w_A          215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT  294 (394)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTC
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccC
Confidence            65 6899999999999999999999999987755433332221000               00     00     11247


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ++++.+||.+||..||.+|||+.++++||||+...+
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          295 PPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            899999999999999999999999999999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=273.93  Aligned_cols=164  Identities=27%  Similarity=0.464  Sum_probs=139.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE--ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL--DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl--d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.+....   .....+||+.|+|||++
T Consensus       184 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~  260 (373)
T 2x4f_A          184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVV  260 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhc
Confidence            5788899999999999999999999999999999999  456789999999998764332   23455799999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++|||||||++|+|++|..||...+...................+..+++++.+||.+||..||.+|||+.++
T Consensus       261 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~  340 (373)
T 2x4f_A          261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA  340 (373)
T ss_dssp             TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            88889999999999999999999999999877654444433333334444456789999999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      ++||||...
T Consensus       341 l~hp~~~~~  349 (373)
T 2x4f_A          341 LKHPWLSDH  349 (373)
T ss_dssp             HHSHHHHCH
T ss_pred             hcCcCcCCC
Confidence            999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.98  E-value=1.6e-32  Score=274.45  Aligned_cols=166  Identities=25%  Similarity=0.468  Sum_probs=129.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+............+||+.|+|||++.+
T Consensus       152 ~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence            46788999999999999999999999999999999996 68999999999987654333333456789999999999975


Q ss_pred             -----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         81 -----------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        81 -----------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                                 ..++.++|||||||++|+|++|..||............... ...........+.++.+||.+||..||
T Consensus       231 ~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP  309 (390)
T 2zmd_A          231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDP  309 (390)
T ss_dssp             C------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred             ccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-ccccCCCCccchHHHHHHHHHHcccCh
Confidence                       36888999999999999999999999875443222222222 112222223457899999999999999


Q ss_pred             CCCCCHHHHHhCcccccCC
Q psy11119        150 STRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       150 ~~Rps~~eil~hpwf~~~~  168 (407)
                      .+|||+.++++||||....
T Consensus       310 ~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          310 KQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             TTSCCHHHHHTSHHHHSCC
T ss_pred             hhCCCHHHHhhCcCccccC
Confidence            9999999999999998643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.98  E-value=3.7e-33  Score=291.58  Aligned_cols=166  Identities=29%  Similarity=0.447  Sum_probs=137.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++......   .....+||+.|+|||++.+
T Consensus       283 l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~  359 (576)
T 2acx_A          283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN  359 (576)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcC
Confidence            5789999999999999999999999999999999999999999999999998764322   2345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC----
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTAD---CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL----  153 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp----  153 (407)
                      ..++.++||||+||++|+|++|..||......   .........   .....+..+++++.+||.+||..||.+||    
T Consensus       360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~  436 (576)
T 2acx_A          360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VPEEYSERFSPQARSLCSQLLCKDPAERLGCRG  436 (576)
T ss_dssp             CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSS
T ss_pred             CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---ccccCCccCCHHHHHHHHHhccCCHHHcCCCCC
Confidence            88899999999999999999999999875421   111111111   12222356899999999999999999999    


Q ss_pred             -CHHHHHhCcccccCCCCCC
Q psy11119        154 -NIEKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       154 -s~~eil~hpwf~~~~~~~~  172 (407)
                       +++||++||||+...|...
T Consensus       437 ~sa~eil~HpfF~~i~w~~l  456 (576)
T 2acx_A          437 GSAREVKEHPLFKKLNFKRL  456 (576)
T ss_dssp             SHHHHHHTSGGGTTCCHHHH
T ss_pred             CCHHHHHhChhhccCCHHHH
Confidence             7999999999998765443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.5e-32  Score=269.07  Aligned_cols=164  Identities=26%  Similarity=0.374  Sum_probs=135.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       125 l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhC
Confidence            57889999999999999999999999999999999999999999999999986432     2345689999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------CCC----CCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------MQR----SPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------~~~----~~~~~  132 (407)
                       ..++.++||||+||++|+|++|+.||.+.+..............                       ...    ..+..
T Consensus       200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (367)
T 1cm8_A          200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN  279 (367)
T ss_dssp             TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred             CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC
Confidence             57899999999999999999999999877654332222111000                       001    12345


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .++.+.+||.+||..||.+|||+.++++||||.....
T Consensus       280 ~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          280 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             CCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            7899999999999999999999999999999987543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=9.3e-33  Score=279.70  Aligned_cols=164  Identities=25%  Similarity=0.331  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc--EEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~--lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...     ......+||+.|+|||++
T Consensus       197 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-----QRVYTYIQSRFYRAPEVI  271 (429)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-----CcccccCCCCCccChHHH
Confidence            578899999999999999999999999999999999999987  9999999997532     123456899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC--------------------------------
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ--------------------------------  126 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------------  126 (407)
                      .+..++.++|||||||++|+|++|..||...+................                                
T Consensus       272 ~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
T 3kvw_A          272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS  351 (429)
T ss_dssp             HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--
T ss_pred             hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccc
Confidence            998899999999999999999999999988765543222211100000                                


Q ss_pred             ------------------CCC-----CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        127 ------------------RSP-----WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       127 ------------------~~~-----~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                                        ...     ....++++.+||++||..||.+|||+.|+++||||++..+
T Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred             ccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence                              000     0123788999999999999999999999999999998653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=6.7e-33  Score=288.34  Aligned_cols=166  Identities=26%  Similarity=0.363  Sum_probs=136.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+....  ......+||+.|+|||++.+
T Consensus       286 l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~  363 (543)
T 3c4z_A          286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLG  363 (543)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTT
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcC
Confidence            5788999999999999999999999999999999999999999999999998754332  22345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC---
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTAD---CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN---  154 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps---  154 (407)
                      ..++.++|||||||++|+|++|..||......   ......... ..  ...+..+++++.+||.+||..||.+||+   
T Consensus       364 ~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  440 (543)
T 3c4z_A          364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRD  440 (543)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred             CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence            88899999999999999999999999865321   111111111 11  2223568999999999999999999996   


Q ss_pred             --HHHHHhCcccccCCCCC
Q psy11119        155 --IEKIKSHRWYSKHMPND  171 (407)
Q Consensus       155 --~~eil~hpwf~~~~~~~  171 (407)
                        +++|++||||+...|..
T Consensus       441 ~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          441 GSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             TBSHHHHTSGGGTTCCHHH
T ss_pred             cCHHHHHcCccccCCCHHH
Confidence              58999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.98  E-value=2.3e-32  Score=270.13  Aligned_cols=169  Identities=28%  Similarity=0.402  Sum_probs=136.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+.|+|||++.
T Consensus       125 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc
Confidence            57889999999999999999999999999999999999999999999999987643322 22245568999999999976


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------CCCC----CCC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------MQRS----PWD  131 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------~~~~----~~~  131 (407)
                      +. .++.++||||+||++|+|++|..||.+................                       ....    .+.
T Consensus       205 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
T 3qyz_A          205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  284 (364)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCC
Confidence            54 6899999999999999999999999877654433222111000                       0000    124


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .+++++.+||.+||..||.+|||+.|+++||||++...
T Consensus       285 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            57899999999999999999999999999999998643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=1.8e-32  Score=271.36  Aligned_cols=169  Identities=40%  Similarity=0.659  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc--EEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~--lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....   ......+||+.|+|||++
T Consensus       113 ~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhh
Confidence            578999999999999999999999999999999999987765  999999998743222   223456799999999999


Q ss_pred             hcCCCCC-cchhhhHHHHHHHHHhCCCCCCCCChhHH--HHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         79 VRSYLAE-PADIWSCGIILVAMLAGELPWDKPTADCI--EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        79 ~~~~~~~-~sDiwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .+..+.. ++||||+||++|+|++|..||........  .............+....+++++.+||.+||..||.+|||+
T Consensus       190 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  269 (361)
T 3uc3_A          190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISI  269 (361)
T ss_dssp             HCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             cCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCH
Confidence            8875544 48999999999999999999986543211  11111112233344455689999999999999999999999


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      .++++||||.+..+...
T Consensus       270 ~ell~hp~f~~~~~~~~  286 (361)
T 3uc3_A          270 PEIKTHSWFLKNLPADL  286 (361)
T ss_dssp             HHHHTSHHHHTTCCCC-
T ss_pred             HHHHhCcchhcCCchhh
Confidence            99999999988765443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.98  E-value=2.8e-32  Score=268.57  Aligned_cols=166  Identities=31%  Similarity=0.563  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....   ......+||+.|+|||+
T Consensus       145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~  221 (349)
T 2w4o_A          145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEI  221 (349)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHH
Confidence            578899999999999999999999999999999999975   889999999999865322   22345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++|||||||++|+|++|..||................ .....+.+..++.++.+||++||..||++|||+.
T Consensus       222 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (349)
T 2w4o_A          222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTF  301 (349)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHH
Confidence            998888999999999999999999999998766554333333332 2333445678899999999999999999999999


Q ss_pred             HHHhCcccccCCC
Q psy11119        157 KIKSHRWYSKHMP  169 (407)
Q Consensus       157 eil~hpwf~~~~~  169 (407)
                      ++++||||.....
T Consensus       302 e~l~hp~~~~~~~  314 (349)
T 2w4o_A          302 QALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHSTTTTSTTC
T ss_pred             HHhcCcccCCCcc
Confidence            9999999987643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.98  E-value=2.5e-32  Score=270.56  Aligned_cols=163  Identities=33%  Similarity=0.612  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+....   .....+||+.|+|||++.+
T Consensus       197 l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccc
Confidence            5788999999999999999999999999999999999999999999999998764332   2345689999999999874


Q ss_pred             C------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         81 S------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ~------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                      .      .++.++|||||||++|+|++|..||.....................+.|..++..+.+||.+||..||.+|||
T Consensus       274 ~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  353 (365)
T 2y7j_A          274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT  353 (365)
T ss_dssp             TTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             cccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC
Confidence            3      5788999999999999999999999876654333332222223333345678999999999999999999999


Q ss_pred             HHHHHhCccccc
Q psy11119        155 IEKIKSHRWYSK  166 (407)
Q Consensus       155 ~~eil~hpwf~~  166 (407)
                      +.++++||||++
T Consensus       354 ~~ell~hp~f~r  365 (365)
T 2y7j_A          354 AEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHSGGGCC
T ss_pred             HHHHhcCcccCC
Confidence            999999999974

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.98  E-value=2e-32  Score=259.33  Aligned_cols=164  Identities=32%  Similarity=0.585  Sum_probs=137.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......   .......||+.|+|||+
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQV  179 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---cchhccCCCCCccChHH
Confidence            5788999999999999999999999999999999999   78899999999999876432   23345679999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+. ++.++||||+|+++|+|++|..||...................+...+..+++.+.+||.+||+.||.+|||+.+
T Consensus       180 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~  258 (277)
T 3f3z_A          180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ  258 (277)
T ss_dssp             HTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHH
Confidence            8765 789999999999999999999999987765444333333222332234468999999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||++..
T Consensus       259 ~l~h~~~~~~~  269 (277)
T 3f3z_A          259 ALEHEWFEKQL  269 (277)
T ss_dssp             HTTSHHHHHHH
T ss_pred             HhcCHHHhccc
Confidence            99999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.98  E-value=1.2e-32  Score=265.80  Aligned_cols=169  Identities=31%  Similarity=0.595  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCC-----ccCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGK-----ERPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y   72 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++......+.     .......+||+.|
T Consensus       108 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  187 (316)
T 2ac3_A          108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY  187 (316)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCc
Confidence            578899999999999999999999999999999999998776   99999999876543221     1123345799999


Q ss_pred             Cchhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--------------HHHHHHHhh-cccCCCCCCCc
Q psy11119         73 VAPEVLVR-----SYLAEPADIWSCGIILVAMLAGELPWDKPTAD--------------CIEYLEWKD-NRHMQRSPWDR  132 (407)
Q Consensus        73 ~APE~l~~-----~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~--------------~~~~~~~~~-~~~~~~~~~~~  132 (407)
                      +|||++.+     ..++.++||||+||++|+|++|..||......              ......... ....+...+..
T Consensus       188 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  267 (316)
T 2ac3_A          188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAH  267 (316)
T ss_dssp             CCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTT
T ss_pred             cChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhccc
Confidence            99999975     45788999999999999999999999765321              111111111 11112222356


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      +++++.+||.+||..||.+|||+.++++||||+...+
T Consensus       268 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            8899999999999999999999999999999987543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.98  E-value=8.3e-33  Score=269.65  Aligned_cols=166  Identities=33%  Similarity=0.594  Sum_probs=115.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....  .......+||+.|+|||+
T Consensus       103 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~  180 (325)
T 3kn6_A          103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPEL  180 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcccccCCCcCccCHHH
Confidence            57899999999999999999999999999999999998766   7999999999865432  223456689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-------HHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD-------CIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      +.+..++.++||||+||++|+|++|..||......       .................|..+++++.+||.+||..||.
T Consensus       181 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  260 (325)
T 3kn6_A          181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN  260 (325)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTT
T ss_pred             hcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChh
Confidence            99888999999999999999999999999764321       11111111112222233456899999999999999999


Q ss_pred             CCCCHHHHHhCcccccCC
Q psy11119        151 TRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       151 ~Rps~~eil~hpwf~~~~  168 (407)
                      +|||+.++++||||+...
T Consensus       261 ~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          261 KRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             TCCCTTTSTTCGGGCTTC
T ss_pred             HCCCHHHHhcChhhccCc
Confidence            999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=1.7e-32  Score=269.90  Aligned_cols=160  Identities=23%  Similarity=0.288  Sum_probs=128.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-------------------------CCcEEEEecCCceeec
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------------------------QDTLKISDFGLATVFR   55 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-------------------------~g~lkL~DFGla~~~~   55 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.                         ++.+||+|||+++...
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  213 (360)
T 3llt_A          134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS  213 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence            468899999999999999999999999999999999975                         7899999999998633


Q ss_pred             cCCCccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC---------
Q psy11119         56 MNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ---------  126 (407)
Q Consensus        56 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------  126 (407)
                      .     .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...................+         
T Consensus       214 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  288 (360)
T 3llt_A          214 D-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK  288 (360)
T ss_dssp             S-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT
T ss_pred             C-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh
Confidence            2     22456799999999999998899999999999999999999999987665433222111100000         


Q ss_pred             ---------------CCC------------------CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccc
Q psy11119        127 ---------------RSP------------------WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS  165 (407)
Q Consensus       127 ---------------~~~------------------~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~  165 (407)
                                     .+.                  ....++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus       289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                           000                  001236788999999999999999999999999995

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.98  E-value=1.2e-32  Score=266.60  Aligned_cols=161  Identities=25%  Similarity=0.258  Sum_probs=117.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~--------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~   70 (407)
                      ++++++.+++.|++.||+|||++        ||+||||||+|||++.++++||+|||+|+........  ......+||+
T Consensus        97 l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~  176 (303)
T 3hmm_A           97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccc
Confidence            46788999999999999999987        9999999999999999999999999999877544332  2234568999


Q ss_pred             CCCchhhhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCCh-------------hHHHHHH-Hhhc-ccCCCCC
Q psy11119         71 PYVAPEVLVRS------YLAEPADIWSCGIILVAMLAGELPWDKPTA-------------DCIEYLE-WKDN-RHMQRSP  129 (407)
Q Consensus        71 ~Y~APE~l~~~------~~~~~sDiwSlGviL~elltG~~Pf~~~~~-------------~~~~~~~-~~~~-~~~~~~~  129 (407)
                      .|+|||++.+.      .++.++|||||||+||||+||..||.....             ....... .... .....+.
T Consensus       177 ~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~  256 (303)
T 3hmm_A          177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  256 (303)
T ss_dssp             GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             cccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCc
Confidence            99999999764      356789999999999999999776532110             0011111 1111 1111111


Q ss_pred             -C--CcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        130 -W--DRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       130 -~--~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                       +  ...+..+.+||.+||+.||++|||+.||++.
T Consensus       257 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             1  1123468899999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.98  E-value=1.9e-32  Score=260.79  Aligned_cols=163  Identities=24%  Similarity=0.422  Sum_probs=125.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL-   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l-   78 (407)
                      +++.+++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......   .......||+.|+|||++ 
T Consensus       106 ~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~  182 (290)
T 3fme_A          106 IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERIN  182 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHS
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcC
Confidence            57889999999999999999998 9999999999999999999999999999765432   222345799999999997 


Q ss_pred             ---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         79 ---VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        79 ---~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                         .+..++.++||||+||++|+|++|..||............... ......+...+++++.+||.+||+.||.+|||+
T Consensus       183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  261 (290)
T 3fme_A          183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTY  261 (290)
T ss_dssp             CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-cCCCCcccccCCHHHHHHHHHHhhcChhhCcCH
Confidence               4457889999999999999999999999865443333333333 222333345689999999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      .++++||||+..
T Consensus       262 ~e~l~hp~f~~~  273 (290)
T 3fme_A          262 PELMQHPFFTLH  273 (290)
T ss_dssp             HHHTTSHHHHHH
T ss_pred             HHHHhCcccccC
Confidence            999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=1.4e-32  Score=271.21  Aligned_cols=168  Identities=26%  Similarity=0.436  Sum_probs=133.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ......+||+.|+|||++.+
T Consensus       156 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  234 (355)
T 1vzo_A          156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRG  234 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcC
Confidence            57889999999999999999999999999999999999999999999999987543222 22345689999999999986


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----  153 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----  153 (407)
                      .  .++.++|||||||++|+|++|..||..........................++..+.+||.+||..||.+||     
T Consensus       235 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~  314 (355)
T 1vzo_A          235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR  314 (355)
T ss_dssp             CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence            3  578899999999999999999999975432111111111111112223356889999999999999999999     


Q ss_pred             CHHHHHhCcccccCCC
Q psy11119        154 NIEKIKSHRWYSKHMP  169 (407)
Q Consensus       154 s~~eil~hpwf~~~~~  169 (407)
                      ++.++++||||....+
T Consensus       315 s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          315 DADEIKEHLFFQKINW  330 (355)
T ss_dssp             THHHHHTSGGGTTCCH
T ss_pred             CHHHHHcCcchhcCCh
Confidence            9999999999997654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=9.3e-32  Score=272.41  Aligned_cols=171  Identities=23%  Similarity=0.411  Sum_probs=127.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--------------------   60 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--------------------   60 (407)
                      |++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........                    
T Consensus       126 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (432)
T 3n9x_A          126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK  205 (432)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence            578999999999999999999999999999999999999999999999999876433211                    


Q ss_pred             cCCcCccCCCCCCchhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCC-----------CCCCh-----------------
Q psy11119         61 RPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPW-----------DKPTA-----------------  111 (407)
Q Consensus        61 ~~~~~~~gt~~Y~APE~l~-~~~~~~~sDiwSlGviL~elltG~~Pf-----------~~~~~-----------------  111 (407)
                      ......+||+.|+|||++. ...++.++||||+||++|+|++|..||           .+...                 
T Consensus       206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~  285 (432)
T 3n9x_A          206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN  285 (432)
T ss_dssp             -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHH
T ss_pred             ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccch
Confidence            2246678999999999974 457899999999999999999854444           33210                 


Q ss_pred             hHHH----------------------HHHHhhcccCCCC-----CCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCccc
Q psy11119        112 DCIE----------------------YLEWKDNRHMQRS-----PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       112 ~~~~----------------------~~~~~~~~~~~~~-----~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      ....                      ...+........+     .+..+++++.+||++||..||.+|||++|+++||||
T Consensus       286 ~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  365 (432)
T 3n9x_A          286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL  365 (432)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence            0000                      0000000000000     124589999999999999999999999999999999


Q ss_pred             ccCCCCC
Q psy11119        165 SKHMPND  171 (407)
Q Consensus       165 ~~~~~~~  171 (407)
                      +...+..
T Consensus       366 ~~~~~~~  372 (432)
T 3n9x_A          366 KDVRKKK  372 (432)
T ss_dssp             TTTCCTT
T ss_pred             hhccCcc
Confidence            9876544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=4.2e-32  Score=274.05  Aligned_cols=165  Identities=27%  Similarity=0.402  Sum_probs=133.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+....   .....+||+.|+|||++.
T Consensus       153 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIF  229 (420)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHc
Confidence            5778899999999999999999999999999999999965 568999999998754322   234568999999999997


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc---------------cCCCC-----C-----CCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR---------------HMQRS-----P-----WDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~---------------~~~~~-----~-----~~~~  133 (407)
                      +. .++.++||||+||++|+|++|+.||.+.+.............               ....+     +     ...+
T Consensus       230 ~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  309 (420)
T 1j1b_A          230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT  309 (420)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTS
T ss_pred             CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCC
Confidence            65 789999999999999999999999988765443332222100               00000     1     1346


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++++.+||.+||..||.+|||+.|+++||||....
T Consensus       310 ~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          310 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            89999999999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.98  E-value=2.6e-32  Score=264.15  Aligned_cols=157  Identities=21%  Similarity=0.324  Sum_probs=126.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   ......+||+.|+|||++.+
T Consensus       154 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  230 (311)
T 3p1a_A          154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG  230 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---CCCcccCCCccccCHhHhcC
Confidence            578899999999999999999999999999999999999999999999998765432   23345679999999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                       .++.++||||+||++|+|++|..|+.....    ...... .......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       231 -~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          231 -SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQ-GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTT-TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhc-cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             678999999999999999999766543221    111111 11121223567899999999999999999999999999


Q ss_pred             Cccccc
Q psy11119        161 HRWYSK  166 (407)
Q Consensus       161 hpwf~~  166 (407)
                      ||||++
T Consensus       305 hp~~~~  310 (311)
T 3p1a_A          305 LPVLRQ  310 (311)
T ss_dssp             SGGGSC
T ss_pred             CccccC
Confidence            999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=3.9e-32  Score=269.69  Aligned_cols=164  Identities=25%  Similarity=0.374  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       129 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcC
Confidence            57889999999999999999999999999999999999999999999999976432     2345689999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------CCCC----CCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------MQRS----PWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------~~~~----~~~~  132 (407)
                       ..++.++||||+||++|+|++|+.||.+.+..............                       ....    .+..
T Consensus       204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (367)
T 2fst_X          204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  283 (367)
T ss_dssp             CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTT
T ss_pred             CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCC
Confidence             58899999999999999999999999887654332222111000                       0000    1235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .++.+.+||.+||..||.+|||+.++++||||.....
T Consensus       284 ~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            6889999999999999999999999999999997643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=3.4e-32  Score=271.15  Aligned_cols=168  Identities=17%  Similarity=0.330  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-----ccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-----ERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~AP   75 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+......+.     .......+||+.|+||
T Consensus       125 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence            57889999999999999999999999999999999999999999999999876533221     1122345799999999


Q ss_pred             hhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc------------------------------
Q psy11119         76 EVLVR--SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR------------------------------  123 (407)
Q Consensus        76 E~l~~--~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~------------------------------  123 (407)
                      |++.+  ..++.++||||+||++|+|++|+.||.+...............                              
T Consensus       205 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (389)
T 3gni_B          205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS  284 (389)
T ss_dssp             HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------
T ss_pred             HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccc
Confidence            99987  5788999999999999999999999976544332221111000                              


Q ss_pred             ------------cCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        124 ------------HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       124 ------------~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                  ....+.+..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             ---------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                        001122355788999999999999999999999999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=3.2e-32  Score=279.67  Aligned_cols=164  Identities=34%  Similarity=0.600  Sum_probs=138.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe---cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld---~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+...   ......+||+.|+|||+
T Consensus       118 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHH
Confidence            57889999999999999999999999999999999995   4567999999999765432   23345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||.+.+.................+.|..+++++++||.+||..||.+|||+.+
T Consensus       195 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~  273 (486)
T 3mwu_A          195 LRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (486)
T ss_dssp             GGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            876 4789999999999999999999999987766544444444344555667889999999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||++..
T Consensus       274 ~l~hp~~~~~~  284 (486)
T 3mwu_A          274 CLEHPWIQKYS  284 (486)
T ss_dssp             HHHCHHHHHTC
T ss_pred             HhcCHhhccCc
Confidence            99999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=1.3e-32  Score=273.01  Aligned_cols=165  Identities=27%  Similarity=0.359  Sum_probs=124.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||++.+
T Consensus       124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  200 (371)
T 2xrw_A          124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG  200 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTT
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc---cccCCceecCCccCHHHhcC
Confidence            478889999999999999999999999999999999999999999999999765322   22345689999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-----------------CCCCC-------------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-----------------QRSPW-------------  130 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~-------------  130 (407)
                      ..++.++||||+||++|+|++|..||.+.+...............                 ..+.+             
T Consensus       201 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (371)
T 2xrw_A          201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL  280 (371)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG
T ss_pred             CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc
Confidence            888999999999999999999999998876543322221110000                 00000             


Q ss_pred             --------CcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 --------DRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 --------~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                              ...++++++||.+||..||.+|||++|+++||||....
T Consensus       281 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          281 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                    01256789999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=1.3e-32  Score=282.13  Aligned_cols=165  Identities=34%  Similarity=0.610  Sum_probs=141.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+....   .....+||+.|+|||+
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV  199 (484)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCcee
Confidence            5788999999999999999999999999999999999   467899999999998654322   2345679999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||...+.................+.|..+++++++||++||..+|.+|||+.+
T Consensus       200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  278 (484)
T 3nyv_A          200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARD  278 (484)
T ss_dssp             HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            876 5789999999999999999999999988766544444444344555667889999999999999999999999999


Q ss_pred             HHhCcccccCCC
Q psy11119        158 IKSHRWYSKHMP  169 (407)
Q Consensus       158 il~hpwf~~~~~  169 (407)
                      +++||||+....
T Consensus       279 ~l~h~~~~~~~~  290 (484)
T 3nyv_A          279 ALDHEWIQTYTK  290 (484)
T ss_dssp             HHTSHHHHHHTC
T ss_pred             HhhChhhccccc
Confidence            999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.3e-31  Score=259.47  Aligned_cols=165  Identities=27%  Similarity=0.396  Sum_probs=136.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   .......||+.|+|||++.+
T Consensus       117 ~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  193 (326)
T 1blx_A          117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQ  193 (326)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhc
Confidence            578899999999999999999999999999999999999999999999999765322   23345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-----------------------CCCCCCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-----------------------QRSPWDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~s~~~  137 (407)
                      ..++.++||||+||++|+|++|..||...................                       ....+..+++.+
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 1blx_A          194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  273 (326)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHH
Confidence            888999999999999999999999999876554333222110000                       001124578999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      .+||.+||..||.+|||+.++++||||+...
T Consensus       274 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          274 KDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            9999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=4e-32  Score=263.59  Aligned_cols=164  Identities=31%  Similarity=0.477  Sum_probs=136.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++......   ......+||+.|+|||
T Consensus       112 ~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE  188 (321)
T 2a2a_A          112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPE  188 (321)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT---CCCCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc---ccccccCCCCCccCcc
Confidence            36788999999999999999999999999999999999888    7999999999875432   2234567999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|..||.......................+..+++.+.+||.+||..||.+|||+.
T Consensus       189 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  268 (321)
T 2a2a_A          189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ  268 (321)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred             cccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence            99988889999999999999999999999988765543333222211222122356789999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      ++++||||...
T Consensus       269 e~l~hp~~~~~  279 (321)
T 2a2a_A          269 EALRHPWITPV  279 (321)
T ss_dssp             HHHHSTTTSCS
T ss_pred             HHhcCccccCC
Confidence            99999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=5.9e-32  Score=278.34  Aligned_cols=163  Identities=34%  Similarity=0.606  Sum_probs=139.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++..+...   ......+||+.|+|||+
T Consensus       133 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~  209 (494)
T 3lij_A          133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEV  209 (494)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC---ccccccCCCcCeeCHHH
Confidence            5788999999999999999999999999999999999764   45999999999876532   23455689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||...+.................+.|..+++++.+||++||..+|.+|||+.+
T Consensus       210 l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  288 (494)
T 3lij_A          210 LRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQ  288 (494)
T ss_dssp             HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             Hcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence            864 5789999999999999999999999988776554444444445555667889999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||++.
T Consensus       289 ~l~hp~~~~~  298 (494)
T 3lij_A          289 ALEHPWIKEM  298 (494)
T ss_dssp             HHTCHHHHHH
T ss_pred             HhcCcccccC
Confidence            9999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=1e-31  Score=256.42  Aligned_cols=161  Identities=27%  Similarity=0.557  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++..+...   ......+||+.|+|||+
T Consensus       121 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEV  197 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCcccccCcCChHH
Confidence            5788999999999999999999999999999999999   45678999999999765432   22345679999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||................. ........+++++.+||.+||+.||.+|||+.|
T Consensus       198 ~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  275 (285)
T 3is5_A          198 FKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQ  275 (285)
T ss_dssp             HTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             hcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-ccccccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence            864 568899999999999999999999998776544333322222 222223447899999999999999999999999


Q ss_pred             HHhCccccc
Q psy11119        158 IKSHRWYSK  166 (407)
Q Consensus       158 il~hpwf~~  166 (407)
                      +++||||++
T Consensus       276 ~l~hp~f~~  284 (285)
T 3is5_A          276 VLHHEWFKQ  284 (285)
T ss_dssp             HHTSGGGGC
T ss_pred             HhcCHHhhc
Confidence            999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1e-31  Score=260.76  Aligned_cols=166  Identities=21%  Similarity=0.450  Sum_probs=131.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   .....+|++.|+|||++.
T Consensus       127 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhc
Confidence            57889999999999999999999999999999999999777 89999999998754332   334568999999999998


Q ss_pred             c-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh------------hccc----------------------
Q psy11119         80 R-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK------------DNRH----------------------  124 (407)
Q Consensus        80 ~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~------------~~~~----------------------  124 (407)
                      + ..++.++||||+||++|+|++|..||..............            ....                      
T Consensus       204 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (330)
T 3nsz_A          204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  283 (330)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGG
T ss_pred             CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhh
Confidence            7 5789999999999999999999999954432211111100            0000                      


Q ss_pred             CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       125 ~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      ........+++++.+||.+||+.||.+|||++|+++||||+....
T Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          284 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            011112337899999999999999999999999999999997643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=5.2e-33  Score=275.51  Aligned_cols=156  Identities=17%  Similarity=0.162  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc--CCCC
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR--SYLA   84 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~   84 (407)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....     ......+|+.|+|||++.+  ..++
T Consensus       197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  271 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFT  271 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECC
T ss_pred             HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcC
Confidence            45559999999999999999999999999999999999999999986421     1114457799999999987  6789


Q ss_pred             CcchhhhHHHHHHHHHhCCCCCCCCChhHHHHH-----HHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         85 EPADIWSCGIILVAMLAGELPWDKPTADCIEYL-----EWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        85 ~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .++||||+||++|+|++|+.||...........     ..........+.+..+++.+.+||.+||+.||++|||+.+++
T Consensus       272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  351 (371)
T 3q60_A          272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM  351 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999999999999999999987643211100     000111233344467899999999999999999999999999


Q ss_pred             hCcccccC
Q psy11119        160 SHRWYSKH  167 (407)
Q Consensus       160 ~hpwf~~~  167 (407)
                      +||||++.
T Consensus       352 ~hp~f~~~  359 (371)
T 3q60_A          352 ETPEFLQL  359 (371)
T ss_dssp             TSHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=2e-31  Score=261.19  Aligned_cols=169  Identities=25%  Similarity=0.406  Sum_probs=133.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--------cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--------RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--------~~~~~~~gt~~Y   72 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........        ......+||+.|
T Consensus       109 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (353)
T 2b9h_A          109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY  188 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence            578899999999999999999999999999999999999999999999999876432211        112345789999


Q ss_pred             Cchhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc------------------------CCC
Q psy11119         73 VAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH------------------------MQR  127 (407)
Q Consensus        73 ~APE~l~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------------~~~  127 (407)
                      +|||++.+ ..++.++||||+||++|+|++|..||.+.+..............                        ...
T Consensus       189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T 2b9h_A          189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA  268 (353)
T ss_dssp             CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred             cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence            99999875 57899999999999999999999999887654332222111000                        000


Q ss_pred             C----CCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        128 S----PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       128 ~----~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .    .+..+++++.+||.+||..||.+|||+.++++||||+...+
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            0    12467899999999999999999999999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.5e-31  Score=255.83  Aligned_cols=166  Identities=30%  Similarity=0.539  Sum_probs=139.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ......+|++.|+|||++. 
T Consensus       121 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  197 (298)
T 1phk_A          121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIEC  197 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC---cccccccCCccccCHHHhcc
Confidence            578899999999999999999999999999999999999999999999999875432   2234567999999999986 


Q ss_pred             -----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         80 -----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        80 -----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                           ...++.++||||+|+++|+|++|..||.....................+.+..++..+.+||.+||+.||.+|||
T Consensus       198 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  277 (298)
T 1phk_A          198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT  277 (298)
T ss_dssp             HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC
Confidence                 336788999999999999999999999877665443333333334444556778999999999999999999999


Q ss_pred             HHHHHhCcccccCCC
Q psy11119        155 IEKIKSHRWYSKHMP  169 (407)
Q Consensus       155 ~~eil~hpwf~~~~~  169 (407)
                      +.++++||||++...
T Consensus       278 ~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          278 AEEALAHPFFQQYVV  292 (298)
T ss_dssp             HHHHTTSGGGCTTC-
T ss_pred             HHHHHhChHhhhccc
Confidence            999999999997654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=8.6e-32  Score=255.47  Aligned_cols=160  Identities=29%  Similarity=0.474  Sum_probs=132.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....    ......+||+.|+|||++.+
T Consensus       106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~  181 (279)
T 3fdn_A          106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEG  181 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----ccccccCCCCCccCHhHhcc
Confidence            47889999999999999999999999999999999999999999999998854322    12345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+|+++|+|++|..||...............    .......+++++.+||.+||+.||.+|||+.++++
T Consensus       182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            88899999999999999999999999987655433222221    12223457899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||+...
T Consensus       258 h~~~~~~~  265 (279)
T 3fdn_A          258 HPWITANS  265 (279)
T ss_dssp             CHHHHHHC
T ss_pred             CccccCCc
Confidence            99998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=6.8e-32  Score=259.94  Aligned_cols=166  Identities=25%  Similarity=0.453  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus        99 ~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  176 (311)
T 4agu_A           99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVG  176 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhc
Confidence            5788999999999999999999999999999999999999999999999998754222  23345689999999999986


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-------------------cCCCC--------CCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-------------------HMQRS--------PWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~~--------~~~~  132 (407)
                       ..++.++||||+||++|+|++|..||.................                   ..+.+        .+..
T Consensus       177 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 4agu_A          177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN  256 (311)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTT
T ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccc
Confidence             4789999999999999999999999988765543332211100                   00000        1245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            788999999999999999999999999999999754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=1.8e-31  Score=255.99  Aligned_cols=166  Identities=29%  Similarity=0.487  Sum_probs=137.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+
T Consensus       106 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence            57889999999999999999999999999999999999999999999999987643333333345679999999999976


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .  .++.++||||+||++|+|++|..||............ .. ..  ......+++.+.+||.+||..||.+|||+.++
T Consensus       186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-~~-~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  261 (305)
T 2wtk_C          186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-GK-GS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI  261 (305)
T ss_dssp             CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HH-CC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-hc-CC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            4  3477999999999999999999999987654332222 11 11  22234678999999999999999999999999


Q ss_pred             HhCcccccCCCC
Q psy11119        159 KSHRWYSKHMPN  170 (407)
Q Consensus       159 l~hpwf~~~~~~  170 (407)
                      ++||||++..+.
T Consensus       262 l~~~~~~~~~~~  273 (305)
T 2wtk_C          262 RQHSWFRKKHPP  273 (305)
T ss_dssp             HHSHHHHSCCCC
T ss_pred             hcCcccccCCCC
Confidence            999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=8.7e-32  Score=267.99  Aligned_cols=164  Identities=24%  Similarity=0.341  Sum_probs=134.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....   ......+||+.|+|||++.
T Consensus       138 l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~  214 (383)
T 3eb0_A          138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELML  214 (383)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhc
Confidence            57889999999999999999999999999999999998 5889999999999876433   2334567899999999988


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC---------------C-----CC-----CCCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM---------------Q-----RS-----PWDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------------~-----~~-----~~~~~  133 (407)
                      +. .++.++||||+||++|+|++|..||.+.+...............               .     ..     ....+
T Consensus       215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (383)
T 3eb0_A          215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT  294 (383)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred             CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence            75 58999999999999999999999999876654433322210000               0     00     12347


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++++.+||.+||..||.+|||+.|+++||||...
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            8899999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=8.4e-32  Score=263.75  Aligned_cols=154  Identities=31%  Similarity=0.523  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   ......+||+.|+|||++.+
T Consensus       127 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~  203 (335)
T 3dls_A          127 LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMG  203 (335)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC---CceeccCCCccccChhhhcC
Confidence            578899999999999999999999999999999999999999999999999875432   23345689999999999987


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. .+.++||||+||++|+|++|..||......          ..........+++++.+||.+||.+||.+|||+.+++
T Consensus       204 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell  273 (335)
T 3dls_A          204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLV  273 (335)
T ss_dssp             CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            74 488999999999999999999999753211          1122233445899999999999999999999999999


Q ss_pred             hCcccccC
Q psy11119        160 SHRWYSKH  167 (407)
Q Consensus       160 ~hpwf~~~  167 (407)
                      +||||++.
T Consensus       274 ~hp~~~~~  281 (335)
T 3dls_A          274 TDPWVTQP  281 (335)
T ss_dssp             HCTTTTCC
T ss_pred             cCccccCC
Confidence            99999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=9.5e-32  Score=262.67  Aligned_cols=163  Identities=25%  Similarity=0.339  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE-------------------ecCCcEEEEecCCceeeccCCCcc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL-------------------DLQDTLKISDFGLATVFRMNGKER   61 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl-------------------d~~g~lkL~DFGla~~~~~~~~~~   61 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||+                   +.++.+||+|||+++....     
T Consensus       120 ~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----  194 (355)
T 2eu9_A          120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----  194 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-----
Confidence            5788999999999999999999999999999999999                   6678999999999976322     


Q ss_pred             CCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC---------------
Q psy11119         62 PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ---------------  126 (407)
Q Consensus        62 ~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------  126 (407)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...................+               
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  274 (355)
T 2eu9_A          195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK  274 (355)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEET
T ss_pred             cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcc
Confidence            22456899999999999988889999999999999999999999987765432222111100000               


Q ss_pred             -------------------------CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        127 -------------------------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       127 -------------------------~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                                               .......+.++.+||.+||..||.+|||+.++++||||....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence                                     001112245788999999999999999999999999999754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.5e-31  Score=265.23  Aligned_cols=163  Identities=28%  Similarity=0.398  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....     .....+||+.|+|||++.+
T Consensus       141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcC
Confidence            57889999999999999999999999999999999999999999999999976432     2345678999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc-----------------------cCCCC----CCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR-----------------------HMQRS----PWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------------~~~~~----~~~~  132 (407)
                       ..++.++||||+||++|+|++|..||.+.+.............                       .....    .+..
T Consensus       216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (371)
T 4exu_A          216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR  295 (371)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTT
T ss_pred             CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccc
Confidence             5889999999999999999999999988765433322211100                       00000    1245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       296 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          296 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             cChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            789999999999999999999999999999998653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=6.3e-32  Score=268.91  Aligned_cols=163  Identities=27%  Similarity=0.333  Sum_probs=128.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEEe--cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH--SKGIAHRDLKPENVLLD--LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH--~~gIvHrDLkp~NILld--~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||+++....     .....+||+.|+|||
T Consensus       154 ~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE  228 (382)
T 2vx3_A          154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPE  228 (382)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChH
Confidence            478899999999999999999  47999999999999995  477899999999986532     234568999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC------------------CCCCC--------
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM------------------QRSPW--------  130 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------------~~~~~--------  130 (407)
                      ++.+..++.++||||+||++|+|++|..||...+...............                  +...|        
T Consensus       229 ~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (382)
T 2vx3_A          229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDG  308 (382)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTT
T ss_pred             HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccccccccc
Confidence            9998889999999999999999999999999876554333222110000                  00000        


Q ss_pred             ---------Cc-------------------------CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        131 ---------DR-------------------------LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       131 ---------~~-------------------------~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                               ..                         .++++.+||.+||..||++|||+.|+++||||++..
T Consensus       309 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          309 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             ccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence                     00                         013789999999999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=1.2e-32  Score=273.74  Aligned_cols=150  Identities=17%  Similarity=0.217  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC-
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS-   81 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-   81 (407)
                      +..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...     ......+| +.|+|||++.+. 
T Consensus       205 ~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~  278 (377)
T 3byv_A          205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRA  278 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccc
Confidence            47788899999999999999999999999999999999999999999998532     12345578 999999999887 


Q ss_pred             ----------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         82 ----------YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        82 ----------~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                                .++.++|||||||++|+|++|..||........        .......+..+++++.+||.+||..||.+
T Consensus       279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG--------SEWIFRSCKNIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC--------SGGGGSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred             cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc--------hhhhhhhccCCCHHHHHHHHHHcCCCchh
Confidence                      889999999999999999999999976443211        11111223568999999999999999999


Q ss_pred             CCCHHHHHhCccccc
Q psy11119        152 RLNIEKIKSHRWYSK  166 (407)
Q Consensus       152 Rps~~eil~hpwf~~  166 (407)
                      |||+.++++||||+.
T Consensus       351 Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          351 RLLPLQAMETPEYEQ  365 (377)
T ss_dssp             CCCHHHHHTSHHHHH
T ss_pred             CCCHHHHhhChHHHH
Confidence            999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=8e-32  Score=278.02  Aligned_cols=165  Identities=33%  Similarity=0.587  Sum_probs=140.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.+...   ......+||+.|+|||+
T Consensus       143 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEV  219 (504)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHH
Confidence            57899999999999999999999999999999999999876   6999999999876432   23455689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||.+.+.................+.|..+++++++||++||.+||.+|||+.+
T Consensus       220 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e  298 (504)
T 3q5i_A          220 LKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE  298 (504)
T ss_dssp             HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            875 5789999999999999999999999988766544444333333344456778999999999999999999999999


Q ss_pred             HHhCcccccCCC
Q psy11119        158 IKSHRWYSKHMP  169 (407)
Q Consensus       158 il~hpwf~~~~~  169 (407)
                      +++||||++...
T Consensus       299 ~l~h~~~~~~~~  310 (504)
T 3q5i_A          299 ALNSRWIKKYAN  310 (504)
T ss_dssp             HHTSHHHHHTCC
T ss_pred             HhcCHhhhhchh
Confidence            999999988643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=1.2e-31  Score=257.85  Aligned_cols=164  Identities=32%  Similarity=0.544  Sum_probs=138.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....    ......+||+.|+|||+
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEV  178 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCCCCccChHH
Confidence            5788999999999999999999999999999999999   7788999999999875321    22344579999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+||++|+|++|..||.....................+.+..+++++.+||.+||..||.+|||+.+
T Consensus       179 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  258 (304)
T 2jam_A          179 LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEK  258 (304)
T ss_dssp             BSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             hccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            98888899999999999999999999999887665433333333233344456778999999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||....
T Consensus       259 ~l~h~~~~~~~  269 (304)
T 2jam_A          259 ALSHPWIDGNT  269 (304)
T ss_dssp             HHTSHHHHSSC
T ss_pred             HhcCccccCCC
Confidence            99999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=2.1e-31  Score=258.23  Aligned_cols=162  Identities=25%  Similarity=0.347  Sum_probs=130.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-------------------CCcEEEEecCCceeeccCCCcc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-------------------QDTLKISDFGLATVFRMNGKER   61 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-------------------~g~lkL~DFGla~~~~~~~~~~   61 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.                   ++.+||+|||++.....     
T Consensus       115 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----  189 (339)
T 1z57_A          115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----  189 (339)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----
Confidence            468899999999999999999999999999999999987                   66899999999976322     


Q ss_pred             CCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC---------------
Q psy11119         62 PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ---------------  126 (407)
Q Consensus        62 ~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------  126 (407)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...+...............+               
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  269 (339)
T 1z57_A          190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH  269 (339)
T ss_dssp             CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEET
T ss_pred             ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhh
Confidence            22456799999999999988889999999999999999999999987665432221111100000               


Q ss_pred             -------------------------CCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        127 -------------------------RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       127 -------------------------~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                                               .......++++.+||.+||..||.+|||+.|+++||||+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             ccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence                                     00112235678999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=5.9e-32  Score=261.25  Aligned_cols=167  Identities=22%  Similarity=0.399  Sum_probs=132.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...... ......+||+.|+|||++.
T Consensus       113 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  192 (311)
T 3ork_A          113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  192 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc
Confidence            578899999999999999999999999999999999999999999999999865433221 2233457999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++||||+||++|+|++|+.||.......................+..+++++.+||.+||+.||.+||+..+++
T Consensus       193 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence            88899999999999999999999999998776655444443322222223456899999999999999999999999999


Q ss_pred             hCcccccC
Q psy11119        160 SHRWYSKH  167 (407)
Q Consensus       160 ~hpwf~~~  167 (407)
                      .|+|++..
T Consensus       273 ~~~l~~~~  280 (311)
T 3ork_A          273 RADLVRVH  280 (311)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=7.5e-32  Score=267.65  Aligned_cols=161  Identities=25%  Similarity=0.399  Sum_probs=127.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCC--------------------------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQD--------------------------------------   41 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g--------------------------------------   41 (407)
                      +++.+++.++.||+.||.|||++ ||+||||||+|||++.++                                      
T Consensus       143 ~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (397)
T 1wak_A          143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV  222 (397)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccc
Confidence            57889999999999999999999 999999999999999775                                      


Q ss_pred             -----------cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCC
Q psy11119         42 -----------TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT  110 (407)
Q Consensus        42 -----------~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~  110 (407)
                                 .+||+|||++.....     .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       223 ~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          223 NPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                       799999999986532     2345689999999999999889999999999999999999999997543


Q ss_pred             hh------HHHHHHHhhcccCC--------------------------------------CCCCCcCCHHHHHHHHHhcc
Q psy11119        111 AD------CIEYLEWKDNRHMQ--------------------------------------RSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus       111 ~~------~~~~~~~~~~~~~~--------------------------------------~~~~~~~s~~~~~LI~~~L~  146 (407)
                      ..      .............+                                      .......++.+.+||.+||.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  377 (397)
T 1wak_A          298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE  377 (397)
T ss_dssp             CSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC
T ss_pred             ccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc
Confidence            21      11111100000000                                      00012234678899999999


Q ss_pred             CCCCCCCCHHHHHhCccccc
Q psy11119        147 PLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       147 ~~P~~Rps~~eil~hpwf~~  166 (407)
                      .||.+|||+.|+++||||+.
T Consensus       378 ~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          378 LIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SSGGGSCCHHHHHTSGGGGC
T ss_pred             cChhhcCCHHHHhhCccccC
Confidence            99999999999999999973

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.5e-31  Score=252.97  Aligned_cols=160  Identities=27%  Similarity=0.491  Sum_probs=135.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......    .....+|++.|+|||++.+
T Consensus       111 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  186 (284)
T 2vgo_A          111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEG  186 (284)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhcc
Confidence            578899999999999999999999999999999999999999999999998764322    2235679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||...............  ..  .....++.++.+||.+||..||.+||++.++++
T Consensus       187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--cc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            88899999999999999999999999887655433322221  11  223457899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||+...
T Consensus       263 h~~~~~~~  270 (284)
T 2vgo_A          263 HPWVKANS  270 (284)
T ss_dssp             CHHHHHHC
T ss_pred             CHHHHhhc
Confidence            99998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=2.3e-31  Score=262.22  Aligned_cols=160  Identities=24%  Similarity=0.371  Sum_probs=134.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....      ....+||+.|+|||++. 
T Consensus       151 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~  224 (348)
T 1u5q_A          151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILA  224 (348)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhcc
Confidence            57889999999999999999999999999999999999999999999999976432      23467999999999985 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                        ...++.++||||+||++|+|++|..||...+...........  ..+......+++.+.+||.+||+.||.+|||+++
T Consensus       225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  302 (348)
T 1u5q_A          225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  302 (348)
T ss_dssp             TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence              457788999999999999999999999877655443333222  2222233567899999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||....
T Consensus       303 ll~h~~~~~~~  313 (348)
T 1u5q_A          303 LLKHRFVLRER  313 (348)
T ss_dssp             HTTCHHHHSCC
T ss_pred             HhhChhhhccC
Confidence            99999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=2.3e-31  Score=253.88  Aligned_cols=161  Identities=24%  Similarity=0.386  Sum_probs=131.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....    ......+||+.|+|||+
T Consensus       126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~  201 (290)
T 1t4h_A          126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc----cccccccCCcCcCCHHH
Confidence            478889999999999999999999  99999999999998 789999999999965322    22344579999999998


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|..||............... ...........++++.+||.+||..||.+|||+.+
T Consensus       202 ~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  279 (290)
T 1t4h_A          202 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             GGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             Hhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            864 5789999999999999999999999876554433333332 22222223456789999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||++.
T Consensus       280 ll~h~~f~~~  289 (290)
T 1t4h_A          280 LLNHAFFQEE  289 (290)
T ss_dssp             HHTSGGGC--
T ss_pred             HhhCcccccC
Confidence            9999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=5.5e-31  Score=258.87  Aligned_cols=163  Identities=27%  Similarity=0.379  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....     .....+||+.|+|||++.+
T Consensus       123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhC
Confidence            57889999999999999999999999999999999999999999999999975432     2334578999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-----------------------cc----CCCCCCCc
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-----------------------RH----MQRSPWDR  132 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-----------------------~~----~~~~~~~~  132 (407)
                       ..++.++||||+||++|+|++|..||.+.+............                       ..    .....+..
T Consensus       198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (353)
T 3coi_A          198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR  277 (353)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC
Confidence             578999999999999999999999998776543322211100                       00    01112346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++++.+||.+||..||.+|||+.++++||||....
T Consensus       278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            789999999999999999999999999999998653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=2.7e-31  Score=256.39  Aligned_cols=166  Identities=25%  Similarity=0.472  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...............+||+.|+|||++.+
T Consensus       124 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence            46789999999999999999999999999999999997 58999999999987644333333345679999999999875


Q ss_pred             -----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         81 -----------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        81 -----------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                                 ..++.++|||||||++|+|++|..||............... ...........+.++.+||.+||..||
T Consensus       203 ~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp  281 (313)
T 3cek_A          203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDP  281 (313)
T ss_dssp             CC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred             cccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh-cccccCCcccchHHHHHHHHHHccCCc
Confidence                       46788999999999999999999999876543333322222 122222234568899999999999999


Q ss_pred             CCCCCHHHHHhCcccccCC
Q psy11119        150 STRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       150 ~~Rps~~eil~hpwf~~~~  168 (407)
                      .+||++.++++||||+...
T Consensus       282 ~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          282 KQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TTSCCHHHHHTSHHHHCC-
T ss_pred             ccCcCHHHHhcCccccCCC
Confidence            9999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=253.82  Aligned_cols=162  Identities=33%  Similarity=0.542  Sum_probs=111.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus       109 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  186 (278)
T 3cok_A          109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATR  186 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcC
Confidence            5788999999999999999999999999999999999999999999999998754222  12234679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+|+++|+|++|..||............    ..........++.++.+||.+||..||.+|||+.++++
T Consensus       187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -----CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            88899999999999999999999999876543221111    11112233557899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||.+..
T Consensus       263 h~~~~~~~  270 (278)
T 3cok_A          263 HPFMSRNS  270 (278)
T ss_dssp             STTTC---
T ss_pred             CccccCCC
Confidence            99998743

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=4.9e-31  Score=259.11  Aligned_cols=166  Identities=25%  Similarity=0.334  Sum_probs=133.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH--SKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH--~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||++......   ......+||+.|+|||+
T Consensus       126 ~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~  202 (360)
T 3e3p_A          126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS---EPNVAYICSRYYRAPEL  202 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC---CCcccccCCcceeCHHH
Confidence            467889999999999999999  999999999999999997 899999999999865432   22345678999999999


Q ss_pred             hhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC--------------------C--------CC
Q psy11119         78 LVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM--------------------Q--------RS  128 (407)
Q Consensus        78 l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------------~--------~~  128 (407)
                      +.+. .++.++||||+||++|+|++|..||...+...............                    .        ..
T Consensus       203 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (360)
T 3e3p_A          203 IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD  282 (360)
T ss_dssp             HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT
T ss_pred             HcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccch
Confidence            9765 58999999999999999999999999876554333222110000                    0        00


Q ss_pred             CCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        129 PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       129 ~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .....++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       283 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          283 HSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             hhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            11225678999999999999999999999999999998643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=1.3e-31  Score=254.30  Aligned_cols=164  Identities=32%  Similarity=0.503  Sum_probs=133.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.......   ......|++.|+|||
T Consensus       105 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPE  181 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcc
Confidence            57889999999999999999999999999999999998877    89999999998754322   234557999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+|+++|+|++|..||.......................+..+++.+.+||.+||..||.+|||+.
T Consensus       182 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  261 (283)
T 3bhy_A          182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA  261 (283)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             eecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            99888889999999999999999999999988765543322222212222222356789999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      ++++||||+..
T Consensus       262 ~~l~h~~~~~~  272 (283)
T 3bhy_A          262 QSLEHSWIKAI  272 (283)
T ss_dssp             HHHHCHHHHHH
T ss_pred             HHHhCHHHHHH
Confidence            99999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=3.4e-31  Score=260.89  Aligned_cols=166  Identities=23%  Similarity=0.343  Sum_probs=127.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   ......+||+.|+|||++.+
T Consensus       131 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcC
Confidence            578899999999999999999999999999999999999999999999999754322   23345679999999999987


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc------------------------cCCCC----CCC
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR------------------------HMQRS----PWD  131 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~------------------------~~~~~----~~~  131 (407)
                       ..++.++||||+||++|+|++|..||...+.............                        .....    ...
T Consensus       208 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (362)
T 3pg1_A          208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP  287 (362)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHST
T ss_pred             CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCC
Confidence             5789999999999999999999999988765433222211000                        00000    123


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       288 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          288 TADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence            46888999999999999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1e-31  Score=261.72  Aligned_cols=165  Identities=26%  Similarity=0.438  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+||+.|+|||++.+
T Consensus       121 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~  198 (331)
T 4aaa_A          121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVG  198 (331)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccC
Confidence            5788999999999999999999999999999999999999999999999997654322  23345679999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------CCCC----------CCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------MQRS----------PWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~  132 (407)
                      . .++.++||||+||++|+|++|..||..................                 ...+          .+..
T Consensus       199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (331)
T 4aaa_A          199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK  278 (331)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred             CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence            6 7899999999999999999999999887655433322111000                 0000          1235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      +++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus       279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            78999999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=9.6e-32  Score=271.38  Aligned_cols=164  Identities=32%  Similarity=0.598  Sum_probs=126.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....   .......+||+.|+|||+
T Consensus       236 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~  312 (419)
T 3i6u_A          236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEV  312 (419)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCcee
Confidence            57899999999999999999999999999999999997654   499999999986532   223346789999999999


Q ss_pred             hhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-cccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVR---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.+   ..++.++||||+||++|+|++|..||............... ........+..+++.+.+||.+||..||.+||
T Consensus       313 ~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  392 (419)
T 3i6u_A          313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF  392 (419)
T ss_dssp             TC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             eecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc
Confidence            864   46788999999999999999999999765433222222222 12222223466899999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      |++++++||||+..
T Consensus       393 s~~e~l~hp~~~~~  406 (419)
T 3i6u_A          393 TTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHHHSGGGCCH
T ss_pred             CHHHHhCCcccCCh
Confidence            99999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=3.5e-31  Score=256.50  Aligned_cols=167  Identities=20%  Similarity=0.276  Sum_probs=123.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       134 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  213 (323)
T 3qup_A          134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD  213 (323)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence            47789999999999999999999999999999999999999999999999987644433333344567889999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----  154 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----  154 (407)
                      ..++.++||||+||++|+|++ |..||............... .  .......+++++.+||.+||..||.+|||     
T Consensus       214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  290 (323)
T 3qup_A          214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-N--RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR  290 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-C--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            889999999999999999999 99999887665443332222 1  22233568899999999999999999999     


Q ss_pred             --HHHHHhCcccccCCCC
Q psy11119        155 --IEKIKSHRWYSKHMPN  170 (407)
Q Consensus       155 --~~eil~hpwf~~~~~~  170 (407)
                        +++++.|||+.....+
T Consensus       291 ~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          291 MELENILGHLSVLSTSQD  308 (323)
T ss_dssp             HHHHHHHHC---------
T ss_pred             HHHHHHHHHhhhcCCCCC
Confidence              7888999999876443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=254.93  Aligned_cols=164  Identities=24%  Similarity=0.410  Sum_probs=126.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.......   ......||+.|+|||++.
T Consensus       121 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERID  197 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcc
Confidence            57889999999999999999996 99999999999999999999999999997654322   233457999999999995


Q ss_pred             -----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         80 -----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        80 -----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                           ...++.++||||+||++|+|++|..||.....................+....+++++.+||.+||+.||.+||+
T Consensus       198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  277 (318)
T 2dyl_A          198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK  277 (318)
T ss_dssp             --------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred             cccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC
Confidence                 446788999999999999999999999874433333333333233333344568999999999999999999999


Q ss_pred             HHHHHhCcccccC
Q psy11119        155 IEKIKSHRWYSKH  167 (407)
Q Consensus       155 ~~eil~hpwf~~~  167 (407)
                      +.++++||||++.
T Consensus       278 ~~~ll~h~~~~~~  290 (318)
T 2dyl_A          278 YNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHTTSHHHHHH
T ss_pred             HHHHhhCHHHHhc
Confidence            9999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=8.1e-31  Score=252.73  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=137.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+
T Consensus       122 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  199 (314)
T 3com_A          122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQE  199 (314)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCC
Confidence            5788999999999999999999999999999999999999999999999998754322  22345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||............ .............++..+.+||.+||..||.+|||+.++++
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            88899999999999999999999999876654333222 22222223334567899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||....
T Consensus       279 ~~~~~~~~  286 (314)
T 3com_A          279 HPFVRSAK  286 (314)
T ss_dssp             SHHHHTCC
T ss_pred             CHHHhcCC
Confidence            99998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=1e-31  Score=259.95  Aligned_cols=159  Identities=26%  Similarity=0.417  Sum_probs=126.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc----------cCCcCccCCCCC
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE----------RPLDKKCGTLPY   72 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~----------~~~~~~~gt~~Y   72 (407)
                      +..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........          ......+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            4568899999999999999999999999999999999999999999999876543211          223456799999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTR  152 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~R  152 (407)
                      +|||++.+..++.++||||+||++|+|++|..|+...    ........ .......+...++++.+||.+||+.||.+|
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            9999999888999999999999999999987775321    11111111 111111234567889999999999999999


Q ss_pred             CCHHHHHhCccccc
Q psy11119        153 LNIEKIKSHRWYSK  166 (407)
Q Consensus       153 ps~~eil~hpwf~~  166 (407)
                      ||+.++++||||++
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=7.2e-31  Score=251.01  Aligned_cols=162  Identities=31%  Similarity=0.520  Sum_probs=137.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ......||+.|+|||++.+
T Consensus       112 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  189 (294)
T 2rku_A          112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK  189 (294)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhcc
Confidence            57889999999999999999999999999999999999999999999999987643322  2344679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|+||+|+++|+|++|..||...............  .  ......+++.+.+||.+||+.||++|||+.++++
T Consensus       190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--c--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            88899999999999999999999999887655433222211  1  2223467899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||....
T Consensus       266 ~~~~~~~~  273 (294)
T 2rku_A          266 DEFFTSGY  273 (294)
T ss_dssp             SHHHHTSC
T ss_pred             ChheecCC
Confidence            99998764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=3.4e-31  Score=253.36  Aligned_cols=168  Identities=25%  Similarity=0.458  Sum_probs=129.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC---ccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK---ERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~---~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........   ........||+.|+|||+
T Consensus       118 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence            47889999999999999999999999999999999999999999999999876543221   112334579999999999


Q ss_pred             hhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC------CCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         78 LVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM------QRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        78 l~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      +.+ ..++.++||||+||++|+|++|..||...................      .......++.++.+||.+||+.||.
T Consensus       198 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  277 (303)
T 2vwi_A          198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE  277 (303)
T ss_dssp             HHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred             hccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChh
Confidence            976 478899999999999999999999998766554333332221111      1122356789999999999999999


Q ss_pred             CCCCHHHHHhCcccccCC
Q psy11119        151 TRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       151 ~Rps~~eil~hpwf~~~~  168 (407)
                      +|||+.++++||||.+..
T Consensus       278 ~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          278 KRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             GSCCHHHHHTSTTC----
T ss_pred             hCcCHHHHhhChhhhcCC
Confidence            999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=256.38  Aligned_cols=169  Identities=27%  Similarity=0.400  Sum_probs=132.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCC-CccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNG-KERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~-~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++....... .........+|+.|+|||++
T Consensus       117 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (320)
T 2i6l_A          117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL  196 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHh
Confidence            47889999999999999999999999999999999998 56799999999998653221 12233455789999999998


Q ss_pred             hc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc----------------------cCCCC----CCC
Q psy11119         79 VR-SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR----------------------HMQRS----PWD  131 (407)
Q Consensus        79 ~~-~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~----------------------~~~~~----~~~  131 (407)
                      .+ ..++.++||||+||++|+|++|..||.................                      .....    .+.
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (320)
T 2i6l_A          197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP  276 (320)
T ss_dssp             HCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHST
T ss_pred             cCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcc
Confidence            76 5789999999999999999999999987765433222211100                      00000    124


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .++.++.+||.+||+.||.+|||+.++++||||+...+
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            57899999999999999999999999999999987543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=4.3e-31  Score=260.51  Aligned_cols=164  Identities=23%  Similarity=0.388  Sum_probs=126.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecC------CcEEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQ------DTLKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~------g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++.++..++.||+.||.|||++ ||+||||||+|||++.+      +.+||+|||++.....     .....+||+.|+
T Consensus       128 ~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~  202 (373)
T 1q8y_A          128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYR  202 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGC
T ss_pred             CcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCcccc
Confidence            47889999999999999999998 99999999999999643      3799999999986532     234457999999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH------HHHHHHhhcccC----------------------
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC------IEYLEWKDNRHM----------------------  125 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~------~~~~~~~~~~~~----------------------  125 (407)
                      |||++.+..++.++|||||||++|+|++|..||.......      ............                      
T Consensus       203 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  282 (373)
T 1q8y_A          203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR  282 (373)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred             CcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhc
Confidence            9999998888999999999999999999999998544211      110100000000                      


Q ss_pred             ----------------CCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        126 ----------------QRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       126 ----------------~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                                      .......++.++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             ccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence                            00111234578899999999999999999999999999998643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=5.1e-32  Score=272.87  Aligned_cols=152  Identities=16%  Similarity=0.190  Sum_probs=127.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh---
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL---   78 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l---   78 (407)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++   
T Consensus       209 ~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~  282 (413)
T 3dzo_A          209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAER  282 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhcc
Confidence            45678888999999999999999999999999999999999999999998764321     345678 999999999   


Q ss_pred             -------hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         79 -------VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        79 -------~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                             ....++.++|||||||++|+|++|+.||........        .......+..+++++.+||.+||..||.+
T Consensus       283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG--------SEWIFRSCKNIPQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC--------SGGGGSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred             ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh--------HHHHHhhcccCCHHHHHHHHHHccCChhh
Confidence                   444678899999999999999999999987653321        11112223467899999999999999999


Q ss_pred             CCCHHHHHhCcccccC
Q psy11119        152 RLNIEKIKSHRWYSKH  167 (407)
Q Consensus       152 Rps~~eil~hpwf~~~  167 (407)
                      ||++.++++||||+..
T Consensus       355 Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          355 RLLPLQAMETPEYEQL  370 (413)
T ss_dssp             SCCHHHHTTSHHHHHH
T ss_pred             CcCHHHHHhCHHHHHH
Confidence            9999999999999763

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=6.2e-31  Score=254.90  Aligned_cols=163  Identities=24%  Similarity=0.336  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  ......+||+.|+|||++. 
T Consensus       126 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  203 (326)
T 2x7f_A          126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC  203 (326)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhcc
Confidence            4688899999999999999999999999999999999999999999999987653221  1234457999999999997 


Q ss_pred             ----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 ----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                          +..++.++|||||||++|+|++|..||...............  .........++..+.+||.+||..||.+||++
T Consensus       204 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  281 (326)
T 2x7f_A          204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT  281 (326)
T ss_dssp             -------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccccCCccccCHHHHHHHHHHhccChhhCCCH
Confidence                457889999999999999999999999876654333322221  22222345678999999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      .++++||||+..
T Consensus       282 ~~ll~hp~~~~~  293 (326)
T 2x7f_A          282 EQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHTSHHHHCC
T ss_pred             HHHhhChHHhhC
Confidence            999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=3e-31  Score=261.25  Aligned_cols=164  Identities=26%  Similarity=0.458  Sum_probs=133.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......    .....+||+.|+|||++.
T Consensus       128 ~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~  203 (360)
T 3eqc_A          128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQ  203 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHc
Confidence            46888999999999999999996 9999999999999999999999999998754322    234457999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH----------------------------------------H
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE----------------------------------------W  119 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~----------------------------------------~  119 (407)
                      +..++.++||||+||++|+|++|..||............                                        .
T Consensus       204 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (360)
T 3eqc_A          204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY  283 (360)
T ss_dssp             TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhH
Confidence            888999999999999999999999999876654322111                                        0


Q ss_pred             hhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       120 ~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      .........+...++.++.+||.+||..||.+|||++++++||||++..
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          284 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             HhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence            1111122223345789999999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=7.7e-31  Score=256.33  Aligned_cols=162  Identities=31%  Similarity=0.520  Sum_probs=137.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .....+||+.|+|||++.+
T Consensus       138 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  215 (335)
T 2owb_A          138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK  215 (335)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhcc
Confidence            57889999999999999999999999999999999999999999999999987643322  2345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|||||||++|+|++|..||...............  .  ......+++.+.+||.+||+.||.+|||+.++++
T Consensus       216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--C--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            88899999999999999999999999887655433222222  1  1223457899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      ||||....
T Consensus       292 ~~~~~~~~  299 (335)
T 2owb_A          292 DEFFTSGY  299 (335)
T ss_dssp             SHHHHTSC
T ss_pred             CccccCCC
Confidence            99998765

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.1e-31  Score=262.67  Aligned_cols=164  Identities=34%  Similarity=0.578  Sum_probs=113.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......    .....+||+.|+|||+
T Consensus       125 l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~  200 (336)
T 3fhr_A          125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEV  200 (336)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhh
Confidence            5788999999999999999999999999999999999864   45999999999865322    2345678999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH----HHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY----LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.+..++.++||||+||++|+|++|..||..........    .........+.+.+..+++++.+||.+||..||.+||
T Consensus       201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  280 (336)
T 3fhr_A          201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL  280 (336)
T ss_dssp             ---CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc
Confidence            988888899999999999999999999997655432211    1111112334455677899999999999999999999


Q ss_pred             CHHHHHhCcccccCC
Q psy11119        154 NIEKIKSHRWYSKHM  168 (407)
Q Consensus       154 s~~eil~hpwf~~~~  168 (407)
                      |+.++++||||++..
T Consensus       281 t~~ell~hp~~~~~~  295 (336)
T 3fhr_A          281 TITQFMNHPWINQSM  295 (336)
T ss_dssp             CHHHHHHSHHHHTGG
T ss_pred             CHHHHhcCccccccc
Confidence            999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=5.3e-31  Score=252.44  Aligned_cols=165  Identities=28%  Similarity=0.375  Sum_probs=132.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  ........||+.|+|||++. 
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  191 (302)
T 2j7t_A          114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMC  191 (302)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeecc
Confidence            578899999999999999999999999999999999999999999999987543211  11223457999999999984 


Q ss_pred             ----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 ----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                          ...++.++||||+||++|+|++|..||...+........... ..........++.++.+||.+||..||.+|||+
T Consensus       192 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  270 (302)
T 2j7t_A          192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA  270 (302)
T ss_dssp             HHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             ccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc-CCcccCCccccCHHHHHHHHHHcccChhhCCCH
Confidence                457789999999999999999999999887655433322222 222223345688999999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .++++||||....
T Consensus       271 ~~ll~h~~~~~~~  283 (302)
T 2j7t_A          271 AQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHTTSTTTTTCC
T ss_pred             HHHhcChHHhhhc
Confidence            9999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=4.2e-31  Score=252.00  Aligned_cols=165  Identities=34%  Similarity=0.617  Sum_probs=136.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++   .+||+|||++......   .......||+.|+|||+
T Consensus       118 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEV  194 (287)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC---SSCSCHHHHHTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC---CccccccCcccccChHH
Confidence            57889999999999999999999999999999999997644   6999999998765322   22334568999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+. ++.++||||+|+++|+|++|..||...+.................+.+..+++++.+||.+||..+|.+|||+.+
T Consensus       195 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  273 (287)
T 2wei_A          195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (287)
T ss_dssp             HTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence            8765 789999999999999999999999887765433333233233334445678999999999999999999999999


Q ss_pred             HHhCcccccCCC
Q psy11119        158 IKSHRWYSKHMP  169 (407)
Q Consensus       158 il~hpwf~~~~~  169 (407)
                      +++||||++..+
T Consensus       274 ll~hp~~~~~~~  285 (287)
T 2wei_A          274 CLEHPWIQKYSS  285 (287)
T ss_dssp             HHHSHHHHHHCC
T ss_pred             HhcCHHHhcccc
Confidence            999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=1.5e-30  Score=248.25  Aligned_cols=163  Identities=25%  Similarity=0.415  Sum_probs=130.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.......  .......||+.|+|||++.+
T Consensus       120 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  197 (295)
T 2clq_A          120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDK  197 (295)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcC
Confidence            57788999999999999999999999999999999998 8999999999998754322  22345679999999999976


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .  .++.++||||+|+++|+|++|..||............... .......+..+++++.+||.+||+.||.+||++.++
T Consensus       198 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  276 (295)
T 2clq_A          198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL  276 (295)
T ss_dssp             GGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccccccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            5  4789999999999999999999999754433222211111 122223345689999999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      ++||||+..
T Consensus       277 l~~~~~~~~  285 (295)
T 2clq_A          277 LVDEFLKVS  285 (295)
T ss_dssp             HTSGGGCC-
T ss_pred             hcChhhhhc
Confidence            999999865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=5.7e-31  Score=248.95  Aligned_cols=162  Identities=36%  Similarity=0.662  Sum_probs=126.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   ......+|++.|+|||++.+
T Consensus       108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcC
Confidence            478899999999999999999999999999999999999999999999999765332   22345579999999999987


Q ss_pred             CC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      .. .+.++|+||+|+++|+|++|..||........... ... ...  .....++..+.++|.+||+.||.+|||+.+++
T Consensus       185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l  260 (276)
T 2h6d_A          185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-IRG-GVF--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIR  260 (276)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHH-CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-hhc-Ccc--cCchhcCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            74 46899999999999999999999987765433222 222 111  12345789999999999999999999999999


Q ss_pred             hCcccccCCC
Q psy11119        160 SHRWYSKHMP  169 (407)
Q Consensus       160 ~hpwf~~~~~  169 (407)
                      +||||++..+
T Consensus       261 ~h~~~~~~~~  270 (276)
T 2h6d_A          261 EHEWFKQDLP  270 (276)
T ss_dssp             HSHHHHTTCC
T ss_pred             hChhhccCch
Confidence            9999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=4.5e-31  Score=256.05  Aligned_cols=164  Identities=32%  Similarity=0.602  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......   ......+||+.|+|||+
T Consensus       111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc---cccccccCCcCccCchh
Confidence            578899999999999999999999999999999999987665   999999999865322   12234579999999999


Q ss_pred             hh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-cccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LV---RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~---~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.   ...++.++||||+||++|+|++|..||............... ........+..+++++.+||.+||..||.+||
T Consensus       188 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  267 (322)
T 2ycf_A          188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF  267 (322)
T ss_dssp             HHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCC
Confidence            85   346789999999999999999999999765432211111111 11111122456889999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      ++.++++||||...
T Consensus       268 s~~~~l~h~~~~~~  281 (322)
T 2ycf_A          268 TTEEALRHPWLQDE  281 (322)
T ss_dssp             CHHHHHTSGGGCCH
T ss_pred             CHHHHhhCcCcCCH
Confidence            99999999999763

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.1e-30  Score=247.43  Aligned_cols=155  Identities=21%  Similarity=0.300  Sum_probs=124.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-------------------cEEEEecCCceeeccCCCcc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-------------------TLKISDFGLATVFRMNGKER   61 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-------------------~lkL~DFGla~~~~~~~~~~   61 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++                   .+||+|||++......    
T Consensus       112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----  187 (289)
T 1x8b_A          112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----  187 (289)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS----
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----
Confidence            57889999999999999999999999999999999998544                   7999999999865322    


Q ss_pred             CCcCccCCCCCCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHH
Q psy11119         62 PLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSL  140 (407)
Q Consensus        62 ~~~~~~gt~~Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~L  140 (407)
                        ....||+.|+|||++.+. .++.++||||+||++|+|++|..|+.....    ...... .. .......+++++.+|
T Consensus       188 --~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~~-~~-~~~~~~~~~~~~~~l  259 (289)
T 1x8b_A          188 --QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQ-GR-LPRIPQVLSQEFTEL  259 (289)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHHHT-TC-CCCCSSCCCHHHHHH
T ss_pred             --cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHHHc-CC-CCCCCcccCHHHHHH
Confidence              234699999999999876 666899999999999999999987754322    111122 11 122335689999999


Q ss_pred             HHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        141 IRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       141 I~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      |.+||+.||.+|||+.++++||||...
T Consensus       260 i~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          260 LKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.1e-30  Score=253.76  Aligned_cols=154  Identities=32%  Similarity=0.560  Sum_probs=129.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++......    ......||+.|+|||++.
T Consensus       146 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhc
Confidence            57889999999999999999999999999999999999 7799999999999875422    234567999999999998


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +. +.+.++|||||||++|+|++|..||.....      ....    .......+++++.+||.+||..||.+|||+.++
T Consensus       222 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  291 (320)
T 3a99_A          222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI  291 (320)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc----cccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            76 447889999999999999999999975321      1111    111234578999999999999999999999999


Q ss_pred             HhCcccccCC
Q psy11119        159 KSHRWYSKHM  168 (407)
Q Consensus       159 l~hpwf~~~~  168 (407)
                      ++||||....
T Consensus       292 l~hp~~~~~~  301 (320)
T 3a99_A          292 QNHPWMQDVL  301 (320)
T ss_dssp             HTSGGGSSCC
T ss_pred             hcCHhhcCcc
Confidence            9999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.4e-30  Score=248.47  Aligned_cols=162  Identities=27%  Similarity=0.413  Sum_probs=136.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+
T Consensus       116 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  193 (303)
T 3a7i_A          116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQ  193 (303)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhc
Confidence            5788999999999999999999999999999999999999999999999998754322  22345679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||...............   ........++..+.+||.+||..||.+|||+.++++
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC---CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            88899999999999999999999999877654433322221   122233568899999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||...
T Consensus       271 ~~~~~~~  277 (303)
T 3a7i_A          271 HKFILRN  277 (303)
T ss_dssp             CHHHHHH
T ss_pred             ChhhhcC
Confidence            9999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=1.2e-30  Score=254.14  Aligned_cols=158  Identities=21%  Similarity=0.354  Sum_probs=129.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++...............||+.|+|||++.+
T Consensus       114 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3poz_A          114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc
Confidence            46788999999999999999999999999999999999999999999999987654443333445567889999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||............... .  ..+....++.++.++|.+||+.+|.+||++.+++
T Consensus       194 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell  270 (327)
T 3poz_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI  270 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            999999999999999999999 99999987765443332222 1  2223355789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       271 ~~  272 (327)
T 3poz_A          271 IE  272 (327)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=8.8e-31  Score=257.18  Aligned_cols=159  Identities=23%  Similarity=0.321  Sum_probs=132.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence            46788999999999999999999999999999999999999999999999986544333333455678999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||..................  ......+++++.++|.+||+.||.+|||+.+++
T Consensus       270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  347 (359)
T 3vhe_A          270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  347 (359)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            889999999999999999998 99999877654433333333222  223355889999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       348 ~~  349 (359)
T 3vhe_A          348 EH  349 (359)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.4e-30  Score=253.35  Aligned_cols=158  Identities=18%  Similarity=0.302  Sum_probs=129.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       112 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  191 (325)
T 3kex_A          112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF  191 (325)
T ss_dssp             SCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc
Confidence            46778999999999999999999999999999999999999999999999987654444444456678889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... .  .......++.++.++|.+||..||.+|||+.+++
T Consensus       192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~  268 (325)
T 3kex_A          192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-E--RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA  268 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-C--BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHH
T ss_pred             CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-C--CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            889999999999999999999 99999877655433332222 1  1222344778899999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       269 ~~  270 (325)
T 3kex_A          269 NE  270 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=3e-30  Score=256.15  Aligned_cols=158  Identities=24%  Similarity=0.366  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...............+|+.|+|||++.+
T Consensus       200 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  279 (370)
T 2psq_A          200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  279 (370)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence            46788999999999999999999999999999999999999999999999987654333333445567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.+.......... ....  .......+++++.+||.+||..+|.+||++.+++
T Consensus       280 ~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell  356 (370)
T 2psq_A          280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV  356 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            889999999999999999999 99999887665433322 2211  2223356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       357 ~~  358 (370)
T 2psq_A          357 ED  358 (370)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.5e-30  Score=252.86  Aligned_cols=163  Identities=23%  Similarity=0.436  Sum_probs=133.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++......    ......|++.|+|||++.
T Consensus       148 ~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~  223 (348)
T 2pml_X          148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFS  223 (348)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGS
T ss_pred             CCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhc
Confidence            5788999999999999999999 99999999999999999999999999999875432    234567999999999998


Q ss_pred             cC-CCCC-cchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCC-----------------CCcCCHHHHHH
Q psy11119         80 RS-YLAE-PADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSP-----------------WDRLDVNCLSL  140 (407)
Q Consensus        80 ~~-~~~~-~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~s~~~~~L  140 (407)
                      +. .++. ++||||+||++|+|++|..||............... .....+.                 ...+++++.+|
T Consensus       224 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  302 (348)
T 2pml_X          224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF  302 (348)
T ss_dssp             SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHH
T ss_pred             CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHH
Confidence            77 5555 999999999999999999999876652222222222 1111111                 15688999999


Q ss_pred             HHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        141 IRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       141 I~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      |.+||+.||.+|||+.++++||||....
T Consensus       303 i~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          303 LKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHccCChhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999999998753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=2.2e-30  Score=247.36  Aligned_cols=161  Identities=17%  Similarity=0.292  Sum_probs=128.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc-----EEEEecCCceeeccCCCc-----cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGKE-----RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~-----lkL~DFGla~~~~~~~~~-----~~~~~~~gt~   70 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++.........     ......+||+
T Consensus       103 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  182 (298)
T 1csn_A          103 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  182 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence            578899999999999999999999999999999999988776     999999999876543221     1234567999


Q ss_pred             CCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--HHHHHHhhc--ccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         71 PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC--IEYLEWKDN--RHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        71 ~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~--~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.......  .........  ..........+++++.+||.+||+
T Consensus       183 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  262 (298)
T 1csn_A          183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN  262 (298)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred             ccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhc
Confidence            9999999998888999999999999999999999998743211  111111111  111111224578999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .||.+||++.+|++.
T Consensus       263 ~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          263 LAFDATPDYDYLQGL  277 (298)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             CCcccCCCHHHHHHH
Confidence            999999999999774

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=9e-31  Score=265.40  Aligned_cols=160  Identities=28%  Similarity=0.391  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-------------CcEEEEecCCceeeccCCCc--cCCcCccCC
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-------------DTLKISDFGLATVFRMNGKE--RPLDKKCGT   69 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-------------g~lkL~DFGla~~~~~~~~~--~~~~~~~gt   69 (407)
                      .+..++.||+.||+|||++||+||||||+|||++.+             +.+||+|||+++........  ......+||
T Consensus       116 ~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt  195 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT  195 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------C
T ss_pred             hHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCC
Confidence            457899999999999999999999999999999764             48999999999876533221  123456899


Q ss_pred             CCCCchhhhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCC---CCCCCcCCHHHH
Q psy11119         70 LPYVAPEVLVR-------SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQ---RSPWDRLDVNCL  138 (407)
Q Consensus        70 ~~Y~APE~l~~-------~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~  138 (407)
                      +.|+|||++.+       ..++.++||||+||++|+|++ |..||.........  .........   ......+++++.
T Consensus       196 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~  273 (434)
T 2rio_A          196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEAT  273 (434)
T ss_dssp             CTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--HHHTCCCCCCCTTCCCHHHHHHHH
T ss_pred             CCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--HhcCCCCcccccccccccchHHHH
Confidence            99999999975       578899999999999999999 99999866543322  112211111   111234568899


Q ss_pred             HHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        139 SLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       139 ~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      +||.+||..||.+|||+.++++||||..
T Consensus       274 ~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          274 DLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            9999999999999999999999999964

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.4e-30  Score=251.20  Aligned_cols=158  Identities=22%  Similarity=0.363  Sum_probs=124.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+
T Consensus       114 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3lzb_A          114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC
Confidence            46888999999999999999999999999999999999999999999999987654443333445567889999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||...............   ...+....++.++.+||.+||..||.+||++.+++
T Consensus       194 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  270 (327)
T 3lzb_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI  270 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999999 99999987765543332222   12223355889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       271 ~~  272 (327)
T 3lzb_A          271 IE  272 (327)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=258.09  Aligned_cols=164  Identities=21%  Similarity=0.340  Sum_probs=135.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC---cEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g---~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.+|   .+||+|||+++...............||+.|+|||+
T Consensus       178 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  257 (367)
T 3l9p_A          178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA  257 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHH
Confidence            46788999999999999999999999999999999999665   499999999986543333334445678999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++|||||||++|+|++ |..||............... .  .......+++.+.+||.+||+.+|.+|||+.
T Consensus       258 ~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-G--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            998889999999999999999998 99999887765433332222 1  2223456889999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      +|+++.|+...
T Consensus       335 eil~~l~~~~~  345 (367)
T 3l9p_A          335 IILERIEYCTQ  345 (367)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhh
Confidence            99999887653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=4.8e-30  Score=244.79  Aligned_cols=163  Identities=29%  Similarity=0.417  Sum_probs=122.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC------------CccCCcCccCC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG------------KERPLDKKCGT   69 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~------------~~~~~~~~~gt   69 (407)
                      ++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......            ........+||
T Consensus       114 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (303)
T 1zy4_A          114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT  193 (303)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------
T ss_pred             chHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCc
Confidence            567889999999999999999999999999999999999999999999987643211            01223456799


Q ss_pred             CCCCchhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccC
Q psy11119         70 LPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAP  147 (407)
Q Consensus        70 ~~Y~APE~l~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~  147 (407)
                      +.|+|||++.+. .++.++||||+||++|+|++   ||................ ...+.......+..+.+||.+||+.
T Consensus       194 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  270 (303)
T 1zy4_A          194 AMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH  270 (303)
T ss_dssp             CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCS
T ss_pred             ccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhc
Confidence            999999999865 78899999999999999998   665332221122222211 2222223355678899999999999


Q ss_pred             CCCCCCCHHHHHhCcccccC
Q psy11119        148 LPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       148 ~P~~Rps~~eil~hpwf~~~  167 (407)
                      ||.+|||+.++++||||...
T Consensus       271 dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          271 DPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             SGGGSCCHHHHHHSSCSCCC
T ss_pred             CcccCcCHHHHhCCCCcCCC
Confidence            99999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=7e-30  Score=243.93  Aligned_cols=161  Identities=25%  Similarity=0.363  Sum_probs=120.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++. 
T Consensus       117 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (289)
T 3og7_A          117 FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM  196 (289)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcc
Confidence            4678899999999999999999999999999999999999999999999998654333333445567999999999996 


Q ss_pred             --cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-C-CCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 --RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-M-QRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 --~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                        +..++.++||||+||++|+|++|..||.................. . .......+++++.+||.+||+.+|.+|||+
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  276 (289)
T 3og7_A          197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF  276 (289)
T ss_dssp             ---CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCH
Confidence              456788999999999999999999999876544333322222111 1 112235688999999999999999999999


Q ss_pred             HHHHhC
Q psy11119        156 EKIKSH  161 (407)
Q Consensus       156 ~eil~h  161 (407)
                      .++++.
T Consensus       277 ~ell~~  282 (289)
T 3og7_A          277 PRILAE  282 (289)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999873

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=2.3e-30  Score=255.87  Aligned_cols=160  Identities=18%  Similarity=0.261  Sum_probs=126.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe--cCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD--LQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld--~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~   73 (407)
                      |++.++..++.||+.||.|||++||+||||||+|||++  .++.+||+|||+++.+......     ......+||+.|+
T Consensus       149 l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  228 (364)
T 3op5_A          149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT  228 (364)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCcc
Confidence            57899999999999999999999999999999999999  8899999999999876433221     1223456999999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc--cc-----CCCCCCCcCCHHHHHHHHHhcc
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN--RH-----MQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      |||++.+..++.++|||||||++|+|++|..||.+..............  ..     ........+++++.++|..||.
T Consensus       229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  308 (364)
T 3op5_A          229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKL  308 (364)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHT
T ss_pred             CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhc
Confidence            9999998889999999999999999999999998543222111111100  00     0001124578999999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .+|.+||++.+|++
T Consensus       309 ~~p~~RP~~~~l~~  322 (364)
T 3op5_A          309 LDYTEKPLYENLRD  322 (364)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999999876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=1.2e-30  Score=253.44  Aligned_cols=164  Identities=23%  Similarity=0.365  Sum_probs=113.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL-   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~-gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l-   78 (407)
                      +++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++......   .......||+.|+|||++ 
T Consensus       122 ~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred             CcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceeec
Confidence            46888999999999999999999 9999999999999999999999999999765432   122344799999999998 


Q ss_pred             ---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc--cCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         79 ---VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR--HMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        79 ---~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                         .+..++.++||||+||++|+|++|..||.................  ......+..+++++.+||.+||..||.+||
T Consensus       199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  278 (327)
T 3aln_A          199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP  278 (327)
T ss_dssp             -------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCc
Confidence               455788999999999999999999999986543211111111111  111222346899999999999999999999


Q ss_pred             CHHHHHhCcccccC
Q psy11119        154 NIEKIKSHRWYSKH  167 (407)
Q Consensus       154 s~~eil~hpwf~~~  167 (407)
                      |+.++++||||...
T Consensus       279 s~~ell~hp~~~~~  292 (327)
T 3aln_A          279 KYKELLKHPFILMY  292 (327)
T ss_dssp             CHHHHTTSHHHHHH
T ss_pred             CHHHHHhChHHHHh
Confidence            99999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=2.4e-30  Score=245.04  Aligned_cols=163  Identities=26%  Similarity=0.349  Sum_probs=133.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG-----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g-----IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP   75 (407)
                      +++.+++.++.||+.||.|||++|     |+||||||+||+++.++.+||+|||++.......  .......|++.|+||
T Consensus       108 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSP  185 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccCh
Confidence            578899999999999999999999     9999999999999999999999999987653221  112345789999999


Q ss_pred             hhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         76 EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        76 E~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      |++.+..++.++||||+|+++|+|++|..||...............  .. ......+++++.++|.+||+.||.+|||+
T Consensus       186 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~  262 (279)
T 2w5a_A          186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF-RRIPYRYSDELNEIITRMLNLKDYHRPSV  262 (279)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc--cc-ccCCcccCHHHHHHHHHHcCCCcccCCCH
Confidence            9999888899999999999999999999999987654333222222  11 12234688999999999999999999999


Q ss_pred             HHHHhCcccccCC
Q psy11119        156 EKIKSHRWYSKHM  168 (407)
Q Consensus       156 ~eil~hpwf~~~~  168 (407)
                      .++++|+|+....
T Consensus       263 ~~ll~~~~~~~~~  275 (279)
T 2w5a_A          263 EEILENPLILEHH  275 (279)
T ss_dssp             HHHHTSTTCCGGG
T ss_pred             HHHHhChhhhhhc
Confidence            9999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=9.2e-30  Score=246.39  Aligned_cols=163  Identities=23%  Similarity=0.329  Sum_probs=125.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.....  .......+||+.|+|||++
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~  211 (309)
T 3p86_A          134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVL  211 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhh
Confidence            478889999999999999999999  999999999999999999999999999754322  1223456899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++|||||||++|+|++|..||...+...........  .........+++++.+||.+||..+|.+|||+.++
T Consensus       212 ~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  289 (309)
T 3p86_A          212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI  289 (309)
T ss_dssp             TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS--CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9988899999999999999999999999987765433322212  22223345689999999999999999999999999


Q ss_pred             Hh--CcccccC
Q psy11119        159 KS--HRWYSKH  167 (407)
Q Consensus       159 l~--hpwf~~~  167 (407)
                      ++  +++++..
T Consensus       290 l~~L~~~~~~~  300 (309)
T 3p86_A          290 MDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHC--
T ss_pred             HHHHHHHHHhC
Confidence            98  5666553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=3.6e-30  Score=252.57  Aligned_cols=161  Identities=19%  Similarity=0.316  Sum_probs=127.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC--cEEEEecCCceeeccCCCc-----cCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKE-----RPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g--~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~   73 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.+......     ......+||+.|+
T Consensus       148 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  227 (345)
T 2v62_A          148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT  227 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence            57899999999999999999999999999999999999887  9999999999876433211     1124568999999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-------CCCCcCCHHHHHHHHHhcc
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-------SPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~s~~~~~LI~~~L~  146 (407)
                      |||++.+..++.++|||||||++|+|++|+.||.....................       .+...+++++.++|.+||.
T Consensus       228 aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  307 (345)
T 2v62_A          228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHS  307 (345)
T ss_dssp             CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHT
T ss_pred             CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhh
Confidence            999999888999999999999999999999999653222222111111111111       1112688999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .||.+|||+.+|++.
T Consensus       308 ~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          308 LAYDEKPNYQALKKI  322 (345)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             cCcccCCCHHHHHHH
Confidence            999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=5.5e-30  Score=246.43  Aligned_cols=158  Identities=22%  Similarity=0.319  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  226 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD  226 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence            36788999999999999999999999999999999999999999999999987654433333445567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............ ...  ........+++++.+||.+||+.||.+|||+.+++
T Consensus       227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~  303 (314)
T 2ivs_A          227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTG--HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS  303 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh-hcC--CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999999 99999887665433222 221  12233456899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       304 ~~  305 (314)
T 2ivs_A          304 KD  305 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.9e-30  Score=251.34  Aligned_cols=161  Identities=23%  Similarity=0.284  Sum_probs=133.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+
T Consensus       169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  248 (344)
T 1rjb_A          169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  248 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence            46788999999999999999999999999999999999999999999999987654433333344567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||................  ........+++++.+||.+||..||.+|||+.+++
T Consensus       249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  326 (344)
T 1rjb_A          249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  326 (344)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            889999999999999999998 999998766543333333322  22223355789999999999999999999999999


Q ss_pred             hCcc
Q psy11119        160 SHRW  163 (407)
Q Consensus       160 ~hpw  163 (407)
                      +|..
T Consensus       327 ~~l~  330 (344)
T 1rjb_A          327 SFLG  330 (344)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=6.4e-30  Score=243.69  Aligned_cols=160  Identities=22%  Similarity=0.270  Sum_probs=127.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y   72 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........     .......||+.|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 4hgt_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence            5788999999999999999999999999999999999   78899999999999876543321     123456899999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH---HHHHHHhhc-ccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC---IEYLEWKDN-RHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~---~~~~~~~~~-~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      +|||++.+..++.++||||+||++|+|++|..||.......   ......... ..........+++++.+||.+||+.+
T Consensus       182 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  261 (296)
T 4hgt_A          182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred             cchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcC
Confidence            99999998889999999999999999999999997643211   111111110 11111112457899999999999999


Q ss_pred             CCCCCCHHHHHh
Q psy11119        149 PSTRLNIEKIKS  160 (407)
Q Consensus       149 P~~Rps~~eil~  160 (407)
                      |.+|||+.++++
T Consensus       262 p~~Rpt~~~l~~  273 (296)
T 4hgt_A          262 FDDKPDYSYLRQ  273 (296)
T ss_dssp             TTCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH
Confidence            999999999977

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=2.4e-30  Score=262.42  Aligned_cols=163  Identities=27%  Similarity=0.376  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-----CcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchh
Q psy11119          3 QWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-----DTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-----g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE   76 (407)
                      +.++..++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+++....... .......+||+.|+|||
T Consensus       117 ~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE  196 (432)
T 3p23_A          117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE  196 (432)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGG
T ss_pred             chhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChh
Confidence            34567899999999999999999999999999999532     3588999999987643321 12334568999999999


Q ss_pred             hhhc---CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhccc-CCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         77 VLVR---SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRH-MQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        77 ~l~~---~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                      ++.+   ..++.++||||+||++|+|++ |..||..........  ...... ....+....+..+.+||.+||+.||.+
T Consensus       197 ~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  274 (432)
T 3p23_A          197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQK  274 (432)
T ss_dssp             GTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGG
T ss_pred             hhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCCccccCccccccHHHHHHHHHHHhCCHhh
Confidence            9974   466789999999999999999 999997655433222  122111 112222344567899999999999999


Q ss_pred             CCCHHHHHhCcccccC
Q psy11119        152 RLNIEKIKSHRWYSKH  167 (407)
Q Consensus       152 Rps~~eil~hpwf~~~  167 (407)
                      |||+.++++||||...
T Consensus       275 Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          275 RPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             SCCHHHHHTSTTTCCH
T ss_pred             CCCHHHHHhCccccCh
Confidence            9999999999999753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=6.6e-30  Score=245.76  Aligned_cols=159  Identities=23%  Similarity=0.346  Sum_probs=132.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+
T Consensus       142 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  221 (313)
T 1t46_A          142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence            46889999999999999999999999999999999999999999999999987654433223344567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||................  ........+++++.+||.+||..||.+|||+.+++
T Consensus       222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  299 (313)
T 1t46_A          222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG--FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV  299 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC--CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            889999999999999999999 999998766544333333332  22223356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       300 ~~  301 (313)
T 1t46_A          300 QL  301 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=3.8e-30  Score=246.92  Aligned_cols=164  Identities=29%  Similarity=0.395  Sum_probs=126.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+||+.|+|||++.+
T Consensus       108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~  186 (294)
T 4eqm_A          108 LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKG  186 (294)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcC
Confidence            5788999999999999999999999999999999999999999999999997653222 122345679999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++|+.||...+.............. ........+++.+.++|.+||.+||.+||+..+.+
T Consensus       187 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l  266 (294)
T 4eqm_A          187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM  266 (294)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred             CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence            88899999999999999999999999987765443333322111 11122456889999999999999999999666666


Q ss_pred             hCcccc
Q psy11119        160 SHRWYS  165 (407)
Q Consensus       160 ~hpwf~  165 (407)
                      .+.|..
T Consensus       267 ~~~l~~  272 (294)
T 4eqm_A          267 KDDLSS  272 (294)
T ss_dssp             HHHHHT
T ss_pred             HHHHHH
Confidence            666543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=252.76  Aligned_cols=158  Identities=24%  Similarity=0.378  Sum_probs=133.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+
T Consensus       188 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  267 (382)
T 3tt0_A          188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  267 (382)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence            57889999999999999999999999999999999999999999999999987654333334445567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||............ ....  .......+++++.+||.+||+.+|.+|||+.+++
T Consensus       268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  344 (382)
T 3tt0_A          268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  344 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC--CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            899999999999999999999 99999887765433222 2211  2223356899999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       345 ~~  346 (382)
T 3tt0_A          345 ED  346 (382)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=6.5e-30  Score=246.42  Aligned_cols=154  Identities=32%  Similarity=0.595  Sum_probs=128.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++......    ......|++.|+|||++.
T Consensus       136 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeee
Confidence            57889999999999999999999999999999999999 8899999999999875432    234567999999999998


Q ss_pred             cCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSY-LAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~-~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +.. .+.++||||+||++|+|++|+.||.....      ....  .  ......++.++.+||.+||+.||++|||+.++
T Consensus       212 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  281 (312)
T 2iwi_A          212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--E--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI  281 (312)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--C--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            764 45689999999999999999999975321      1111  1  12234578999999999999999999999999


Q ss_pred             HhCcccccCC
Q psy11119        159 KSHRWYSKHM  168 (407)
Q Consensus       159 l~hpwf~~~~  168 (407)
                      ++||||+...
T Consensus       282 l~~~~~~~~~  291 (312)
T 2iwi_A          282 LLDPWMQTPA  291 (312)
T ss_dssp             HHSTTTCC--
T ss_pred             hcChhhcCch
Confidence            9999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=8.4e-30  Score=246.47  Aligned_cols=157  Identities=21%  Similarity=0.293  Sum_probs=130.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+.
T Consensus       136 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (322)
T 1p4o_A          136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  215 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC
Confidence            67889999999999999999999999999999999999999999999999765433222223345678999999999988


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++||||+||++|+|++ |..||...............  . .......+++.+.+||.+||..||.+|||+.++++
T Consensus       216 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~  292 (322)
T 1p4o_A          216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG--G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  292 (322)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT--C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC--C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            88999999999999999999 89999887655433322222  1 12233568899999999999999999999999998


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      +
T Consensus       293 ~  293 (322)
T 1p4o_A          293 S  293 (322)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=1.3e-29  Score=241.90  Aligned_cols=160  Identities=22%  Similarity=0.263  Sum_probs=126.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y   72 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.........     .......||+.|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 3uzp_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence            5788999999999999999999999999999999999   48899999999999876543321     123456899999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---HHHHHHHhhcc-cCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD---CIEYLEWKDNR-HMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~---~~~~~~~~~~~-~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      +|||++.+..++.++||||+||++|+|++|+.||......   ........... .........+++++.+||.+||+.|
T Consensus       182 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  261 (296)
T 3uzp_A          182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred             CChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcC
Confidence            9999999888999999999999999999999999764321   11111111111 1111112457899999999999999


Q ss_pred             CCCCCCHHHHHh
Q psy11119        149 PSTRLNIEKIKS  160 (407)
Q Consensus       149 P~~Rps~~eil~  160 (407)
                      |.+|||+.++++
T Consensus       262 p~~Rps~~~l~~  273 (296)
T 3uzp_A          262 FDDKPDYSYLRQ  273 (296)
T ss_dssp             TTCCCCHHHHHH
T ss_pred             cCcCCCHHHHHH
Confidence            999999999877

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=5.4e-30  Score=246.69  Aligned_cols=159  Identities=23%  Similarity=0.311  Sum_probs=131.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+.
T Consensus       146 ~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  225 (316)
T 2xir_A          146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  225 (316)
T ss_dssp             EHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence            57789999999999999999999999999999999999999999999999865433322233445688999999999988


Q ss_pred             CCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++||||+||++|+|++ |..||..................  ......+++++.++|.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  303 (316)
T 2xir_A          226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  303 (316)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999998 99999876644333333333222  2223457899999999999999999999999998


Q ss_pred             Cc
Q psy11119        161 HR  162 (407)
Q Consensus       161 hp  162 (407)
                      |.
T Consensus       304 ~L  305 (316)
T 2xir_A          304 HL  305 (316)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=1.1e-29  Score=247.42  Aligned_cols=159  Identities=23%  Similarity=0.345  Sum_probs=125.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc-----EEEEecCCceeeccCCCcc-----CCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGKER-----PLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~-----lkL~DFGla~~~~~~~~~~-----~~~~~~gt~   70 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++.+.......     .....+||+
T Consensus       102 ~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~  181 (330)
T 2izr_A          102 FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA  181 (330)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCc
Confidence            578899999999999999999999999999999999998887     9999999998764432211     234678999


Q ss_pred             CCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH--HHHHHhhc-ccCCCC-CCCcCCHHHHHHHHHhcc
Q psy11119         71 PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI--EYLEWKDN-RHMQRS-PWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        71 ~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~-~~~~~~-~~~~~s~~~~~LI~~~L~  146 (407)
                      .|+|||++.+..++.++|||||||++|+|++|..||........  .+...... ...... ....++ ++.++|.+||+
T Consensus       182 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~  260 (330)
T 2izr_A          182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRR  260 (330)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHH
T ss_pred             cccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHh
Confidence            99999999998889999999999999999999999987543221  11111111 111111 112234 89999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .+|.+||++++|.+
T Consensus       261 ~~p~~RP~~~~l~~  274 (330)
T 2izr_A          261 LDFFEKPDYDYLRK  274 (330)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999999876

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=99.96  E-value=1.1e-29  Score=216.85  Aligned_cols=123  Identities=15%  Similarity=0.246  Sum_probs=109.8

Q ss_pred             ccccCCccccccCCCCcccccccccccCCCCCCCcccCcccccchHHHHHhhhCCCCccccccccccchhhhhhhhhccc
Q psy11119        223 VCEVEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHI  302 (407)
Q Consensus       223 ~~~~a~~~~SfSqp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (407)
                      ..+|||++||||++++|++||...+         .                                           .+
T Consensus         5 ~~lNAFdiIs~S~g~dLSgLFe~~~---------~-------------------------------------------~~   32 (143)
T 2ehb_D            5 LMMNAFEMITLSQGLNLSALFDRRQ---------D-------------------------------------------FV   32 (143)
T ss_dssp             EECCHHHHHTTCTTTCGGGGGCSCC---------C-------------------------------------------SC
T ss_pred             cccCHHHHHHHCcCCCchhhhcccc---------c-------------------------------------------cc
Confidence            3589999999999999999875211         0                                           36


Q ss_pred             CCceeeEEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEe-ecCCCCeeEEEEEEEEec-CeEEEEEEeccCCchHHH
Q psy11119        303 RRMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTIST-VDSRKAQLVFKASVLTLD-NQTLLDFRLSKGCGIEFK  380 (407)
Q Consensus       303 ~r~tRF~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~-~d~rk~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE~~  380 (407)
                      +|+|||+|+.++++|+++||++++.+||+|+++++ .|++++ .+||||+|++.++||||+ +++||||||++||++||+
T Consensus        33 ~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~-~vkl~~~~~grkG~l~v~~EVfevapsl~vVEvrks~GD~lEy~  111 (143)
T 2ehb_D           33 KRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNF-KTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYH  111 (143)
T ss_dssp             CCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSS-EEEEEECCSSGGGCCEEEEEEEEEETTEEEEEEEEEESCHHHHH
T ss_pred             cccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCc-EEEEEEecCCCcceEEEEEEEEEecCCEEEEEEEecCCChHHHH
Confidence            88999999999999999999999999999998875 688875 799999999999999998 889999999999999999


Q ss_pred             HHHHHHHHhhhhhhhcCC
Q psy11119        381 TRFLCIKRALAEDIINKP  398 (407)
Q Consensus       381 ~~f~~~~~~l~~~v~~~~  398 (407)
                      +||++|+++|+||||+.+
T Consensus       112 k~~~~Lr~~L~diV~~~~  129 (143)
T 2ehb_D          112 KFYKKLCSKLENIIWRAT  129 (143)
T ss_dssp             HHHHHHHHHSTTTBCC--
T ss_pred             HHHHHHHHHhhcceecCC
Confidence            999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=1.6e-29  Score=238.12  Aligned_cols=158  Identities=20%  Similarity=0.287  Sum_probs=130.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+
T Consensus       101 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  179 (268)
T 3sxs_A          101 LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHY  179 (268)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhc
Confidence            57889999999999999999999999999999999999999999999999987543322 22334557788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||...............   ........+++.+.++|.+||+.+|.+|||+.+++
T Consensus       180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  256 (268)
T 3sxs_A          180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLL  256 (268)
T ss_dssp             SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC---CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888999999999999999999 99999877765433332222   12222345789999999999999999999999999


Q ss_pred             hCc
Q psy11119        160 SHR  162 (407)
Q Consensus       160 ~hp  162 (407)
                      ++-
T Consensus       257 ~~L  259 (268)
T 3sxs_A          257 SSI  259 (268)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=1.7e-29  Score=240.44  Aligned_cols=156  Identities=23%  Similarity=0.378  Sum_probs=128.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCc-----EEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDT-----LKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~-----lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++..+..++.||+.||+|||++|  |+||||||+|||++.++.     +||+|||+++....     ......||+.|+
T Consensus       119 ~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~  193 (287)
T 4f0f_A          119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWM  193 (287)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTS
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCcccc
Confidence            478889999999999999999999  999999999999998876     99999999874321     234567999999


Q ss_pred             chhhhh--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCC
Q psy11119         74 APEVLV--RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPST  151 (407)
Q Consensus        74 APE~l~--~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~  151 (407)
                      |||++.  ...++.++||||+||++|+|++|..||..........................+++++.+||.+||+.||.+
T Consensus       194 aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  273 (287)
T 4f0f_A          194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKK  273 (287)
T ss_dssp             CGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             CchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhh
Confidence            999984  346788999999999999999999999876655443333333233333445678999999999999999999


Q ss_pred             CCCHHHHHhC
Q psy11119        152 RLNIEKIKSH  161 (407)
Q Consensus       152 Rps~~eil~h  161 (407)
                      |||+.++++.
T Consensus       274 Rps~~~ll~~  283 (287)
T 4f0f_A          274 RPHFSYIVKE  283 (287)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=4.3e-30  Score=248.87  Aligned_cols=159  Identities=22%  Similarity=0.369  Sum_probs=125.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE----ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl----d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++......   .....+||+.|+|||
T Consensus       109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE  185 (319)
T 4euu_A          109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD  185 (319)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHH
Confidence            5788999999999999999999999999999999999    777889999999998764332   234567999999999


Q ss_pred             hhh--------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhhccc--------------------
Q psy11119         77 VLV--------RSYLAEPADIWSCGIILVAMLAGELPWDKPTA----DCIEYLEWKDNRH--------------------  124 (407)
Q Consensus        77 ~l~--------~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~----~~~~~~~~~~~~~--------------------  124 (407)
                      ++.        +..++.++||||+||++|+|++|..||.....    .............                    
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  265 (319)
T 4euu_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM  265 (319)
T ss_dssp             HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence            987        45788999999999999999999999964322    1112222211110                    


Q ss_pred             -CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCc
Q psy11119        125 -MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHR  162 (407)
Q Consensus       125 -~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hp  162 (407)
                       ........++..+.+||++||+.||++|||++|+++||
T Consensus       266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence             00011123456788999999999999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=1e-29  Score=247.79  Aligned_cols=158  Identities=21%  Similarity=0.356  Sum_probs=129.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+
T Consensus       171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  250 (343)
T 1luf_A          171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  250 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence            46788999999999999999999999999999999999999999999999976543322223345578999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||...............  .. ......+++++.+||.+||+.+|.+|||+.+++
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--NI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC--Cc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            889999999999999999999 99999887665433332222  11 122356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       328 ~~  329 (343)
T 1luf_A          328 RI  329 (343)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=1.5e-29  Score=240.42  Aligned_cols=157  Identities=22%  Similarity=0.302  Sum_probs=119.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+
T Consensus       113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  191 (281)
T 1mp8_A          113 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINF  191 (281)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhccc
Confidence            47888999999999999999999999999999999999999999999999987543221 12234457789999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... .  ..+....+++++.++|.+||+.||.+|||+.+++
T Consensus       192 ~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  268 (281)
T 1mp8_A          192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK  268 (281)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-C--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999997 99999877655433322221 1  1223456899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       269 ~~  270 (281)
T 1mp8_A          269 AQ  270 (281)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=1.8e-29  Score=243.48  Aligned_cols=158  Identities=18%  Similarity=0.247  Sum_probs=124.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++................+++.|+|||++.+
T Consensus       144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  223 (313)
T 3brb_A          144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  223 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence            57889999999999999999999999999999999999999999999999987644332233344567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||...............   ........+++++.+||.+||..+|.+|||+.+++
T Consensus       224 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  300 (313)
T 3brb_A          224 RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG---HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR  300 (313)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            889999999999999999999 99999877665433322222   12233456889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       301 ~~  302 (313)
T 3brb_A          301 LQ  302 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.6e-29  Score=238.53  Aligned_cols=157  Identities=17%  Similarity=0.309  Sum_probs=130.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .........+|+.|+|||++.+
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~  181 (269)
T 4hcu_A          103 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSF  181 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc-ccccccCcccccccCCHHHhcC
Confidence            478889999999999999999999999999999999999999999999999764322 1223344567888999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||...............   ........+++++.++|.+||+.+|.+|||+.+++
T Consensus       182 ~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  258 (269)
T 4hcu_A          182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLL  258 (269)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC---ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            889999999999999999999 99999987765433322221   22223355789999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       259 ~~  260 (269)
T 4hcu_A          259 RQ  260 (269)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.3e-29  Score=239.84  Aligned_cols=160  Identities=21%  Similarity=0.293  Sum_probs=132.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.
T Consensus       107 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          107 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence            57889999999999999999999999999999999999999999999999987643322 12233446789999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+||++|+|++ |..||............... .  .......+++++.++|.+||..+|.+||++.++
T Consensus       187 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-K--RMECPPECPPELYALMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-C--cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            8888999999999999999998 99999877655433222221 1  122335689999999999999999999999999


Q ss_pred             HhCcc
Q psy11119        159 KSHRW  163 (407)
Q Consensus       159 l~hpw  163 (407)
                      +++.+
T Consensus       264 ~~~l~  268 (287)
T 1u59_A          264 EQRMR  268 (287)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=1.1e-29  Score=247.10  Aligned_cols=159  Identities=26%  Similarity=0.338  Sum_probs=131.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+
T Consensus       161 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  240 (333)
T 2i1m_A          161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD  240 (333)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence            46788999999999999999999999999999999999999999999999986644433223344567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.................  ........++.+.+||.+||+.||.+|||+.+++
T Consensus       241 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  318 (333)
T 2i1m_A          241 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC  318 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            889999999999999999998 9999987665443333333222  2222345789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       319 ~~  320 (333)
T 2i1m_A          319 SF  320 (333)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=245.32  Aligned_cols=158  Identities=23%  Similarity=0.294  Sum_probs=128.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.
T Consensus       148 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  227 (325)
T 3kul_A          148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA  227 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc
Confidence            47889999999999999999999999999999999999999999999999987643322 11223345678899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+||++|+|++ |..||...............   ...+....+++++.+||.+||..||.+|||+.+|
T Consensus       228 ~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei  304 (325)
T 3kul_A          228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI  304 (325)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence            8888999999999999999999 99999887665433322221   2223345689999999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      ++.
T Consensus       305 l~~  307 (325)
T 3kul_A          305 VSV  307 (325)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=2.9e-29  Score=236.62  Aligned_cols=155  Identities=27%  Similarity=0.442  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcEEEec--------CCcEEEEecCCceeeccCCCccCCcCccCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG---IAHRDLKPENVLLDL--------QDTLKISDFGLATVFRMNGKERPLDKKCGT   69 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g---IvHrDLkp~NILld~--------~g~lkL~DFGla~~~~~~~~~~~~~~~~gt   69 (407)
                      +++.++..++.||+.||.|||++|   |+||||||+||+++.        ++.+||+|||++.......    .....||
T Consensus       102 ~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~  177 (271)
T 3dtc_A          102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGA  177 (271)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCc
Confidence            578899999999999999999999   999999999999986        6789999999997654322    2345799


Q ss_pred             CCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         70 LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        70 ~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                      +.|+|||++.+..++.++||||+|+++|+|++|..||...............  ....+....+++.+.++|.+||+.||
T Consensus       178 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p  255 (271)
T 3dtc_A          178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN--KLALPIPSTCPEPFAKLMEDCWNPDP  255 (271)
T ss_dssp             GGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS--CCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             cceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC--CCCCCCCcccCHHHHHHHHHHhcCCc
Confidence            9999999999888899999999999999999999999987765443333322  22333346688999999999999999


Q ss_pred             CCCCCHHHHHhC
Q psy11119        150 STRLNIEKIKSH  161 (407)
Q Consensus       150 ~~Rps~~eil~h  161 (407)
                      .+|||+.+++++
T Consensus       256 ~~Rps~~e~l~~  267 (271)
T 3dtc_A          256 HSRPSFTNILDQ  267 (271)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             ccCcCHHHHHHH
Confidence            999999999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=247.48  Aligned_cols=161  Identities=17%  Similarity=0.331  Sum_probs=128.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC--cEEEEecCCceeeccCCCc-----cCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKE-----RPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g--~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~   73 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.+......     .......||+.|+
T Consensus       156 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  235 (352)
T 2jii_A          156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI  235 (352)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcccc
Confidence            57899999999999999999999999999999999999998  8999999999865432211     1224458999999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh----hcc---cCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK----DNR---HMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~----~~~---~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      |||++.+..++.++|||||||++|+|++|..||..............    ...   ......+..+++++.+||.+||.
T Consensus       236 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  315 (352)
T 2jii_A          236 SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMA  315 (352)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHT
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHh
Confidence            99999988889999999999999999999999986542222221111    111   11122234679999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .||.+|||+.++++.
T Consensus       316 ~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          316 LTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999774

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=2.7e-29  Score=238.56  Aligned_cols=158  Identities=20%  Similarity=0.306  Sum_probs=130.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ........+|+.|+|||++.+
T Consensus       117 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  195 (283)
T 3gen_A          117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMY  195 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhcc
Confidence            5788999999999999999999999999999999999999999999999997653221 122334567888999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||...............   ........+++.+.+||.+||+.+|.+|||+.+++
T Consensus       196 ~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  272 (283)
T 3gen_A          196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILL  272 (283)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            888999999999999999998 99999887765433322222   22223355789999999999999999999999999


Q ss_pred             hCc
Q psy11119        160 SHR  162 (407)
Q Consensus       160 ~hp  162 (407)
                      +|-
T Consensus       273 ~~L  275 (283)
T 3gen_A          273 SNI  275 (283)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            873

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=4.5e-29  Score=236.93  Aligned_cols=157  Identities=18%  Similarity=0.242  Sum_probs=126.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+
T Consensus       110 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  188 (281)
T 3cc6_A          110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINF  188 (281)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhcc
Confidence            46788999999999999999999999999999999999999999999999976543221 12234567889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... .  ..+....+++.+.++|.+||..+|.+|||+.+++
T Consensus       189 ~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell  265 (281)
T 3cc6_A          189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-D--RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV  265 (281)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-C--CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            888999999999999999998 99999866555433322222 1  1223355789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       266 ~~  267 (281)
T 3cc6_A          266 CS  267 (281)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=1.6e-29  Score=245.08  Aligned_cols=163  Identities=23%  Similarity=0.286  Sum_probs=127.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+
T Consensus       136 ~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  215 (321)
T 2qkw_B          136 MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK  215 (321)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence            46789999999999999999999999999999999999999999999999986543333333345578999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH----HHHH-HHhhcccC--------CCCCCCcCCHHHHHHHHHhccC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADC----IEYL-EWKDNRHM--------QRSPWDRLDVNCLSLIRRILAP  147 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~----~~~~-~~~~~~~~--------~~~~~~~~s~~~~~LI~~~L~~  147 (407)
                      ..++.++||||+||++|+|++|+.||.......    .... ........        ........+..+.++|.+||+.
T Consensus       216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  295 (321)
T 2qkw_B          216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL  295 (321)
T ss_dssp             CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred             CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence            888999999999999999999999997543221    1110 00000100        0111123456789999999999


Q ss_pred             CCCCCCCHHHHHhCcc
Q psy11119        148 LPSTRLNIEKIKSHRW  163 (407)
Q Consensus       148 ~P~~Rps~~eil~hpw  163 (407)
                      ||++|||+.+++++..
T Consensus       296 dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          296 SSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             CcccCcCHHHHHHHHH
Confidence            9999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=4e-29  Score=238.97  Aligned_cols=160  Identities=21%  Similarity=0.348  Sum_probs=123.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+++.|+|||++.
T Consensus       111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (295)
T 3ugc_A          111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT  190 (295)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence            478889999999999999999999999999999999999999999999999876433221 2223445777899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--------------HHHHhhcccCCCCCCCcCCHHHHHHHHHhc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--------------YLEWKDNRHMQRSPWDRLDVNCLSLIRRIL  145 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L  145 (407)
                      +..++.++||||+||++|+|++|..||.........              ...... .....+....+++++.+||.+||
T Consensus       191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l  269 (295)
T 3ugc_A          191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECW  269 (295)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHS
T ss_pred             CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh-ccCcCCCCcCcCHHHHHHHHHHc
Confidence            888999999999999999999999998754322110              001111 12223334678999999999999


Q ss_pred             cCCCCCCCCHHHHHhC
Q psy11119        146 APLPSTRLNIEKIKSH  161 (407)
Q Consensus       146 ~~~P~~Rps~~eil~h  161 (407)
                      +.||.+|||+.++++.
T Consensus       270 ~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          270 NNNVNQRPSFRDLALR  285 (295)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCChhhCCCHHHHHHH
Confidence            9999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=5.3e-29  Score=242.88  Aligned_cols=158  Identities=24%  Similarity=0.366  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+
T Consensus       154 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  233 (334)
T 2pvf_A          154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  233 (334)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence            46788999999999999999999999999999999999999999999999987654333233344567889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............ ....  .......++.++.++|.+||..+|.+|||+.+++
T Consensus       234 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  310 (334)
T 2pvf_A          234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV  310 (334)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH-hcCC--CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999999 99999887655433222 2211  1223356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       311 ~~  312 (334)
T 2pvf_A          311 ED  312 (334)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=4e-29  Score=237.80  Aligned_cols=159  Identities=24%  Similarity=0.359  Sum_probs=129.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+|+.|+|||++.
T Consensus       118 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (291)
T 1u46_A          118 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  197 (291)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence            468899999999999999999999999999999999999999999999999876433221 1233456788999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+|+++|+|++ |..||...+...........  ....+....++.++.++|.+||..||.+|||+.++
T Consensus       198 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  275 (291)
T 1u46_A          198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  275 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence            8888899999999999999999 99999887765433332222  22233345689999999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      +++
T Consensus       276 ~~~  278 (291)
T 1u46_A          276 RDF  278 (291)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=9.2e-30  Score=245.32  Aligned_cols=155  Identities=23%  Similarity=0.309  Sum_probs=123.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc------------CCcCccC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER------------PLDKKCG   68 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~------------~~~~~~g   68 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........            .....+|
T Consensus       105 ~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  184 (310)
T 3s95_A          105 YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG  184 (310)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence            4788999999999999999999999999999999999999999999999998754332111            1125689


Q ss_pred             CCCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH----HHHHhhcccCCCCCCCcCCHHHHHHHHHh
Q psy11119         69 TLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE----YLEWKDNRHMQRSPWDRLDVNCLSLIRRI  144 (407)
Q Consensus        69 t~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~~LI~~~  144 (407)
                      |+.|+|||++.+..++.++||||+||++|+|++|..||.........    ......     ......+++.+.+||.+|
T Consensus       185 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~  259 (310)
T 3s95_A          185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-----RYCPPNCPPSFFPITVRC  259 (310)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-----HTCCTTCCTTHHHHHHHH
T ss_pred             CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-----ccCCCCCCHHHHHHHHHH
Confidence            99999999999988999999999999999999999998653321110    000011     011245678899999999


Q ss_pred             ccCCCCCCCCHHHHHh
Q psy11119        145 LAPLPSTRLNIEKIKS  160 (407)
Q Consensus       145 L~~~P~~Rps~~eil~  160 (407)
                      |+.||.+|||+.++++
T Consensus       260 l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          260 CDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=1.4e-29  Score=245.96  Aligned_cols=161  Identities=25%  Similarity=0.311  Sum_probs=124.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK----------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~----------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~   70 (407)
                      +++.++..++.||+.||.|||+.          ||+||||||+|||++.++.+||+|||+++.+............+||+
T Consensus       118 ~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~  197 (322)
T 3soc_A          118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR  197 (322)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence            47889999999999999999999          99999999999999999999999999998876544444445578999


Q ss_pred             CCCchhhhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCChh--------------HHHHHHHhhcccCCCCC--
Q psy11119         71 PYVAPEVLVRS-----YLAEPADIWSCGIILVAMLAGELPWDKPTAD--------------CIEYLEWKDNRHMQRSP--  129 (407)
Q Consensus        71 ~Y~APE~l~~~-----~~~~~sDiwSlGviL~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~--  129 (407)
                      .|+|||++.+.     .++.++||||+||++|+|++|..||......              .................  
T Consensus       198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (322)
T 3soc_A          198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD  277 (322)
T ss_dssp             GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence            99999999863     4556789999999999999999999754221              01111111111111110  


Q ss_pred             -C--CcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        130 -W--DRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       130 -~--~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                       +  ...++++.+||.+||+.||.+|||+.++++.
T Consensus       278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             0  1123559999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=3.1e-29  Score=243.63  Aligned_cols=164  Identities=20%  Similarity=0.327  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC---CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ---DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~---g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++................||+.|+|||+
T Consensus       137 ~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhH
Confidence            4678899999999999999999999999999999999954   4599999999976543333333345578999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++|||||||++|+|++ |..||............... .  .......+++.+.+||.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  293 (327)
T 2yfx_A          217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-G--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  293 (327)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-C--CCCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            998888999999999999999998 99999877655433222221 1  2223456889999999999999999999999


Q ss_pred             HHHhCcccccC
Q psy11119        157 KIKSHRWYSKH  167 (407)
Q Consensus       157 eil~hpwf~~~  167 (407)
                      +++++.|+...
T Consensus       294 ~ll~~l~~~~~  304 (327)
T 2yfx_A          294 IILERIEYCTQ  304 (327)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhc
Confidence            99999987653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=6.8e-29  Score=239.02  Aligned_cols=159  Identities=25%  Similarity=0.398  Sum_probs=119.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  .......|++.|+|||++.+
T Consensus       133 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  210 (310)
T 2wqm_A          133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE  210 (310)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCC
Confidence            4688899999999999999999999999999999999999999999999987654322  22334579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||||+++|+|++|..||..........................+++++.+||.+||..||.+|||+.++++
T Consensus       211 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            88899999999999999999999999765433222222222233333334668999999999999999999999999987


Q ss_pred             C
Q psy11119        161 H  161 (407)
Q Consensus       161 h  161 (407)
                      +
T Consensus       291 ~  291 (310)
T 2wqm_A          291 V  291 (310)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=4.1e-29  Score=248.42  Aligned_cols=158  Identities=23%  Similarity=0.296  Sum_probs=127.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+
T Consensus       210 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  289 (377)
T 3cbl_A          210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY  289 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc
Confidence            46788999999999999999999999999999999999999999999999976432211111122345778999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............... .  ..+.+..+++++.+||.+||+.||.+|||+.+++
T Consensus       290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  366 (377)
T 3cbl_A          290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-G--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY  366 (377)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            888999999999999999998 99999887655433222111 1  2223356789999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       367 ~~  368 (377)
T 3cbl_A          367 QE  368 (377)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=9.8e-29  Score=236.00  Aligned_cols=157  Identities=21%  Similarity=0.307  Sum_probs=128.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||++.
T Consensus       114 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence            578899999999999999999999999999999999999999999999999876433221 1223345678999999998


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+|+++|+|++ |..||............... .  .......+++++.++|.+||+.||.+||++.++
T Consensus       194 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            8888899999999999999999 99999987765433322221 1  122335689999999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       271 ~~  272 (291)
T 1xbb_A          271 EL  272 (291)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=9.2e-29  Score=236.57  Aligned_cols=158  Identities=22%  Similarity=0.282  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......  ........||+.|+|||++
T Consensus       125 ~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHh
Confidence            46788999999999999999999999999999999999999999999999986533221  1223445678899999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      .+..++.++||||+||++|+|++ |.+||................   .......+++.+.++|.+||+.+|.+|||+.+
T Consensus       205 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            98889999999999999999999 677777665544333332221   12223457899999999999999999999999


Q ss_pred             HHhC
Q psy11119        158 IKSH  161 (407)
Q Consensus       158 il~h  161 (407)
                      +++.
T Consensus       282 ll~~  285 (298)
T 3f66_A          282 LVSR  285 (298)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=2.8e-29  Score=240.03  Aligned_cols=161  Identities=25%  Similarity=0.367  Sum_probs=122.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH--------SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH--------~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~   70 (407)
                      +++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+|||+++........  ......+||+
T Consensus       102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  181 (301)
T 3q4u_A          102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK  181 (301)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCG
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccccc
Confidence            468889999999999999999        999999999999999999999999999999876543321  1233458999


Q ss_pred             CCCchhhhhcC------CCCCcchhhhHHHHHHHHHhC----------CCCCCCCChhH---HHHHHHh-hcccCCCCC-
Q psy11119         71 PYVAPEVLVRS------YLAEPADIWSCGIILVAMLAG----------ELPWDKPTADC---IEYLEWK-DNRHMQRSP-  129 (407)
Q Consensus        71 ~Y~APE~l~~~------~~~~~sDiwSlGviL~elltG----------~~Pf~~~~~~~---~~~~~~~-~~~~~~~~~-  129 (407)
                      .|+|||++.+.      .++.++||||+||++|+|++|          ..||.......   ....... ........+ 
T Consensus       182 ~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (301)
T 3q4u_A          182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN  261 (301)
T ss_dssp             GGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh
Confidence            99999999876      344689999999999999999          88886532211   1111111 111111111 


Q ss_pred             ---CCcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        130 ---WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       130 ---~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                         ....++++.+||.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence               12245789999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.3e-28  Score=235.19  Aligned_cols=158  Identities=22%  Similarity=0.288  Sum_probs=126.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC--CccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG--KERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......  .........+++.|+|||.+
T Consensus       121 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL  200 (298)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhh
Confidence            4678899999999999999999999999999999999999999999999997543221  11223445688999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      .+..++.++||||+||++|+|++ |.+||............... .  ..+....+++.+.+||.+||+.||.+|||+.+
T Consensus       201 ~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R--RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-C--CCCCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence            98888999999999999999999 55556555544333222222 1  22233567899999999999999999999999


Q ss_pred             HHhC
Q psy11119        158 IKSH  161 (407)
Q Consensus       158 il~h  161 (407)
                      +++.
T Consensus       278 ll~~  281 (298)
T 3pls_A          278 LVGE  281 (298)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=8.4e-29  Score=240.56  Aligned_cols=156  Identities=22%  Similarity=0.297  Sum_probs=127.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....   ........+++.|+|||++.+
T Consensus       139 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~  215 (327)
T 1fvr_A          139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNY  215 (327)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhcc
Confidence            46889999999999999999999999999999999999999999999999874321   122234467889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.......... ....  .........+++++.+||.+||..+|.+|||+.+++
T Consensus       216 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  292 (327)
T 1fvr_A          216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  292 (327)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HGGG--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-Hhhc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999998 999998876553322 2222  122233456899999999999999999999999999


Q ss_pred             hCc
Q psy11119        160 SHR  162 (407)
Q Consensus       160 ~hp  162 (407)
                      ++-
T Consensus       293 ~~L  295 (327)
T 1fvr_A          293 VSL  295 (327)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.7e-28  Score=236.81  Aligned_cols=155  Identities=32%  Similarity=0.435  Sum_probs=121.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCcEEEecCCc-EEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS---KGIAHRDLKPENVLLDLQDT-LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~---~gIvHrDLkp~NILld~~g~-lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++..+..++.||+.||.|||+   +||+||||||+||+++.++. +||+|||++......     .....||+.|+|||
T Consensus        99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE  173 (307)
T 2eva_A           99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPE  173 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChh
Confidence            3577889999999999999999   89999999999999998887 799999999754321     23456999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|+.||............... ..........+++.+.+||.+||+.||.+|||+.
T Consensus       174 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  252 (307)
T 2eva_A          174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSME  252 (307)
T ss_dssp             HHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHH
Confidence            999888899999999999999999999999865433222221111 1222333466899999999999999999999999


Q ss_pred             HHHhC
Q psy11119        157 KIKSH  161 (407)
Q Consensus       157 eil~h  161 (407)
                      +++++
T Consensus       253 ell~~  257 (307)
T 2eva_A          253 EIVKI  257 (307)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99884

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=9.2e-29  Score=232.41  Aligned_cols=157  Identities=17%  Similarity=0.309  Sum_probs=129.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .........+++.|+|||++.+
T Consensus       101 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~  179 (267)
T 3t9t_A          101 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSF  179 (267)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc-cccccccccccccccChhhhcC
Confidence            468889999999999999999999999999999999999999999999998764321 1122334567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||...............   ........+++.+.++|.+||+.+|.+|||+.+++
T Consensus       180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  256 (267)
T 3t9t_A          180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLL  256 (267)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC---CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHH
Confidence            888999999999999999999 99999887655433222211   12222345789999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       257 ~~  258 (267)
T 3t9t_A          257 RQ  258 (267)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=1.8e-28  Score=232.31  Aligned_cols=156  Identities=22%  Similarity=0.344  Sum_probs=129.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+
T Consensus       106 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  184 (279)
T 1qpc_A          106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY  184 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhcc
Confidence            47889999999999999999999999999999999999999999999999987643321 22234567889999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||............ ..  .........+++++.+||.+||..+|++|||+.+++
T Consensus       185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  261 (279)
T 1qpc_A          185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR  261 (279)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hc--ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHH
Confidence            888999999999999999999 99999877655332222 22  112223356889999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       262 ~  262 (279)
T 1qpc_A          262 S  262 (279)
T ss_dssp             H
T ss_pred             H
Confidence            7

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=1.1e-28  Score=236.29  Aligned_cols=159  Identities=24%  Similarity=0.335  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.
T Consensus       123 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence            578899999999999999999999999999999999999999999999999876543321 2334567888999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh------------H-HHHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTAD------------C-IEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~------------~-~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +..++.++||||+||++|+|++|..|+......            . ........ .....+....+++++.+||.+||+
T Consensus       203 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  281 (302)
T 4e5w_A          203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWE  281 (302)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred             CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHcC
Confidence            888889999999999999999999987432111            0 01111111 122233345689999999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .||.+|||+.++++
T Consensus       282 ~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          282 FQPSNRTSFQNLIE  295 (302)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.9e-28  Score=232.20  Aligned_cols=152  Identities=22%  Similarity=0.319  Sum_probs=122.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......     .....+++.|+|||++.+
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  188 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE  188 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCC
Confidence            467889999999999999999999999999999999999999999999998754322     223467889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||............. .  .........+++.+.++|.+||..||.+|||+.+++
T Consensus       189 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  265 (278)
T 1byg_A          189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-K--GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR  265 (278)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-T--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-c--CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            888999999999999999998 999998776554332221 1  122233456899999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       266 ~  266 (278)
T 1byg_A          266 E  266 (278)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=1.6e-28  Score=232.66  Aligned_cols=157  Identities=29%  Similarity=0.434  Sum_probs=130.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......   ......||+.|+|||++.+
T Consensus       119 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  195 (284)
T 2a19_B          119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISS  195 (284)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhcc
Confidence            4788899999999999999999999999999999999999999999999998764332   2345579999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|..||....   ........ .    .....++..+.+||.+||..||.+|||+.++++
T Consensus       196 ~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~-~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  267 (284)
T 2a19_B          196 QDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLRD-G----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR  267 (284)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHHT-T----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhhc-c----cccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            888999999999999999999998874221   11111111 1    122457899999999999999999999999999


Q ss_pred             CcccccCC
Q psy11119        161 HRWYSKHM  168 (407)
Q Consensus       161 hpwf~~~~  168 (407)
                      |+|.-...
T Consensus       268 ~l~~~~~~  275 (284)
T 2a19_B          268 TLTVWKKS  275 (284)
T ss_dssp             HHHHHTC-
T ss_pred             HHHHHhhC
Confidence            99876643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.95  E-value=4.8e-29  Score=241.73  Aligned_cols=158  Identities=30%  Similarity=0.366  Sum_probs=110.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc----------cCCcCccC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE----------RPLDKKCG   68 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~----------~~~~~~~g   68 (407)
                      +++.++..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++.........          ......+|
T Consensus       133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (337)
T 3ll6_A          133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT  212 (337)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence            578899999999999999999999  999999999999999999999999999865432211          11124569


Q ss_pred             CCCCCchhhh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhc
Q psy11119         69 TLPYVAPEVL---VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRIL  145 (407)
Q Consensus        69 t~~Y~APE~l---~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L  145 (407)
                      |+.|+|||++   .+..++.++|||||||++|+|++|..||.........    .  .....+.....+..+.+||.+||
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~li~~~l  286 (337)
T 3ll6_A          213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----N--GKYSIPPHDTQYTVFHSLIRAML  286 (337)
T ss_dssp             -----------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHS
T ss_pred             CCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----c--CcccCCcccccchHHHHHHHHHc
Confidence            9999999998   4557888999999999999999999999765432111    1  12223334556788999999999


Q ss_pred             cCCCCCCCCHHHHHhCccc
Q psy11119        146 APLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       146 ~~~P~~Rps~~eil~hpwf  164 (407)
                      +.||.+|||+.++++|.+-
T Consensus       287 ~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          287 QVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             CSSGGGSCCHHHHHHHHHH
T ss_pred             cCChhhCcCHHHHHHHHHH
Confidence            9999999999999998643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.2e-28  Score=245.08  Aligned_cols=158  Identities=22%  Similarity=0.291  Sum_probs=119.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........  .......+|+.|+|||++
T Consensus       189 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHh
Confidence            357789999999999999999999999999999999999999999999999865432211  122344678899999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      .+..++.++||||+||++|+|++ |.+||...+........... ..  ......+++.+.++|.+||..+|.+|||+.+
T Consensus       269 ~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~--~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e  345 (373)
T 3c1x_A          269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  345 (373)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            98889999999999999999999 78888766544333322222 11  2223457899999999999999999999999


Q ss_pred             HHhC
Q psy11119        158 IKSH  161 (407)
Q Consensus       158 il~h  161 (407)
                      ++++
T Consensus       346 ll~~  349 (373)
T 3c1x_A          346 LVSR  349 (373)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=8.6e-29  Score=240.51  Aligned_cols=160  Identities=23%  Similarity=0.381  Sum_probs=129.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ........||+.|+|||++.
T Consensus       124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (327)
T 3lxl_A          124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS  203 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence            57889999999999999999999999999999999999999999999999987643322 12334456888999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH-------------HHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI-------------EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +..++.++||||+||++|+|++|..||........             ....... .....+....+++++.+||.+||+
T Consensus       204 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  282 (327)
T 3lxl_A          204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-EGQRLPAPPACPAEVHELMKLCWA  282 (327)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh-cccCCCCCCcccHHHHHHHHHHcC
Confidence            88889999999999999999999999865433211             1111111 122233345689999999999999


Q ss_pred             CCCCCCCCHHHHHhC
Q psy11119        147 PLPSTRLNIEKIKSH  161 (407)
Q Consensus       147 ~~P~~Rps~~eil~h  161 (407)
                      .||.+|||+.+++++
T Consensus       283 ~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          283 PSPQDRPSFSALGPQ  297 (327)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=1.6e-28  Score=252.24  Aligned_cols=160  Identities=24%  Similarity=0.347  Sum_probs=127.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---ecCCcEEEEecCCceeeccCCCc-----cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL---DLQDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl---d~~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y   72 (407)
                      |++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+......     ......+||+.|
T Consensus       100 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y  179 (483)
T 3sv0_A          100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY  179 (483)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccc
Confidence            5788999999999999999999999999999999999   68899999999999876543321     122366899999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH--HHHHHHhhcc--cCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC--IEYLEWKDNR--HMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      +|||++.+..++.++|||||||+||+|++|..||.......  ..+.......  .........++.++.+||.+||..+
T Consensus       180 ~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~d  259 (483)
T 3sv0_A          180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLR  259 (483)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCC
T ss_pred             cCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCC
Confidence            99999999889999999999999999999999998654321  1111111110  1111112457899999999999999


Q ss_pred             CCCCCCHHHHHh
Q psy11119        149 PSTRLNIEKIKS  160 (407)
Q Consensus       149 P~~Rps~~eil~  160 (407)
                      |.+||++.+|++
T Consensus       260 P~~RPs~~el~~  271 (483)
T 3sv0_A          260 FDDKPDYSYLKR  271 (483)
T ss_dssp             TTCCCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999988765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.1e-28  Score=237.82  Aligned_cols=158  Identities=21%  Similarity=0.327  Sum_probs=122.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ........+|+.|+|||++.
T Consensus       144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (333)
T 1mqb_A          144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  223 (333)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc
Confidence            47889999999999999999999999999999999999999999999999987543321 11222345678899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+||++|+|++ |..||............ ...  ...+....+++.+.+||.+||+.+|.+||++.++
T Consensus       224 ~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDG--FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTT--CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HCC--CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            8888999999999999999999 99999877654433222 221  1222335688999999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      +++
T Consensus       301 ~~~  303 (333)
T 1mqb_A          301 VSI  303 (333)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.8e-28  Score=236.63  Aligned_cols=159  Identities=26%  Similarity=0.353  Sum_probs=118.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ........|++.|+|||++.+
T Consensus       131 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  209 (309)
T 2h34_A          131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSE  209 (309)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcC
Confidence            5788999999999999999999999999999999999999999999999987654322 122345679999999999988


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-CHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-NIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-s~~eil  159 (407)
                      ..++.++||||+|+++|+|++|..||........ ..............+..+++++.++|.+||+.||.+|| ++++++
T Consensus       210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~  288 (309)
T 2h34_A          210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS  288 (309)
T ss_dssp             ----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence            8889999999999999999999999987665422 22222222222233456889999999999999999999 888887


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       289 ~~  290 (309)
T 2h34_A          289 AA  290 (309)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=1.9e-28  Score=249.67  Aligned_cols=156  Identities=22%  Similarity=0.347  Sum_probs=128.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ........+++.|+|||++..
T Consensus       281 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  359 (454)
T 1qcf_A          281 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINF  359 (454)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhcc
Confidence            4677889999999999999999999999999999999999999999999998653211 112233456788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.+.............   ...+.+..+++++.+||.+||+.||.+|||+.+|+
T Consensus       360 ~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~  436 (454)
T 1qcf_A          360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ  436 (454)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            889999999999999999999 99999887665433322221   22233456899999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       437 ~  437 (454)
T 1qcf_A          437 S  437 (454)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.9e-28  Score=228.96  Aligned_cols=152  Identities=21%  Similarity=0.294  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.++..++.||+.||.|||++|  |+||||||+||+++.++.++|+|||++...       ......||+.|+|||++
T Consensus       108 ~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-------~~~~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEAL  180 (271)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-------SCTTCBSCGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-------cccCccCCccccChhhh
Confidence            578899999999999999999999  999999999999999999999999886532       22345789999999999


Q ss_pred             hcCCCCC---cchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         79 VRSYLAE---PADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        79 ~~~~~~~---~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .+..++.   ++||||+||++|+|++|..||...............  ......+..+++++.++|.+||+.||.+|||+
T Consensus       181 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (271)
T 3kmu_A          181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--GLRPTIPPGISPHVSKLMKICMNEDPAKRPKF  258 (271)
T ss_dssp             HSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS--CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            8764333   799999999999999999999887765443333333  22223345689999999999999999999999


Q ss_pred             HHHHhC
Q psy11119        156 EKIKSH  161 (407)
Q Consensus       156 ~eil~h  161 (407)
                      .++++.
T Consensus       259 ~~il~~  264 (271)
T 3kmu_A          259 DMIVPI  264 (271)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.2e-28  Score=237.59  Aligned_cols=161  Identities=30%  Similarity=0.381  Sum_probs=121.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK--------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~--------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~   70 (407)
                      +++.++..++.|++.||.|||++        ||+||||||+|||++.++.+||+|||++..+......  ......+||+
T Consensus       131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  210 (337)
T 3mdy_A          131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK  210 (337)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCc
Confidence            46888999999999999999999        9999999999999999999999999999765433221  1223568999


Q ss_pred             CCCchhhhhcCCCCCc------chhhhHHHHHHHHHhC----------CCCCCCCChhH---HHHHHHhhcccCCCCCC-
Q psy11119         71 PYVAPEVLVRSYLAEP------ADIWSCGIILVAMLAG----------ELPWDKPTADC---IEYLEWKDNRHMQRSPW-  130 (407)
Q Consensus        71 ~Y~APE~l~~~~~~~~------sDiwSlGviL~elltG----------~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~-  130 (407)
                      .|+|||++.+......      +||||+||++|+|++|          ..||.......   ................. 
T Consensus       211 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
T 3mdy_A          211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN  290 (337)
T ss_dssp             GGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccc
Confidence            9999999987755555      9999999999999999          77775432211   11111111111111111 


Q ss_pred             ----CcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        131 ----DRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       131 ----~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                          ..+++++.+||.+||+.||.+|||+.++++|
T Consensus       291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                2456779999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=1e-28  Score=237.33  Aligned_cols=160  Identities=26%  Similarity=0.347  Sum_probs=124.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+
T Consensus       130 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence            46788999999999999999999999999999999999999999999999987644333333345679999999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--H-HHHhhcc--------cCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--Y-LEWKDNR--------HMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--~-~~~~~~~--------~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                      . ++.++|||||||++|+|++|..||.........  . .......        ..........+..+.++|.+||..+|
T Consensus       210 ~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  288 (307)
T 2nru_A          210 E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKK  288 (307)
T ss_dssp             E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSST
T ss_pred             C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCc
Confidence            4 678999999999999999999999765432110  0 0000000        00111123345678999999999999


Q ss_pred             CCCCCHHHHHhC
Q psy11119        150 STRLNIEKIKSH  161 (407)
Q Consensus       150 ~~Rps~~eil~h  161 (407)
                      .+|||+.+++++
T Consensus       289 ~~Rps~~~l~~~  300 (307)
T 2nru_A          289 NKRPDIKKVQQL  300 (307)
T ss_dssp             TTSCCHHHHHHH
T ss_pred             ccCcCHHHHHHH
Confidence            999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=7e-29  Score=245.09  Aligned_cols=158  Identities=18%  Similarity=0.190  Sum_probs=125.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-----------CCcEEEEecCCceeeccCCCccCCcCccCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-----------QDTLKISDFGLATVFRMNGKERPLDKKCGT   69 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-----------~g~lkL~DFGla~~~~~~~~~~~~~~~~gt   69 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.           ++.+||+|||+++.+............+||
T Consensus       169 l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt  248 (365)
T 3e7e_A          169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET  248 (365)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence            578899999999999999999999999999999999998           899999999999876544344445667899


Q ss_pred             CCCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCC
Q psy11119         70 LPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP  149 (407)
Q Consensus        70 ~~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P  149 (407)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.......     +..  ...... ...++.+.+++.+||+.+|
T Consensus       249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~--~~~~~~-~~~~~~~~~~~~~~l~~~p  320 (365)
T 3e7e_A          249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CKP--EGLFRR-LPHLDMWNEFFHVMLNIPD  320 (365)
T ss_dssp             TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----EEE--CSCCTT-CSSHHHHHHHHHHHHCCCC
T ss_pred             CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----eee--chhccc-cCcHHHHHHHHHHHcCCCC
Confidence            99999999999889999999999999999999999996433211     000  111111 1246778999999999999


Q ss_pred             CCCCC-HHHHHh--Cccccc
Q psy11119        150 STRLN-IEKIKS--HRWYSK  166 (407)
Q Consensus       150 ~~Rps-~~eil~--hpwf~~  166 (407)
                      .+|++ +.++.+  ..|+.+
T Consensus       321 ~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          321 CHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHHHHHHHHHHHHH
Confidence            99965 444443  445544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=2.6e-28  Score=242.52  Aligned_cols=158  Identities=23%  Similarity=0.339  Sum_probs=117.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.
T Consensus       144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (373)
T 2qol_A          144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA  223 (373)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc
Confidence            467889999999999999999999999999999999999999999999999876433211 1122234578899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|||||||++|+|++ |..||...............   ...+....++..+.+||.+||+.+|.+||++.++
T Consensus       224 ~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i  300 (373)
T 2qol_A          224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI  300 (373)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence            8889999999999999999998 99999877655433222211   1223345678999999999999999999999999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      ++.
T Consensus       301 ~~~  303 (373)
T 2qol_A          301 VSI  303 (373)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=1.7e-28  Score=233.30  Aligned_cols=157  Identities=22%  Similarity=0.296  Sum_probs=129.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ........+|+.|+|||++.+
T Consensus       108 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  186 (288)
T 3kfa_A          108 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY  186 (288)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHH
T ss_pred             ccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhcc
Confidence            4678899999999999999999999999999999999999999999999997654222 122234457889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+|+++|+|++ |..||............. .  .........+++.+.+||.+||..||.+|||+.+++
T Consensus       187 ~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~  263 (288)
T 3kfa_A          187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-K--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH  263 (288)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-c--cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHH
Confidence            889999999999999999999 999998776554333222 2  222233456899999999999999999999999997


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       264 ~~  265 (288)
T 3kfa_A          264 QA  265 (288)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=99.95  E-value=8.1e-29  Score=206.51  Aligned_cols=117  Identities=15%  Similarity=0.174  Sum_probs=101.4

Q ss_pred             cccCCccccccCCCCcccccccccccCCCCCCCcccCcccccchHHHHHhhhCCCCccccccccccchhhhhhhhhcccC
Q psy11119        224 CEVEPHLFSFSQPTHLDDLLVSSQFVSTQSTQSNQHGTEASQKDDQVLRKIHGGGGCRKTLYDVGQAGLLVAILFSCHIR  303 (407)
Q Consensus       224 ~~~a~~~~SfSqp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (407)
                      .+|||++||||++++|++||...+                                                     ..+
T Consensus         5 ~lNAFdiIs~S~g~dLSgLFe~~~-----------------------------------------------------~~~   31 (123)
T 2zfd_B            5 RMNAFDIISGSPGFNLSGLFGDAR-----------------------------------------------------KYD   31 (123)
T ss_dssp             CCCHHHHHHTSTTSSSGGGGGGGC-----------------------------------------------------SSC
T ss_pred             cccHHHHHHHCcCCCchHhcCccc-----------------------------------------------------ccc
Confidence            579999999999999999875210                                                     247


Q ss_pred             CceeeEEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecCCCCeeEEEEEEEEec-CeEEEEEEeccCCchHHHHH
Q psy11119        304 RMTRFFVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSRKAQLVFKASVLTLD-NQTLLDFRLSKGCGIEFKTR  382 (407)
Q Consensus       304 r~tRF~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~rk~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE~~~~  382 (407)
                      |+|||+|+.|+++|+++||++++.+||+|++++++   ..+.+||||+|++.++||||+ .++||||||++||++||++|
T Consensus        32 r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~  108 (123)
T 2zfd_B           32 RVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDL  108 (123)
T ss_dssp             CCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEEEEEEEECSSSCEEEEEEEEESCC---CCH
T ss_pred             cceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEEEEEEEEecCCEEEEEEEecCCChHHHHHH
Confidence            89999999999999999999999999999988765   556789999999999999998 88999999999999999996


Q ss_pred             HH-HHHHhhhhhhhc
Q psy11119        383 FL-CIKRALAEDIIN  396 (407)
Q Consensus       383 f~-~~~~~l~~~v~~  396 (407)
                      |. +|+++|+||||.
T Consensus       109 ~~~~L~~~L~diV~~  123 (123)
T 2zfd_B          109 WTDTLRPFFVELVHE  123 (123)
T ss_dssp             HHHTHHHHHHHTBC-
T ss_pred             HHHHHHHHHhhhhcC
Confidence            65 699999999984

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=233.72  Aligned_cols=158  Identities=23%  Similarity=0.355  Sum_probs=123.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCC---CccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG---KERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~---~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++......   .........||+.|+|||+
T Consensus       127 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             CCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHH
Confidence            46788999999999999999999999999999999998 7899999999987543211   1223344568999999999


Q ss_pred             hhc---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         78 LVR---------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        78 l~~---------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      +.+         ..++.++||||+||++|+|++|..||...............  .........++.++.++|.+||..|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~  283 (319)
T 2y4i_B          206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--MKPNLSQIGMGKEISDILLFCWAFE  283 (319)
T ss_dssp             HSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT--CCCCCCCSSCCTTHHHHHHHHHCSS
T ss_pred             hhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC--CCCCCCcCCCCHHHHHHHHHHhcCC
Confidence            975         35788999999999999999999999887765433322222  2222223457889999999999999


Q ss_pred             CCCCCCHHHHHhC
Q psy11119        149 PSTRLNIEKIKSH  161 (407)
Q Consensus       149 P~~Rps~~eil~h  161 (407)
                      |.+|||+.++++.
T Consensus       284 p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          284 QEERPTFTKLMDM  296 (319)
T ss_dssp             TTTSCCHHHHHHH
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999884

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.95  E-value=3.1e-28  Score=236.05  Aligned_cols=163  Identities=23%  Similarity=0.356  Sum_probs=125.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSK---GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~---gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++........ .......||+.|+|||+
T Consensus       128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~  206 (326)
T 3uim_A          128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEY  206 (326)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHH
Confidence            46788999999999999999999   999999999999999999999999999987643322 22344569999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhc----cc--------CCCCCCCcCCHHHHHHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTA---DCIEYLEWKDN----RH--------MQRSPWDRLDVNCLSLIR  142 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~----~~--------~~~~~~~~~s~~~~~LI~  142 (407)
                      +.+..++.++||||+||++|+|++|..||.....   .......+...    ..        .........+..+.++|.
T Consensus       207 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (326)
T 3uim_A          207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL  286 (326)
T ss_dssp             HHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHH
T ss_pred             hccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHH
Confidence            9888889999999999999999999999952110   00011111110    00        000111223467899999


Q ss_pred             HhccCCCCCCCCHHHHHhCccc
Q psy11119        143 RILAPLPSTRLNIEKIKSHRWY  164 (407)
Q Consensus       143 ~~L~~~P~~Rps~~eil~hpwf  164 (407)
                      +||+.||.+|||+.++++|.+-
T Consensus       287 ~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          287 LCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhCcCCccCCCHHHHHHHhcC
Confidence            9999999999999999998753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=1.7e-28  Score=233.48  Aligned_cols=150  Identities=21%  Similarity=0.318  Sum_probs=120.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc--------EEEEecCCceeeccCCCccCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT--------LKISDFGLATVFRMNGKERPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~--------lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y   72 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.        +||+|||++....      ......||+.|
T Consensus       110 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y  183 (289)
T 4fvq_A          110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPW  183 (289)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcc
Confidence            477889999999999999999999999999999999999887        9999999986432      11234688999


Q ss_pred             Cchhhhhc-CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         73 VAPEVLVR-SYLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        73 ~APE~l~~-~~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      +|||++.+ ..++.++||||+||++|+|++| .+||....... .........    ......++++.+||.+||+.||.
T Consensus       184 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~  258 (289)
T 4fvq_A          184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRH----QLPAPKAAELANLINNCMDYEPD  258 (289)
T ss_dssp             SCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTC----CCCCCSSCTTHHHHHHHSCSSGG
T ss_pred             cCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccC----CCCCCCCHHHHHHHHHHcCCChh
Confidence            99999987 5789999999999999999995 55555544332 222222211    12233577899999999999999


Q ss_pred             CCCCHHHHHhC
Q psy11119        151 TRLNIEKIKSH  161 (407)
Q Consensus       151 ~Rps~~eil~h  161 (407)
                      +|||+.++++|
T Consensus       259 ~Rps~~~ll~~  269 (289)
T 4fvq_A          259 HRPSFRAIIRD  269 (289)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=239.85  Aligned_cols=166  Identities=22%  Similarity=0.301  Sum_probs=120.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCcEEEecCCcEEEEecCCceeeccCC------CccCCcCc
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSK---------GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNG------KERPLDKK   66 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~---------gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~------~~~~~~~~   66 (407)
                      ++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+|||+++.+....      ........
T Consensus       109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~  188 (336)
T 3g2f_A          109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE  188 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCT
T ss_pred             chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccC
Confidence            5678899999999999999999         99999999999999999999999999998764321      11223355


Q ss_pred             cCCCCCCchhhhhc-------CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh------------------hHHHHHHHhh
Q psy11119         67 CGTLPYVAPEVLVR-------SYLAEPADIWSCGIILVAMLAGELPWDKPTA------------------DCIEYLEWKD  121 (407)
Q Consensus        67 ~gt~~Y~APE~l~~-------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~------------------~~~~~~~~~~  121 (407)
                      +||+.|+|||++.+       ..++.++||||+||++|+|++|..||.....                  ..........
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (336)
T 3g2f_A          189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE  268 (336)
T ss_dssp             TSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS
T ss_pred             CCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc
Confidence            79999999999986       3556789999999999999999777532111                  0001111111


Q ss_pred             cccCCC----CCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh------CcccccC
Q psy11119        122 NRHMQR----SPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS------HRWYSKH  167 (407)
Q Consensus       122 ~~~~~~----~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~------hpwf~~~  167 (407)
                      ......    .....+++++.+||.+||+.||++|||+.++++      ++|-++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            111111    111224557999999999999999999999955      6666554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=6e-28  Score=245.77  Aligned_cols=152  Identities=22%  Similarity=0.326  Sum_probs=125.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....     .....+++.|+|||++.+
T Consensus       286 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~  360 (450)
T 1k9a_A          286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE  360 (450)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcC
Confidence            467889999999999999999999999999999999999999999999999854321     123367889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||............. .  ....+.+..+++++.+||.+||+.||.+|||+.+++
T Consensus       361 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~--~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~  437 (450)
T 1k9a_A          361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-K--GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLR  437 (450)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-T--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c--CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            889999999999999999998 999998766544332222 2  122233456899999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       438 ~  438 (450)
T 1k9a_A          438 E  438 (450)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=2.3e-28  Score=236.88  Aligned_cols=159  Identities=26%  Similarity=0.357  Sum_probs=127.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.
T Consensus       131 ~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  210 (318)
T 3lxp_A          131 IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK  210 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence            578899999999999999999999999999999999999999999999999876543221 2234456888899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH-------------HHHHHhhcccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI-------------EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      +..++.++||||+||++|+|++|..||........             ....... .....+....+++++.+||++||+
T Consensus       211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  289 (318)
T 3lxp_A          211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWE  289 (318)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh-cccCCCCCccccHHHHHHHHHHcC
Confidence            88888999999999999999999999975432211             0111111 122333446689999999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .||.+|||+.++++
T Consensus       290 ~dP~~Rps~~ell~  303 (318)
T 3lxp_A          290 TEASFRPTFENLIP  303 (318)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=7.9e-28  Score=245.01  Aligned_cols=162  Identities=20%  Similarity=0.307  Sum_probs=126.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ........+++.|+|||++..
T Consensus       277 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  355 (452)
T 1fmk_A          277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY  355 (452)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhc
Confidence            4678899999999999999999999999999999999999999999999998654321 112233457788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||.+.......... ..  ....+....+++.+.+||.+||+.||.+|||+++++
T Consensus       356 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~  432 (452)
T 1fmk_A          356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ  432 (452)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            889999999999999999999 99999887655433222 22  112223356899999999999999999999999998


Q ss_pred             h--Cccccc
Q psy11119        160 S--HRWYSK  166 (407)
Q Consensus       160 ~--hpwf~~  166 (407)
                      +  +.++..
T Consensus       433 ~~L~~~~~~  441 (452)
T 1fmk_A          433 AFLEDYFTS  441 (452)
T ss_dssp             HHHHTTTSC
T ss_pred             HHHHHHhcc
Confidence            7  345543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=6e-28  Score=255.97  Aligned_cols=157  Identities=21%  Similarity=0.307  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ........+|+.|+|||++.
T Consensus       466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~  545 (635)
T 4fl3_A          466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  545 (635)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence            57889999999999999999999999999999999999999999999999986543322 12233445788999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|||||||++|+|++ |..||.+............. .  .......+++++.+||.+||+.||++||++.+|
T Consensus       546 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  622 (635)
T 4fl3_A          546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  622 (635)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            8889999999999999999998 99999987765433332222 1  222335689999999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       623 ~~  624 (635)
T 4fl3_A          623 EL  624 (635)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=9.4e-29  Score=238.57  Aligned_cols=161  Identities=25%  Similarity=0.345  Sum_probs=124.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-------cCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-------RPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-------~~~~~~~gt~~Y~   73 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........       .......||+.|+
T Consensus       131 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  210 (317)
T 2buj_A          131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR  210 (317)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence            578899999999999999999999999999999999999999999999998764221100       0112345799999


Q ss_pred             chhhhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCC
Q psy11119         74 APEVLVRS---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPS  150 (407)
Q Consensus        74 APE~l~~~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~  150 (407)
                      |||++.+.   .++.++|||||||++|+|++|..||............... .....+....+++++.+||.+||+.||.
T Consensus       211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~  289 (317)
T 2buj_A          211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPH  289 (317)
T ss_dssp             CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC--CCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-ccCCCCccccCCHHHHHHHHHHhhcChh
Confidence            99998754   3688999999999999999999999532111000111111 1222333456899999999999999999


Q ss_pred             CCCCHHHHHhCc
Q psy11119        151 TRLNIEKIKSHR  162 (407)
Q Consensus       151 ~Rps~~eil~hp  162 (407)
                      +|||+.+++++-
T Consensus       290 ~Rps~~~ll~~L  301 (317)
T 2buj_A          290 QRPHIPLLLSQL  301 (317)
T ss_dssp             GSCCHHHHHHHH
T ss_pred             hCCCHHHHHHHh
Confidence            999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=252.91  Aligned_cols=157  Identities=21%  Similarity=0.299  Sum_probs=124.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ........+++.|+|||++.
T Consensus       433 l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          433 IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  512 (613)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence            57889999999999999999999999999999999999999999999999976533221 11122334678999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|||||||++|+|++ |+.||...+........... .  .......+++++.+||.+||..+|.+||++.+|
T Consensus       513 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-K--RMECPPECPPELYALMSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-C--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            8889999999999999999998 99999887665433322222 2  122335689999999999999999999999998


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       590 ~~  591 (613)
T 2ozo_A          590 EQ  591 (613)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=9.8e-28  Score=247.16  Aligned_cols=157  Identities=21%  Similarity=0.303  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ........+++.|+|||++..
T Consensus       315 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  393 (495)
T 1opk_A          315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY  393 (495)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhc
Confidence            4678899999999999999999999999999999999999999999999998754322 122234456788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|++ |..||...+........ ..  ......+..+++++.+||.+||+.||.+|||+.+|+
T Consensus       394 ~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~  470 (495)
T 1opk_A          394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH  470 (495)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc--CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            888999999999999999999 99999887655433222 22  222233456899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       471 ~~  472 (495)
T 1opk_A          471 QA  472 (495)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=5.2e-28  Score=232.21  Aligned_cols=144  Identities=29%  Similarity=0.525  Sum_probs=112.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++....                      
T Consensus       114 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------  171 (299)
T 3m2w_A          114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------------  171 (299)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------------
Confidence            578899999999999999999999999999999999998   7889999999986532                      


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc----cCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR----HMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                        +..++.++||||+||++|+|++|..||.................    ..+.+.+..+++++.+||.+||+.||.+||
T Consensus       172 --~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  249 (299)
T 3m2w_A          172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM  249 (299)
T ss_dssp             --TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             --cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC
Confidence              12356789999999999999999999976543221100000000    011111246899999999999999999999


Q ss_pred             CHHHHHhCcccccCC
Q psy11119        154 NIEKIKSHRWYSKHM  168 (407)
Q Consensus       154 s~~eil~hpwf~~~~  168 (407)
                      |+.++++||||.+..
T Consensus       250 s~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          250 TITEFMNHPWIMQST  264 (299)
T ss_dssp             CHHHHHTSHHHHTGG
T ss_pred             CHHHHhcChhhcccc
Confidence            999999999998753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=232.85  Aligned_cols=159  Identities=21%  Similarity=0.351  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||++.
T Consensus       142 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence            467889999999999999999999999999999999999999999999999876433221 1223446788899999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--------------HHHHhhcccCCCCCCCcCCHHHHHHHHHhc
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--------------YLEWKDNRHMQRSPWDRLDVNCLSLIRRIL  145 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L  145 (407)
                      +..++.++||||+||++|+|++|..||.........              ...... .....+....+++++.+||.+||
T Consensus       222 ~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl  300 (326)
T 2w1i_A          222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECW  300 (326)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHS
T ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh-cCCCCCCCCcccHHHHHHHHHHc
Confidence            888889999999999999999999998643211100              001111 11122334568999999999999


Q ss_pred             cCCCCCCCCHHHHHh
Q psy11119        146 APLPSTRLNIEKIKS  160 (407)
Q Consensus       146 ~~~P~~Rps~~eil~  160 (407)
                      ..||.+|||+.++++
T Consensus       301 ~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          301 NNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=1e-27  Score=233.52  Aligned_cols=161  Identities=25%  Similarity=0.292  Sum_probs=122.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH--------SKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH--------~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~   70 (407)
                      +++.++..++.||+.||.|||        ++||+||||||+|||++.++.+||+|||++.........  ......+||+
T Consensus       136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~  215 (342)
T 1b6c_B          136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  215 (342)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCc
Confidence            467889999999999999999        899999999999999999999999999999876543321  1234568999


Q ss_pred             CCCchhhhhcCC------CCCcchhhhHHHHHHHHHhC----------CCCCCCCChh---HHHHHHHhhcccCCCCCC-
Q psy11119         71 PYVAPEVLVRSY------LAEPADIWSCGIILVAMLAG----------ELPWDKPTAD---CIEYLEWKDNRHMQRSPW-  130 (407)
Q Consensus        71 ~Y~APE~l~~~~------~~~~sDiwSlGviL~elltG----------~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~-  130 (407)
                      .|+|||++.+..      ++.++|||||||++|+|++|          ..||......   .................. 
T Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (342)
T 1b6c_B          216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  295 (342)
T ss_dssp             GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc
Confidence            999999998752      23689999999999999999          7898754321   111111111111111111 


Q ss_pred             ----CcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        131 ----DRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       131 ----~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                          ...+..+.+||.+||+.||.+|||+.++++|
T Consensus       296 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                1234578999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=4.3e-28  Score=242.60  Aligned_cols=158  Identities=22%  Similarity=0.367  Sum_probs=121.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE----ecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLL----DLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILl----d~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++.....   ......+||+.|+|||
T Consensus       109 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE  185 (396)
T 4eut_A          109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPD  185 (396)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHH
Confidence            5788999999999999999999999999999999999    77778999999999875432   2334567999999999


Q ss_pred             hhhc--------CCCCCcchhhhHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhhcccC-----------------CC
Q psy11119         77 VLVR--------SYLAEPADIWSCGIILVAMLAGELPWDKPT----ADCIEYLEWKDNRHM-----------------QR  127 (407)
Q Consensus        77 ~l~~--------~~~~~~sDiwSlGviL~elltG~~Pf~~~~----~~~~~~~~~~~~~~~-----------------~~  127 (407)
                      ++.+        ..++.++||||+||++|+|++|..||....    ...............                 ..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  265 (396)
T 4eut_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM  265 (396)
T ss_dssp             HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSC
T ss_pred             HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccC
Confidence            9875        466789999999999999999999996422    112222222211100                 00


Q ss_pred             C----CCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        128 S----PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       128 ~----~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                      +    ....++..+.++|++||..||++||++.+++++
T Consensus       266 ~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            1    112345678899999999999999999998664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=2.2e-28  Score=238.69  Aligned_cols=152  Identities=14%  Similarity=0.080  Sum_probs=119.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEecCC--------------------cEEEEecCCceeeccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLH-SKGIAHRDLKPENVLLDLQD--------------------TLKISDFGLATVFRMNGK   59 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH-~~gIvHrDLkp~NILld~~g--------------------~lkL~DFGla~~~~~~~~   59 (407)
                      +++.+++.++.||+.||+||| ++||+||||||+|||++.++                    .+||+|||+|+....   
T Consensus       158 ~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---  234 (336)
T 2vuw_A          158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---  234 (336)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---
Confidence            578999999999999999999 99999999999999999987                    899999999987642   


Q ss_pred             ccCCcCccCCCCCCchhhhhcCCCCCcchhhhHHHH-HHHHHhCCCCCCCCChhHHHHHHHhhcccCC----CCCCCcCC
Q psy11119         60 ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGII-LVAMLAGELPWDKPTADCIEYLEWKDNRHMQ----RSPWDRLD  134 (407)
Q Consensus        60 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDiwSlGvi-L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~s  134 (407)
                          ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||....................    ...+..++
T Consensus       235 ----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  309 (336)
T 2vuw_A          235 ----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK  309 (336)
T ss_dssp             ----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHH
T ss_pred             ----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcC
Confidence                2348999999999998776 889999998776 7889999999853211011111111111111    11134578


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHH-hCcccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIK-SHRWYS  165 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil-~hpwf~  165 (407)
                      +++.+||++||..|     |++|++ +||||+
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            89999999999977     999999 999995

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=2.6e-27  Score=246.29  Aligned_cols=157  Identities=20%  Similarity=0.301  Sum_probs=128.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .........+++.|+|||++..
T Consensus       360 l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~  438 (535)
T 2h8h_A          360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALY  438 (535)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCSTTSCGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecccCCcCcccccCHHHhcc
Confidence            467889999999999999999999999999999999999999999999999764321 1112233457788999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||+||+|++ |..||.+.......... ...  ...+....+++.+.+||.+||..||++|||+.+|+
T Consensus       439 ~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  515 (535)
T 2h8h_A          439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERG--YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ  515 (535)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcC--CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            889999999999999999999 99999887655433222 221  12223356899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       516 ~~  517 (535)
T 2h8h_A          516 AF  517 (535)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=4.9e-27  Score=249.85  Aligned_cols=157  Identities=22%  Similarity=0.298  Sum_probs=126.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ........+|+.|+|||++.+
T Consensus       488 l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~  566 (656)
T 2j0j_A          488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINF  566 (656)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcC
Confidence            4678899999999999999999999999999999999999999999999998653322 122234567889999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++ |..||.+............. ..  .+....+++.+.+||.+||..||.+|||+.+++
T Consensus       567 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~  643 (656)
T 2j0j_A          567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK  643 (656)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            889999999999999999997 99999887665433322222 11  223356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +.
T Consensus       644 ~~  645 (656)
T 2j0j_A          644 AQ  645 (656)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.94  E-value=7.7e-28  Score=254.54  Aligned_cols=163  Identities=22%  Similarity=0.259  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCc---EEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT---LKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~---lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++..++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||++......   ......+||+.|+|||+
T Consensus       118 lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~  194 (676)
T 3qa8_A          118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPEL  194 (676)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc---cccccccCCcccCChHH
Confidence            467789999999999999999999999999999999997775   999999999865432   23345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHH--------HHH-Hhhc---c--------cCCCCCCCcCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIE--------YLE-WKDN---R--------HMQRSPWDRLDVNC  137 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~--------~~~-~~~~---~--------~~~~~~~~~~s~~~  137 (407)
                      +.+..++.++||||+||++|+|++|..||.........        ... ....   .        ..+......+++.+
T Consensus       195 l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L  274 (676)
T 3qa8_A          195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL  274 (676)
T ss_dssp             SCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHH
T ss_pred             hccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHH
Confidence            98888999999999999999999999999754322110        000 0000   0        00111223467889


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      .+||.+||..||.+|||+.++++||||..
T Consensus       275 ~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             HHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            99999999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=3.6e-26  Score=244.19  Aligned_cols=147  Identities=25%  Similarity=0.352  Sum_probs=122.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....      ...+||+.|+|||++.+
T Consensus       179 l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~  251 (681)
T 2pzi_A          179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRT  251 (681)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcC
Confidence            5789999999999999999999999999999999999974 9999999999865322      45679999999999977


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .+ +.++||||+||++|+|++|..||.......          .....+....++.+.+||.+||.+||.+||+..+.+.
T Consensus       252 ~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  320 (681)
T 2pzi_A          252 GP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS  320 (681)
T ss_dssp             CS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CC-CCceehhhhHHHHHHHHhCCCCCccccccc----------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence            65 889999999999999999999987532110          0011112234678999999999999999999999999


Q ss_pred             Ccccc
Q psy11119        161 HRWYS  165 (407)
Q Consensus       161 hpwf~  165 (407)
                      |+|+.
T Consensus       321 ~~l~~  325 (681)
T 2pzi_A          321 AQLTG  325 (681)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.88  E-value=1.3e-23  Score=201.15  Aligned_cols=130  Identities=12%  Similarity=0.075  Sum_probs=100.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      .+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|                      |++       
T Consensus       127 ~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------  177 (286)
T 3uqc_A          127 SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------  177 (286)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------
T ss_pred             ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------
Confidence            355788999999999999999999999999999999999999998443                      333       


Q ss_pred             CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHH---HHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         82 YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY---LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .++.++|||||||++|+|++|+.||...+......   ................+++++.+||.+||+.||.+| |+.++
T Consensus       178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el  256 (286)
T 3uqc_A          178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTL  256 (286)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence            26789999999999999999999998765421100   000000000001124688999999999999999999 99999


Q ss_pred             HhC
Q psy11119        159 KSH  161 (407)
Q Consensus       159 l~h  161 (407)
                      ++.
T Consensus       257 ~~~  259 (286)
T 3uqc_A          257 LNL  259 (286)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            884

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.80  E-value=8e-22  Score=206.36  Aligned_cols=139  Identities=16%  Similarity=0.231  Sum_probs=87.4

Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcCCCCCc
Q psy11119          7 QKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRSYLAEP   86 (407)
Q Consensus         7 ~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~   86 (407)
                      ..|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......  ....+.+||+.|+|||++.+. +..+
T Consensus       342 ~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~  418 (569)
T 4azs_A          342 EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWN  418 (569)
T ss_dssp             HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC--------
T ss_pred             HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCC-CCCc
Confidence            4689999999999999999999999999999999999999999998654332  234567899999999999765 4568


Q ss_pred             chhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccc
Q psy11119         87 ADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYS  165 (407)
Q Consensus        87 sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~  165 (407)
                      +|+||+|+++++++++..|+.        ...+..    ..   ..  ..+..+...+...+|..|+.......++|..
T Consensus       419 ~d~~s~g~~~~~l~~~~~~~~--------~~l~~~----~~---~~--~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          419 GFWRSAPVHPFNLPQPWSNWL--------YAVWQE----PV---ER--WNFVLLLALFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             ----------CCCCTTHHHHH--------HHHHTS----CG---GG--CSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             ccccccccchhhhccccchhH--------HHhhcC----CC---CC--CcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence            999999999988876643321        111110    00   00  1245666677777777777666555566543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.54  E-value=6.5e-16  Score=160.56  Aligned_cols=100  Identities=20%  Similarity=0.210  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc-----CCcCccCCCCCCchhhhhc
Q psy11119          6 AQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER-----PLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         6 a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~   80 (407)
                      +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+++.........     .....+||+.|+|||++..
T Consensus       433 ~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence            3578999999999999999999999999999998  99999999998764321110     1235689999999999987


Q ss_pred             --CCCCCcchhhhHHHHHHHHHhCCCCCC
Q psy11119         81 --SYLAEPADIWSCGIILVAMLAGELPWD  107 (407)
Q Consensus        81 --~~~~~~sDiwSlGviL~elltG~~Pf~  107 (407)
                        ..|+..+|+|+..+-..+...++.+|.
T Consensus       511 ~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          511 FLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             HHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence              467788899999888888777776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.33  E-value=7.3e-13  Score=126.29  Aligned_cols=60  Identities=25%  Similarity=0.326  Sum_probs=53.5

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.               +..|.|||++.+
T Consensus       194 ~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            4568999999999999999999999999999999 99999999999863               345789999864

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.23  E-value=8.3e-11  Score=97.31  Aligned_cols=83  Identities=14%  Similarity=0.182  Sum_probs=75.9

Q ss_pred             EEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecC-CCCeeEEEEEEEEec--CeEEEEEEeccCCchHHHHHHHH
Q psy11119        309 FVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDS-RKAQLVFKASVLTLD--NQTLLDFRLSKGCGIEFKTRFLC  385 (407)
Q Consensus       309 ~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~-rk~~l~~~~~i~~~~--~~~~v~f~k~~Gd~lE~~~~f~~  385 (407)
                      +|..+|.+|+.+|+.||+.+|+.|+.++++.+.+.+.++ .++.+.++++|+++.  +++.|+|+|.+||.++|++++.+
T Consensus        34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~  113 (120)
T 3ose_A           34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (120)
T ss_dssp             EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence            789999999999999999999999998877899988654 467899999999994  99999999999999999999999


Q ss_pred             HHHhhh
Q psy11119        386 IKRALA  391 (407)
Q Consensus       386 ~~~~l~  391 (407)
                      |...|+
T Consensus       114 il~~L~  119 (120)
T 3ose_A          114 IANELK  119 (120)
T ss_dssp             HHHHCC
T ss_pred             HHHHhc
Confidence            988774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.01  E-value=1.3e-10  Score=108.94  Aligned_cols=49  Identities=20%  Similarity=0.350  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119          3 QWEAQKFFRQLISGVEYLH-SKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus         3 e~~a~~i~~QL~~aL~~LH-~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      +.++..++.||+.||.||| +.||+||||||+|||++.  .++|+|||+|..
T Consensus       169 ~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            3467899999999999999 999999999999999997  999999999975

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=98.85  E-value=1.4e-08  Score=81.20  Aligned_cols=82  Identities=20%  Similarity=0.375  Sum_probs=71.7

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecC-CCCeeEEEEEEEEec-CeEEEEEEeccCC--------chHH
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDS-RKAQLVFKASVLTLD-NQTLLDFRLSKGC--------GIEF  379 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~-rk~~l~~~~~i~~~~-~~~~v~f~k~~Gd--------~lE~  379 (407)
                      |...+.+||..|..||+.+|+.|+..++..|+|+.... ....+.+.+++|+++ +.+|+||++..||        .+||
T Consensus        14 S~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~~F   93 (106)
T 4eai_A           14 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTIEF   93 (106)
T ss_dssp             ECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHHHH
T ss_pred             eCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcEeH
Confidence            67779999999999999999999999889999997543 346789999999996 8899999999995        8999


Q ss_pred             HHHHHHHHHhhh
Q psy11119        380 KTRFLCIKRALA  391 (407)
Q Consensus       380 ~~~f~~~~~~l~  391 (407)
                      =.++..+-..|.
T Consensus        94 ~d~ca~li~~la  105 (106)
T 4eai_A           94 FEMCANLIKILA  105 (106)
T ss_dssp             HHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHh
Confidence            999998766653

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=98.85  E-value=4.1e-09  Score=87.19  Aligned_cols=83  Identities=13%  Similarity=0.126  Sum_probs=74.5

Q ss_pred             EEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecC-CCCeeEEEEEEEEec--CeEEEEEEeccCCchHHHHHHHH
Q psy11119        309 FVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDS-RKAQLVFKASVLTLD--NQTLLDFRLSKGCGIEFKTRFLC  385 (407)
Q Consensus       309 ~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~-rk~~l~~~~~i~~~~--~~~~v~f~k~~Gd~lE~~~~f~~  385 (407)
                      +|+.++.+||..|..||+.+|+.|+..+...+++...+. .+..+.|+++|+++.  +++.|+|+|.+||...|++++.+
T Consensus        34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~  113 (126)
T 1v5s_A           34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (126)
T ss_dssp             CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred             ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence            467789999999999999999999987878899987543 457899999999994  99999999999999999999999


Q ss_pred             HHHhhh
Q psy11119        386 IKRALA  391 (407)
Q Consensus       386 ~~~~l~  391 (407)
                      |-..|+
T Consensus       114 IL~eLk  119 (126)
T 1v5s_A          114 IANELK  119 (126)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            988877

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=98.82  E-value=9.2e-09  Score=87.06  Aligned_cols=69  Identities=17%  Similarity=0.359  Sum_probs=58.9

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecCC-CCeeEEEEEEEEec-CeEEEEEEeccCCchH
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSR-KAQLVFKASVLTLD-NQTLLDFRLSKGCGIE  378 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~r-k~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE  378 (407)
                      |+..+.+||..|..||+.||+.||+.++..|+|+..-.. ...+.+.+++|+|+ +.+||||++..||+-|
T Consensus        11 Srs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e   81 (157)
T 2v8q_A           11 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   81 (157)
T ss_dssp             ECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence            566799999999999999999999999999999975433 34789999999997 8999999999999866

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=98.78  E-value=1.5e-08  Score=86.82  Aligned_cols=69  Identities=17%  Similarity=0.359  Sum_probs=59.1

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecCC-CCeeEEEEEEEEec-CeEEEEEEeccCCchH
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSR-KAQLVFKASVLTLD-NQTLLDFRLSKGCGIE  378 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~r-k~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE  378 (407)
                      |+..+.+||..|..||+.||+.||+.++..|+++...+. ...+.+.+++|+|+ +.+||||++..||+-|
T Consensus        25 Srs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e   95 (173)
T 2y8l_A           25 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   95 (173)
T ss_dssp             ECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence            566899999999999999999999999999999985433 34689999999997 9999999999999866

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=98.69  E-value=4.1e-08  Score=82.35  Aligned_cols=82  Identities=10%  Similarity=0.003  Sum_probs=68.9

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeec---------CceEEEEEeecCC------CCeeEEEEEEEEec-CeEEEEEEecc
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSY---------SPAIVTISTVDSR------KAQLVFKASVLTLD-NQTLLDFRLSK  373 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~---------~~~~v~i~~~d~r------k~~l~~~~~i~~~~-~~~~v~f~k~~  373 (407)
                      |+..+.+||..|..||+.||+.|+..         +...|+++..-..      ...+.+.+++|+|+ +.+||||++..
T Consensus        19 Srs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDFk~~~   98 (137)
T 2qrd_A           19 CRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKSNG   98 (137)
T ss_dssp             EESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEEEE
T ss_pred             cCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEEEecC
Confidence            66789999999999999999999988         8889999874221      24688999999998 89999999999


Q ss_pred             CC---------------c----hHHHHHHHHHHHhhh
Q psy11119        374 GC---------------G----IEFKTRFLCIKRALA  391 (407)
Q Consensus       374 Gd---------------~----lE~~~~f~~~~~~l~  391 (407)
                      |+               .    .+|-.++..+-..|+
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa  135 (137)
T 2qrd_A           99 YKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  135 (137)
T ss_dssp             EEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             CccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence            99               5    888888887766665

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=98.59  E-value=2.4e-07  Score=80.19  Aligned_cols=81  Identities=16%  Similarity=0.229  Sum_probs=66.6

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecC---ceEEEEEeec----------CCCCeeEEEEEEEEec-CeEEEEEEeccC-
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYS---PAIVTISTVD----------SRKAQLVFKASVLTLD-NQTLLDFRLSKG-  374 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~---~~~v~i~~~d----------~rk~~l~~~~~i~~~~-~~~~v~f~k~~G-  374 (407)
                      |+..+.+||..|..||+.||+.|++.+   .+.|+|+..-          +....+.+.+++|+|+ +.+||||+ ..| 
T Consensus        57 S~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~G~  135 (179)
T 3t4n_A           57 SRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FDGW  135 (179)
T ss_dssp             ECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EEEE
T ss_pred             cCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-eccc
Confidence            567799999999999999999999976   7889998631          1224689999999997 99999999 788 


Q ss_pred             ---------------------CchHHHHHHHHHHHhhh
Q psy11119        375 ---------------------CGIEFKTRFLCIKRALA  391 (407)
Q Consensus       375 ---------------------d~lE~~~~f~~~~~~l~  391 (407)
                                           .+..|-.++.++-..|+
T Consensus       136 e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa  173 (179)
T 3t4n_A          136 ESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA  173 (179)
T ss_dssp             ECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence                                 66788888877666664

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.55  E-value=2.7e-08  Score=98.68  Aligned_cols=49  Identities=22%  Similarity=0.340  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----------cEEEEecCCcee
Q psy11119          5 EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----------TLKISDFGLATV   53 (407)
Q Consensus         5 ~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----------~lkL~DFGla~~   53 (407)
                      ++..++.||+.+|.|||++||+||||||.|||++.+|          .+.|+||+-+..
T Consensus       206 ~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            4678899999999999999999999999999999877          389999997653

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=98.52  E-value=2.8e-07  Score=75.59  Aligned_cols=71  Identities=15%  Similarity=0.287  Sum_probs=56.1

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeecCC-CCeeEEEEEEEEec-CeEEEEEEeccCCchHHH
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVDSR-KAQLVFKASVLTLD-NQTLLDFRLSKGCGIEFK  380 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d~r-k~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE~~  380 (407)
                      |...+.+||..|..||+.||+.||..++..|+|.....+ .....+.+++|+++ +.+|+||++..||-.|..
T Consensus        14 S~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~   86 (130)
T 4eag_A           14 SQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG   86 (130)
T ss_dssp             CCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred             cCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence            456689999999999999999999998899999875444 34678999999997 889999999999976644

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.82  E-value=1.3e-05  Score=76.28  Aligned_cols=77  Identities=21%  Similarity=0.365  Sum_probs=49.6

Q ss_pred             CCeecCCCCCcEEEec--CCcEEEEecCCceeeccCCCccCCcCccCCCCC---Cchhhhh---cCCCCC----------
Q psy11119         24 GIAHRDLKPENVLLDL--QDTLKISDFGLATVFRMNGKERPLDKKCGTLPY---VAPEVLV---RSYLAE----------   85 (407)
Q Consensus        24 gIvHrDLkp~NILld~--~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y---~APE~l~---~~~~~~----------   85 (407)
                      .++|+|++|.||+++.  .+.+.|+||+.+..-... .+     ......+   ..|+...   ..|...          
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D-----l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~  265 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND-----FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYR  265 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH-----HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH-----HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHH
Confidence            4799999999999998  456899999998753211 00     0011111   2333322   112111          


Q ss_pred             -cchhhhHHHHHHHHHhCCCCC
Q psy11119         86 -PADIWSCGIILVAMLAGELPW  106 (407)
Q Consensus        86 -~sDiwSlGviL~elltG~~Pf  106 (407)
                       -.+.|++|.++|.+.+|..+|
T Consensus       266 ~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          266 MKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHcCCHHH
Confidence             158999999999999998776

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.38  E-value=0.0012  Score=59.88  Aligned_cols=110  Identities=18%  Similarity=0.107  Sum_probs=71.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |+|++||-++.|.+.+|.-+-. +.-..+=+.|..|++..+|++-+.+ +.+.              .....+.|||...
T Consensus        46 lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~  110 (229)
T 2yle_A           46 INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGY  110 (229)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------------------CCSS
T ss_pred             cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------ccccCCCChhhcc
Confidence            6899999999999999877622 2212334557899999999988764 2111              1122466887753


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccC
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAP  147 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~  147 (407)
                       ...+.+.=|||||+++|..+--..|                     ......+|+++.+||..|..-
T Consensus       111 -~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          111 -SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             -ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence             3456788999999999988752222                     111245789999999999866

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.31  E-value=0.00022  Score=69.26  Aligned_cols=53  Identities=21%  Similarity=0.439  Sum_probs=45.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------------
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS----------------------------------------------------------   22 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~----------------------------------------------------------   22 (407)
                      +++.+...++.+++..|..||+                                                          
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            3567788899999999999997                                                          


Q ss_pred             CCCeecCCCCCcEEEecCCc--EEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDT--LKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~--lkL~DFGla~~   53 (407)
                      .+++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            36899999999999997754  69999999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.19  E-value=0.0002  Score=65.37  Aligned_cols=29  Identities=21%  Similarity=0.228  Sum_probs=25.4

Q ss_pred             CeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         25 IAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        25 IvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ++|+|++|.||+++.++.+.|+|||.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998766677999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.18  E-value=0.00019  Score=66.23  Aligned_cols=31  Identities=19%  Similarity=0.223  Sum_probs=25.7

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+++|+|++|.||+++.++.+.|+||+.+..
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            4589999999999998755567999997753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.04  E-value=0.0069  Score=57.47  Aligned_cols=30  Identities=20%  Similarity=0.376  Sum_probs=27.4

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=94.78  E-value=0.036  Score=52.42  Aligned_cols=30  Identities=40%  Similarity=0.648  Sum_probs=25.5

Q ss_pred             CCeecCCCCCcEEEec---CCc-EEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDL---QDT-LKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~---~g~-lkL~DFGla~~   53 (407)
                      .++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            5699999999999997   455 48999998865

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.55  E-value=0.021  Score=56.48  Aligned_cols=32  Identities=16%  Similarity=0.308  Sum_probs=28.1

Q ss_pred             HHCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         21 HSKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        21 H~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      +...++|+|++|.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456899999999999999776 99999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.43  E-value=0.052  Score=51.18  Aligned_cols=31  Identities=29%  Similarity=0.368  Sum_probs=26.2

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3699999999999999766568999997753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.94  E-value=0.063  Score=50.98  Aligned_cols=31  Identities=26%  Similarity=0.358  Sum_probs=27.3

Q ss_pred             CCCeecCCCCCcEEEecC----CcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQ----DTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~----g~lkL~DFGla~~   53 (407)
                      .+++|||+++.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999874    6899999998865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=91.50  E-value=0.078  Score=48.47  Aligned_cols=29  Identities=21%  Similarity=0.421  Sum_probs=25.7

Q ss_pred             CeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         25 IAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        25 IvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ++|+|+++.||+++.++.+-|+||+.+..
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            79999999999999777778999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.08  E-value=0.13  Score=48.44  Aligned_cols=29  Identities=21%  Similarity=0.087  Sum_probs=25.0

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4689999999999999 4 899999987653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=90.98  E-value=0.3  Score=45.61  Aligned_cols=29  Identities=28%  Similarity=0.335  Sum_probs=25.2

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|+.|.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4799999999999 6677899999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=90.95  E-value=0.084  Score=50.54  Aligned_cols=32  Identities=16%  Similarity=0.212  Sum_probs=26.5

Q ss_pred             HCCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         22 SKGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        22 ~~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      ...++|+|++|.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35799999999999999544579999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.78  E-value=0.17  Score=48.38  Aligned_cols=31  Identities=23%  Similarity=0.402  Sum_probs=27.8

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3689999999999999888899999988765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.44  E-value=0.27  Score=47.31  Aligned_cols=29  Identities=24%  Similarity=0.413  Sum_probs=24.5

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      +++|+|+++.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999998554 89999988764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=88.44  E-value=0.3  Score=47.50  Aligned_cols=30  Identities=20%  Similarity=0.289  Sum_probs=25.5

Q ss_pred             HCCCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         22 SKGIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        22 ~~gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      ...++|+|++|.||+++.+ .++++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            4579999999999999865 48999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.38  E-value=0.28  Score=49.21  Aligned_cols=15  Identities=27%  Similarity=0.395  Sum_probs=14.2

Q ss_pred             CCeecCCCCCcEEEe
Q psy11119         24 GIAHRDLKPENVLLD   38 (407)
Q Consensus        24 gIvHrDLkp~NILld   38 (407)
                      .++|+|+.+.|||++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            589999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.78  E-value=0.3  Score=48.44  Aligned_cols=30  Identities=33%  Similarity=0.485  Sum_probs=24.6

Q ss_pred             CCeecCCCCCcEEEecC----------------------------CcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQ----------------------------DTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~----------------------------g~lkL~DFGla~~   53 (407)
                      .++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            58999999999999875                            6789999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=83.89  E-value=0.47  Score=46.38  Aligned_cols=30  Identities=30%  Similarity=0.509  Sum_probs=26.8

Q ss_pred             CCeecCCCCCcEEEecC----CcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQ----DTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~----g~lkL~DFGla~~   53 (407)
                      .++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            58999999999999876    7899999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	407
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-37
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-35
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-35
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-28
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-26
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-26
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-26
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-21
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-20
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 98/170 (57%), Positives = 126/170 (74%), Gaps = 2/170 (1%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           M + +AQ+FF QL++GV YLH  GI HRD+KPEN+LLD +D LKISDFGLATVFR N +E
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159

Query: 61  RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           R L+K CGTLPYVAPE+L R  + AEP D+WSCGI+L AMLAGELPWD+P+  C EY +W
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
           K+ +    +PW ++D   L+L+ +IL   PS R+ I  IK  RWY+K + 
Sbjct: 220 KEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-42
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 8/163 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
               +  +L + + Y HSK + HRD+KPEN+LL     LKI+DFG +     +       
Sbjct: 107 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 162

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGTL Y+ PE++      E  D+WS G++    L G+ P++  T        +K    
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISR 218

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
           ++ +  D +      LI R+L   PS R  + ++  H W + +
Sbjct: 219 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  136 bits (343), Expect = 6e-38
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 9/174 (5%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +++ E +K  R L+  +  LH   I HRDLKPEN+LLD    +K++DFG +       K 
Sbjct: 107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 165

Query: 61  RPLDKKCGTLPYVAPEVL------VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI 114
             L + CGT  Y+APE++            +  D+WS G+I+  +LAG  P+       +
Sbjct: 166 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223

Query: 115 EYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
             +    N       WD        L+ R L   P  R   E+  +H ++ +++
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-38
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 3/165 (1%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +     R+ +  +E+LHS  + HRD+K +N+LL +  ++K++DFG          +R   
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S 174

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
              GT  ++APEV+ R       DIWS GI+ + M+ GE P+         YL   +   
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP 169
             ++P ++L       + R L      R + +++  H++     P
Sbjct: 235 ELQNP-EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 8/173 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           + Q   +Q +  + YLH   I HRDLK  N+L  L   +K++DFG++         +  D
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRD 168

Query: 65  KKCGTLPYVAPEVLV-----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
              GT  ++APEV++            AD+WS GI L+ M   E P  +     +  L+ 
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKI 227

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
             +     +   R   N    +++ L      R    ++  H + +      I
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 43/188 (22%), Positives = 83/188 (44%), Gaps = 6/188 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNGKERP 62
           E   + RQ   G++++H   I H D+KPEN++ + +   ++KI DFGLAT       +  
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEI 184

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
           +     T  + APE++ R  +    D+W+ G++   +L+G  P+             + +
Sbjct: 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFN 182
                  +  +       I+ +L   P  RL +     H W  K   +++    PSS +N
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL-KGDHSNLTSRIPSSRYN 303

Query: 183 STAKRMRS 190
              ++++ 
Sbjct: 304 KIRQKIKE 311

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  132 bits (334), Expect = 5e-36
 Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 6/181 (3%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNG 58
           M++ EA ++ RQ+  G+ ++H     H DLKPEN++   +    LK+ DFGL        
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLD 177

Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
            ++ +    GT  + APEV     +    D+WS G++   +L+G  P+     D      
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK-HMPNDIVDGPP 177
              + +M  S +  +  +    IR++L   P+TR+ I +   H W +  + P      P 
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297

Query: 178 S 178
           S
Sbjct: 298 S 298

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-35
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 4/167 (2%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             +   + +  +++S +EYLH KGI HRDLKPEN+LL+    ++I+DFG A V     K+
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
              +   GT  YV+PE+L      + +D+W+ G I+  ++AG  P+        EYL ++
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQ 220

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH 167
               ++    ++       L+ ++L    + RL  E+++ +     H
Sbjct: 221 KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (329), Expect = 1e-35
 Identities = 39/183 (21%), Positives = 69/183 (37%), Gaps = 11/183 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E        + G+ YLHS  + HRD+K  N+LL     +K+ DFG A++        P +
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169

Query: 65  KKCGTLPYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
              GT  ++APEV++           D+WS GI  + +   + P      + +  L    
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIA 227

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDF 181
                            + +   L  +P  R   E +  HR+  +  P  ++        
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

Query: 182 NST 184
           ++ 
Sbjct: 288 DAV 290

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 6/171 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +     RQ   G++YLH+K I HRDLK  N+ L    T+KI DFGLATV          +
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164

Query: 65  KKCGTLPYVAPEVLV---RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           +  G++ ++APEV+    ++  +  +D+++ GI+L  ++ G+LP+               
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

Query: 122 NRHMQRSP--WDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH-RWYSKHMP 169
                               L+   L      R    +I +     ++ +P
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 37/162 (22%), Positives = 74/162 (45%), Gaps = 9/162 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKER 61
             + + RQ++ G+++LH++   I HRDLK +N+ +     ++KI D GLAT+ R +    
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---- 168

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
                 GT  ++APE+    Y  E  D+++ G+ ++ M   E P+ +   +  +      
Sbjct: 169 FAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVT 226

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +     S           +I   +      R +I+ + +H +
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 8e-35
 Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 45/209 (21%)

Query: 5   EAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
              K    +I G+ YL  K  I HRD+KP N+L++ +  +K+ DFG++        +   
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMA 160

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD---------------- 107
           +   GT  Y++PE L  ++ +  +DIWS G+ LV M  G  P                  
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220

Query: 108 ------------------------KPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRR 143
                                   +P     E L++  N    + P     +     + +
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280

Query: 144 ILAPLPSTRLNIEKIKSHRWYSKHMPNDI 172
            L   P+ R +++++  H +  +    ++
Sbjct: 281 CLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 9e-35
 Identities = 38/172 (22%), Positives = 72/172 (41%), Gaps = 5/172 (2%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD--TLKISDFGLATVFRMNG 58
           + + E   +  Q+   +++LHS  I H D++PEN++   +   T+KI +FG A   +   
Sbjct: 99  LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

Query: 59  KERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
             R L        Y APEV     ++   D+WS G ++  +L+G  P+   T   I    
Sbjct: 159 NFRLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPN 170
                      +  + +  +  + R+L     +R+   +   H W  + +  
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 6e-33
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 11/207 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           EA +  + +   ++YLHS  IAHRD+KPEN+L   +     LK++DFG A   +      
Sbjct: 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHN 168

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   C T  YVAPEVL      +  D+WS G+I+  +L G  P+       I       
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228

Query: 122 NRHMQ----RSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPP 177
            R  Q       W  +      LIR +L   P+ R+ I +  +H W  +           
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 288

Query: 178 SSDFNSTAKRMRSDLETEANRACPTFD 204
           S       +R   D++ E   A  T  
Sbjct: 289 SRVLKEDKERW-EDVKEEMTSALATMR 314

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 10/164 (6%)

Query: 5   EAQKFFRQLISGVEYLHSKG-----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK 59
              +   QL   ++  H +      + HRDLKP NV LD +  +K+ DFGLA +   N  
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHD 167

Query: 60  ERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
                   GT  Y++PE + R    E +DIWS G +L  + A   P+   +   +     
Sbjct: 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
           +      R    R       +I R+L      R ++E+I  +  
Sbjct: 228 EGKF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (304), Expect = 5e-32
 Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 6/170 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMNGKER 61
           +A +   Q++  V+YLH  GI HRDLKPEN+L    D    + ISDFGL+ +        
Sbjct: 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---S 164

Query: 62  PLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
            L   CGT  YVAPEVL +   ++  D WS G+I   +L G  P+       +     K 
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPND 171
                   WD +  +    IR ++   P  R   E+   H W +     D
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 18/217 (8%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
            ++ + + +  ++I G+E++H++ + +RDLKP N+LLD    ++ISD GLA  F     +
Sbjct: 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----K 159

Query: 61  RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
           +      GT  Y+APEVL +       AD +S G +L  +L G  P+ +        +  
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D 218

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDIVD 174
           +    M     D       SL+  +L    + RL       +++K   ++       +  
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278

Query: 175 G-------PPSSDFNSTAKRMRSDLETEANRACPTFD 204
                   PP  + N+         + E  +     D
Sbjct: 279 QKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLD 315

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-31
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 7/163 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A  +  ++I G+++LHSKGI +RDLK +N+LLD    +KI+DFG+     +   +   +
Sbjct: 104 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--N 161

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT  Y+APE+L+        D WS G++L  ML G+ P+     + +    +   R 
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRM 217

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK-IKSHRWYSK 166
                   L+     L+ ++    P  RL +   I+ H  + +
Sbjct: 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 5e-31
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 16/170 (9%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           + +  A+ FF Q++  V + H+ G+ HRD+K EN+L+DL    LK+ DFG   +     K
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----K 162

Query: 60  ERPLDKKCGTLPYVAPEVLV-RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
           +       GT  Y  PE +    Y    A +WS GI+L  M+ G++P++         + 
Sbjct: 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM 168
           ++           R+   C  LIR  LA  PS R   E+I++H W    +
Sbjct: 223 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 3/158 (1%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +   F  Q+  G+E+L  K   HRDL   NVL+     +KI DFGLA     +       
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + ++APE L        +D+WS GI+L  + + G  P+     D   Y   ++  
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
            M +  +         +++   A     R +   + S 
Sbjct: 285 KMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-30
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 7/167 (4%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT----LKISDFGLATVFRM 56
           + + EA +F +Q+++GV YLHS  IAH DLKPEN++L  ++     +KI DFGLA     
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169

Query: 57  NGKERPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEY 116
             +        GT  +VAPE++    L   AD+WS G+I   +L+G  P+   T      
Sbjct: 170 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226

Query: 117 LEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRW 163
                N   +   +          IRR+L   P  R+ I+    H W
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 14/177 (7%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
                A+ +  ++   +EYLHSK I +RDLKPEN+LLD    +KI+DFG A         
Sbjct: 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
                 CGT  Y+APEV+      +  D WS GI++  MLAG  P+            ++
Sbjct: 161 L-----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YE 211

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----IEKIKSHRWYSKHMPNDI 172
              + +       + +   L+ R++    S RL       E +K+H W+ + +   +
Sbjct: 212 KILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 8e-29
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 30/212 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           ++      F  Q++ G++Y+HS  + HRDLKP N+LL+    LKI DFGLA V   +   
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165

Query: 61  RPL-DKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPW------------ 106
                +   T  Y APE+++ S    +  DIWS G IL  ML+    +            
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

Query: 107 -----DKPTADCIEYLEWKDNRHMQRSP----------WDRLDVNCLSLIRRILAPLPST 151
                     D    +  K   ++   P          +   D   L L+ ++L   P  
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285

Query: 152 RLNIEKIKSHRWYSK-HMPNDIVDGPPSSDFN 182
           R+ +E+  +H +  + + P+D         F+
Sbjct: 286 RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 317

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 11/170 (6%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             +  A+ +  +++S +EYLHS+ + +RD+K EN++LD    +KI+DFGL      +G  
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK 120
             +   CGT  Y+APEVL  +      D W  G+++  M+ G LP+     + +    ++
Sbjct: 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FE 215

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----IEKIKSHRWYS 165
                +      L     SL+  +L   P  RL       +++  HR++ 
Sbjct: 216 LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-28
 Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 26/183 (14%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
              +    QL+ G+++LHS  + HRDLKP+N+L+     +K++DFGLA ++        +
Sbjct: 116 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 175

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT------------- 110
                TL Y APEVL++S  A P D+WS G I   M   +  +   +             
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 111 ----------ADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS 160
                                +          +D     L+ + L   P+ R++     S
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

Query: 161 HRW 163
           H +
Sbjct: 293 HPY 295

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 6e-28
 Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 32/204 (15%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
               E ++  + L++G+ Y+H   I HRD+K  NVL+     LK++DFGLA  F +    
Sbjct: 114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173

Query: 61  RPLDKK--CGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPW----------- 106
           +P        TL Y  PE+L+       P D+W  G I+  M                  
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233

Query: 107 -----------------DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLP 149
                            +    + +E ++ +  +   R      D   L LI ++L   P
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293

Query: 150 STRLNIEKIKSHRW-YSKHMPNDI 172
           + R++ +   +H + +S  MP+D+
Sbjct: 294 AQRIDSDDALNHDFFWSDPMPSDL 317

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 8e-28
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 14/167 (8%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
            A+ +  Q++   EYLHS  + +RDLKPEN+L+D Q  ++++DFG A   +         
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--- 198

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
             CGT   +APE+++     +  D W+ G+++  M AG  P+       I    ++    
Sbjct: 199 --CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVS 252

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----IEKIKSHRWYSK 166
            +         +   L+R +L    + R       +  IK+H+W++ 
Sbjct: 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 8/172 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
              +   Q+  G++YL      HRDL   NVLL  Q   KISDFGL+   R +       
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 65  KK-CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN 122
                 + + APE +     +  +D+WS G+++    + G+ P+       +  +  K  
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 227

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVD 174
           R                L+          R     ++      ++   D+V+
Sbjct: 228 R---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL---RNYYYDVVN 273

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (269), Expect = 3e-27
 Identities = 33/154 (21%), Positives = 64/154 (41%), Gaps = 2/154 (1%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           E     RQ+ +G+ YL  +   HRDL   N L+     +KI+DFGL+         +   
Sbjct: 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
                + ++ PE +  +     +D+W+ G++L  + +  L      A        +D   
Sbjct: 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 260

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           +  +  +   +   +L+R   + LP+ R +   I
Sbjct: 261 L--ACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 28/174 (16%), Positives = 66/174 (37%), Gaps = 14/174 (8%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDT-----LKISDFGLATVFR 55
            +        +Q+++ V+ +H K + +RD+KP+N L+   ++     + + DFG+   +R
Sbjct: 98  FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157

Query: 56  MNGKERPLDKK-----CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPT 110
               ++ +  +      GT  Y++    +    +   D+ + G + +  L G LPW    
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217

Query: 111 ADCIEYLEWKDNRHMQRSPWDRLDVNC----LSLIRRILAPLPSTRLNIEKIKS 160
           A   +    +     Q +P   L           +            + + ++ 
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 4e-27
 Identities = 34/158 (21%), Positives = 65/158 (41%), Gaps = 4/158 (2%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
               +  Q+  G+ YL  + + HRDL   NVL+     +KI+DFGLA +     KE   +
Sbjct: 112 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + ++A E ++       +D+WS G+ +  ++  G  P+D   A  I  +  K  R
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                      ++   ++ +       +R    ++   
Sbjct: 232 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (267), Expect = 4e-27
 Identities = 38/186 (20%), Positives = 71/186 (38%), Gaps = 15/186 (8%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD---TLKISDFGLATVFRMN 57
            +         Q+IS +EY+HSK   HRD+KP+N L+ L      + I DFGLA  +R  
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159

Query: 58  GKERPLDKK-----CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTAD 112
              + +  +      GT  Y +    +    +   D+ S G +L+    G LPW    A 
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

Query: 113 CIEYLEWKDNRHMQRSPWDRLDVNC----LSLIRRILAPLPSTRLNIEKIKS---HRWYS 165
                  + +     +P + L         + +    +     + +   ++    + ++ 
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

Query: 166 KHMPND 171
           +    D
Sbjct: 280 QGFSYD 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 5e-27
 Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 7/168 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +      Q+ SG+ Y+      HRDL+  N+L+      K++DFGLA +   N +     
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQ 172

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + + APE  +       +D+WS GI+L  +   G +P+          +  +  R
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVER 229

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS--HRWYSKHMP 169
             +         +   L+ +     P  R   E +++    +++   P
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (265), Expect = 6e-27
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 1/150 (0%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
             A +        + + H  GI HRD+KP N+++   + +K+ DFG+A     +G     
Sbjct: 111 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 64  DK-KCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
                GT  Y++PE      +   +D++S G +L  +L GE P+   +   + Y   +++
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTR 152
                +  + L  +  +++ + LA  P  R
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENR 260

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 9e-27
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 4/159 (2%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL- 63
              ++  Q+  G+ YL SK   HRDL   N+LL  +D +KI DFGL      N     + 
Sbjct: 112 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN 122
           + +     + APE L     +  +D W  G+ L  M   G+ PW       I +   K+ 
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
             + R   +    +  +++ +  A  P  R     ++  
Sbjct: 232 ERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 35/224 (15%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +     + +  QL   + Y+HS GI HRD+KP+N+LLD     LK+ DFG A       +
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV---R 175

Query: 60  ERPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWD----------- 107
             P      +  Y APE++  +       D+WS G +L  +L G+  +            
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

Query: 108 -----KPTADCIEYLEWKDNRHM---------QRSPWDRLDVNCLSLIRRILAPLPSTRL 153
                 PT + I  +                  +    R     ++L  R+L   P+ RL
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

Query: 154 NIEKIKSHRWYSKHMPNDIVDGPPSSD----FNSTAKRMRSDLE 193
              +  +H ++   + +  V  P   D    FN T + + S+  
Sbjct: 296 TPLEACAHSFF-DELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (263), Expect = 2e-26
 Identities = 34/161 (21%), Positives = 63/161 (39%), Gaps = 7/161 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +     R + +G++YL      HRDL   N+L++     K+SDFGL+     +  +    
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188

Query: 65  KK---CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWK 120
                   + + APE +        +D+WS GI++  +++ GE P+   T   +     +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248

Query: 121 DNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
           D R     P          L+        + R    +I + 
Sbjct: 249 DYR---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-26
 Identities = 47/199 (23%), Positives = 73/199 (36%), Gaps = 28/199 (14%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
              + +    + G+EYLH   I HRDLKP N+LLD    LK++DFGLA  F      R  
Sbjct: 100 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAY 157

Query: 64  DKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPW---------------- 106
             +  T  Y APE+L          D+W+ G IL  +L                      
Sbjct: 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217

Query: 107 ----DKPTADCIEYLEWKDNRHMQRSPWDR----LDVNCLSLIRRILAPLPSTRLNIEKI 158
               ++   D     ++   +     P          + L LI+ +    P  R+   + 
Sbjct: 218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

Query: 159 KSHRWYS-KHMPNDIVDGP 176
              +++S +  P      P
Sbjct: 278 LKMKYFSNRPGPTPGCQLP 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-26
 Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 5/164 (3%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +      Q+  G+ ++  +   HRDL+  N+L+    + KI+DFGLA +   N      
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR- 167

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR 123
           +     + + APE +        +D+WS GI+L  ++           +       +   
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS--HRWYS 165
            M R   D        L+R      P  R   + ++S    +++
Sbjct: 228 RMVR--PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 9/158 (5%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
              KF   +   +EYL      HRDL   NVL+   +  K+SDFGL             D
Sbjct: 104 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 158

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + + APE L     +  +D+WS GI+L  + + G +P+ +     +     K  +
Sbjct: 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 218

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                  D        +++       + R +  +++  
Sbjct: 219 M---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 8/179 (4%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
             + E Q +  +++  +E+LH  GI +RD+K EN+LLD    + ++DFGL+  F  +  E
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

Query: 61  RPLDKKCGTLPYVAPEVL--VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE 118
                 CGT+ Y+AP+++    S   +  D WS G+++  +L G  P+        +   
Sbjct: 186 -RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

Query: 119 WKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NIEKIKSHRWYSKHMPNDI 172
            +     +      +      LI+R+L   P  RL     + ++IK H ++ K   +D+
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-25
 Identities = 38/166 (22%), Positives = 65/166 (39%), Gaps = 8/166 (4%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
              +   Q+  G++YL  K   HRDL   NVLL  +   KISDFGL+     +       
Sbjct: 110 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 65  KK-CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN 122
                 L + APE +     +  +D+WS G+ +   L+ G+ P+ K     +     +  
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQG 228

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS---HRWYS 165
           + M+  P         +L+          R +   ++      +YS
Sbjct: 229 KRMECPPE--CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 29/196 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +     + F  QL+ G+ + HS+ + HRDLKP+N+L++    LK+++FGLA  F +    
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155

Query: 61  RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPW------------- 106
           R    +  TL Y  P+VL  +   +   D+WS G I   +     P              
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

Query: 107 -----DKPTADCIEYLEWKDNRHMQRSP--------WDRLDVNCLSLIRRILAPLPSTRL 153
                           +  D +     P          +L+     L++ +L   P  R+
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

Query: 154 NIEKIKSHRWYSKHMP 169
           + E+   H ++S   P
Sbjct: 276 SAEEALQHPYFSDFCP 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 2e-25
 Identities = 36/157 (22%), Positives = 60/157 (38%), Gaps = 1/157 (0%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
               +  Q+  G+E+L S+   HRDL   N+LL  ++ +KI DFGLA     +       
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
                L ++APE +        +D+WS G++L  + +             E+        
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 254

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
             R+P D         +       PS R    ++  H
Sbjct: 255 RMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 31/195 (15%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             + +  QL+ G+ + HS  + HRDLKP+N+L++ +  +K++DFGLA  F +  +     
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--T 160

Query: 65  KKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWD--------------KP 109
            +  TL Y APE+L+   Y +   DIWS G I   M+     +                 
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

Query: 110 TADCIEYLEWKDNRHMQRS-----------PWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
           T D + +         + S               LD +  SL+ ++L   P+ R++ +  
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

Query: 159 KSHRW---YSKHMPN 170
            +H +    +K +P+
Sbjct: 281 LAHPFFQDVTKPVPH 295

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 7/184 (3%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           ++  +   F   +  G++YL  K   HRDL   N+L+      KI+DFGL+    +  K+
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEW 119
                    + ++A E L  S     +D+WS G++L  +++ G  P+   T      L  
Sbjct: 184 T---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE 237

Query: 120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSS 179
           K  +  +       D     L+R+     P  R +  +I              V+     
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297

Query: 180 DFNS 183
            F  
Sbjct: 298 KFTY 301

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 7e-25
 Identities = 34/154 (22%), Positives = 58/154 (37%), Gaps = 1/154 (0%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +   F  Q+  G+ +L SK   HRDL   N+LL      KI DFGLA   + +       
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
                + ++APE +        +D+WS GI L  + +             ++ +      
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
              SP +        +++      P  R   ++I
Sbjct: 266 RMLSP-EHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 1e-24
 Identities = 33/159 (20%), Positives = 70/159 (44%), Gaps = 5/159 (3%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +  +  + +   +EYL SK   HRDL   N L++ Q  +K+SDFGL+  + ++ +    
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSS 158

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDN 122
                 + +  PEVL+ S  +  +DIW+ G+++  + + G++P+++ T            
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQG 217

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
             + R           +++          R   + + S+
Sbjct: 218 LRLYRPHL--ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-24
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 5/158 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
               +  QL + + YL SK   HRD+   NVL+   D +K+ DFGL+     +   +   
Sbjct: 109 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-AS 167

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
           K    + ++APE +        +D+W  G+ +  +L  G  P+     + +        R
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                          SL+ +  A  PS R    ++K+ 
Sbjct: 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 3e-24
 Identities = 29/156 (18%), Positives = 57/156 (36%), Gaps = 3/156 (1%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERP- 62
            +     R + +G++YL +    HRDL   N+L++     K+SDFGL+ V   + +    
Sbjct: 110 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN 122
                  + + APE +        +D+WS GI++  ++          ++        D 
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
             +              L+ +      + R     I
Sbjct: 230 FRLPT--PMDCPSAIYQLMMQCWQQERARRPKFADI 263

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 34/200 (17%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +     Q    Q++ G++Y+HS  I HRDLKP N+ ++    LKI DFGLA         
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177

Query: 61  RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWD------------ 107
                   T  Y APE+++   +  +  DIWS G I+  +L G   +             
Sbjct: 178 Y-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

Query: 108 ----KPTADCIEYLEWKDNRHMQRSP-----------WDRLDVNCLSLIRRILAPLPSTR 152
                P A+ ++ +  +  R+  +S            +   +   + L+ ++L      R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

Query: 153 LNIEKIKSHRWYSK-HMPND 171
           +   +  +H ++++ H P+D
Sbjct: 293 ITAAQALAHAYFAQYHDPDD 312

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 99.2 bits (246), Expect = 4e-24
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 28/192 (14%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +    A+ F  QL++G+ Y H + + HRDLKP+N+L++ +  LKI+DFGLA  F +  ++
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156

Query: 61  RPLDKKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEW 119
                +  TL Y AP+VL+ S   +   DIWS G I   M+ G   +   +        +
Sbjct: 157 YT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

Query: 120 KDNRHMQRSPWD-------------------------RLDVNCLSLIRRILAPLPSTRLN 154
           +         W                           LD + + L+ ++L   P+ R+ 
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274

Query: 155 IEKIKSHRWYSK 166
            ++   H ++ +
Sbjct: 275 AKQALEHAYFKE 286

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 8e-24
 Identities = 28/158 (17%), Positives = 60/158 (37%), Gaps = 5/158 (3%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
                   +  G+ YL    + HRDL   N L+     +K+SDFG+   F ++ +     
Sbjct: 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSST 160

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + + +PEV   S  +  +D+WS G+++  + + G++P++  +   +        R
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 220

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                       +   ++       P  R    ++   
Sbjct: 221 LY---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 1e-23
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
             Q    Q++ G+ Y+H+ GI HRDLKP N+ ++    LKI DFGLA        +  + 
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMT 176

Query: 65  KKCGTLPYVAPEVLVRS-YLAEPADIWSCGIILVAMLAGELPWD---------------- 107
               T  Y APEV++      +  DIWS G I+  M+ G+  +                 
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 108 KPTADCIEYLEWKDNRHMQR-----------SPWDRLDVNCLSLIRRILAPLPSTRLNIE 156
            P A+ ++ L+  + ++  +           S         ++L+ ++L      R+   
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 157 KIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLE 193
           +  +H ++     +D  D P    ++ +   +   L+
Sbjct: 297 EALAHPYFESL--HDTEDEPQVQKYDDSFDDVDRTLD 331

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.8 bits (240), Expect = 3e-23
 Identities = 36/199 (18%), Positives = 79/199 (39%), Gaps = 39/199 (19%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGK 59
           +  ++ + +  +++  ++Y HS GI HRD+KP NV++D +   L++ D+GLA  +    +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185

Query: 60  ERPLDKKCGTLPYVAPEVLVR-SYLAEPADIWSCGIILVAMLAGELPWDKPTAD------ 112
                 +  +  +  PE+LV         D+WS G +L +M+  + P+     +      
Sbjct: 186 YNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242

Query: 113 ------CIEYLEWKDNRHMQRSP----------------------WDRLDVNCLSLIRRI 144
                   +  ++ D  +++  P                         +    L  + ++
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

Query: 145 LAPLPSTRLNIEKIKSHRW 163
           L     +RL   +   H +
Sbjct: 303 LRYDHQSRLTAREAMEHPY 321

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 1e-22
 Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 4/160 (2%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +   F  Q+  G+++L SK   HRDL   N +LD + T+K++DFGLA        +   
Sbjct: 130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189

Query: 64  DKK--CGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD 121
           +K      + ++A E L        +D+WS G++L  ++    P           +    
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 122 NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
            R + +  +         ++ +   P    R +  ++ S 
Sbjct: 250 GRRLLQPEY--CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 2e-22
 Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 4/155 (2%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
           +      Q+  G+EYL SK   HRDL   NVL+   + +KI+DFGLA         +   
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNR 123
                + ++APE L        +D+WS G++L  +   G  P+     + + +   K+  
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGH 254

Query: 124 HMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI 158
            M +            ++R     +PS R   +++
Sbjct: 255 RMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.0 bits (233), Expect = 2e-22
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 5/172 (2%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
                  Q+ S +EYL  K   HRDL   N L+     +K++DFGL+             
Sbjct: 116 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHA 174

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH 124
                + + APE L  +  +  +D+W+ G++L  +    +           Y   + +  
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234

Query: 125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS--HRWYSKHMPNDIVD 174
           M+R   +        L+R      PS R +  +I       + +   +D V+
Sbjct: 235 MER--PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (231), Expect = 1e-21
 Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 41/227 (18%)

Query: 5   EAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLD 64
                  Q++ G+++LHS GI HRDLKP N+++    TLKI DFGLA   R  G    + 
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMT 176

Query: 65  KKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWD----------------K 108
               T  Y APEV++     E  DIWS G I+  M+  ++ +                  
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 109 PTADCIEYLEWKDNRHMQRSP----------------------WDRLDVNCLSLIRRILA 146
           P  + ++ L+     +++  P                                L+ ++L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 147 PLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNSTAKRMRSDLE 193
             P+ R++++    H + +       V+ PP   ++         +E
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 343

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 1e-20
 Identities = 41/189 (21%), Positives = 65/189 (34%), Gaps = 34/189 (17%)

Query: 5   EAQKFFRQLISGVEYLHS--------KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRM 56
              K      SG+ +LH           IAHRDLK +N+L+    T  I+D GLA     
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160

Query: 57  NGK--ERPLDKKCGTLPYVAPEVLVRSYLA------EPADIWSCGIILVAMLAGELPWDK 108
                +   + + GT  Y+APEVL  S         + ADI++ G++   +         
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220

Query: 109 PTADCIEYLEW--------------KDNRHMQRSPWDRLDVNCL----SLIRRILAPLPS 150
                + Y +                + +     P        L     ++R       +
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280

Query: 151 TRLNIEKIK 159
            RL   +IK
Sbjct: 281 ARLTALRIK 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 2e-20
 Identities = 33/159 (20%), Positives = 61/159 (38%), Gaps = 4/159 (2%)

Query: 4   WEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPL 63
            +  +   ++  G+ YL++    HRDL   N ++    T+KI DFG+          R  
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 64  DKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDN 122
            K    + +++PE L        +D+WS G++L  +    E P+   + + +     +  
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252

Query: 123 RHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSH 161
                   D        L+R      P  R +  +I S 
Sbjct: 253 L---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.8 bits (203), Expect = 4e-18
 Identities = 37/225 (16%), Positives = 77/225 (34%), Gaps = 46/225 (20%)

Query: 5   EAQKFFRQLISGVEYLHSK-GIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERP 62
             ++  +QL+ G++Y+H + GI H D+KPENVL+++ D    +    +A +      +  
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 63  LDKKCGTLPYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC--------- 113
                 T  Y +PEVL+ +     ADIWS   ++  ++ G+  ++               
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 114 -----------------------------------IEYLEWKDNRHMQRSPWDRLDVNCL 138
                                              +++   +D    +            
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 139 SLIRRILAPLPSTRLNIEKIKSHRWYSKHMPNDIVDGPPSSDFNS 183
             +  +L   P  R +   + +H W    +  + +  P    + S
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 62.5 bits (151), Expect = 4e-12
 Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 6/91 (6%)

Query: 1   MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE 60
           +      +    ++  V   + +GI H DL   NVL+  ++ + I DF  +      G  
Sbjct: 100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR 158

Query: 61  RPLDKKCGTLPYVAPEVLVRSYLAEPADIWS 91
             L++              R+Y  E  DI S
Sbjct: 159 EILERDV----RNIITYFSRTYRTE-KDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	407
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.45
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.4
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	98.63
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	98.4
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	98.03
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.73
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	91.03
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	89.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	87.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	86.32

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=321.46  Aligned_cols=167  Identities=59%  Similarity=1.108  Sum_probs=145.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|.+++.++.||++||+|||++||+||||||+|||++.+|++||+|||+|+..............+||+.|+|||++.+
T Consensus       100 l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence            68999999999999999999999999999999999999999999999999998765555555667899999999999987


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      . +++.++||||+||++|+|++|+.||.........+..... ......++..+++++.+||.+||+.||++|||++|++
T Consensus       180 ~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            7 4578899999999999999999999877655555554444 3344556678999999999999999999999999999


Q ss_pred             hCcccccCC
Q psy11119        160 SHRWYSKHM  168 (407)
Q Consensus       160 ~hpwf~~~~  168 (407)
                      +||||++..
T Consensus       259 ~hpwf~~~l  267 (271)
T d1nvra_         259 KDRWYNKPL  267 (271)
T ss_dssp             TCTTTTCCC
T ss_pred             cCHhhCcCC
Confidence            999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-40  Score=313.00  Aligned_cols=164  Identities=25%  Similarity=0.418  Sum_probs=142.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....  ......+||+.|+|||++.+
T Consensus       113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~  190 (293)
T d1yhwa1         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR  190 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcC
Confidence            6899999999999999999999999999999999999999999999999998764332  23456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++||||+||++|+|++|+.||.+.+........... .......+..+++++++||.+||.+||.+|||+.|+++
T Consensus       191 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            88899999999999999999999999887765544443333 33334445778999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||+..
T Consensus       270 Hp~~~~~  276 (293)
T d1yhwa1         270 HQFLKIA  276 (293)
T ss_dssp             CGGGGGC
T ss_pred             CHhhCCC
Confidence            9999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=311.54  Aligned_cols=171  Identities=28%  Similarity=0.456  Sum_probs=140.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+............+||+.|+|||++.+
T Consensus       105 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence            68999999999999999999999999999999999999999999999999998765544445566789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH---
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK---  157 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e---  157 (407)
                      ..++.++||||+||++|+|++|+.||.+.+...........  .  ...+..+++++++||.+||.+||.+|||++|   
T Consensus       185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            98999999999999999999999999987765444333322  1  2223568999999999999999999999987   


Q ss_pred             ---HHhCcccccCCCCCCCCC
Q psy11119        158 ---IKSHRWYSKHMPNDIVDG  175 (407)
Q Consensus       158 ---il~hpwf~~~~~~~~~~~  175 (407)
                         |++||||+...|..+...
T Consensus       261 ~~~i~~Hpff~~i~w~~l~~~  281 (288)
T d1uu3a_         261 YGPLKAHPFFESVTWENLHQQ  281 (288)
T ss_dssp             HHHHHTSGGGTTCCCTTGGGS
T ss_pred             CHHHHcCCccCCCCHHHhhcC
Confidence               688999998877655443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=307.79  Aligned_cols=159  Identities=29%  Similarity=0.479  Sum_probs=137.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....    .....+||+.|+|||++.+
T Consensus       103 l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcC
Confidence            688999999999999999999999999999999999999999999999999764322    2345689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      ..++.++|||||||++|+|++|+.||.+.+...........  .  ...+..+|+++.+||.+||++||.+|||++|+++
T Consensus       179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            88899999999999999999999999987765443332222  2  2233568999999999999999999999999999


Q ss_pred             CcccccC
Q psy11119        161 HRWYSKH  167 (407)
Q Consensus       161 hpwf~~~  167 (407)
                      ||||++.
T Consensus       255 hp~~~~~  261 (263)
T d2j4za1         255 HPWITAN  261 (263)
T ss_dssp             CHHHHHH
T ss_pred             CcCcCCc
Confidence            9999764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-38  Score=307.40  Aligned_cols=164  Identities=32%  Similarity=0.549  Sum_probs=131.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe---cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD---LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld---~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |+|.+++.++.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+.....   ......+||+.|+|||+
T Consensus       104 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~  180 (307)
T d1a06a_         104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEV  180 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC---CeeeeeeeCccccCcHH
Confidence            68999999999999999999999999999999999995   5789999999999865422   23456789999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+..++.++||||+||++|+|++|..||.+...................+.+..+|+++.+||.+||.+||.+|||++|
T Consensus       181 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  260 (307)
T d1a06a_         181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ  260 (307)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            99988899999999999999999999999988766555555444445555566789999999999999999999999999


Q ss_pred             HHhCcccccC
Q psy11119        158 IKSHRWYSKH  167 (407)
Q Consensus       158 il~hpwf~~~  167 (407)
                      +++||||++.
T Consensus       261 il~hp~~~~~  270 (307)
T d1a06a_         261 ALQHPWIAGD  270 (307)
T ss_dssp             HHHSTTTTSS
T ss_pred             HhcCHhhCCC
Confidence            9999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-39  Score=312.41  Aligned_cols=165  Identities=28%  Similarity=0.468  Sum_probs=141.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  .......+||+.|+|||++.+
T Consensus       102 ~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~  179 (337)
T d1o6la_         102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSS
T ss_pred             CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--CcccccceeCHHHhhhhhccC
Confidence            589999999999999999999999999999999999999999999999999865332  233456799999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----H
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----I  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----~  155 (407)
                      ..++.++|||||||++|+|++|+.||.+.+...........  .  ...+..+|+++++||++||++||.+|++     +
T Consensus       180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~  255 (337)
T d1o6la_         180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  255 (337)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred             CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--C--CCCCccCCHHHHHHHHhhccCCchhhcccccccH
Confidence            98899999999999999999999999988876543333322  2  2334568999999999999999999994     9


Q ss_pred             HHHHhCcccccCCCCC
Q psy11119        156 EKIKSHRWYSKHMPND  171 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~  171 (407)
                      +|+++||||++..|..
T Consensus       256 ~eil~Hp~f~~i~~~~  271 (337)
T d1o6la_         256 KEVMEHRFFLSINWQD  271 (337)
T ss_dssp             HHHHTSGGGTTCCHHH
T ss_pred             HHHHcCcccccCCHHH
Confidence            9999999998865443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-39  Score=305.49  Aligned_cols=164  Identities=25%  Similarity=0.358  Sum_probs=138.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh-
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV-   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-   79 (407)
                      |++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......  ......+||+.|+|||++. 
T Consensus       107 l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~  184 (288)
T d2jfla1         107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMC  184 (288)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhh
Confidence            6899999999999999999999999999999999999999999999999997653221  1234568999999999984 


Q ss_pred             ----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         80 ----RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        80 ----~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                          +..++.++||||+||++|+|++|+.||.+.+........... .......+..+++++.+||.+||++||.+|||+
T Consensus       185 ~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~  263 (288)
T d2jfla1         185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT  263 (288)
T ss_dssp             CSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHccCChhHCcCH
Confidence                346789999999999999999999999987766554444333 222334456789999999999999999999999


Q ss_pred             HHHHhCcccccC
Q psy11119        156 EKIKSHRWYSKH  167 (407)
Q Consensus       156 ~eil~hpwf~~~  167 (407)
                      +|+++||||+..
T Consensus       264 ~ell~hp~~~~~  275 (288)
T d2jfla1         264 SQLLQHPFVTVD  275 (288)
T ss_dssp             HHHTTSGGGCCC
T ss_pred             HHHhcCcccCCC
Confidence            999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-38  Score=310.58  Aligned_cols=167  Identities=27%  Similarity=0.458  Sum_probs=143.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec--CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL--QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~--~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+|.+++.|+.||+.||.|||++||+||||||+|||++.  +|.+||+|||+|+.+...   ......+||+.|+|||++
T Consensus       121 l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccCHHHH
Confidence            589999999999999999999999999999999999964  578999999999876432   233457899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||.+.+...................+..+++++++||.+||.+||++|||++|+
T Consensus       198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei  277 (350)
T d1koaa2         198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA  277 (350)
T ss_dssp             HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            99888999999999999999999999999887665444444443444445556789999999999999999999999999


Q ss_pred             HhCcccccCCCC
Q psy11119        159 KSHRWYSKHMPN  170 (407)
Q Consensus       159 l~hpwf~~~~~~  170 (407)
                      ++||||+.....
T Consensus       278 l~hp~~~~~~~~  289 (350)
T d1koaa2         278 LEHPWLTPGNAP  289 (350)
T ss_dssp             HHSTTTSCTTCC
T ss_pred             hcCcccCCCCCC
Confidence            999999986543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=299.84  Aligned_cols=159  Identities=24%  Similarity=0.387  Sum_probs=132.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCcEEEe-cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG--IAHRDLKPENVLLD-LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g--IvHrDLkp~NILld-~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      +++.+++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+....    ......+||+.|+|||+
T Consensus       109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~  184 (270)
T d1t4ha_         109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM  184 (270)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGG
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC----CccCCcccCccccCHHH
Confidence            578999999999999999999999  99999999999996 578999999999975322    22345689999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                      +.+ .++.++||||+||++|+|++|+.||.+.......+..... ...+...+...++++.+||.+||++||++|||++|
T Consensus       185 ~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  262 (270)
T d1t4ha_         185 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  262 (270)
T ss_dssp             GGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            876 4789999999999999999999999876544333333332 22222233557899999999999999999999999


Q ss_pred             HHhCcccc
Q psy11119        158 IKSHRWYS  165 (407)
Q Consensus       158 il~hpwf~  165 (407)
                      +++||||+
T Consensus       263 ll~Hp~fk  270 (270)
T d1t4ha_         263 LLNHAFFQ  270 (270)
T ss_dssp             HHTSGGGC
T ss_pred             HhCCcccC
Confidence            99999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-38  Score=304.14  Aligned_cols=163  Identities=31%  Similarity=0.462  Sum_probs=140.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....     .....+||+.|+|||++.+
T Consensus       101 ~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~  175 (316)
T d1fota_         101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVST  175 (316)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTT
T ss_pred             ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcC
Confidence            46788999999999999999999999999999999999999999999999987542     2345789999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++||||+||++|+|++|+.||.+.+...........  .  ...+..+++++.++|.+||.+||.+|+     |+
T Consensus       176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~  251 (316)
T d1fota_         176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT  251 (316)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTT
T ss_pred             CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--C--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhH
Confidence            88899999999999999999999999988766544433332  2  222356899999999999999999996     99


Q ss_pred             HHHHhCcccccCCCCCC
Q psy11119        156 EKIKSHRWYSKHMPNDI  172 (407)
Q Consensus       156 ~eil~hpwf~~~~~~~~  172 (407)
                      +++++||||++..|...
T Consensus       252 ~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         252 EDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             HHHHTSGGGSSCCHHHH
T ss_pred             HHHHcCcccccCCHHHH
Confidence            99999999998765543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-38  Score=310.98  Aligned_cols=161  Identities=27%  Similarity=0.416  Sum_probs=139.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....     .....+||+.|+|||++.+
T Consensus       138 l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCccccCCHHHHcC
Confidence            68899999999999999999999999999999999999999999999999987642     2345689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----CH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----NI  155 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----s~  155 (407)
                      ..++.++|||||||++|+|++|+.||.+.+...........    ....+..+++++.+||++||.+||.+|+     |+
T Consensus       213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~  288 (350)
T d1rdqe_         213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC----CCCCCccCCHHHHHHHHHHhhhCHHhccccccccH
Confidence            98899999999999999999999999987765443333322    1223456899999999999999999995     99


Q ss_pred             HHHHhCcccccCCCC
Q psy11119        156 EKIKSHRWYSKHMPN  170 (407)
Q Consensus       156 ~eil~hpwf~~~~~~  170 (407)
                      +++++||||+...|.
T Consensus       289 ~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         289 NDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHTSGGGTTCCHH
T ss_pred             HHHHcCccccCCCHH
Confidence            999999999986554

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4e-38  Score=310.40  Aligned_cols=166  Identities=27%  Similarity=0.364  Sum_probs=139.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...    .....+||+.|+|||++..
T Consensus       104 ~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~  179 (364)
T d1omwa3         104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK  179 (364)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHST
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhc
Confidence            578999999999999999999999999999999999999999999999999876432    2345689999999999975


Q ss_pred             -CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC-----
Q psy11119         81 -SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN-----  154 (407)
Q Consensus        81 -~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps-----  154 (407)
                       ..++.++|||||||++|+|++|+.||.......... ............+..+|+++++||.+||.+||.+|||     
T Consensus       180 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~  258 (364)
T d1omwa3         180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG  258 (364)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSST
T ss_pred             CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccC
Confidence             478999999999999999999999998765443222 2222233344445679999999999999999999999     


Q ss_pred             HHHHHhCcccccCCCCC
Q psy11119        155 IEKIKSHRWYSKHMPND  171 (407)
Q Consensus       155 ~~eil~hpwf~~~~~~~  171 (407)
                      ++++++||||+...|..
T Consensus       259 a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         259 AQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             HHHHHTSGGGTTCCHHH
T ss_pred             HHHHHcCccccCCCHHH
Confidence            79999999999876543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=298.94  Aligned_cols=166  Identities=26%  Similarity=0.377  Sum_probs=136.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......  ......+||+.|+|||++..
T Consensus        97 l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  174 (299)
T d1ua2a_          97 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFG  174 (299)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHcc
Confidence            5778999999999999999999999999999999999999999999999997654322  23445689999999999875


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC------------------------CCCcCCH
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS------------------------PWDRLDV  135 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~  135 (407)
                      . .++.++||||+||++|+|++|..||.+.+..+...............                        .+..+++
T Consensus       175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  254 (299)
T d1ua2a_         175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD  254 (299)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred             CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCH
Confidence            5 78999999999999999999999998877655444333221111000                        0135688


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        136 NCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       136 ~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++.+||.+||..||++|||++|+++||||+...
T Consensus       255 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         255 DLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            999999999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.2e-38  Score=308.80  Aligned_cols=165  Identities=24%  Similarity=0.428  Sum_probs=144.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEe--cCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLD--LQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld--~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+|.+++.++.||+.||.|||++||+||||||+|||++  .+|.+||+|||+|+.+...   ......+||+.|+|||++
T Consensus       124 l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIV  200 (352)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccCHHHH
Confidence            58999999999999999999999999999999999998  5789999999999876432   234556899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||.+.+...............+...+..+++++.+||.+||.+||.+|||+.|+
T Consensus       201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  280 (352)
T d1koba_         201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA  280 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            99989999999999999999999999999887765544444444444555667899999999999999999999999999


Q ss_pred             HhCcccccCC
Q psy11119        159 KSHRWYSKHM  168 (407)
Q Consensus       159 l~hpwf~~~~  168 (407)
                      ++||||+...
T Consensus       281 l~Hp~~~~~~  290 (352)
T d1koba_         281 LEHPWLKGDH  290 (352)
T ss_dssp             HTSTTTSSCC
T ss_pred             hcCHhhCCCc
Confidence            9999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-38  Score=302.64  Aligned_cols=160  Identities=24%  Similarity=0.369  Sum_probs=136.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....      ....+||+.|+|||++.+
T Consensus       112 l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~  185 (309)
T d1u5ra_         112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILA  185 (309)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhc
Confidence            68999999999999999999999999999999999999999999999999976432      245689999999999964


Q ss_pred             ---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHH
Q psy11119         81 ---SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEK  157 (407)
Q Consensus        81 ---~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~e  157 (407)
                         ..++.++|||||||++|+|++|..||.+.+...........  ..+......+|+++.+||.+||+.||.+|||++|
T Consensus       186 ~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence               35788999999999999999999999887765444443333  2222334568999999999999999999999999


Q ss_pred             HHhCcccccCC
Q psy11119        158 IKSHRWYSKHM  168 (407)
Q Consensus       158 il~hpwf~~~~  168 (407)
                      +++||||.+..
T Consensus       264 ll~Hp~~~~~~  274 (309)
T d1u5ra_         264 LLKHRFVLRER  274 (309)
T ss_dssp             HTTCHHHHSCC
T ss_pred             HHhCHHhcCCC
Confidence            99999998743

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=298.56  Aligned_cols=159  Identities=26%  Similarity=0.348  Sum_probs=126.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCch
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKG-----IAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP   75 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~g-----IvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP   75 (407)
                      |+|.+++.++.||+.||.|||++|     |+||||||+|||++.+|.+||+|||+|+.+....  ......+||+.|+||
T Consensus       106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~AP  183 (269)
T d2java1         106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSP  183 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCH
Confidence            578999999999999999999976     9999999999999999999999999998764322  233467899999999


Q ss_pred             hhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         76 EVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        76 E~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      |++.+..++.++|||||||++|+|++|+.||.+.+...........  .. ...+..+|+++.+||.+||+.||.+|||+
T Consensus       184 E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~  260 (269)
T d2java1         184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF-RRIPYRYSDELNEIITRMLNLKDYHRPSV  260 (269)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC-CCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            9999888999999999999999999999999987765433332222  22 12345689999999999999999999999


Q ss_pred             HHHHhCccc
Q psy11119        156 EKIKSHRWY  164 (407)
Q Consensus       156 ~eil~hpwf  164 (407)
                      +|+++|||+
T Consensus       261 ~ell~hp~i  269 (269)
T d2java1         261 EEILENPLI  269 (269)
T ss_dssp             HHHHTSTTC
T ss_pred             HHHHhCCcC
Confidence            999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=304.90  Aligned_cols=164  Identities=26%  Similarity=0.453  Sum_probs=132.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.+...    ...+.+||+.|+|||++.
T Consensus       101 l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_         101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHc
Confidence            5789999999999999999997 49999999999999999999999999999865432    234568999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH----------------------------------------H
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE----------------------------------------W  119 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~----------------------------------------~  119 (407)
                      +..++.++||||+||++|+|++|+.||...+........                                        .
T Consensus       177 ~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (322)
T d1s9ja_         177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY  256 (322)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhh
Confidence            999999999999999999999999999765533221110                                        0


Q ss_pred             hhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        120 KDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       120 ~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ......+..+...+|.++.+||.+||..||.+|||++|+++||||++..
T Consensus       257 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             HHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             hhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            0001111112234688999999999999999999999999999998753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=297.41  Aligned_cols=164  Identities=27%  Similarity=0.404  Sum_probs=137.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....   .......+||+.|+|||++.+
T Consensus       113 ~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcC
Confidence            57889999999999999999999999999999999999999999999999876432   234456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhccc-----------------------CCCCCCCcCCHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRH-----------------------MQRSPWDRLDVNC  137 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~s~~~  137 (407)
                      ..++.++||||+||++|+|++|..||.+.+..............                       .....+..+++.+
T Consensus       190 ~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  269 (305)
T d1blxa_         190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  269 (305)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred             CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHH
Confidence            99999999999999999999999999988765544333221000                       0001234578999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        138 LSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       138 ~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++||.+||.+||++|||++|+++||||++.
T Consensus       270 ~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         270 KDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            999999999999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-38  Score=299.34  Aligned_cols=167  Identities=32%  Similarity=0.493  Sum_probs=139.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC----cEEEEecCCceeeccCCCccCCcCccCCCCCCchh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD----TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPE   76 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g----~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE   76 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.+|    .+|++|||+|+.....   ......+||+.|+|||
T Consensus       110 l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE  186 (293)
T d1jksa_         110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPE  186 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHH
T ss_pred             cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC---ccccccCCCCcccCHH
Confidence            68899999999999999999999999999999999998776    5999999999876433   2335568999999999


Q ss_pred             hhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         77 VLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        77 ~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      ++.+..++.++||||+||++|+|++|..||.+.+...................+..+|+++++||++||++||.+|||++
T Consensus       187 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~  266 (293)
T d1jksa_         187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ  266 (293)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             HHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            99988889999999999999999999999998776654433333322333333467899999999999999999999999


Q ss_pred             HHHhCcccccCCCC
Q psy11119        157 KIKSHRWYSKHMPN  170 (407)
Q Consensus       157 eil~hpwf~~~~~~  170 (407)
                      |+++||||+...+.
T Consensus       267 eil~hp~~~~~~~~  280 (293)
T d1jksa_         267 DSLQHPWIKPKDTQ  280 (293)
T ss_dssp             HHHHSTTTCC----
T ss_pred             HHhcCcccCCCChh
Confidence            99999999875443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-37  Score=294.29  Aligned_cols=164  Identities=30%  Similarity=0.538  Sum_probs=142.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....   .....+||+.|+|||++.+
T Consensus       107 l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~  183 (277)
T d1phka_         107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIEC  183 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhc
Confidence            6899999999999999999999999999999999999999999999999998764332   3345689999999999964


Q ss_pred             ------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCC
Q psy11119         81 ------SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLN  154 (407)
Q Consensus        81 ------~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps  154 (407)
                            ..++.++||||+||++|+|++|+.||.+.+.................+.+..+|+++++||.+||++||.+|||
T Consensus       184 ~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s  263 (277)
T d1phka_         184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT  263 (277)
T ss_dssp             HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred             cccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC
Confidence                  25678999999999999999999999988876555444444445555666789999999999999999999999


Q ss_pred             HHHHHhCcccccC
Q psy11119        155 IEKIKSHRWYSKH  167 (407)
Q Consensus       155 ~~eil~hpwf~~~  167 (407)
                      ++||++||||++.
T Consensus       264 ~~eil~h~~~~~~  276 (277)
T d1phka_         264 AEEALAHPFFQQY  276 (277)
T ss_dssp             HHHHTTSGGGCTT
T ss_pred             HHHHHcCHHHHHh
Confidence            9999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-38  Score=302.39  Aligned_cols=164  Identities=29%  Similarity=0.482  Sum_probs=140.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      ++|.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  .......+||+.|+|||++.+
T Consensus       100 ~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_         100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHcC
Confidence            578999999999999999999999999999999999999999999999999865432  233455789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH-HHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE-KIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~-eil  159 (407)
                      ..++.++||||+||++|+|++|+.||.+.+...........  ..  ..+..+|+++.+||++||.+||.+|||+. +++
T Consensus       178 ~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            98999999999999999999999999988766544333222  22  22346899999999999999999999995 899


Q ss_pred             hCcccccCCCC
Q psy11119        160 SHRWYSKHMPN  170 (407)
Q Consensus       160 ~hpwf~~~~~~  170 (407)
                      +||||++..+.
T Consensus       254 ~hpff~~~~~~  264 (320)
T d1xjda_         254 QHPLFREINWE  264 (320)
T ss_dssp             GSGGGTTCCHH
T ss_pred             hCchhccCCHH
Confidence            99999876543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=293.36  Aligned_cols=153  Identities=33%  Similarity=0.569  Sum_probs=130.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC-CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ-DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~-g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      ++|.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....    ...+..+||+.|+|||++.
T Consensus       107 l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~  182 (273)
T d1xwsa_         107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIR  182 (273)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc----ccccccccCCCcCCHHHHc
Confidence            5899999999999999999999999999999999999965 7899999999986432    2345678999999999998


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +. +++.++||||+||++|+|++|+.||.....      ....    .......+|+++++||++||.+||++|||++|+
T Consensus       183 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  252 (273)
T d1xwsa_         183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI  252 (273)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc----ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            76 567889999999999999999999975321      1111    112335689999999999999999999999999


Q ss_pred             HhCcccccC
Q psy11119        159 KSHRWYSKH  167 (407)
Q Consensus       159 l~hpwf~~~  167 (407)
                      ++||||++.
T Consensus       253 l~hp~~~~~  261 (273)
T d1xwsa_         253 QNHPWMQDV  261 (273)
T ss_dssp             HTSGGGSSC
T ss_pred             hcCHhhCCC
Confidence            999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=288.72  Aligned_cols=166  Identities=27%  Similarity=0.446  Sum_probs=137.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |+|.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....  .......+||+.|+|||++..
T Consensus        99 l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~  176 (298)
T d1gz8a_          99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG  176 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC--cccceeecccceeeehhhhcc
Confidence            689999999999999999999999999999999999999999999999999765332  234456689999999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCC-------------------------CCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRS-------------------------PWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s  134 (407)
                      . +++.++|+||+||++|+|++|+.||.+.+.....+............                         ....++
T Consensus       177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  256 (298)
T d1gz8a_         177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD  256 (298)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred             ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence            6 67899999999999999999999999877665544443321111110                         012467


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++.+||++||.+||.+|||++|+++||||++..
T Consensus       257 ~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            8999999999999999999999999999998653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-37  Score=297.85  Aligned_cols=165  Identities=31%  Similarity=0.528  Sum_probs=134.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~   77 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||+|+.....   ......+||+.|+|||+
T Consensus       108 l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEV  184 (335)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC---CCCCCCSCCCSSCCCCC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC---CccccccCCcccCCcHH
Confidence            578999999999999999999999999999999999985   457999999999876433   23456789999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh----cccCCCCCCCcCCHHHHHHHHHhccCCCCCCC
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD----NRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL  153 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp  153 (407)
                      +.+..++.++|||||||++|+|++|+.||.+.+...........    ....+.+.+..+|+++.+||++||+.||++||
T Consensus       185 ~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  264 (335)
T d2ozaa1         185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM  264 (335)
T ss_dssp             CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred             HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc
Confidence            99888899999999999999999999999765543222211111    11222333457899999999999999999999


Q ss_pred             CHHHHHhCcccccCC
Q psy11119        154 NIEKIKSHRWYSKHM  168 (407)
Q Consensus       154 s~~eil~hpwf~~~~  168 (407)
                      |+.|+++||||.+..
T Consensus       265 s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         265 TITEFMNHPWIMQST  279 (335)
T ss_dssp             CHHHHHHSHHHHTTT
T ss_pred             CHHHHHcCHHhhCCC
Confidence            999999999997653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=286.41  Aligned_cols=162  Identities=25%  Similarity=0.352  Sum_probs=127.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..............+||+.|+|||++.+
T Consensus       101 ~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  180 (276)
T d1uwha_         101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM  180 (276)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhc
Confidence            57889999999999999999999999999999999999999999999999987654433444566789999999999974


Q ss_pred             C---CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCC--CCCCCcCCHHHHHHHHHhccCCCCCCCCH
Q psy11119         81 S---YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQ--RSPWDRLDVNCLSLIRRILAPLPSTRLNI  155 (407)
Q Consensus        81 ~---~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~LI~~~L~~~P~~Rps~  155 (407)
                      .   .++.++||||+||++|||+||+.||.+.+...............+  ...+..+++++.+||.+||+.||.+|||+
T Consensus       181 ~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  260 (276)
T d1uwha_         181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF  260 (276)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCH
Confidence            3   578899999999999999999999987665433333333221111  22345688999999999999999999999


Q ss_pred             HHHHhCc
Q psy11119        156 EKIKSHR  162 (407)
Q Consensus       156 ~eil~hp  162 (407)
                      ++|+++-
T Consensus       261 ~~il~~L  267 (276)
T d1uwha_         261 PQILASI  267 (276)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=286.91  Aligned_cols=167  Identities=26%  Similarity=0.444  Sum_probs=134.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l   78 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....  .......+||+.|+|||++
T Consensus       114 ~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~  193 (318)
T d3blha1         114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  193 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred             cccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHH
Confidence            47889999999999999999999999999999999999999999999999987653322  2334456899999999999


Q ss_pred             hcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCC--------------------------
Q psy11119         79 VRS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWD--------------------------  131 (407)
Q Consensus        79 ~~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------  131 (407)
                      .+. +++.++||||+||++|+|++|+.||.+.+...................+.                          
T Consensus       194 ~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (318)
T d3blha1         194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK  273 (318)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHH
T ss_pred             cCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhc
Confidence            865 78999999999999999999999998776554433322221111111111                          


Q ss_pred             --cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        132 --RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       132 --~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                        ..++++++||.+||.+||++|||++|+++||||+..
T Consensus       274 ~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence              136788999999999999999999999999999853

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6e-36  Score=284.61  Aligned_cols=164  Identities=30%  Similarity=0.490  Sum_probs=131.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+.......  .......|++.|+|||.+.+
T Consensus        97 l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~  174 (286)
T d1ob3a_          97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMG  174 (286)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTT
T ss_pred             cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhC
Confidence            6899999999999999999999999999999999999999999999999998654322  22345579999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCC-------------------------CCCCcCC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQR-------------------------SPWDRLD  134 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~s  134 (407)
                      . +++.++||||+||++|+|++|+.||.+.+.................                         .....++
T Consensus       175 ~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  254 (286)
T d1ob3a_         175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD  254 (286)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred             CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCC
Confidence            5 7899999999999999999999999887665444333221111100                         1124578


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHhCccccc
Q psy11119        135 VNCLSLIRRILAPLPSTRLNIEKIKSHRWYSK  166 (407)
Q Consensus       135 ~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~  166 (407)
                      +++.+||++||.+||++|||++|+++||||++
T Consensus       255 ~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         255 ESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            89999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=294.89  Aligned_cols=165  Identities=22%  Similarity=0.450  Sum_probs=141.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecC--CcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQ--DTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVL   78 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~--g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l   78 (407)
                      |+|.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....   ......+||+.|+|||.+
T Consensus        99 l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~  175 (321)
T d1tkia_          99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC---Ccccccccccccccchhc
Confidence            5899999999999999999999999999999999999854  47999999999875432   223456899999999999


Q ss_pred             hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         79 VRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        79 ~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      .+..++.++||||+||++|+|++|..||...+...............+...+..+|+++++||.+||.+||.+|||++|+
T Consensus       176 ~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  255 (321)
T d1tkia_         176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            98888999999999999999999999999888765544444443344444456789999999999999999999999999


Q ss_pred             HhCcccccCC
Q psy11119        159 KSHRWYSKHM  168 (407)
Q Consensus       159 l~hpwf~~~~  168 (407)
                      ++||||++..
T Consensus       256 l~hp~~~~~~  265 (321)
T d1tkia_         256 LQHPWLKQKI  265 (321)
T ss_dssp             HHSHHHHSCG
T ss_pred             hcCHhhccCc
Confidence            9999998653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=292.00  Aligned_cols=159  Identities=23%  Similarity=0.291  Sum_probs=135.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+..............+||+.|+|||++.+
T Consensus       161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            57889999999999999999999999999999999999999999999999987654443333445678999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||+| |..||.+.+.............  ..+.+..+|+++.+||.+||+.||++|||++||+
T Consensus       241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~  318 (325)
T d1rjba_         241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  318 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999998 8999987665544443333322  2333456899999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       319 ~~  320 (325)
T d1rjba_         319 SF  320 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-36  Score=285.51  Aligned_cols=159  Identities=23%  Similarity=0.298  Sum_probs=128.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+..............+||+.|+|||++.+
T Consensus       131 l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  210 (299)
T d1ywna1         131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  210 (299)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence            47889999999999999999999999999999999999999999999999987654444444456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||++| ..||..................  ...+..+++++.+||.+||+.||.+|||++||+
T Consensus       211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil  288 (299)
T d1ywna1         211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  288 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9999999999999999999986 5688766544333333333222  233456899999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       289 ~~  290 (299)
T d1ywna1         289 EH  290 (299)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-35  Score=288.04  Aligned_cols=164  Identities=26%  Similarity=0.397  Sum_probs=134.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+...   ....+.+||+.|+|||++.
T Consensus       119 l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRYYRAPELIF  195 (350)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT---SCCCSCCSCTTSCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC---cccccccccccccChHHhh
Confidence            67899999999999999999999999999999999999875 8999999999876433   2345578999999999987


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc---------------cC-----C-----CCCCCcC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR---------------HM-----Q-----RSPWDRL  133 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~---------------~~-----~-----~~~~~~~  133 (407)
                      +. +++.++||||+||++|+|++|..||...+.............               ..     .     ......+
T Consensus       196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (350)
T d1q5ka_         196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT  275 (350)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred             cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence            65 789999999999999999999999987765543332221100               00     0     0112457


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKH  167 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~  167 (407)
                      ++++.+||.+||..||.+|||+.|+++||||++.
T Consensus       276 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            8999999999999999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-36  Score=288.55  Aligned_cols=170  Identities=26%  Similarity=0.444  Sum_probs=137.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+..... ......+|++.|+|||.+.+
T Consensus       126 ~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~  204 (322)
T d1vzoa_         126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRG  204 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTT
T ss_pred             ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccc-ccccccccccccchhHHhhc
Confidence            46889999999999999999999999999999999999999999999999987643322 23456789999999999976


Q ss_pred             C--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCC-----
Q psy11119         81 S--YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRL-----  153 (407)
Q Consensus        81 ~--~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rp-----  153 (407)
                      .  +++.++||||+||+||+|++|..||.....................+.+..+++++.+||.+||.+||.+||     
T Consensus       205 ~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~  284 (322)
T d1vzoa_         205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR  284 (322)
T ss_dssp             CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred             CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcc
Confidence            4  678899999999999999999999977654433333333222233333456899999999999999999999     


Q ss_pred             CHHHHHhCcccccCCCCC
Q psy11119        154 NIEKIKSHRWYSKHMPND  171 (407)
Q Consensus       154 s~~eil~hpwf~~~~~~~  171 (407)
                      |++|+++||||++..+..
T Consensus       285 t~~eil~Hpff~~i~~~~  302 (322)
T d1vzoa_         285 DADEIKEHLFFQKINWDD  302 (322)
T ss_dssp             THHHHHTSGGGTTCCHHH
T ss_pred             cHHHHHcCHhhcCCCHHH
Confidence            589999999998765433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-35  Score=284.31  Aligned_cols=163  Identities=26%  Similarity=0.376  Sum_probs=135.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+....     ..+..+||+.|+|||++.+
T Consensus       118 l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHT
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcC
Confidence            68999999999999999999999999999999999999999999999999986532     2356789999999999976


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-----------------------ccCCC----CCCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-----------------------RHMQR----SPWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-----------------------~~~~~----~~~~~  132 (407)
                      . +++.++||||+||++|+|++|+.||.+.+............                       .....    .....
T Consensus       193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (346)
T d1cm8a_         193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN  272 (346)
T ss_dssp             TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred             CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC
Confidence            5 77999999999999999999999998776543322211100                       01111    12245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       273 ~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            789999999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-35  Score=285.76  Aligned_cols=169  Identities=29%  Similarity=0.414  Sum_probs=137.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....... .......+||+.|+|||++.
T Consensus       106 l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  185 (345)
T d1pmea_         106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  185 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh
Confidence            68999999999999999999999999999999999999999999999999987643322 22345678999999999985


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhc-----------------------ccCCCC----CCC
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDN-----------------------RHMQRS----PWD  131 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-----------------------~~~~~~----~~~  131 (407)
                      .. .++.++||||+||++|+|++|..||................                       ......    .+.
T Consensus       186 ~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (345)
T d1pmea_         186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  265 (345)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCC
Confidence            54 78899999999999999999999998776543322211100                       000011    134


Q ss_pred             cCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        132 RLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       132 ~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .+++++++||.+||..||.+|||+.|+++||||+....
T Consensus       266 ~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            57889999999999999999999999999999997654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-35  Score=277.49  Aligned_cols=161  Identities=21%  Similarity=0.327  Sum_probs=132.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.
T Consensus       104 l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~  183 (277)
T d1xbba_         104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  183 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence            57899999999999999999999999999999999999999999999999987654332 22334557999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+||++|||++ |+.||.+.+........... .  ..+.+..+|+++.+||.+||+.||.+|||+++|
T Consensus       184 ~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-~--~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i  260 (277)
T d1xbba_         184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  260 (277)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-C--CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            9888999999999999999998 89999987765433322221 1  223345689999999999999999999999998


Q ss_pred             H---hCccc
Q psy11119        159 K---SHRWY  164 (407)
Q Consensus       159 l---~hpwf  164 (407)
                      +   +|+|+
T Consensus       261 ~~~L~~~~~  269 (277)
T d1xbba_         261 ELRLRNYYY  269 (277)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHhhCHHh
Confidence            5   56554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-35  Score=277.30  Aligned_cols=165  Identities=22%  Similarity=0.391  Sum_probs=129.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+........ .......+||+.|+|||++.
T Consensus       108 l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         108 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc
Confidence            57899999999999999999999999999999999999999999999999876543322 23345668999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +..++.++||||+||++|+|++|..||.+.+...............+...+..+|+++.+||.+||++||.+||+..+.+
T Consensus       188 ~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l  267 (277)
T d1o6ya_         188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  267 (277)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence            88889999999999999999999999998877655555544434444445677999999999999999999999544444


Q ss_pred             hCcccc
Q psy11119        160 SHRWYS  165 (407)
Q Consensus       160 ~hpwf~  165 (407)
                      .|+|.+
T Consensus       268 ~~~l~r  273 (277)
T d1o6ya_         268 RADLVR  273 (277)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            566654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-34  Score=280.11  Aligned_cols=166  Identities=21%  Similarity=0.448  Sum_probs=133.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCC-cEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQD-TLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g-~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....   ......+||+.|+|||++.
T Consensus       126 l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLV  202 (328)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---CCCCSCCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC---CcccccccCccccCccccc
Confidence            68999999999999999999999999999999999999765 5999999999876433   2345678999999999988


Q ss_pred             cC-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHh------------hcc----------------------c
Q psy11119         80 RS-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWK------------DNR----------------------H  124 (407)
Q Consensus        80 ~~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~------------~~~----------------------~  124 (407)
                      +. .++.++|+||+||++|+|++|..||..............            ...                      .
T Consensus       203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (328)
T d3bqca1         203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  282 (328)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred             CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence            75 679999999999999999999999976543321111000            000                      0


Q ss_pred             CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        125 MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       125 ~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .....+..+++++++||++||.+||.+|||++|+++||||+...+
T Consensus       283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            111123457899999999999999999999999999999987543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-35  Score=275.13  Aligned_cols=162  Identities=20%  Similarity=0.350  Sum_probs=133.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ........||+.|+|||++.+
T Consensus       106 l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~  184 (272)
T d1qpca_         106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINY  184 (272)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhC
Confidence            5788999999999999999999999999999999999999999999999998764332 233445679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||+|| .+||......... ......  .....+..+++++.+||.+||+.||++|||+++|+
T Consensus       185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i~~~--~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~  261 (272)
T d1qpca_         185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERG--YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR  261 (272)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHHHhc--CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            8889999999999999999995 5555555544322 222221  22223456899999999999999999999999999


Q ss_pred             h--Cccccc
Q psy11119        160 S--HRWYSK  166 (407)
Q Consensus       160 ~--hpwf~~  166 (407)
                      +  |+||..
T Consensus       262 ~~L~~~fts  270 (272)
T d1qpca_         262 SVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHH
T ss_pred             HHhhhhhhc
Confidence            8  888864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-35  Score=277.00  Aligned_cols=162  Identities=22%  Similarity=0.320  Sum_probs=135.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      |++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... .......+||+.|+|||++.
T Consensus       106 l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence            57899999999999999999999999999999999999999999999999987654332 22334567999999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      ...++.++||||+||++|||+| |+.||.+.......... .....  .+.+..+++++.+||.+||+.||++|||+.+|
T Consensus       186 ~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i  262 (285)
T d1u59a_         186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTV  262 (285)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            8888999999999999999998 99999887655433222 22122  22345689999999999999999999999888


Q ss_pred             ---HhCcccc
Q psy11119        159 ---KSHRWYS  165 (407)
Q Consensus       159 ---l~hpwf~  165 (407)
                         ++|+|+.
T Consensus       263 ~~~L~~~~~~  272 (285)
T d1u59a_         263 EQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence               5678774

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=279.14  Aligned_cols=159  Identities=20%  Similarity=0.349  Sum_probs=130.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+...............||+.|+|||++.+
T Consensus       108 ~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  187 (317)
T d1xkka_         108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  187 (317)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc
Confidence            57889999999999999999999999999999999999999999999999987654444334445578999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +.++.++|||||||++|||+| |..||.+.+........ .....  .+.+..+++++.+||.+||+.||.+|||+.||+
T Consensus       188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil  264 (317)
T d1xkka_         188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELI  264 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence            999999999999999999998 89999887765443322 22122  223356899999999999999999999999999


Q ss_pred             hCc
Q psy11119        160 SHR  162 (407)
Q Consensus       160 ~hp  162 (407)
                      +|.
T Consensus       265 ~~l  267 (317)
T d1xkka_         265 IEF  267 (317)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-34  Score=274.01  Aligned_cols=158  Identities=20%  Similarity=0.297  Sum_probs=121.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCcc---CCcCccCCCCCCchhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKER---PLDKKCGTLPYVAPEV   77 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~---~~~~~~gt~~Y~APE~   77 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.......   ......||+.|+|||+
T Consensus       125 l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  204 (299)
T d1jpaa_         125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA  204 (299)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHH
Confidence            5788999999999999999999999999999999999999999999999998765432221   1223457999999999


Q ss_pred             hhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHH
Q psy11119         78 LVRSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIE  156 (407)
Q Consensus        78 l~~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~  156 (407)
                      +.+..++.++|||||||++|||+| |+.||.+........... .  ....+.+..+++++.+||.+||+.||.+|||+.
T Consensus       205 ~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-Q--DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-T--TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-c--CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence            998889999999999999999998 899998877654333222 2  222334466899999999999999999999999


Q ss_pred             HHHhC
Q psy11119        157 KIKSH  161 (407)
Q Consensus       157 eil~h  161 (407)
                      ||+++
T Consensus       282 ei~~~  286 (299)
T d1jpaa_         282 QIVNT  286 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-34  Score=279.11  Aligned_cols=163  Identities=25%  Similarity=0.366  Sum_probs=131.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....     ......+||+.|+|||++.+
T Consensus       118 l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~  192 (348)
T d2gfsa1         118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLN  192 (348)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTT
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-----cccccccccccccCchhhcC
Confidence            6899999999999999999999999999999999999999999999999987542     23345689999999999776


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccC-----------------------CCC----CCCc
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHM-----------------------QRS----PWDR  132 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------------~~~----~~~~  132 (407)
                      . +++.++||||+||++|+|++|..||.+.+...............                       ...    .+..
T Consensus       193 ~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (348)
T d2gfsa1         193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  272 (348)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred             CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence            5 67899999999999999999999998776544332222111100                       000    1245


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        133 LDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       133 ~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      +++++++||++||..||.+|||+.|+++||||++..
T Consensus       273 ~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            789999999999999999999999999999999754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=268.16  Aligned_cols=166  Identities=25%  Similarity=0.399  Sum_probs=132.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......  .......+++.|+|||++..
T Consensus        98 ~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~  175 (292)
T d1unla_          98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTT
T ss_pred             cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--ccceeeccccchhhhhHhcc
Confidence            4788999999999999999999999999999999999999999999999998764332  23344567888999999876


Q ss_pred             C-CCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh-ccc-------------------------CCCCCCCcC
Q psy11119         81 S-YLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKD-NRH-------------------------MQRSPWDRL  133 (407)
Q Consensus        81 ~-~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~  133 (407)
                      . +++.++||||+||++|+|++|..||............... ...                         ........+
T Consensus       176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (292)
T d1unla_         176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL  255 (292)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred             CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccC
Confidence            6 6799999999999999999999996544332222222111 000                         011122456


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        134 DVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       134 s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                      ++.+.+||++||.+||.+|||++|+++||||++..
T Consensus       256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            88999999999999999999999999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-34  Score=270.22  Aligned_cols=157  Identities=22%  Similarity=0.300  Sum_probs=122.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.++..++.||++||.|||++||+||||||+||+++.++.+||+|||+|+.+.... ........||+.|+|||++.+
T Consensus       105 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~  183 (273)
T d1mp8a_         105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINF  183 (273)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhcc
Confidence            5788999999999999999999999999999999999999999999999998754322 223345678999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||++ |.+||...+........... .  ..+.+..+|+++.+||.+||+.||.+|||+.||+
T Consensus       184 ~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~  260 (273)
T d1mp8a_         184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK  260 (273)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            999999999999999999998 89999987766544333222 2  2234567899999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       261 ~~  262 (273)
T d1mp8a_         261 AQ  262 (273)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-34  Score=267.67  Aligned_cols=157  Identities=17%  Similarity=0.305  Sum_probs=119.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++....... .......||+.|+|||++.+
T Consensus        98 ~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~  176 (263)
T d1sm2a_          98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSF  176 (263)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcC
Confidence            46888999999999999999999999999999999999999999999999987643322 22334679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||+| |.+||...+....... .....  ....+..+++++.+||.+||+.||++|||+++|+
T Consensus       177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~--~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il  253 (263)
T d1sm2a_         177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGF--RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL  253 (263)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcC--CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            889999999999999999999 5667766555433222 22211  2223356789999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       254 ~~  255 (263)
T d1sm2a_         254 RQ  255 (263)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=268.92  Aligned_cols=157  Identities=19%  Similarity=0.270  Sum_probs=120.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC-ccCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK-ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~   79 (407)
                      +++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.
T Consensus       107 ~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~  186 (283)
T d1mqba_         107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  186 (283)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             ccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc
Confidence            57888999999999999999999999999999999999999999999999987644322 22233457899999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++||||+||++|||++|..| |....... .........  ..+.+..++.++.+||.+||+.||++|||+.+|
T Consensus       187 ~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccC--CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence            99999999999999999999996555 55444432 222222222  223345688999999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       264 l~  265 (283)
T d1mqba_         264 VS  265 (283)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-34  Score=271.44  Aligned_cols=156  Identities=21%  Similarity=0.270  Sum_probs=127.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...... ........|++.|+|||++.+
T Consensus       112 ~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~  190 (287)
T d1opja_         112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY  190 (287)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcC
Confidence            5788999999999999999999999999999999999999999999999998654322 222234468999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPW-DKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|+|++|..|| ...+.. ........  ....+.+..+++++.+||.+||+.||.+|||+++|+
T Consensus       191 ~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~  267 (287)
T d1opja_         191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH  267 (287)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhc--CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            98999999999999999999966665 444433 22222222  222334467899999999999999999999999997


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       268 ~  268 (287)
T d1opja_         268 Q  268 (287)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=268.57  Aligned_cols=164  Identities=18%  Similarity=0.256  Sum_probs=128.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++..
T Consensus       110 l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~  188 (285)
T d1fmka3         110 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY  188 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhC
Confidence            5789999999999999999999999999999999999999999999999998654322 223345679999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELP-WDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||++|..| +......... .......  ..+.+..+++++.+||.+||+.||++|||+++|+
T Consensus       189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  265 (285)
T d1fmka3         189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ  265 (285)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcC--CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            9999999999999999999996555 5554443332 2222222  2234467899999999999999999999999998


Q ss_pred             h--CcccccCC
Q psy11119        160 S--HRWYSKHM  168 (407)
Q Consensus       160 ~--hpwf~~~~  168 (407)
                      +  ++||....
T Consensus       266 ~~L~~~~~~~~  276 (285)
T d1fmka3         266 AFLEDYFTSTE  276 (285)
T ss_dssp             HHHHTTTSCSC
T ss_pred             HHHhhhhcCCC
Confidence            8  88987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-33  Score=263.56  Aligned_cols=157  Identities=20%  Similarity=0.313  Sum_probs=133.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+.+++.||++||+|||++||+||||||+|||++.++.+||+|||+++.+.... ........||+.|+|||++.+
T Consensus        97 ~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~  175 (258)
T d1k2pa_          97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMY  175 (258)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcC
Confidence            4678899999999999999999999999999999999999999999999998654332 223345679999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++||||+||++|||+| |+.||...+...........   .....+...++++.+||.+||+.||++|||+++|+
T Consensus       176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil  252 (258)
T d1k2pa_         176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILL  252 (258)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC---CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            989999999999999999998 89999988866544433222   12234466889999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       253 ~~  254 (258)
T d1k2pa_         253 SN  254 (258)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=276.38  Aligned_cols=165  Identities=25%  Similarity=0.324  Sum_probs=126.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++.+++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....   ......+||+.|+|||++.+
T Consensus       116 ~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~  192 (355)
T d2b1pa1         116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG  192 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc---cccccccccccccChhhhcC
Confidence            578999999999999999999999999999999999999999999999998765432   33456689999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcc----------------------cCCCC----------
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNR----------------------HMQRS----------  128 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~----------------------~~~~~----------  128 (407)
                      ..++.++||||+||++|+|++|..||.+.+.............                      .....          
T Consensus       193 ~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (355)
T d2b1pa1         193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  272 (355)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG
T ss_pred             CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc
Confidence            8999999999999999999999999987765433222111000                      00000          


Q ss_pred             ------CCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCC
Q psy11119        129 ------PWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHM  168 (407)
Q Consensus       129 ------~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~  168 (407)
                            .....++++.+||++||..||++|||++|+++||||+...
T Consensus       273 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                  0112456889999999999999999999999999999754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=265.52  Aligned_cols=158  Identities=24%  Similarity=0.362  Sum_probs=130.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc-cCCcCccCCCCCCchhhhh
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE-RPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~   79 (407)
                      |++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......|++.|+|||++.
T Consensus       108 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh
Confidence            578899999999999999999999999999999999999999999999999986544332 2233456788999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKI  158 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~ei  158 (407)
                      +..++.++|||||||++|||+| |..||.+.+...........  ....+.+..+|+++.+||.+||+.||++|||+.+|
T Consensus       188 ~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            9999999999999999999998 89999988776544433333  22334456789999999999999999999999999


Q ss_pred             Hh
Q psy11119        159 KS  160 (407)
Q Consensus       159 l~  160 (407)
                      ++
T Consensus       266 ~~  267 (273)
T d1u46a_         266 RD  267 (273)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-33  Score=269.23  Aligned_cols=157  Identities=21%  Similarity=0.351  Sum_probs=129.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..............+||+.|+|||++.+
T Consensus       137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (301)
T d1lufa_         137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  216 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence            56788999999999999999999999999999999999999999999999987654444444556789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGE-LPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|||++|. +||.+.+..+..... .. .. ..+.+..+++++.+||.+||+.+|++|||+.||+
T Consensus       217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v-~~-~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~  293 (301)
T d1lufa_         217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RD-GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH  293 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT-TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHH-Hc-CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999999999999999999985 678877665433322 22 11 2233457899999999999999999999999996


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       294 ~  294 (301)
T d1lufa_         294 R  294 (301)
T ss_dssp             H
T ss_pred             H
Confidence            5

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-33  Score=265.54  Aligned_cols=157  Identities=24%  Similarity=0.388  Sum_probs=135.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+
T Consensus       132 l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~  211 (299)
T d1fgka_         132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  211 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence            57899999999999999999999999999999999999999999999999988765555445566789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      +.++.++|||||||++|+|++ |.+||.+.+.... +..+....  ..+.+..+++++.+||.+||+.||++|||+.||+
T Consensus       212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil  288 (299)
T d1fgka_         212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  288 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-HHHHHcCC--CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            999999999999999999998 7999987776543 23333322  2233456899999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       289 ~  289 (299)
T d1fgka_         289 E  289 (299)
T ss_dssp             H
T ss_pred             H
Confidence            7

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.3e-32  Score=263.11  Aligned_cols=169  Identities=21%  Similarity=0.272  Sum_probs=131.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec---CCcEEEEecCCceeeccCCCc-----cCCcCccCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL---QDTLKISDFGLATVFRMNGKE-----RPLDKKCGTLPY   72 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~---~g~lkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y   72 (407)
                      +++.++..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+......     ......+||+.|
T Consensus       100 ~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y  179 (299)
T d1ckia_         100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  179 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence            578999999999999999999999999999999999864   456999999999987543321     223456899999


Q ss_pred             CchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHH--Hhhc--ccCCCCCCCcCCHHHHHHHHHhccCC
Q psy11119         73 VAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLE--WKDN--RHMQRSPWDRLDVNCLSLIRRILAPL  148 (407)
Q Consensus        73 ~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~--~~~~--~~~~~~~~~~~s~~~~~LI~~~L~~~  148 (407)
                      +|||++.+..++.++||||+||++|+|++|..||............  ....  ..........+|+++.+||.+||+.+
T Consensus       180 ~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~  259 (299)
T d1ckia_         180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR  259 (299)
T ss_dssp             CCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSC
T ss_pred             cCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCC
Confidence            9999999988999999999999999999999999865543322211  1111  11111123468899999999999999


Q ss_pred             CCCCCCHHH---HHhCcccccCCC
Q psy11119        149 PSTRLNIEK---IKSHRWYSKHMP  169 (407)
Q Consensus       149 P~~Rps~~e---il~hpwf~~~~~  169 (407)
                      |.+||++.+   +++|+|.+....
T Consensus       260 p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         260 FDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hhHCcCHHHHHHHHHHHHHHcCCC
Confidence            999999875   577888766543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-32  Score=263.03  Aligned_cols=158  Identities=23%  Similarity=0.342  Sum_probs=131.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++..|+.||+.||+|||++||+||||||+||+++.++++|++|||+++..............+||+.|+|||++.+
T Consensus       142 l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  221 (311)
T d1t46a_         142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence            57889999999999999999999999999999999999999999999999987654444444456789999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|+|+| |.+||.................  .......+++++.+||.+||++||.+|||+++|+
T Consensus       222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il  299 (311)
T d1t46a_         222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV  299 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999998 6666766555433333333322  2223356789999999999999999999999998


Q ss_pred             h
Q psy11119        160 S  160 (407)
Q Consensus       160 ~  160 (407)
                      +
T Consensus       300 ~  300 (311)
T d1t46a_         300 Q  300 (311)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.6e-32  Score=261.55  Aligned_cols=156  Identities=21%  Similarity=0.285  Sum_probs=131.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhcC
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVRS   81 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~   81 (407)
                      ++..+.+++.|++.||.|||+++|+||||||+|||++.++++||+|||+|+..............+||+.|+|||.+.+.
T Consensus       131 ~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~  210 (308)
T d1p4oa_         131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  210 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence            56788999999999999999999999999999999999999999999999876544433344556799999999999999


Q ss_pred             CCCCcchhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHh
Q psy11119         82 YLAEPADIWSCGIILVAMLAG-ELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKS  160 (407)
Q Consensus        82 ~~~~~sDiwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~  160 (407)
                      .++.++||||+||++|||+|| .+||.+.+........... ..  .+.+..+++.+.+||.+||+.+|.+|||+.+|++
T Consensus       211 ~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-CC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999998 5888877665443332222 22  2233568899999999999999999999999988

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=251.83  Aligned_cols=153  Identities=23%  Similarity=0.336  Sum_probs=123.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      +++..+..++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++....     ......+|+.|+|||++.+
T Consensus       100 l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~  174 (262)
T d1byga_         100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE  174 (262)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhC
Confidence            57889999999999999999999999999999999999999999999999976432     2234578999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLA-GELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|||+| |.+||...+........... ...  +....+++++.+||++||..||.+|||+.+++
T Consensus       175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~  251 (262)
T d1byga_         175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR  251 (262)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC--CCCccCCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            889999999999999999998 79999887766544333221 222  23356889999999999999999999999998


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       252 ~~  253 (262)
T d1byga_         252 EQ  253 (262)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1e-31  Score=262.90  Aligned_cols=164  Identities=23%  Similarity=0.389  Sum_probs=126.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEecCCc------EEEEecCCceeeccCCCccCCcCccCCCCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS-KGIAHRDLKPENVLLDLQDT------LKISDFGLATVFRMNGKERPLDKKCGTLPYV   73 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~-~gIvHrDLkp~NILld~~g~------lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~   73 (407)
                      +++..++.++.||+.||+|||+ +||+||||||+|||++.++.      ++++|||.+.....     .....+||+.|+
T Consensus       122 ~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~  196 (362)
T d1q8ya_         122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYR  196 (362)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGC
T ss_pred             CcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-----cccccccccccc
Confidence            4678999999999999999998 89999999999999987664      99999999976432     234568999999


Q ss_pred             chhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhH------HHHHHHhhcc------------------------
Q psy11119         74 APEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADC------IEYLEWKDNR------------------------  123 (407)
Q Consensus        74 APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~------~~~~~~~~~~------------------------  123 (407)
                      |||++....++.++|+||+||++++|++|+.||.......      ..........                        
T Consensus       197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  276 (362)
T d1q8ya_         197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR  276 (362)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred             ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhh
Confidence            9999998888999999999999999999999997432210      0000000000                        


Q ss_pred             c--------------CCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHHhCcccccCCC
Q psy11119        124 H--------------MQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIKSHRWYSKHMP  169 (407)
Q Consensus       124 ~--------------~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil~hpwf~~~~~  169 (407)
                      .              .....+...++++.+||.+||..||.+|||++|+++||||++...
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             ccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence            0              000111234678999999999999999999999999999996543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=256.90  Aligned_cols=155  Identities=22%  Similarity=0.280  Sum_probs=127.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCchhhhhc
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAPEVLVR   80 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~   80 (407)
                      |++.++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   ......+||+.|+|||.+.+
T Consensus       124 l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~  200 (309)
T d1fvra_         124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNY  200 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc---ccccceecCCcccchHHhcc
Confidence            578899999999999999999999999999999999999999999999999754322   22245579999999999999


Q ss_pred             CCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         81 SYLAEPADIWSCGIILVAMLAGE-LPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        81 ~~~~~~sDiwSlGviL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ..++.++|||||||++|||++|. +||.+.+....... ....  ...+.+..+++++.+||.+||+.||++|||+.+|+
T Consensus       201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil  277 (309)
T d1fvra_         201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQG--YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  277 (309)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGT--CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhc--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            98899999999999999999964 67877665543322 2221  22334467899999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      ++
T Consensus       278 ~~  279 (309)
T d1fvra_         278 VS  279 (309)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-31  Score=255.29  Aligned_cols=158  Identities=21%  Similarity=0.245  Sum_probs=125.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCC--ccCCcCccCCCCCCchhhhh
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGK--ERPLDKKCGTLPYVAPEVLV   79 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l~   79 (407)
                      ++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......  ........||+.|+|||++.
T Consensus       128 ~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  207 (311)
T d1r0pa_         128 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ  207 (311)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred             hHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh
Confidence            4677889999999999999999999999999999999999999999999987643322  12233457899999999999


Q ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhcccCCCCCCCcCCHHHHHHHHHhccCCCCCCCCHHHHH
Q psy11119         80 RSYLAEPADIWSCGIILVAMLAGELPWDKPTADCIEYLEWKDNRHMQRSPWDRLDVNCLSLIRRILAPLPSTRLNIEKIK  159 (407)
Q Consensus        80 ~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~LI~~~L~~~P~~Rps~~eil  159 (407)
                      ...++.++||||||+++|||++|..||...................  .....+++++.+||.+||+.||++||++.||+
T Consensus       208 ~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~  285 (311)
T d1r0pa_         208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV  285 (311)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            9999999999999999999999777776433221111112221222  22355789999999999999999999999999


Q ss_pred             hC
Q psy11119        160 SH  161 (407)
Q Consensus       160 ~h  161 (407)
                      +|
T Consensus       286 ~~  287 (311)
T d1r0pa_         286 SR  287 (311)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1.1e-30  Score=249.29  Aligned_cols=160  Identities=18%  Similarity=0.283  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEec-----CCcEEEEecCCceeeccCCC-----ccCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDL-----QDTLKISDFGLATVFRMNGK-----ERPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~-----~g~lkL~DFGla~~~~~~~~-----~~~~~~~~gt~   70 (407)
                      +++.++..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+.....     .......+||+
T Consensus        98 ~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~  177 (293)
T d1csna_          98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  177 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence            577889999999999999999999999999999999974     57899999999988654322     12344568999


Q ss_pred             CCCchhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhHH--HHHHHhhc--ccCCCCCCCcCCHHHHHHHHHhcc
Q psy11119         71 PYVAPEVLVRSYLAEPADIWSCGIILVAMLAGELPWDKPTADCI--EYLEWKDN--RHMQRSPWDRLDVNCLSLIRRILA  146 (407)
Q Consensus        71 ~Y~APE~l~~~~~~~~sDiwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~--~~~~~~~~~~~s~~~~~LI~~~L~  146 (407)
                      .|+|||++.+..++.++||||+||++|+|++|..||.+......  .+......  ..........+|+++.+++..|+.
T Consensus       178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~  257 (293)
T d1csna_         178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN  257 (293)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred             hhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhc
Confidence            99999999999999999999999999999999999975433211  11111111  111111124578999999999999


Q ss_pred             CCCCCCCCHHHHHh
Q psy11119        147 PLPSTRLNIEKIKS  160 (407)
Q Consensus       147 ~~P~~Rps~~eil~  160 (407)
                      .+|.+||+++.+.+
T Consensus       258 ~~~~~rP~y~~l~~  271 (293)
T d1csna_         258 LAFDATPDYDYLQG  271 (293)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999887755

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.5e-30  Score=244.69  Aligned_cols=161  Identities=24%  Similarity=0.241  Sum_probs=118.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCc--cCCcCccCCC
Q psy11119          1 MAQWEAQKFFRQLISGVEYLHS--------KGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKE--RPLDKKCGTL   70 (407)
Q Consensus         1 L~e~~a~~i~~QL~~aL~~LH~--------~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~--~~~~~~~gt~   70 (407)
                      +++.+...++.|++.||+|||+        +||+||||||+|||++.++.+||+|||+++........  ......+||+
T Consensus        97 l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~  176 (303)
T d1vjya_          97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceeccc
Confidence            4678889999999999999997        59999999999999999999999999999887544332  2334568999


Q ss_pred             CCCchhhhhcCC------CCCcchhhhHHHHHHHHHhCCCCCCCCCh-------------hHHHHHHHhhcccCCCCCCC
Q psy11119         71 PYVAPEVLVRSY------LAEPADIWSCGIILVAMLAGELPWDKPTA-------------DCIEYLEWKDNRHMQRSPWD  131 (407)
Q Consensus        71 ~Y~APE~l~~~~------~~~~sDiwSlGviL~elltG~~Pf~~~~~-------------~~~~~~~~~~~~~~~~~~~~  131 (407)
                      .|+|||++.+..      ++.++|||||||+||||+||..||.....             ....................
T Consensus       177 ~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  256 (303)
T d1vjya_         177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  256 (303)
T ss_dssp             GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             CcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc
Confidence            999999987642      56789999999999999999887742110             00111111111111111111


Q ss_pred             -----cCCHHHHHHHHHhccCCCCCCCCHHHHHhC
Q psy11119        132 -----RLDVNCLSLIRRILAPLPSTRLNIEKIKSH  161 (407)
Q Consensus       132 -----~~s~~~~~LI~~~L~~~P~~Rps~~eil~h  161 (407)
                           .....+.+|+.+||+.||++|||+.||+++
T Consensus       257 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 122458899999999999999999999874

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.45  E-value=1.7e-13  Score=108.08  Aligned_cols=83  Identities=12%  Similarity=0.127  Sum_probs=76.2

Q ss_pred             EEecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEee-cCCCCeeEEEEEEEEec--CeEEEEEEeccCCchHHHHHHHH
Q psy11119        309 FVKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTV-DSRKAQLVFKASVLTLD--NQTLLDFRLSKGCGIEFKTRFLC  385 (407)
Q Consensus       309 ~s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~-d~rk~~l~~~~~i~~~~--~~~~v~f~k~~Gd~lE~~~~f~~  385 (407)
                      +|+.+|++||.+|+.||+.+|+.|+.+++..+++.+. +++++.++|+++|+++.  ++++|+|+|.+||.++|++++.+
T Consensus        16 TS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~   95 (102)
T d1ul7a_          16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK   95 (102)
T ss_dssp             CBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHH
T ss_pred             CcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHH
Confidence            5899999999999999999999999888788999985 46788999999999995  99999999999999999999999


Q ss_pred             HHHhhh
Q psy11119        386 IKRALA  391 (407)
Q Consensus       386 ~~~~l~  391 (407)
                      |-..|+
T Consensus        96 il~~l~  101 (102)
T d1ul7a_          96 IANELK  101 (102)
T ss_dssp             HHHHCC
T ss_pred             HHHhcc
Confidence            887764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.40  E-value=4.5e-14  Score=124.50  Aligned_cols=81  Identities=20%  Similarity=0.195  Sum_probs=59.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEecCCcEEEEecCCceeeccCCCccCCcCccCCCCCCch------
Q psy11119          2 AQWEAQKFFRQLISGVEYLHSKGIAHRDLKPENVLLDLQDTLKISDFGLATVFRMNGKERPLDKKCGTLPYVAP------   75 (407)
Q Consensus         2 ~e~~a~~i~~QL~~aL~~LH~~gIvHrDLkp~NILld~~g~lkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP------   75 (407)
                      ++..+..++.||+.+|.|||++||+||||||+|||++. +.++|+|||.|.........          .|...      
T Consensus       101 ~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~  169 (191)
T d1zara2         101 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWR----------EILERDVRNII  169 (191)
T ss_dssp             CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCCTTCEETTSTTHH----------HHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEECCCcccCCCCCcH----------HHHHHHHHHHH
Confidence            44567889999999999999999999999999999995 45899999999764322111          12211      


Q ss_pred             hhhhcCCCCCcchhhhHHH
Q psy11119         76 EVLVRSYLAEPADIWSCGI   94 (407)
Q Consensus        76 E~l~~~~~~~~sDiwSlGv   94 (407)
                      +.+ .+.++.++|+||+.-
T Consensus       170 ~~f-~r~y~~~~d~~s~~~  187 (191)
T d1zara2         170 TYF-SRTYRTEKDINSAID  187 (191)
T ss_dssp             HHH-HHHHCCCCCHHHHHH
T ss_pred             HHH-cCCCCCcccHHHHHH
Confidence            112 245678899999653

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.63  E-value=4.9e-08  Score=79.94  Aligned_cols=70  Identities=17%  Similarity=0.345  Sum_probs=59.8

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCceEEEEEeec-CCCCeeEEEEEEEEec-CeEEEEEEeccCCchHH
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSPAIVTISTVD-SRKAQLVFKASVLTLD-NQTLLDFRLSKGCGIEF  379 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~~~v~i~~~d-~rk~~l~~~~~i~~~~-~~~~v~f~k~~Gd~lE~  379 (407)
                      |+..+.+||..|..||+.||+.||+.+++.|+++... .....+++.+++|+|+ +.|||||+...|+-.|=
T Consensus         7 S~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e~   78 (153)
T d2v8qa1           7 SQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITEA   78 (153)
T ss_dssp             ECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred             cCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhcc
Confidence            6778999999999999999999999999999999854 3456888999999997 88999999999987663

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=98.40  E-value=5.7e-07  Score=72.04  Aligned_cols=82  Identities=11%  Similarity=0.079  Sum_probs=62.4

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecCc---------eEEEEEee------cCCCCeeEEEEEEEEec-CeEEEEEE---
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYSP---------AIVTISTV------DSRKAQLVFKASVLTLD-NQTLLDFR---  370 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~~---------~~v~i~~~------d~rk~~l~~~~~i~~~~-~~~~v~f~---  370 (407)
                      |+..+-+||-.|..||+.||+.|++-++         ..|+++..      .+....+.+.+++|+|+ +.+||||+   
T Consensus         9 Srs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK~dg   88 (127)
T d2qrda1           9 CRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKSNG   88 (127)
T ss_dssp             EESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEEEE
T ss_pred             cCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEccCC
Confidence            7888999999999999999999987665         68999852      22344678999999997 99999997   


Q ss_pred             --eccCC--------------chHHHHHHHHHHHhhh
Q psy11119        371 --LSKGC--------------GIEFKTRFLCIKRALA  391 (407)
Q Consensus       371 --k~~Gd--------------~lE~~~~f~~~~~~l~  391 (407)
                        .+-|.              +.+|-.++.++-..|.
T Consensus        89 ~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~  125 (127)
T d2qrda1          89 YKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  125 (127)
T ss_dssp             EEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             cccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence              22222              4567777776555554

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=98.03  E-value=8.6e-06  Score=68.35  Aligned_cols=62  Identities=16%  Similarity=0.321  Sum_probs=48.5

Q ss_pred             EecCHHHHHHHHHHHHHHhCCeeeecC---ceEEEEEee-c---------CCCCeeEEEEEEEEec-CeEEEEEEe
Q psy11119        310 VKYTAEEAVEKLCMMLDKLGYSWRSYS---PAIVTISTV-D---------SRKAQLVFKASVLTLD-NQTLLDFRL  371 (407)
Q Consensus       310 s~~~~~~i~~~l~~~~~~l~~~~~~~~---~~~v~i~~~-d---------~rk~~l~~~~~i~~~~-~~~~v~f~k  371 (407)
                      |+..+-+||-.|..||+.||+.|++.+   ...|+++.. +         .....+.+.+++|+|+ +.+||||+-
T Consensus        52 Srs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK~  127 (171)
T d2qlva1          52 SRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKF  127 (171)
T ss_dssp             ECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEEE
T ss_pred             cCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEec
Confidence            678899999999999999999998765   478888852 1         1123578999999997 889999974

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.73  E-value=0.016  Score=52.43  Aligned_cols=31  Identities=29%  Similarity=0.368  Sum_probs=27.3

Q ss_pred             CCCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         23 KGIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        23 ~gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .|++|+|+.++||+++.+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3799999999999999887778999998753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=91.03  E-value=0.044  Score=47.67  Aligned_cols=30  Identities=20%  Similarity=0.254  Sum_probs=25.6

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|+.|.||+++.++..-|+||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            379999999999999766667999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=89.87  E-value=0.053  Score=46.89  Aligned_cols=30  Identities=20%  Similarity=0.184  Sum_probs=25.7

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            379999999999999776678999998753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=87.76  E-value=0.15  Score=46.09  Aligned_cols=27  Identities=22%  Similarity=0.096  Sum_probs=22.5

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCce
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLAT   52 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~   52 (407)
                      +++|+|+.|.|||++. + ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            6899999999999973 3 4589998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=86.32  E-value=0.13  Score=47.98  Aligned_cols=29  Identities=21%  Similarity=0.292  Sum_probs=25.1

Q ss_pred             CCeecCCCCCcEEEecCCcEEEEecCCcee
Q psy11119         24 GIAHRDLKPENVLLDLQDTLKISDFGLATV   53 (407)
Q Consensus        24 gIvHrDLkp~NILld~~g~lkL~DFGla~~   53 (407)
                      .++|+|++|.|||++.++ ++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            699999999999998654 89999988753